Citrus Sinensis ID: 012336
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 465 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.901 | 0.931 | 0.636 | 1e-154 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.634 | 0.709 | 0.752 | 1e-142 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.634 | 0.709 | 0.749 | 1e-141 | |
| P49674 | 416 | Casein kinase I isoform e | yes | no | 0.634 | 0.709 | 0.749 | 1e-141 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | no | no | 0.634 | 0.732 | 0.745 | 1e-140 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | no | no | 0.634 | 0.721 | 0.742 | 1e-140 | |
| Q06486 | 415 | Casein kinase I isoform d | no | no | 0.634 | 0.710 | 0.738 | 1e-140 | |
| Q9DC28 | 415 | Casein kinase I isoform d | no | no | 0.634 | 0.710 | 0.738 | 1e-140 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.634 | 0.710 | 0.738 | 1e-140 | |
| P48730 | 415 | Casein kinase I isoform d | no | no | 0.634 | 0.710 | 0.738 | 1e-140 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 545 bits (1405), Expect = e-154, Method: Compositional matrix adjust.
Identities = 282/443 (63%), Positives = 338/443 (76%), Gaps = 24/443 (5%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+ T EE+A+KLE+VKTKHPQL YESKLY +LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVP++KWFGVEG+YNV+V+DLLGPSLEDLFN+C+RK SLK+VLMLADQ+INRVE+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR++NQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKY++ISEKK+ T IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
C+ YPSEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREG+QFDYVFDWTILKY Q
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQ--- 297
Query: 301 SSRSRPSGKPNLNPA-GPSAERVERPSGQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHK 359
S + P + LNPA G SA P G DR+ G E H + SR +
Sbjct: 298 SQLTAPPSRA-LNPAVGTSA---ALPPGISNIDRYTGEEEGRP---------HMESSRRR 344
Query: 360 SSDDVPSSKDV--QPDSERPR-SLSRNSSSLKRAIMSGGRPSSSGDHSDNRSG--RLVSG 414
S + +S ++ QP S R S+ +SS ++ S R ++ DN G L+
Sbjct: 345 VSGALDNSGNISNQPTSSSARDSMIPSSSLFAQSAGSSRRVTAVSGSRDNFPGSEELLQR 404
Query: 415 SGSGRLS--TTQRAQPGYESKSS 435
S +G +S R PG KS+
Sbjct: 405 SRTGDVSRGVIPRNSPGEAGKST 427
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 504 bits (1298), Expect = e-142, Method: Compositional matrix adjust.
Identities = 222/295 (75%), Positives = 269/295 (91%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G K++LGRKIGSGSFG++YLG N+ TGEEVA+KLE VKTKHPQLH ESK Y ++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P +KW G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF++Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 503 bits (1296), Expect = e-141, Method: Compositional matrix adjust.
Identities = 221/295 (74%), Positives = 269/295 (91%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G K++LGRKIGSGSFG++YLG N+ +GEEVA+KLE VKTKHPQLH ESK Y ++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P +KW G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF++Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P49674|KC1E_HUMAN Casein kinase I isoform epsilon OS=Homo sapiens GN=CSNK1E PE=1 SV=1 | Back alignment and function description |
|---|
Score = 503 bits (1294), Expect = e-141, Method: Compositional matrix adjust.
Identities = 221/295 (74%), Positives = 269/295 (91%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G K++LGRKIGSGSFG++YLG N+ +GEEVA+KLE VKTKHPQLH ESK Y ++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P +KW G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF++Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 220/295 (74%), Positives = 269/295 (91%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ TGEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P +KW G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 219/295 (74%), Positives = 268/295 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ GEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P +KW G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 218/295 (73%), Positives = 268/295 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ GEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P ++W G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 498 bits (1282), Expect = e-140, Method: Compositional matrix adjust.
Identities = 218/295 (73%), Positives = 268/295 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ GEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P ++W G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1281), Expect = e-140, Method: Compositional matrix adjust.
Identities = 218/295 (73%), Positives = 267/295 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ EEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P +KW G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 498 bits (1281), Expect = e-140, Method: Compositional matrix adjust.
Identities = 218/295 (73%), Positives = 268/295 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ GEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P ++W G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 465 | ||||||
| 359477666 | 464 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.995 | 0.884 | 0.0 | |
| 224107441 | 462 | predicted protein [Populus trichocarpa] | 0.993 | 1.0 | 0.886 | 0.0 | |
| 225433171 | 456 | PREDICTED: casein kinase I isoform delta | 0.978 | 0.997 | 0.864 | 0.0 | |
| 224099929 | 463 | predicted protein [Populus trichocarpa] | 0.993 | 0.997 | 0.886 | 0.0 | |
| 255575881 | 463 | casein kinase, putative [Ricinus communi | 0.993 | 0.997 | 0.864 | 0.0 | |
| 449458832 | 463 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.997 | 0.849 | 0.0 | |
| 449432534 | 461 | PREDICTED: casein kinase I isoform delta | 0.989 | 0.997 | 0.860 | 0.0 | |
| 356576519 | 456 | PREDICTED: casein kinase I isoform delta | 0.980 | 1.0 | 0.860 | 0.0 | |
| 356535370 | 468 | PREDICTED: casein kinase I isoform delta | 0.991 | 0.985 | 0.834 | 0.0 | |
| 357441141 | 468 | Casein kinase I isoform delta-like prote | 0.991 | 0.985 | 0.834 | 0.0 |
| >gi|359477666|ref|XP_002285287.2| PREDICTED: casein kinase I isoform delta-like isoform 1 [Vitis vinifera] gi|296083671|emb|CBI23660.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/467 (88%), Positives = 437/467 (93%), Gaps = 5/467 (1%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIGSGSFGELYLG+NVQTGEEVAVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLEPVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVPHLKWFGVEGEYN MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGVPHLKWFGVEGEYNAMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRD QTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDFQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CKSYPSEFTSYFHYCRSLRF+DKPDYSYLKRLFRDLFIREGYQFDYVFDWT+LKYPQ GS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 301 SSRSR-PSGKPNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRH 358
SSR R PSGKP LNP GPSAER+ERPS GQE+RDRF+G +EAF+RRN SG G HGD SRH
Sbjct: 301 SSRVRQPSGKPALNP-GPSAERMERPSVGQEIRDRFSGAVEAFSRRNNSGSGYHGDQSRH 359
Query: 359 KSSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSG 418
+ S+DVPSSKDVQ DSERPRS SRN S+ KRA++S RPSSSG+ ++ R+ RLV SGSG
Sbjct: 360 RGSEDVPSSKDVQTDSERPRSSSRNGSTSKRAVVSSSRPSSSGEPTETRASRLV--SGSG 417
Query: 419 RLSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
RLSTTQR+QPG+ESKSSSF+R +A R GR+D LRSFELLTIGSGK+K
Sbjct: 418 RLSTTQRSQPGFESKSSSFTRASAARGGREDPLRSFELLTIGSGKKK 464
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224107441|ref|XP_002314480.1| predicted protein [Populus trichocarpa] gi|222863520|gb|EEF00651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2104), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/465 (88%), Positives = 435/465 (93%), Gaps = 3/465 (0%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKF+LGRKIGSGSFGELYLG+NVQ+GEEVAVKLESVKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFRLGRKIGSGSFGELYLGINVQSGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGL KKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD+ISEKKMLTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKMLTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CK+YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ GS
Sbjct: 241 CKNYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERPSGQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHKS 360
SSRSR SGKP +NP GPSAERVE PSGQE+RDRF+G +EAFAR+N++GH +H D SRH+S
Sbjct: 301 SSRSRLSGKPAVNP-GPSAERVEWPSGQEIRDRFSGAVEAFARKNSTGHAMHRDRSRHRS 359
Query: 361 SDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGRL 420
SDDVPSSKDV PDSERPRS SRN S+ KRA++S RPSSSG+ S+NRS RL S SGRL
Sbjct: 360 SDDVPSSKDVHPDSERPRSSSRNGSTSKRAVISSSRPSSSGEPSENRSSRL--ASSSGRL 417
Query: 421 STTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
STTQR QPG ESKSSSF+R ATR GRDD LRSFELL+IG GKRK
Sbjct: 418 STTQRIQPGLESKSSSFTRALATRGGRDDTLRSFELLSIGRGKRK 462
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433171|ref|XP_002285289.1| PREDICTED: casein kinase I isoform delta-like isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2093), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/466 (86%), Positives = 427/466 (91%), Gaps = 11/466 (2%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIGSGSFGELYLG+NVQTGEEVAVKLE VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLEPVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVPHLKWFGVEGEYN MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGVPHLKWFGVEGEYNAMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRD QTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDFQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CKSYPSEFTSYFHYCRSLRF+DKPDYSYLKRLFRDLFIREGYQFDYVFDWT+LKYPQ GS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHK 359
SSR RPSGKP LNP GPSAER+ERPS GQE+RDRF+G +EAF+RRN SG G HGD SRH+
Sbjct: 301 SSRVRPSGKPALNP-GPSAERMERPSVGQEIRDRFSGAVEAFSRRNNSGSGYHGDQSRHR 359
Query: 360 SSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGR 419
S+DVPSSKDV S N + KRA++S RPSSSG+ ++ R+ RLV SGSGR
Sbjct: 360 GSEDVPSSKDVV-------SCCNNKITSKRAVVSSSRPSSSGEPTETRASRLV--SGSGR 410
Query: 420 LSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
LSTTQR+QPG+ESKSSSF+R +A R GR+D LRSFELLTIGSGK+K
Sbjct: 411 LSTTQRSQPGFESKSSSFTRASAARGGREDPLRSFELLTIGSGKKK 456
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099929|ref|XP_002311677.1| predicted protein [Populus trichocarpa] gi|222851497|gb|EEE89044.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 809 bits (2089), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/466 (88%), Positives = 435/466 (93%), Gaps = 4/466 (0%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIGSGSFGELYLG+NVQ+GEEVAVKLESVKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGINVQSGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVE +YN MVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEVDYNAMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG+KAG KKQKYDKISEKKML PIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGMKAGNKKQKYDKISEKKMLVPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CK+YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ GS
Sbjct: 241 CKNYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHK 359
SSRSRPSGKP + P GPSAERVERPS GQEVRDRF+GG+EAFARRN+SGH LH D SRH+
Sbjct: 301 SSRSRPSGKPAVYP-GPSAERVERPSVGQEVRDRFSGGVEAFARRNSSGHALHSDQSRHR 359
Query: 360 SSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGR 419
SSDD PSSKDV PDSERPRS SRN S+ KRA+MS RPSSSG+ S+NRS RLV S SGR
Sbjct: 360 SSDDAPSSKDVHPDSERPRSSSRNGSTSKRAVMSSSRPSSSGEPSENRSSRLV--SSSGR 417
Query: 420 LSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
LSTTQR QPG+ESKSSSF+R +AT GR + LRSFELL+IG+GKRK
Sbjct: 418 LSTTQRVQPGFESKSSSFTRASATSGGRVNTLRSFELLSIGTGKRK 463
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255575881|ref|XP_002528838.1| casein kinase, putative [Ricinus communis] gi|223531750|gb|EEF33572.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/466 (86%), Positives = 432/466 (92%), Gaps = 4/466 (0%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MD +IGGKFKLGRKIGSGSFGELYLG+NVQ+GEEVAVKLES KTKHPQLHYESKLY+LLQ
Sbjct: 1 MDVLIGGKFKLGRKIGSGSFGELYLGINVQSGEEVAVKLESAKTKHPQLHYESKLYVLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEG+YNVM IDLLGPSLEDLFNYCNRKFSLKTVLMLADQL+NRVE+MH
Sbjct: 61 GGTGIPHLKWFGVEGDYNVMAIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLLNRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKY+DLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYKDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEFL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CK+YPSEFTSYFHYCRSLRFED PDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ GS
Sbjct: 241 CKNYPSEFTSYFHYCRSLRFEDAPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHK 359
SSR+RP KP +NP GPSAER ERPS GQE+RDRF+G +EAFARRN SGH LHGDHSRH+
Sbjct: 301 SSRARPISKPAVNP-GPSAERTERPSVGQEIRDRFSGAVEAFARRNGSGHALHGDHSRHR 359
Query: 360 SSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGR 419
SSDDVPSSKDV DSERPRS SRN S+ KRA++S RPSSSG+ +++RS S SGR
Sbjct: 360 SSDDVPSSKDVHLDSERPRSSSRNGSTSKRAVISSSRPSSSGEPTESRS--SRLLSSSGR 417
Query: 420 LSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
LSTT R QPG+ESKSSSF+R AATRS RDDALRSFELL++G+GKRK
Sbjct: 418 LSTTHRVQPGFESKSSSFTRAAATRSSRDDALRSFELLSMGTGKRK 463
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458832|ref|XP_004147150.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] gi|449498610|ref|XP_004160583.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2017), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/466 (84%), Positives = 424/466 (90%), Gaps = 4/466 (0%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+HVIGGKFKLGRKIGSGSFGELYLG NVQT EEVAVKLESVKTKHPQLHYESKLYMLLQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGTNVQTEEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGL KKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL+AGTKKQKYDKISEKKMLTPIEVL
Sbjct: 181 SINTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLRAGTKKQKYDKISEKKMLTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CKSYP+EFTSYFHYCR+LRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ GS
Sbjct: 241 CKSYPTEFTSYFHYCRALRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERP-SGQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHK 359
SSR+RP+GK + P GPSAERVERP GQ++RD+F+G +EAFARRN +G GLH DHSRH+
Sbjct: 301 SSRTRPTGKAAITP-GPSAERVERPLVGQDLRDKFSGPVEAFARRNGTGIGLHSDHSRHR 359
Query: 360 SSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGR 419
SSDDVPSSKDVQPD+ER RS SR S+ KR I+S RPSSSG+ S+ RS + S S
Sbjct: 360 SSDDVPSSKDVQPDAERARSSSRQGSASKRPILSSSRPSSSGEPSELRS-SRLFSSSSRL 418
Query: 420 LSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
+TQR QPG ESK SSF R +AT+ RDDALRSFELLTIG+GK+K
Sbjct: 419 SGSTQRIQPGVESK-SSFLRSSATKGSRDDALRSFELLTIGTGKKK 463
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432534|ref|XP_004134054.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2013), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/466 (86%), Positives = 427/466 (91%), Gaps = 6/466 (1%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+H+IGGKFKLGRKIGSGSFGELYLG NVQTGEEVAVKLES KTKHPQLHYESKLYMLLQ
Sbjct: 1 MEHIIGGKFKLGRKIGSGSFGELYLGTNVQTGEEVAVKLESAKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEG+YNVMVIDLLGPSLEDLFNYCNRK SLK+VLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKSVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ GS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVER-PSGQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHK 359
SS++RPSGKP P GPSAER E+ P GQE+RDR+ GG EAF RRN SGH LHGDHSRH+
Sbjct: 301 SSKARPSGKPGHTP-GPSAERGEKHPVGQEIRDRYPGGAEAFGRRNASGH-LHGDHSRHR 358
Query: 360 SSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGR 419
SDDVPSSKDVQPDSER RS RN S KR ++S RPSSSG+ S+ RS RLV S S R
Sbjct: 359 -SDDVPSSKDVQPDSERGRSSYRNGSISKRPVLSSSRPSSSGEPSEIRSSRLV--SASSR 415
Query: 420 LSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
LS QR QPG+ESK+++F+R + T+ GRDDALRSFELL+IG+GKRK
Sbjct: 416 LSAGQRVQPGFESKTTTFTRSSTTKGGRDDALRSFELLSIGTGKRK 461
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576519|ref|XP_003556378.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2003), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/465 (86%), Positives = 427/465 (91%), Gaps = 9/465 (1%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIGSGSFGELYLGVNVQ+GEEVAVKLESVKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQSGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEG+YNVMVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGY+LMYFLRGSLPWQGL+AGTKKQKYDKISEKKMLTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYLLMYFLRGSLPWQGLRAGTKKQKYDKISEKKMLTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CKSYP EFTSYFHYCR+LRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT+LKYPQ GS
Sbjct: 241 CKSYPLEFTSYFHYCRTLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTMLKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERPSGQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHKS 360
SSR+RPSGKP +NP G S ER+ERPSG F+G +EAFARRN SG L +HSRH+S
Sbjct: 301 SSRARPSGKPVINP-GQSGERIERPSGG-----FSGAVEAFARRNGSGLVLQSEHSRHRS 354
Query: 361 SDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGSGSGRL 420
SDDVPSSKDVQ DSERPRS SRN SS K+ ++S RPSSSG+ S++R+ RLV SGRL
Sbjct: 355 SDDVPSSKDVQADSERPRSSSRNGSSSKKPVLSSSRPSSSGEPSESRTSRLV--LSSGRL 412
Query: 421 STTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
STTQR QPG+ESK +S SR +ATR GRDD LRSFELL++GSGKRK
Sbjct: 413 STTQRLQPGFESK-TSLSRASATRGGRDDTLRSFELLSLGSGKRK 456
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356535370|ref|XP_003536219.1| PREDICTED: casein kinase I isoform delta-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/472 (83%), Positives = 416/472 (88%), Gaps = 11/472 (2%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIGSGSFGELYLGVNVQ+GEEVAVKLESVKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQSGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEG+YNVMVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL+AGTKKQKYDKISEKKMLTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLRAGTKKQKYDKISEKKMLTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
CKSYP EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT+LKYPQ GS
Sbjct: 241 CKSYPLEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTMLKYPQIGS 300
Query: 301 SSRSRPSGKPNLNPAGPSAERVERPSG-------QEVRDRFAGGIEAFARRNTSGHGLHG 353
SSR+RPSGKP +NP G S ER+ERPSG V F+G +EAFARRN SG LH
Sbjct: 301 SSRARPSGKPVINP-GQSGERIERPSGFHQQKIFTYVFGGFSGAVEAFARRNGSGLVLHS 359
Query: 354 DHSRHKSSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVS 413
+ SRHKSSDDVPSSKDVQ +SERPRS SRN SS K+ ++S S + S
Sbjct: 360 ELSRHKSSDDVPSSKDVQANSERPRSSSRNGSSSKKPVLS--SSRPSSSGEPSESRSSRL 417
Query: 414 GSGSGRLSTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
SGRLSTTQR QPG+ESK +S SR +ATR GRDD LRSFELL++GSGKRK
Sbjct: 418 VLSSGRLSTTQRLQPGFESK-TSLSRASATRGGRDDTLRSFELLSLGSGKRK 468
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357441141|ref|XP_003590848.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355479896|gb|AES61099.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 393/471 (83%), Positives = 424/471 (90%), Gaps = 10/471 (2%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIG GSFGELYLGVN+QTGEEVA+KLE KTKHPQLHYESKLYMLLQ
Sbjct: 2 MDHVIGGKFKLGRKIGGGSFGELYLGVNIQTGEEVALKLEPAKTKHPQLHYESKLYMLLQ 61
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEG+YN M IDLLGPSLEDLFNYCNRKFSLKTVLMLADQL+NRVEYMH
Sbjct: 62 GGTGIPHLKWFGVEGDYNAMAIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLLNRVEYMH 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKK+RDL THKHIPYRENKNLTGTARYA
Sbjct: 122 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKFRDLHTHKHIPYRENKNLTGTARYA 181
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE-- 238
SVNTHLGVEQSRRDDLESLG+VLMYFLRGSLPWQGLKAG KKQKYDKISEKKMLTP+E
Sbjct: 182 SVNTHLGVEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGNKKQKYDKISEKKMLTPVEVL 241
Query: 239 --VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296
VLCKS+P EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP
Sbjct: 242 QPVLCKSHPLEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 301
Query: 297 QTGSSSRSRPSGKPNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDH 355
Q GSSSR+RPSGKP +NP G S ERVERPS G E+RDRF+G ++AFARRN SGHG+HGDH
Sbjct: 302 QIGSSSRARPSGKPVINP-GQSGERVERPSGGPEIRDRFSGAVQAFARRNGSGHGVHGDH 360
Query: 356 SRHKSSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLVSGS 415
SRH+SSD+ PSSKDVQ DSERPRS SR+ SS KR ++S RP+SSG+ S++RS
Sbjct: 361 SRHRSSDE-PSSKDVQADSERPRSSSRHGSSSKRPVLSSSRPNSSGEPSESRS--SRLLL 417
Query: 416 GSGRLSTTQRAQPGYESKSSSF-SRGAATRSGRDDALRSFELLTIGSGKRK 465
S RLSTTQR QPG ESKSSSF +R + R GRDD LRSFELL++G+GKRK
Sbjct: 418 SSSRLSTTQRTQPGLESKSSSFNNRASGARGGRDDTLRSFELLSLGTGKRK 468
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 465 | ||||||
| TAIR|locus:2129640 | 457 | CKI1 "casein kinase I" [Arabid | 0.965 | 0.982 | 0.712 | 1.8e-174 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.920 | 0.968 | 0.727 | 1.7e-171 | |
| TAIR|locus:2176431 | 480 | ckl8 "casein kinase I-like 8" | 0.995 | 0.964 | 0.682 | 5.6e-171 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.987 | 0.958 | 0.687 | 5.8e-169 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.980 | 0.984 | 0.690 | 2e-168 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.980 | 0.968 | 0.694 | 1.1e-167 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.980 | 0.984 | 0.688 | 1.8e-167 | |
| TAIR|locus:2018269 | 468 | CKL13 "casein kinase like 13" | 0.993 | 0.987 | 0.675 | 6.8e-166 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.984 | 0.962 | 0.675 | 8.7e-166 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.733 | 0.757 | 0.728 | 2.1e-141 |
| TAIR|locus:2129640 CKI1 "casein kinase I" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1695 (601.7 bits), Expect = 1.8e-174, P = 1.8e-174
Identities = 332/466 (71%), Positives = 359/466 (77%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRK+GSGSFGELYLG+N+QTGEEVAVKLE VKT+HPQL YESK+YM LQ
Sbjct: 7 MDHVIGGKFKLGRKLGSGSFGELYLGINIQTGEEVAVKLEPVKTRHPQLQYESKIYMFLQ 66
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVPHLKWFGVEGEY+ MVIDLLGPSLEDLFNYC R FSLK+VLMLADQLI RVEYMH
Sbjct: 67 GGTGVPHLKWFGVEGEYSCMVIDLLGPSLEDLFNYCKRIFSLKSVLMLADQLICRVEYMH 126
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGR++NQVYIIDYGLAKKY+DLQT KHIPYRENKNLTGTARYA
Sbjct: 127 SRGFLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYKDLQTQKHIPYRENKNLTGTARYA 186
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT +E L
Sbjct: 187 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTSVETL 246
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CKSYPSEFTSYFHYCRSLRFEDKPDYSYL+RLFRDLFIREGYQ DYVFDWTI KYPQ
Sbjct: 247 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLRRLFRDLFIREGYQLDYVFDWTISKYPQIGS 306
Query: 301 XXXXXXXXXXNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHX 359
L+P GP AER E+P+ GQ++R RF G IEAF RRN S G GD SRH
Sbjct: 307 SSRPRPTPRPALDPPGPPAERAEKPTVGQDLRGRFTGAIEAFTRRNVSSQGALGDRSRHR 366
Query: 360 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAIMSGGRPSSSGDHSDNXXXXXXXXXXXXX 419
++S RP SS + S+N
Sbjct: 367 SSDDIPSSAKEVHESRNGSTSKR-------GVISSTRPGSSAEPSENHSSRLFSSGSRHA 419
Query: 420 XXTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
TTQR YES AA R G +DA+R+FELLTIGSGK++
Sbjct: 420 --TTQRVPQSYES-------AAAARPGHEDAIRNFELLTIGSGKKR 456
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1667 (591.9 bits), Expect = 1.7e-171, P = 1.7e-171
Identities = 325/447 (72%), Positives = 352/447 (78%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MDHVIGGKFKLGRKIGSGSFGELY+G+NVQTGEEVA+KLE VKTKHPQLHYESK+YMLLQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVPH+KWFGVEG YN M IDLLGPSLEDLFNYC R FSLKTVLMLADQLINRVEYMH
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLG+EQSRRDDLESLGYVLMYF+RGSLPWQGLKAGTKKQKY+KISEKKMLTP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ+
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQSGS 300
Query: 301 XXXXXXXXXXNLNPAGPSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHX 359
L+P GPSAER E+P GQ++R+RF+G +EAFARRN HG+ H
Sbjct: 301 ISKPRPNPKPALDPPGPSAERNEKPIVGQDLRERFSGAVEAFARRNVPSHGIRPKH---- 356
Query: 360 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAIMSGGRPSSSGDHSDNXXXXXXXXXXXXX 419
A+MS +P SSG+ S+N
Sbjct: 357 ------IFSDDASKEVQVSEKTRNEIATKMAVMSSSQPGSSGELSENRSSKLFSS----- 405
Query: 420 XXTTQRAQPGYESK-SSSFSRGAATRS 445
+ Q+ QP E+K S+ R RS
Sbjct: 406 --SAQKIQPVQETKLSARLGRDDGLRS 430
|
|
| TAIR|locus:2176431 ckl8 "casein kinase I-like 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1662 (590.1 bits), Expect = 5.6e-171, P = 5.6e-171
Identities = 329/482 (68%), Positives = 366/482 (75%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MD V+GGK+KLGRK+GSGSFGEL+LGVNVQTGEEVAVKLE + +HPQLHYESKLYMLLQ
Sbjct: 1 MDRVVGGKYKLGRKLGSGSFGELFLGVNVQTGEEVAVKLEPARARHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKW+GVEGEYN MVIDLLGPS+EDLFNYC+R+F+LKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWYGVEGEYNCMVIDLLGPSMEDLFNYCSRRFNLKTVLMLADQMINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
RGFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTH+HIPYRENKNLTGTARYA
Sbjct: 121 VRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGL+AGTKKQKYDKISEKK LTP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLRAGTKKQKYDKISEKKRLTPVEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CKS+P EFTSYF Y RSLRFEDKPDY YLKRLFRDLFIREGYQFDYVFDWTILKYPQ
Sbjct: 241 CKSFPPEFTSYFLYVRSLRFEDKPDYPYLKRLFRDLFIREGYQFDYVFDWTILKYPQFSS 300
Query: 301 XXXXXXXXXXNL----NPAGPSAERVERPS---GQEVRDRFAGGIEAFARRNTSGHGL-H 352
+L NP P AER ++PS GQ+ RDRF+G +EA+ARRN SG G+
Sbjct: 301 GSSSSSKPRSSLRPAMNPPVPIAERPDKPSAGAGQDSRDRFSGALEAYARRNGSGSGVVQ 360
Query: 353 GDHSRHXXXXXXXXXXXXXXXXXXXX-----XXXXXXXXXXXAIMSGGRPSSSGDHSDNX 407
D SR A++S R +SS D ++N
Sbjct: 361 ADRSRPRTSENVLASSKDTTPQNYERVERPISSTRHASSSRKAVVSSVRATSSADFTENR 420
Query: 408 XXXXXXXXXXXXXXTTQRAQ----PGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGK 463
T QR Q P SSSF+R A +R+ RD L+SFELLTIG+GK
Sbjct: 421 SSRVVPSNGRSS--TAQRTQLVPDPTTRPSSSSFTRAAPSRTARDITLQSFELLTIGNGK 478
Query: 464 RK 465
RK
Sbjct: 479 RK 480
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1643 (583.4 bits), Expect = 5.8e-169, P = 5.8e-169
Identities = 325/473 (68%), Positives = 363/473 (76%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MD+VIGGKFKLGRKIG GSFGEL+L V++QTGEE AVKLE KTKHPQLHYESK+YMLLQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG+G+P LKWFGV+G+YN MVIDLLGPSLEDLFNYCNR+ +LK VLMLADQLI+RVEYMH
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRK+NQVYIID+GLAKKYRDLQTH+HIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD+ISEKK+ TPIEVL
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CKSYP EF SYF YCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT LK+PQ+
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQSSA 304
Query: 301 XXXXXXXXXXNLN-P---AGPSAERVERPSGQEVRDRFAGGIEAFARRNTSGHGLHGDHS 356
P AGPSAE+ ER S +RD+F+G +EAFARRN G H +H+
Sbjct: 305 RSHSSTHERHRTGKPGMGAGPSAEKPERISVGNIRDKFSGAVEAFARRNVRGPSPHQNHT 364
Query: 357 RHXXXXXXXXXX-XXXXXXXXXXXXXXXXXXXXXAIMSGGRPSSSGDHSDNXXXXXXXXX 415
RH A+ SG RPSSSG+ ++
Sbjct: 365 RHRTLDEIPSMKPAVNMVSEKGRNTSRYGSASRRAVASGSRPSSSGEQRESRDSSRVASS 424
Query: 416 XXXXXXTT-QRAQP-----GYESKSSS-FSRG--AATRSGRDDALRSFELLTI 459
+ QR Q GYESK++S F+R AA+R+ RD+ALRSFELL+I
Sbjct: 425 GGGVRPSVFQRTQAAAAVSGYESKTASAFNRDRVAASRTARDEALRSFELLSI 477
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1638 (581.7 bits), Expect = 2.0e-168, P = 2.0e-168
Identities = 326/472 (69%), Positives = 362/472 (76%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+HVIGGKFKLGRKIGSGSFGELYLGVN+Q+ EEVA+KLESVK++HPQLHYESKLYMLLQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRK++QVY+IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CKSYP+EF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ DY+FDWT +
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT-----KQGS 295
Query: 301 XXXXXXXXXXNLNPAGPSAERVERPSG-QEVRDRFAGGIEAFARRNTSGHGLHGDHSRHX 359
GPSAER ER + Q+V DRF+G ++ FARR SG G +G+H++H
Sbjct: 296 ESNRLRSSGRTSGLVGPSAERTERAAARQDVPDRFSGTVDPFARRTGSGSGHYGEHTKHR 355
Query: 360 XXXXXXXXXXXXXXXXXX--XXXXXXXXXXXXAIMSGGRPSSSGDHSD-NXXXXXXXXXX 416
A++S RPSS GD D N
Sbjct: 356 NILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKALLSSSRPSS-GDPIDPNRSNLIPTSSG 414
Query: 417 XXXXXTTQRAQP--GYESKSSSFSRGAATRSGRDD-ALRSFELLTIGSGKRK 465
T QR G E++SS ++ A R+ DD LR+FE L+I + +RK
Sbjct: 415 SSRPSTMQRLHQSTGLETRSS-LTKTA--RNVHDDPTLRTFERLSISADRRK 463
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
Identities = 328/472 (69%), Positives = 362/472 (76%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MD VIGGKFKLGRKIGSGSFGELYLG+NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVP+LKW+GVEG+YNVMVIDLLGPSLEDLFNYCNRK SLKTVLMLADQLINRVE+MH
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRK+NQVYIID+GL KKYRDLQTH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGTKKQKYD+ISEKK+ TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ--T 298
CK+ PSEF SYF YCRSLRF+DKPDYSYLKRLFRDLFIREGYQFDYVFDWT+LKYPQ +
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 299 XXXXXXXXXXXXNLNP---AGPSAERVERPSGQEVRD-RFAGGIEAFARRNTSGHGLHGD 354
NP AG S E+ ER +G+E R+ RF+G +EAF+RR+ + D
Sbjct: 301 SSGSSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHPATSTTR-D 359
Query: 355 HSRHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAIMSGGRPSSSGDHSDNXXXXXXXX 414
S AI S RPSS+G SD+
Sbjct: 360 RSASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRRAIPSSSRPSSAGGPSDSRSSSRLVT 419
Query: 415 XX------XXXXXTTQRAQPGYESKSSSFSRGAATRSGRDDALR-SFELLTI 459
T+QR Q G ES++SSFSR A R+ R+D LR S ELLT+
Sbjct: 420 STGGVGTVSNRASTSQRIQAGNESRTSSFSRAA--RNTREDPLRRSLELLTL 469
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1629 (578.5 bits), Expect = 1.8e-167, P = 1.8e-167
Identities = 325/472 (68%), Positives = 361/472 (76%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+HVIGGKFKLGRKIGSGSFGELYLGVN+Q+ EEVA+KLESVK++HPQLHYESKLYMLLQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRK++QVY+IDY LAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CKSYP+EF SYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ DY+FDWT +
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT-----KQGS 295
Query: 301 XXXXXXXXXXNLNPAGPSAERVERPSG-QEVRDRFAGGIEAFARRNTSGHGLHGDHSRHX 359
GPSAER ER + Q+V DRF+G ++ FARR SG G +G+H++H
Sbjct: 296 ESNRLRSSGRTSGLVGPSAERTERAAARQDVPDRFSGTVDPFARRTGSGSGHYGEHTKHR 355
Query: 360 XXXXXXXXXXXXXXXXXX--XXXXXXXXXXXXAIMSGGRPSSSGDHSD-NXXXXXXXXXX 416
A++S RPSS GD D N
Sbjct: 356 NILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKALLSSSRPSS-GDPIDPNRSNLIPTSSG 414
Query: 417 XXXXXTTQRAQP--GYESKSSSFSRGAATRSGRDD-ALRSFELLTIGSGKRK 465
T QR G E++SS ++ A R+ DD LR+FE L+I + +RK
Sbjct: 415 SSRPSTMQRLHQSTGLETRSS-LTKTA--RNVHDDPTLRTFERLSISADRRK 463
|
|
| TAIR|locus:2018269 CKL13 "casein kinase like 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1614 (573.2 bits), Expect = 6.8e-166, P = 6.8e-166
Identities = 318/471 (67%), Positives = 357/471 (75%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MD V+GGKFKLGRK+GSGSFGE++LGVNVQTGEEVAVKLE ++ +HPQLHYESKLYMLLQ
Sbjct: 1 MDRVVGGKFKLGRKLGSGSFGEIFLGVNVQTGEEVAVKLEPLRARHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+PHLKWFGVEGE+N MVIDLLGPS+E+ FNYC+R FSLKTVLMLADQ+INRVEYMH
Sbjct: 61 GGTGIPHLKWFGVEGEFNCMVIDLLGPSMEEFFNYCSRSFSLKTVLMLADQMINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
+GFLHRDIKPDNFLMGLGRK+NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 VKGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLG+EQSRRDDLESLGY+LMYFLRGSLPWQGL+AGTKKQKYDKISEKK LTP+EVL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYLLMYFLRGSLPWQGLRAGTKKQKYDKISEKKRLTPVEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
CK++P EFTSYF Y RSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL+YPQ
Sbjct: 241 CKNFPPEFTSYFLYVRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILRYPQFGS 300
Query: 301 XXXXXXXXXXNLNPAG----PSAERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDH 355
L PA PSA++ E+P GQ+ R+RF+G EA+ RRN SG G+ D
Sbjct: 301 SSSSNSKPRPTLRPAMNIPVPSADKAEKPPIGQDSRERFSGVFEAYTRRNGSGTGVQADQ 360
Query: 356 SRHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAIM-SGGRPSSSGDHSDNXXXXXXXX 414
S AI S R +SS D ++N
Sbjct: 361 SSRPRTSENVLASKDTQNQERPNSLSRNLSSSRKAIAGSSVRATSSADFTENRLSRLIPN 420
Query: 415 XXXXXXXTTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKRK 465
TT R Q S SS ++ A TR+ RD L+S ELL+IG+ KRK
Sbjct: 421 NDRSS--TTLRTQFA-PSSSSVATKAAPTRAARDITLQSLELLSIGNSKRK 468
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1613 (572.9 bits), Expect = 8.7e-166, P = 8.7e-166
Identities = 321/475 (67%), Positives = 358/475 (75%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
MD VIGGKFKLG+KIGSGSFGELYLGVNVQTGEEVAVKLE+VKTKHPQLHYESKLYMLLQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG+G+P++KWFGVEG+Y+VMVIDLLGPSLEDLFNYCNRK +LKTVLMLADQL+NRVE+MH
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRK+NQVYIID+GL KKYRDLQTHKHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLGVEQSRRDDLESLGYVLMYFL+GSLPWQGLKAGTKKQKYD+ISEKK+ TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ--T 298
CK+ PSEF SYFHYCRSLRF+DKPDYSYLKRLFRDLFIREGYQFDYVFDWT+LKYPQ +
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 299 XXXXXXXXXXXXNLNP---AGPSAERVERPSGQEV-RDRFAGGIEAFARRN--TSGHGLH 352
P A P ER ER G+E R + G +EAF+RR+ T+
Sbjct: 301 SSGSSSRTRHHTTAKPGFNADP-IERQERILGKETTRYKIPGAVEAFSRRHPTTTSSPRD 359
Query: 353 GDHSRHXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXAIMSGGRPSSSGDHSDNXXXXXX 412
SR+ S RPSS+G S++
Sbjct: 360 RSRSRNSDDGPFSKQTHGDSERANSSSRYRASSSRKAVAASSSRPSSAGGPSESRTSSRL 419
Query: 413 XXXXXXXXX--------TTQRAQPGYESKSSSFSRGAATRSGRDDALRSFELLTI 459
T+QR Q GYESK+ SFSR A R+ R+D LRSFELL++
Sbjct: 420 VSSSGGGGSGSGNGRPSTSQRVQAGYESKTLSFSRATAARNTREDQLRSFELLSL 474
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1367 (486.3 bits), Expect = 2.1e-141, Sum P(2) = 2.1e-141
Identities = 258/354 (72%), Positives = 298/354 (84%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+ T EE+A+KLE+VKTKHPQL YESKLY +LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTGVP++KWFGVEG+YNV+V+DLLGPSLEDLFN+C+RK SLK+VLMLADQ+INRVE+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR++NQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKY++ISEKK+ T IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTXX 300
C+ YPSEF SYFHYCRSLRF+DKPDY+YLKR+FRDLFIREG+QFDYVFDWTILKY Q+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 XXXXXXXXXXNLNPA-GPSAERVERPSGQEVRDRFAGGIEA-----FARRNTSG 348
LNPA G SA P G DR+ G E +RR SG
Sbjct: 301 TAPPSRA----LNPAVGTSAAL---PPGISNIDRYTGEEEGRPHMESSRRRVSG 347
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.6734 | 0.6322 | 0.6901 | yes | no |
| P49674 | KC1E_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7491 | 0.6344 | 0.7091 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7213 | 0.6559 | 0.9413 | N/A | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6310 | 0.6924 | 0.9442 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7322 | 0.6344 | 0.7108 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7328 | 0.6279 | 0.8 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6881 | 0.6344 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6723 | 0.6301 | 0.9071 | yes | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7525 | 0.6344 | 0.7091 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7474 | 0.6301 | 0.8746 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7389 | 0.6344 | 0.7108 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7491 | 0.6344 | 0.7091 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00020288001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (464 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 465 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-19 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-11 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-10 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-09 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-05 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-05 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 7e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-05 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-04 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-04 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 0.001 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.001 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 0.002 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.002 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.002 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.002 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.003 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.003 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.003 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.003 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.003 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.004 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.004 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 0.004 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-44
Identities = 67/254 (26%), Positives = 108/254 (42%), Gaps = 21/254 (8%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY----ESKLYMLLQGGTG 64
++L RK+GSGSFG +Y + TG+ VAVK+ +++ + E ++ L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSR 122
V + F + ++ +V++ DLF+Y S +A Q++ +EY+HS
Sbjct: 61 VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
G +HRD+KP+N L+ ++ V I D+GLAKK GT Y +
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167
Query: 183 NTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
LG + D+ SLG +L L G P+ G + Q +I +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 242 KSYPSEFTSYFHYC 255
S E C
Sbjct: 228 -SGSEEAKDLIKKC 240
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-33
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY---ESKLYMLLQGGTGVPHLKWF 71
+G G FG +YL + +TG++VA+K+ + L E ++ L + L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGV 59
Query: 72 GVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 130
+ + +V++ G SL+DL K S +L + Q++ +EY+HS G +HRD+K
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 131 PDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VE 189
P+N L L + +V + D+GL+K K + GT Y + LG
Sbjct: 120 PENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 190 QSRRDDLESLGYVLMYFL 207
S + D+ SLG V++Y L
Sbjct: 171 YSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 7e-32
Identities = 94/390 (24%), Positives = 146/390 (37%), Gaps = 22/390 (5%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQT--GEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV 65
+++ RK+G GSFGE+YL + + + +A KLES + + E ++ L +
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 66 PHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSR 122
L F + +V++ + G SLEDL S L + Q+++ +EY+HS+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
G +HRDIKP+N L L R V +ID+GLAK D + IP + ++ GT Y +
Sbjct: 121 GIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAP 177
Query: 183 NTHLGVEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYDKISEKKMLTPIE 238
LG+ S D+ SLG L L G P++G K Q I E +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 239 VLCKSYPSEFTSYFH--YCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296
L S P + + L + K S L DL D + L P
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL---KLKESDLSDLLKP 294
Query: 297 QTGSSSRSRPSGKPNLNPAGPSAERVERPSGQEVRDRFAGGIEAFARRNTSGHGLHGDHS 356
+ R + + + + + S
Sbjct: 295 DDSAPLR-----LSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSS 349
Query: 357 RHKSSDDVPSSKDVQPDSERPRSLSRNSSS 386
S + S R S +SSS
Sbjct: 350 SLLLSTASSKRSSLPKISARSSPSSLSSSS 379
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 60/234 (25%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGV 65
+++ K+G GSFG++YL + +TG+ VA+K + +K ++ E K+ L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PH----LKWFGVEGEYNVMVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYM 119
P+ F + + +V++ DLF+ + S Q+++ +EY+
Sbjct: 57 PNIVRLYDVF-EDEDKLYLVMEYC--EGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
HS+G +HRD+KP+N L+ + V + D+GLA++ + GT Y
Sbjct: 114 HSKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKLTT--------FVGTPEY 162
Query: 180 ASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKK 232
+ LG + D+ SLG V++Y L G P+ G + + KI + K
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPK 213
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 22/220 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTK-HPQLHYESKLYMLLQGGT 63
+++ G KIG G+FG++Y VN+ TGE +AVK ++ K ++ E K+ LL+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GVPHL-KWFGVEGEYNVMVIDL---LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
P+L K++GVE + I + G +LE+L + R + + QL+ + Y+
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
HS G +HRDIKP N + + + + D+G A K L+ + E ++L GT Y
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVK---LKNNTTTMGEEVQSLAGTPAY 169
Query: 180 ASVNTHLGVEQS---RRDDLESLGYVLMYFLRGSLPWQGL 216
+ G + R D+ SLG V++ G PW L
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 4e-22
Identities = 81/294 (27%), Positives = 131/294 (44%), Gaps = 33/294 (11%)
Query: 4 VIGGKFKLGRKIGSGSFGELY---LGVNVQTGEEVAVKLESVKTKHPQLH-------YES 53
+ G ++K+ + IG G FG +Y + + K+E+++ + + Y+
Sbjct: 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDI 68
Query: 54 KLYMLLQGGTGVPHL---KWFGVEG-EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLA 109
L + + HL K++G + M + LE L N K K +
Sbjct: 69 DKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI--LLEKL--VENTKEIFKRIKCKN 124
Query: 110 DQLINRV--------EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
+LI + EY+H G H DIKP+N ++ +N+ YIIDYG+A + +
Sbjct: 125 KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---GNNRGYIIDYGIASHF--IIH 179
Query: 162 HKHIPY-RENKNL-TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
KHI Y +E K+L GT YA ++ H G +RR DLESLGY ++ + LPW+G
Sbjct: 180 GKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239
Query: 220 TKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273
K K L ++ K+ + L +E+KPDY L ++F
Sbjct: 240 GNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 70/263 (26%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL------------ESVK---------TKHP 47
FK G+ IG GSF + L +T +E A+K+ + VK HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 48 ---QLHY----ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKF 100
+L+Y E LY +L+ + GE L
Sbjct: 63 GIIKLYYTFQDEENLYFVLE----------YAPNGE------------LLQYIRK-YGSL 99
Query: 101 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK------ 154
K A +++ +EY+HS+G +HRD+KP+N L+ K + I D+G AK
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS 156
Query: 155 -------KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL 207
++ + R + GTA Y S + DL +LG ++ L
Sbjct: 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
Query: 208 RGSLPWQGLKAGTKKQKYDKISE 230
G P++G + + KI +
Sbjct: 217 TGKPPFRG---SNEYLTFQKILK 236
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP------QLHYESKLYMLLQG 61
++ G +G GSFG +YL ++ TGE +AVK SV+ L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVK--SVELSGDSEEELEALEREIRILSSLQH 58
Query: 62 GTGVPHL-KWFGVEGEYNVMVIDLL-----GPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
P++ +++G E + +++ G SL L K + Q++
Sbjct: 59 ----PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEG 113
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
+ Y+HS G +HRDIK N L+ V + D+G AK+ D++T + ++ G
Sbjct: 114 LAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIETGE-----GTGSVRG 165
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
T + + G E R D+ SLG ++ G PW
Sbjct: 166 TPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 48/171 (28%), Positives = 90/171 (52%), Gaps = 20/171 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
F++ KIG G FGE+Y + +TG+EVA+K+ +++K + +++ +L + H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKK----CKH 56
Query: 68 ---LKWFG---VEGEYNVMVI--DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
+K++G + E + ++ G SL+DL N+ + + + +L+ +EY+
Sbjct: 57 PNIVKYYGSYLKKDE--LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI---PY 167
HS G +HRDIK N L+ +V +ID+GL+ + D + + PY
Sbjct: 115 HSNGIIHRDIKAANILLTS---DGEVKLIDFGLSAQLSDTKARNTMVGTPY 162
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGT 63
++K+ +IG G+ G ++ + +TGE VA+K +++ Q E K Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
V L F G V+V++ + L ++ R V L+ V YMH+ G
Sbjct: 61 VVKLLDVF-PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY----RDLQTHKHIP--YRENKNLTGTA 177
+HRD+KP N L+ + I D+GLA+ + L +H+ YR + L G
Sbjct: 120 IMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176
Query: 178 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 210
+Y GV DL ++G + L GS
Sbjct: 177 KYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 2e-16
Identities = 66/256 (25%), Positives = 107/256 (41%), Gaps = 77/256 (30%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP---QLHY 51
+G GSFG++ L TG+ A+K +E T HP +LHY
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 52 ----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR--KFSL 102
E KLY++L+ GG +LF++ ++ +FS
Sbjct: 61 AFQTEEKLYLVLEYAPGG----------------------------ELFSHLSKEGRFSE 92
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-YRDLQT 161
+ A +++ +EY+HS G ++RD+KP+N L+ + + D+GLAK+ +
Sbjct: 93 ERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSR 149
Query: 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 220
GT Y + LG + D SLG VL+Y L G P+ A
Sbjct: 150 --------TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AED 197
Query: 221 KKQKYDKISEKKMLTP 236
+K+ Y+KI + + P
Sbjct: 198 RKEIYEKILKDPLRFP 213
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 44/178 (24%), Positives = 70/178 (39%), Gaps = 58/178 (32%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL-------ESV------------KTKHPQ- 48
++ K+G G++G +Y + +TGE VA+K E + + KHP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 49 ------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY---CNRK 99
+H E KLY++ EY D DL Y
Sbjct: 61 VKLLDVIHTERKLYLVF----------------EY----CD------MDLKKYLDKRPGP 94
Query: 100 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
S + + QL+ + Y HS LHRD+KP N L+ + + + D+GLA+ +
Sbjct: 95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 71/268 (26%), Positives = 114/268 (42%), Gaps = 53/268 (19%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKL------ 55
++ + R IG G GE+YL + VA+K L + E+K+
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 56 ------YMLLQGGTGVPHLKWFGVEGEY------NVMVIDLLGPSLEDLFNYCNRKFSLK 103
Y + G V + + +EG +V + L L + K S+
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPY-IEGYTLKSLLKSVWQKESLSKELAE-------KTSVG 113
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK---KYRDLQ 160
L + ++ +EY+HS+G LHRD+KPDN L+GL +V I+D+G A +
Sbjct: 114 AFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDL 170
Query: 161 THKHIPYREN--KNLT------GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 212
+ R ++T GT Y + LGV S D+ +LG +L L S P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 213 WQGLKAGTKKQKYDKISEK-KMLTPIEV 239
+ +++K KIS + +L+PIEV
Sbjct: 231 Y-------RRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLES-----VKTKHPQLHYESKLYMLLQGGTGVPH 67
+ I G+FG +YL TG+ A+K+ K + + E + M+ V
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 68 LKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQ--------LINRVEY 118
L + +Y +V++ L G L +KT+ L + ++ VE
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASL---------IKTLGGLPEDWAKQYIAEVVLGVED 112
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+H RG +HRDIKP+N L+ ++ + + D+GL++ ENK GT
Sbjct: 113 LHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKFVGTPD 158
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238
Y + T LGV + D SLG V+ FL G P+ A T +D I +++ P E
Sbjct: 159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRINWPEE 215
Query: 239 V 239
V
Sbjct: 216 V 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 6e-15
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLH-----YESKLYMLLQGGT 63
+K+ +++G G+FG +YL N +TGE VA+K +K K E K L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEHP 58
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLF-NYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ LK E + V + + +L L + + FS + + Q++ + ++H
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
GF HRD+KP+N L+ V I D+GLA++ R
Sbjct: 119 GFFHRDLKPENLLV---SGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 33/226 (14%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL-------ESVKTKHPQLHYESKLYMLLQG 61
++ G+ +G G+FG +YL +V TG E+AVK K + L E +L LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 62 GTGVPHLKWFGVEGEYNVMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLADQLIN 114
V + + ++ + + G S++D L RK++ Q++
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--------QILE 115
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDLQT-HKHIPYRENKN 172
VEY+HS +HRDIK N L R S V + D+G +K+ LQT K+
Sbjct: 116 GVEYLHSNMIVHRDIKGANIL----RDSAGNVKLGDFGASKR---LQTICSSGTGM--KS 166
Query: 173 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKH--PQLHYESKLYMLLQ 60
+++ G +GSGSFG +Y G+N+ G+ AVK + + QL E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKF-SLKTVL--MLADQLINRVE 117
V +L E + + + G SL L +K+ S + + Q++ +E
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLE 116
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
Y+H R +HRDIK N L+ + V + D+G+AK+
Sbjct: 117 YLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQ 151
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 1e-13
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 26/176 (14%)
Query: 10 KLGRKIGSGSFGELYLGV----NVQTGEEVAVK--LESVKTKHPQ-LHYESKLYMLLQGG 62
LG+K+G G+FGE+Y G + EVAVK E + + E+++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD-- 59
Query: 63 TGVPH---LKWFGV-EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRV 116
H +K GV E + ++ L K SL +L A Q+ +
Sbjct: 60 ----HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 117 EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD----LQTHKHIPYR 168
EY+ S+ F+HRD+ N L+G ++ V I D+GL++ D + +P R
Sbjct: 116 EYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 27/177 (15%)
Query: 10 KLGRKIGSGSFGELYLGV----NVQTGEEVAVK--LESVKTKHPQ-LHYESKLYMLLQGG 62
LG+K+G G+FGE+Y G EVAVK E + + E+++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-- 59
Query: 63 TGVPH---LKWFGV-EGEYNVMVIDLLGP--SLED-LFNYCNRKFSLKTVLMLADQLINR 115
H +K GV E +M++ P L D L ++ SL +L A Q+
Sbjct: 60 ----HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH----IPYR 168
+EY+ S+ F+HRD+ N L+G ++ V I D+GL++ D +K +P R
Sbjct: 116 MEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM---------LLQGG 62
G IG G++G +YL +NV TGE +AVK + H + M L+
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 63 TGVPHLKWFGVEGEYNVMVIDL---LGPSLEDLF-NYCNRKFSLKTVLMLADQLINRVEY 118
+ +++ G E + I L G S+ Y +F + V +Q++ + Y
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAY 123
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+HS+G LHRD+K DN L+ I D+G++KK D+ + +N ++ G+
Sbjct: 124 LHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMSMQGSVF 175
Query: 179 YAS--VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ + V S + D+ SLG V++ G PW +A
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 35/168 (20%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHY----ESKLYMLLQ 60
+++ G+K+G G++ +Y + +TG VA+K L K +++ E KL L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 61 GGTGVPH------LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD---- 110
H L FG + N +V + + LE + ++ VL AD
Sbjct: 61 ------HPNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK--DKS----IVLTPADIKSY 107
Query: 111 --QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ +EY+HS LHRD+KP+N L+ + + D+GLA+ +
Sbjct: 108 MLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSF 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 67/300 (22%), Positives = 111/300 (37%), Gaps = 64/300 (21%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGTG 64
F++ + IG G+FGE++L + TG+ A+K+ + +K + +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSR 122
+ L + + E+ +V++ + DL N RK F +T +L+ ++ +H
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD-----------------LQTHKHI 165
GF+HRDIKPDN L+ + + D+GL KK
Sbjct: 121 GFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 166 PYRENKN-----LTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG 219
+ + GT Y + G D SLG V++Y L G P +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---FYSD 233
Query: 220 TKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279
T ++ Y+KI ++ SLRF P S DL R
Sbjct: 234 TLQETYNKII-----------------------NWKESLRFPPDPPVS---PEAIDLICR 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 9e-12
Identities = 82/303 (27%), Positives = 125/303 (41%), Gaps = 93/303 (30%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVK---LESVKT----------------KHP---QLH 50
+IG G++G++Y N +TGE VA+K +E+ K +HP +L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 51 --YESK----LYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKT 104
SK +YM+ EY M DL G L + KF+
Sbjct: 65 EIVTSKGKGSIYMVF----------------EY--MDHDLTG-----LLDSPEVKFTESQ 101
Query: 105 VLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ--VYIIDYGLAKKYRDLQ-- 160
+ QL+ ++Y+HS G LHRDIK N L+ +N + + D+GLA+ Y
Sbjct: 102 IKCYMKQLLEGLQYLHSNGILHRDIKGSNILI-----NNDGVLKLADFGLARPYTKRNSA 156
Query: 161 --THKHIP--YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
T++ I YR + L G RY V D+ S+G +L G +QG
Sbjct: 157 DYTNRVITLWYRPPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG- 204
Query: 217 KAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFED--KPDYSYLKRLFR 274
T+ ++ +KI E LC S P++ + L + + KP Y KR R
Sbjct: 205 --STELEQLEKIFE---------LCGS-PTD--ENWPGVSKLPWFENLKPKKPY-KRRLR 249
Query: 275 DLF 277
+ F
Sbjct: 250 EFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 40/165 (24%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--------LESVKT--------KHPQL-- 49
+K KIG G+ GE+Y + TG+EVA+K E + KHP +
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 50 HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLML 108
+Y+S L L W +V++ + G SL D+ + + + +
Sbjct: 80 YYDSYLVG--------DEL-W---------VVMEYMDGGSLTDIITQNFVRMNEPQIAYV 121
Query: 109 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+++ +EY+HS+ +HRDIK DN L+ K V + D+G A
Sbjct: 122 CREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-11
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGT 63
++LG IG G+FG +Y G+N++TG+ VA+K S++ + E L L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDL---FNYCNRKFSLKTVLMLADQLINRVEYMH 120
V ++ +++ SL + F SL V + Q++ + Y+H
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE--SLVAVYVY--QVLQGLAYLH 116
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159
+G +HRDIK N L K V + D+G+A K D+
Sbjct: 117 EQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDV 152
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 65/239 (27%), Positives = 100/239 (41%), Gaps = 29/239 (12%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH- 67
F+L R IG G+FG++ + T + A+K K K + + + + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMK-YMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 68 ----LKWFGVEGEYNVMVIDLLGPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHS 121
L + + E +V+DLL DL + KFS + V +++ +EY+HS
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT---GTAR 178
+G +HRDIKPDN L+ + V+I D+ +A K + T GT
Sbjct: 119 KGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTP-----------DTLTTSTSGTPG 164
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
Y + S D SLG V Y LRG P++G + Q K +L P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP 222
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 27/240 (11%)
Query: 12 GRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQ--------LHYESKLYMLLQ 60
G IGSGSFG +YLG+N +GE +AVK L SV L E L LQ
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
V +L N+ + + G S+ L N F V Q++ + Y+H
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH 123
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR----DLQTHKHIPYRENKNLTGT 176
+RG +HRDIK N L+ + I D+G++KK +T+ P +L G+
Sbjct: 124 NRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SLQGS 175
Query: 177 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
+ + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGENASPEI 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 41/146 (28%), Positives = 67/146 (45%), Gaps = 8/146 (5%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHY-ESKLYMLLQGGTGVPHL 68
KIG G++G +Y + TGE VA+K ++ + P+ E KL L + L
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 69 KWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 128
F +G+ +V + + L L R + QL+ + + HS G LHRD
Sbjct: 65 DVFRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD 123
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAK 154
+KP+N L+ + + D+GLA+
Sbjct: 124 LKPENLLI---NTEGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 57/198 (28%), Positives = 88/198 (44%), Gaps = 36/198 (18%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVA---VKLESVKTKHP-----------QLHYES 53
KF + +IG G++G++Y + TGE VA V+L++ K P QL++ +
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 54 KLYM---LLQGGTGVPHLK---WFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLM 107
+ + + + K F + EY M DL+G L + FS +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEY--MDHDLMGLLESGLVH-----FSEDHIKS 120
Query: 108 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY----RDLQTHK 163
QL+ + Y H + FLHRDIK N L+ Q+ + D+GLA+ Y T+K
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 164 HIP--YRENKNLTGTARY 179
I YR + L G RY
Sbjct: 178 VITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 47/190 (24%), Positives = 76/190 (40%), Gaps = 29/190 (15%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY----ESKLYMLLQGGTG 64
+++ K+G G+FGE+Y ++TG VA+K + + E K+ L+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 VPHLKWFGVEGE---------YNV---MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 112
VP + + Y V M DL G L + K + + QL
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-----LLENPSVKLTESQIKCYMLQL 124
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172
+ + Y+H LHRDIK N L+ + I D+GLA+ Y P +
Sbjct: 125 LEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDG-----PPPNPKGGG 176
Query: 173 LTGTARYASV 182
GT +Y ++
Sbjct: 177 GGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 60/232 (25%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP---QLHY 51
I G++G ++L TG+ A+K ++ V T + P +L+Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 52 ----ESKLYML---LQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKT 104
+ LY++ L GG L+ G E R + +
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------------------RIYIAEI 102
Query: 105 VLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-YRDLQTHK 163
VL L EY+HS G +HRD+KPDN L+ + + + D+GL+K Q +
Sbjct: 103 VLAL--------EYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINL 151
Query: 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ +E+K + GT Y + LG S+ D SLG +L FL G P+ G
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (146), Expect = 4e-10
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 27/172 (15%)
Query: 9 FKLGRKIGSGSFGELYLGV----NVQTGEEVAVKLESVKTKHPQ---LHYESKLYMLLQG 61
+LG+K+G G+FGE+Y G T +VAVK + E+ + L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 62 GTGVPHL-KWFGV--EGEYNVMVIDL--LGPSLEDLFNY---CNRKFSLKTVLMLADQLI 113
P++ + GV +GE +V + G DL ++ K +LK +L +A Q+
Sbjct: 61 ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112
Query: 114 NRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK-KYRDLQTHKH 164
+EY+ S+ F+HRD+ N L+ ++ V I D+GL++ Y D K
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSRDIYEDDYYRKR 161
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 6e-10
Identities = 75/294 (25%), Positives = 122/294 (41%), Gaps = 64/294 (21%)
Query: 13 RKIGSGSFGELYLGV---NVQTGEEVAVKLESVKTKHP-----QLHYESKLYMLLQGGTG 64
+K+G G+FGE+Y G EVAVK ++K E+++ L G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVK--TLKEDASEEERKDFLKEARVMKKL----G 54
Query: 65 VPH-LKWFGV--EGEYNVMVI------DLLG---PSLEDLFNYCNRKFSLKTVLMLADQL 112
P+ ++ GV E E +V+ DLL S + SLK +L A Q+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-----YRDLQTHKHIPY 167
+EY+ S+ F+HRD+ N L+G + V I D+GL++ Y +T +P
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 168 R----ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTK 221
R E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 172 RWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSN--- 213
Query: 222 KQKYDKISE-KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274
++ + + + ++ P + P E C L ED+P +S L
Sbjct: 214 EEVLEYLRKGYRLPKP-----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 9e-10
Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 72/187 (38%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---------------------LESVKTKH 46
K+++ ++IG GSFG++YL G+ +K L+ + H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN--H 58
Query: 47 PQL--HYES-----KLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY- 95
P + +YES KL ++++ GG DL
Sbjct: 59 PNIIKYYESFEEKGKLCIVMEYADGG----------------------------DLSQKI 90
Query: 96 -----CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDN-FLMGLGRKSNQVYIID 149
+ F + +L QL ++Y+HSR LHRDIKP N FL + V + D
Sbjct: 91 KKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGD 146
Query: 150 YGLAKKY 156
+G++K
Sbjct: 147 FGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 28/159 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTG 64
F L IG GSFGE+Y ++ +T + VA+K LE + + + E + L Q
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQE--IQFLSQ--CR 57
Query: 65 VPHL-KWFG--VEG-------EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLIN 114
P++ K++G ++G EY G S DL K + + +++
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEY------CGGGSCLDLLKPG--KLDETYIAFILREVLL 109
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+EY+H G +HRDIK N L+ + V + D+G++
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 52/169 (30%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---------------------LESVKTK-----HP 47
KIG G++G ++ N +T E VA+K L+ +K K +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 48 QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLM 107
LH + KL +V + L+ F+ CN + V
Sbjct: 67 VLHSDKKL-----------------------TLVFEYCDQDLKKYFDSCNGDIDPEIVKS 103
Query: 108 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
QL+ + + HS LHRD+KP N L+ K+ ++ + D+GLA+ +
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 47/185 (25%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVA---VKLESVKTKHPQLHYESKLYMLLQGG-------- 62
+I G++G +Y + +TGE VA +K+E K P + ++ +LL+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFP-ITSLREINILLKLQHPNIVTVK 70
Query: 63 ---TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
G K + MV++ + L+ L + F V L QL++ V ++
Sbjct: 71 EVVVGSNLDKIY--------MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD-LQTHKHIP----YRENKNLT 174
H LHRD+K N L+ + I D+GLA++Y L+ + + YR + L
Sbjct: 123 HDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLL 179
Query: 175 GTARY 179
G Y
Sbjct: 180 GAKEY 184
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP--QLHYESKLYML-LQGGTG 64
K+ KIG G+ G +Y ++V TG+EVA+K +++ + P +L L M +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNI 78
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
V +L + V E V++ L G SL D+ + + + + +E++HS
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
+HRDIK DN L+G+ V + D+G + Q + + GT + +
Sbjct: 137 IHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------SKRSTMVGTPYWMAPEV 186
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 38/150 (25%), Positives = 61/150 (40%), Gaps = 26/150 (17%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-YRDLQTHKHIPYRE 169
++ EY+H+RG ++RD+KP+N L+ + V ++D+G AKK +T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQKTW------- 150
Query: 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA---------- 218
GT Y + L D SLG +L+Y L G P+
Sbjct: 151 --TFCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 219 -GTKKQKYDKISEKKMLTPIEVLCKSYPSE 247
G K ++ +K I+ L + P E
Sbjct: 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 39/150 (26%), Positives = 78/150 (52%), Gaps = 13/150 (8%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH- 67
F + K+G GS+G +Y ++ +TG+ VA+K+ V+ ++ ++ +L Q + P+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEI--IKEISILKQCDS--PYI 60
Query: 68 LKWFG---VEGEY-NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
+K++G + VM G S+ D+ N+ + + + + Q + +EY+HS
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAG-SVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+HRDIK N L+ + Q + D+G++
Sbjct: 120 KIHRDIKAGNILLN---EEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 45/161 (27%), Positives = 85/161 (52%), Gaps = 21/161 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGTG 64
+ + +G+G+FG ++L + + A+K+ E ++ K Q H ++ +L +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-HVHNEKRVLKE---- 57
Query: 65 VPH-----LKWFGVEGEYNVMVIDLLGPSLEDLFNY--CNRKFSLKTVLMLADQLINRVE 117
V H L W + + M+++ + P E LF+Y + +FS T L A +++ +E
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYV-PGGE-LFSYLRNSGRFSNSTGLFYASEIVCALE 115
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
Y+HS+ ++RD+KP+N L+ K + + D+G AKK RD
Sbjct: 116 YLHSKEIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRD 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 8e-09
Identities = 49/209 (23%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG--V 65
K+ KIG G+ G +Y ++V TG+EVA++ +++ + + +++ ++ + V
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+L + V E V++ L G SL D+ C + + V + + +E++HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
+HRDIK DN L+G+ V + D+G + Q+ + + GT + +
Sbjct: 138 IHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 41/171 (23%), Positives = 71/171 (41%), Gaps = 38/171 (22%)
Query: 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--------ESVKT------KHPQLHY 51
G F+L IG G++G++Y + +TG+ VA+K+ E +K K+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 52 ESKLY--MLLQGGTGVPHLKWFGVEGEYNVMVIDL------LGPSL-EDLFNYCNRKFSL 102
+ Y + + G W +E V DL G L E+ Y R
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR---- 120
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+ + + Y+H +HRDIK N L+ K+ +V ++D+G++
Sbjct: 121 --------ETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 57/203 (28%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK----LESVKTKHPQ-LHYESKLYMLLQGGT 63
F++ +KIG G F E+Y + + VA+K E + K Q E L L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMH 120
+ +L F + E N+++ L + Y ++ L +TV QL + VE+MH
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
SR +HRDIKP N + + V + D GL + + T H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAH-------SLVGTPYYM 173
Query: 181 SVNTHLGVEQSRRDDLESLGYVL 203
S + + D+ SLG +L
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYE-SKLYMLLQGGTGVPH 67
++LG+ +G G+FG +YL + TG E+AVK + P+ E + L +Q + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 68 ---LKWFGV-----EGEYNVMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLADQL 112
++++G E ++ + + G S++D L RK++ Q+
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--------RQI 115
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172
+ V Y+HS +HRDIK N L V + D+G +K+ LQT + K+
Sbjct: 116 LEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKR---LQT-ICLSGTGMKS 168
Query: 173 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 63/182 (34%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLES----VKTK----------------HP- 47
F+ + +G+GSFG + L + +G+ A+K+ S VK K HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 48 --QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
L+ +S LY+++ GG +LF++ +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGG----------------------------ELFSHLRK 94
Query: 99 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+F A Q++ +EY+HS ++RD+KP+N L+ + I D+G AK+
Sbjct: 95 SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRV 151
Query: 157 RD 158
+
Sbjct: 152 KG 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 48/209 (22%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG--V 65
K+ KIG G+ G +Y +++ TG+EVA+K +++ + + +++ ++ + V
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+L + V E V++ L G SL D+ C + + V + + ++++HS
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQV 136
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
+HRDIK DN L+G+ V + D+G + Q+ + + GT + +
Sbjct: 137 IHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 186
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 10/104 (9%)
Query: 100 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159
F + VL Q+++ V Y+H G LHRDIK N + K+ + + D+G++K
Sbjct: 98 FEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSE 154
Query: 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVL 203
+ + + GT Y S GV+ + + D+ +LG VL
Sbjct: 155 YSMA-------ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK--TKHPQL--HYESKLYMLLQGGT 63
K++ R +G G+FG ++L + V +K V+ TK +L E ++ LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ + + F + +++ G +L + CN T+L Q++ + ++H++
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
LHRD+K N L+ + V I D+G++K + + K Y + GT Y S
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISK----ILSSKSKAY----TVVGTPCYISP 170
Query: 183 NTHLGVEQSRRDDLESLGYVL 203
G +++ D+ +LG VL
Sbjct: 171 ELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 69/275 (25%), Positives = 125/275 (45%), Gaps = 40/275 (14%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH- 67
F L RK+GSG FGE++ G+ + VA+K+ Q ++ ++ L + H
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQAL----KRLRHK 62
Query: 68 --LKWFGV--EGEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+ F V GE ++ +L+ G L L + + + +++ +A Q+ + Y+
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD---LQTHKHIPYRENKNLTGTAR 178
+ +HRD+ N L+G + D+GLA+ ++ L + K IPY+ TA
Sbjct: 123 QNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAP 173
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK-KMLT 235
A+ + S + D+ S G +L+Y F G +P+ G+ + YD+I+ +M
Sbjct: 174 EAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQITAGYRMPC 225
Query: 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270
P + C P E C + ED+P + L+
Sbjct: 226 PAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 37/151 (24%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYES--KLYMLLQGGTGV 65
++L ++IGSG++G++Y ++ TGE VA+K+ ++ P +E + +L+
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHP 60
Query: 66 PHLKWFGVEGEYNVMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ +FG + + I + G SL+D++ S + + + + + Y+H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
G +HRDIK N L+ + V + D+G++
Sbjct: 121 GKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHY-ESKLYMLLQGG 62
K++ KIG G+FGE++ + +T + VA+K +E+ K P E K+ LL+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 63 TGVPHLKWFGVEGE-YN------VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
V ++ + YN +V + L L + N KF+L + + L+N
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNG 131
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ Y+H LHRD+K N L+ K + + D+GLA+ +
Sbjct: 132 LYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 53/202 (26%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESV-KTKHPQLHYESKLYML-LQGGTGVPHLKWF 71
KIG GS G + + +G +VAVK+ + K + +L + + M Q V K +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131
V E V++ L G +L D+ + + + + + + + ++ + Y+HS+G +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 191
D+ L+ L +V + D+G Q K +P R K+L GT + +
Sbjct: 146 DSILLTL---DGRVKLSDFGFCA-----QISKDVPKR--KSLVGTPYWMAPEVISRTPYG 195
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 65/227 (28%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTG-VPHLKW 70
IG G FGE+Y TG+ A+K + +K K + ++ ML TG P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP---- 57
Query: 71 FGVEGEYNVMVIDLLGPSLE-----DLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRG 123
F V Y D L L+ DL + ++ FS + A ++I +E+MH+R
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF 117
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
++RD+KP N L+ + V I D GLA + + H ASV
Sbjct: 118 VVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH-----------------ASVG 157
Query: 184 TH---------LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
TH GV D SLG +L LRG P++ K K
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 6e-08
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 62/190 (32%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY--------MLL 59
+++L + IGSG++G + V+ +TG +VA+K K + ++ + LL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIK----KISNV---FDDLIDAKRILREIKLL 53
Query: 60 QGGTGVPHLKWFGVEGEYNVM-VIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD------ 110
+ HL+ N++ ++D+L P + FN Y + T LM D
Sbjct: 54 R------HLR------HENIIGLLDILRPPSPEDFNDVY------IVTELMETDLHKVIK 95
Query: 111 ---------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAK 154
Q++ ++Y+HS +HRD+KP N L+ SN + I D+GLA+
Sbjct: 96 SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151
Query: 155 KYRDLQTHKH 164
+ K
Sbjct: 152 GVDPDEDEKG 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 39/150 (26%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
++L +++GSG++G++Y N+ TGE AVK+ ++ + +++M+ + +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIV 69
Query: 69 KWFGVEGEYNVMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
+FG + I + G SL+D+++ L+ + + L + Y+HS+G +
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-QGLAYLHSKGKM 128
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
HRDIK N L+ + V + D+G+A K
Sbjct: 129 HRDIKGANILL---TDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 61/235 (25%), Positives = 103/235 (43%), Gaps = 26/235 (11%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQ-LHYESKLYMLLQGGT 63
F++G +G+GSFG + + + TGE A+K E +K K Q + E + M L
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS 121
V + F E ++ ++G +LF + + +F +L+ EY+HS
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVG---GELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
+ ++RD+KP+N L L K + V + D+G AKK D L GT Y +
Sbjct: 137 KDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPD----------RTFTLCGTPEYLA 183
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
+ D ++G +L F+ G P+ T + Y+KI ++ P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLKFP 235
|
Length = 329 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 10 KLGRKIGSGSFGELYLG----VNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGG 62
K +++G G FG++ L + TGE+VAVK + E ++ L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 63 TGVPHLKWFGVEGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
V + G ++ +I P SL D + +LK +L+ + Q+ ++Y+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
S+ ++HRD+ N L+ + V I D+GLAK
Sbjct: 127 SQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 52/208 (25%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLH-YESKLYMLLQGGTGVPHL-KWF 71
+IG GSFGE++ G++ +T + VA+K+ ++ ++ + ++ +L Q + P++ K++
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS--PYVTKYY 68
Query: 72 G--VEGEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 127
G ++G ++++ L G +L+ L +F + T+L +++ ++Y+HS +HR
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHR 125
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 187
DIK N L+ + V + D+G+A + D Q + GT + +
Sbjct: 126 DIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-------NTFVGTPFWMAPEV--- 172
Query: 188 VEQSRRD---DLESLGYVLMYFLRGSLP 212
++QS D D+ SLG + +G P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 73/283 (25%), Positives = 129/283 (45%), Gaps = 49/283 (17%)
Query: 13 RKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQ-----LHYESKLYMLLQGGTGVP 66
+++G G+FG + GV +++G+EV V ++++K +H E+ + L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 HL-KWFGV-EGEYNVMVIDL--LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ + GV +GE ++V++L LGP L+ L R+ + + LA Q+ + Y+ S+
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK------KYRDLQTHKHIPYRENKNLTGT 176
F+HRD+ N L+ +Q I D+G+++ Y T P +
Sbjct: 115 HFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------- 163
Query: 177 ARYA--SVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEKK 232
YA +N + S + D+ S G V ++ F G+ P+ +K + S ++
Sbjct: 164 -WYAPECINYG---KFSSKSDVWSYG-VTLWEAFSYGAKPYGEMKGAEVIAMLE--SGER 216
Query: 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275
+ P E C P E S C R ED+P +S L+ FR
Sbjct: 217 LPRPEE--C---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 45/165 (27%), Positives = 80/165 (48%), Gaps = 28/165 (16%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP--QLHYESKLYMLLQGGTGVPHLKW 70
+GSG++G + + + ++VAVK K P L + + Y L+ + H+K
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVK----KLSRPFQSLIHARRTYRELRL---LKHMKH 73
Query: 71 FGVEGEYNV--------------MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRV 116
V G +V +V +L+G L ++ +K S + V L QL+ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGL 131
Query: 117 EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
+Y+HS G +HRD+KP N + + ++ I+D+GLA++ D T
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 68/276 (24%), Positives = 110/276 (39%), Gaps = 36/276 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKLYMLLQGG 62
F++ +KIG G F E+Y + G VA+K L K + + E L L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHP 62
Query: 63 TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYM 119
+ + F + E N+++ L + + ++ L KTV QL + +E+M
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
HSR +HRDIKP N + + V + D GL + + T H +L GT Y
Sbjct: 123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 180 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE- 238
S + + D+ SLG +L P+ G DK++ + IE
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----------DKMNLYSLCKKIEQ 222
Query: 239 -----VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269
+ Y E + C + E +PD +Y+
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 22/66 (33%), Positives = 33/66 (50%), Gaps = 4/66 (6%)
Query: 91 DLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148
DLF+ K S V + QL+ + +H +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 149 DYGLAK 154
DYGL K
Sbjct: 153 DYGLCK 158
|
Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP--QLHYESKLYML-LQGGTG 64
K+ KIG G+ G ++ ++V TG+EVA+K +++ K P +L L M L+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNI 78
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRG 123
V L F V E V++ L G SL D+ C + + V + + +E++H+
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
+HRDIK DN L+G+ V + D+G + Q+ + + GT + +
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPE 185
Query: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 57/229 (24%), Positives = 102/229 (44%), Gaps = 37/229 (16%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-------LESVKTKHPQLHYESKLYMLLQG 61
++LG+ +G G+FGE+YL + TG E+AVK + + L E +L L+
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 62 GTGVPHLKWFGV-----EGEYNVMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLA 109
V +++G E + ++ V + G S++D L R+++
Sbjct: 64 DRIV---QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT-------- 112
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
Q++ V Y+HS +HRDIK N L + V + D+G +K+ + + +
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTG 165
Query: 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 65/203 (32%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---LES----------------VKTKHPQ------ 48
KIG G++G +Y G N +TG+ VA+K LES + +HP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 49 -LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC-----NRKFSL 102
L ES+LY++ E+ M DL Y +
Sbjct: 67 VLMQESRLYLIF----------------EFLSM----------DLKKYLDSLPKGQYMDA 100
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR---DL 159
+ V Q++ + + HSR LHRD+KP N L+ + + D+GLA+ + +
Sbjct: 101 ELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRV 157
Query: 160 QTHKHIP--YRENKNLTGTARYA 180
TH+ + YR + L G+ RY+
Sbjct: 158 YTHEVVTLWYRAPEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 44/181 (24%), Positives = 70/181 (38%), Gaps = 55/181 (30%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVA---VKLESVKTKHP-----------QLHYESKL 55
KL R IG G++G +Y + +GE VA V++++ + P L + +
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN-- 67
Query: 56 YMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLF---NYCN-----------RKFS 101
+ LK V+V G L+ +F YC FS
Sbjct: 68 ---------IVELK--------EVVV----GKHLDSIFLVMEYCEQDLASLLDNMPTPFS 106
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
V L QL+ ++Y+H +HRD+K N L+ + I D+GLA+ Y
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAK 163
Query: 162 H 162
Sbjct: 164 P 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK----------LESVKTKHPQLHYESKLYMLLQGGT 63
+IG GSFGE+Y G++ +T E VA+K +E ++ + L Y+ G+
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 64 GVPHLK-WFGVEGEYNVMVIDLLGPS-LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+ K W +E +DLL P LE+ + + T+L +++ ++Y+HS
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETY--------IATILR---EILKGLDYLHS 119
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
+HRDIK N L+ + V + D+G+A + D Q ++ GT + +
Sbjct: 120 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 182 VNTHLGVEQSRRD---DLESLGYVLMYFLRGSLPWQGL 216
++QS D D+ SLG + +G P L
Sbjct: 170 PEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGV 65
++L IG G+ +Y + + E+VA+K LE +T +L E +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN----- 57
Query: 66 PH---LKWFG--VEGEYNVMVIDLL-GPSLEDLFNYCNRK-----FSLKTVLMLADQLIN 114
H +K++ V G+ +V+ L G SL D+ + + TVL +++
Sbjct: 58 -HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLK 113
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+EY+HS G +HRDIK N L+G + V I D+G++
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 50/205 (24%), Positives = 80/205 (39%), Gaps = 58/205 (28%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-------LESVKT------------KHPQL 49
F+ KIG G++G +Y N TGE VA+K E V + HP +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 50 -------HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK-FS 101
H E+KLY+ V + L L+ +
Sbjct: 62 VKLLDVIHTENKLYL-----------------------VFEFLHQDLKKFMDASPLSGIP 98
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR-DLQ 160
L + QL+ + + HS LHRD+KP N L+ + + D+GLA+ + ++
Sbjct: 99 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVR 155
Query: 161 THKH----IPYRENKNLTGTARYAS 181
T+ H + YR + L G Y++
Sbjct: 156 TYTHEVVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 22/49 (44%), Positives = 30/49 (61%), Gaps = 1/49 (2%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDN-FLMGLGRKSNQVYIIDYGLAKKYRD 158
Q++N V Y+HS LHRD+KP N +MG G + V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 59/208 (28%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK----LESVKTKHPQ-LHYESKLYMLLQG 61
G FK+ +KIG G F +Y + + G VA+K E + K Q E L L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 62 GTGVPHLKWFGVEGEYNVMVIDLLGPSLEDL------FNYCNRKFSLKTVLMLADQLINR 115
+ +L F E N+ V++L DL F R +T+ QL +
Sbjct: 62 PNVIKYLASFIENNELNI-VLELADAG--DLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
+E+MHS+ +HRDIKP N + + V + D GL + + T H +L G
Sbjct: 119 LEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVL 203
T Y S + + D+ SLG +L
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 58/188 (30%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK--------LESVK-----------TKHP-- 47
+K+ KIG G+F E+ + +TG+ A+K LE V + HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 48 ----QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK--FS 101
++ ++ K TG L V +L+ +L +L RK
Sbjct: 61 LRLIEVLFDRK--------TGRLAL------------VFELMDMNLYELIK--GRKRPLP 98
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
K V QL+ +++MH G HRDIKP+N L+ K + + + D+G +
Sbjct: 99 EKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCRG-----I 149
Query: 162 HKHIPYRE 169
+ PY E
Sbjct: 150 YSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ--GGTGVP 66
+KLG IG+GSFG +Y + + T E+VA+K + PQ Y+++ ++++ +
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQ--YKNRELLIMKNLNHINII 122
Query: 67 HLK-WFGVE----GEYNV---MVIDLLGPSLEDLFNYC---NRKFSLKTVLMLADQLINR 115
LK ++ E E N+ +V++ + ++ + N L V + + QL
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP------YRE 169
+ Y+HS+ HRD+KP N L + ++ + + D+G AK L + + YR
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAKNL--LAGQRSVSYICSRFYRA 238
Query: 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG 209
+ + G Y TH+ DL SLG ++ + G
Sbjct: 239 PELMLGATNYT---THI--------DLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK----------LESVKTKHPQLHYESKLYMLLQGGT 63
KIG GSFGE++ G++ +T + VA+K +E ++ + L Y+ G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 64 GVPHLK-WFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ K W +E +DLL P D + + T+L +++ ++Y+HS
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
+HRDIK N L+ + +V + D+G+A + D Q ++ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 183 NTHLGVEQSRRD---DLESLGYVLMYFLRGSLP 212
++QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 16/156 (10%)
Query: 9 FKLGRKIGSGSFGEL----YLGVNVQTGEEVAVKLESVKTKHPQLHYES--KLYMLLQGG 62
K R +G G FG++ Y N TGE VAVK ++K + Q + K +L+
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVK--TLKRECGQQNTSGWKKEINILKTL 63
Query: 63 TGVPHLKWFGV---EGEYNVMVIDLLGPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEY 118
+K+ G +G + +I P L L +Y + K +L +L+ A Q+ + Y
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLNLAQLLLFAQQICEGMAY 122
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+HS+ ++HRD+ N L+ V I D+GLAK
Sbjct: 123 LHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 29/223 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGGT 63
+ + +G GS G +Y + TG+ A+K + K QL E K L
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK--QLLRELKT--LRS--C 56
Query: 64 GVPHL-KWFGV---EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
P++ K +G EGE ++ V++ + G SL DL K + +A Q++ ++Y
Sbjct: 57 ESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDY 114
Query: 119 MHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 177
+H+ R +HRDIKP N L+ +V I D+G++K + + GT
Sbjct: 115 LHTKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLDQCN-------TFVGTV 164
Query: 178 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
Y S G S D+ SLG L+ G P+ +
Sbjct: 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYE-SKLYMLLQGGTGVPH 67
++ G+ +G G+FG +YL +V TG E+A K + P+ E S L +Q + H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 68 ---LKWFGV-----EGEYNVMVIDLLGPSLED-------LFNYCNRKFSLKTVLMLADQL 112
++++G E + + + G S++D L RK++ Q+
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--------RQI 115
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172
+ + Y+HS +HRDIK N L + V + D+G +K+ LQT + ++
Sbjct: 116 LEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKR---LQT-ICMSGTGIRS 168
Query: 173 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+TGT + S G R+ D+ SLG ++ L PW +A
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 40/169 (23%)
Query: 9 FKLGRKIGSGSFGELYLGV-NVQTGEEVAVK------------LESV----KTKHPQLHY 51
KL RK+G+G FGE+++G N T +VAVK L+ K +H +L
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL-- 63
Query: 52 ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLA 109
+LY + E E +V + + G L+ L + +K L ++ +A
Sbjct: 64 -VQLYAVCS-------------EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
Q+ + Y+ SR ++HRD+ N L+G ++ I D+GLA+ D
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 13/169 (7%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQ-LHYESKLYMLLQGGTGVPHLKWFG 72
+G G++G +Y ++ T +A+K + +++ Q LH E L+ L+ V +L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 73 VEGEYNVMVIDLLGPSLEDLF--NYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK 130
G + + + + G SL L + K + +T++ Q++ ++Y+H +HRDIK
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 131 PDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
DN L + S V I D+G +K+ + P E TGT +Y
Sbjct: 136 GDNVL--VNTYSGVVKISDFGTSKRLAGIN-----PCTE--TFTGTLQY 175
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGTG 64
+++ + IG G+FGE+ L + T + A+KL E +K +E + M
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 VPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
V L + + Y MV++ + G L +L + N K +++ ++ +HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
F+HRD+KPDN L+ KS + + D+G K
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 66/207 (31%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVK--------LESVKTKHPQLHYESKLYMLLQGGTG 64
R IG G+FG ++ + + G+ VA+K L S K ++ E K+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCK----RVFRELKM--------- 52
Query: 65 VPHLKWFGVEGEYNVM-VIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------------- 110
L +F + NV+ +D+L P D F + + T LM +D
Sbjct: 53 ---LCFFKHD---NVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSS 102
Query: 111 --------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDLQT 161
Q++ ++Y+HS G LHRDIKP N L+ SN + I D+GLA+ +
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDE 157
Query: 162 HKHIP-------YRENKNLTGTARYAS 181
KH+ YR + L G+ Y S
Sbjct: 158 SKHMTQEVVTQYYRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 6e-07
Identities = 42/165 (25%), Positives = 72/165 (43%), Gaps = 37/165 (22%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK---------------------LESVKT-KHPQLHYE 52
IG G++G +Y ++ TG VA+K L+ +++ +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI--- 63
Query: 53 SKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK-FSLKTVLMLADQ 111
+L + G LK +V + + L + C + +T+ L Q
Sbjct: 64 VRLLDVCHGPRTDRELKLT--------LVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 112 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
L+ V+++HS +HRD+KP N L+ QV I D+GLA+ Y
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTKHPQLHYESKL-YMLLQG 61
+ + + +GSG+FG +Y GV + GE VA+K+ ++ + + L +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKV--LREETSPKANKEILDEAYVMA 64
Query: 62 GTGVPHL-KWFGVEGEYNVMVIDLLGPSLEDLFNYC-NRKFSLKTVLML--ADQLINRVE 117
PH+ + G+ V +I L P L L +Y N K ++ + +L Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQVQLITQLMP-LGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
Y+ + +HRD+ N L+ + V I D+GLAK
Sbjct: 124 YLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 64/203 (31%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---LESVK----------------TKHPQ------ 48
KIG G++G +Y + TGE VA+K LE+ HP
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 49 -LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLM 107
+H E+KLY++ E+ +DL DL Y +
Sbjct: 66 VVHSENKLYLVF----------------EF----LDL------DLKKYMDSSPLTGLDPP 99
Query: 108 LAD----QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR-DLQTH 162
L QL+ + Y HS LHRD+KP N L+ + + + D+GLA+ + ++T+
Sbjct: 100 LIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVRTY 156
Query: 163 KH----IPYRENKNLTGTARYAS 181
H + YR + L G+ +Y++
Sbjct: 157 THEVVTLWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 39/161 (24%), Positives = 77/161 (47%), Gaps = 25/161 (15%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESK---------------LYMLL 59
+GSG+FG +Y V + + + L+ + +P + + + L
Sbjct: 8 LGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 60 QGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINR 115
+ V + K F +E + +V+DL+ G L + FN K F+ + + + Q++
Sbjct: 67 RHPNIVRYYKTF-LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 116 VEYMHSRGFL-HRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ Y+H + HRD+ P+N ++G + ++V I D+GLAK+
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 9e-07
Identities = 39/153 (25%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH- 67
F+L ++IGSG++G++Y NV TGE A+K+ ++ + ++ M+ H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMM----KDCKHS 66
Query: 68 --LKWFGVEGEYNVMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ +FG + + I + G SL+D++ + S + ++ + + + Y+HS+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
G +HRDIK N L+ + V + D+G++ +
Sbjct: 126 GKMHRDIKGANILL---TDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 39/153 (25%), Positives = 75/153 (49%), Gaps = 23/153 (15%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM--LLQGGTGVPHLKWFG 72
+GSG++G + ++ +TGE+VA+K K P ++S+++ + T + H++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK----KLSRP---FQSEIFAKRAYRELTLLKHMQHEN 75
Query: 73 VEGEYNVMVIDLLGPSLEDLF-----------NYCNRKFSLKTVLMLADQLINRVEYMHS 121
V G +V + G +D + S V L Q++ ++Y+HS
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHS 135
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
G +HRD+KP N + + ++ I+D+GLA+
Sbjct: 136 AGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 12 GRKIGSGSFGELYLGVNVQTGEEVAVK----LESVKTKHPQLHYESKLYMLLQGGTGVPH 67
G+++G+G+F Y +V+TG +AVK + + ++ ++ + + L PH
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 68 L-KWFGV---EGEYNVMVIDLLGPSLEDLF-NYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ + G + +N+ V + G S+ L Y F ++ +QL+ + Y+H
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 123 GFLHRDIKPDNFLM-GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
+HRD+K N L+ G++ + I D+G A + L L GT + +
Sbjct: 123 QIIHRDVKGANLLIDSTGQR---LRIADFGAAAR---LAAKGTGAGEFQGQLLGTIAFMA 176
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
G + R D+ S+G V++ PW
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 36/157 (22%), Positives = 77/157 (49%), Gaps = 11/157 (7%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQL----HYESKLYMLLQ 60
+G ++K IGSG++G + ++ ++G++VA+K P L E K+ +
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 61 GGTGVPHLKWF---GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
+ G + + +V+DL+ L + + ++ + + + QL+ ++
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRGLK 121
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
Y+HS +HRD+KP N L+ + ++ I D+G+A+
Sbjct: 122 YIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 55/190 (28%), Positives = 85/190 (44%), Gaps = 28/190 (14%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQ--LHYESKLYMLLQGGTGVPHL 68
KIG G++G++Y + TG+ VA+K LE + P L S L ML + V L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 69 KWFGVEGEYNVMVIDLLGPSLE-DLFNYCN-------RKFSLKTVLMLADQLINRVEYMH 120
VE + + L+ L+ DL + + R KT+ QL+ V + H
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA-------KKYRDLQTHKHIP--YRENK 171
G +HRD+KP N L + ++ + I D GL K Y TH+ + YR +
Sbjct: 128 KHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSY----THEIVTLWYRAPE 181
Query: 172 NLTGTARYAS 181
L G+ Y++
Sbjct: 182 VLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 48/202 (23%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFG 72
KIG GS G + + TG++VAVK ++ K + +L + + M V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 73 VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131
+ G+ +V++ L G +L D+ + + + + + + ++ + Y+H++G +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 191
D+ L+ ++ + D+G Q K +P R K+L GT + + +
Sbjct: 147 DSILL---TSDGRIKLSDFGFCA-----QVSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 33/185 (17%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV----- 65
G +G G++G++ + TG+ VA+K K K ++ + L G G+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 66 ---------PHLKWFG-----VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 111
H G VEG++ +V+D++ L+ + + + + V + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD-RKIRLTESQVKCILLQ 127
Query: 112 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY------RDLQTHKHI 165
++N + +H F+HRD+ P N + I D+GLA++Y L + +
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 166 PYREN 170
RE
Sbjct: 185 QRREE 189
|
Length = 335 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 37/150 (24%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG--VPHLKWF 71
++G G+FG++Y N +TG A K+ K++ Y ++ +L V L F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 72 GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131
+G+ +M+ G +++ + +R + + ++ Q++ ++Y+HS +HRD+K
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 132 DNFLMGLGRKSNQVYIIDYGL-AKKYRDLQ 160
N L+ L + + D+G+ AK + LQ
Sbjct: 139 GNVLLTL---DGDIKLADFGVSAKNVKTLQ 165
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHY-ESKLYMLLQGGTGVP 66
+GSG++G++ + +TG +VA+K +S H + Y E +L + +
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIG 78
Query: 67 HLKWF----GVEGEYNV-MVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMH 120
L F +E +V +V L+G DL N +K S + L Q++ ++Y+H
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMG---ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 121 SRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDLQT 161
S G +HRD+KP N + + ++ I+D+GLA+ D T
Sbjct: 136 SAGIIHRDLKPSN----IAVNEDCELKILDFGLARHTDDEMT 173
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 70/230 (30%), Positives = 102/230 (44%), Gaps = 60/230 (26%)
Query: 7 GKFKLGRKIGSGSFGELYL-----GVNVQTGEEVAVKLES---VKTKHP---QLHY---- 51
GK L RKI G+LY ++ + V K+E + HP +LHY
Sbjct: 10 GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT 69
Query: 52 ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLML 108
E KLY++L +GG L S E +F + KF L L L
Sbjct: 70 EGKLYLILDFLRGGDLFTRL-------------------SKEVMFTEEDVKFYLAE-LAL 109
Query: 109 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168
A ++++HS G ++RD+KP+N L+ + + + D+GL+K+ D H+ Y
Sbjct: 110 A------LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY- 156
Query: 169 ENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
+ GT Y + V G QS D S G VLM+ L GSLP+QG
Sbjct: 157 ---SFCGTVEYMAPEVVNRRGHTQSA--DWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 40/164 (24%)
Query: 10 KLGRKIGSGSFGELYLGV-NVQTGEEVAVK-LES---------------VKTKHPQLHYE 52
+L RK+G+G FGE++ G+ N T VAVK L+ K +HP+L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL--- 63
Query: 53 SKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLAD 110
+LY + E +V +L+ G LE L R L ++ +A
Sbjct: 64 IQLYAVC-------------TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
Q+ + + Y+ ++ ++HRD+ N L+G ++N + D+GLA+
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 51/285 (17%)
Query: 14 KIGSGSFGELYLGV--NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL--- 68
++GSG+FG + G+ ++ + VAVK+ P L E LL+ + L
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDE-----LLREANVMQQLDNP 56
Query: 69 ---KWFGV-EGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+ G+ E E ++V++L + F N+ + K + L Q+ ++Y+ F
Sbjct: 57 YIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 125 LHRDIKPDNFLMGLGRKSNQVY--IIDYGLAK------KYRDLQTHKHIPYRENKNLTGT 176
+HRD+ N L+ Q Y I D+GL+K Y +TH P +
Sbjct: 117 VHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK-------- 163
Query: 177 ARYAS--VNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEKK 232
YA +N + + S + D+ S G VLM+ F G P++G+K Q + ++
Sbjct: 164 -WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GER 216
Query: 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
M P + P E C + +++P ++ ++ R+ +
Sbjct: 217 MECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQT--GEEVAVKLE-SVKTKHP----QLHYESKLYMLLQ 60
++ L +++G GSFG +YL + + E + V E V +P Q + E++L L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN---RKFSLKTVLMLADQLINRVE 117
V F + ++ G L+ + S V QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR---DLQTHKHIPYRENKNLT 174
YMH R LHRD+K N + K+N + I D+G+++ DL T T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 175 GTARYASVN--THLGVEQSRRDDLESLGYVL 203
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139
+V + L L+ + C S+ V + QL+ + Y H R LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLES 198
+ ++ + D+GLA+ K +P + N T Y + LG E S D+
Sbjct: 138 -EKGELKLADFGLARA-------KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG 189
Query: 199 LGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP-----SEFTSY 251
+G +L G + G T K++ I + + TP E +++P EF SY
Sbjct: 190 VGCILYEMATGRPMFPG---STVKEELHLIF-RLLGTPTE---ETWPGITSNEEFRSY 240
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 49/153 (32%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 11 LGRKIGSGSFGELYLGVNV-QTGEEVAVKLESVKTKHPQLHYE---SKLYMLLQGGTGVP 66
LGR IG G FG++Y GV + E++AV +++ K E + Y++ Q P
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQ--FDHP 67
Query: 67 HL-KWFGVEGEYNVMVIDLLGPSLEDLFNYCN-RKFSLK--TVLMLADQLINRVEYMHSR 122
H+ K GV E V ++ L P L +L +Y K+SL ++++ + QL + Y+ S+
Sbjct: 68 HIVKLIGVITENPVWIVMELAP-LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 123 GFLHRDIKPDNFLMGLGRKSNQ-VYIIDYGLAK 154
F+HRDI N L+ S V + D+GL++
Sbjct: 127 RFVHRDIAARNVLVS----SPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 13/109 (11%)
Query: 116 VEYMHSRGFLHRDIKPDNFLM-GLGRKSNQVYIIDYGLAK-KYRDLQT-----HKHIPYR 168
+EY+H+ G +HRD+KPDN L+ +G + + D+GL+K L T H R
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 169 E--NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
E +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 42/167 (25%), Positives = 71/167 (42%), Gaps = 11/167 (6%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK----LESVKTKHPQLHYESKLYMLLQGG 62
K+++ +G G++G + N TGE VA+K E + E K+ L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 63 TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
V + F +G +V + + +L +L V QL+ + Y HS
Sbjct: 61 NIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
+HRDIKP+N L+ +S + + D+G A R L+ P +
Sbjct: 120 NIIHRDIKPENILV---SESGVLKLCDFGFA---RALRARPASPLTD 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 28/163 (17%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP--QLHYESKLYMLLQGGTGVPHLKWFG 72
+GSG++G + + +TG VAVK K P + + + Y L+ + H+K
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRL---LKHMKHEN 77
Query: 73 VEG------------EYN--VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
V G E+N +V L+G L ++ C +K + V L Q++ ++Y
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-C-QKLTDDHVQFLIYQILRGLKY 135
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
+HS +HRD+KP N + + ++ I+D+GLA+ D T
Sbjct: 136 IHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 34/158 (21%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK--LESVKTKH------------PQLHYESKLYMLL 59
+G GS+G + + +TG+ VA+K LES K QL +E+ L L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN-LVNLI 66
Query: 60 QGGTGVPHLK--WFGVEGEYNVMVIDLLGPS-LEDLFNYCNRKFSLKTVLMLADQLINRV 116
+ V K + +V + + + L+DL Y N V Q++ +
Sbjct: 67 E----VFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGI 113
Query: 117 EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
E+ HS +HRDIKP+N L+ +S V + D+G A+
Sbjct: 114 EFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 29/154 (18%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQG--GTGVPHL-KWF 71
IG G++G +Y G +V TG VA+K+ ++ T + + LL + P++ K++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 72 GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR------------VEYM 119
G L GP L + Y S++T LM A + + ++Y+
Sbjct: 69 GSY---------LKGPRLWIIMEYAEGG-SVRT-LMKAGPIAEKYISVIIREVLVALKYI 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
H G +HRDIK N L+ + V + D+G+A
Sbjct: 118 HKVGVIHRDIKAANILV---TNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 40/150 (26%), Positives = 72/150 (48%), Gaps = 19/150 (12%)
Query: 12 GRKIGSGSFGELYLGVNVQTGEEVAVKL------ESVKTKHPQLHYESKLYMLLQGGTGV 65
+IGSG+ G +Y ++ TG A+K+ ++V+ Q+ E ++ + V
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR---QICREIEILRDVNHPNVV 135
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLM-LADQLINRVEYMHSRGF 124
F GE V++ + G SLE + + L +A Q+++ + Y+H R
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLE------GTHIADEQFLADVARQILSGIAYLHRRHI 189
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+HRDIKP N L+ + V I D+G+++
Sbjct: 190 VHRDIKPSNLLINSAK---NVKIADFGVSR 216
|
Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 24/110 (21%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP---- 166
QL+ ++Y+HS +HRD+KP N L L V + D+GLA+ +L+ + P
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLADFGLARSLSELEENPENPVLTD 171
Query: 167 ------YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 210
YR + L G+ RY GV D+ S+G +L L G
Sbjct: 172 YVATRWYRAPEILLGSTRYTK-----GV------DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTG----VPH 67
IG G FGE+Y TG+ A+K + +K K + ++ ML TG +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFL 125
+ + + ++DL+ DL + ++ FS K + A ++I +E+MH+R +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT- 184
+RD+KP N L+ + V I D GLA + + H + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-06
Identities = 41/160 (25%), Positives = 67/160 (41%), Gaps = 9/160 (5%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY-----ESKLYMLLQGGTGVPH 67
R+IG GSFG +Y +V+T E VA+K S K + E K ++ + +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 127
+ E +++ LG S DL + + + + + Y+HS +HR
Sbjct: 91 KGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 149
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
DIK N L+ + QV + D+G A + PY
Sbjct: 150 DIKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEE----VAVKLESVKTKHPQLHYESKLYMLLQGGT 63
+ K + +GSG+FG +Y G+ V GE VA+K+ + +T P+ + E L+
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASM 66
Query: 64 GVPHL-KWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLML--ADQLINRVEYMH 120
PHL + GV + ++ L P L K ++ + L+L Q+ + Y+
Sbjct: 67 DHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
R +HRD+ N L+ + N V I D+GLA+
Sbjct: 127 ERRLVHRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 50/202 (24%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYML-LQGGTGVPHLKWF 71
KIG GS G + + + TG +VAVK ++ K + +L + + M Q V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 72 GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131
V E V++ L G +L D+ + + + + + ++ + ++H++G +HRDIK
Sbjct: 86 LVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 191
D+ L+ +V + D+G Q K +P R K+L GT + + +
Sbjct: 144 DSILL---TSDGRVKLSDFGFCA-----QVSKEVPRR--KSLVGTPYWMAPEVISRLPYG 193
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 56/277 (20%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV-----PH 67
KIG G+FG++Y GV ++ EVAVK + ++ P LQ + P+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKRK----FLQEAEILKQYDHPN 53
Query: 68 L-KWFGVEGE-YNVMVIDLLGPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEYMHSR 122
+ K GV + + ++ L P L + +K ++K +L ++ +EY+ S+
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPG-GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-----YRDLQTHKHIPYR----ENKNL 173
+HRD+ N L+G +N + I D+G++++ Y K IP + E N
Sbjct: 113 NCIHRDLAARNCLVGE---NNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN- 168
Query: 174 TGTARYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKI-SE 230
RY S D+ S G +L++ F G P+ G+ + +Q ++I S
Sbjct: 169 --YGRYTS-----------ESDVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERIESG 211
Query: 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS 267
+M P + P E C + E++P +S
Sbjct: 212 YRMPAP-----QLCPEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 57/200 (28%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQ---------------------- 48
KIG G++G +Y + T E +A+K LE P
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 49 -LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL-LGPSLEDLFNYCNRKFSLKTVL 106
+H E +LY++ EY +DL L ++ ++ +KT L
Sbjct: 69 VVHSEKRLYLVF----------------EY----LDLDLKKHMDSSPDFAKNPRLIKTYL 108
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR-DLQTHKH- 164
Q++ + Y HS LHRD+KP N L + R++N + + D+GLA+ + ++T H
Sbjct: 109 Y---QILRGIAYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHE 163
Query: 165 ---IPYRENKNLTGTARYAS 181
+ YR + L G+ Y++
Sbjct: 164 VVTLWYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 61/272 (22%), Positives = 111/272 (40%), Gaps = 21/272 (7%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY-ESKLYMLLQGGTGVPH 67
+L K+G G FGE+++G T VA+K T P+ E+++ L+ V
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL 66
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 127
E Y V G L+ L + L ++ +A Q+ + + Y+ ++HR
Sbjct: 67 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 128 DIKPDNFLMGLGRKSNQV-YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186
D++ N L+G N V + D+GLA+ D + Y + ++ + L
Sbjct: 127 DLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAPEAAL 176
Query: 187 GVEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245
+ + D+ S G +L +G +P+ G+ ++ D++ E+ P C P
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC---P 229
Query: 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
C E++P + YL+ D F
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 52/213 (24%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFG 72
K+G GS+ +Y G++ G+ VA+K+ S+KT+ E + ++ + + LK
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTE------EGVPFTAIREASLLKGLKHAN 64
Query: 73 VEGEYNVMVIDLL--GPSLEDLFNYCNRKFSL-----------KTVLMLADQLINRVEYM 119
+ V++ D++ +L +F Y + + V + QL+ + Y+
Sbjct: 65 I-----VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 120 HSRGFLHRDIKPDNFLMG-LGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
H + LHRD+KP N L+ LG ++ + D+GLA+ K IP + + T
Sbjct: 120 HGQHILHRDLKPQNLLISYLG----ELKLADFGLARA-------KSIPSQTYSSEVVTLW 168
Query: 179 YASVNTHLG-VEQSRRDDLESLGYVLMYFLRGS 210
Y + LG + S D+ G + + L+G
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 13/161 (8%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYES--KLYMLLQGGTGVPHLKWF 71
+IG GSFG +Y N T E VAVK S K ++ K LQ + H
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ---LKHPNTI 84
Query: 72 GVEGEY-----NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 126
+G Y +V++ S DL + + + + + Y+HS +H
Sbjct: 85 EYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIH 144
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
RDIK N L+ + QV + D+G A K + PY
Sbjct: 145 RDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 40/165 (24%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM--------LLQGGTG 64
+++GSG++G + ++ +TG +VA+K K P ++S+L+ LL+
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIK----KLYRP---FQSELFAKRAYRELRLLK---- 69
Query: 65 VPHLKWFGVEGEYNV--------------MVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD 110
H+K V G +V +V+ +G L L + K S + L
Sbjct: 70 --HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVY 125
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
Q++ ++Y+H+ G +HRD+KP N + + ++ I+D+GLA++
Sbjct: 126 QMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 39/158 (24%), Positives = 66/158 (41%), Gaps = 19/158 (12%)
Query: 92 LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151
++N F + A Q+I +E++H R ++RD+KP+N L+ V I D G
Sbjct: 84 IYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD---DHGNVRISDLG 140
Query: 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 211
LA + + + K GT Y + G D +LG L + G
Sbjct: 141 LAVELKGGKK--------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
Query: 212 PWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFT 249
P++ +K+K +K K+ + V YP +F+
Sbjct: 193 PFR-----QRKEKVEKEELKRRTLEMAV---EYPDKFS 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 50/173 (28%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-----------------KHPQL-------H 50
+G G+FG++Y + +TG A K+ +++ KHP +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 51 YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD 110
YE+KL++L++ G G + ++++L E Y R
Sbjct: 73 YENKLWILIEFCDG----------GALDSIMLELERGLTEPQIRYVCR------------ 110
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL-AKKYRDLQTH 162
Q++ + ++HS +HRD+K N L+ L V + D+G+ AK LQ
Sbjct: 111 QMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKR 160
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 45/169 (26%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL------------ESVKTKHPQLHYESK-- 54
F + + I G+FG++YLG + AVK+ V+ + L SK
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL-SKSP 64
Query: 55 ----LYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLG---PSLEDLFNYCNRKFSLKTVLM 107
LY LQ V Y VM L+G SL ++ Y + + ++K +
Sbjct: 65 FIVHLYYSLQSANNV-----------YLVMEY-LIGGDVKSLLHIYGYFDEEMAVKYISE 112
Query: 108 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYI--IDYGLAK 154
+A L +Y+H G +HRD+KPDN L+ SN+ +I D+GL+K
Sbjct: 113 VALAL----DYLHRHGIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK--LESVKTKHPQL-HYESKLYMLLQGGTG-VPHLKW 70
IG G+FGE+ L TG+ A+K L+S K QL H +++ +L + + V L +
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYY 68
Query: 71 FGVEGEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 128
+ +Y ++++ L G + L Y FS + + +E +H GF+HRD
Sbjct: 69 SFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY------RENKNLTGTARYASV 182
IKPDN L+ + + + D+GL+ + + H Y + NKN +V
Sbjct: 127 IKPDNILID---RGGHIKLSDFGLSTGFH--KQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181
Query: 183 NT 184
++
Sbjct: 182 DS 183
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 54/221 (24%), Positives = 84/221 (38%), Gaps = 39/221 (17%)
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+F A ++I ++++H +G ++RD+K DN L+ K + I D+G+ K+
Sbjct: 92 RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENM- 147
Query: 159 LQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
E K T GT Y + G + + D S G VL+Y L G P+ G
Sbjct: 148 --------NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
Query: 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275
E ++ I +P + C S FE P KRL D
Sbjct: 199 E------------DEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT----KRLGVD 242
Query: 276 LFIREGYQFDYVFDWTILKYPQTGSSSRSRPSGKPNLNPAG 316
IR+ + F DW L+ + P KP +
Sbjct: 243 GDIRQ-HPFFRGIDWERLEKREI------PPPFKPKVKSPS 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 33/271 (12%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKL--ESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
+++GSG FG ++LG + +VA+K+ E ++ + E+K+ M L P+L
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSH----PNL 61
Query: 69 -KWFGVEGEYNVMVIDLLGPSLEDLFNYCNR---KFSLKTVLMLADQLINRVEYMHSRGF 124
+ +GV + + I + L NY K + +L + + +EY+ S GF
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
+HRD+ N L+G + N V + D+GLA+ D Q Y ++ ++A
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQ------YTSSQGTKFPVKWAPPEV 172
Query: 185 HLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEKKML-TPIEVLC 241
S + D+ S G VLM+ F G +P++ + + +S L P
Sbjct: 173 FDYSRFSSKSDVWSFG-VLMWEVFSEGKMPYERFSNS---EVVESVSAGYRLYRP----- 223
Query: 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRL 272
K P+E + + C + ED+P + L
Sbjct: 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 50/182 (27%), Positives = 76/182 (41%), Gaps = 47/182 (25%)
Query: 14 KIGSGSFGELYLGVNVQTGEE---VAVK--------------LESVKTKHPQLHYES--K 54
K+G GSFG + G +G + VAVK L+ H L +E+ +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMH-SLDHENLIR 60
Query: 55 LYMLLQGGTGVPHLKWFGVEGEYNVMVIDL--LGPSLEDLFNYCNRKFSLKTVLMLADQL 112
LY GV V +MV +L LG L+ L F + T+ A Q+
Sbjct: 61 LY-------GV-------VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI 106
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-------YRDLQTHKHI 165
N + Y+ S+ F+HRD+ N L+ K V I D+GL + Y ++ H +
Sbjct: 107 ANGMRYLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDHYV-MEEHLKV 162
Query: 166 PY 167
P+
Sbjct: 163 PF 164
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 47/193 (24%), Positives = 91/193 (47%), Gaps = 14/193 (7%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTGV 65
F+ + IG G+FGE+ L TG A+K+ + K H ++ +L++ +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMHSR 122
++ + + N+ +I P D+ +K +L +T +A+ ++ ++ +H
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPG-GDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQL 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE-NKNLTGTARYAS 181
GF+HRDIKPDN L+ V + D+GL + + H+ YR N +L + +
Sbjct: 121 GFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDFTFQN 175
Query: 182 VNTHLGVEQSRRD 194
+N+ E +R+
Sbjct: 176 MNSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQG--GTGVPHLKWF 71
K+G GS+ +Y G + G+ VA+K+ ++ + + LL+G + L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 72 GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131
E +V + + L + + V + QL+ + Y+H R LHRD+KP
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKP 131
Query: 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQ 190
N L+ + ++ + D+GLA+ K +P N T Y + LG E
Sbjct: 132 QNLLIS---DTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 191 SRRDDLESLGYVLMYFLRGSLPWQGLK 217
S D+ +G + + ++G + G+K
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 11/131 (8%)
Query: 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139
+V + L L+ + C ++ V + QL+ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLES 198
+ ++ + D+GLA+ K IP + N T Y + LG + S + D+
Sbjct: 139 -ERGELKLADFGLARA-------KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWG 190
Query: 199 LGYVLMYFLRG 209
+G + G
Sbjct: 191 VGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 61/272 (22%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY-ESKLYMLLQGGTGVPH 67
+L K+G G FGE+++G T +VA+K T P+ E+++ L+ VP
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL 66
Query: 68 LKWFGVEGEYNVMVIDLLGP-SLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSRGFL 125
E Y +V + +G SL D + K+ L ++ +A Q+ + + Y+ ++
Sbjct: 67 YAVVSEEPIY--IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKSNQV-YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
HRD++ N L+G N V I D+GLA+ D + Y + ++ +
Sbjct: 125 HRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWTAPEA 174
Query: 185 HLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243
L + + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV-ERGYRMPCPQGC-- 228
Query: 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275
P C +++P + Y++ D
Sbjct: 229 -PESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 10/117 (8%)
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
KF L A ++I ++++HS+G ++RD+K DN L+ + I D+G+ K+
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKE--- 145
Query: 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + GT Y + LG + + D S G +L L G P+ G
Sbjct: 146 ----NMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 12 GRKIGSGSFGELYLGVNVQTGEEVAVK--------LESVKTKHPQLHYESKLYMLLQGGT 63
G +G G++G +Y G+ G+ +AVK + + + ++ +L E L L+
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 64 GVPHLKWFGVEGEYNVM-----------VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQL 112
V +L + ++ +++ GP E +F K++ Q+
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF----CKYT--------KQI 111
Query: 113 INRVEYMHSRGFLHRDIKPDN-FLMGLGRKSNQVYIIDYGLAKKYRDLQ---THKHIPYR 168
++ V Y+H+ +HRDIK +N LM G + +ID+G A++ + TH ++
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML-- 165
Query: 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 166 --KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 37/163 (22%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVK--LESVKTKHPQLHYESKLYMLLQGGTGVPH 67
KL KIG GS+G ++ N +TG+ VA+K +ES P + K+ + +
Sbjct: 5 KLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVES--EDDPVIK---KIAL-----REIRM 53
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD----------------Q 111
LK N++ + L +F YC+ TVL + Q
Sbjct: 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH-----TVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 112 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+ V + H +HRD+KP+N L+ K Q+ + D+G A+
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 11/131 (8%)
Query: 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139
+V + L L+ + C S+ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN-- 138
Query: 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLES 198
+ ++ + D+GLA+ K +P + N T Y + LG E S + D+
Sbjct: 139 -ERGELKLADFGLARA-------KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG 190
Query: 199 LGYVLMYFLRG 209
+G + G
Sbjct: 191 VGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 31/226 (13%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPH-- 67
L R++G G+FG+++L L +VK K P L + T + H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 68 -LKWFGV--EGEYNVMVIDLL------------GPSLEDLFN----YCNRKFSLKTVLML 108
+K++GV +G+ +MV + + GP L + + L +L +
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 109 ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168
A Q+ + + Y+ S+ F+HRD+ N L+G V I D+G++ RD+ + + YR
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY--YR 180
Query: 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPW 213
+ R+ + + + + D+ S G +L F G PW
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 44/205 (21%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGVPHLK 69
++G+G+ G + ++ TG+ +AVK LE + Q+ E + V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 70 WFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRD 128
F G+ ++ + + G SL+ + + + + +A ++ + Y+H +HRD
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRD 126
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV 188
+KP N L+ Q+ + D+G++ + + K GT+ Y + G
Sbjct: 127 VKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPERIQGN 174
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPW 213
+ S + D+ SLG L+ G P+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 13 RKIGSGSFGELYL------GVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
R +G G FG++ L G N TGE+VAVK ++ + K +L+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 67 HLKWFGV---EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+K+ G+ +G + +I P SL++ K +LK L A Q+ ++Y+ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
R ++HRD+ N L+ +QV I D+GL K
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 70/299 (23%), Positives = 114/299 (38%), Gaps = 69/299 (23%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYE------SKLYMLLQGGTG 64
G+ +G+G+FG++ + AV +VK P H S+L ++ G
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG-- 96
Query: 65 VPHLKWFGVEGEYNVMVIDLL------GPSL--------EDLFNYCNRK----FSLKTVL 106
H +++LL GP L DL N+ RK +L+ +L
Sbjct: 97 -NHEN-----------IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL 144
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166
+ Q+ + ++ S+ +HRD+ N L+ G+ V I D+GLA RD I
Sbjct: 145 SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLA---RD------IM 192
Query: 167 YRENKNLTGTARYA-------SVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPWQGLKA 218
N + G AR S+ + +S D+ S G +L F GS P+ G+
Sbjct: 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFES---DVWSYGILLWEIFSLGSNPYPGMPV 249
Query: 219 GTKKQKYDKISEK-KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+K Y I E +M P P+E C +P + + +L
Sbjct: 250 DSK--FYKLIKEGYRMAQPEHA-----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 46/183 (25%), Positives = 69/183 (37%), Gaps = 51/183 (27%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY--ESKLYMLLQ 60
+G ++ R +G GS G ++ V+ + VAVK + H E K+ L
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTV-----LMLAD----- 110
H + V V ++LGPS DL L +V M D
Sbjct: 61 ------H--------DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL 106
Query: 111 ---------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ----VYIIDYG 151
QL+ ++Y+HS LHRD+KP N + N + I D+G
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFG 160
Query: 152 LAK 154
LA+
Sbjct: 161 LAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 7e-05
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHY---------ESK-LYMLLQGGT 63
I G+ E+YLG + G + +K K +HP+L E++ + + G
Sbjct: 4 IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 64 GVPHLKWFGVEGEYNVM-VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
VP + + E VM I+ G L+DL N + + +L+ + +HS
Sbjct: 62 NVPAVYFVDPENFIIVMEYIE--GEPLKDLINSNGME--ELELSREIGRLVGK---LHSA 114
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
G +H D+ N ++ ++Y+ID+GLA+ +DL+
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDLEDR 150
|
Length = 211 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 20/55 (36%), Positives = 31/55 (56%), Gaps = 5/55 (9%)
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYREN 170
+E +H GF+HRDIKPDN L+ + + + D+GL +R TH Y++
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG 163
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 39/150 (26%), Positives = 76/150 (50%), Gaps = 11/150 (7%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV 73
K+G G +GE+Y GV + VAVK ++K ++ K +++ ++ GV
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVK--TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 74 ---EGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLML--ADQLINRVEYMHSRGFLHRD 128
E + ++ + +L D CNR+ + V++L A Q+ + +EY+ + F+HRD
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+ N L+G +++ V + D+GL++
Sbjct: 130 LAARNCLVG---ENHLVKVADFGLSRLMTG 156
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 20/67 (29%), Positives = 35/67 (52%), Gaps = 5/67 (7%)
Query: 91 DLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148
DLF Y +R L+ + + +L+ + Y+H RG +HRD+K +N + + +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227
Query: 149 DYGLAKK 155
D+G A K
Sbjct: 228 DFGAACK 234
|
Length = 392 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 59/209 (28%), Positives = 87/209 (41%), Gaps = 53/209 (25%)
Query: 39 LESVKTKHP---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPS 88
LE+VK HP L Y KLY++L+ GG HL E E G
Sbjct: 54 LEAVK--HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----ERE---------GIF 97
Query: 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148
+ED F L + + +E++H +G ++RD+KP+N L+ V +
Sbjct: 98 MEDT-----ACFYLSEISL-------ALEHLHQQGIIYRDLKPENILLD---AQGHVKLT 142
Query: 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FL 207
D+GL K+ T H GT Y + + + D SLG LMY L
Sbjct: 143 DFGLCKESIHEGTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLG-ALMYDML 194
Query: 208 RGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
G+ P+ A +K+ DKI + K+ P
Sbjct: 195 TGAPPFT---AENRKKTIDKILKGKLNLP 220
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 60/232 (25%), Positives = 92/232 (39%), Gaps = 28/232 (12%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWF 71
IG GSFG++ L G AVK+ KT K Q H ++ +LL+ + H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKN---LKHPFLV 59
Query: 72 GVEGEYNV-----MVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGF 124
G+ + V+D + +LF + R+ F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
++RD+KP+N L+ V + D+GL K+ + P GT Y +
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKEGVE-------PEETTSTFCGTPEYLAPEV 167
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
R D LG VL L G P+ Q YD I K + P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 23/225 (10%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY----ESKLYMLLQGGTGVPHLKW 70
+G G FGE+ + TG+ A+K+ Q E + + + +P L++
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 71 FGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 129
+ + +V++ G L L N +F +L+ + +H G++HRDI
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI 128
Query: 130 KPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY------ASVN 183
KP+N L+ ++ + + D+G A + L +K + +K GT Y ++N
Sbjct: 129 KPENVLID---RTGHIKLADFGSAAR---LTANKMV---NSKLPVGTPDYIAPEVLTTMN 179
Query: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 228
D SLG + + G P+ GT + Y+ I
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFH---EGTSAKTYNNI 221
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 39/155 (25%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYES-KLYMLLQGGTGVPH---LK 69
+IG G++G +Y + +G VA+K V+T L + + LL+ H ++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 70 WFGV----EGEYNVMVIDLLGPSLEDLFNYCNR----KFSLKTVLMLADQLINRVEYMHS 121
V + V + +DL Y ++ +T+ L Q + ++++H+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+HRD+KP+N L+ G QV + D+GLA+ Y
Sbjct: 127 NCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 59/178 (33%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL-------------------------ESVK 43
FK K+G G++ +Y G N TGE VA+K E++
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 44 TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN-----R 98
H +H E+KL ++ EY +D +DL Y +
Sbjct: 62 RLHDVIHTENKLMLVF----------------EY----MD------KDLKKYMDTHGVRG 95
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
TV QL+ + + H LHRD+KP N L+ K ++ + D+GLA+ +
Sbjct: 96 ALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAF 150
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 35/152 (23%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH----LK 69
++G G+FG++Y N +TG A K+ K++ Y ++ +L P+ L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDIL--ASCDHPNIVKLLD 69
Query: 70 WFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 129
F E +++ G +++ + R + + ++ Q + + Y+H +HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 130 KPDNFLMGLGRKSNQVYIIDYGL-AKKYRDLQ 160
K N L L + + D+G+ AK R +Q
Sbjct: 130 KAGNILFTL---DGDIKLADFGVSAKNTRTIQ 158
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 33/268 (12%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTGVPHLKWF 71
IG GSFG++ L + G+ AVK+ +++ K Q H ++ +LL+ V H F
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKN---VKHP--F 57
Query: 72 GVEGEYNVMVIDLLGPSLE-----DLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGF 124
V Y+ D L L+ +LF + R+ F A ++ + + Y+HS
Sbjct: 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
++RD+KP+N L+ V + D+GL K+ ++ K GT Y +
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKE--GIEHSK-----TTSTFCGTPEYLAPEV 167
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--KMLTPIEVLCK 242
R D LG VL L G P+ + + YD I K ++ I V +
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLYGLPPFY---SRDTAEMYDNILNKPLRLKPNISVSAR 224
Query: 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLK 270
R+ R K D+ +K
Sbjct: 225 HL---LEGLLQKDRTKRLGAKDDFLEIK 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 1e-04
Identities = 36/160 (22%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV 65
G F+L +G+G++G++Y G +V+TG+ A+K+ V T + + ++ ML +
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 63
Query: 66 PHLKWFGVEGEYNV--------MVIDLLGP-SLEDLF-NYCNRKFSLKTVLMLADQLINR 115
++G + N +V++ G S+ DL N + + + +++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ ++H +HRDIK N L+ ++ +V ++D+G++ +
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 70/298 (23%), Positives = 119/298 (39%), Gaps = 58/298 (19%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGGTGVPHLK 69
+G GSFG++ L GE AVK + + E ++ L + HL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 70 WFGVEGEYNVMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHR 127
E+ V++ L DL + K F L A +++ ++++HS+G ++R
Sbjct: 63 CTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTH 185
D+K DN ++ + + I D+G+ K+ + +N+ T GT Y +
Sbjct: 121 DLKLDNVMLD---RDGHIKIADFGMCKEN---------VFGDNRASTFCGTPDYIAPEIL 168
Query: 186 LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-KMLTPIEVLCKSY 244
G++ + D S G +L L G P+ G D++ E ++ TP
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-------DDEDELFESIRVDTP-------- 213
Query: 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLF-RDLFIREG-------YQFDYVFDWTILK 294
HY R + E K L++LF RD R G + F +WT L+
Sbjct: 214 --------HYPRWITKESK---DILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALE 260
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 28/105 (26%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYREN 170
Q++ ++++HS G +HRD+KP N ++ + + I+D+GLA+ PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART--ACTNFMMTPY--- 182
Query: 171 KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
T Y + LG+ D+ S+G ++ ++GS+ +QG
Sbjct: 183 ---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 49/202 (24%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYML-LQGGTGVPHLKWF 71
KIG GS G + + +G+ VAVK ++ K + +L + + M Q V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72 GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131
V E V++ L G +L D+ + + + + + + ++ + +H++G +HRDIK
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144
Query: 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS 191
D+ L+ +V + D+G Q K +P R K+L GT + + +
Sbjct: 145 DSILL---THDGRVKLSDFGFCA-----QVSKEVPRR--KSLVGTPYWMAPELISRLPYG 194
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 34/137 (24%), Positives = 61/137 (44%), Gaps = 13/137 (9%)
Query: 92 LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151
++N N F + L A +++ +E +H ++RD+KP+N L+ + I D G
Sbjct: 91 IYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLG 147
Query: 152 LAKKYRDLQTHKHIPYREN-KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 210
LA K IP E+ + GT Y + + D LG ++ + G
Sbjct: 148 LAVK---------IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
Query: 211 LPWQGLKAGTKKQKYDK 227
P++G K K+++ D+
Sbjct: 199 SPFRGRKEKVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 61/271 (22%), Positives = 113/271 (41%), Gaps = 29/271 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ L ++IGSG FG ++LG +VA+K + E+++ M L V
Sbjct: 5 ELTLVQEIGSGQFGLVWLG-YWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV- 62
Query: 67 HLKWFGVEGEYN--VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
+ +GV E + +V + + L D KFS +T+L + + + Y+ S
Sbjct: 63 --QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
+HRD+ N L+G ++ V + D+G+ + D Q Y + +++S
Sbjct: 121 VIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQ------YTSSTGTKFPVKWSSPE 171
Query: 184 THLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK-KMLTPIEVL 240
+ S + D+ S G VLM+ F G P++ + + + I+ ++ P
Sbjct: 172 VFSFSKYSSKSDVWSFG-VLMWEVFSEGKTPYENR---SNSEVVETINAGFRLYKP---- 223
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271
+ +C R ED+P +S L
Sbjct: 224 -RLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGTGVPHLKW 70
IG G+FGE+ L + + + A+KL E +K +E + M V L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 71 FGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 129
+ +Y MV++ + G L +L + N K +++ ++ +HS G +HRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 130 KPDNFLMGLGRKSNQVYIIDYGLAKK 155
KPDN L+ K + + D+G K
Sbjct: 169 KPDNMLLD---KHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVK--LESVKTK--HPQLHYESKLYMLLQGGTGVPHL 68
+ +G G+FG + + TG+ VA+K ++ T + + E KL L+ +
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 69 KWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 128
F E V +LLG L L +R + + Q++ ++Y+HS G +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAK 154
+KP N L+ ++ + I D+GLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 52/168 (30%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGGTGVPHLK 69
IG G++G + N +T E+VA+K ++ L E KL L H
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLD------H-- 63
Query: 70 WFGVEGEYNVMVIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD----------------- 110
E + + D++ P + FN Y + LM D
Sbjct: 64 ------ENVIAIKDIMPPPHREAFNDVY------IVYELMDTDLHQIIRSSQTLSDDHCQ 111
Query: 111 ----QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
QL+ ++Y+HS LHRD+KP N L+ + + I D+GLA+
Sbjct: 112 YFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 19/47 (40%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
+L VE +H GF+HRDIKPDN L+ + + + D+GL +R
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 36/238 (15%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-------KHPQLHYESKL 55
H+ L R++G G+FG+++L E L +VKT H E++L
Sbjct: 1 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 60
Query: 56 YMLLQGGTGVPHLKWFGV--EGEYNVMVIDLL------------GPSLEDLFNYCN--RK 99
LQ V K++GV EG+ +MV + + GP L N +
Sbjct: 61 LTNLQHEHIV---KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAV-LMAEGNRPAE 116
Query: 100 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159
+ +L +A Q+ + Y+ S+ F+HRD+ N L+G ++ V I D+G++ RD+
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDV 170
Query: 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
+ + YR + R+ + + + + D+ SLG VL F G PW L
Sbjct: 171 YSTDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 39/148 (26%), Positives = 63/148 (42%), Gaps = 13/148 (8%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYES--KLYMLLQGGTGVPHLKW 70
R+IG GSFG +Y +V+T E VA+K S K ++ K LQ + H
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ---QLRHPNT 77
Query: 71 FGVEGEY-----NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
+G Y +V++ S D+ + + + + + Y+HS +
Sbjct: 78 IEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
HRDIK N L+ + V + D+G A
Sbjct: 138 HRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 39/142 (27%), Positives = 69/142 (48%), Gaps = 10/142 (7%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGTGVPHLKW 70
IG G+FGE+ L + + + A+KL E +K +E + M + L +
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 71 FGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 129
+ +Y MV++ + G L +L + N K +++ ++ +HS GF+HRD+
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 130 KPDNFLMGLGRKSNQVYIIDYG 151
KPDN L+ KS + + D+G
Sbjct: 169 KPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEE----VAVKLESVKTKHPQLHYESKLYMLLQGGT 63
+FK + +GSG+FG +Y G+ + GE+ VA+K T P+ + E +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASV 66
Query: 64 GVPHL-KWFGVEGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
PH+ + G+ V +I L P L D + +L Q+ + Y+
Sbjct: 67 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
R +HRD+ N L+ + V I D+GLAK
Sbjct: 127 ERRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGG 62
++K+ IG GS+G + ++ TGE+VA+K E V L E KL LL+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 63 --TGVPHLKWFGVEGEYN--VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
+ H+ E+ +V +L+ L + N + + QL+ ++Y
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLRALKY 118
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+H+ HRD+KP N L K + I D+GLA+
Sbjct: 119 IHTANVFHRDLKPKNILANADCK---LKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
K + +A+ ++ + Y+HSR +HRDIKP N L+ + QV + D+G++ + +
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 212
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYES--KLYMLLQGGTGVPHLKW 70
R+IG GSFG +Y +V+ E VA+K S K ++ K LQ +++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 71 FG--VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 128
G + +V++ S DL + + + + + Y+HS +HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
+K N L+ + V + D+G A PY
Sbjct: 141 VKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTGVPHLK 69
+ +G G+FGE+ L V T A+K + V ++ H +++ +L +
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 70 WFGVEGEYNV-MVIDLLGPSLEDLFNYCNRKFSLKTVL--MLADQLINRVEYMHSRGFLH 126
++ + + N+ V+D + D+ + R VL +L +E +H GF+H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGG--DMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH 124
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 173
RDIKPDN L+ L + + D+GL +R TH Y++ ++
Sbjct: 125 RDIKPDNILIDL---DGHIKLTDFGLCTGFR--WTHNSKYYQKGSHI 166
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 61/275 (22%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 9 FKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+L +K+G+G FGE+++G N T +VAVK T P+ E M + H
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNT--KVAVKTLKPGTMSPESFLEEAQIM-----KKLRH 60
Query: 68 ---LKWFGVEGEYNVMVIDLL---GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
++ + V E + ++ G L+ L + R L ++ +A Q+ + Y+
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
++HRD++ N L+G G I D+GLA+ D + Y + ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
L + + D+ S G +L + +G +P+ G+ ++ +++ E+ P
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQD 227
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275
C P C E++P + YL+ D
Sbjct: 228 C---PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 14/213 (6%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
++++ +KIG GSFG++YL E +K + + SK ++L P+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 68 L-KWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK----FSLKTVLMLADQLINRVEYMHSR 122
+ +F E + I + DL NR+ FS +L Q+ ++++H R
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
LHRDIK N L + + D+G+A R L + Y GT Y S
Sbjct: 121 KILHRDIKSQNIF--LSKNGMVAKLGDFGIA---RQLNDSMELAY----TCVGTPYYLSP 171
Query: 183 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + D+ SLG VL P++G
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 18/49 (36%), Positives = 29/49 (59%), Gaps = 3/49 (6%)
Query: 91 DLFNYCNRK---FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 136
DL+ Y + L V +A QL++ ++Y+H G +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 13/100 (13%)
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
V+ +H G++HRD+KP+NFL+ S + + D+GL+K ++ G
Sbjct: 114 VDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA----------NSVVG 160
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ Y + G D SLG +L FL G P+ G
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 46/180 (25%), Positives = 84/180 (46%), Gaps = 40/180 (22%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYML--LQGG 62
+G +++ IG G++G + + TG +VA+K S P +E + + L+
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-----P---FEHQTFCQRTLRE- 53
Query: 63 TGVPHLKWFGVEGEYNVMVI-DLLGPSLEDLFN--YCNRKF---SLKTVL---MLAD--- 110
+ L+ F E N++ I D++ P + FN Y ++ L ++ L++
Sbjct: 54 --IKILRRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHI 108
Query: 111 -----QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDLQTHKH 164
Q++ ++Y+HS LHRD+KP N L+ +N + I D+GLA+ H H
Sbjct: 109 QYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLARI--ADPEHDH 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 35/160 (21%), Positives = 80/160 (50%), Gaps = 14/160 (8%)
Query: 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV 65
G F+L +G+G++G++Y G +V+TG+ A+K+ V T+ + + ++ ML +
Sbjct: 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHR 73
Query: 66 PHLKWFGV--------EGEYNVMVIDLLGP-SLEDLF-NYCNRKFSLKTVLMLADQLINR 115
++G + +V++ G S+ DL N + + +++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ ++H+ +HRDIK N L+ ++ +V ++D+G++ +
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 170
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 11/149 (7%)
Query: 13 RKIGSGSFGELYLGVNVQTGEE----VAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
+ +GSG+FG +Y G+ + GE VA+K+ T P+ + E + G G P++
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYV 71
Query: 69 -KWFGVEGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
+ G+ V ++ L P L D + + +L Q+ + Y+ +
Sbjct: 72 CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
HRD+ N L+ + N V I D+GLA+
Sbjct: 132 HRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 16/172 (9%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTGV 65
F+ + IG G+FGE+ L TG A+K+ + K H ++ +L++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSL---KTVLMLADQLINRVEYMHSR 122
++ + + N+ +I P D+ +K +L T +A+ ++ ++ +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPG-GDMMTLLMKKDTLSEEATQFYIAETVL-AIDAIHQL 120
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174
GF+HRDIKPDN L+ V + D+GL + + H+ YR NLT
Sbjct: 121 GFIHRDIKPDNLLLD---AKGHVKLSDFGLCTGLK--KAHRTEFYR---NLT 164
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 17/151 (11%)
Query: 15 IGSGSFGEL----YLGVNVQTGEEVAVK-LESVKTKHPQ-LHYESKLYMLLQGGTGVPHL 68
+G G+FG + Y + TGE VAVK L+ +H + E ++ LQ V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV--- 68
Query: 69 KWFGV---EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
K+ GV G N+ ++ P SL D + + +L+ A Q+ +EY+ S+
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
++HRD+ N L+ N+V I D+GL K
Sbjct: 129 YVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 15/162 (9%)
Query: 11 LGRKIGSGSFGELYLGV-----NVQTGEEVAVK-LESVKTKHPQLHY-ESKLYMLLQGGT 63
L R +G G+FGE+Y G+ +VAVK L ++ + + L M
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69
Query: 64 GVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYC----NRKFSL--KTVLMLADQLINRV 116
+ L E ++++L+ G L+ R SL K +L A +
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 117 EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-YR 157
+Y+ F+HRDI N L+ I D+G+A+ YR
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 39/150 (26%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFG 72
+KIG GSFG+ L + + G++ +K ++ P+ ES+ + + P++ +
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 73 VEGEYN---VMVIDLLGPSLEDLFNYCNRK----FSLKTVLMLADQLINRVEYMHSRGFL 125
E N +V+D DL+ N + F +L Q+ ++++H R L
Sbjct: 66 ESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 126 HRDIKPDN-FLMGLGRKSNQVYIIDYGLAK 154
HRDIK N FL K + + D+G+A+
Sbjct: 124 HRDIKSQNIFLT----KDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHY-ESKLYMLLQGGTG 64
F++ KIG GSFG ++ V A+K L + + + E+++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRG 123
+ + + F +G+ N+++ L L R V Q++ + ++HS+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
LHRDIK N + + V I D G+AK
Sbjct: 122 ILHRDIKSLNLFLD---AYDNVKIGDLGVAK 149
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 47/235 (20%), Positives = 97/235 (41%), Gaps = 28/235 (11%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
FK+ +K+G GS+G +Y + + A+K + + + ++ + + P++
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61
Query: 69 KWFG---VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVL------MLADQLINRVEYM 119
+ ++G N + I + DL +++ + ++ + QL+ ++ +
Sbjct: 62 ISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
H + LHRD+K N L+ + V I D G++K + K GT Y
Sbjct: 120 HEQKILHRDLKSANILLVAN---DLVKIGDLGISKVLKKNMA---------KTQIGTPHY 167
Query: 180 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG-----LKAGTKKQKYDKIS 229
+ G S + D+ SLG +L + P++ L+ ++ KY I
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 29/183 (15%)
Query: 97 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
N F Q+I+ +E++H R ++RD+KP+N L+ V I D GLA +
Sbjct: 91 NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVEL 147
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL--RGSLPWQ 214
+D Q+ + K GT + + G E D +LG L + RG +
Sbjct: 148 KDGQS-------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200
Query: 215 GLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFT-SYFHYCRSLRFEDKPDYSYLKRL- 272
G K K+ K +++ + +YP +F+ + +C +L P+ KRL
Sbjct: 201 GEKVENKELKQRILND-----SV-----TYPDKFSPASKSFCEAL-LAKDPE----KRLG 245
Query: 273 FRD 275
FRD
Sbjct: 246 FRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 13/117 (11%)
Query: 97 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
N++F A Q++ EY+ S ++RD+KP+N L+ K + + D+G AK
Sbjct: 125 NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAKVV 181
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
D +T+ L GT Y + L V + D +LG + L G P+
Sbjct: 182 -DTRTY---------TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 9e-04
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFL-MGLGRKSNQVYIIDYGLAKKY 156
Q+++ + Y+H+ LHRD+KP N L MG G + +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 26/131 (19%), Positives = 52/131 (39%), Gaps = 16/131 (12%)
Query: 31 TGEEVAVKLESVKTKHPQLHYESKLYMLLQG-GTGVPHLKWFGVEGEYNVMVIDLL-GPS 88
E+ +K+ + K E + LL G VP + G ++ ++++ + G +
Sbjct: 20 KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79
Query: 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS---RGFLHRDIKPDNFLMGLGRKSNQV 145
L+++ S + +A+QL + +H H D+ P N L+ +
Sbjct: 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV---DDGKIL 128
Query: 146 YIIDYGLAKKY 156
IID+ A
Sbjct: 129 GIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 19/47 (40%), Positives = 30/47 (63%), Gaps = 1/47 (2%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFL-MGLGRKSNQVYIIDYGLAKKY 156
Q+++ + Y+H+ LHRD+KP N L MG G + +V I D G A+ +
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 28/229 (12%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTGVPHLKWF 71
IG GSFG++ L + + AVK+ +++ K + H S+ +LL+ V H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKN---VKHPFLV 59
Query: 72 GVEGEYNV-----MVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRGF 124
G+ + V+D + +LF + R+ F A ++ + + Y+HS
Sbjct: 60 GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
++RD+KP+N L+ + + D+GL K+ + GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHIVLTDFGLCKENIE-------HNGTTSTFCGTPEYLAPEV 167
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233
R D LG VL L G P+ + YD I K +
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 18/46 (39%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
QL+ ++++HS +HRD+KP N L+ S Q+ + D+GLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 15/152 (9%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
KLG IG G FG++ LG G++VAVK L+ T E+ + L+ P+L
Sbjct: 9 KLGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNL 62
Query: 69 -KWFGV--EGEYNVMVIDLLGP-SLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRG 123
+ GV +G +V + + SL D R +L L A + +EY+ +
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
F+HRD+ N L+ + + D+GLAK+
Sbjct: 123 FVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 13/151 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
K LG IG G FG + G TG++VAVK E+ + L V
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK----FSLKTVLMLADQLINRVEYMHSRG 123
L G Y VM + G +L N+ + S+ +L + + +EY+ S+
Sbjct: 65 LGVILHNGLYIVMELMSKG----NLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+HRD+ N L+ + + D+GLA+
Sbjct: 121 LVHRDLAARNILVS---EDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 52/204 (25%), Positives = 89/204 (43%), Gaps = 24/204 (11%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVK-TKHPQLHYESKLYMLLQGGTGVPHL-KWFG 72
+G G+ G +Y ++ T +AVK+ + T Q S+L +L + + P++ ++G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS--PYIIGFYG 66
Query: 73 ---VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 129
VE ++ + G SL D++ RK + +A ++ + Y+ S LHRD+
Sbjct: 67 AFFVENRISICTEFMDGGSL-DVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 130 KPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE 189
KP N L+ QV + D+G++ Q I K GT Y + G +
Sbjct: 122 KPSNMLVN---TRGQVKLCDFGVST-----QLVNSIA----KTYVGTNAYMAPERISGEQ 169
Query: 190 QSRRDDLESLGYVLMYFLRGSLPW 213
D+ SLG M G P+
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGELYLG--VNVQTGEE---VAVKL--ESVKTKHPQLHYESKLYMLLQGGTGVP 66
++G G+FG+++L N+ ++ VAVK E+ ++ E++L +LQ V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV- 70
Query: 67 HLKWFGV--EGEYNVMVIDLL------------GPS---LEDLFNYCNRKFSLKTVLMLA 109
+++GV EG +MV + + GP L + + +L +L +A
Sbjct: 71 --RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
Q+ + + Y+ S F+HRD+ N L+G G V I D+G++ RD+ + + YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180
Query: 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 62/271 (22%), Positives = 117/271 (43%), Gaps = 41/271 (15%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQ---LHYESKLYMLLQGGTGVPHL-KW 70
+G G+FGE++ G ++ VAVK + K PQ + + S+ +L Q P++ K
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDH--PNIVKL 57
Query: 71 FGVEGEYNVMVIDLLGPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEYMHSRGFLHR 127
GV + + I + D ++ +K K ++ A + Y+ S+ +HR
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD----LQTHKHIPYR-ENKNLTGTARYASV 182
D+ N L+G ++N + I D+G++++ D K IP + RY+S
Sbjct: 118 DLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS- 173
Query: 183 NTHLGVEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYDKISEK-KMLTPIEVL 240
D+ S G +L F G P+ G+ T +Q +++ + +M P
Sbjct: 174 ----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQVEKGYRMSCP---- 216
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271
+ P + C + E++P +S L++
Sbjct: 217 -QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
Q++ ++Y+HS LHRD+KP N L+ ++ I D+GLA+ +
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 65/280 (23%), Positives = 120/280 (42%), Gaps = 48/280 (17%)
Query: 15 IGSGSFGELYLGVNVQTGEE-----VAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPH- 67
+G G FGE++L EE V VK L+ K ++ Q + +L M + + H
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK----LSHK 68
Query: 68 --LKWFGV--EGEYNVMVIDLLGPSLEDL--FNYCNRK---------FSLKTVLMLADQL 112
++ G+ E E + M+++ L DL F + S K + L Q+
Sbjct: 69 NVVRLLGLCREAEPHYMILEYT--DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK-KYRDLQTHKHIPYRENK 171
++++ + F+HRD+ N L+ +V + L+K Y + +K +
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVS---SQREVKVSLLSLSKDVYNS-EYYKL------R 176
Query: 172 NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKIS 229
N R+ + + S + D+ S G VLM+ F +G LP+ GL + ++ +++
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFG-VLMWEVFTQGELPFYGL---SDEEVLNRLQ 232
Query: 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269
K+ P+ C PS C ++ +D+P +S L
Sbjct: 233 AGKLELPVPEGC---PSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 59/274 (21%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPH-LKWFG 72
IG G++G+++ +N + G + AVK L+ + ++ E Y +L+ + P+ +K++G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKALSDHPNVVKFYG 82
Query: 73 -------VEGEYNVMVIDLL-GPSLEDL----FNYCNRKFSLKTVLMLADQLINRVEYMH 120
G+ +V++L G S+ DL R +L + L+ ++++H
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG-LQHLH 141
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
+HRD+K +N L+ V ++D+G++ + L + + R N ++ GT +
Sbjct: 142 VNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQ---LTSTRL---RRNTSV-GTPFWM 191
Query: 181 -----SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
+ L R D+ SLG + G P L K + +
Sbjct: 192 APEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251
Query: 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269
P + + +EF + C + +E +P S L
Sbjct: 252 P-----ELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 11/44 (25%), Positives = 24/44 (54%), Gaps = 4/44 (9%)
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
+H G +H D+ N ++ +++Y+ID+GL K +++
Sbjct: 106 LHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEIEDK 145
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 39/178 (21%)
Query: 11 LGRKIGSGSFGELYLG--VNVQTGEE---VAVKL---ESVKTKHPQLHYESKLYMLLQGG 62
L R++G G+FG+++LG +++ + VAVK + E++L Q
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-- 66
Query: 63 TGVPH---LKWFGV--EGEYNVMVIDLL------------GPSLEDLFNYCNRKFSLKTV 105
H +K++GV EG+ +MV + + GP L + + L
Sbjct: 67 ----HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 106 LML--ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
+L A Q+ + + Y+ S+ F+HRD+ N L+G V I D+G++ RD+ T
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---RDVYT 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 14/39 (35%), Positives = 23/39 (58%), Gaps = 3/39 (7%)
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
++ +H G++HRDIKPDN L+ + + D+GL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 38/150 (25%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY-ESKLYMLLQGGTGVPHL 68
KL +K+G+G FGE+++G +VA+K + P+ E+ L LQ P L
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH----PRL 63
Query: 69 -KWFGVEGEYNVMVID--LLGPSLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+ + V + + +I + SL D L K ++ ++ +A Q+ + ++ + +
Sbjct: 64 VRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+HRD++ N L+ ++ I D+GLA+
Sbjct: 124 IHRDLRAANILVS---ETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.003
Identities = 57/233 (24%), Positives = 102/233 (43%), Gaps = 38/233 (16%)
Query: 8 KFKLGRKIGSGSFGELYLGV--NVQTGE---EVAVKLESVK-TKHPQLHYESKLYMLLQG 61
K L R++G GSFG +Y G+ V GE VA+K + + ++ + ++ ++ +
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66
Query: 62 GTGVPHL-KWFGV--EGEYNVMVIDLLGPSLEDLFNYC------NRKFSLKTVLML---- 108
H+ + GV G+ ++V++L+ DL +Y L
Sbjct: 67 NC--HHVVRLLGVVSTGQPTLVVMELMA--KGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 109 --ADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166
A ++ + + Y+ ++ F+HRD+ N ++ + V I D+G+ RD+ +
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMT---RDIYETDY-- 174
Query: 167 YR-ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVL--MYFLRGSLPWQGL 216
YR K L A + GV + + D+ S G VL M L P+QGL
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-AEQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 23/67 (34%), Positives = 35/67 (52%), Gaps = 6/67 (8%)
Query: 91 DLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYI 147
DL Y C S+ V + QL+ + Y H R LHRD+KP N L+ + ++ +
Sbjct: 88 DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKL 144
Query: 148 IDYGLAK 154
D+GLA+
Sbjct: 145 ADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 32/141 (22%), Positives = 58/141 (41%), Gaps = 17/141 (12%)
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-Y 156
+F A +++ ++++H RG ++RD+K DN L+ + I D+G+ K+
Sbjct: 91 GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGI 147
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T GT Y + D +LG VL+Y L G P++G
Sbjct: 148 LGGVT--------TSTFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPFEG 198
Query: 216 LKAGTKKQKYDKISEKKMLTP 236
+ + + I E ++ P
Sbjct: 199 ---DDEDELFQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 12/117 (10%)
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK-Y 156
R F+ + ++++ +EY+HSR ++RDIK +N ++ K + I D+GL K+
Sbjct: 90 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGI 146
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
D T K GT Y + + R D LG V+ + G LP+
Sbjct: 147 SDGATM--------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 33/171 (19%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV--- 65
KLG+ +G G FG + G + + +K+ +VKT +H S++ L +
Sbjct: 1 LKLGKILGEGEFGSVMEG-QLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDF 58
Query: 66 --PH-LKWFGV-------EGEYNVMVI-------DL----LGPSLEDLFNYCNRKFSLKT 104
P+ +K GV + MVI DL L L L K L+T
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL----PEKLPLQT 114
Query: 105 VLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+L + +EY+ +R F+HRD+ N ++ R+ V + D+GL+KK
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 64/284 (22%), Positives = 124/284 (43%), Gaps = 55/284 (19%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAV-----KLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
++GSG+FG + GV +++ V K E+ K+ ++ E+++ L P++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57
Query: 69 -KWFGV-EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
+ GV E E ++V+++ G L + + ++ V+ L Q+ ++Y+ + F+
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 126 HRDIKPDNFLMGLGRKSNQVY--IIDYGLAK------KYRDLQTHKHIPYRENKNLTGTA 177
HRD+ N L+ NQ Y I D+GL+K Y ++ P +
Sbjct: 118 HRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK--------- 163
Query: 178 RYAS--VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
YA +N + S R D+ S G + W+ G K Y K+ ++++
Sbjct: 164 WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGPEVMS 209
Query: 236 PIE----VLC-KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274
IE + C P E + C ++ED+P+++ ++ R
Sbjct: 210 FIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 18/151 (11%)
Query: 15 IGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTGVPHLKWF 71
IG GSFG++ L G+ AVK+ + V + Q H ++ +LL+ V H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKN---VKHPFLV 59
Query: 72 GVEGEYNV-----MVIDLLGPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGF 124
G+ + V+D + +LF + R F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
++RD+KP+N L+ V + D+GL K+
Sbjct: 118 VYRDLKPENILLD---SQGHVVLTDFGLCKE 145
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 28/136 (20%), Positives = 58/136 (42%), Gaps = 11/136 (8%)
Query: 92 LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151
++N N F + + A ++ +E +H ++RD+KP+N L+ + I D G
Sbjct: 91 IYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD---DYGHIRISDLG 147
Query: 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 211
LA + + +T + GT Y + + D LG ++ + G
Sbjct: 148 LAVEIPEGET--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 212 PWQGLKAGTKKQKYDK 227
P++ K K+++ ++
Sbjct: 200 PFRQRKEKVKREEVER 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 30/118 (25%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+F + V + + +++ +E++H G ++RDIK +N L+ + V + D+GL+K++ +
Sbjct: 101 RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFHE 157
Query: 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMY-FLRGSLPW 213
+ + + GT Y + + G + + D S+G VLMY L G+ P+
Sbjct: 158 DEVERAY------SFCGTIEYMAPDIVRGGDGGHDKAVDWWSMG-VLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 58/280 (20%), Positives = 110/280 (39%), Gaps = 39/280 (13%)
Query: 9 FKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHY-ESKLYMLLQGGTGVP 66
KL +K+G+G FGE+++ N T +VAVK + + E+ + LQ V
Sbjct: 8 LKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 67 HLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 126
E Y + G L+ L + K L ++ + Q+ + ++ R ++H
Sbjct: 66 LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186
RD++ N L+ S I D+GLA+ D + Y + ++ +
Sbjct: 126 RDLRAANILVS---ASLVCKIADFGLARVIEDNE------YTAREGAKFPIKWTAPEAIN 176
Query: 187 GVEQSRRDDLESLGYVLMYFLR-GSLPWQG---------LKAGTKKQKYDKISEKKMLTP 236
+ + D+ S G +LM + G +P+ G L+ G + + +
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE---------- 226
Query: 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+ P E + C R E++P + Y++ + D
Sbjct: 227 ------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 465 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.99 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.69 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.5 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.43 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.4 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.25 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.77 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.7 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.55 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.53 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.25 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.24 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.23 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.07 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.97 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.95 | |
| PLN02236 | 344 | choline kinase | 96.81 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.72 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.69 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.6 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.35 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.14 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.64 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.56 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.49 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.9 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.67 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.31 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.04 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.21 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.01 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.2 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.02 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-59 Score=429.48 Aligned_cols=294 Identities=70% Similarity=1.265 Sum_probs=288.7
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+++++|+++++||+|+||.+|+|....+|++||||+.+.+..++++..|..++..|++..++|.+.+|+.+..+.++||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+++|++|+++++.|++.|+.++++.+|.||+..|+|+|.+++|||||||+|+|++++...+.++|+|||+++.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.++||++..+..||.+|++...+.+.++++++|+.|+|++|+++..|.+||+++.+.+++|++++|.+.++..+++.+|+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
++|.||.-++.+|..+-+++.|++..|.++++-+|....+++|+.|||+.+++.
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk 304 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQK 304 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHH
Confidence 999999999999999999999999999999999999999999999999998743
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=409.76 Aligned_cols=292 Identities=57% Similarity=1.028 Sum_probs=284.6
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+++-.|+++++||.|+||++++|++.-++++||||....+...+++..|...++.|.+..+||.+++|+.++.+++||+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC--CCCCcEEEEecCCcccccccc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG--RKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~--d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++|++|+|++.-|+++|+.++++++|.||+..|+|+|++.+|+|||||+|+||+.. .+.+.+.|+|||+|+.|.+..
T Consensus 104 dLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 999999999999999999999999999999999999999999999999999999853 346789999999999999999
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
+.+++||++.+.+.||.+||+-..+.|.++++++|+.|||-+++++|.|.+||+++++.+.+++|.+|.+.+..++++.+
T Consensus 184 TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L 263 (449)
T KOG1165|consen 184 TKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL 263 (449)
T ss_pred ccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
|.++|.+|..++.+...+++++-|+|+.+..+|.+++.+.|..+|+.|||+.+.
T Consensus 264 c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 264 CEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred HhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 999999999999999999999999999999999999999999999999999875
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=377.39 Aligned_cols=267 Identities=24% Similarity=0.326 Sum_probs=226.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+-.++|++++.||+|+||+||+++.+.+++.||+|+++++. .......|..+|..+.|+.+|.....| .+...+
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-Qt~~kL 100 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-QTEEKL 100 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-ccCCeE
Confidence 34678999999999999999999999999999999988653 344688999999998887666666555 455577
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+|++|+ ||.|..++++ .+.|++..+..++.+|+.||.|||++|||||||||+|||+ |.+|+++|+|||||+...
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcc
Confidence 8888887 8899999986 6789999999999999999999999999999999999999 799999999999999655
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
...+ .+.+++||+.|||||++.+.+|++.+||||||+++|||++|.+||.+ ....+.++++...+...+.
T Consensus 177 ~~~~-------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~~p 246 (357)
T KOG0598|consen 177 KDGD-------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPLPP 246 (357)
T ss_pred cCCC-------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCCCC
Confidence 4332 34678999999999999999999999999999999999999999988 5557777777777744332
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCC----CHHHHHHHHHHHHHHcCCCCCccccccccCCCCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKP----DYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTG 299 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RP----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (465)
.-++.+.++++..+|..||+.|. ++.+| ..++++...||..+......
T Consensus 247 ----~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i----------k~HpfF~~inW~~l~~k~l~ 298 (357)
T KOG0598|consen 247 ----GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI----------KRHPFFKGINWEKLLAKKLS 298 (357)
T ss_pred ----ccCCHHHHHHHHHHhccCHHHhcCCCCChHHh----------hcCcccccCCHHHHHhcCCC
Confidence 23689999999999999999995 44443 34889999999987644433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=385.64 Aligned_cols=266 Identities=26% Similarity=0.396 Sum_probs=232.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
..+|.+++.||.|+|++|++|+.+.++++||||++.++ ...+-+..|..+|.+|.+|++|..|.+.+.+...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46899999999999999999999999999999997754 4456688899999999999999999888888888899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|++|+ +|+|.+++.. -+.|++..+..++.||+.+|+|||++|||||||||+|||+ |.+++++|+|||.|+.+...
T Consensus 152 vLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence 99998 9999999986 4789999999999999999999999999999999999999 79999999999999988654
Q ss_pred cCccccc----ccCC--CCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 160 QTHKHIP----YREN--KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 160 ~~~~~~~----~~~~--~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
......+ +... .+++||..|.+||++.....++.+|||+||||||.|+.|.+||.+.+. .-.+.+|....+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne---yliFqkI~~l~y 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE---YLIFQKIQALDY 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH---HHHHHHHHHhcc
Confidence 3331111 1112 569999999999999999999999999999999999999999998544 555666666555
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
..+ .++|+.+.+||.++|..||.+|++.++|++ ++|+..+||..+
T Consensus 305 ~fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nl 349 (604)
T KOG0592|consen 305 EFP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENL 349 (604)
T ss_pred cCC-----CCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhh
Confidence 555 688999999999999999999999888765 789999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=381.33 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=215.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---------CccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---------HPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---------~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
.-+.+.|.+.+.||+|+||.|-+|..+.|++.||||+++++.. .....+|+++|++|+|+++|. ++.+++
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~-~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVR-IKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEE-Eeeeee
Confidence 3478899999999999999999999999999999999886422 224679999999999866555 455556
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
..++.||||||+ ||.|.+.+-. ++.+.+..-..++.||+.||.|||++||+||||||+|||+..++.+..+||+|||+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 666779999999 9999999875 67899999999999999999999999999999999999998666779999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
|+..... ....++||||.|.|||++.+.. +..++|+|||||+||-+|+|.+||.+..... ...+.|.
T Consensus 326 AK~~g~~--------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~ 395 (475)
T KOG0615|consen 326 AKVSGEG--------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQIL 395 (475)
T ss_pred hhccccc--------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHh
Confidence 9987532 2357899999999999998765 3458899999999999999999998754332 1344455
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+.+...+. ....++++..+||.+||.+||++||++++ .|.+.|.+
T Consensus 396 ~G~y~f~p~-~w~~Iseea~dlI~~mL~VdP~~R~s~~e---aL~hpW~~ 441 (475)
T KOG0615|consen 396 KGRYAFGPL-QWDRISEEALDLINWMLVVDPENRPSADE---ALNHPWFK 441 (475)
T ss_pred cCcccccCh-hhhhhhHHHHHHHHHhhEeCcccCcCHHH---HhcChhhh
Confidence 565554433 33678999999999999999999999554 45655544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=383.62 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=225.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+|...+.||+|||+.||.+++..+|+.||+|++.+. ...+.+.+|+++.+.|+|+++|. +..|+++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~-f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQ-FYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEe-eeeEeecCCceEEE
Confidence 5799999999999999999999999999999998763 33456899999999999866554 55566778889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+|+| .++|..+++ ..++|++.+++.++.||+.||.|||+.+|||||||..|+|+ +.+.+|||+|||||+.+..+.
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 899999988 47889999999999999999999999999999999999999 689999999999999887542
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
....+.+|||.|.|||++.....+..+||||+||+||.||+|++||.. .+.++.+.+|....+..|.
T Consensus 173 -------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~P~--- 239 (592)
T KOG0575|consen 173 -------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSMPS--- 239 (592)
T ss_pred -------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccccc---
Confidence 235689999999999999999999999999999999999999999987 5678999999988888774
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDY 286 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~ 286 (465)
.++.++++||..+|+.||.+||+++ +.|.+.|...|+..+.
T Consensus 240 --~ls~~A~dLI~~lL~~~P~~Rpsl~---~vL~h~Ff~~g~~p~~ 280 (592)
T KOG0575|consen 240 --HLSAEAKDLIRKLLRPNPSERPSLD---EVLDHPFFKSGFTPAR 280 (592)
T ss_pred --ccCHHHHHHHHHHhcCCcccCCCHH---HHhcCHhhhCCCcCCC
Confidence 6789999999999999999999954 5567777766655443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=367.14 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=220.4
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
..+++.+..||+|..|+||+|+++.|++.+|+|++.... ...++.+|+++++.++++.+|..++.|..++....|+|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 457888999999999999999999999999999985443 23578999999999998888888888887776788999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||+ +|+|.+++.. .+++++..+..|+.+++.||.|||. .+||||||||.|||+ ...|.|||||||.++.+.+..
T Consensus 158 EYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~ 233 (364)
T KOG0581|consen 158 EYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI 233 (364)
T ss_pred hhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh
Confidence 999 9999999986 4789999999999999999999995 999999999999999 589999999999999877642
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCC--CCCchHHHHHHHhhhhccCcHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
..+++||..|||||.+.+..|+.++||||||++++|+++|+.||... ......+.+..|.....+..+.
T Consensus 234 ---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 234 ---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE 304 (364)
T ss_pred ---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence 36889999999999999999999999999999999999999999874 2234556666666544333322
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
..++++|..|+..||.+||.+||+ ..++|.+.|++.-
T Consensus 305 ---~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 305 ---GEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred ---ccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 147999999999999999999999 5566788887653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=349.18 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=230.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+|+.++.||.|+||.|.+++.+.++..||+|+++.+.. .+...+|..+|+.+.| +.+..+.+.+.+....+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeEEEE
Confidence 579999999999999999999999999999999886532 3457889999999986 5566666666788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+|. ||-|..++.. .++|++..+..+|.||+.||+|||+++|++|||||+|||+ |.+|.+||+|||+|+...+.
T Consensus 123 meyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc-
Confidence 9998 9999999986 5689999999999999999999999999999999999999 79999999999999987652
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
+-+.||||.|+|||++...+|.+.+|||||||++|||+.|.+||...+ ..+.|.+|.+.....|
T Consensus 198 ---------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~---~~~iY~KI~~~~v~fP---- 261 (355)
T KOG0616|consen 198 ---------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN---PIQIYEKILEGKVKFP---- 261 (355)
T ss_pred ---------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC---hHHHHHHHHhCcccCC----
Confidence 357899999999999999999999999999999999999999999844 4889999999988877
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRS 304 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (465)
.-+++++++|+..+|+.|-..|.. .++. ....-.+++|+..++|.......+..+..|
T Consensus 262 -~~fs~~~kdLl~~LL~vD~t~R~g--nlkn---G~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 262 -SYFSSDAKDLLKKLLQVDLTKRFG--NLKN---GVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred -cccCHHHHHHHHHHHhhhhHhhhc--CcCC---CccccccCcccccccHHHHhhccccCCCCC
Confidence 467899999999999999999931 1111 122225689999999998765555444433
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=367.55 Aligned_cols=267 Identities=24% Similarity=0.350 Sum_probs=219.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-++|++++.||+|+||+||+|+.+.||..||||++++.. ....++.|..+|.. ...+.|+.+++.+.+..++||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeEE
Confidence 478999999999999999999999999999999988653 33457889999988 455777777777788889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+|||+ ||++..++.. ...|++..+..++.+++.||+.||+.|+|||||||+|+|| |..|++||+|||||+.+...
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 99998 9999999985 5789999999999999999999999999999999999999 79999999999999643220
Q ss_pred c------------------Cccccc----------------------ccCCCCccccccccccccccCCCCCCcchHHHH
Q 012336 160 Q------------------THKHIP----------------------YRENKNLTGTARYASVNTHLGVEQSRRDDLESL 199 (465)
Q Consensus 160 ~------------------~~~~~~----------------------~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSL 199 (465)
. .....+ ......++|||.|||||++.+..|+..+|||||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 000000 001234789999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh--ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHH
Q 012336 200 GYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD---YSYLKRLFR 274 (465)
Q Consensus 200 GviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt---~~~l~~~L~ 274 (465)
|||+||||.|.+||.+. +..+.+.+|..-. ...|.+. .+++++++||.+|+. ||+.|.- ++||+
T Consensus 375 G~ImyEmLvGyPPF~s~---tp~~T~rkI~nwr~~l~fP~~~---~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK---- 443 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSE---TPQETYRKIVNWRETLKFPEEV---DLSDEAKDLITRLLC-DPENRLGSKGAEEIK---- 443 (550)
T ss_pred HHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhhhccCCCcC---cccHHHHHHHHHHhc-CHHHhcCcccHHHHh----
Confidence 99999999999999984 4455665555433 3334332 347999999999999 9999975 55554
Q ss_pred HHHHHcCCCCCccccccccC
Q 012336 275 DLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 275 ~~~~~~~~~~~~~~dw~~~~ 294 (465)
.++|+..+||+.+.
T Consensus 444 ------~HPfF~~v~W~~l~ 457 (550)
T KOG0605|consen 444 ------KHPFFKGVDWDHLR 457 (550)
T ss_pred ------cCCccccCCcchhh
Confidence 38999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.94 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=206.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.-++|.+.+.||.|+||+||+|+++.++.+||||.+.++. ..+.+..|+.+|+.++|++ |..+..|....++.++
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~n-IV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPN-IVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcc-eeeEEEEEecCCeEEE
Confidence 4578999999999999999999999999999999887664 3345788999999999755 5556667777889999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC---CcEEEEecCCcccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS---NQVYIIDYGLAKKY 156 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~---~~vkL~DFGla~~~ 156 (465)
||||| ||+|.+++.. .+.+++.++..++.||+.||++||+++||||||||+|||+.....+ -.+||+|||+|+.+
T Consensus 87 VMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999 8999999986 4589999999999999999999999999999999999999754222 57899999999987
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
... ....+++|++.|||||++....|+.|+|+||+|+|||++++|+.||.. .+..+.+..+.......+
T Consensus 166 ~~~--------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a---~t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 166 QPG--------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA---ETPKELLLYIKKGNEIVP 234 (429)
T ss_pred Cch--------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc---cCHHHHHHHHhccccccC
Confidence 642 345688999999999999999999999999999999999999999987 444555555544443333
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS 267 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~ 267 (465)
... ..++....+++...+..++.+|-++.
T Consensus 235 ~~~--~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 235 VLP--AELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred chh--hhccCchhhhhhHHHhcCccccCchH
Confidence 221 23355667899999999999998844
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=373.77 Aligned_cols=270 Identities=21% Similarity=0.288 Sum_probs=232.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
--++|.+++.||+|.||+|+++..+.+++.||||+++++. ..+....|..|+.....|+.+..+..++...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3478999999999999999999999999999999988753 34568889999999998999999999999999999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+||||+ ||++..+.. .+.|++..+..||.+++.||.|||++||||||||.+|||+ |..|++||+|||+++....
T Consensus 446 fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCC
Confidence 999999 777333222 5789999999999999999999999999999999999999 7999999999999987543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. ..+.+++|||.|||||++.+..|++.+|||||||+|||||.|..||.+ ++..+.++.|.......|
T Consensus 521 ~g-------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g---ddEee~FdsI~~d~~~yP-- 588 (694)
T KOG0694|consen 521 QG-------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG---DDEEEVFDSIVNDEVRYP-- 588 (694)
T ss_pred CC-------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCCCC--
Confidence 22 346789999999999999999999999999999999999999999998 455677777777766666
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDY-----SYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRS 304 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~-----~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (465)
..++.++.++++++|.++|++|.-+ ++|++ ++++...||..+...+...+-.|
T Consensus 589 ---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~----------hpFFr~i~w~~L~~r~i~PPf~P 646 (694)
T KOG0694|consen 589 ---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK----------HPFFRSIDWDDLLNRRIKPPFVP 646 (694)
T ss_pred ---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhh----------CCccccCCHHHHhhccCCCCCCc
Confidence 4669999999999999999999754 44433 78888999999876655554444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=343.43 Aligned_cols=244 Identities=25% Similarity=0.307 Sum_probs=208.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEE-EeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKW-FGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~-~~~~~~~~~lv 81 (465)
.+|+++++||.|.||+||++.+..++..||.|.+.-.. ..+....|+.+|++|+|+|+|..+.+ |..++...+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35999999999999999999999999999999776432 23468899999999999999999984 55556668999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 82 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHS--RG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs--~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
||+| +|+|..+++.. .+.+++.+++.++.|++.||..+|+ .. |+||||||.||++ +.+|.|||.||||+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence 9999 99999988642 4669999999999999999999999 44 9999999999999 59999999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
+.+....+ ...+++|||.||+||.+.+.+|++|+|||||||++|||+.-..||.+. ...+...+|.....
T Consensus 176 r~l~s~~t-------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTT-------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhH-------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence 98876543 345789999999999999999999999999999999999999999984 44555555666544
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDY 266 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (465)
...+. .-++..+..+|..|+..||+.||+.
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCc
Confidence 32222 2458899999999999999999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=354.46 Aligned_cols=258 Identities=25% Similarity=0.380 Sum_probs=213.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcE-EEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEE-VAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~-vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
..++.+.+.||.|+||+||+|.+ .|+. ||||++..... ...|..|+.+|.+++|+|+|..++.+.......+|
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 44566777899999999999997 4555 99998875422 33799999999999999999988777666556889
Q ss_pred EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCceeeccCCCCC-cEEEEecCCcccc
Q 012336 81 VIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRG-FLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKY 156 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~-~~~~ls~~~~~~ia~qi~~gL~yLHs~g-ivHrDLKP~NILl~~~d~~~-~vkL~DFGla~~~ 156 (465)
||||+ +|+|.+++.. ..+.+++..++.||.||+.||+|||+++ ||||||||+|||+ +.+. ++||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceee
Confidence 99998 9999999987 3688999999999999999999999999 9999999999999 5776 9999999999876
Q ss_pred ccccCcccccccCCCCcccccccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHL--GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~--~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.... .......||+.|||||++. ...|+.|+||||||++||||+||+.||.++.. .+....+......
T Consensus 195 ~~~~-------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 195 VISK-------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLR 264 (362)
T ss_pred cccc-------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCC
Confidence 5421 1123478999999999999 55899999999999999999999999998765 3333334333333
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
.+.+ ..+|+.+..+|..||..||+.||++.+|...|+.+.....
T Consensus 265 p~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 265 PPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 3322 2369999999999999999999999999999998876543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=352.82 Aligned_cols=263 Identities=23% Similarity=0.304 Sum_probs=212.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHc-CCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQ-GGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~-~~~~i~~l~~~~~~~~~~~ 79 (465)
++-++|.++++||.|.||.||+|+.+.+++.||||.++.+-.. ..-++|++.|++|. |+++|.....+.+....++
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 5678999999999999999999999999999999988765322 24688999999999 6666666666665555999
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+||||+..+|.++++..++.|++..+..|+.||+.||+|+|++||.||||||+|||+. .+..+||+|||+|+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999998888999999999999999999999999999999999999994 6899999999999976542
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc-----
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM----- 233 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (465)
. || ...+-|-+|.|||++... -|+.++|+||+|||++|+.+=++-|+|.+.-+...++..+.....
T Consensus 164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 2 22 345789999999998765 489999999999999999999999999655333333322222110
Q ss_pred -----------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 234 -----------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 234 -----------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..+...+...+++++.++|..|+.+||++|||++++ |++.|.+.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a---l~~pffq~ 296 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA---LQHPFFQV 296 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH---hcCccccc
Confidence 112233444578999999999999999999997765 44444433
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.47 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=213.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-------CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-------TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-------~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
...++|.+++.||+|+||.|++|.+..++..||||+++.+ .....+.+|+.+++.+.+|++|..+..+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4578999999999999999999999999999999987764 224456789999999995556666655555555
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC-CcEEEEecCCcc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS-NQVYIIDYGLAK 154 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~-~~vkL~DFGla~ 154 (465)
.+++||||+ ||+|.+.+.. .+++.+..+..++.|++.||+|||++||+||||||+|||+ |.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 699999999 7899999997 7889999999999999999999999999999999999999 577 999999999998
Q ss_pred ccc-cccCcccccccCCCCccccccccccccccCCC-CC-CcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 155 KYR-DLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 155 ~~~-~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s-~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
... .. ....+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||.. ......+.++...
T Consensus 170 ~~~~~~--------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 170 ISPGED--------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRKG 238 (370)
T ss_pred ccCCCC--------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhcC
Confidence 773 21 2346889999999999999988 75 899999999999999999999988 4445555556665
Q ss_pred hccCcHHHHhccC-cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 232 KMLTPIEVLCKSY-PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 232 ~~~~~~~~~~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+ ..+ ++++..|+..||..||..|+++.+|. .+.|.+.
T Consensus 239 ~~~~p-----~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~---~h~w~~~ 280 (370)
T KOG0583|consen 239 EFKIP-----SYLLSPEARSLIEKMLVPDPSTRITLLEIL---EHPWFQK 280 (370)
T ss_pred CccCC-----CCcCCHHHHHHHHHHcCCCcccCCCHHHHh---hChhhcc
Confidence 55554 334 89999999999999999999966664 4444433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=360.13 Aligned_cols=255 Identities=23% Similarity=0.349 Sum_probs=214.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
..+++++.||+|.||+||+|.+. ....||+|.++.... ...|+.|+++|++|+|.++|..+.+|..++ ..+|||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEec
Confidence 45677899999999999999973 445999998887543 467999999999999999888888876655 788999998
Q ss_pred -CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 86 -GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 86 -g~sL~~ll~~-~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
.|+|.+++.. ....+...+.+.++.|||+|++||+++++|||||.++|||| +.+..+||+|||||+...++.
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~--- 357 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDE--- 357 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCc---
Confidence 9999999986 45679999999999999999999999999999999999999 589999999999999544432
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
|.....-.-+..|+|||.+....++.|+|||||||+|||++| |+.||.++.. .+.+..+..+ ...+.+.
T Consensus 358 ---Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~~~le~G-yRlp~P~--- 427 (468)
T KOG0197|consen 358 ---YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVLELLERG-YRLPRPE--- 427 (468)
T ss_pred ---eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHHHHHhcc-CcCCCCC---
Confidence 233344445789999999999999999999999999999999 9999999654 4444444433 3344443
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+|+++.++|..||..+|++|||++.+...|++++..
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 4599999999999999999999999999999988753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=345.91 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=208.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCc-EEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE-YNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~-~~~lv~e 83 (465)
.+|...+.||+|+||.||++.+..+|..+|||....... ...+.+|+.+|..|+|+++|+.++....... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 458899999999999999999999999999998765521 3458999999999998777777765444444 7888899
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC-CCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-SNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~-~~~vkL~DFGla~~~~~~~~ 161 (465)
|+ +|+|.+++...+.+|++..+..++.|++.||.|||++|||||||||+|||+ +. ++.+||+|||+++.......
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE---eCCCCeEEeccCccccccccccc
Confidence 88 999999999755589999999999999999999999999999999999999 46 68999999999987653111
Q ss_pred cccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.......+.||+.|||||++.+ ....+++|||||||++.||+||+.||... ....+.+..+......+ .+
T Consensus 174 ----~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P---~i 244 (313)
T KOG0198|consen 174 ----KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLP---EI 244 (313)
T ss_pred ----cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCC---CC
Confidence 1133456889999999999995 33456999999999999999999999874 22233333333333222 33
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
...++++.++|+..|+..+|+.|||+++ +|.+.|.....
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~e---LL~hpf~~~~~ 283 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEE---LLEHPFLKQNS 283 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHH---HhhChhhhccc
Confidence 3567999999999999999999999665 46666655544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=330.28 Aligned_cols=254 Identities=20% Similarity=0.271 Sum_probs=206.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc----cHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|+.+.++|+|+||.||+|+++.||+.||||.+......+ -.++|+.+|++|+|+|.|..+..|-. ...+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence 57899999999999999999999999999999887554433 36889999999999999888877754 44678999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|||.-++.+.++...+.++.+.+..|+.|++.|+.|+|++++|||||||+|||++ .++.+||||||+|+.+.....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcc-
Confidence 9999988888887788899999999999999999999999999999999999996 999999999999998764221
Q ss_pred ccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh---------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 232 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (465)
.-...+-|-+|.|||.+.+ ..|++.+||||+||++.||++|.+.|++..+-+..-.+.+.....
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 1234578999999999998 669999999999999999999999999965433222222211110
Q ss_pred --------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 --------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 --------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+.+.+.-..+++.-+.+|++.||..||++|++.+++..
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 001112222345567899999999999999999777654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.86 Aligned_cols=269 Identities=22% Similarity=0.332 Sum_probs=223.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-++|++++.||.|.-|+||+|+...++..+|||++.+. ....+...|.+||..+.| +.+|.++..++..++.|+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCL 154 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEE
Confidence 35788999999999999999999999999999998864 334567889999999977 667777777788889999
Q ss_pred EEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 81 VIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||| ||+|..+++.. ++.|++..+..|+.+++.||+|||-+|||+|||||+|||| .++|+|.|+||.|+.....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred EEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCC
Confidence 99999 99999999865 4679999999999999999999999999999999999999 5999999999999865421
Q ss_pred ccCc-------------------------------cc-----------------cc-ccCCCCccccccccccccccCCC
Q 012336 159 LQTH-------------------------------KH-----------------IP-YRENKNLTGTARYASVNTHLGVE 189 (465)
Q Consensus 159 ~~~~-------------------------------~~-----------------~~-~~~~~~~~Gt~~Y~APE~~~~~~ 189 (465)
..+. +. -| -.....++||..|.|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0000 00 00 01234578999999999999999
Q ss_pred CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCC----
Q 012336 190 QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD---- 265 (465)
Q Consensus 190 ~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt---- 265 (465)
.+.++|||+|||+|||||.|..||.|. ...+.+..+.......+.. ..++..+++||+.+|.+||.+|..
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~---~~~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGS---NNKETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCC---CchhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999999984 4466676666665555533 245689999999999999999997
Q ss_pred HHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 266 YSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 266 ~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+.+|++ ++|+..++|....
T Consensus 386 A~eIK~----------HpFF~gVnWaLir 404 (459)
T KOG0610|consen 386 AAEIKR----------HPFFEGVNWALIR 404 (459)
T ss_pred hHHhhc----------CccccCCChhhee
Confidence 556654 8999999999654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=344.38 Aligned_cols=261 Identities=18% Similarity=0.311 Sum_probs=206.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~~~ 74 (465)
+-.++|++.+.||.|+||.||+|.+. .++..||||++..... ...+..|+.++..+ +|++++..+..+...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 45689999999999999999999752 3457899998864322 23578899999999 666666666666666
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcC--------------------------------------------------------
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCN-------------------------------------------------------- 97 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~-------------------------------------------------------- 97 (465)
+...+++|+|+ +++|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 66788999998 999999886421
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCC
Q 012336 98 -----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172 (465)
Q Consensus 98 -----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 172 (465)
..+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....... +.....
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~ 235 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVRKGS 235 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcc-----hhcccC
Confidence 247888999999999999999999999999999999999 5789999999999986543211 112234
Q ss_pred ccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHH
Q 012336 173 LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSY 251 (465)
Q Consensus 173 ~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~l 251 (465)
..+++.|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+....... ....+++++.++
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~l~~l 309 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTRMR----APENATPEIYRI 309 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCCCC----CCCCCCHHHHHH
Confidence 456789999999999999999999999999999997 999998754322 1122222221111 124568999999
Q ss_pred HHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 252 FHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 252 i~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
+..||..||++||++.+|.+.|+.++.
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.24 Aligned_cols=257 Identities=24% Similarity=0.288 Sum_probs=215.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc----cHHHHHHHHHHHcCCCCCceeEEEeEe-CcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQGGTGVPHLKWFGVE-GEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~ 79 (465)
-.+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+ -..+|+.||++|.|+|+|......... ...+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 3567899999999999999999999999999999888776544 367899999999999988887776665 56899
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||+||+.-+|.-++....-+|++.++..|+.||+.||+|+|.+||+|||||..|||| |.+|.+||+|||||+.+...
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccCC
Confidence 999999999999998655689999999999999999999999999999999999999 79999999999999988764
Q ss_pred cCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc----
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML---- 234 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (465)
... ...+.+-|.+|.|||.+.|.. |+..+|+||.||||.||+.|++.|++.......+.+.++......
T Consensus 272 ~~~------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 272 GSA------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCc------ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 432 134567899999999999865 999999999999999999999999996554444444444321100
Q ss_pred ---C--------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 ---T--------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ---~--------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. .....++.+|+...+|+..+|.+||++|.|+.+.+
T Consensus 346 ~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 346 VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 0 01223567899999999999999999999977654
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=338.78 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=212.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+|++++.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.|++++..+..+....+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987532 22356788899999999888888888888888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~- 155 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGG- 155 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCC-
Confidence 998 8999988875 4679999999999999999999999999999999999999 588999999999987532211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+.+..+.......+
T Consensus 156 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~~~~----- 221 (324)
T cd05587 156 ------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNVSYP----- 221 (324)
T ss_pred ------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCC-----
Confidence 11234579999999999999999999999999999999999999998743 3344444443333222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCccccccccC
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSY-LKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++++.+++..||..||.+|++... ..+.+ ..+++....+|....
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~------~~hp~~~~~~~~~~~ 269 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDI------REHAFFRRIDWEKLE 269 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH------hcCCCcCCCCHHHHH
Confidence 457899999999999999999997521 11111 235677777887654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=346.86 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=217.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.... ..+.+|+.|++.++|+|+|..+.+|... ...++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-AHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-ceEEEEe
Confidence 5799999999999999999999999999999988765433 2588999999999999999988888654 4678899
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
||+-|+|..++.+ .+.++++.+..|+.+++.||.|||+.+|+|||+||.|||+ +.++.+|+||||+|+.......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 9997799999986 7789999999999999999999999999999999999999 5999999999999998755221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......|||.|||||...+.+|+..+|+||||||+||+++|++||.. ....+.+..|......+|.
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCcc-----
Confidence 23456899999999999999999999999999999999999999986 4556666666666666553
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.++..+.+|+.-+|.+||..|.+ .-+++.+.|.+.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred cccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 56899999999999999999999 555666777654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=350.27 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=214.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
...|....+||+|+.|.||.|....+++.||||.+.... ..+-+++|+.+|+.++|+|+|..+..|... +..++|||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVME 350 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVME 350 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEe
Confidence 357888999999999999999999999999999887654 345689999999999999999999888776 45678888
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|+ ||+|.|.+. ...+++.++..|..+++.||+|||.+||+|||||.+|||++ .++.+||+|||+|..+.....
T Consensus 351 ym~ggsLTDvVt--~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 351 YMEGGSLTDVVT--KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred ecCCCchhhhhh--cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccC-
Confidence 87 999999998 45699999999999999999999999999999999999995 888999999999998876543
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
...+++|||.|||||+.....|++|+||||||++++||+-|++||...++ .+..+.....+.... ....
T Consensus 425 ------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAlyLIa~ng~P~l---k~~~ 493 (550)
T KOG0578|consen 425 ------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNGTPKL---KNPE 493 (550)
T ss_pred ------ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHHHHhhcCCCCc---CCcc
Confidence 34678999999999999999999999999999999999999999987332 233332222222211 1225
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
.++++|++|+.+||..|++.|+++ .++|++.|.+...+
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA---~eLL~HpFl~~a~p 531 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASA---KELLEHPFLKMAKP 531 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCH---HHHhcChhhhhcCC
Confidence 679999999999999999999995 55577777655443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=332.20 Aligned_cols=270 Identities=19% Similarity=0.289 Sum_probs=216.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+-.+.|++...||.|.-++||+|+.+.+++.||||+++.+. ..+.+.+|++.+..+.|+|++.....| ..+..+++
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF-vv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF-VVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE-EecceeEE
Confidence 34689999999999999999999999999999999988653 335689999999999887776665555 45567789
Q ss_pred EEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 81 VIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
||.++ +|++.+++... ...|.+..+..|+.++++||.|||.+|.||||||+.|||| +.+|.|||+|||.+..+.+
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99998 99999999743 5669999999999999999999999999999999999999 6999999999999987766
Q ss_pred ccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC-
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT- 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~- 235 (465)
..... .++. .+++||++|||||++.. ..|+.|+||||||++..||.+|..||..+.+ .+.+..-..+..+.
T Consensus 179 ~G~R~--~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP---mkvLl~tLqn~pp~~ 252 (516)
T KOG0582|consen 179 SGDRQ--VTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP---MKVLLLTLQNDPPTL 252 (516)
T ss_pred cCcee--eEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh---HHHHHHHhcCCCCCc
Confidence 44222 1222 78899999999999554 4599999999999999999999999998755 23332222222221
Q ss_pred ----cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCc
Q 012336 236 ----PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDY 286 (465)
Q Consensus 236 ----~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~ 286 (465)
......+.++..|.+++..||.+||.+||++++ +|++.|.+.....++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAsk---Llkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASK---LLKHAFFKKAKSKEY 304 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHH---HhccHHHhhccchhh
Confidence 112233567889999999999999999999665 566777666554443
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=337.49 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=209.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+..+ ..+...++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-QDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EcCCEEEE
Confidence 478999999999999999999999999999999987432 234578899999999988777766555 45667899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence 99987 8899999875 5679999999999999999999999999999999999999 58899999999999865431
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+
T Consensus 172 ----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~p--- 235 (329)
T PTZ00263 172 ----------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRLKFP--- 235 (329)
T ss_pred ----------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCcCCC---
Confidence 124579999999999999999999999999999999999999997643 3444444444433322
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDY--SYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
..++.++.+|+..||..||.+||+. ..+.+++. +++....+|...
T Consensus 236 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~-------hp~f~~~~~~~~ 282 (329)
T PTZ00263 236 --NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN-------HPYFHGANWDKL 282 (329)
T ss_pred --CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-------CCccCCCCHHHH
Confidence 3468899999999999999999973 11333333 455556677754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=335.89 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=211.4
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+|.+++.||+|+||.||+|++..+++.||||++..... ...+..|..++..+.+++++..+..+....+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999875421 1235667788888888888888888888888999999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ +++|.+.+.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~- 155 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDG- 155 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCC-
Confidence 998 8899988875 4679999999999999999999999999999999999999 588999999999997543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.......+
T Consensus 156 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~p----- 221 (323)
T cd05616 156 ------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP----- 221 (323)
T ss_pred ------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----
Confidence 112356799999999999999999999999999999999999999987443 344444444333222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..++.++.+++..||..+|.+|++.. ...+++ ..++....||....
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~-------~h~~~~~~~~~~~~ 269 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK-------EHAFFRYIDWEKLE 269 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHh-------cCCCcCCCCHHHHH
Confidence 45789999999999999999999852 111222 25666667888654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=332.50 Aligned_cols=255 Identities=21% Similarity=0.341 Sum_probs=208.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++++..+ .+..+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF-WTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhH-hhhccCCeEEEE
Confidence 47999999999999999999999999999999986432 223577899999999987766655 444566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCC-
Confidence 9988 8899999875 5679999999999999999999999999999999999999 57899999999999765431
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~---- 218 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKLEFP---- 218 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcCCC----
Confidence 124579999999999999999999999999999999999999998743 3344444444333222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++.+.+++.+||..||.+||+ ++++. .++|...++|....
T Consensus 219 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l----------~h~~~~~~~~~~~~ 266 (291)
T cd05612 219 -RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK----------NHRWFKSVDWDDVP 266 (291)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh----------cCccccCCCHHHHh
Confidence 356889999999999999999995 55443 25666667787543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=328.74 Aligned_cols=263 Identities=19% Similarity=0.225 Sum_probs=205.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.|++++..+.. ..++...+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~-~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYA-YETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEE-EccCCeEEEEE
Confidence 3889999999999999999999999999999876432 12346789999999988766555444 45556788899
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 888 88998887643 3469999999999999999999999999999999999999 588999999999997653221
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..... ......
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 1245689999999999999999999999999999999999999987554333222222111 111123
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
...+++++.+|+..||..||.+||+ ++++. + ++++...+|..+...
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~---~-------h~~~~~~~~~~~~~~ 275 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVK---Q-------HPIFKNINFKRLEAN 275 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHh---c-------CHhhcCCCHHHHHhC
Confidence 3567899999999999999999997 44443 3 445556777766533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=333.54 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=202.1
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+. +...+...++|||++ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~-~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY-SFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEE-EEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999987532 2235678999999998876665554 455667889999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~------ 149 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCC------
Confidence 899888875 5679999999999999999999999999999999999999 588999999999987542211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ....+..+....... ...+++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~~~-----p~~~~~ 220 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRF-----PRTLSP 220 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCC-----CCCCCH
Confidence 11235679999999999999999999999999999999999999997643 233333333322222 246789
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.++|..||..||++|| ++.+|. + ++|....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll---~-------h~~f~~~~~~~~~ 263 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIM---E-------HRFFASINWQDVV 263 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHH---c-------CCCcCCCCHHHHH
Confidence 999999999999999999 655553 2 5666667787653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.84 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=207.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+. +...+...++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~-~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY-AFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEE-EEEcCCEEEEE
Confidence 57999999999999999999999999999999987542 2235778999999998766666554 45567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCccccc--
Confidence 9998 8999999975 5679999999999999999999999999999999999999 5889999999999976543
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.........+..
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKYWKETLQRPVY 222 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHhccccccCCCC
Confidence 12356799999999999999999999999999999999999999987443 2333332221111110101
Q ss_pred ---hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 ---CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ---~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
...+++++.+++..||..+|.+||++.+|.+ +++...++|....
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~----------h~~~~~~~~~~~~ 269 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN----------HPFFKEVDWNELR 269 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHHh----------CcccCCCCHHHHh
Confidence 1256899999999999999999999666644 4555556676543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.79 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=213.1
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.|++++..+..+.......++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999987532 12346778888888888899988888888888899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
||+ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCC-
Confidence 998 8899998874 4679999999999999999999999999999999999999 588999999999987543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .+.+..+.......+
T Consensus 156 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~~p----- 221 (323)
T cd05615 156 ------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVSYP----- 221 (323)
T ss_pred ------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----
Confidence 122456799999999999999999999999999999999999999987433 334444444333222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCccccccccCC
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSY-LKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
..++.++.+++.+||..+|.+|++..+ ..+.+ ..+++...++|.....
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i------~~h~~f~~~~~~~~~~ 270 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDI------REHAFFRRIDWDKLEN 270 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHH------hcCcccCCCCHHHHhc
Confidence 456899999999999999999997431 11111 2356777788876653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.17 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=217.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
|-|++++.||.|+-|.|-+|++..||+.+|||++..... ...+.+|+-+|+.+.|+|++..+.++ .+..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-e~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-ENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-ccCceEEEE
Confidence 679999999999999999999999999999999987632 34588999999999997766666555 455566777
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
.||+ ||-|.+++-. .++|++.++..++.||+.|+.|+|..+|+||||||+|+|+ |..+++||+|||+|..-...
T Consensus 91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCC-
Confidence 7766 9999999875 6789999999999999999999999999999999999999 67777999999999765432
Q ss_pred CcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
..-++-||.|.|+|||++.|.+| +.++||||.|||||-||+|++||.+ +.....+.++..+.+.+|
T Consensus 166 -------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 166 -------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFEMP--- 232 (786)
T ss_pred -------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCcccCC---
Confidence 23467899999999999999997 6899999999999999999999986 677888888888888877
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
..+|+++++|+.+|+.+||+.|.|.++ .++++|.....
T Consensus 233 --s~Is~eaQdLLr~ml~VDp~~RiT~~e---I~kHP~l~g~~ 270 (786)
T KOG0588|consen 233 --SNISSEAQDLLRRMLDVDPSTRITTEE---ILKHPFLSGYT 270 (786)
T ss_pred --CcCCHHHHHHHHHHhccCccccccHHH---HhhCchhhcCC
Confidence 678999999999999999999999554 56777765533
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=326.44 Aligned_cols=266 Identities=25% Similarity=0.417 Sum_probs=193.2
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCCCccHHHH------------H---HHHHHHcCC
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTKHPQLHYE------------S---KLYMLLQGG 62 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~~~~~~~E------------~---~il~~l~~~ 62 (465)
+.++.+++|++.+.||+|+||.||+|.+..+ +..+|+|+....... +..| + ..+..+.|.
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~--~~~e~~~~~~~~~~~~~~~~~~~~~~~h~ 83 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENET--IVMETLVYNNIYDIDKIALWKNIHNIDHL 83 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCc--hhhHHHHHHhhhhHHHHHHHHHhccCCCC
Confidence 3567889999999999999999999998777 678888875543321 1111 1 222233444
Q ss_pred CCCceeEEEeEeC----cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 63 TGVPHLKWFGVEG----EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 63 ~~i~~l~~~~~~~----~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
+++..+ .++... .+.+++++.+..++.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 84 ~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill-- 159 (294)
T PHA02882 84 GIPKYY-GCGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV-- 159 (294)
T ss_pred CCCcEE-EeeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 444444 333322 25578888888899888875 3457889999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~ 218 (465)
+.++.++|+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 160 -~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 160 -DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred -cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 5788999999999987653222111111122345799999999999999999999999999999999999999987633
Q ss_pred CchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 219 GTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
..........................|+++.+++..||.++|++||++.+|.+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 239 NGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred chHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2221111110000001111112345689999999999999999999999999876
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=332.81 Aligned_cols=265 Identities=19% Similarity=0.273 Sum_probs=206.2
Q ss_pred ceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+|++++.||+|+||.||+|++. .+++.||+|++.... ....+..|+.++..+.+++++..+..+.......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 478999999986421 1235678999999998778788777777777888
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999998 8899998874 5679999999999999999999999999999999999999 588999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH-HHHhhhhccC
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISEKKMLT 235 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (465)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...........+ ..+......
T Consensus 157 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 229 (332)
T cd05614 157 SEEK------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP- 229 (332)
T ss_pred ccCC------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC-
Confidence 3221 1123457999999999998754 789999999999999999999999754333222222 222221111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+...+++++.+++..||..||++||++. .+.++++ ++|....+|....
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~-------h~~~~~~~~~~~~ 279 (332)
T cd05614 230 ----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE-------HPFFKGLDWEALA 279 (332)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc-------CCCcCCCCHHHHH
Confidence 1245789999999999999999999433 2344443 4566666777644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.23 Aligned_cols=255 Identities=20% Similarity=0.251 Sum_probs=198.8
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC----cEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----EYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~ 79 (465)
+|++.+.||+|+||.||+|++..++..||||++.... ....+.+|+.++..++|++++..+..+.... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999876431 2235788999999999988777766654322 3579
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence 9999999999999875 4579999999999999999999999999999999999999 58899999999999765332
Q ss_pred cCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH----------
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK---------- 227 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~---------- 227 (465)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..
T Consensus 157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 1111 11234579999999999876 5789999999999999999999999977432111111100
Q ss_pred --H-----------hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 228 --I-----------SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 228 --i-----------~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+ .......+.......+++++.+++..||..||++||++.++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 0 001111222223346788999999999999999999976654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=332.42 Aligned_cols=258 Identities=23% Similarity=0.327 Sum_probs=209.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCC-cEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTG-EEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~-~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+.-++|++.+.||+|+||.||+|.+..++ ..||||++... .....+..|+.++..+.|++++..+..+ .+...
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-~~~~~ 105 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-KDESY 105 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-EeCCE
Confidence 34568999999999999999999876654 68999987643 2234577899999999987777666555 55668
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++..
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 89999998 8899999875 5679999999999999999999999999999999999999 58899999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.......+
T Consensus 182 ~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~~p 248 (340)
T PTZ00426 182 DTR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGIIYFP 248 (340)
T ss_pred CCC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCCCCC
Confidence 321 234579999999999999899999999999999999999999998743 3334444444433322
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++++.++|..||..||++|+ ++++|. .++|+..++|....
T Consensus 249 -----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~----------~hp~f~~~~~~~~~ 296 (340)
T PTZ00426 249 -----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK----------EHPWFGNIDWVSLL 296 (340)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH----------cCCCcCCCCHHHHH
Confidence 45688999999999999999996 655553 36777778888644
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=329.55 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=200.4
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..++..||+|++.... ....+..|+.++..+.|++++..+..| ......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-QTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-ecCCEEEEEEeCCCC
Confidence 47999999999999999999999999987532 223466799999999887666655544 5666889999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~------ 149 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCC------
Confidence 899888874 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ...+..+.......+ ..+++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~~~p-----~~~~~ 220 (323)
T cd05595 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEIRFP-----RTLSP 220 (323)
T ss_pred -CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCCH
Confidence 112346799999999999999999999999999999999999999976433 233333332222222 46789
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.++|..||..||.+|| ++.++. + +++...++|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l---~-------h~~~~~~~~~~~~ 263 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVM---E-------HRFFLSINWQDVV 263 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHH---c-------CCCcCCCCHHHHH
Confidence 999999999999999998 644443 3 5666667787654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=330.33 Aligned_cols=253 Identities=20% Similarity=0.268 Sum_probs=204.1
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|++|..+..+.......++|||++ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987532 12346678888887766777777777777778899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~------ 150 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNG------ 150 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCC------
Confidence 899888874 5679999999999999999999999999999999999999 588999999999997543211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..+.+..+.......+ ..++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~~p-----~~~~~ 221 (321)
T cd05591 151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVLYP-----VWLSK 221 (321)
T ss_pred -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCC-----CCCCH
Confidence 11234579999999999999999999999999999999999999998743 3344444443333222 34689
Q ss_pred HHHHHHHHHhcCCCCCCC-------CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKP-------DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RP-------t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.+++..||..||++|| ++.++. .+++...++|....
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~----------~hp~~~~~~~~~~~ 266 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIK----------QHPFFKEIDWVLLE 266 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHh----------cCCccCCCCHHHHH
Confidence 999999999999999999 544443 25667778888654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=326.48 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=199.9
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|++|..+..+...+...++|||++ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987532 22345567777766655666666666666777899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~------ 150 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGE------ 150 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCC------
Confidence 999988875 4579999999999999999999999999999999999999 588999999999997543211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......+ ..++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDRPHFP-----RWISK 221 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC-----CCCCH
Confidence 122356799999999999999999999999999999999999999987543 333333333222211 35689
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.+++..||..+|.+||++. ++.+ +++....+|....
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~~l~~----------h~~~~~~~~~~~~ 260 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDGDIRQ----------HPFFRGIDWERLE 260 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHHc----------CcccCCCCHHHHH
Confidence 999999999999999999853 2322 4566667777543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.22 Aligned_cols=263 Identities=19% Similarity=0.284 Sum_probs=206.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|.+.+.||+|+||+||+|++..+++.||||++..... ...+..|+.++..+.|++++. +..+..+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~-~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQ-LQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcc-eeeEEecCCeEEEE
Confidence 479999999999999999999999999999999875422 234677888888877655554 44455567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9998 999999998765789999999999999999999999999999999999999 588999999999998664322
Q ss_pred CcccccccCCCCcccccccccccccc------CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHL------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
. .......||+.|+|||++. ...++.++|||||||++|||++|..||..... ...+..+......
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 227 (330)
T cd05601 157 M------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF 227 (330)
T ss_pred c------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence 1 1123357899999999987 45678999999999999999999999976432 3333333322111
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
...+ ....+++++.+|+..||. +|.+||++.++.+ +++....+|....
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~----------h~~~~~~~~~~~~ 275 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC----------HPFFSKIDWNNIR 275 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC----------CCCcCCCCHHHHh
Confidence 1100 113568999999999998 9999999776643 5666667887543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=321.70 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=198.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||.|+||.||+|++..+++.||+|++.... ....+.+|+.++..++|++++..+.. .......+++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI-IHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEE-EcCCCeEEEEEe
Confidence 57999999999999999999999999999999886532 23357789999999988776655544 455668899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~--- 157 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPT--- 157 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCC---
Confidence 99889999988766678999999999999999999999999999999999999 588999999999997543211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC-------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT------- 235 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------- 235 (465)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.... +.+..+.......
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 158 ----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred ----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhc
Confidence 11234568999999999876 56899999999999999999999999874432 2222221110000
Q ss_pred ------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 ------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+.......+++++.+|+..||..||.+|||+.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00111234678899999999999999999977764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.49 Aligned_cols=243 Identities=21% Similarity=0.279 Sum_probs=197.9
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+..+ ......+++|+++ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-QSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-ecCCeEEEEEcCCCCCc
Confidence 699999999999999999999999886431 223567899999999887777655544 5667889999998 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9999875 5679999999999999999999999999999999999999 5889999999999975432211
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEF 248 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l 248 (465)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+ ..+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPLRFP-----DGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCCCC-----CcCCHHH
Confidence 1235679999999999999999999999999999999999999998743 3344444333332222 4578999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 249 TSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.+++..||..||.+||++..+.++|.+.|
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 99999999999999998766677666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=325.42 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=205.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----------------CccHHHHHHHHHHHcCCCCCce
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----------------HPQLHYESKLYMLLQGGTGVPH 67 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----------------~~~~~~E~~il~~l~~~~~i~~ 67 (465)
..=+.|++++.||+|.||.|.+|++..+++.||||++.+... .+....|+.+|++|.|+|+|..
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345789999999999999999999999999999999875421 1357899999999999777777
Q ss_pred eEEEeE-eCcEEEEEEecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc
Q 012336 68 LKWFGV-EGEYNVMVIDLL-GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ 144 (465)
Q Consensus 68 l~~~~~-~~~~~~lv~e~~-g~sL~~ll~~~~~~-ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~ 144 (465)
+..... +.+..|||++|| .|.+... . +..+ +++.+++.|+.+++.||+|||.+|||||||||+|+|++ .+|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-P-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-C-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CCCc
Confidence 666654 457899999999 4443322 1 2445 99999999999999999999999999999999999995 8899
Q ss_pred EEEEecCCccccccccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCc
Q 012336 145 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (465)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~ 220 (465)
|||+|||.+.......... .........|||.|+|||...+.. .+++.|||||||+||.|+.|++||.+ ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~--~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~ 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEG--SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DF 323 (576)
T ss_pred EEeeccceeeecccCCccc--cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---ch
Confidence 9999999997652211100 001123368999999999988733 46789999999999999999999987 56
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+.+.+|.......|.. ..+.+.+++||.++|.+||+.|.+..+|+.
T Consensus 324 ~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 688888888877766643 245789999999999999999999666553
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=322.56 Aligned_cols=254 Identities=19% Similarity=0.209 Sum_probs=198.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++|++++..+..+ ......++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-RRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-ecCCEEEEEE
Confidence 57999999999999999999999999999999887542 234578899999999988777665554 5566889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
||+.+++.+.+......+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 155 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSN- 155 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCccccccccc-
Confidence 999666666666556679999999999999999999999999999999999999 5889999999999987543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh-----------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK----------- 231 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+...
T Consensus 156 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 156 -----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred -----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 1123457899999999999989999999999999999999999999875432211111111000
Q ss_pred -----hccCc--------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 -----KMLTP--------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 -----~~~~~--------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....+ .......++.++.+|+.+||..||++||+++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000 0011123678899999999999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=329.22 Aligned_cols=256 Identities=18% Similarity=0.276 Sum_probs=204.2
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||+||+|++..+++.||||++.... ....+..|..++..+.+|++|..+..+.......++||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999887432 22346678888887766667777777777788899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~------ 150 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNG------ 150 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCC------
Confidence 899988875 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. ..+.+..+.......+ ..++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~-----~~~~~ 221 (320)
T cd05590 151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEVVYP-----TWLSQ 221 (320)
T ss_pred -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCCCCC-----CCCCH
Confidence 11234679999999999999999999999999999999999999998743 3334444433332222 34689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHH---HHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKPDYSYL---KRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l---~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.+++..||..||.+||++.++ .+.+ .++|...++|....
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~-------~h~~f~~~~~~~~~ 265 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLGGEEAIL-------RHPFFKELDWEKLN 265 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCCCHHHHH-------cCCCcCCCCHHHHH
Confidence 99999999999999999997332 2222 36677777887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.02 Aligned_cols=266 Identities=24% Similarity=0.331 Sum_probs=210.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.++..+.|++++..+. +..++...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY-SFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhh-heecCCeEEEE
Confidence 57999999999999999999999999999999987532 2335778999999998766665554 44567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9998 8999999985 3689999999999999999999999999999999999999 588999999999998654432
Q ss_pred Cc----------------------ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC
Q 012336 161 TH----------------------KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (465)
Q Consensus 161 ~~----------------------~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~ 218 (465)
.. ............||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00 00000122345799999999999999999999999999999999999999987542
Q ss_pred CchHHHHHHHhh--hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 219 GTKKQKYDKISE--KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD-YSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 219 ~~~~~~~~~i~~--~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
.+.+..+.. .....+. ...+++++.++|..|+. +|.+||+ +.++.+ +++...++|....
T Consensus 236 ---~~~~~~i~~~~~~~~~p~---~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~----------hp~~~~~~~~~~~ 297 (350)
T cd05573 236 ---QETYNKIINWKESLRFPP---DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS----------HPFFKGIDWENLR 297 (350)
T ss_pred ---HHHHHHHhccCCcccCCC---CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 333333333 1111111 12368999999999997 9999999 888754 5666777887544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=327.89 Aligned_cols=253 Identities=21% Similarity=0.298 Sum_probs=200.4
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..+++.||||++... ........|..++..+.+++++..+..+..+..+.++|||++ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999998753 223346677777776655666666666667778899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~------ 150 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGD------ 150 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCC------
Confidence 899988875 4679999999999999999999999999999999999999 588999999999987432111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+....... ...++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~~~~-----~~~~~~ 221 (316)
T cd05620 151 -NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDTPHY-----PRWITK 221 (316)
T ss_pred -CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC-----CCCCCH
Confidence 112356799999999999999999999999999999999999999987433 33333333222211 134688
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.+++..||..||++||++. +|. .+++....+|....
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~----------~h~~f~~~~~~~~~ 260 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR----------GHPFFKTINWTALE 260 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH----------cCCCcCCCCHHHHH
Confidence 999999999999999999963 332 25666677777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.65 Aligned_cols=252 Identities=20% Similarity=0.249 Sum_probs=196.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.++|++.+.||.|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.|++++..+.. .......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI-IHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEE-EecCCeEEEEE
Confidence 4789999999999999999999999999999999875432 2356789999999988776655544 45667889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+++.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCC--
Confidence 999999999988656779999999999999999999999999999999999999 588999999999987543211
Q ss_pred ccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT------ 235 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------ 235 (465)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ....+..+.......
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 158 -----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred -----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhcc
Confidence 11234568999999999875 4588999999999999999999999987533 222222211100000
Q ss_pred -----------------c--HH--HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 -----------------P--IE--VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 -----------------~--~~--~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+ .. .....+++.+.+|+..||..||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 0 00 00012457899999999999999999966553
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.69 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=211.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
|..+.+.+...||+|.||+||+|+|. -.||||+++++... +.|.+|+.+|++-+|.|++..+++|-..+. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~--A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL--A 463 (678)
T ss_pred cCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce--e
Confidence 45677889999999999999999985 46999999987543 358999999999999998888877765553 7
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
||..+| |.+|..++.....+|.+.+++.||+|++.|+.|||.++|||||||..||++ ..+++|||.||||+..-..
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeee
Confidence 888888 889999998767789999999999999999999999999999999999999 5779999999999964322
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
-.. -.......|...|||||++..+ +|++.+||||||+|+|||++|.+||.. ....+++..+..+....
T Consensus 541 w~g-----~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi---~~~dqIifmVGrG~l~p 612 (678)
T KOG0193|consen 541 WSG-----EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI---QNRDQIIFMVGRGYLMP 612 (678)
T ss_pred ecc-----ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC---CChhheEEEecccccCc
Confidence 110 0122345688999999998754 489999999999999999999999985 33345554444454444
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.........|.++++|+..||..++++||.+.+|...|+.+.
T Consensus 613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 444555677899999999999999999999999999887664
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=325.34 Aligned_cols=253 Identities=22% Similarity=0.285 Sum_probs=202.5
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||.|+||+||+|++..+++.||||++.... ....+..|..++..+.+|+++..+..+.......+++|+++ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999987532 22346678888888866666776666667777899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~------ 150 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGG------ 150 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCC------
Confidence 899988875 4579999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+ ..+++
T Consensus 151 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~~~~-----~~~~~ 221 (318)
T cd05570 151 -VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEVRYP-----RWLSK 221 (318)
T ss_pred -CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCCCC-----CcCCH
Confidence 11234579999999999999999999999999999999999999998643 2333333333332222 45789
Q ss_pred HHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKPDY-----SYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~-----~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.++|..||..||.+||++ .++. ..++...++|....
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll----------~~~~~~~~~~~~~~ 264 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIK----------GHPFFREIDWDKLE 264 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHh----------cCCCcCCCCHHHHH
Confidence 99999999999999999997 4432 25666667786543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.67 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=205.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|.+..+++.||||++.... ....+..|+.++..++|++++..+. +..+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~-~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY-SFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEE-EEecCCeEEEE
Confidence 47999999999999999999999999999999987532 2235778999999998766555554 44566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9998 8899999875 5679999999999999999999999999999999999999 588999999999997643211
Q ss_pred Ccc-------c---------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC
Q 012336 161 THK-------H---------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 212 (465)
Q Consensus 161 ~~~-------~---------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~P 212 (465)
... . .........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 0 000011345799999999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHhhhh--ccCcHHHHhccCcHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCcc
Q 012336 213 WQGLKAGTKKQKYDKISEKK--MLTPIEVLCKSYPSEFTSYFHYCRSLRFE---DKPDYSYLKRLFRDLFIREGYQFDYV 287 (465)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~p~~l~~li~~cl~~dp~---~RPt~~~l~~~L~~~~~~~~~~~~~~ 287 (465)
|.+.. ..+.+..+.... ...+.. ..+++++.++|.+++. +|. .||++++|++ ++|...
T Consensus 236 f~~~~---~~~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~----------hp~f~~ 298 (363)
T cd05628 236 FCSET---PQETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKT----------NPFFEG 298 (363)
T ss_pred CCCCC---HHHHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhC----------CCCCCC
Confidence 98743 334444443321 111211 2457899999988654 444 4588777643 678888
Q ss_pred ccccccC
Q 012336 288 FDWTILK 294 (465)
Q Consensus 288 ~dw~~~~ 294 (465)
++|....
T Consensus 299 ~~~~~~~ 305 (363)
T cd05628 299 VDWEHIR 305 (363)
T ss_pred CCHHHHH
Confidence 8998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.73 Aligned_cols=237 Identities=22% Similarity=0.279 Sum_probs=190.5
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHH---HcCCCCCceeEEEeEeCcEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYML---LQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~---l~~~~~i~~l~~~~~~~~~~~l 80 (465)
|++++.||+|+||.||+|.+..+++.||||++.... ....+..|..++.. +.|++++. +..+...+...|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~-~~~~~~~~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN-LFACFQTEDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhc-eeeEEEcCCEEEE
Confidence 789999999999999999999999999999987432 12346667666654 44555444 4455567778899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|||++ +++|..++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 80 v~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 80 VMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCC
Confidence 99998 889988776 4579999999999999999999999999999999999999 58899999999998753221
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+..+.......+
T Consensus 155 ~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~---~~~~~~~i~~~~~~~p--- 221 (324)
T cd05589 155 G-------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD---EEEVFDSIVNDEVRYP--- 221 (324)
T ss_pred C-------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC---
Confidence 1 12245679999999999999999999999999999999999999998743 3334444433333222
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDY 266 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (465)
..+++++.++|.+||..||.+||+.
T Consensus 222 --~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 222 --RFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --CCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 4568999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=336.54 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=213.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-...|..++.||.|.||.||+|.+..+++.||+|++..+... ..+..|+.++..+.++++.. ++.....+..+.++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~-yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITE-YYGSYLKGTKLWII 89 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHh-hhhheeecccHHHH
Confidence 356788899999999999999999999999999999877544 35788999999999854444 44444566677888
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+|| ||++.++++- +..+.+..+.-++.+++.||.|||.++.+|||||+.|||+. ..+.+||+|||.+..+....
T Consensus 90 Mey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred HHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechh
Confidence 9998 9999999984 44569999999999999999999999999999999999995 66999999999998876543
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. ...+++||+.|||||++.+..|+.|+||||||++.|||++|.+||..+.+......+ .. ..++.+
T Consensus 166 ~-------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---pk----~~PP~L 231 (467)
T KOG0201|consen 166 K-------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---PK----SAPPRL 231 (467)
T ss_pred h-------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---cC----CCCCcc
Confidence 2 237899999999999999999999999999999999999999999987663332221 11 222333
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYV 287 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~ 287 (465)
...+++.|++|+..||.+||+.||++. ++|++-|++........
T Consensus 232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~---~LLKh~FIk~a~k~s~L 275 (467)
T KOG0201|consen 232 DGDFSPPFKEFVEACLDKNPEFRPSAK---ELLKHKFIKRAKKTSEL 275 (467)
T ss_pred ccccCHHHHHHHHHHhhcCcccCcCHH---HHhhhHHHHhcCCchHH
Confidence 347789999999999999999999955 45677777764443333
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=334.95 Aligned_cols=269 Identities=22% Similarity=0.250 Sum_probs=202.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+|.+++.||+|+||+||+|++..+++.||||++.... ....+..|+.++..+.|++++..+..| .++...++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-EeCCEEEEE
Confidence 36999999999999999999999999999999887532 234577899999999887666655554 566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence 9998 8899999875 4679999999999999999999999999999999999999 588999999999986432110
Q ss_pred Cccc----------------------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHH
Q 012336 161 THKH----------------------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLG 200 (465)
Q Consensus 161 ~~~~----------------------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLG 200 (465)
.... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 000011245799999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 201 YVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 201 viL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
|+||||++|..||.+... .+....+.........+ ....+++++.++|.+|+ .+|++|++...+.+++.
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~------ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA------ 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc------
Confidence 999999999999987433 22232222211111111 11356889999998876 59999997222223333
Q ss_pred CCCCCccccccc
Q 012336 281 GYQFDYVFDWTI 292 (465)
Q Consensus 281 ~~~~~~~~dw~~ 292 (465)
+++...++|..
T Consensus 305 -hp~f~~~~~~~ 315 (382)
T cd05625 305 -HPFFKTIDFSS 315 (382)
T ss_pred -CCCcCCcChHH
Confidence 56666677764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=332.74 Aligned_cols=270 Identities=20% Similarity=0.286 Sum_probs=205.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.++..+.|++++..+. ++..+...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~-~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYY-SFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEE-EEEcCCeEEEE
Confidence 47999999999999999999999999999999987532 1234678999999998766665554 45567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9998 8899999875 5579999999999999999999999999999999999999 589999999999997643211
Q ss_pred Ccccc-----------------c---------c-----cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcC
Q 012336 161 THKHI-----------------P---------Y-----RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG 209 (465)
Q Consensus 161 ~~~~~-----------------~---------~-----~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG 209 (465)
..... + + ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00000 0 0 011235799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccc
Q 012336 210 SLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFD 289 (465)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~d 289 (465)
..||.+... .+.+..+.........+. ...+++++.++|..|+. +|.+|++...+.++|. ++|...++
T Consensus 236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~-------h~~~~~~~ 303 (364)
T cd05599 236 YPPFCSDNP---QETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS-------HPFFKGVD 303 (364)
T ss_pred CCCCCCCCH---HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc-------CCCcCCCC
Confidence 999987432 333333332211111111 12568999999999996 9999998333333333 56666678
Q ss_pred cccc
Q 012336 290 WTIL 293 (465)
Q Consensus 290 w~~~ 293 (465)
|...
T Consensus 304 ~~~~ 307 (364)
T cd05599 304 WEHI 307 (364)
T ss_pred HHHH
Confidence 8753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=324.29 Aligned_cols=262 Identities=19% Similarity=0.253 Sum_probs=199.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC----------------CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ----------------TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTG 64 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~----------------~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~ 64 (465)
+..++|++.++||+|+||.||+|.+.. ++..||||++..... ...+.+|+.++..+.|+++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 456899999999999999999997532 345799998875432 2358889999999988777
Q ss_pred CceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 012336 65 VPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCN------------------RKFSLKTVLMLADQLINRVEYMHSRGFL 125 (465)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~------------------~~ls~~~~~~ia~qi~~gL~yLHs~giv 125 (465)
+..+..+. +....+++||++ +++|.+++.... ..+++.++..++.||+.||.|||+.||+
T Consensus 82 v~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 82 IRLLGVCV-DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eEEEEEEe-cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 66665554 455688999988 889999886421 2478889999999999999999999999
Q ss_pred ccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHH
Q 012336 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY 205 (465)
Q Consensus 126 HrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~e 205 (465)
||||||+|||+ +.++.+||+|||+++....... +.......++..|+|||++.+..++.++||||||+++||
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999 5789999999999976533211 112234456889999999998899999999999999999
Q ss_pred Hhc--CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 206 FLR--GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 206 llt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
|++ +..||.+............................+|..+.+++.+||..+|++||++.+|.+.|+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 986 678888754332222211111111000000112356899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.86 Aligned_cols=252 Identities=19% Similarity=0.251 Sum_probs=200.2
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++++... .+.......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceE-EEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999987542 223567899999999886655544 4455667889999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+.+.. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~------ 149 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDA------ 149 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCcc------
Confidence 899888864 5679999999999999999999999999999999999999 588999999999987543211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. .+.+..+....... ...+++
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~~~-----p~~~~~ 220 (328)
T cd05593 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDIKF-----PRTLSA 220 (328)
T ss_pred -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCccC-----CCCCCH
Confidence 112346799999999999999999999999999999999999999976432 22332222222222 246789
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.+++..||..||.+|| ++.+|.+ +++....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~~ 263 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR----------HSFFTGVNWQDVY 263 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc----------CCCcCCCCHHHHH
Confidence 999999999999999997 6555543 4566667777543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.19 Aligned_cols=261 Identities=18% Similarity=0.211 Sum_probs=194.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCC------CCceeEEEeEeCcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGT------GVPHLKWFGVEGEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~------~i~~l~~~~~~~~~ 77 (465)
..++|++++.||+|+||+||+|.+..+++.||||++.... .......|++++..+.+.+ ++..+.+|..+..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 3588999999999999999999999999999999986432 2334677888888887644 33334445555668
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCC-------------CCC
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGR-------------KSN 143 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d-------------~~~ 143 (465)
+|+||++++++|.+++.. .+.+++..+..|+.||+.||+|||+ .|||||||||+|||+..++ ...
T Consensus 207 ~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 899999999999998875 4679999999999999999999998 5999999999999995211 012
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~ 223 (465)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+......
T Consensus 286 ~vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 286 RVRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred eEEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 599999998854321 1235689999999999999999999999999999999999999998754322222
Q ss_pred HHHHHhhhh---------------------c---cCcHHHH----------hccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 224 KYDKISEKK---------------------M---LTPIEVL----------CKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 224 ~~~~i~~~~---------------------~---~~~~~~~----------~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.+....... . ......+ .....+.+.+||..||..||++||++.++
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 221111000 0 0000000 00113567899999999999999996665
Q ss_pred HHHHHHHHHH
Q 012336 270 KRLFRDLFIR 279 (465)
Q Consensus 270 ~~~L~~~~~~ 279 (465)
|.+.|..
T Consensus 436 ---L~Hp~~~ 442 (467)
T PTZ00284 436 ---TTHPYVL 442 (467)
T ss_pred ---hcCcccc
Confidence 4555543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.62 Aligned_cols=250 Identities=20% Similarity=0.260 Sum_probs=196.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcC-CCcEEEEEEeecCCC----CccHHHHHHHHHHHc---CCCCCceeEEEeE----e
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQ-TGEEVAVKLESVKTK----HPQLHYESKLYMLLQ---GGTGVPHLKWFGV----E 74 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~-~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~---~~~~i~~l~~~~~----~ 74 (465)
.+|++++.||+|+||.||+|++.. ++..||||++..... ...+.+|+.++..+. |++++..+..+.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 468899998875432 224667888887764 6666666555532 3
Q ss_pred CcEEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
....+++|+++.++|.+++... ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 4568999999999999998754 3458999999999999999999999999999999999999 58899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
+.+... .......||+.|+|||.+.+..++.++|||||||++|||++|..||.+..... .+..+.....
T Consensus 158 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~ 226 (290)
T cd07862 158 RIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 226 (290)
T ss_pred EeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhC
Confidence 765432 11235578999999999999899999999999999999999999998754322 2222221110
Q ss_pred ----------------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 ----------------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ----------------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+.+.....+++.+.+++.+||+.||++||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 227 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred CCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0112223345788899999999999999999977665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.04 Aligned_cols=261 Identities=20% Similarity=0.277 Sum_probs=201.9
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..+++.||+|++..... ...+..|..++..+.+|++|..+..+.......++|||++ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999875421 1246678888887755556666666667777889999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~------ 150 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPG------ 150 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCC------
Confidence 899888764 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC------chHHHHHHHhhhhccCcHHHH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p---- 225 (329)
T cd05618 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----
Confidence 1123567999999999999999999999999999999999999999632211 11122222222222222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSY---LKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..++.++.+++..||..||.+||++.. +.+. ..++++..++|......
T Consensus 226 -~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i-------~~hp~f~~~~~~~~~~~ 276 (329)
T cd05618 226 -RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADI-------QGHPFFRNVDWDLMEQK 276 (329)
T ss_pred -CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHH-------hcCCCCCCCCHHHHHcC
Confidence 456889999999999999999998421 1122 23677888889866543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=319.66 Aligned_cols=261 Identities=19% Similarity=0.227 Sum_probs=205.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.|++.+.||+|+||+||++.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+ ..++..+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-cCCCeEEEEE
Confidence 4899999999999999999998899999999886432 123467899999999887766655444 5556889999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+|||+ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 988 88999887643 3569999999999999999999999999999999999999 578999999999997653221
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .....|++.|+|||.+.+..++.++|||||||++|||++|..||.+.......+.+...... .....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----ccccc
Confidence 1 12347899999999999989999999999999999999999999875433222222211111 11112
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
...+++.+.+++..||..||.+|| ++++|.+ +++...++|...+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~----------~~~~~~~~~~~~~ 273 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA----------HPFFRTANFKRLE 273 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc----------CcCccCCCHHHHh
Confidence 345789999999999999999999 6555432 5666777888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.04 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=198.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE-------eCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV-------EGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~-------~~~ 76 (465)
...++|++++.||+|+||.||+|.+..+++.||||++.... .....|+.+++.+.|++++..+..|.. ...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 34578999999999999999999999999999999875432 345679999999999888887665532 123
Q ss_pred EEEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 77 YNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
+.++||||++++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+. ..++.+||+|||++
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccc
Confidence 5779999999999888753 246799999999999999999999999999999999999994 23457999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.........+.......
T Consensus 219 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 219 KNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred hhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 8654321 12345789999999998764 58999999999999999999999998754322211111110000
Q ss_pred ----------------cc--C---cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 233 ----------------ML--T---PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 233 ----------------~~--~---~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.. . ....+....|+++.+||.+||..||.+||++.++ |.+.|.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~---l~hp~f 354 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA---LADPFF 354 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH---hCChhH
Confidence 00 0 0011223467899999999999999999996655 555543
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=325.95 Aligned_cols=259 Identities=19% Similarity=0.268 Sum_probs=202.5
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..+++.||||+++... ....+..|..++..+.+|++|..+..++......+++||++ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999987532 12346788999988876666666666777778899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~------ 150 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPG------ 150 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCC------
Confidence 899888864 5689999999999999999999999999999999999999 588999999999987432111
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc------hHHHHHHHhhhhccCcHHHH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~~~~~ 240 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .......+.......+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p---- 225 (329)
T cd05588 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP---- 225 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----
Confidence 12235679999999999999999999999999999999999999996432111 1112222222222222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSY---LKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..++.++.+++..||..||.+||++.. +.+.+ .++|...++|....
T Consensus 226 -~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~-------~hp~~~~~~~~~~~ 274 (329)
T cd05588 226 -RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK-------SHPFFRNIDWDLLE 274 (329)
T ss_pred -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh-------cCCCCCCCCHHHHH
Confidence 456899999999999999999998421 22223 36677778887654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=324.31 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=203.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||++++..+++.||||++... .....+..|+.++..+.|++++ .+..+..++...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~-~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT-NLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCC-ceEEEEecCCeEEEE
Confidence 5799999999999999999999999999999998642 1223467788888888765554 455555667788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9987 999999998656789999999999999999999999999999999999999 588999999999987654322
Q ss_pred CcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. ..+.+..+.......
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05597 157 T------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEHF 227 (331)
T ss_pred C------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 1 11223469999999999873 347889999999999999999999998643 334444443322211
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCC--CCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFE--DKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~--~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
........+++++.+++..|+..+++ .|+++.++. . ++|+..++|....
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l---~-------hp~~~~~~~~~~~ 278 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFK---D-------HPFFEGIDWDNIR 278 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHh---c-------CCCCCCCCHHHHh
Confidence 21222245789999999998865333 366755543 3 5777778887654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=327.54 Aligned_cols=262 Identities=19% Similarity=0.242 Sum_probs=206.2
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||+||+|++..+++.||||++..... ...+..|..++..+.++++|..+..+.......++|||++ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999875421 2346788999999987788888888888888899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~------ 150 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPG------ 150 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCC------
Confidence 899888864 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC----chHHHHHHHhhhhccCcHHHHhc
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..+....... ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----p~ 224 (327)
T cd05617 151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRI-----PR 224 (327)
T ss_pred -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCC-----CC
Confidence 1123567999999999999999999999999999999999999999653221 1122222222222222 24
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
.++.++.+++..||..||.+|+++.... .+. .-..++++...+|....
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~~-~~~---~i~~h~~f~~~~~~~~~ 272 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQT-GFS---DIKSHTFFRSIDWDLLE 272 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCC-CHH---HHHcCCCCCCCCHHHHH
Confidence 5689999999999999999999843110 001 11246788888898764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=334.40 Aligned_cols=267 Identities=22% Similarity=0.257 Sum_probs=203.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+..| .++...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-QDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-EcCCEEEEE
Confidence 4799999999999999999999999999999988642 2234577899999999887766665554 556688999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9998 8999999875 4578999999999999999999999999999999999999 588999999999986432110
Q ss_pred Cccc------------------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHH
Q 012336 161 THKH------------------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM 204 (465)
Q Consensus 161 ~~~~------------------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ 204 (465)
.... ........+.||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0000 0001112457999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcC
Q 012336 205 YFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKP---DYSYLKRLFRDLFIREG 281 (465)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RP---t~~~l~~~L~~~~~~~~ 281 (465)
||++|+.||.+.... +....+......... .....+++++.++|.+|+ .+|.+|+ ++.++. .
T Consensus 236 ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell---~------- 300 (376)
T cd05598 236 EMLVGQPPFLADTPA---ETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK---A------- 300 (376)
T ss_pred ehhhCCCCCCCCCHH---HHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh---C-------
Confidence 999999999875432 222222211111110 011356889999999977 5999999 655553 3
Q ss_pred CCCCcccccccc
Q 012336 282 YQFDYVFDWTIL 293 (465)
Q Consensus 282 ~~~~~~~dw~~~ 293 (465)
++|...++|...
T Consensus 301 h~~~~~~~~~~~ 312 (376)
T cd05598 301 HPFFKGIDFASL 312 (376)
T ss_pred CCCcCCCCHHHH
Confidence 455666666654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=331.84 Aligned_cols=265 Identities=22% Similarity=0.267 Sum_probs=202.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
..|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.++..+.|++++..+ .+..+....++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~-~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY-YSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeE-EEEecCCEEEEE
Confidence 36999999999999999999999999999999987542 123577899999999886655555 444567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccc
Confidence 9998 8899999875 4679999999999999999999999999999999999999 588999999999986432110
Q ss_pred Cccc----------------------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHH
Q 012336 161 THKH----------------------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLG 200 (465)
Q Consensus 161 ~~~~----------------------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLG 200 (465)
.... ........+.||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0000 000011346799999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCchHHHHHHHhhh--hccCcHHHHhccCcHHHHHHHHH--HhcCCCCCCCCHHHHHHHHHHH
Q 012336 201 YVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--KMLTPIEVLCKSYPSEFTSYFHY--CRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 201 viL~elltG~~Pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~p~~l~~li~~--cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
|++|||++|..||..... .+....+... ....+. ...+++++.++|.+ |+..++..||++.+|+.
T Consensus 236 ~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~----- 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA----- 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc-----
Confidence 999999999999987443 2222222211 111111 12468999999998 44556667999777653
Q ss_pred HHHcCCCCCccccccc
Q 012336 277 FIREGYQFDYVFDWTI 292 (465)
Q Consensus 277 ~~~~~~~~~~~~dw~~ 292 (465)
++++..++|..
T Consensus 305 -----hp~f~~~~~~~ 315 (381)
T cd05626 305 -----HPFFSEVDFSS 315 (381)
T ss_pred -----CcccCCCChhH
Confidence 56777778864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=322.87 Aligned_cols=252 Identities=23% Similarity=0.305 Sum_probs=199.4
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||+||+|++..+++.||||++... ........|..++..+.+|++|..+..+..+....+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999998754 222346667777776655556666666666777899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++.++..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~------ 150 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGD------ 150 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCC------
Confidence 999999875 4579999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+. .+.+..+.......+ ..++.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~-----~~~~~ 221 (316)
T cd05619 151 -AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNPCYP-----RWLTR 221 (316)
T ss_pred -CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC-----ccCCH
Confidence 112345799999999999999999999999999999999999999987443 333333332222111 34688
Q ss_pred HHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCcccccccc
Q 012336 247 EFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
++.+++..||..||.+||++. +|. .+++....+|...
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~----------~h~~~~~~~~~~~ 259 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR----------QHPFFREIDWSAL 259 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH----------cCcccCCCCHHHH
Confidence 999999999999999999975 332 2566666778754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.96 Aligned_cols=256 Identities=21% Similarity=0.248 Sum_probs=197.9
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHH-HHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKL-YMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||+||+|++..+++.||+|++.... ....+..|... ++.+.|++++. +..+.......+++||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~-~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCc-eeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999987532 11234444443 45566655554 555556677889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~----- 150 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHN----- 150 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCC-----
Confidence 8899988875 5678999999999999999999999999999999999999 588999999999997543211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+....... ...++
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~-----~~~~~ 220 (325)
T cd05602 151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPLQL-----KPNIT 220 (325)
T ss_pred --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCcCC-----CCCCC
Confidence 12235679999999999999999999999999999999999999998743 334444443332221 24678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+++.+++..||..+|.+||+..+....+ ....+...++|....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i------~~~~~~~~~~~~~~~ 263 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEI------KNHIFFSPINWDDLI 263 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHH------hcCcccCCCCHHHHH
Confidence 9999999999999999999865322111 235667778888654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.44 Aligned_cols=267 Identities=21% Similarity=0.277 Sum_probs=202.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|.+..+++.||||++.... ....+..|++++..+.|++++..+ .++.+..+.|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~-~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEE-EEEEcCCeeEEE
Confidence 47999999999999999999999999999999876432 123567899999999886655554 445667789999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9998 8999999875 5679999999999999999999999999999999999999 588999999999997442211
Q ss_pred Cccc-------cc---------------------------------ccCCCCccccccccccccccCCCCCCcchHHHHH
Q 012336 161 THKH-------IP---------------------------------YRENKNLTGTARYASVNTHLGVEQSRRDDLESLG 200 (465)
Q Consensus 161 ~~~~-------~~---------------------------------~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLG 200 (465)
.... .. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0000 00 0001135799999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHH
Q 012336 201 YVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKP---DYSYLKRLFRDLF 277 (465)
Q Consensus 201 viL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RP---t~~~l~~~L~~~~ 277 (465)
|++|||++|..||.+... .+.+..+.........+ ....++.++.+||..|+. +|.+|+ ++.++. .
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l---~--- 304 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK---S--- 304 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh---c---
Confidence 999999999999976433 33333333211111100 012467899999999997 777764 755543 3
Q ss_pred HHcCCCCCcccccccc
Q 012336 278 IREGYQFDYVFDWTIL 293 (465)
Q Consensus 278 ~~~~~~~~~~~dw~~~ 293 (465)
+++...++|...
T Consensus 305 ----hp~~~~~~~~~~ 316 (377)
T cd05629 305 ----HPFFRGVDWDTI 316 (377)
T ss_pred ----CCCcCCCCHHHH
Confidence 555666777654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=325.81 Aligned_cols=265 Identities=19% Similarity=0.250 Sum_probs=203.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||++++..+++.||||++.... ....+..|..++..+.| ++|..+..+.....+.++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999886421 12236677777777766 4555566666777889999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ |++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9998 999999998656789999999999999999999999999999999999999 588999999999997654322
Q ss_pred CcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
. .......||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.... ..+.+..+.......
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05624 157 T------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERF 227 (331)
T ss_pred c------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcc
Confidence 1 11234579999999999876 457889999999999999999999998643 334444443322222
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+.+.....+++++.+++.+|+..++.. |++++++ +. ++++..++|....
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~---~~-------h~~f~~~~~~~~~ 278 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDF---KK-------HAFFEGIDWENIR 278 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHH---hc-------CCCcCCCCHHHHh
Confidence 222223457899999999999865433 3454443 32 5666678888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.62 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=216.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
-+...|.+.+.||.|.||.||+|+.+.+|+.||+|++.+.... ..+.+|+++|+.+.+|+++..+....+.....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3567899999999999999999999999999999998866432 47899999999999667777777777777799
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC-CCcEEEEecCCcccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-SNQVYIIDYGLAKKY 156 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~-~~~vkL~DFGla~~~ 156 (465)
++|||++ ||.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+...+. ++.++++|||++..+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999 89999999864 3999999999999999999999999999999999999975443 458999999999887
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
... ......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.. ....+..+........
T Consensus 190 ~~~--------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~---~~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 190 KPG--------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET---EFEIFLAILRGDFDFT 258 (382)
T ss_pred cCC--------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC---hhHHHHHHHcCCCCCC
Confidence 651 12457799999999999999999999999999999999999999999843 3445556666655444
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+. ...++..+.++|..|+..||..|+++.++.+
T Consensus 259 ~~~-w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 259 SEP-WDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCC-ccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 333 3577899999999999999999999666544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=332.24 Aligned_cols=251 Identities=15% Similarity=0.185 Sum_probs=196.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..++|++++.||.|+||.||+|++..+++.||||... ...+..|++++..|+|++++..+..| ..+...++++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQLKGTF-TYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCCEeEEE-EECCeeEEEEec
Confidence 4578999999999999999999999999999999754 23578999999999988777765554 556788999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 85 LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 85 ~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 165 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~--- 237 (391)
T PHA03212 165 YKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINA--- 237 (391)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCcccccccccc---
Confidence 99999988875 4579999999999999999999999999999999999999 5889999999999975432211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc----hHHHHHHHhhhh--------
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYDKISEKK-------- 232 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~----~~~~~~~i~~~~-------- 232 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||....... ....+..+....
T Consensus 238 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 238 ---NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ---cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11234679999999999999999999999999999999999998876432100 000111110000
Q ss_pred ------------------c----cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ------------------M----LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ------------------~----~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ..+.......+|.++.+||.+||..||++||++.++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 0 0000011124577899999999999999999976654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=337.29 Aligned_cols=206 Identities=24% Similarity=0.347 Sum_probs=180.4
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHc-----CCCCCceeEEEeEeC
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQ-----GGTGVPHLKWFGVEG 75 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~-----~~~~i~~l~~~~~~~ 75 (465)
++.+..+|.+++.||+|+||+|.+|.+..|++.||||+++.+. ...+...|+.+|..|. +..++..+..|+...
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3556779999999999999999999999999999999998664 3567888999999998 345777888888999
Q ss_pred cEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
++.|||+|++.-+|.++++..+ ..|+...+..|+.||+.+|.+||+.||||+||||+||||..- ....|||+|||.+.
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEeccccc
Confidence 9999999999999999998643 569999999999999999999999999999999999999633 34599999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~ 218 (465)
...... .+..-+..|.|||++.|.+|+.+.|+||||||++||++|.+.|+|.+.
T Consensus 340 ~~~q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 340 FESQRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred ccCCcc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 654321 145678899999999999999999999999999999999999998544
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=324.09 Aligned_cols=260 Identities=18% Similarity=0.284 Sum_probs=203.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+..++|++++.||+|+||.||+|++..++..||+|++..... ...+..|++++..++|++++..+..+. .+...++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEE
Confidence 456899999999999999999999999999999999875432 246889999999999887777666554 5567889
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
||+++ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence 99988 8899999875 45799999999999999999999986 59999999999999 5889999999999976543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH----------
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI---------- 228 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i---------- 228 (465)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...
T Consensus 157 ~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred cc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 21 23457999999999999999999999999999999999999999764322111111000
Q ss_pred -----------------------------hhhh-ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 229 -----------------------------SEKK-MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 229 -----------------------------~~~~-~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.... ...........+++++.+||.+||.+||++||++.+| |++.|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el---l~h~~~ 304 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML---MNHTFI 304 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH---hcChHH
Confidence 0000 0000000012467899999999999999999996655 566666
Q ss_pred Hc
Q 012336 279 RE 280 (465)
Q Consensus 279 ~~ 280 (465)
..
T Consensus 305 ~~ 306 (331)
T cd06649 305 KR 306 (331)
T ss_pred hh
Confidence 54
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=313.35 Aligned_cols=256 Identities=14% Similarity=0.213 Sum_probs=203.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+-..+|++.+.||+|+||.||+|.+. ..+..||+|++..... ...+..|+.++..+.|++++..+. +...+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEG-VITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEE-EEecCCC
Confidence 44678999999999999999999865 3467999998875432 235778999999998876666554 4456678
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++|||++ +++|.+++......+++..++.++.||+.||+|||++|++||||||+|||+ +.++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 89999999 779999987655679999999999999999999999999999999999999 58899999999987653
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+.... ..+..+..... .
T Consensus 158 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~-~ 227 (266)
T cd05064 158 KSEAI------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFR-L 227 (266)
T ss_pred cccch------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCC-C
Confidence 22111 11123345678999999999999999999999999999775 99999875432 22222222211 1
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+. ...+|..+.+++.+||+.+|++||++.+|.+.|..+
T Consensus 228 ~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 21 245789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=311.67 Aligned_cols=253 Identities=20% Similarity=0.228 Sum_probs=206.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc----cHHHHHHHHHHHcCCCCCceeEE-EeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQGGTGVPHLKW-FGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~i~~l~~-~~~~~~~~~lv 81 (465)
++|+.+..|++|.||.||+|+++.|++.||+|.++.+.... .-++|+.++..++|+|+|..-.+ .+.+-+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 57889999999999999999999999999999988776544 35899999999998777766543 34566679999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|+||..+|..++....++|...++..++.|++.||+|||...|+||||||+|+|+. ..|.+||+|||+|+.|...
T Consensus 156 Me~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 156 MEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred HHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCC--
Confidence 99999999999998888999999999999999999999999999999999999995 8999999999999998764
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc-------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM------- 233 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------- 233 (465)
.......+-|.+|.|||.+.+.. |+..+|+||+|||+.||+++++-|+|...-+....+..+..-.-
T Consensus 231 -----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 231 -----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred -----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 23445678899999999999865 99999999999999999999999998654333333222221000
Q ss_pred ------------cCcHHHH-----hccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 234 ------------LTPIEVL-----CKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 234 ------------~~~~~~~-----~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
..+...+ +.++++.-.+|+..+|..||.+|.|+++.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~ 358 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG 358 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence 0000011 11245778899999999999999997654
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=323.23 Aligned_cols=265 Identities=19% Similarity=0.254 Sum_probs=205.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||++++..+++.||+|++.... ....+..|+.++..+.|++ +..+..+..+....++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW-ITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCC-EeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999986421 1223667888887776654 55555556677788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9988 899999998656789999999999999999999999999999999999999 588999999999997654322
Q ss_pred CcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..+.+..+.......
T Consensus 157 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 T------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKERF 227 (332)
T ss_pred c------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC---HHHHHHHHhCCCccc
Confidence 1 1123457999999999986 3457889999999999999999999998743 344444444333222
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+..+..+++++.+++.+|+..++.. |+++.++.+ ++|+..++|....
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~----------h~~f~~~~~~~~~ 278 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ----------HPFFTGIDWDNIR 278 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC----------CCCcCCCCHHHHh
Confidence 222233567899999999998664443 567655543 5677778887654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.18 Aligned_cols=261 Identities=23% Similarity=0.269 Sum_probs=204.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+ .+..++...++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~-~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH-YAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE-EEEecCCEEEE
Confidence 468999999999999999999999999999999986431 223467899999998876665554 45566778999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||||+ +++|.+++. +..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence 99998 899999987 3568999999999999999999999999999999999999 58999999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCC----CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+.......
T Consensus 196 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~ 266 (370)
T cd05596 196 GM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMDHKNSL 266 (370)
T ss_pred Cc------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHHHHHHHcCCCcC
Confidence 11 112356799999999998754 378999999999999999999999987432 33444443322111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccc
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGYQFDYVFDWTI 292 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 292 (465)
..+. ...++.++.++|..||..+|.+ |+++++|.+ ++|....+|..
T Consensus 267 ~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~----------h~~~~~~~~~~ 314 (370)
T cd05596 267 TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS----------HPFFKNDQWTF 314 (370)
T ss_pred CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc----------CcccCCCChhh
Confidence 1110 1246899999999999999987 999766543 44554556654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.36 Aligned_cols=257 Identities=20% Similarity=0.337 Sum_probs=199.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCC-----cEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEeEeCc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTG-----EEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~-----~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~~~~~ 76 (465)
.++|++.+.||+|+||.||+|++..++ ..||||++..... ...+..|+.++..+ .|++++. +..++....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~-~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVN-LLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceee-EeeEecCCC
Confidence 457999999999999999999865443 5799999875432 23577899999999 5555555 444555666
Q ss_pred EEEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN---------------------------------------------------------- 97 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~---------------------------------------------------------- 97 (465)
..+++|+|+ +++|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 789999998 899999885321
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 98 -----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 98 -----------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
..+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcc-----
Confidence 247889999999999999999999999999999999999 5788999999999976543221
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .+........... ....+|
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~---~~~~~~ 341 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMS---RPDFAP 341 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCcc---CCCCCC
Confidence 111223446678999999999899999999999999999997 999998754322 1112222211111 112458
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
+++.+++.+||..||++||++.+|.++|++++
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=313.63 Aligned_cols=261 Identities=22% Similarity=0.313 Sum_probs=220.0
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
.+|.+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++.+ ...+.+.+|+.|.+.|+|++++.....+. +..+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-cccee
Confidence 57889999999999999999999999999999999988754 24557889999999999977766655554 45578
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+||++++ |++|..-+-. .-.+++..+-.+++||+.+|.|+|.+||||||+||.|+|+...+...-+||+|||++..+.
T Consensus 86 ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 8999998 8888755543 2458899999999999999999999999999999999999877778899999999999876
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
+.. ....+.|||.|||||++...+|+..+|||+.|||||-||.|.+||.+ ++....|..|....+..+.
T Consensus 165 ~g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 DGE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPS 233 (355)
T ss_pred Ccc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCC
Confidence 322 22467899999999999999999999999999999999999999998 3455667777777776665
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+.. ..++++.++|+.+||..||.+|.| ..+.|++.|+..
T Consensus 234 ~~w-~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~ 272 (355)
T KOG0033|consen 234 PEW-DTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICN 272 (355)
T ss_pred ccc-CcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcc
Confidence 332 578899999999999999999999 555677776644
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.62 Aligned_cols=255 Identities=21% Similarity=0.266 Sum_probs=197.9
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHH-HHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKL-YMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||+||+|++..+++.||||++.... ....+..|..+ +..+.|++++..+ .+.......+++|+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~-~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH-YSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCee-EEEEeCCEEEEEEcCCC
Confidence 47999999999999999999999999987432 12234455554 4556666655544 4445667889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~----- 150 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHS----- 150 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCC-----
Confidence 8899988875 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+....... ...++
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~-----~~~~~ 220 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPLRL-----KPNIS 220 (323)
T ss_pred --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCCCC-----CCCCC
Confidence 12235679999999999999999999999999999999999999998743 334444444333222 24568
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+++.+++..||..||.+||++. .+.+++ .+++...++|....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il-------~~~~~~~~~~~~~~ 263 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIK-------NHVFFSSINWDDLV 263 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHH-------cCCCcCCCCHHHHh
Confidence 9999999999999999999864 222333 35666667787543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.18 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=222.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec-----CCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV-----KTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~-----~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
-.++|.+++.||.|+||+|.+++.+.+++.||+|++++ ......|..|..+|..-. ..+|..+++.+.++.++|
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceE
Confidence 35789999999999999999999999999999999875 233345777777776444 577778888888889999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|||+|+ ||+|..++.... +++++.+.+|+..|+.||.-||+.|+|||||||+|||+ |..|++||+|||.|..+..
T Consensus 152 lVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCC
Confidence 999998 999999998655 89999999999999999999999999999999999999 7999999999999988876
Q ss_pred ccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
+... .....+|||.|++||++.. ..|++.+|||||||++|||+.|..||+. ....+.|.+|...+.
T Consensus 228 dG~V------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 228 DGTV------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKE 298 (1317)
T ss_pred CCcE------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhh
Confidence 5542 3457789999999999863 4589999999999999999999999987 667888888887743
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD---YSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt---~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
....+.. ..+++++++||...+. +|+.|.. +++|+. ++|+...||..+.
T Consensus 299 ~l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~----------HpFF~g~~W~~iR 350 (1317)
T KOG0612|consen 299 SLSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN----------HPFFEGIDWDNIR 350 (1317)
T ss_pred hcCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh----------CccccCCChhhhh
Confidence 3222211 2479999999999886 7888877 777654 8999999997654
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.84 Aligned_cols=256 Identities=23% Similarity=0.337 Sum_probs=203.0
Q ss_pred EeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 12 GRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++.||+|+||.||++++. .+++.||||++.... ....+..|++++..+.|++++..+..+ ..+...|+|||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-QTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-EcCCEEEEEEcC
Confidence 367999999999999863 578999999987532 223467799999999887777655554 556678899999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~--- 152 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHE--- 152 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCC---
Confidence 8 8899988864 5679999999999999999999999999999999999999 588999999999987653321
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+..+.......+ ..
T Consensus 153 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~~p-----~~ 220 (318)
T cd05582 153 ----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLGMP-----QF 220 (318)
T ss_pred ----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCCCC-----CC
Confidence 11235679999999999999889999999999999999999999998643 3334443333332222 45
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCccccccccC
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+++++.+++..||+.||++||++.+ +.+++. ++++..++|....
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~-------~~~~~~~~~~~~~ 266 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKR-------HPFFSTIDWNKLY 266 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhC-------CCCcCCCCHHHHH
Confidence 6899999999999999999999766 555544 4555566777543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=331.46 Aligned_cols=250 Identities=22% Similarity=0.244 Sum_probs=219.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.++|.+++++|.|+||.+++++++..+..|++|.+...... .....|..++.+++|+++|.....|..++.+.+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 46899999999999999999999999999999988865432 25688999999999999999999998889889999
Q ss_pred Eecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|+|| ||+|.+.+.... .-|+++.+..|+.||+.||+|||++.|+|||||+.||+++ .++.|+|.|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 999999998655 5699999999999999999999999999999999999996 7888899999999988654
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. ...++.||+.||+||++.+.+|..|+|||||||++|||++=+.+|... +....+.++....+.+..
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~~~Plp-- 227 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGLYSPLP-- 227 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhccCCCCC--
Confidence 31 346789999999999999999999999999999999999999999874 445566666665543222
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRL 272 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (465)
..++.++..+|..|+..+|+.||++.+|...
T Consensus 228 --~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 --SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 5678999999999999999999998877664
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=329.39 Aligned_cols=269 Identities=20% Similarity=0.296 Sum_probs=207.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+.. .......++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS-FQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE-EEcCCEEEEE
Confidence 4799999999999999999999999999999998642 123457789999999988666655554 4566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ |++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9998 8899999875 5679999999999999999999999999999999999999 588999999999987543211
Q ss_pred Cccc----------------------------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC
Q 012336 161 THKH----------------------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP 212 (465)
Q Consensus 161 ~~~~----------------------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~P 212 (465)
.... .........+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCCCchHHHHHHHhhhh--ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccc
Q 012336 213 WQGLKAGTKKQKYDKISEKK--MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDW 290 (465)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw 290 (465)
|.+... ...+..+.... ...+.. ..+++++.++|.+|+ .+|.+|++...+.+++. ++|+..++|
T Consensus 236 f~~~~~---~~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~-------hp~f~~~~~ 301 (360)
T cd05627 236 FCSETP---QETYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIGSNGVEEIKS-------HPFFEGVDW 301 (360)
T ss_pred CCCCCH---HHHHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc-------CCCCCCCCH
Confidence 987443 33333333211 111111 236789999999977 49999996433434333 677888899
Q ss_pred cccC
Q 012336 291 TILK 294 (465)
Q Consensus 291 ~~~~ 294 (465)
....
T Consensus 302 ~~~~ 305 (360)
T cd05627 302 GHIR 305 (360)
T ss_pred HHHh
Confidence 8754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.44 Aligned_cols=246 Identities=22% Similarity=0.370 Sum_probs=213.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc-----cHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP-----QLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~-----~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
-+..+|++.+.||.|.||.|-+|.....|+.||||.+.++...+ .+.+|++||..|+|+++|..+.+| ++.+..
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-ENkdKI 128 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-ENKDKI 128 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-cCCceE
Confidence 35678999999999999999999998999999999887654332 478999999999998877766555 567788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+|||||. +|.|.|++.. .+.|++.++..++.||+.++.|+|+++++|||||.+|||+ |.|+++||+||||+-.|.
T Consensus 129 vivMEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEEEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhc
Confidence 9999998 9999999987 4679999999999999999999999999999999999999 799999999999998887
Q ss_pred cccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
+... ..++||.+.|++||++.|.+| ++.+|.|||||+||.|+.|.+||.+. +.+..+..|..+.+.-|
T Consensus 205 ~~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 205 DKKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYREP 273 (668)
T ss_pred cccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccCC
Confidence 6433 468999999999999999997 68999999999999999999999984 44566666776666544
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..|....-||++||.++|+.|.|+++|..
T Consensus 274 ------~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 274 ------ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 34788999999999999999999777754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=324.60 Aligned_cols=251 Identities=20% Similarity=0.273 Sum_probs=197.8
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|.+..++..||+|++.... ....+..|++++..+.|++++.. ..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~-~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCce-EEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999987532 12346778888888887665554 44556667889999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
++|.+++.. .+.+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 899888764 5679999999999999999999997 799999999999999 5889999999999875432111
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+....+.......+ ..++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEIRFP-----RTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCCCCC-----CCCC
Confidence 12345799999999999999999999999999999999999999987432 223333322222222 4578
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 246 SEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
+++.+++..||..||++|+ ++.++.+ +++...++|...
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~----------h~~~~~~~~~~~ 263 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ----------HKFFAGIVWQDV 263 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc----------CCCcCCCCHHHH
Confidence 9999999999999999997 7555543 455555667644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=338.40 Aligned_cols=253 Identities=23% Similarity=0.252 Sum_probs=202.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeC----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEG---- 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (465)
...++|++.+.||+|+||+||+|++..+++.||||++...... ..+..|+.++..+.|++++.....+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 4578999999999999999999999999999999998754322 34677888888888877766555443221
Q ss_pred ---cEEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 76 ---EYNVMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 76 ---~~~~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
...++||+|+ +++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEE
Confidence 2467899998 89999988642 3569999999999999999999999999999999999999 588999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i 228 (465)
|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+
T Consensus 186 DFGls~~~~~~~~~-----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSD-----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKT 257 (496)
T ss_pred ecccCeeccccccc-----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 99999876432211 12345679999999999999999999999999999999999999998643 23333333
Q ss_pred hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...... .+...+++++.+++..||..||.+||++.++.+
T Consensus 258 ~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 322221 122467899999999999999999999887654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=321.89 Aligned_cols=272 Identities=19% Similarity=0.289 Sum_probs=209.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+..++|++.++||.|+||.||+|.+..++..||+|++..... ...+..|+++++.++|++++..+..| ..+...++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 80 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGEISI 80 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE-EECCEEEE
Confidence 567899999999999999999999999999999998775432 24588999999999987777666555 45668899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|+|+ +++|.+++.. .+.+++..+..++.|++.+|.|||+. +|+|+||||+|||+ +.++.+||+|||++..+..
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhhh
Confidence 99998 8899999875 45789999999999999999999985 79999999999999 5788999999999976533
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH------------
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD------------ 226 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~------------ 226 (465)
.. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 157 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (333)
T cd06650 157 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227 (333)
T ss_pred hc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccccc
Confidence 21 234578999999999999889999999999999999999999997643211111100
Q ss_pred -------------------------HHhhhhccCcHHHH-hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 227 -------------------------KISEKKMLTPIEVL-CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 227 -------------------------~i~~~~~~~~~~~~-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+............ ...++.++.+|+.+||.+||++||++.+| |.+.|.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el---l~h~~~~~ 304 (333)
T cd06650 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL---MVHAFIKR 304 (333)
T ss_pred CcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH---hhCHHHhc
Confidence 00000000000000 11357889999999999999999996555 56677655
Q ss_pred CC-CCCccccccc
Q 012336 281 GY-QFDYVFDWTI 292 (465)
Q Consensus 281 ~~-~~~~~~dw~~ 292 (465)
.. +......|..
T Consensus 305 ~~~~~~~~~~~~~ 317 (333)
T cd06650 305 SEAEEVDFAGWLC 317 (333)
T ss_pred CccccccHHHHHH
Confidence 43 4444567753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.03 Aligned_cols=252 Identities=18% Similarity=0.228 Sum_probs=195.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHc---CCCCCceeEEEeE----eCc
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQ---GGTGVPHLKWFGV----EGE 76 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~---~~~~i~~l~~~~~----~~~ 76 (465)
+|++++.||+|+||+||+|++..+++.||||++..... ......|+.+++.+. |++++..+..+.. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999998875432 224667888888774 6555555555433 235
Q ss_pred EEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++++++.++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 678999999889999887543 459999999999999999999999999999999999999 5889999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh---
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--- 232 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--- 232 (465)
+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 158 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 54321 1234568999999999999899999999999999999999999997644322222221111000
Q ss_pred ----------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ----------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ----------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+.......++.++.+++.+||..||++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 00111222345788899999999999999999977664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=300.88 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=203.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+|..+++||+|.||.||+|++..+|+.||||.++..... -..++|++.|+.++|+++|..+..|... ...-+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-SNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-CceEEEE
Confidence 5799999999999999999999999999999988865433 3578999999999988877777666544 4567999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|++..+|+..++.....|+...+..++.+++.||+|||.+.|+||||||.|+|++ .+|.+||+|||+++.+.....
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~- 156 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNR- 156 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCc-
Confidence 9999999999998788899999999999999999999999999999999999995 999999999999998865332
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh---------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 232 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (465)
.....+-|-+|.|||.+.|.. |+..+|+||.|||+.||+.|.+-|+|..+-+....+..+....
T Consensus 157 ------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 ------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 112236799999999998754 8999999999999999999999998854422222222111100
Q ss_pred ----------cc-CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 233 ----------ML-TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 233 ----------~~-~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.+ .+...+....++++.+|+..+|..||.+|+++.+.
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qa 278 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQA 278 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHH
Confidence 00 11111233456778999999999999999996554
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=326.07 Aligned_cols=261 Identities=20% Similarity=0.303 Sum_probs=205.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~~~ 74 (465)
+-+++|++.+.||.|+||.||+|.+.. +++.||+|++..... ...+..|+.++..+ .|++++..+..|...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 346799999999999999999997543 457899998864332 23567899999999 566677777777777
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcC--------------------------------------------------------
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCN-------------------------------------------------------- 97 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~-------------------------------------------------------- 97 (465)
+...+++++|+ +++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 77788889988 889998885321
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCc
Q 012336 98 ----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 173 (465)
Q Consensus 98 ----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 173 (465)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..+..... .......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~-----~~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcc-----hhhccCC
Confidence 268999999999999999999999999999999999999 5788999999999987543211 1122345
Q ss_pred cccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHH
Q 012336 174 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYF 252 (465)
Q Consensus 174 ~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li 252 (465)
.++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .+........... ....+++++.+++
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~l~ 309 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMR---APEYATPEIYSIM 309 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCC---CCccCCHHHHHHH
Confidence 56788999999999999999999999999999998 999997643221 1211111111111 1135688999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 253 HYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 253 ~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+||+.+|++||++.+|.+.|+.++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=322.23 Aligned_cols=255 Identities=22% Similarity=0.263 Sum_probs=196.5
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHH-HHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKL-YMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||+||+|++..+++.||||++.... ....+..|..+ ++.+.|++++. +..........+++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~-~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG-LHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCcc-EEEEEecCCEEEEEEcCCC
Confidence 46999999999999999999999999987532 12234555554 44566655555 444555667889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~----- 150 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQS----- 150 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCC-----
Confidence 8899888764 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ..+.+..+....... ...++
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~~~-----~~~~~ 220 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPLVL-----RPGAS 220 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCccC-----CCCCC
Confidence 12235679999999999999999999999999999999999999998743 334444433332221 23568
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCccccccccC
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYSY-LKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
.++.+++..|+..+|.+||++.+ +.+++ .+++...++|....
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~-------~h~~f~~~~~~~~~ 263 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQ-------EHPFFESLSWTDLE 263 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHHHh-------cCCCcCCCCHHHHH
Confidence 89999999999999999998642 22333 35666667776543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.07 Aligned_cols=256 Identities=16% Similarity=0.190 Sum_probs=201.9
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEc--CCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNV--QTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.++..+|.+++.||.|+||.||+|... .++..||||.+... ....+|+.+++.++|++++..+..+. .....++
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~l 163 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIHAYR-WKSTVCM 163 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceeeeEe-eCCEEEE
Confidence 356778999999999999999999754 35678999987643 34678999999999988777766554 5567899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+|++++++|.+++.. ...+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+....
T Consensus 164 v~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCccc
Confidence 999999999998853 5679999999999999999999999999999999999999 588999999999997654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML------ 234 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------ 234 (465)
.. .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..+......
T Consensus 240 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 240 DT-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cc-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 11 1223567999999999999999999999999999999999999999876544332333222211100
Q ss_pred -----------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 -----------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 -----------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+.......++.++.++|.+||..||++||++.++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0100111245778999999999999999999777644
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=313.14 Aligned_cols=256 Identities=21% Similarity=0.252 Sum_probs=195.5
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.++|++++. +..+.......+++|+++ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~-~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEee-eeEEEcCCCeEEEEEeCCCCCC
Confidence 6999999999999999999999998864321 234678999999997655554 455555667789999988 889
Q ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 89 LEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 89 L~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
|.+++.. .+..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..+.....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence 9887743 24569999999999999999999999999999999999999 5789999999999976543221
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH-HHHHHHhhhhccCcHHHHhccC
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .....+.... ......+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-----VTYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----CCCcccC
Confidence 123457899999999999999999999999999999999999999764332211 1111111111 1122457
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCcccccccc
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
++++.+++..||..||++||++++ +.+++.+ +|...++|...
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h-------~~~~~~~~~~~ 268 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH-------PLFRDLNWRQL 268 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC-------hhhhcCCHhHH
Confidence 899999999999999999995421 3334443 44445667754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=314.43 Aligned_cols=288 Identities=42% Similarity=0.690 Sum_probs=242.0
Q ss_pred cCC-ceEEEeeEeeeCceEEEEEEEcCCC-cEEEEEEeecCCC--CccHHHHHHHHHHHc---CCCCCceeEEEe-EeCc
Q 012336 5 IGG-KFKLGRKIGSGSFGELYLGVNVQTG-EEVAVKLESVKTK--HPQLHYESKLYMLLQ---GGTGVPHLKWFG-VEGE 76 (465)
Q Consensus 5 ~~~-~y~l~~~LG~G~fG~Vyla~~~~~~-~~vAvKi~~~~~~--~~~~~~E~~il~~l~---~~~~i~~l~~~~-~~~~ 76 (465)
... +|++.++||+|+||.||+|.+..++ ..+|+|+...... ...+..|..++..+. +..+++.+.+.+ ..+.
T Consensus 15 ~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 15 KVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 344 8999999999999999999987764 6899998876533 237999999999998 467899999999 5888
Q ss_pred EEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC--CcEEEEecCCc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS--NQVYIIDYGLA 153 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~--~~vkL~DFGla 153 (465)
+.+|||+++|.+|.++..... +.|+..+++.|+.|++.+|++||+.|++||||||+|++++..... ..++|+|||++
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 999999999999999997554 789999999999999999999999999999999999999843212 67999999999
Q ss_pred c--ccccccCcccccccC-CCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 154 K--KYRDLQTHKHIPYRE-NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 154 ~--~~~~~~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
+ .+.........+.+. ...+.||..|++++.+.+.++++++|+|||++++.||+.|.+||.+.......+.+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 443333222234444 3467799999999999999999999999999999999999999988776656555555554
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCC
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
...... .+...|.++.+++..+-..++.++|+|..+...|++.+...+......+||.....
T Consensus 255 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~~ 316 (322)
T KOG1164|consen 255 KLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKLR 316 (322)
T ss_pred hhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccccccc
Confidence 444332 34456789999999999999999999999999999999999999999999997553
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.07 Aligned_cols=253 Identities=20% Similarity=0.229 Sum_probs=197.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG---- 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (465)
.+-++|++++.||+|+||.||+|++..++..||||++.... ....+.+|+.+++.+.|++++..+..+....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999999999999999986432 2345778999999999988888887765433
Q ss_pred -cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 -EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 -~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...+++|+++.++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence 3578999999888887765 358999999999999999999999999999999999999 588999999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH------
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI------ 228 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i------ 228 (465)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 172 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 172 TACTNF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccCc--------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 543211 123457899999999999999999999999999999999999999875432111111000
Q ss_pred -------------hhhhccC---cHH------------HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 229 -------------SEKKMLT---PIE------------VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 229 -------------~~~~~~~---~~~------------~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....... ... ......++++.+||.+||..||++||++.++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 0000000 000 00112357899999999999999999966654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.05 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=199.0
Q ss_pred EeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 12 GRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++.||+|+||.||+|++. .+++.||||++.... ....+..|+.++..++|++++..+..|. .+...+++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-TGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-cCCeEEEEE
Confidence 368999999999999864 468899999987431 1234678999999999887777666654 456788999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 988 8899998875 5678999999999999999999999999999999999999 5889999999999875432111
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.+..+.......+
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~~~~~~~~~~~----- 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTIDKILKGKLNLP----- 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCCC-----
Confidence 12345799999999999998999999999999999999999999987432 333333333332222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
..+++++.++|..||..+|++|| +++++.+ +++....+|...
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~----------h~~~~~~~~~~~ 267 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS----------HPFFRHVNWDDL 267 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc----------CCCcCCCCHHHH
Confidence 45689999999999999999999 6555543 455555566654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=327.29 Aligned_cols=257 Identities=19% Similarity=0.310 Sum_probs=198.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEE-----cCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVN-----VQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~-----~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|++.+.||+|+||.||+|++ ..++..||||+++... ....+.+|+.++..+.+|++|..+..++..+..
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999974 3456789999986432 223578899999999544555555555566777
Q ss_pred EEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN----------------------------------------------------------- 97 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~----------------------------------------------------------- 97 (465)
.+++|||+ +++|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 89999998 999998886421
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 98 ---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 98 ---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~- 269 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIRNDSN- 269 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE---ECCCcEEEecCccceeccCccc-
Confidence 247888999999999999999999999999999999999 4788999999999986543221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
........++..|+|||.+.+..++.++|||||||++|||++ |..||....... ..+..+... .... ..
T Consensus 270 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~-~~~~---~~ 339 (375)
T cd05104 270 ----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEG-YRML---SP 339 (375)
T ss_pred ----ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhC-ccCC---CC
Confidence 111233446678999999999999999999999999999998 999998754322 122222222 1111 11
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...|.++.+++..||..||++||++.+|.+.|+..
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 24578999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=314.14 Aligned_cols=266 Identities=20% Similarity=0.289 Sum_probs=217.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+--++|..++.||+|.||.|.+++.+.+++.||||+++++.. ...-+.|..+|+...|+ .+..+++.+...+.+
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HP-FLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHP-FLTSLKYSFQTQDRL 243 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCc-HHHHhhhhhccCceE
Confidence 345789999999999999999999999999999999886532 23456788888888874 455566666777789
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+||+|. ||.|.-++.+ .+.|++.....+-.+|+.+|.|||+++||+||||.+|.|+ |.+|++||+|||+++.--
T Consensus 244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcc
Confidence 9999998 8899888875 5789999999999999999999999999999999999999 799999999999998543
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ...++++|||.|.|||++....|++.+|||.+||++|||++|++||...+. ...+.-|.-.....|
T Consensus 320 ~~g-------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFP- 388 (516)
T KOG0690|consen 320 KYG-------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFP- 388 (516)
T ss_pred ccc-------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCC-
Confidence 221 245789999999999999999999999999999999999999999998543 233333333333333
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKP--DYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RP--t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..++++++.|+.-+|.+||.+|. .-++.++..+ +.++..++|+..-..
T Consensus 389 ----r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~-------h~FF~~v~W~~~~~K 438 (516)
T KOG0690|consen 389 ----RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR-------HRFFASVDWEATYRK 438 (516)
T ss_pred ----ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh-------hhhhccCCHHHHHHh
Confidence 56789999999999999999996 3344555544 456677899975433
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=309.13 Aligned_cols=261 Identities=20% Similarity=0.266 Sum_probs=204.5
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
|+.+...+|++++.||+|+||+||+|.+..++. .||||++..... ...+..|..++..+.|++++..+..+..
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT 80 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence 678889999999999999999999999877766 489998764432 2357788889998988777766665543
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
. ..+++++++ +++|.+++......+++.+++.++.|++.||.|||+++|+||||||+|||+ ++++.+||+|||+
T Consensus 81 -~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~---~~~~~~kL~dfG~ 155 (279)
T cd05109 81 -S-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV---KSPNHVKITDFGL 155 (279)
T ss_pred -C-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCCCc
Confidence 3 345666666 899999987655679999999999999999999999999999999999999 4788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
++.+....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ....+..
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~- 226 (279)
T cd05109 156 ARLLDIDETEY-----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK- 226 (279)
T ss_pred eeeccccccee-----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC-
Confidence 98764322111 1112345678999999999899999999999999999998 999997643322 2222222
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
....+.. ..++.++.+++..||..||++||++.++.+.|..+..
T Consensus 227 ~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 227 GERLPQP---PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCcCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2111211 3468999999999999999999999999988876643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=321.77 Aligned_cols=255 Identities=21% Similarity=0.258 Sum_probs=196.8
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
||+|+||+||+|++..+++.||||++..... ......|..++..+. +++++..+..+.......+++|+|+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999864321 123455666666554 5666777777777778899999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~------ 150 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDN------ 150 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCC------
Confidence 899888874 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred ccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 167 YRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+. ..++
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~----~~~~ 222 (330)
T cd05586 151 -KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFPK----NVLS 222 (330)
T ss_pred -CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCCC----ccCC
Confidence 112356799999999998765 48999999999999999999999998743 34444444433333221 2468
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+++.+++..||..||.+||+.. .+.++++ +++....+|....
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~-------h~~~~~~~~~~~~ 265 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE-------HPFFADIDWDLLS 265 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc-------CccccCCCHHHHH
Confidence 9999999999999999999532 2333333 4555566776543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=322.64 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=197.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEe-----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVE----- 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (465)
.+.++|++++.||.|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++++..+..+...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 35789999999999999999999999999999999886432 123567899999999998888777655422
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
....++++++++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCccce
Confidence 24568999999999998886 4679999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... .+..+.....
T Consensus 167 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~ 233 (343)
T cd07878 167 QADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVG 233 (343)
T ss_pred ecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhC
Confidence 65431 134578999999999887 468999999999999999999999997643221 1111111000
Q ss_pred cC--------------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 LT--------------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ~~--------------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.. .........++.+.+|+..||..||++||++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00 00112234567789999999999999999966654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=313.28 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=198.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|.+++.||+|+||.||+|++..+++.||||.+..... ...+.+|+.++..++|++++..+..+ ..+...+++|+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV-HTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEE-eeCCeEEEEEe
Confidence 679999999999999999999999999999998874432 23577899999999987766655554 55667899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc--
Confidence 99889999988766679999999999999999999999999999999999999 5889999999999975432211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh----------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 232 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (465)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.......
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 -----TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred -----ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 1234467899999999875 458999999999999999999999998754433222222111000
Q ss_pred ------c------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ------M------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ------~------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ..+.......+++++.++|.+||..||.+|||+.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 0 0000112235688999999999999999999966654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.90 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=195.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+.|++++..+. +..++...
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~-~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC-AFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE-EEEcCCEE
Confidence 34678999999999999999999999999999999986421 2234678888888888776666554 44567788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++|||++ +++|.+++. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~--~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMS--NYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecc
Confidence 9999998 899999987 3468999999999999999999999999999999999999 588999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.. ....+..+.....
T Consensus 194 ~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKN 264 (370)
T ss_pred cCCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCc
Confidence 3211 1224567999999999997643 7889999999999999999999998743 3334444443221
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCC--CCCCHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFE--DKPDYSYLK 270 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~--~RPt~~~l~ 270 (465)
....+. ...++..+.+++..|+..++. .|+++.+++
T Consensus 265 ~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 265 SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 111110 124688999999999985443 377865543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=318.08 Aligned_cols=254 Identities=24% Similarity=0.277 Sum_probs=196.6
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHH-HHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESK-LYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~-il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||.||+|++..+++.||||++.... ....+..|.. +++.+.|++++.. ..+.......++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~-~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL-HYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccce-eeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999986432 1223455554 4566777666554 45556677889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~----- 150 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPE----- 150 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCC-----
Confidence 8899888764 5679999999999999999999999999999999999999 588999999999987532211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
.......||+.|+|||++.+..++.++|||||||++|||++|..||...+ ..+.+..+.......+ ...+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~~-----~~~~ 220 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPLQLP-----GGKT 220 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCCCCC-----CCCC
Confidence 12235679999999999999899999999999999999999999998743 3344444443332222 3568
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCcccccccc
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
.++.+++..||+.+|.+||+.. ++.+.+ ..++....+|...
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~-------~~~~~~~~~~~~~ 262 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIK-------NHVFFSPINWDDL 262 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHh-------CCCCcCCCCHHHH
Confidence 8999999999999999999753 233332 3556666777754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=305.98 Aligned_cols=255 Identities=21% Similarity=0.353 Sum_probs=203.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++.++||+|+||.||+|.+..+ ..||||++..... ...+..|++++..+.|++++..+..+ .....+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~~~~~lv~ 79 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVT 79 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE--CCCCcEEEE
Confidence 5678999999999999999999987555 5699998875332 34688999999999987776665544 334578999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.|++.+|.|||+.+++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE---cCCCcEEeccCCceeeccccc
Confidence 998 78999999743 3468999999999999999999999999999999999999 478899999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+.+..+... ...+
T Consensus 157 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~-~~~~--- 223 (262)
T cd05071 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERG-YRMP--- 223 (262)
T ss_pred c------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcC-CCCC---
Confidence 1 11223456788999999998899999999999999999999 8899976432 2333332221 1111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
....+|..+.+++.+||+.+|++||++.++.++|++.|
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 12456899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=311.53 Aligned_cols=262 Identities=19% Similarity=0.247 Sum_probs=208.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeE----eCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGV----EGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~----~~~ 76 (465)
+..+|..++.||.|+||.|+.+.+..+|+.||||.+... ....+..+|+++++.++|.|+|..+..+.. .-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 467788899999999999999999999999999976622 233468899999999999998888887765 234
Q ss_pred EEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
..|+|+++++.+|...++. ++.++.+.+..+++||+.||.|+|+.+|+||||||.|+|+ +.+..+||||||+|+..
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 6799999999999999984 5559999999999999999999999999999999999999 58999999999999987
Q ss_pred ccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH--------
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK-------- 227 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~-------- 227 (465)
... ... ......+-|-+|.|||++.. .+|+...||||.|||+.||++|++-|.|.+.-...+.+..
T Consensus 176 ~~~-~~~----~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 176 DKF-FED----GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ccc-Ccc----cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 543 110 11245678999999998764 5699999999999999999999999998543221111111
Q ss_pred ----Hh---------h--hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 228 ----IS---------E--KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 228 ----i~---------~--~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
+. . .....+-....++.++.+.+|+.+||..||.+|+|+++ .|++.+.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~e---AL~hPYl 313 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEE---ALAHPYL 313 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHH---HhcChhh
Confidence 11 0 11112233445677899999999999999999999554 4555543
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.05 Aligned_cols=250 Identities=23% Similarity=0.269 Sum_probs=195.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+.|++++..+.. ...+.+.
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~-~~~~~~~ 118 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-FQDDRYL 118 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE-EEcCCEE
Confidence 34589999999999999999999999999999999986422 12346678888888887666655544 4567789
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcC
Confidence 9999998 8999999873 568999999999999999999999999999999999999 588999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||...+ ....+..+.....
T Consensus 194 ~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 264 (371)
T cd05622 194 KEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMNHKN 264 (371)
T ss_pred cCCc------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC
Confidence 3211 1223567999999999987643 7889999999999999999999998733 3444444443322
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCC---CCCHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFED---KPDYSYLK 270 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~---RPt~~~l~ 270 (465)
....+ ....++.++.++|..||. +|.. |+++++|+
T Consensus 265 ~~~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~ 302 (371)
T cd05622 265 SLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 302 (371)
T ss_pred cccCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence 11111 113578999999999998 5554 56755544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=312.11 Aligned_cols=243 Identities=18% Similarity=0.177 Sum_probs=197.9
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeE--e-CcEEEEEEec
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGV--E-GEYNVMVIDL 84 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~--~-~~~~~lv~e~ 84 (465)
..||+|++|.||+|.. +|+.||||.+..... ...+.+|+.++.+++|++++..++.+.. + ....+++||+
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999987 789999998875432 2346699999999999877777766644 2 3467899999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+ +++|.+++.. .+.+++.....++.|++.||.|||+ .+++||||||+|||+ +.++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchHhhhcccc--
Confidence 8 8899999975 4679999999999999999999998 499999999999999 588999999999997653311
Q ss_pred ccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||.+.. ..+.+..+.......+.
T Consensus 178 --------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~--- 243 (283)
T PHA02988 178 --------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLIINKNNSLKL--- 243 (283)
T ss_pred --------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcCCCCCC---
Confidence 23468899999999976 678999999999999999999999998753 23334433322222221
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
...+|+++.+++.+||+.||++||++.+|.+.|+.+.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1346899999999999999999999999999988763
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=304.20 Aligned_cols=248 Identities=21% Similarity=0.292 Sum_probs=204.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
..+|++.+.||+|+||.||+|.. .+..||+|.+........+..|+.+++.+.|+++++.+..+...+...+++++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35899999999999999999975 5888999998766555678899999999999888887777666777789999998
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 86 -GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 86 -g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+++|.+++.... ..+++..++.++.|++.+|+|||++|++||||||+|||+ +.++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccC---
Confidence 789999987533 348999999999999999999999999999999999999 588999999999987543211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... .+....+.... .. ....
T Consensus 157 -------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~~---~~~~ 222 (256)
T cd05082 157 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY-KM---DAPD 222 (256)
T ss_pred -------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC-CC---CCCC
Confidence 23345678999999998889999999999999999997 9999976432 22222222211 11 1124
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
.+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 578999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.67 Aligned_cols=260 Identities=19% Similarity=0.270 Sum_probs=200.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC----cEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----EYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~ 79 (465)
+|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..++|++++..+..+.... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 5889999999999999999999999999999876432 1235788999999999988887776665443 2678
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+++++++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecccC
Confidence 9999999999888864 5679999999999999999999999999999999999999 58899999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh---------
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS--------- 229 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~--------- 229 (465)
.. .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 157 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 157 ES------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cc------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 11 112234678999999999875 47899999999999999999999998754322221111100
Q ss_pred -----------hhhccCc-HH---HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 230 -----------EKKMLTP-IE---VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 230 -----------~~~~~~~-~~---~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
......+ .. ......++++.+||.+||..||++||++.+ +|.+.|...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e---~l~hp~~~~ 293 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAAD---ALAHPYLDE 293 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHH---HhcCHhhCC
Confidence 0000000 00 112345789999999999999999999655 466666544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.03 Aligned_cols=259 Identities=20% Similarity=0.284 Sum_probs=202.8
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcE----EEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEE----VAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~----vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+-..+|++.+.||+|+||.||+|++..+++. ||||++..... ...+..|+.+++.+.|++++..++.+.. .
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~ 81 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 81 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-C
Confidence 34567899999999999999999998666654 89998764322 2457889999999999888877766544 3
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
. .+++++++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~-~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157 (316)
T ss_pred C-ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccc
Confidence 3 34555555 999999998656679999999999999999999999999999999999999 478899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.+....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+..... +..+.....
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGE 228 (316)
T ss_pred cccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCC
Confidence 765322110 1122335678999999999999999999999999999998 999998753322 222222222
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+.. ..++.++.+++..||..+|++||++.+|...|..+..
T Consensus 229 ~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 22221 3457899999999999999999999999998877753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.25 Aligned_cols=261 Identities=22% Similarity=0.329 Sum_probs=218.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+-..+.++.+.||+|.||+||+|+... ..+-||||.++.+... .+|.+|++++..|+|+|+|..++.|. ++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-~~ 561 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-EG 561 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-cC
Confidence 345677889999999999999998543 3468999998866544 47999999999999988777777664 56
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC---------CC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN---------RK----FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~---------~~----ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
+.+|||+||+ .|+|.+|+.... .. |+..+.+.||.||+.|++||-++.||||||..+|+||+ +
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---E 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---c
Confidence 6788999998 999999997431 22 88999999999999999999999999999999999996 8
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
+..|||+||||++......+. +......-.++|||||.+...+++.++|||||||+|||+++ |+.||.++..
T Consensus 639 ~l~VKIsDfGLsRdiYssDYY-----k~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-- 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYY-----KVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-- 711 (774)
T ss_pred ceEEEecccccchhhhhhhhh-----cccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--
Confidence 999999999999876554442 23335556899999999999999999999999999999999 9999999654
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+.+..+..... .+.+ ..+|.++.+||..||..+|.+||++.+|...|++.....
T Consensus 712 -~EVIe~i~~g~l-L~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 -QEVIECIRAGQL-LSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -HHHHHHHHcCCc-ccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 666666777666 4444 355999999999999999999999999999998875443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=296.24 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=214.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-++|.+++.||.|-||.||+|+...++-.||+|++.+.+ ...++.+|++|...|+|+|++..+++|- +....|+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-d~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-DSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-ccceeEE
Confidence 468999999999999999999999999999999977542 3457899999999999988877777665 4456677
Q ss_pred EEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 81 VIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~-~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++||. .|.|...+.. ....|++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|||-+..-..
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecCC
Confidence 77776 7888777763 356799999999999999999999999999999999999995 899999999999875432
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
....+++||..|.+||+..+..++..+|+|++|++.|||+.|.+||.... ..+.|.+|.......|
T Consensus 177 ---------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p-- 242 (281)
T KOG0580|consen 177 ---------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFP-- 242 (281)
T ss_pred ---------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCC--
Confidence 34568899999999999999999999999999999999999999998744 5667777777666666
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..++.++.++|.+|+.++|.+|.. +.+.+.+.|+..
T Consensus 243 ---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 ---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred ---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 567999999999999999999999 555667777654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.59 Aligned_cols=254 Identities=20% Similarity=0.358 Sum_probs=203.9
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+..++|+++++||+|+||.||+|.. .+++.||+|.+..... ...+..|+.+++.++|++++..+..+ .....+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV--TQEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE--ccCCcEEE
Confidence 46788999999999999999999985 5678999998775432 34688999999999987776665543 33457888
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++++ +++|.+++... +..+++.++..++.|++.+|+|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence 9888 88999988643 3568999999999999999999999999999999999999 58899999999999765422
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. .......++..|+|||++....++.++||||||+++||+++ |+.||.+.... +....+.... ..+
T Consensus 156 ~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~-~~~-- 223 (260)
T cd05067 156 EY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERGY-RMP-- 223 (260)
T ss_pred Cc------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcCC-CCC--
Confidence 11 11223456788999999998889999999999999999999 99999875432 2222222221 111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....+|.++.+++.+||..+|++||++++|...|++
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 124568999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=305.98 Aligned_cols=257 Identities=19% Similarity=0.319 Sum_probs=206.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+...+|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.+.|+++++.+..+. .....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-CCCCcEEEE
Confidence 445679999999999999999999999999999998764432 246788999999999988777776654 445678888
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..++.++.|++.+|+|||++|++||||||+|||+ +.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCcEEeCCCccccccccce
Confidence 887 89999998754 3468999999999999999999999999999999999999 588999999999997664321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+... .+....+... ... .
T Consensus 159 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~---~ 225 (263)
T cd05052 159 Y------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKG-YRM---E 225 (263)
T ss_pred e------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCC-CCC---C
Confidence 1 11122344678999999999999999999999999999998 9999987433 2222222221 111 1
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
....+|.++.+++.+||..+|++||++.++.+.|+.++
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 23567899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=317.93 Aligned_cols=251 Identities=18% Similarity=0.227 Sum_probs=197.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeC----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEG---- 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (465)
.+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++++..+..+....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 356899999999999999999999999999999998865322 235678999999999998888887765432
Q ss_pred -cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 -EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 -~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...+++|+++.++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcccc
Confidence 3578999999888888775 358999999999999999999999999999999999999 588999999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... .+..+......
T Consensus 168 ~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~ 236 (355)
T cd07874 168 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGT 236 (355)
T ss_pred cCCCcc--------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCC
Confidence 643321 1234578999999999999999999999999999999999999998743211 11111110000
Q ss_pred C---------------------------c----------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 T---------------------------P----------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 ~---------------------------~----------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. + ........+.++.+||.+||..||++||++.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 0 00001123567899999999999999999766543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=308.47 Aligned_cols=243 Identities=21% Similarity=0.266 Sum_probs=193.4
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.|+..+.||+|+||+||+|.+..+++.||+|++..... ...+..|+++++.++|++++..... ...++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~-~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYA-YETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEE-EecCCEEEEEE
Confidence 48899999999999999999999999999998865321 2346789999999988766665444 45566888999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 888 78998887643 3469999999999999999999999999999999999999 578899999999997643211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.......+.. ... ........
T Consensus 157 --------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~---~~~-~~~~~~~~ 224 (285)
T cd05632 157 --------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV---DRR-VLETEEVY 224 (285)
T ss_pred --------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHh-hhcccccc
Confidence 112457899999999999989999999999999999999999999874332221221 111 11111123
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDY 266 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (465)
...+++++.+|+..||..||++||+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCC
Confidence 35678999999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=319.65 Aligned_cols=249 Identities=18% Similarity=0.222 Sum_probs=197.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEe-----C
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVE-----G 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-----~ 75 (465)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++++..+..+... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4689999999999999999999999999999999886532 223577899999999998888887766432 2
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...|+||+++.++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 4579999999999988875 358999999999999999999999999999999999999 5889999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+..+.......
T Consensus 176 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~ 244 (364)
T cd07875 176 AGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTP 244 (364)
T ss_pred cCCCC--------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 53321 123457899999999999999999999999999999999999999875432 2222221110000
Q ss_pred cH-------------------------H------------HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 PI-------------------------E------------VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ~~-------------------------~------------~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.. + ......+.++.+||.+||..||.+||++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00 0 00011246789999999999999999976653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=322.77 Aligned_cols=246 Identities=21% Similarity=0.271 Sum_probs=190.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
-++|+++++||.|+||.||+|++..+++.||||++..... ...+.+|+++++.++|++++..+..+ ..+...+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-ccCCeEEEEE
Confidence 3578899999999999999999999999999999865432 23578899999999987777666555 5556778899
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
||+ +++|.+. ..+.+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceeccccc-
Confidence 988 7777542 345778889999999999999999999999999999999 588999999999998654321
Q ss_pred cccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||..............+.....
T Consensus 223 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 223 ------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--- 293 (353)
T ss_pred ------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---
Confidence 11234579999999998743 2345689999999999999999999985333322222222211111
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
......++.++.+||..||..||++||++.+|.+
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1112456899999999999999999999776643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=339.10 Aligned_cols=254 Identities=21% Similarity=0.279 Sum_probs=202.1
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeE-eCc
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGV-EGE 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~ 76 (465)
+.++-++|++++.||.|+||+||+|++..++..||+|++..... ...+..|+.++..|.|+++|..+..|.. ...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 35567899999999999999999999999999999998875432 2457889999999999998888877654 456
Q ss_pred EEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCceeeccC------
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSR-------GFLHRDIKPDNFLMGLG------ 139 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~-------givHrDLKP~NILl~~~------ 139 (465)
.+||||+|+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||..+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 789999998 78999998743 35799999999999999999999985 49999999999999521
Q ss_pred --------CCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcC
Q 012336 140 --------RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRG 209 (465)
Q Consensus 140 --------d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG 209 (465)
+....+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 123469999999997654321 1234579999999999865 4488999999999999999999
Q ss_pred CCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 210 SLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..||..... ..+.+..+.... ..+ ...++.++.+||..||..+|.+||++.+++
T Consensus 240 k~PF~~~~~--~~qli~~lk~~p-~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 240 KTPFHKANN--FSQLISELKRGP-DLP----IKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CCCCCcCCc--HHHHHHHHhcCC-CCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 999976432 222322222221 111 135689999999999999999999976654
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=308.21 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=200.7
Q ss_pred CCce-EEEeeEeeeCceEEEEEE----EcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe-Cc
Q 012336 6 GGKF-KLGRKIGSGSFGELYLGV----NVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE-GE 76 (465)
Q Consensus 6 ~~~y-~l~~~LG~G~fG~Vyla~----~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~ 76 (465)
.++| ++++.||+|+||+||++. ...++..||+|++..... ...+.+|++++..+.|++++..+..+... ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 4566 999999999999998865 335688999999875432 34577899999999988777777665543 45
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++|+++ +++|.+++.. ..+++.++..++.|++.||.|||++||+|+||||+|||+ +.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE---cCCCcEEEeecccccc
Confidence 678999988 8899999874 469999999999999999999999999999999999999 4789999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH-----------HH
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----------QK 224 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~-----------~~ 224 (465)
+...... +.......++..|+|||.+.+..++.++||||||+++|||++|..||......... ..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 6432211 11122334667899999999888999999999999999999999998653321100 00
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
...........+ ....+|.++.+++..||..+|++||++.+|.+.|+++.
T Consensus 233 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000111111 12356899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=309.14 Aligned_cols=258 Identities=19% Similarity=0.203 Sum_probs=198.5
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||+|+||.||++++..+++.||+|.+.... .......|++++..+.|++++.... +...+...+++||++ |++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~-~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY-AFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEE-EEecCCeEEEEEecCCCCC
Confidence 699999999999999999999999876432 1234566999999998766555444 445667889999998 899
Q ss_pred HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccc
Q 012336 89 LEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167 (465)
Q Consensus 89 L~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (465)
|.+++... ...+++..+..++.|++.||+|||+.||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence 98887643 3468999999999999999999999999999999999999 5889999999999976543211
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch-HHHHHHHhhhhccCcHHHHhccCcH
Q 012336 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.....|++.|+|||++.+..++.++|||||||++|||++|..||........ .+........... .....+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK----FEHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc----cccccCCH
Confidence 1234689999999999998999999999999999999999999976433211 1222221111111 11245789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 247 EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
++.+++.+||..||++||++.++.+.+. .++++..++|....
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~------~h~~f~~~~~~~~~ 266 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKNDDPR------KHEFFKTINFPRLE 266 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccchhhhh------cChhhcCCCHHHHh
Confidence 9999999999999999999866543221 25666667786554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.08 Aligned_cols=260 Identities=21% Similarity=0.300 Sum_probs=203.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcC-CCCCceeEEEeEeCc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQG-GTGVPHLKWFGVEGE 76 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~-~~~i~~l~~~~~~~~ 76 (465)
.++|++.+.||.|+||.||+|.+. .+++.||||++..... ...+..|+.++..+.| ++++..+..+...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 578999999999999999999843 4678999999875432 2357789999999965 455555666666677
Q ss_pred EEEEEEecc-CCCHHHHHHHcC----------------------------------------------------------
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN---------------------------------------------------------- 97 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~---------------------------------------------------------- 97 (465)
..+++|||+ +++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 888999998 899999886421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccC
Q 012336 98 --------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169 (465)
Q Consensus 98 --------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (465)
..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++........ +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-----~~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPD-----YVR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcc-----hhh
Confidence 246888899999999999999999999999999999999 5789999999999976533211 112
Q ss_pred CCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHH
Q 012336 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEF 248 (465)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l 248 (465)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +....+..... ... ...+++++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~-~~~---~~~~~~~~ 311 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTR-MRA---PDYTTPEM 311 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHhccCC-CCC---CCCCCHHH
Confidence 233456778999999998899999999999999999997 999998753321 12222222111 111 12357899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 249 TSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+++..||..+|++||++.+|.+.|+.++..
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=307.21 Aligned_cols=255 Identities=20% Similarity=0.292 Sum_probs=201.2
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
...-.++|++++.||+|+||.||+|++..+++.||+|++..... ...+..|+.++..+.|++++..+..+ ..+...+
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-~~~~~~~ 82 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY-LSREKLW 82 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEE-EeCCEEE
Confidence 34556789999999999999999999999999999999875432 23567899999999998777766555 4556788
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|++++ +++|.+++.. ...+++..+..++.|++.+|.|||+.||+|+||||+|||+ +.++.++|+|||++.....
T Consensus 83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence 999998 7899998874 4679999999999999999999999999999999999999 5788999999999986543
Q ss_pred ccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.. .......|++.|+|||.+. ...++.++|||||||++|||++|..||...... .....+.......
T Consensus 159 ~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~ 228 (267)
T cd06646 159 TI-------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMSKSNFQP 228 (267)
T ss_pred cc-------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---hhheeeecCCCCC
Confidence 21 1123456889999999885 344788999999999999999999999764322 1111111111111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.......++.++.+++..||..+|++||++++|.+
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 111122457899999999999999999999888765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=319.45 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=215.6
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
-.|.+-|.+.+.||+|.|+.|.+|++.-||+.||||++.+... ...+..|+..|+.++|+|+|..+.+. .....+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceE
Confidence 4577889999999999999999999999999999999886543 24688999999999998776665544 455678
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+++|+- +|+|.|++......+.++.+.+|+.||+.+|.|+|+..+|||||||+|+.+. .+-|.|||.|||++-.+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCC
Confidence 8999998 8899999998788899999999999999999999999999999999999887 788999999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s-~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.. ....+.+|...|.|||++.|..|+ +++||||||||||.|++|.+||+..++ .+.+..|...++..|
T Consensus 171 PG--------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtvP 239 (864)
T KOG4717|consen 171 PG--------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTVP 239 (864)
T ss_pred Cc--------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccCc
Confidence 43 334678999999999999999986 689999999999999999999998655 445555666666655
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.+..+||..||..||.+|.+.++|..
T Consensus 240 -----shvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 240 -----SHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -----hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 345789999999999999999999887754
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=328.50 Aligned_cols=237 Identities=19% Similarity=0.318 Sum_probs=198.5
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCH
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSL 89 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (465)
-++.||+|+.|.||+|+. .++.||||..+ +....+++-|++|+|+|+|.+.++|. ...++||+|||| .|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~-----elkETdIKHLRkLkH~NII~FkGVCt-qsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVR-----ELKETDIKHLRKLKHPNIITFKGVCT-QSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHh-----hhhhhhHHHHHhccCcceeeEeeeec-CCceeEEeeeccccccH
Confidence 356799999999999986 67999999654 23345788899999999888877765 455889999999 9999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccC
Q 012336 90 EDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169 (465)
Q Consensus 90 ~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (465)
...++. .++++...+..|..+|+.|++|||...|||||||.-||||+ .+..|||+|||-++.+.+..+
T Consensus 200 ~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~ST-------- 267 (904)
T KOG4721|consen 200 YEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKST-------- 267 (904)
T ss_pred HHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhh--------
Confidence 999985 77899999999999999999999999999999999999996 788999999999998766432
Q ss_pred CCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHH
Q 012336 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFT 249 (465)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~ 249 (465)
.-.++||..|||||++.+.+++.|+|||||||+|||||||..||.+.+.. .++.-+.......+.+ ..+|+-|+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvP---stcP~Gfk 341 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVP---STCPDGFK 341 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCc---ccCchHHH
Confidence 23689999999999999999999999999999999999999999875432 2222222223333433 34599999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 250 SYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 250 ~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
-||++||+..|..||++.+|...|
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHH
Confidence 999999999999999999888766
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=307.76 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=193.4
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..++|+++++.+..+. .....+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-TKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-cCCEEEEEE
Confidence 48899999999999999999999999999998764321 234678999999998877776665554 456788999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++.++..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 887 89999888643 3469999999999999999999999999999999999999 578899999999987543211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .....|+..|+|||++.+..++.++||||||+++|+|++|..||..............+... .....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhhc
Confidence 1 12346899999999999999999999999999999999999999874432222222211111 11122
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPD 265 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt 265 (465)
...+++++.+|+..||..||++||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccC
Confidence 3457899999999999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=324.06 Aligned_cols=258 Identities=20% Similarity=0.278 Sum_probs=201.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC-----CcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT-----GEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~-----~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|++++.||+|+||.||+|++... +..||||++..... ...+..|++++..+..|++|+.+..++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 57888999999999999999986433 34799998865432 23578899999999734445555555566677
Q ss_pred EEEEEecc-CCCHHHHHHHc------------------------------------------------------------
Q 012336 78 NVMVIDLL-GPSLEDLFNYC------------------------------------------------------------ 96 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~------------------------------------------------------------ 96 (465)
.++||||+ +++|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 89999998 89999887542
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 97 -----------------------------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 97 -----------------------------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
...+++..++.++.||+.||+|||+.+|+||||||+|||+ +.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eC
Confidence 1247888899999999999999999999999999999999 47
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
++.++|+|||+++.+..... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 88999999999986543221 112234557789999999999899999999999999999997 999998753322
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
. .+..+... ...+ ....+|.++.+++.+||..+|++||++.+|.+.|+.++
T Consensus 348 ~--~~~~~~~~-~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 T--FYNKIKSG-YRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H--HHHHHhcC-CCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 12222222 1111 12456899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=306.51 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=202.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCC-----cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTG-----EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~-----~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
-++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+..|+.++..+.|++++..+..+. ....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-KEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-CCCc
Confidence 468999999999999999999876555 6899998764432 235788999999998877777666554 5556
Q ss_pred EEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
.+++++++ +++|.+++.... ..+++.++..++.|++.||.|||+.|++|+||||+|||+ ++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV---GE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEE---cC
Confidence 78889988 889999987531 458899999999999999999999999999999999999 47
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
++.++|+|||++........ +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-- 232 (283)
T ss_pred CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 88999999999976533211 112234456889999999998899999999999999999998 9999987543
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
.+....+...... + ....+|+++.+++..||+.||++||++.+|.+.|+.
T Consensus 233 -~~~~~~i~~~~~~-~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 -QEVIEMIRSRQLL-P---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHcCCcC-C---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2333333322221 1 124679999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=306.34 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=202.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|.+.+.||+|+||.||+|.+.. ++..||||++...... ..+.+|++++..+.|++++..+..+ .....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC-TEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE-ecCCC
Confidence 5679999999999999999998643 3678999998754333 4688999999999987766655554 45567
Q ss_pred EEEEEecc-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN-------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~-------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~ 143 (465)
.+++|+++ +++|.+++.... ..+++..+..++.|++.+|.|||++|++||||||+|||+ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 89999988 899999987431 347899999999999999999999999999999999999 5889
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~ 222 (465)
.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~ 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---E 231 (280)
T ss_pred eEEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence 999999999976432211 111234456789999999999999999999999999999998 9999987543 2
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
.....+........ ...+|.++.+++..||..||++||++.+|.+.|+
T Consensus 232 ~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 33333333222221 1457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=303.52 Aligned_cols=248 Identities=20% Similarity=0.332 Sum_probs=195.9
Q ss_pred eEeeeCceEEEEEEEc--CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CC
Q 012336 14 KIGSGSFGELYLGVNV--QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GP 87 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (465)
.||+|+||.||+|.+. ..+..||+|++..... ...+..|+.+++.+.|++++..+..+. ....+++||++ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence 4899999999999764 3456799998875432 235788999999999988888777653 34678899888 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccc
Q 012336 88 SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167 (465)
Q Consensus 88 sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (465)
+|.+++......+++.+++.++.|++.+|.|||++|++|+||||+|||+ +.++.++|+|||++..+...... +
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~----~ 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSY----Y 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccc----e
Confidence 9999987656679999999999999999999999999999999999999 57889999999999765432211 1
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.......++..|+|||.+.+..++.++||||||+++|++++ |..||.+..... ....+.... ... .....++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~-~~~---~~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQGK-RLD---CPAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCC-CCC---CCCCCCH
Confidence 11122234678999999998889999999999999999996 999998754322 222222221 111 1135689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 247 EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
++.+++..||..+|++||++.+|.+.|+.+|
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=309.13 Aligned_cols=256 Identities=18% Similarity=0.203 Sum_probs=192.7
Q ss_pred EeeEeeeCceEEEEEEEc--CCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEEEEEEeccCCC
Q 012336 12 GRKIGSGSFGELYLGVNV--QTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNVMVIDLLGPS 88 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv~e~~g~s 88 (465)
.++||+|+||+||+|++. .+++.||||.+........+.+|+.++..+.|++++..+..+.. .+...++++++++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 468999999999999965 46789999998766555678899999999999988888777654 355788999999999
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-CCCCcEEEEecCCccccccc
Q 012336 89 LEDLFNYC--------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 89 L~~ll~~~--------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~-d~~~~vkL~DFGla~~~~~~ 159 (465)
|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+... +..+.+||+|||++..+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 99887642 1258999999999999999999999999999999999999432 35678999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch------HHHHHHHhhhh
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYDKISEKK 232 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~------~~~~~~i~~~~ 232 (465)
.. +........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...... ...+..+....
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 11 11223456789999999999874 589999999999999999999999975332110 01111111000
Q ss_pred c-------------cC--------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 M-------------LT--------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ~-------------~~--------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .. ..+......+.++.+||..||..||.+|||++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00 000001123467889999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.49 Aligned_cols=262 Identities=18% Similarity=0.262 Sum_probs=201.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC--ccHHHHHHHHHHHcCCCCCceeEE-EeE----eC--c
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTGVPHLKW-FGV----EG--E 76 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~i~~l~~-~~~----~~--~ 76 (465)
+.+++|.+.|.+|||+.||+|.+...+.+||+|.+-..... ..+.+|+.+|++|.+|++|+.+.+ ... .+ -
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 56789999999999999999999888899999976655332 357899999999997766666544 322 12 3
Q ss_pred EEEEEEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 77 YNVMVIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~-~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
.++|+|||| |++|-|+++. ....|++.++++|++|++.||.+||.+. |||||||-+||||. .++++||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccc
Confidence 568899999 5899999984 3556999999999999999999999998 99999999999994 889999999999
Q ss_pred cccccccc-Ccccccc-cCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 153 AKKYRDLQ-THKHIPY-RENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 153 a~~~~~~~-~~~~~~~-~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
+....... ......+ ...-....|+.|.|||++. +.+.+.|+|||+|||+||-|+....||.+... ..
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------la 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LA 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------ee
Confidence 86432211 1000000 0111234799999999874 67789999999999999999999999976311 12
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
|....+..|.. ..|+..+++||..||+.||++||++-++...+..+....
T Consensus 266 Ilng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 266 ILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred EEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 33444444432 467899999999999999999999666666555554433
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.27 Aligned_cols=258 Identities=17% Similarity=0.271 Sum_probs=201.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCc--EEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGE--EVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~--~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++.+.||+|+||.||+|.+..++. .+++|.++... ....+..|+.++.++.+|+++..+..+.......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999877665 46888776322 1235788999999996555555565566666778899
Q ss_pred Eecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 82 IDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
++++ +++|.+++.... ..+++..+..++.|++.||+|||+.|++||||||+|||+ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9987 889999986421 358899999999999999999999999999999999999 578899
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~ 224 (465)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... .+.
T Consensus 159 kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL 227 (297)
T ss_pred EECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 999999986432110 1112233567999999998889999999999999999997 9999987543 223
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
+..+.... ... ....++.++.+|+.+||..+|.+||++++|.+.|..++.....
T Consensus 228 ~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 228 YEKLPQGY-RME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHhcCC-CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 33332221 111 1135689999999999999999999999999999988875543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=307.19 Aligned_cols=262 Identities=17% Similarity=0.304 Sum_probs=203.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
..++|.+.+.||+|+||.||+|++.. +...||+|++...... ..+..|+.++..+..|+++..+..++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 35789999999999999999998643 2357999988754322 3577899999999544555555555566
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
....+++|+++ +++|.+++.... ..+++.+++.++.|++.||+|||+.|++||||||+|||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill-- 173 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 173 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE--
Confidence 66788999998 789999997532 248899999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
+.++.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 174 -~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 174 -TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred -cCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 57899999999998765432110 11122234578999999999889999999999999999998 899997643
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
. .+....+...... . ....++.++.+++.+||..+|++||++.++.+.|..++....
T Consensus 248 ~---~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 248 V---EELFKLLKEGHRM-D---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred H---HHHHHHHHcCCCC-C---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 2 2333333222211 1 123568999999999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.69 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=199.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
++|++.+.||+|+||.||+|.+. .+..||+|.+.... ....+..|+.+++.+.|++++..+.. +......+++|+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV-CTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEE-EccCCCEEEEEEcC
Confidence 67999999999999999999864 55689999876432 23578889999999998776665554 45566789999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++......+++..+..++.|++.||+|||++||+|+||||+||++ +.++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEY--- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCce---
Confidence 899999987545579999999999999999999999999999999999999 5788999999999976533211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. .+.+..+........ ...
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~~~----~~~ 225 (256)
T cd05114 156 ---TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRLYR----PKL 225 (256)
T ss_pred ---eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCCCC----CCC
Confidence 11123345678999999998889999999999999999999 9999976432 333333333222111 123
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
.+.++.+++.+||..+|++||++.+|.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 578999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.06 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=200.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC-CcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT-GEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~-~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
...|.+.+.||.|+||.||+|.+..+ ++.||+|.+..... ...+..|+.++..+.|++++..+..| ..+...||||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDF-KSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-EECCEEEEEE
Confidence 34599999999999999999998777 78899997654322 23467799999999887766666655 5566889999
Q ss_pred ecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 83 DLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 83 e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence 998 89999887532 3468999999999999999999999999999999999999 5889999999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......
T Consensus 222 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~~--- 290 (478)
T PTZ00267 222 SVS-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYDP--- 290 (478)
T ss_pred ccc-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC---
Confidence 221 112345679999999999999999999999999999999999999997643 233333333322211
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....++.++.++|..||..+|++||++.++..
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11356889999999999999999999887753
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=299.84 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=212.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----------ccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----------PQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.+|.-.+.||.|..+.|-++.++.++.++|+|++..-... +.-..|+.||+++.+|++|..+.++.+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677788999999999999999999999999988753211 124678999999999999999999999999
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+.|+|++++ .|.|.|++.. .-.++++....|+.|++.|++|||.++||||||||+|||+ |++.+++|+|||+++.
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeec
Confidence 999999999 8999999984 3469999999999999999999999999999999999999 7999999999999988
Q ss_pred cccccCcccccccCCCCcccccccccccccc------CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHL------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
+..... ...+||||+|.|||++. ...|+..+|+|++|||+|.||.|.+||... ...-.+..|.
T Consensus 173 l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRMIM 241 (411)
T ss_pred cCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHHHH
Confidence 765332 34689999999999875 245899999999999999999999999752 2234455566
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
++++....+.+ ..++..+++||.+||+.||.+|.|..+ .|.+.|
T Consensus 242 eGkyqF~speW-adis~~~KdLIsrlLqVdp~~Ritake---~LaHpf 285 (411)
T KOG0599|consen 242 EGKYQFRSPEW-ADISATVKDLISRLLQVDPTKRITAKE---ALAHPF 285 (411)
T ss_pred hcccccCCcch-hhccccHHHHHHHHHeeCchhcccHHH---HhcChH
Confidence 66666554443 578899999999999999999999555 455544
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.54 Aligned_cols=246 Identities=20% Similarity=0.344 Sum_probs=194.7
Q ss_pred eEeeeCceEEEEEEE--cCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 14 KIGSGSFGELYLGVN--VQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~--~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
.||+|+||.||+|.+ ..++..||||++...... ..+..|+.++..+.|++++..+..+. ....+++|+++ +
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 689999999999964 457889999998754332 35788899999999887777765542 44567889988 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++..+..++.|++.+|+|||++||+||||||.|||+ +.++.++|+|||++.........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~---- 151 (257)
T cd05116 80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENY---- 151 (257)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCe----
Confidence 889999874 4679999999999999999999999999999999999999 57889999999999865432211
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCc
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p 245 (465)
+.......++..|+|||.+....++.++|||||||++|||++ |..||..... ......+...... + ....+|
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~~~~~~-~---~~~~~~ 224 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIESGERM-E---CPQRCP 224 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHCCCCC-C---CCCCCC
Confidence 111122345679999999988889999999999999999998 9999987543 2233333322221 1 124578
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+++.++|.+||..||++||++.+|.+.|++.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=299.92 Aligned_cols=253 Identities=20% Similarity=0.378 Sum_probs=201.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|.+.+.||+|+||.||+|.+..+ ..||+|++..... ...+.+|+.+++.+.|+++++.+..+. ....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEE
Confidence 4568899999999999999999987544 5699998764332 346788999999999988887766553 34568999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||||+|||+ ++++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence 988 67999999753 3458999999999999999999999999999999999999 588999999999997653321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+....+... ...+
T Consensus 157 ~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~-~~~~--- 223 (260)
T cd05069 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERG-YRMP--- 223 (260)
T ss_pred c------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC-CCCC---
Confidence 1 11223456788999999998889999999999999999999 9999987543 2223322222 1111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....+|..+.+++.+||.++|++||++++|.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 124578999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.85 Aligned_cols=255 Identities=20% Similarity=0.307 Sum_probs=199.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+..++|++.+.||+|+||.||+|.+.. ++..||||++..... ...+..|+.+++.+.|++++..+.. ..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~-~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV-VSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE-EcCC
Confidence 567899999999999999999998642 356899998754322 2347789999999988776665544 4566
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~---------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
...+++|+++ +++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||||+|||+ +.++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~---~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---cCCCCE
Confidence 6788999987 889999986422 236788999999999999999999999999999999999 478999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~ 224 (465)
+|+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+... .+.
T Consensus 159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQV 230 (277)
T ss_pred EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999998765332111 11223356788999999999889999999999999999999 7899987543 223
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+..+....... ....+++++.+++.+||..+|++||++.++.+.|+
T Consensus 231 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 32222222211 12456899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.50 Aligned_cols=258 Identities=17% Similarity=0.212 Sum_probs=198.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+-.++|++++.||.|+||+||+|.+..+++ .|++|.+..... ...+..|+.++..+.|++++..+..+ ...
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~-~~~- 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGIC-PGA- 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEE-CCC-
Confidence 345789999999999999999999877776 477777653322 12455566677778887766666554 333
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++++++ +++|.+++......+++..+..++.||+.||.|||++|++||||||+|||+ +.++.+||+|||+++.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCcccee
Confidence 345556655 899999998766789999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
....... .......++..|+|||.+.+..++.++||||||+++||+++ |..||.+... +.+..+......
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~----~~~~~~~~~~~~ 229 (279)
T cd05111 159 LYPDDKK-----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP----HEVPDLLEKGER 229 (279)
T ss_pred ccCCCcc-----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHCCCc
Confidence 5432211 11234557789999999998899999999999999999998 9999987533 222222222222
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+.. ..++.++.+++..||..+|++||++.++.+.|..+..
T Consensus 230 ~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 2221 2347889999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=301.26 Aligned_cols=250 Identities=27% Similarity=0.450 Sum_probs=196.2
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCcc----HHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQ----LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~----~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
|++++.||+|+||+||+|++..+++.||+|++........ ...|+.++..+.|++++..+..+ ......+++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-QDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-EESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-cccccccccccc
Confidence 8999999999999999999999999999999887654332 34589999999776666555554 447777899999
Q ss_pred cCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 LGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~g~-sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+.+ +|.+++.. .+.+++..+..++.||+.+|.+||+.|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~--- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENN--- 152 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTT---
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc---
Confidence 855 99999983 5789999999999999999999999999999999999999 589999999999997642111
Q ss_pred cccccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......++..|+|||.+. +..++.++||||||+++|+|++|..||...........+............ ....
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 227 (260)
T PF00069_consen 153 ----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-QQSR 227 (260)
T ss_dssp ----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-TSHT
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-cccc
Confidence 1234567899999999998 788999999999999999999999999875222222222222211111000 0001
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+.++.+++..||+.||++||++.++.+
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22489999999999999999999777653
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=302.48 Aligned_cols=253 Identities=21% Similarity=0.370 Sum_probs=202.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++++.||+|+||.||+|.+. .+..||+|.+..... ...+..|+.+++.+.|++++..+..+. ....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~ 79 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVT 79 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEE
Confidence 56789999999999999999999864 667899998875432 346889999999999888777766553 34467999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++.++..++.|++.+|.|||+.|++|+||||+|||++ .++.++|+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCcc
Confidence 988 78999998753 34689999999999999999999999999999999999994 78899999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+....+... ...+
T Consensus 157 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~-~~~~--- 223 (260)
T cd05070 157 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVERG-YRMP--- 223 (260)
T ss_pred c------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcC-CCCC---
Confidence 1 11123345678999999998889999999999999999999 9999987543 2233332221 1111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....++.++.+++.+||..+|.+||++.++.++|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 124568999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=302.65 Aligned_cols=253 Identities=19% Similarity=0.334 Sum_probs=198.4
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCc--EEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEe-----CcE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGE--EVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVE-----GEY 77 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~--~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-----~~~ 77 (465)
|.+.+.||+|+||.||+|.+..++. .||||.++... ....+..|..+++.++|++++..+..+... ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877665 69999876542 223577899999999988888777655332 124
Q ss_pred EEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 78 NVMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~-----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
.+++++++ +++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence 57788887 78998887431 2458999999999999999999999999999999999999 588999999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
+++....... ........+++.|++||.+.+..++.++||||||+++|||++ |..||.+... .+.+..+..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQ 229 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 9987643221 111233456788999999999999999999999999999999 8999987432 333333333
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..... ....++..+.+++.+||..+|++||++.+|.+.|+++
T Consensus 230 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRLK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22211 1245688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=316.88 Aligned_cols=259 Identities=23% Similarity=0.295 Sum_probs=201.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|.-...||+|+||.||+|.. .++..||||.+..... ..+|..|+.++.+++|+|.|..+++|.+.+...+||+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence 35777788999999999999984 5569999998876554 45699999999999988888887777766656889999
Q ss_pred cc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 84 LL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRG---FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~-~ls~~~~~~ia~qi~~gL~yLHs~g---ivHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|+ +|+|.+++..... .++|.+.++||.++|.||+|||... ||||||||.|||+ |.+.++||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 98 8999999986555 8999999999999999999999864 9999999999999 7999999999999965543
Q ss_pred -ccCcccccccCCCCc-cccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc---hHHHHHHHhhh-h
Q 012336 159 -LQTHKHIPYRENKNL-TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYDKISEK-K 232 (465)
Q Consensus 159 -~~~~~~~~~~~~~~~-~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~---~~~~~~~i~~~-~ 232 (465)
... .... .||..|+|||++.....+.|+|||||||+|+|+++|+.|.....+.. ........... .
T Consensus 230 ~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 111 1112 79999999999999899999999999999999999998887533111 11111111111 1
Q ss_pred cc-CcHHHHh-ccCc-----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 233 ML-TPIEVLC-KSYP-----SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 233 ~~-~~~~~~~-~~~p-----~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.. ...+.+. ..++ ..+..+...|+..+|.+||++.++.+.|+.+
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 11 0011111 2333 2266777899999999999999998888554
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=299.26 Aligned_cols=255 Identities=15% Similarity=0.266 Sum_probs=203.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.++|++.+.||+|+||.||+|.+..+ ...||||++...... ..+..|+.++..++|++++..+..+ ..+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-TKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-ecCCceE
Confidence 57899999999999999999997644 458999987654322 3577899999999887666655544 5566788
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|+++ +++|.+++......+++.++..++.|++.||.|||+++|+|+||||+|||+ +.++.++|+|||++..+..
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999988 889999998655689999999999999999999999999999999999999 5889999999999987752
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+.... ..+.
T Consensus 159 ~~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~~~~ 229 (266)
T cd05033 159 SEAT-----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGY-RLPP 229 (266)
T ss_pred cccc-----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCC-CCCC
Confidence 1110 01122345678999999999899999999999999999998 9999976432 23333333221 1121
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
. ..+|+.+.+++..||+.+|++||++.+|.+.|..+
T Consensus 230 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 35689999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=296.25 Aligned_cols=247 Identities=20% Similarity=0.269 Sum_probs=201.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.|++++.||.|+||.||++.+..+++.||||.+..... ...+..|+++++.+.|++++..+..+.......+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999998875432 23577899999999988877776666555667889999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++... ...+++.++..++.|++.+|.|||++|++|+||||+|||+ +.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccC-
Confidence 98 78999988753 4569999999999999999999999999999999999999 588999999999997664321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.......|++.|+|||++.+..++.++||||||+++|+|++|..||...+ .......+....... ..
T Consensus 157 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~----~~ 223 (257)
T cd08223 157 ------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKLPP----MP 223 (257)
T ss_pred ------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCCC----Cc
Confidence 12235578999999999999999999999999999999999999997633 222222222222211 22
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+++++.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 467899999999999999999999777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=315.36 Aligned_cols=281 Identities=20% Similarity=0.222 Sum_probs=225.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.+-.+.|++-+.||.|+||+||-++-..||+.||+|.+.++ ......++|.+++.++..+ .|+.+.+..+..+.
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETKDA 259 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCCCc
Confidence 34567899999999999999999999999999999976543 3445678999999999876 56666666677778
Q ss_pred EEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+|+|+.++ ||+|.-++-+.+ ..|++..++.+|.+|+.||++||..+||+|||||+|||+ |+.|+|.|+|+|||..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEe
Confidence 89999998 999988776543 579999999999999999999999999999999999999 7999999999999998
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
+...... ..-+||.+|||||++.+..|+...|||||||+||||+.|+.||...+.....+.+ +.....
T Consensus 337 i~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv----drr~~~ 404 (591)
T KOG0986|consen 337 IPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV----DRRTLE 404 (591)
T ss_pred cCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH----HHHHhc
Confidence 7654321 2338999999999999999999999999999999999999999876544333333 233334
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRS 304 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (465)
..+.+...++++++++...+|.+||.+|.-...- ..-.-..++++..++|..+...-...+-.|
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~-----ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGE-----GAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccCCCc-----CcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 4555668899999999999999999999753200 111112378889999998765444433333
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=300.57 Aligned_cols=253 Identities=19% Similarity=0.347 Sum_probs=199.6
Q ss_pred eEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCc-----
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE----- 76 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~----- 76 (465)
|++.+.||+|+||.||+|....+ +..||||++..+.. ...+..|+.+++.+.|++++..+..+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 47899998875432 2357889999999998887776665544332
Q ss_pred EEEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEec
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~-----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
..+++++++ +++|..++... ...+++..+..++.|++.||.|||+.+++||||||+|||+ ++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence 468888887 89999887532 2368999999999999999999999999999999999999 57889999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (465)
|+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+..+.
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR 229 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence 999866433221 11223345678999999988889999999999999999999 9999977433 33333333
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...... ....++.++.+++.+||..||.+||++.+|.+.|+++
T Consensus 230 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNRLK----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCCCC----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 222211 1245789999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.65 Aligned_cols=261 Identities=21% Similarity=0.336 Sum_probs=209.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC----CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ----TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+-+++|++.+.||+|+||.||+|.+.. ++..|++|++..... ...+..|+.+++.+.|+++++.+..+...+.
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 557899999999999999999999865 368899998764322 2347789999999999888888877766667
Q ss_pred EEEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN-------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~-------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
..+++++++ +++|.+++.... ..+++.++..++.|++.||+|||+.+++|+||||+|||+ +.++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE---cCCCcEEEC
Confidence 788888887 789999987532 458999999999999999999999999999999999999 478999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (465)
|||+++.+....... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...+. .+....
T Consensus 160 d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~ 231 (280)
T cd05043 160 DNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAY 231 (280)
T ss_pred CCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHH
Confidence 999998664322111 1123356778999999998889999999999999999999 9999977533 222222
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
+... ..... ...+|+++.+++.+||..+|++||++.++.+.|.++..+
T Consensus 232 ~~~~-~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 232 LKDG-YRLAQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HHcC-CCCCC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 2221 11111 134589999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.46 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=204.0
Q ss_pred eEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec-cCCCHH
Q 012336 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL-LGPSLE 90 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~-~g~sL~ 90 (465)
.||+|.||+||-|++..|...+|||-+..+. ..+-+..|+.+...|.|.|+|.+++.+..++ +.-|.||- .||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCcHH
Confidence 6999999999999999999999999877543 3345888999999999999999999987777 44555555 499999
Q ss_pred HHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 91 DLFNYCNRKF--SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 91 ~ll~~~~~~l--s~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
+++...=+++ .+.++..+..||+.||.|||.+.|||||||-+|+|+. .-.|.+||+|||-++.+..-. -
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAgin-------P 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGIN-------P 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCC-------c
Confidence 9998655666 7889999999999999999999999999999999996 568999999999999876532 1
Q ss_pred CCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 169 ENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~--~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.+.++.||..|||||++..++ |++++|||||||++.||.||++||..+.. ......++.-.+..++.+ ..++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs--pqAAMFkVGmyKvHP~iP---eelsa 806 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS--PQAAMFKVGMYKVHPPIP---EELSA 806 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC--hhHhhhhhcceecCCCCc---HHHHH
Confidence 357899999999999998765 89999999999999999999999987643 222333333333333322 34578
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 247 EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
+.+.||.+|+..+|.+||++. ++|.+.|...+
T Consensus 807 eak~FilrcFepd~~~R~sA~---~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAK---DLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHH---HhccCcccccC
Confidence 899999999999999999955 45666665443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=305.08 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=198.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||.|+||.||+|++..+++.||+|.+..... ...+..|+.+++.++|++++..+..+ ......+++++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEE-ecCCeEEEEEe
Confidence 579999999999999999999999999999998764432 23577899999999987766666554 56668899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~--- 158 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT--- 158 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCC---
Confidence 99889999988666779999999999999999999999999999999999999 588899999999997543211
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh----------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 232 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (465)
.......+++.|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+..+....
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 ----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred ----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 112234678999999998764 47889999999999999999999998754322111111110000
Q ss_pred ------ccC------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 ------MLT------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ------~~~------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
... ........+++++.+||.+||..||.+||++.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 011122457889999999999999999999766643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.84 Aligned_cols=246 Identities=20% Similarity=0.237 Sum_probs=199.3
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+|++.+.||.|+||.||++.+..+++.||+|.+.... ....+..|+.++..++|++++..+. +...+...++++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEE-EEEECCEEEEEEee
Confidence 5899999999999999999999999999999876432 2346778999999998876655555 44666788999999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 85 L-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 85 ~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+ +++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 8 88999888643 4568999999999999999999999999999999999999 5889999999999976543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+ ....+..+....... ...
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSYKP----LPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCCCC----CCc
Confidence 1234578999999999999899999999999999999999999998633 223333332222211 113
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.++..+.+++.+||..||++||++.+|..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 46889999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=298.03 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=203.2
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++.+.||.|+||.||+|++..+++.||||.+..... ...+..|+.+++.++|++++..+..+. .....+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-EDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-ECCeEEEE
Confidence 689999999999999999999999999999998754221 234778999999999877776665554 55677889
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 82 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE---cCCCCEEECccccceecc
Confidence 9988 78999888642 3458999999999999999999999999999999999999 478899999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... ......|++.|+|||.+.+..++.++|+||||+++|||++|..||..... ........+........
T Consensus 158 ~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~- 228 (267)
T cd08228 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPPL- 228 (267)
T ss_pred chhH-------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCCC-
Confidence 3211 11245688999999999988899999999999999999999999976432 12222222222221111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
....++..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1134678999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=301.79 Aligned_cols=267 Identities=20% Similarity=0.297 Sum_probs=204.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+..++|++.+.||+|+||.||+|.+.. .+..||+|++...... ..+..|+.+++.+.|++++..+ .+....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLL-GVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEE-EEEcCC
Confidence 456899999999999999999997542 3458999987644322 2467788899999876655544 445566
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~---------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
...+++|||+ +++|.+++.... ..++...+..++.|++.||.|||+++|+||||||+|||+ +.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili---~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV---AHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---cCCCcE
Confidence 6789999998 899999997421 235678899999999999999999999999999999999 478999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~ 224 (465)
+|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.
T Consensus 159 ~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQV 230 (288)
T ss_pred EECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 9999999976543221 111223346778999999998899999999999999999998 8899987433 222
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccc
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDW 290 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw 290 (465)
+..+....... ....+++++.+++.+||..+|++||++.++.+.|++.+ .+++..+||
T Consensus 231 ~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~----~~~~~~~~~ 288 (288)
T cd05061 231 LKFVMDGGYLD----QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL----HPSFPEVSF 288 (288)
T ss_pred HHHHHcCCCCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc----CCCCCCCCC
Confidence 22222221111 12356899999999999999999999999998887764 556666666
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=299.40 Aligned_cols=254 Identities=22% Similarity=0.363 Sum_probs=203.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+-.++|+++++||+|+||.||+|.+ .++..||+|.+.... ....+..|+.++..++|++++..+..+ ......++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-TKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCCcEEEE
Confidence 3467899999999999999999985 466789999876432 235688899999999987776655444 4556778999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++.++..++.|++.+|+|||+.+++|+||||+|||+ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence 987 88999998753 4568999999999999999999999999999999999999 588999999999998754321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ......+.... ..+
T Consensus 158 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~-~~~--- 224 (261)
T cd05072 158 Y------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGY-RMP--- 224 (261)
T ss_pred e------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCC-CCC---
Confidence 1 11123346778999999998889999999999999999998 9999976433 22333332221 111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....+|.++.+++.+||..+|++||++++|.++|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 113578999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=302.05 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=205.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+-..+|.+.+.||.|+||.||++.+. .++..||+|.+.... ....+..|++++..++|++++..+. ++....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYG-VCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEE-EEecCC
Confidence 44678999999999999999999852 345679999876432 2345888999999998866655554 455667
Q ss_pred EEEEEEecc-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~ 143 (465)
..+++++++ +++|.+++.... ..+++.++..++.|++.+|+|||++|++||||||+|||+ +.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence 889999988 899999986432 248999999999999999999999999999999999999 5889
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~ 222 (465)
.++|+|||++........ ........+++.|+|||++.+..++.++|||||||++|+|++ |..||..... .
T Consensus 158 ~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~ 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---N 229 (288)
T ss_pred cEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---H
Confidence 999999999976533211 111233456789999999998889999999999999999998 9999977543 2
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
..+..+....... ....++.++.+++.+||+.+|.+||++.++...|+++...
T Consensus 230 ~~~~~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 230 EVIECITQGRVLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHHHcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 3333333332221 1235689999999999999999999999999999888643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=296.79 Aligned_cols=252 Identities=19% Similarity=0.312 Sum_probs=202.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|++.+.||.|+||.||+|.+..+++.|++|++.... ....+..|+++++.++|++++..+.. ...+...+++|+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~-~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS-YLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEE-EEeCCEEEEEEe
Confidence 368999999999999999999998899999999987543 23468899999999988777776554 456678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++......+++.++..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhh--
Confidence 98 779999887644789999999999999999999999999999999999999 588999999999997654321
Q ss_pred ccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+....+.......+...
T Consensus 156 -----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 156 -----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK 227 (262)
T ss_pred -----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence 122345789999999999877 789999999999999999999999987442 222222222211211111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....++.++.+++.+||..+|.+||++.+|..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23456789999999999999999999877753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=320.44 Aligned_cols=255 Identities=20% Similarity=0.215 Sum_probs=197.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+.+..|.+.+.||.|+||.||+|.+..+++.||||... ...+.+|+.+++.|+|++++..+.. +..+...+++|+
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l~~~-~~~~~~~~lv~e 240 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLALLDV-RVVGGLTCLVLP 240 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcEEEE-EEECCEEEEEEE
Confidence 34678999999999999999999999999999999633 3457789999999998877776655 455667889999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++........
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceeccccccc-
Confidence 99899999887655679999999999999999999999999999999999999 57889999999999865432110
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC-----chHHHHHHHhhhhcc---C
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYDKISEKKML---T 235 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~---~ 235 (465)
.......||+.|+|||++.+..++.++|||||||+||||++|..|+...... ...+....+...... .
T Consensus 317 ----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 317 ----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 1123467999999999999999999999999999999999988765442211 112222222211110 0
Q ss_pred c------------------------H--HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 P------------------------I--EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~------------------------~--~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+ . ......++.++.+||.+||..||.+||++.+|++
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 0 0000134568999999999999999999766643
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=305.93 Aligned_cols=257 Identities=17% Similarity=0.259 Sum_probs=200.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcE--EEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEE--VAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~--vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-++|++.+.||+|+||.||+|.+..++.. +|+|.+.... ....+..|+.++.++.+|+++..+..++..+...++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46899999999999999999998777764 5666654322 223577899999999555666666666677778899
Q ss_pred EEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc
Q 012336 81 VIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ 144 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~ 144 (465)
+|+++ +++|.+++.... ..+++.+++.++.||+.||+|||++|++||||||+|||+ +.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence 99998 899999987432 258899999999999999999999999999999999999 58889
Q ss_pred EEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHH
Q 012336 145 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (465)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~ 223 (465)
++|+|||++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +
T Consensus 163 ~kl~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E 231 (303)
T ss_pred EEeCccccCcccchh--------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H
Confidence 999999998642211 01112234678999999988889999999999999999998 99999765432 2
Q ss_pred HHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 224 KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+..+.... ... ....+++++.+++.+||..+|++||+++++.+.|..++...
T Consensus 232 ~~~~~~~~~-~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 232 LYEKLPQGY-RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHHhcCC-cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 232222211 111 11346889999999999999999999999999998887655
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=296.62 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=203.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++.+.||+|+||.||+|.+. .++.||||.+.... ....+..|+.++..++|++++..+. +.......+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~ 80 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYA-VCTLEEPIYIVT 80 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeE-EEecCCCeeeee
Confidence 56789999999999999999999864 55789999886543 2346888999999999877666555 455566778999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||+++.+....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---GENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---cCCCCEEECCcceEEEccCCc
Confidence 998 999999997533 569999999999999999999999999999999999999 588999999999998765321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ........+..|+|||.+.+..++.++||||||+++|||++ |+.||.+... .+.+..+..... .+.
T Consensus 158 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~~~-- 225 (261)
T cd05068 158 Y------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYR-MPC-- 225 (261)
T ss_pred c------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-CCC--
Confidence 1 11112233568999999999899999999999999999999 9999987532 233333322211 111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
...++..+.+++.+||..+|++||++.+|.+.|++
T Consensus 226 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 -PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 13568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=301.16 Aligned_cols=261 Identities=19% Similarity=0.271 Sum_probs=207.9
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
|..+..++|++.+.||+|+||.||+|.+..++. .||+|.+..... ...+.+|+.++..+.|++++..+..+..
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 456778999999999999999999999876655 689998765533 2357789999999999888877776654
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
...+++++++ +++|.+++......+++..+..++.||+.||+|||+.|++|+||||+|||+ +.++.++|+|||+
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~ 155 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGL 155 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcc
Confidence 5677888887 899999998655679999999999999999999999999999999999999 5888999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
++......... ......++..|+|||.+....++.++||||||+++||+++ |..||.+..... ....+...
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~ 227 (279)
T cd05057 156 AKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEKG 227 (279)
T ss_pred cccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhCC
Confidence 98654321110 1112234678999999988889999999999999999998 999998754322 22222222
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
...+.+ ..++.++.+++.+||..+|.+||++.+|.+.|..+..
T Consensus 228 -~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 -ERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -CCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111 2357889999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=306.06 Aligned_cols=258 Identities=19% Similarity=0.253 Sum_probs=199.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCC----------------cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTG----------------EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGV 65 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~----------------~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i 65 (465)
..++|++++.||+|+||.||+|.+..++ ..||+|++..... ...+..|+.++..+.|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4578999999999999999999876543 5689998875432 34677899999999987766
Q ss_pred ceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 012336 66 PHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCN----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 134 (465)
Q Consensus 66 ~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~----------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NI 134 (465)
..+..+ ..+...+++++++ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||
T Consensus 83 ~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 83 RLLGVC-TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEE-ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 665554 4456778888887 889999987533 2689999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCC
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLP 212 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt--G~~P 212 (465)
|+ +.++.++|+|||++......... .......+++.|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 162 li---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 162 LV---GKNYTIKIADFGMSRNLYSSDYY-----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred ee---cCCCceEEccccceeecccCcce-----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 99 47799999999999765432211 11234456789999999998889999999999999999998 7888
Q ss_pred CCCCCCCchHHHHHHHhhh---hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 213 WQGLKAGTKKQKYDKISEK---KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
|..... .+.+...... ............+|.++.+++..||+.||++||++.+|.+.|+
T Consensus 234 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTD---QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcCh---HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 876443 2222222221 0000000112346789999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=301.09 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=207.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+++++.+.|++++..+. +..++...+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG-SFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceee-EEEcCCeEEEE
Confidence 47999999999999999999999999999999886432 2345788999999999766665554 44566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. ...+++..+..++.||+.+|.|||+.|++|+||+|+|||+ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC-
Confidence 9999 9999999875 4679999999999999999999999999999999999999 57899999999999875432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+....+.......+
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~---- 218 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKVRFP---- 218 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCccCC----
Confidence 234568999999999998889999999999999999999999997644 2233333332222222
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++.+.+++.+||..+|.+|+ ++.++ + .+++...++|....
T Consensus 219 -~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l---~-------~~~~~~~~~~~~~~ 266 (290)
T cd05580 219 -SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI---K-------NHPWFAGIDWIALL 266 (290)
T ss_pred -ccCCHHHHHHHHHHccCCHHHccCcccCCHHHH---H-------cCcccccCCHHHHh
Confidence 45689999999999999999999 43333 2 25777778888764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=312.47 Aligned_cols=249 Identities=18% Similarity=0.212 Sum_probs=191.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
..+|++++.||+|+||.||+|++..++..||+|+... .....|+.++..++|++++..+..+ ......++|++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~----~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK----GTTLIEAMLLQNVNHPSVIRMKDTL-VSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc----cccHHHHHHHHhCCCCCCcChhheE-EeCCeeEEEEEcc
Confidence 4579999999999999999999999999999997542 3456799999999987776666554 4566788999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
.++|.+++......+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~----- 211 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAP----- 211 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCc-----
Confidence 999999987666789999999999999999999999999999999999999 588999999999997532211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH--------HHHHHHhhhhcc---
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--------QKYDKISEKKML--- 234 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~--------~~~~~i~~~~~~--- 234 (465)
......||+.|+|||++.+..++.++|||||||++|||+++..|+......... .....+......
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 123457999999999999999999999999999999999855554332221100 011101000000
Q ss_pred Cc-------------------------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 TP-------------------------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ~~-------------------------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+ .......++.++.+||.+||..||.+||++.++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 00 0000124567788899999999999999976653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=300.78 Aligned_cols=253 Identities=19% Similarity=0.231 Sum_probs=201.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCc------E
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGE------Y 77 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~------~ 77 (465)
.|..+++||+|+||+||+|+.+.+|+.||+|.+..+... ....+|+.+++.|+|.++|..+..+....+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 477788999999999999999999999999998876542 246899999999999996666666655544 7
Q ss_pred EEEEEeccCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 78 NVMVIDLLGPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~---~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
.++|++++.-+|..++.... ..++...+..++.||+.||+|||+++|+||||||+|||| +..|.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHH
Confidence 89999999999999999776 468889999999999999999999999999999999999 589999999999999
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK- 232 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (465)
.+... .+......+|.+|.|||++.+. .|+..+||||+|||++||++++.-|.+..+......+..+....
T Consensus 169 a~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 169 AFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 66532 2334566899999999999987 59999999999999999999999999965522222221111100
Q ss_pred -ccCc-----------------HHHHh---ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 -MLTP-----------------IEVLC---KSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 -~~~~-----------------~~~~~---~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+| ...++ +...+...+++.+|+..+|.+|.++..+.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al 300 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGAL 300 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHh
Confidence 0000 00111 12224789999999999999999966543
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.65 Aligned_cols=250 Identities=21% Similarity=0.286 Sum_probs=199.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-+..|+++++||.||.+.||++.. .+.+.||+|....... ...+..|+.+|.+|+++..|..+.+|...+.++||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 367899999999999999999985 4456666665443322 23589999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+-..+|..+++.....++.-.+..|..||+.++.++|..||||.||||.|||+ -.|.+||+|||+|.....+.
T Consensus 438 vmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 438 VMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccc
Confidence 99999999999999765556655899999999999999999999999999999999 68999999999999887766
Q ss_pred CcccccccCCCCccccccccccccccCCC-----------CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-----------~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
+.. .....+||+.||+||.+.... .++++||||||||||+|+.|+.||.... ....++..|.
T Consensus 514 TsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~ 586 (677)
T KOG0596|consen 514 TSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAIT 586 (677)
T ss_pred cce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhc
Confidence 543 235678999999999886433 4679999999999999999999997532 1122222222
Q ss_pred hhhccCcHHHHhccC--cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 230 EKKMLTPIEVLCKSY--PSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~--p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....... .+.+ +.++.++++.||.+||.+||++.+|+
T Consensus 587 ~P~~~Ie----fp~~~~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 587 DPNHEIE----FPDIPENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred CCCcccc----ccCCCCchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 2211111 1122 24499999999999999999966553
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=300.80 Aligned_cols=252 Identities=20% Similarity=0.307 Sum_probs=199.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEc----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNV----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.+|++.+.||+|+||.||+|.+. .++..||+|.+..... ...+..|+.++..++|++++..+.. ...+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~-~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGV-VTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEE-EecCCceE
Confidence 57999999999999999999853 3567899998864332 2357789999999988776665554 45566788
Q ss_pred EEEecc-CCCHHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 80 MVIDLL-GPSLEDLFNYC----------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~----------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
++||++ +++|.+++... ...+++.+++.++.||+.+|.|||++|++|+||||+|||+ +.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999988 78999998532 1247899999999999999999999999999999999999 578
Q ss_pred CcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCch
Q 012336 143 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (465)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~ 221 (465)
+.++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred CcEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 8999999999986543221 112234456788999999998889999999999999999998 9999987543
Q ss_pred HHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 222 KQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
......+...... + ....+++++.+++.+||..+|++||++.+|.+.|+
T Consensus 233 ~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 233 QEVIEMVRKRQLL-P---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 2222222222211 1 22467899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=301.76 Aligned_cols=256 Identities=23% Similarity=0.293 Sum_probs=203.8
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeC----cEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----EYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~lv~e 83 (465)
.|.-.+.+|.|+||.||.|....+++.||||..-.+.. --.+|+++|+.+.|+|+|..+..|.... -+..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 58899999999999999999999999999997654433 3456999999999999888888776532 25678999
Q ss_pred ccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 84 LLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 84 ~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+..+|.+.++. .+..++...+.-+..||+.||.|||+.||+||||||.|+|+. -+.+.+||||||.|+.+....
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCC
Confidence 999999999884 267899999999999999999999999999999999999994 356999999999999876543
Q ss_pred CcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK------- 232 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (465)
. +.+...|-.|.|||.+.|.. |+.+.||||.|||+.||+-|++-|.|.........+.++..-.
T Consensus 181 p--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 181 P--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred C--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 2 34566789999999998864 9999999999999999999999999955433322222222100
Q ss_pred --cc---------Cc---HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 233 --ML---------TP---IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 233 --~~---------~~---~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.. .. ...+....++++.+|+.++|..+|.+|.++.+ .|.+.|.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~---~l~h~fF 309 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE---ALAHPFF 309 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH---Hhcchhh
Confidence 00 00 01133457899999999999999999999554 4444443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=326.00 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=213.3
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.|.-++.||.|+||.||-|++..+.+.||||.++... .+.+++.|+..|..+.|+|.|.+-+. .-.....++||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC-yLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC-YLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce-eeccchHHHHH
Confidence 4667889999999999999999999999999887542 34578999999999999887765544 44455567999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+||-|+-.|++.-..+++.+..+..|..+.+.||.|||+.+.||||||+.|||++ +.|.|||+|||.|.....
T Consensus 106 EYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 106 EYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred HHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc----
Confidence 9999999999998888999999999999999999999999999999999999995 899999999999976543
Q ss_pred ccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
..+++|||.|||||++. .+.|+-++||||||++..||.-.++|+.++++.. .+-.|.....++.
T Consensus 179 -------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---ALYHIAQNesPtL--- 245 (948)
T KOG0577|consen 179 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPTL--- 245 (948)
T ss_pred -------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---HHHHHHhcCCCCC---
Confidence 45789999999999986 4569999999999999999999999999976533 2333333222221
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFD 289 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~d 289 (465)
....++..|.+|+..||.+-|.+||+.++ +|++.|.....+.+-+.|
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~---ll~H~fv~R~Rp~tvi~d 292 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEE---LLKHRFVLRERPPTVIMD 292 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHH---HhhcchhccCCCchHHHH
Confidence 23567899999999999999999999665 567777766666555444
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=301.70 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=205.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCCC--ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
-.++|.+.+.||+|+||.||+|.+. .++..|++|.+...... ..+.+|++++..+.|++++..+. ++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG-VCGDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEE-EEccCCc
Confidence 3568999999999999999999853 34567999987654332 45888999999998866665554 4556677
Q ss_pred EEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 78 NVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
.++||+++ +++|.+++... ...+++..++.++.||+.+|+|||++||+||||||+|||+ +.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---GA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---cc
Confidence 89999998 89999998642 1348999999999999999999999999999999999999 58
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
++.++|+|||++........ ........++..|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-- 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-- 231 (291)
T ss_pred CCcEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 89999999999976533211 112234557889999999999899999999999999999998 9999977543
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+.+..+....... ....+|.++.+++.+||..+|++||++.+|.+.|+++...
T Consensus 232 -~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 232 -TEVIECITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred -HHHHHHHhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 22333332222211 1234689999999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=304.05 Aligned_cols=252 Identities=19% Similarity=0.297 Sum_probs=198.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
..++.|+++++||.|+||.||+|++..++..|++|++..... ...+..|+.++..+.|++++..+..+. .+...+++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 87 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-WDGKLWIM 87 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-eCCeEEEE
Confidence 346789999999999999999999999999999999875432 235778999999999877666666554 45578889
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|..++......+++..+..++.|++.+|.|||+.|++||||||+|||+ +.++.++|+|||++.......
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceeccccc
Confidence 9988 788888776556679999999999999999999999999999999999999 578999999999987543211
Q ss_pred CcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.......+++.|+|||++. ...++.++|||||||++|||++|..||..... .+.+..+.... .
T Consensus 165 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~--~ 232 (292)
T cd06644 165 -------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSE--P 232 (292)
T ss_pred -------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCC--C
Confidence 1123456889999999985 34468899999999999999999999976432 22222222111 1
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.......++.++.++|.+||..+|++||++.++.+
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111112356789999999999999999999776643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=303.51 Aligned_cols=258 Identities=19% Similarity=0.276 Sum_probs=200.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHc-CCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQ-GGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~-~~~~i~~l~~~~~~ 74 (465)
+..++|.+.+.||+|+||.||+|.+. .++..||||++..... ...+..|+.++.++. |++++..+. ++..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~-~~~~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG-ACTI 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEE-EEec
Confidence 34568999999999999999999753 3456899998765422 235788999999994 555555544 4556
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
....+++|+++ +++|.+++.... ..+++.++..++.|++.||.|||+++|+|+||||+|||+ +.++.++|+|||+
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCcc
Confidence 66788999987 789999987533 348999999999999999999999999999999999999 5788999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
+..+...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .+......
T Consensus 188 ~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~~~~~ 259 (302)
T cd05055 188 ARDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYKLIKE 259 (302)
T ss_pred cccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHHHHHc
Confidence 9765432210 11223456788999999999899999999999999999998 999998754322 22222222
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..... .....++++.+++.+||..+|++||++.+|.+.|+++
T Consensus 260 ~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 GYRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11111 1134688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.09 Aligned_cols=278 Identities=19% Similarity=0.232 Sum_probs=233.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+-..+|.++..||.|+||.|-+|..+.+.+.||||+++++-. .+--..|-.+|.....++.+..++.|+..-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 345689999999999999999999999999999999887532 222456777777777888899999999999999
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+||||+ ||+|-..+++ -++|.+..+..+|.+|+-||-|||++|||+||||.+|||+ |.+|++||+|||+++...
T Consensus 426 yFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 501 (683)
T ss_pred eeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccc
Confidence 9999999 9999998886 5689999999999999999999999999999999999999 799999999999998643
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ..+.+++|||.|+|||++.-++|+..+||||+||+|||||.|.+||.+. +..+.+..|.+.....|
T Consensus 502 ~~~-------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvsyP- 570 (683)
T KOG0696|consen 502 FDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVSYP- 570 (683)
T ss_pred cCC-------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCcCc-
Confidence 221 3457899999999999999999999999999999999999999999994 45667777777777666
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRSRP 306 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~ 306 (465)
+.++.++..++...|.+.|.+|.-.. +-.+.+ ..++++.-.||..+...+++.+-+|..
T Consensus 571 ----KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di------~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 571 ----KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDI------REHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred ----ccccHHHHHHHHHHhhcCCccccCCCCccccch------hhCcchhhccHHHHhhccCCCCCCCcc
Confidence 67799999999999999999995321 001111 126777789999987777776666654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=298.21 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=198.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.... ....+..|+.+++.++|++++.. ..+.......+++|++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~-~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL-YGVCTKQRPIFIVTEY 80 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEE-EEEEcCCCceEEEEec
Confidence 357999999999999999999875 56789999876433 23468889999999988765554 4445566678999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++......+++..+..++.||+.+|.|||++||+||||||+|||+ +.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceecccccc--
Confidence 8 889999987655578999999999999999999999999999999999999 5889999999999976533211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......++..|+|||.+.+..++.++||||||+++|++++ |..||..... .+....+.... ... ...
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~~~---~~~ 224 (256)
T cd05059 156 ----TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGY-RLY---RPK 224 (256)
T ss_pred ----cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCC-cCC---CCC
Confidence 11122234568999999999899999999999999999999 8999976443 22333332221 111 113
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
.+|.++.+++.+||..+|++||++.++.+.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 4689999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=297.04 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=198.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
+.|.+.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.|++++..+..+ .+....+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-RDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-ccCCeEE
Confidence 579999999999999999999989999999998764321 23577899999999887766555554 4556889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++++++ +++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999988 8899998875 4578999999999999999999999999999999999999 5789999999999976543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
..... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+......... .
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~---~ 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTN---P 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCCC---C
Confidence 21100 011245688999999999999999999999999999999999999976432 2222222211111 1
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+...++.++.+++..||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 122467899999999999999999999777654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=294.84 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=204.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+..|+++++.+.|.+++..+..+. .....+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-ENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCeEEEE
Confidence 68999999999999999999998899999999876321 2346788999999998877666666554 45678899
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 82 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+++ +++|.+++... ...+++.++..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9988 78999988642 3458999999999999999999999999999999999999 588999999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........+...... +.
T Consensus 158 ~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~-~~ 228 (267)
T cd08224 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYP-PL 228 (267)
T ss_pred CCCc-------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCC-CC
Confidence 3211 12234688999999999988899999999999999999999999965331 222223222222211 11
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+ ...++.++.++|.+||..+|++||++.+|.+.|+++
T Consensus 229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 125688999999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=296.97 Aligned_cols=258 Identities=16% Similarity=0.258 Sum_probs=202.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
|..++|+..+.||+|+||.||+|++..++. .||||.+..... ...+..|++++..+.|++++..+. +......
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEG-VVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEE-EEccCCC
Confidence 456789999999999999999999876554 799998765432 235788999999998876555544 4455667
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++||++ +++|.+++......+++.++..++.|++.||+|||+.|++|+||||+|||+ +.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE---cCCCcEEECCCccceec
Confidence 88999988 789999997656779999999999999999999999999999999999999 47889999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
....... ........++.|+|||++.+..++.++|||||||++||+++ |..||..... ......+... ...
T Consensus 158 ~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~-~~~ 229 (268)
T cd05063 158 EDDPEGT----YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDG-FRL 229 (268)
T ss_pred ccccccc----eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcC-CCC
Confidence 4321110 01112223567999999998889999999999999999997 9999976443 2223223222 111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+. ...++.++.+++.+||..+|++||++.+|.+.|+++
T Consensus 230 ~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 21 134689999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=301.36 Aligned_cols=258 Identities=18% Similarity=0.312 Sum_probs=200.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC-----CcEEEEEEeecCCCC---ccHHHHHHHHHHH-cCCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEVAVKLESVKTKH---PQLHYESKLYMLL-QGGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l-~~~~~i~~l~~~~~~ 74 (465)
+-.++|++.+.||+|+||.||++.+... ...||+|++...... ..+..|+.++..+ .|++++..+. +...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~-~~~~ 87 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG-VCTQ 87 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE-EEcC
Confidence 4468999999999999999999987643 378999987754322 3477899999999 4655555554 4455
Q ss_pred CcEEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
+...+++|+++ +++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||+
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~-- 165 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV-- 165 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE--
Confidence 56678888887 88999998632 3468999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
+.++.++|+|||+++.+...... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.+..
T Consensus 166 -~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 166 -TEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred -cCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 47899999999999876432211 11222345678999999998889999999999999999998 999998743
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
. .+.+..+...... . ....++.++.+++.+||..+|++||++.+|.+.|+++.
T Consensus 240 ~---~~~~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 V---EELFKLLKEGYRM-E---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H---HHHHHHHHcCCcC-C---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 3 2233322222111 1 11345789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=299.35 Aligned_cols=248 Identities=23% Similarity=0.378 Sum_probs=194.3
Q ss_pred EEEeeEeeeCceEEEEEEEc----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 10 KLGRKIGSGSFGELYLGVNV----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 10 ~l~~~LG~G~fG~Vyla~~~----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+.+.||.|.||.||+|.+. ..+..|+||+++.... ...+..|++.+.+++|++++..++.+. .....++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-ccccccccc
Confidence 57899999999999999987 3467899999965433 357899999999998877777666665 555578888
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|++ +++|.+++... ...+++.++..|+.||+.||.|||+++++|+||+++|||+ +.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 988 78999999875 4679999999999999999999999999999999999999 588999999999998763211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. .......+...|+|||.+.+..++.++||||||+++||+++ |..||.+.. ..+....+........
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~~~~~~~~--- 226 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLKQGQRLPI--- 226 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHHTTEETTS---
T ss_pred cc-----ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccee---
Confidence 11 12234457789999999999889999999999999999999 789998753 3444444433333221
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
...+|..+.+++..||..+|++||++.+|.+.|
T Consensus 227 -~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 -PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 135699999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=303.15 Aligned_cols=256 Identities=15% Similarity=0.282 Sum_probs=200.8
Q ss_pred ceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
+|++.+.||+|+||.||+|++.. ....|++|++..... ...+..|+.++..+.|++++..+..+ ......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-SQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-ecCCCcE
Confidence 58999999999999999998643 235799998764432 23578899999999988777766555 4555677
Q ss_pred EEEecc-CCCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcee
Q 012336 80 MVIDLL-GPSLEDLFNYC-----------------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 135 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~-----------------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NIL 135 (465)
++++++ +++|.+++... ...+++.+++.++.|++.+|.|||+.+++||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 888887 79999988642 134889999999999999999999999999999999999
Q ss_pred eccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCC
Q 012336 136 MGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (465)
Q Consensus 136 l~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~ 214 (465)
+ ++++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 160 l---~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 V---AEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred E---cCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 9 47889999999999765432211 11223456778999999998889999999999999999998 999997
Q ss_pred CCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 215 GLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
+.... +.... .......+. ...++.++.+++..||+.+|++||++.+|.+.|++++.+
T Consensus 232 ~~~~~---~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAPE---RLFNL-LKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCHH---HHHHH-HhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 75432 22222 222221111 245689999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=337.05 Aligned_cols=259 Identities=20% Similarity=0.287 Sum_probs=210.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCC-----cEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTG-----EEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~-----~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
-....++.+.||+|.||+||.|...... ..||||.+.... ....|++|..+|..+.|+|++..++.+...+.
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 3567889999999999999999865432 348999877543 33479999999999999999999999988554
Q ss_pred EEEEEEecc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEe
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~D 149 (465)
.+|++||+ ||+|..++... ...++...++.++.|||+|++||+++++|||||.++|+|+ +....|||+|
T Consensus 770 -~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaD 845 (1025)
T KOG1095|consen 770 -PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL---DERRVVKIAD 845 (1025)
T ss_pred -cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee---cccCcEEEcc
Confidence 45555655 99999999977 5679999999999999999999999999999999999999 4779999999
Q ss_pred cCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHH
Q 012336 150 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (465)
||+|+...+... |+......-...|||||.+....++.|+|||||||+|||+++ |..||.+... .+....+
T Consensus 846 FGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~~~ 917 (1025)
T KOG1095|consen 846 FGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLLDV 917 (1025)
T ss_pred cchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHHHH
Confidence 999995443332 222223345679999999999999999999999999999999 9999998654 4444434
Q ss_pred hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+...+ +.+ ..+|+.+.++|..||+.+|++||++..|++.+..+...
T Consensus 918 ~~ggRL-~~P---~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 918 LEGGRL-DPP---SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HhCCcc-CCC---CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 444432 223 34599999999999999999999999999977776543
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=305.51 Aligned_cols=260 Identities=19% Similarity=0.276 Sum_probs=197.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCC--------------cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCcee
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTG--------------EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHL 68 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~--------------~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l 68 (465)
.++|++.+.||+|+||.||+|++..++ ..||||++..... ...+.+|++++..+.|++++..+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 468999999999999999999865432 3589998765422 23578899999999987766665
Q ss_pred EEEeEeCcEEEEEEecc-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceee
Q 012336 69 KWFGVEGEYNVMVIDLL-GPSLEDLFNYCN-----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 136 (465)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~-----------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl 136 (465)
..+ ......+++||++ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+|||+
T Consensus 84 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 84 GVC-VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEE-cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 555 4556788999988 889999986421 137889999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCC
Q 012336 137 GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLPWQ 214 (465)
Q Consensus 137 ~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt--G~~Pf~ 214 (465)
+.++.+||+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 163 ---~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 163 ---GNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred ---cCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 4788999999999976543211 111233456789999999998899999999999999999988 778887
Q ss_pred CCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 215 GLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
........+....................+|+.+.+++.+||+.+|++||++.+|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 654322222211111110000000112346899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=296.98 Aligned_cols=256 Identities=16% Similarity=0.270 Sum_probs=202.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.++|++.+.||+|+||.||+|.+..++. .||+|.+..... ...+..|+.++..++|++++... .+...+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE-GVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEE-EEEecCCccE
Confidence 5789999999999999999998765443 799998764322 23578899999999887665554 4455667889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|+++ +++|.+++......+++.++..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||++..+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCccccccc
Confidence 999998 789999998655679999999999999999999999999999999999999 5788999999999987644
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
..... .......++..|+|||.+.+..++.++|+||||+++||+++ |..||.+.... +.+..+.... ..+.
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~-~~~~ 230 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGY-RLPA 230 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCC-cCCC
Confidence 22111 11122234578999999998889999999999999999887 99999875432 2233333221 1121
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...+|+.+.+++.+||..+|.+||++.++.+.|.++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 ---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 135689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=300.81 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=198.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC--ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+..|+.++..++|++++..+..+ ......++++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-LRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE-EeCCEEEEEEe
Confidence 46899999999999999999999999999999998755322 3467899999999887776666554 55667889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++.. .+.+++.++..++.|++.+|.|||+.|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCcc--
Confidence 98 7899998874 5679999999999999999999999999999999999999 588899999999987654321
Q ss_pred ccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.......|+..|+|||++. ...++.++|||||||++|+|++|..||....... ............+...
T Consensus 161 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (267)
T cd06645 161 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMTKSNFQPPKLK 232 (267)
T ss_pred -----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhhhccCCCCCccc
Confidence 1223557899999999974 4558889999999999999999999997644321 1111111111111111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....++..+.+++..||..+|++||++.+|.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11246789999999999999999999877653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=309.60 Aligned_cols=257 Identities=19% Similarity=0.321 Sum_probs=218.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
-|.++.+||+|+||.||+|.++.+|+.+|||...++...+.+..|+.++.++..+..|.+++.|+...+ +++||||| .
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhhcCC
Confidence 367889999999999999999999999999999999888899999999999999888888888877665 56899999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
|+..|.+...+++|++.++..++...+.||+|||...-||||||+.|||+ ..+|..||+|||.+-.+.+...
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMA----- 184 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMA----- 184 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHH-----
Confidence 89999998888999999999999999999999999999999999999999 5899999999999988876543
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh--ccC
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC--KSY 244 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~--~~~ 244 (465)
...++.|||.|||||++....|+.++||||||++..||..|++||.+..+... +..+. ..|++.+. ..+
T Consensus 185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIP----T~PPPTF~KPE~W 255 (502)
T KOG0574|consen 185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIP----TKPPPTFKKPEEW 255 (502)
T ss_pred --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---eEecc----CCCCCCCCChHhh
Confidence 23578899999999999999999999999999999999999999987544222 11111 11222211 235
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFD 285 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~ 285 (465)
+.+|.+|++.||-+.|++|-| ..+++++.|++.....+
T Consensus 256 S~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNAPGCD 293 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCCCccc
Confidence 789999999999999999999 55667788877655443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=316.07 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=221.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..+..+..+||-|.||+||.|.|+.-.-.||||.++.+.. ...|+.|..+|+.++|+|.|..+++|..+..+++|...+
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 3466788999999999999999999999999999886643 467999999999999999999999998888776666666
Q ss_pred cCCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 LGPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~g~sL~~ll~~~~~~-ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
|.|+|.|++..|++. ++.-.++.+|.||..|++||..++||||||.++|+|++ .+..||++||||++.+..+....
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceec
Confidence 799999999998754 77778899999999999999999999999999999996 89999999999999987765422
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
--...-.+.|.|||.+.-..++.|+|||+|||+|||+.| |..||.+.+ ..+.|.. .++.+.+..+ .
T Consensus 423 ------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---lSqVY~L-LEkgyRM~~P---e 489 (1157)
T KOG4278|consen 423 ------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYGL-LEKGYRMDGP---E 489 (1157)
T ss_pred ------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---HHHHHHH-HhccccccCC---C
Confidence 223334688999999999999999999999999999999 999999954 3455543 3443333332 5
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
++|+.+.+||..||++.|.+||++.+|.+.|+.+|....+
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 7799999999999999999999999999999999854433
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=298.99 Aligned_cols=255 Identities=19% Similarity=0.320 Sum_probs=200.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC-----CcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~-----~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+..++|++.+.||+|+||.||+|.+... +..||+|++..... ...+..|+.++..+.|++++..+. +....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-~~~~~ 81 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLG-VVSTG 81 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEE-EEcCC
Confidence 5578999999999999999999987644 47999998764432 235778999999998876655444 44556
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~---------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
...+++|+++ +++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||||+|||+ +.++.+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~~ 158 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLTV 158 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCCE
Confidence 7788999998 889999986421 247888999999999999999999999999999999999 588999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~ 224 (465)
+|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++||+++ |..||.+... .+.
T Consensus 159 kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~ 230 (277)
T cd05032 159 KIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEV 230 (277)
T ss_pred EECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHH
Confidence 9999999976543221 112234457889999999988889999999999999999998 9999976433 333
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
...+...... . ....++.++.+++..||..+|++||++.+|.+.|+
T Consensus 231 ~~~~~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 231 LKFVIDGGHL-D---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHHhcCCCC-C---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 3333322211 1 11345899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=302.61 Aligned_cols=259 Identities=17% Similarity=0.308 Sum_probs=201.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-------CCCcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-------QTGEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFG 72 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-------~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~ 72 (465)
+-.++|.+.+.||+|+||.||+|++. ..+..||+|++..... ...+..|+.++..+ .|++++..+. +.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~-~~ 90 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG-AC 90 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE-EE
Confidence 45678999999999999999999753 2345799998764322 24578899999999 5555555444 44
Q ss_pred EeCcEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceee
Q 012336 73 VEGEYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 136 (465)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl 136 (465)
......+++|+++ +++|.+++.... ..+++.++..++.||+.||.|||++|++||||||+|||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 5566778999988 789999987531 347889999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCC
Q 012336 137 GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 215 (465)
Q Consensus 137 ~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~ 215 (465)
+.++.++|+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 171 ---~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 171 ---TENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred ---cCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 47899999999999876432211 11223346678999999998889999999999999999998 8899976
Q ss_pred CCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.. ..+....+....... ....++.++.+++.+||..+|.+||++.+|.+.|+.++.
T Consensus 243 ~~---~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 243 IP---VEELFKLLKEGHRMD----KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CC---HHHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 43 233333333222211 113568999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=296.31 Aligned_cols=245 Identities=20% Similarity=0.274 Sum_probs=199.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
-++|++.+.||+|+||.||++. .+++.||+|++........+..|+.++..++|+++++.+..+..+ ..+++|+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEECC
Confidence 3689999999999999999986 478899999987665556788999999999998888877766443 357889988
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 86 -GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 86 -g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+++|.+++.... ..+++.++..++.|++.+|.|||+.|++||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV---SEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCcEEECCCccceeccccC---
Confidence 789999997543 458999999999999999999999999999999999999 578899999999997643211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.....+..|+|||++.+..++.++|+||||+++|+|++ |..||...... +....+... .... ...
T Consensus 155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-~~~~---~~~ 220 (254)
T cd05083 155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVEKG-YRME---PPE 220 (254)
T ss_pred -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhCC-CCCC---CCC
Confidence 12234578999999998899999999999999999997 99999875432 222222222 1111 124
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
.+|+++.+++.+||..+|++||++.+|.+.|+
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 67899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=295.32 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=196.4
Q ss_pred eeEeeeCceEEEEEEEcC---CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQ---TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~---~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||.||+|.+.. ....||||.+..... ...+..|+.+++.+.|++++..+..+...+...+++++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998654 345799998754322 2367789999999999888888876666666778899887
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+++......+++..+..++.|++.||.|||+.+++||||||+|||+ +.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCccccccccCCcce---
Confidence 899999998655667888899999999999999999999999999999999 57889999999999765432110
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
.........++..|+|||.+.+..++.++|||||||++|||++ |.+||...+. ......+.... ..+. ...+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~---~~~~ 227 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGR-RLLQ---PEYC 227 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCC-CCCC---CCcC
Confidence 0111223456788999999998899999999999999999999 5667765432 22222222211 1111 1345
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
|+.+.+++..||..+|++||++.+|.+.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 8899999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=309.42 Aligned_cols=258 Identities=19% Similarity=0.209 Sum_probs=198.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEe----CcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVE----GEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~----~~~ 77 (465)
++++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++|++++..+..+... ...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 6789999999999999999999999999999999876322 223577899999999988877776654332 235
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.++++++++++|.+++. .+.+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence 78999999999988886 5679999999999999999999999999999999999999 588999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH---------
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK--------- 227 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~--------- 227 (465)
...... .......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..........
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred cccccc----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 322111 12234578999999998765 4689999999999999999999999976432111110000
Q ss_pred ---Hhh-----------hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 228 ---ISE-----------KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 228 ---i~~-----------~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.. .....+.......+++++.+++.+||..+|++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00001112223456788999999999999999999766543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=297.84 Aligned_cols=250 Identities=19% Similarity=0.328 Sum_probs=196.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHc-CCCCCceeEEEeEe-----CcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQ-GGTGVPHLKWFGVE-----GEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~-~~~~i~~l~~~~~~-----~~~ 77 (465)
..+.|.+.+.||.|+||+||+|.+..+++.||+|++..... ...+..|+.++..+. |++++..+..|... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 46789999999999999999999999999999999875432 345788999999985 55555555555432 246
Q ss_pred EEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.+++||++ +++|.+++... ...+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence 78999998 77999998753 3568999999999999999999999999999999999999 5888999999999976
Q ss_pred cccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
..... .......|++.|+|||++. +..++.++|||||||++|||++|..||...... ........
T Consensus 161 ~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~ 230 (272)
T cd06637 161 LDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 230 (272)
T ss_pred ccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc
Confidence 53321 1223567899999999986 335788999999999999999999999764322 11111111
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.... ......++.++.+|+.+||..+|.+||++.++.
T Consensus 231 ~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 267 (272)
T cd06637 231 NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM 267 (272)
T ss_pred CCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1111 111235688999999999999999999977664
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.72 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=199.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|.+.+.||+|+||.||+|++. .++..||||++...... ..+..|+.++..+.+|++|..+..++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 467889999999999999999864 34578999998754322 2577899999999833444444445555667
Q ss_pred EEEEEecc-CCCHHHHHHHcC-----------------------------------------------------------
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN----------------------------------------------------------- 97 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~----------------------------------------------------------- 97 (465)
.++|+||+ +++|.+++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 89999998 899999986421
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC
Q 012336 98 --------------------------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139 (465)
Q Consensus 98 --------------------------------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~ 139 (465)
..+++..++.|+.||+.||+|||+.+++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl--- 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI--- 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE---
Confidence 136778889999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCC
Q 012336 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (465)
Q Consensus 140 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~ 218 (465)
+.++.++|+|||+++.+...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 47889999999999865332110 11233457889999999999889999999999999999998 8999976432
Q ss_pred CchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 219 GTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.. .....+.. ...... ...++.++.+++..||..+|++||++.+|.+.|+.++
T Consensus 348 ~~--~~~~~~~~-~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE--QFYNAIKR-GYRMAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH--HHHHHHHc-CCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 21 11222221 111111 1346899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=306.39 Aligned_cols=201 Identities=21% Similarity=0.279 Sum_probs=164.9
Q ss_pred EeeEeeeCceEEEEEEEcC--CCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEEEEEEeccCCC
Q 012336 12 GRKIGSGSFGELYLGVNVQ--TGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNVMVIDLLGPS 88 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~--~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv~e~~g~s 88 (465)
..+||+|+||+||+|++.. ++..||+|.+........+.+|+.++..++|++++..+..+.. .+...++++++++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 4689999999999999654 5689999988766555678899999999999888887777654 456788999999999
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-CCCCcEEEEecCCccccccc
Q 012336 89 LEDLFNYC--------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 89 L~~ll~~~--------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~-d~~~~vkL~DFGla~~~~~~ 159 (465)
|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+... +.++.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 99887532 1248899999999999999999999999999999999999432 35679999999999876432
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCC
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~ 216 (465)
.. +........||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cc----cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 21 11123356789999999998774 5799999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=298.53 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=194.6
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++++.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.|++++..+..+ .++...++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-MQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-eeCCeEEEEEe
Confidence 58999999999999999999988999999998764322 24578899999999987766665554 45678899999
Q ss_pred ccCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LLGPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++.++|.+++.... ..+++..+..++.||+.||.|||++|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCc-
Confidence 99889998886533 569999999999999999999999999999999999999 588999999999997543221
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh-----------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS----------- 229 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~----------- 229 (465)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+..............
T Consensus 156 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 156 ------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred ------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 112234578999999988754 47889999999999999999999998643211111100000
Q ss_pred ----h------hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 ----E------KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ----~------~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .............+++++.++|.+||..||++||++.+|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000001112357899999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=299.47 Aligned_cols=251 Identities=20% Similarity=0.227 Sum_probs=195.6
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++.+.||.|+||.||+|++..+|+.||+|.+..... ...+..|+++++.++|++++..+..+ .+....+++++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-HSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-ccCCceEEEEe
Confidence 69999999999999999999999999999998865422 23577899999999887766655544 55668899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+++++|.+++......+++..+..++.||+.||.|||++|++|+||||+|||+ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence 99889999887656779999999999999999999999999999999999999 5889999999999976543211
Q ss_pred cccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc--------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML-------- 234 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (465)
......+++.|+|||.+.+.. ++.++|||||||++|+|++|..||..... ....+..+......
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 112345789999999987754 78999999999999999999988644222 11222211110000
Q ss_pred ----------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 ----------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 ----------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.........+++++.+++.+||..||.+|||+.++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0001122356789999999999999999999777643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=297.37 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=202.4
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
.++|++.+.||+|+||.||+|++..++..|++|.+........+..|+++++.+.|++++..+..+. .....+++++++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYF-KNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-cCCcEEEEEecC
Confidence 3689999999999999999999988899999999876655667899999999998877776665554 456788899888
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++......+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~--- 154 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMA--- 154 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---CCCCcEEEcccccchhcccCcc---
Confidence 789999997666789999999999999999999999999999999999999 5788999999999987643221
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ...+.... .........+
T Consensus 155 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~---~~~~~~~~--~~~~~~~~~~ 225 (256)
T cd06612 155 ----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA---IFMIPNKP--PPTLSDPEKW 225 (256)
T ss_pred ----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---hhhhccCC--CCCCCchhhc
Confidence 12345688999999999999999999999999999999999999986433221 11111110 1101112346
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.++.+++..||+.+|++||++.++.+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 789999999999999999999777653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.93 Aligned_cols=262 Identities=17% Similarity=0.296 Sum_probs=202.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC-------CcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT-------GEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFG 72 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~-------~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~ 72 (465)
+...+|++++.||+|+||.||+|.+... ...||+|++..... ...+..|++++.++ .|++++. +..++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~-~~~~~ 87 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN-LLGAC 87 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeee-eeEEE
Confidence 4566899999999999999999986432 23799998775432 23578899999999 4555554 44444
Q ss_pred EeCcEEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceee
Q 012336 73 VEGEYNVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 136 (465)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl 136 (465)
......+++++++ +++|.+++... ...+++.+++.++.||+.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 5556778888888 88999998642 1347889999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCC
Q 012336 137 GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 215 (465)
Q Consensus 137 ~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~ 215 (465)
+.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.+
T Consensus 168 ---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 168 ---TEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred ---cCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 47899999999999765432111 11222344578999999999999999999999999999998 8999987
Q ss_pred CCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
... ...+..+...... . ....++.++.+++..||..+|++||++.+|.+.|+.++....
T Consensus 240 ~~~---~~~~~~~~~~~~~-~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 240 IPV---EELFKLLKEGHRM-D---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CCH---HHHHHHHHcCCCC-C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 432 2333333222111 1 123568899999999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=295.85 Aligned_cols=250 Identities=18% Similarity=0.283 Sum_probs=198.2
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
.++|++++.||+|+||.||+|.+. .+..||||.+.... ....+..|+.++..+.|++++..+. ++......+++|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG-VCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEE-EEccCCCcEEEEEc
Confidence 467999999999999999999864 45579999876432 2346889999999998866655544 44556678999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++......+++.+++.++.||+.||.|||+.|++|+||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCce--
Confidence 8 789999987655579999999999999999999999999999999999999 5788999999999876533211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+........ ..
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~----~~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRLYR----PH 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCCCC----CC
Confidence 11223346778999999998889999999999999999998 9999976543 223333333222111 13
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
..++++.+++..||..+|++||++.+|...|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4588999999999999999999998887765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=301.90 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=198.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
..+|++.+.||+|+||.||+|++..+++.||+|.+..... ...+..|+.+++.+.|++++..+..+ ..+...++|++
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~-~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE-EeCCEEEEeec
Confidence 4789999999999999999999999999999998875432 34677899999999887766666554 45668899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++. ...+++.++..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 98 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred ccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhcccccc-
Confidence 88 889999986 4568999999999999999999999999999999999999 5788999999999876543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...+. +..... +......
T Consensus 172 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~-~~~~~~--~~~~~~~ 240 (296)
T cd06654 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL-IATNGT--PELQNPE 240 (296)
T ss_pred ------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH-HhcCCC--CCCCCcc
Confidence 123456899999999999888999999999999999999999999764321 11111 111111 1111124
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.++..+.+++.+||..+|++||++.+|.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 57889999999999999999999777654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=298.26 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=199.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+-.++|++.+.||+|+||.||+|.+.. ++..||+|....... ...+..|+.++..+.|++++..+..+ .+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS-FER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ccC
Confidence 456789999999999999999999876 778999998764332 23578899999999887666655544 445
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
...+++|+++ +++|.+++.... ..+++..++.++.||+.+|+|||+++++|+||||+|||+........++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 5668899988 899999987542 258999999999999999999999999999999999999532224579999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (465)
|||+++....... .........+..|+|||++.+..++.++|||||||++|||++ |..||.+.... .....
T Consensus 162 dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASY-----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEF 233 (277)
T ss_pred cCccccccCCccc-----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 9999986532211 011223334578999999998899999999999999999997 99999874432 22222
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+...... .....+|.++.+++.+||..+|++||++.+|.+.|.
T Consensus 234 ~~~~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGGGRL----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2221111 112457899999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=299.93 Aligned_cols=244 Identities=20% Similarity=0.317 Sum_probs=192.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++++.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.|++++..+..+. .....+++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-VENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-ECCEEEEEEe
Confidence 478999999999999999999999999999998865422 235778999999998877777666654 4567789999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc---
Confidence 98 6666533 357899999999999999999999999999999999999 58899999999999765432
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch----HHHHHHHhhhhccCcHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYDKISEKKMLTPIE 238 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~~~~~~ 238 (465)
......||..|+|||++.+..++.++|+||||+++|+|++|+.||........ .+....+.... +..
T Consensus 149 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~ 219 (279)
T cd06619 149 ------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---PPV 219 (279)
T ss_pred ------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---CCC
Confidence 12345789999999999999999999999999999999999999976432211 11111111111 111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....+++++.+++.+||..+|++||+++++.+
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112346889999999999999999999776643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.98 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=202.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+ .++...+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-SDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-eeCCEEEEE
Confidence 689999999999999999999999999999998865322 23578899999999987777666544 556688999
Q ss_pred Eecc-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEec
Q 012336 82 IDLL-GPSLEDLFNYC----------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~----------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
|+++ |++|.+++... ...++...++.++.||+.||+|||++||+||||||+|||+ +.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9998 89999988642 1245677889999999999999999999999999999999 58899999999
Q ss_pred CCccccccccCc-----------ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC
Q 012336 151 GLAKKYRDLQTH-----------KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (465)
Q Consensus 151 Gla~~~~~~~~~-----------~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~ 219 (465)
|+++........ ............||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999866211100 000111223467999999999999999999999999999999999999999764321
Q ss_pred chHHHHHHHhhhhccCcHHH-HhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 012336 220 TKKQKYDKISEKKMLTPIEV-LCKSYPSEFTSYFHYCRSLRFEDKP-DYSYLKRLFRDLFI 278 (465)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~-~~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~~~~ 278 (465)
... . ......+... ....+|+.+.+++.+||..||++|| +++++.+.|+....
T Consensus 238 ki~--~----~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KIS--Y----RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh--h----hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1 1111111111 1246789999999999999999997 56677777776553
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=302.22 Aligned_cols=270 Identities=20% Similarity=0.274 Sum_probs=209.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||++.+..+++.||||.+..... ...+..|+.+++.+.|++++..+ .....+.+.+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~-~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF-CSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeE-EEEecCCEEEEE
Confidence 479999999999999999999999999999998775431 23567899999999887666555 445566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ |++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9998 8899999975 4579999999999999999999999999999999999999 588999999999987422111
Q ss_pred Cccc--------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 161 THKH--------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 161 ~~~~--------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
.... ..........|+..|+|||.+.+..++.++|+||||+++|||++|..||.+.. ..+.+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Confidence 1000 00011223568889999999998889999999999999999999999998643 233333333322
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
...+.. ...+|.++.++|.+||..+|++||+...+.++|++ +++...||...
T Consensus 233 ~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~-------~~~~~~~~~~~ 284 (305)
T cd05609 233 IEWPEG--DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH-------RFFLGLDWNGL 284 (305)
T ss_pred cCCCCc--cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC-------ccccCCCHHHH
Confidence 222211 12578999999999999999999998777777664 45555677753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.88 Aligned_cols=253 Identities=19% Similarity=0.240 Sum_probs=199.4
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC-----CcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT-----GEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
..+|++.+.||.|+||.||+|.+..+ +..||||++...... ..+..|..++..++|++++..+..+. ....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-KEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCCc
Confidence 35688999999999999999987543 578999998755432 34778899999999887777666554 4445
Q ss_pred EEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 78 NVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
.+++++++ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+ ++
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV---FD 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe---cC
Confidence 77888887 88999888521 2348889999999999999999999999999999999999 47
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
++.+||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 232 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 232 (283)
T ss_pred CCceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 88999999999876543211 111234456789999999998889999999999999999998 8899987433
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
.+.+..+....... ....+|.++.+++..||+.+|++||++.+|...|+
T Consensus 233 -~~~~~~i~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 -QDVIEMIRNRQVLP----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred -HHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 33444433333221 22467999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=302.54 Aligned_cols=258 Identities=19% Similarity=0.286 Sum_probs=196.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcC----------------CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQ----------------TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGV 65 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~----------------~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i 65 (465)
-.++|++.+.||+|+||.||+|.+.. +...||+|++..... ...+..|+.++..++|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 35789999999999999999986432 345799998875432 23578899999999886666
Q ss_pred ceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 012336 66 PHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCN----------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 134 (465)
Q Consensus 66 ~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~----------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NI 134 (465)
..+. +.......+++|+++ +++|.+++.... ..+++.++..++.|++.||+|||+.|++|+||||+||
T Consensus 83 ~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 83 RLLA-VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred eEEE-EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 5554 455666788999988 889999987532 2477889999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCC
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLP 212 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt--G~~P 212 (465)
|+ +.++.++|+|||+++.+..... ........+++.|++||...+..++.++|||||||++|||++ |..|
T Consensus 162 li---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 162 LV---GKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred EE---cCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 99 4788999999999986533211 011223345688999999888889999999999999999998 7899
Q ss_pred CCCCCCCchHHHHHHHhhh---hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 213 WQGLKAGTKKQKYDKISEK---KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
|.................. ....+. ...+|+.+.+++..||..||.+||++.+|.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 234 YSQLSDEQVIENTGEFFRDQGRQVYLPK---PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccccChHHHHHHHHHHHhhccccccCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9765432222111111000 011111 1345789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=299.30 Aligned_cols=252 Identities=20% Similarity=0.243 Sum_probs=193.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCc-----E
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE-----Y 77 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~-----~ 77 (465)
++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+.+++++..+..+..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 579999999999999999999999999999998765432 2457889999999987655555555444333 3
Q ss_pred EEEEEeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 78 NVMVIDLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
.+++|+++.++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+. +.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 7899999988999888643 24589999999999999999999999999999999999994 23889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
..+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+..... .+..+....
T Consensus 159 ~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~ 228 (295)
T cd07837 159 RAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ---QLLHIFKLL 228 (295)
T ss_pred eecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHh
Confidence 7653321 11223357889999998865 457899999999999999999999998743322 221111100
Q ss_pred -----------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 -----------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 -----------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...........+++++.+||..||..||.+||++.++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00011112245789999999999999999999976654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=292.14 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=200.6
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|.+.+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+++++.++|++++..+..+ .+....+++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-LDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-ccCCEEEEEEE
Confidence 5899999999999999999999999999999876432 234578899999999887777766554 45567889999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccc
Confidence 87 89999998764 4679999999999999999999999999999999999999 4789999999999986643211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||.... .......+....... ..
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08529 157 -------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFPP----VS 222 (256)
T ss_pred -------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1234568899999999999999999999999999999999999997654 223333333222221 11
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+++.+||+.+|++||++.+|.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 356899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.38 Aligned_cols=258 Identities=15% Similarity=0.249 Sum_probs=201.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.+.|++.+.||+|+||.||+|.+..++. .||||++..... ...+..|+.+++.+.|++++..+.. ...+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~-~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEE-ECCCCceE
Confidence 4679999999999999999999876654 699998875422 2368889999999988776665544 45666788
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++||++ +++|.+++....+.+++.++..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999988 789999998666679999999999999999999999999999999999999 5888999999999876543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
..... .+........+..|+|||.+.+..++.++|||||||++||+++ |..||...... .....+... ...+.
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~-~~~~~ 232 (269)
T cd05065 159 DTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD-YRLPP 232 (269)
T ss_pred Ccccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC-CcCCC
Confidence 22110 0111111122457999999999899999999999999999886 99999775432 222222221 11121
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
. ..+|..+.+++..||..+|.+||++.+|...|+.+
T Consensus 233 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 P---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 35689999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.48 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=195.8
Q ss_pred eeEeeeCceEEEEEEEcCCC---cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQTG---EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~---~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
++||+|+||.||+|++...+ ..||+|++..... ...+..|+++++.+.|++++..+..+. ....+++|+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence 47999999999999876655 7999998875543 346788999999998877777665443 44568888887
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+++.. ...+++..+..++.|++.+|.|||..+++|+||||+|||+ +.++.++|+|||+++........
T Consensus 79 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence 7899999975 3479999999999999999999999999999999999999 58899999999999866432211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
+.......++..|+|||.+.+..++.++||||||+++|++++ |..||..... .+....+...... + ....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~-~---~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGERL-P---RPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCcC-C---CCCCC
Confidence 111222334578999999998899999999999999999998 9999977543 2333333222211 1 12456
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+.++.+++.+||..+|++||++.+|.+.|+..
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=320.42 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=208.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCc---E-EEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGE---E-VAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~-vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.++-.+.++||+|+||+||+|+....+. . ||||....+. ....+.+|.++|+.++|+|+|..++ +.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG-Va~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG-VAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE-EEcCCC
Confidence 4556677999999999999998765422 3 8999877522 2336899999999999877665555 455666
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.+++|||+| ||+|.+++......++..+...++.+.+.||+|||++++|||||-++|+|++ .++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccC
Confidence 789999999 9999999997555799999999999999999999999999999999999994 677889999999876
Q ss_pred cccccCcccccccCCC-CccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 156 YRDLQTHKHIPYRENK-NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~-~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
... |.... ...-...|+|||.+....|+.++|||||||++||+++ |..||.++.. .+...++....+
T Consensus 312 ~~~--------~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI~~~~~ 380 (474)
T KOG0194|consen 312 GSQ--------YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKIVKNGY 380 (474)
T ss_pred Ccc--------eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHHHhcCc
Confidence 431 11112 2235689999999999999999999999999999999 8999999665 344444433333
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
..+.+ ...|.++..++..||..+|++||++.++.+.|+.+.....
T Consensus 381 r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 RMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 33332 2558999999999999999999999999999998875543
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=296.63 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=203.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++.+.||.|+||.||+|.+..++..||||.+.... ....+..|+.+++.+.|++++..+..+ ..+...+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-IEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-EeCCeEEEE
Confidence 57899999999999999999998999999999776422 123577899999999887777666555 455677888
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 82 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++++ +++|.+++... ...+++.++..++.||+.+|.|||++|++|+||||+||++ +.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 8888 78999988642 3568999999999999999999999999999999999999 578899999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .......+........
T Consensus 158 ~~~~-------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~- 228 (267)
T cd08229 158 SKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPL- 228 (267)
T ss_pred cCCc-------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhcCCCCCC-
Confidence 3211 112456899999999999888999999999999999999999999764321 1222222222111111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
....+++++.+++.+||..+|++|||+.+|.+.++.+
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1134688999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=299.31 Aligned_cols=249 Identities=19% Similarity=0.330 Sum_probs=192.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++++.||+|+||.||+|++..+++.||||.+..... ...+..|..++.+..+++++..+..+...+...+++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998875432 23466677765555555555555555566677899999
Q ss_pred ccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 84 LLGPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 84 ~~g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++.++|.+++... ...+++.++..++.||+.||+|||++ +++||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999998888642 34699999999999999999999997 99999999999999 58899999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLG----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ..+.+..........
T Consensus 158 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 227 (283)
T cd06617 158 V--------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSPQ 227 (283)
T ss_pred c--------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCCC
Confidence 1 1123468899999998865 4468899999999999999999999975322 122222222211111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....+|.++.++|..||..+|++||++.+|.+
T Consensus 228 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 ---LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111347899999999999999999999766643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=301.47 Aligned_cols=259 Identities=22% Similarity=0.263 Sum_probs=200.7
Q ss_pred CceEEEeeEeeeCceEEEEEEE----cCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVN----VQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYN 78 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~----~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~ 78 (465)
.-|++++.||+|+||.||+|.. ..++..||+|.+..... ...+.+|+.+++.+.|++++.....+... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3579999999999999999974 45688999998764322 23578899999999998877776666554 4678
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++||++ +++|.+++......+++.++..++.||+.+|+|||++|++||||||+|||+ +.++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE---cCCCCEEECCCccccccc
Confidence 8999998 999999987645578999999999999999999999999999999999999 478899999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC-----------C-chHHHH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------G-TKKQKY 225 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~-----------~-~~~~~~ 225 (465)
..... ........++..|+|||++.+..++.++||||||+++|||+++..|+..... . ......
T Consensus 161 ~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 32211 1122345678889999999988899999999999999999998776532110 0 000111
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..+... ...+ ....++.++.+|+.+||+.+|++||++.++.+.|+.+
T Consensus 237 ~~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEG-KRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcC-ccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111 1111 1135789999999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=295.81 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=195.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.++|++++..+..+ ......+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-RRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-eeCCEEEEEE
Confidence 57999999999999999999999899999999876432 223467899999999987766665544 5567788999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+++.+.+.+.+......+++.++..++.||+.+|.|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCcc-
Confidence 999554444443335679999999999999999999999999999999999999 5788999999999987643221
Q ss_pred ccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh----------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---------- 231 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (465)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+................
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 156 ------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred ------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 1123467889999999876 45788999999999999999999999875432222111111000
Q ss_pred -------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 -------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 -------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....+.+.....++..+.+|+.+||..+|++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 000111223356789999999999999999999987664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.59 Aligned_cols=254 Identities=21% Similarity=0.340 Sum_probs=202.6
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+..++|++.+.||+|+||.||+|.+ ..+..||+|.+..... ...+..|+.+++.++|++++.....+.. ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEE
Confidence 36789999999999999999999985 4567799998765432 3468889999999998877777655544 567889
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|+++ +++|.+++... ...+++.++..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---cCCCcEEECCCcceeeccCC
Confidence 9988 78999998753 3468899999999999999999999999999999999999 58899999999999765432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. .......++..|+|||++....++.++|+|||||++|++++ |..||.+....... ..+.... ..+
T Consensus 156 ~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~-~~~-- 223 (260)
T cd05073 156 EY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALERGY-RMP-- 223 (260)
T ss_pred Cc------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHhCCC-CCC--
Confidence 11 11223346678999999998889999999999999999998 99999875432222 2222221 111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....+|.++.+++.+||..+|++||++.++.+.|++
T Consensus 224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 124678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.77 Aligned_cols=262 Identities=18% Similarity=0.306 Sum_probs=202.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
+-.++|.+.+.||+|+||.||+|.+.. ....||+|++...... ..+..|+.++..+.+|++|..+..++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 346789999999999999999998632 3457999987744322 357789999999964445555554555
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeec
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 137 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~ 137 (465)
.....+++|+++ +++|.+++.... ..+++.++..++.||+.||.|||++|++||||||+|||+
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV- 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE-
Confidence 666788999988 889999986521 358999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCC
Q 012336 138 LGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 216 (465)
Q Consensus 138 ~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~ 216 (465)
+.++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.
T Consensus 168 --~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 168 --TEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred --cCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 47889999999999865432111 11112234568999999998889999999999999999999 89999774
Q ss_pred CCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 217 KAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.. ...+..+...... . ....++.++.+++.+||..+|++||++.++.+.|..+....
T Consensus 241 ~~---~~~~~~~~~~~~~-~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 241 PV---EELFKLLREGHRM-D---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CH---HHHHHHHHcCCCC-C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 43 2333333322211 1 12356889999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.96 Aligned_cols=252 Identities=19% Similarity=0.206 Sum_probs=199.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~l 80 (465)
.++|++.+.||.|+||.||+|.+..+++.||+|++...... .....|+.+++.++|++++..+..+... ....++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46899999999999999999999999999999988754322 2456899999999998888777666543 356899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||+++.++|.+++......+++.++..++.||+.+|.|||+.|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCcc
Confidence 99999989999998766789999999999999999999999999999999999999 588999999999998764321
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc-----
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML----- 234 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~----- 234 (465)
. ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.+... .+.+..+......
T Consensus 163 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~ 232 (309)
T cd07845 163 K-------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESI 232 (309)
T ss_pred C-------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhh
Confidence 1 1122345788999999876 4578999999999999999999999987543 2222222221000
Q ss_pred --------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 --------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 --------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.........+++++.++|.+||..||++||++.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 000011123578899999999999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=294.96 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=204.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+-..+|.+.+.||.|+||.||+|.+... ...||||....... ...+..|+.+++.+.|++++..+..+.. ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CC
Confidence 3467899999999999999999987544 35799998765432 2368889999999999887777765543 34
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++ +++|.+++......+++..+..++.|++.||+|||+.|++|+||||+|||+ +.++.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV---SSPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE---ecCCCeEEccCceeeec
Confidence 56888887 889999998655579999999999999999999999999999999999999 47889999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
...... ......++..|+|||.+....++.++||||||+++||+++ |..||...... +....+.......
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~~ 228 (270)
T cd05056 158 EDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERLP 228 (270)
T ss_pred ccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcCC
Confidence 432211 1122335578999999988889999999999999999986 99999875432 2333333222111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
....+|.++.+++.+||..+|++||++.++.+.|.++..+
T Consensus 229 ----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 229 ----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1246689999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=300.42 Aligned_cols=271 Identities=20% Similarity=0.266 Sum_probs=206.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|++++..+.|++++..+ .+...+...+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY-ASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhhe-eeeecCCEEEEE
Confidence 479999999999999999999988999999998875432 23578899999999977665555 444566788999
Q ss_pred Eecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|+++ +++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||||+|||+ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE---cCCCCEEEeecchhhccccc
Confidence 9987 88999998753 3579999999999999999999999999999999999999 57899999999998765332
Q ss_pred cCcccc----------------------cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCC
Q 012336 160 QTHKHI----------------------PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (465)
Q Consensus 160 ~~~~~~----------------------~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~ 217 (465)
...... .-.....+.||..|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110000 0001224578999999999999889999999999999999999999998754
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH-HHHHHHHHHHcCCCCCccccccccC
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL-KRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l-~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
. ...+..+.......+. ...+++++.+++.+||..+|++||+.... .++|. ++++..++|....
T Consensus 237 ~---~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~-------~~~~~~~~~~~~~ 301 (316)
T cd05574 237 R---DETFSNILKKEVTFPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ-------HPFFRGVNWALIR 301 (316)
T ss_pred h---HHHHHHHhcCCccCCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc-------CchhhcCChhhcc
Confidence 3 2333333322222221 12368999999999999999999993222 22222 3455556666543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=299.79 Aligned_cols=250 Identities=18% Similarity=0.347 Sum_probs=196.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeE------eCcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGV------EGEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~------~~~~ 77 (465)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.+|+++..+..++. ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 4578999999999999999999999999999999886543 33467888999999965555555544432 3467
Q ss_pred EEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.+++||++ +++|.+++... ...+++..+..++.||+.+|.|||+.||+|+||+|+||++ +.++.++|+|||++..
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhh
Confidence 89999999 67999998753 3458999999999999999999999999999999999999 5788999999999876
Q ss_pred cccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
..... .......|++.|+|||.+. +..++.++|||||||++|||++|..||..... ...+..+..
T Consensus 171 ~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~ 240 (282)
T cd06636 171 LDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPR 240 (282)
T ss_pred hhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhh
Confidence 53211 1123457899999999986 34578899999999999999999999976432 222222222
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.. ........++.++.++|.+||..||.+||++.+|.
T Consensus 241 ~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 241 NP---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred CC---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 11 11122346789999999999999999999987764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=298.58 Aligned_cols=261 Identities=22% Similarity=0.242 Sum_probs=199.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEE----cCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVN----VQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~----~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~ 78 (465)
..+|++++.||+|+||.||+|.. ..++..||||.+..... ...+..|++++..++|++++..+..+.. .....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46899999999999999999973 45788999998765432 2357889999999998887776665543 34567
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++++++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccccc
Confidence 8999988 899999997655679999999999999999999999999999999999999 578899999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH------------HHH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK------------QKY 225 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~------------~~~ 225 (465)
..... +.......++..|+|||++.+..++.++||||||+++|||++|..|+......... ...
T Consensus 160 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEY----YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcc----eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 32211 01111223455699999999888999999999999999999988776543211000 000
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..........+ ....++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 236 ~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00011111111 1135688999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=293.10 Aligned_cols=246 Identities=18% Similarity=0.294 Sum_probs=193.2
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
+.||+|+||.||+|++..+++.||+|....... ...+..|+++++.+.|++++..+..+ ......++|||++ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE-cCCCCeEEEEeeccCCc
Confidence 468999999999999988999999998754322 24588899999999887776666554 4556788999987 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
|.+++......+++.++..++.|++.+|.|||++|++|+||||+|||+ +.++.++|+|||++......... .
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~ 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYA-----S 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCccccccccc-----c
Confidence 999987545578999999999999999999999999999999999999 57889999999998754321110 0
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+. .....+ ....+|.+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~---~~~~~~~-~~~~~~---~~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ---QTREAIE-QGVRLP---CPELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH---HHHHHHH-cCCCCC---CcccCCHH
Confidence 0111223567999999998889999999999999999997 99999764332 2222221 111111 12356899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 248 FTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+.+++.+||..+|++||++.+|.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.51 Aligned_cols=259 Identities=20% Similarity=0.275 Sum_probs=203.0
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+-.++|+..+.||+|+||.||+|.+..++. .||+|++...... ..+..|+.++..+.|++++..+..+.. .
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~ 81 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-P 81 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-C
Confidence 4557889999999999999999999877776 4788877644322 256789999999998888887776643 2
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
..+++++++ +++|.+++......+++..+..++.|++.||.|||++||+|+||||+|||+ +.++.+||+|||+++
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill---~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV---KSPNHVKITDFGLAR 157 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee---cCCCceEEccccccc
Confidence 345677776 789999988655679999999999999999999999999999999999999 478899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.... + ...+.....
T Consensus 158 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~-~~~~~~~~~ 228 (303)
T cd05110 158 LLEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---E-IPDLLEKGE 228 (303)
T ss_pred cccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---H-HHHHHHCCC
Confidence 65432211 11123345778999999999899999999999999999997 99999774322 2 222222222
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+.. ..++..+.+++..||..+|++||++.+|.+.|..+..
T Consensus 229 ~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 229 RLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 22211 3457899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=294.69 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=189.4
Q ss_pred eEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
.||+|+||.||++.+..+++.||||++...... .....|..++..+. +++++..+..+....+..+++||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999987654221 12344444444443 3455666666666667888999988
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+++.. ...+++..+..++.|++.||.|||+.+|+|+||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~----- 151 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKK----- 151 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccC-----
Confidence 8899988874 4679999999999999999999999999999999999999 588999999999987553211
Q ss_pred cccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 166 PYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~-~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||......... ....... ... ..+...+
T Consensus 152 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---~~~-~~~~~~~ 222 (279)
T cd05633 152 ----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---TVN-VELPDSF 222 (279)
T ss_pred ----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---cCC-cCCcccc
Confidence 12346899999999986 456899999999999999999999999765433322 2221111 111 1123467
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 245 PSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
++++.+++..||..||.+|| ++.++. + ++|+..++|...
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~---~-------h~~~~~~~~~~~ 266 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVK---E-------HVFFKGIDWQQV 266 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH---h-------CccccCCCHhHH
Confidence 89999999999999999999 555543 3 455555666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=291.33 Aligned_cols=245 Identities=27% Similarity=0.388 Sum_probs=199.6
Q ss_pred eeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||.||+|.+... +..|++|++..... ...+..|+.++..+.|++++..+.++. .....+++|+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-EEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-CCCceEEEEEecc
Confidence 4789999999999998765 89999999876544 356888999999999766666555544 477889999998
Q ss_pred CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 86 GPSLEDLFNYC--------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 86 g~sL~~ll~~~--------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|.+++... ...+++..+..++.|++.||+|||++|++|+||||+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 99999999865 3679999999999999999999999999999999999999 578999999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.... +.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+...... .
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~-~ 227 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGYRL-P 227 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC-C
Confidence 4321 122345567899999999998889999999999999999999 6999987633 3333333322111 1
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
....+|+++.+++..||..+|.+||++.++.+.|
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 228 ---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred ---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1235589999999999999999999999988766
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=298.71 Aligned_cols=248 Identities=17% Similarity=0.272 Sum_probs=195.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++++.||+|+||.||+|.+..++..||+|.+..... ...+..|+.++..+.|++++..+..+ ......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF-FIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-ecCCeEEEEEe
Confidence 479999999999999999999988999999998765422 24678899999999887777666654 44667889999
Q ss_pred cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 84 LL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 84 ~~-g~sL~~ll~~~--~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++ +++|..++... ...+++..+..++.||+.+|.|||+ .+|+|+||||+|||+ +.++.++|+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC
Confidence 98 88998888743 2379999999999999999999997 599999999999999 47899999999999765332
Q ss_pred cCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
. .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 L---------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred c---------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 1 2334688899999998554 358899999999999999999999976433222222222222211
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .....+++++.++|.+||..+|++||++.++.+
T Consensus 228 ~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 P----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred C----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 122347899999999999999999999776654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=295.07 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=204.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
-..+|++++.||.|+||.||+|.+.. +..||+|++..... ...+..|+.+++.++|++++..+..+ ......+++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC-SVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE-ecCCCeEEEE
Confidence 35689999999999999999999876 89999999876543 45688899999999887766665554 4556788999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.||+.||.|||+.|++|+||||+|||+ +.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE---cCCceEEEccccchhhcCCcc
Confidence 988 78999999753 3568999999999999999999999999999999999999 488899999999997764322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..+.+..+..... .+.
T Consensus 159 ~-------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~-~~~-- 225 (261)
T cd05148 159 Y-------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGYR-MPC-- 225 (261)
T ss_pred c-------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCCc-CCC--
Confidence 1 1123446778999999998889999999999999999998 899997744 2333333332211 111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
...+|+++.+++.+||..+|.+||++.+|.+.|+.
T Consensus 226 -~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 -PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 14568999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=293.24 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=199.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++.+.||.|+||.||+|.+..++..||||++..... ...+..|+.+++.+.|++++..+..+ ..+...++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-PHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-ecCCeeEEEec
Confidence 69999999999999999999999999999999875432 34688899999999977766655554 45678899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+++++|.+++......+++.++..++.||+.+|+|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCC--
Confidence 99999999998666789999999999999999999999999999999999999 5789999999999986643221
Q ss_pred cccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc---------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM--------- 233 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (465)
.......|+..|+|||++.+.. ++.++||||||+++|||++|.+||.+.... ..+..+.....
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhh
Confidence 1123456899999999987544 689999999999999999998888764321 22211111100
Q ss_pred ----------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 ----------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 ----------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+........+.++.+++..||..+|++||+++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 228 LTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred ccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00111222456789999999999999999999776643
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=299.49 Aligned_cols=257 Identities=19% Similarity=0.298 Sum_probs=198.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||+|+||.||++.+..++..||+|++..... ..++..|++++..++|++++..+..| ..+...++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF-YSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCEEEEEee
Confidence 479999999999999999999999999999998875432 23578899999999887766666555 55668889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|+ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCcccccccc-
Confidence 88 8899999975 4679999999999999999999997 589999999999999 578899999999987543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh-----------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE----------- 230 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~----------- 230 (465)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+.......+.....
T Consensus 155 --------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 --------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred --------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 2345789999999999888899999999999999999999999975432221111100000
Q ss_pred ------------------hhc-cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 231 ------------------KKM-LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 231 ------------------~~~-~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
... ..+.......++.++.+|+.+||..+|++||++.+| +.+.|...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l---l~~~~~~~ 292 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL---TKHPFIKR 292 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH---hcChhhhh
Confidence 000 000000011367889999999999999999996554 55555433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=290.86 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=201.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+-.++|++.+.||.|+||.||+|.. .++.||||.+..... ..++..|+.++..++|++++..+..+. +....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~ 79 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-QGNPLYIVT 79 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-CCCCeEEEE
Confidence 3467899999999999999999986 489999999876644 457889999999999877776665554 466788999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEccccccccccccc
Confidence 988 689999987543 369999999999999999999999999999999999999 588999999999998763211
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ...++..|+|||.+.+..++.++||||||+++|++++ |..||..... ......+..... ..
T Consensus 157 ~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~-~~--- 219 (256)
T cd05039 157 D----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR-ME--- 219 (256)
T ss_pred c----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC-CC---
Confidence 1 2234678999999998889999999999999999997 9999976432 222222222211 11
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....+|+++.+++.+||..+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 124568999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.14 Aligned_cols=252 Identities=19% Similarity=0.320 Sum_probs=195.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHc-CCCCCceeEEEe----EeCcEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQ-GGTGVPHLKWFG----VEGEYN 78 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~-~~~~i~~l~~~~----~~~~~~ 78 (465)
..++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..+. |++++..+..+. ..+...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 46799999999999999999999999999999998764322 346788999999995 666555555443 244678
Q ss_pred EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
+++||++ +++|.+++.. ....+++..+..++.|++.||.|||+.+++||||||+||++ +.++.++|+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE---CCCCCEEEccCCcee
Confidence 9999998 8999988753 23568999999999999999999999999999999999999 478889999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...... ..+..+.
T Consensus 173 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~~ 242 (286)
T cd06638 173 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKIP 242 (286)
T ss_pred ecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhcc
Confidence 6543211 1234468999999998753 44788999999999999999999999765331 2221111
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
... .+.......++.++.+++.+||..+|++||++.+|.+
T Consensus 243 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 243 RNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred ccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111 1111112345788999999999999999999777754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.24 Aligned_cols=262 Identities=22% Similarity=0.228 Sum_probs=199.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEe-------
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVE------- 74 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~------- 74 (465)
-++|++.+.||.|+||.||+|++..+++.||||++..... ...+.+|+++++.++|+++++.+..+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5799999999999999999999999999999998764432 23567899999999998888776655432
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
....+++++++.++|...+......+++.++..++.||+.+|.|||++||+|+||||+|||+ +.++.++|+|||++.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccch
Confidence 33578999999989988887655679999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccc----cccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 155 KYRDLQTHKHI----PYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 155 ~~~~~~~~~~~----~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
........... .........+++.|+|||.+.+. .++.++||||||+++|||++|+.||.+.......+.+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 65432211100 00112345678999999988654 47899999999999999999999998754432222221111
Q ss_pred hhh----------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 230 EKK----------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 230 ~~~----------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
... ...........+.+.+.+++.+||..+|++||++.++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 000 00001111234557899999999999999999976654
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=292.68 Aligned_cols=251 Identities=20% Similarity=0.323 Sum_probs=196.3
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
+|++.+.||.|+||+||+|.+ .+++.||||++..... ...+..|+++++.+.|++++..+..+ .+....+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-LDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-ecCCeEE
Confidence 588999999999999999985 5789999998765422 13577899999999887666555554 4567889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++++++ +++|.+++.. ...+++..+..++.|++.+|+|||+.+|+|+||+|+||++ +.++.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999988 8899999875 4578999999999999999999999999999999999999 5889999999999976532
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
....... ........|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .....+.... ...+
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~--~~~~ 228 (265)
T cd06631 155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAHR--GLMP 228 (265)
T ss_pred ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhcc--CCCC
Confidence 1111000 01123456899999999999988999999999999999999999999764321 1111111111 1111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....++.++.++|.+||..+|++||++.++.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 23356789999999999999999999977664
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=318.02 Aligned_cols=270 Identities=20% Similarity=0.282 Sum_probs=216.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+++.+..||-|+||.|-++........+|+|++++... .+.+..|..+|+.+..+.+|..+.. +.+..+.||+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-frd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-FRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-hccchhhhhh
Confidence 467788899999999999998655555699998886533 2347789999999986555544444 4567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||.| ||.|+..+.. .+.|...+...++.+++.|++|||.+|||+|||||+|+|+ |.+|.+||.|||+|+.+...
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g- 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSG- 573 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccC-
Confidence 9987 9999999985 6789999999999999999999999999999999999999 69999999999999987653
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
..+-+++|||.|.|||++.+...+..+|.||||+++||||+|.+||.+.++ +..|..|..+..... +
T Consensus 574 -------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid~i~---~ 640 (732)
T KOG0614|consen 574 -------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGIDKIE---F 640 (732)
T ss_pred -------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhhhhh---c
Confidence 234689999999999999999999999999999999999999999999655 455555554433322 2
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCCCCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 300 (465)
.+.++....+||++++..+|.+|.-+. ...+-.-..+.|+..|||.-++.....+
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~-----~~gI~DIkkH~Wf~gfdweglr~~~L~p 695 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQ-----KGGINDIKKHRWFEGFDWEGLRSRTLPP 695 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccc-----cCChHHHHhhhhhhcCChhhhhhccCCC
Confidence 256789999999999999999997531 1111111236788899999886544433
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=299.35 Aligned_cols=249 Identities=18% Similarity=0.300 Sum_probs=198.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|++++.||.|+||.||+|.+..++..||+|++.... ....+..|++++..++|++++..+..+ ..+...++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY-FYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-ecCCeEEEEee
Confidence 367999999999999999999998899999999987543 223577899999999976655555554 46678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++......+++..+..++.|++.+|.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence 98 889999988666789999999999999999999999999999999999999 5889999999999876533211
Q ss_pred ccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
......|++.|+|||.+. ...++.++||||||+++|+|++|..||..... .+.+..+.......
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPT-- 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCC--
Confidence 123456899999999975 34578899999999999999999999987533 22232222221111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
......++.++.++|..||..+|.+||++.++.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 011235688999999999999999999976653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=306.05 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=197.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG---- 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (465)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|++++..+..|....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999876432 1235678999999999988888877665432
Q ss_pred -cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 -EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 -~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...++||+++.++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 35799999999999988863 29999999999999999999999999999999999999 588999999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ..+..+......
T Consensus 167 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~ 235 (353)
T cd07850 167 TAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI---DQWNKIIEQLGT 235 (353)
T ss_pred eCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 654321 123346889999999999999999999999999999999999999864321 111111110000
Q ss_pred Cc-------------------------HHHH-------------hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 TP-------------------------IEVL-------------CKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ~~-------------------------~~~~-------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+ .... ....++++.++|.+||..||.+||++.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00 0000 113467789999999999999999966654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=288.14 Aligned_cols=246 Identities=23% Similarity=0.287 Sum_probs=200.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++++.||.|+||.||.+++..+++.|++|.+.... ....+.+|+.++++++|+++++.+..+ .+....+++|+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-MDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-ecCCeEEEEEE
Confidence 6999999999999999999999999999999876542 223578899999999876655555554 55678899999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++... ...+++.++..++.|++.+|.|||+.|++|+||+|+||++ +.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccc
Confidence 98 88999998753 3568999999999999999999999999999999999999 4788999999999986644221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+........ .
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~~----~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPV----V 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCC----c
Confidence 1234568999999999998889999999999999999999999997632 3333333333222211 1
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 567899999999999999999999877765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=294.90 Aligned_cols=252 Identities=20% Similarity=0.345 Sum_probs=202.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||.|+||.||+|++..+++.||+|++..... ...+..|+.+++.++|+++++.+. +..++...+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG-SFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeE-EEEECCeEEEEEE
Confidence 579999999999999999999999999999999875432 235788999999999877666555 4456678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++.. ..+++..+..++.|++.+|.|||+++++|+||+|+||++ +.++.++|+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence 88 8899999874 389999999999999999999999999999999999999 5889999999999987654321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ......+....... ....
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~---~~~~ 221 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPPS---LEGN 221 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCCC---Cccc
Confidence 12345688999999999998899999999999999999999999976442 22222222221111 1112
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+++++.+++..||..+|++||+++++ +.+.|...
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~i---l~~~~~~~ 256 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKEL---LKHKFIKK 256 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHH---hhChhhcC
Confidence 378999999999999999999997666 44555443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.14 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=215.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCC----CcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQT----GEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~----~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
....+.++||.|.||.||.|....- .--||||..+.+. ..+.|+.|..+|+.+.|+++|..++.|.+.. .+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P--~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP--MW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc--ee
Confidence 4456678999999999999986432 3368899877643 2457999999999999999999998887655 56
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
||||++ .|.|..+++.....++..++..++.||+.+|.|||++.+|||||..+|||+. ....|||+|||+++.+.+
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccc
Confidence 899998 8999999997777899999999999999999999999999999999999995 889999999999998877
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
+...+ .....-.+.|||||.+.-..++.++|||-|||++||+|. |..||++....+..-.+ +.....|.
T Consensus 544 ~~yYk------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i----EnGeRlP~ 613 (974)
T KOG4257|consen 544 DAYYK------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI----ENGERLPC 613 (974)
T ss_pred cchhh------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe----cCCCCCCC
Confidence 65422 234556789999999998899999999999999999997 99999998765543333 22333343
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
+ ..+|+.+..++.+||+.+|.+||.+.+|+..|.++++.+..
T Consensus 614 P---~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 614 P---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred C---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 3 35599999999999999999999999999999999985544
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=291.47 Aligned_cols=248 Identities=20% Similarity=0.213 Sum_probs=190.4
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC--cEEEEEEe
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG--EYNVMVID 83 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~--~~~~lv~e 83 (465)
|++++.||+|+||.||+|.+..+++.||+|++..... ......|+.++.++.+|+++..+..++.+. ...+++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7899999999999999999999999999998765322 223457888888887444444444444444 67899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++.++..++.|++.||+|||+.|++|+||+|+||++. . +.++|+|||++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCC--
Confidence 998899988876556799999999999999999999999999999999999994 5 9999999999976543211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc--------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML-------- 234 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (465)
.....++..|+|||.+.. ..++.++|||||||++|||++|..||.+.+.. ..+..+......
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 155 ------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred ------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHh
Confidence 123457899999997654 45788999999999999999999999874432 222211110000
Q ss_pred ----------C------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 ----------T------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 ----------~------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. ........++.++.++|.+||..+|++||++.++.+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 011122356899999999999999999999777653
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=290.43 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=203.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|.+.+.||.|+||.||+|.+. .+..||||.+.... ....+..|+.+++.+.|++++..+.. .......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV-CSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeee-eecCCceEEEE
Confidence 66789999999999999999999864 56889999887543 33568899999999998766555544 45556788999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... +..+++.++..++.||+.||.|||++|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---GENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---cCCCCEEECccccceeccchh
Confidence 987 88999998753 3579999999999999999999999999999999999999 488999999999997664321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+... ...+..+.... ..+.
T Consensus 158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~-~~~~-- 225 (261)
T cd05034 158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGY-RMPR-- 225 (261)
T ss_pred h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC-CCCC--
Confidence 1 11223345678999999998889999999999999999998 9999976432 23333333221 1111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
....|.++.+++.+||..+|++||++.++.+.|++
T Consensus 226 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 -PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 13458999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=300.44 Aligned_cols=252 Identities=17% Similarity=0.272 Sum_probs=193.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|...+.||+|+||.||++.+..+++.||||.+..... ...+..|+.++.++..++++..+..+.......+++|+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788999999999999999999999999998765422 23578899999999734444444444455667889999
Q ss_pred ccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 84 LLGPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 84 ~~g~sL~~ll~~----~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+++.+|.++... ....+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.++|+|||++..+..
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhcc
Confidence 998888776542 246799999999999999999999975 99999999999999 4788999999999976543
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.... ...+.+..+.......
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 211 1234688999999998876 68999999999999999999999997643 1222222221111111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
........++.++.+|+.+||..+|++||++++|..
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111347899999999999999999999776654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=297.07 Aligned_cols=248 Identities=19% Similarity=0.297 Sum_probs=195.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+-|++.+.||.|+||.||+|.+..++..+++|.+..... ...+..|+++++.+.|++++..+..+ ......++++++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEE-eeCCEEEEEEEe
Confidence 346889999999999999999999999999998864432 23577899999999887777766655 455677889988
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|..++......+++..+..++.|++.+|.|||+.|++|+||||+|||+ +.++.++|+|||++.......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~--- 157 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTI--- 157 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEccccccccccccc---
Confidence 8 788888876555679999999999999999999999999999999999999 588999999999987653321
Q ss_pred cccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 164 HIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.......+++.|+|||++. +..++.++|||||||++|+|++|..||..... .+.+..+....... .
T Consensus 158 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~ 228 (282)
T cd06643 158 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--L 228 (282)
T ss_pred ----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--C
Confidence 1123457899999999984 44578899999999999999999999987432 22222222221111 1
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....++.++.++|..||..+|++||++.++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11235689999999999999999999977664
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.96 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=203.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEc----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeE-eCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNV----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~ 77 (465)
...|++.+.||+|+||.||+|+.. .++..||||++..... ...+..|+++++.+.|++++..+.++.. .+..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 467899999999999999999864 3478999999876544 3568899999999988777766655433 2557
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++ +++|.+++......+++..+..++.|++.||+|||++|++|+||||+|||+ +.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKVL 159 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEccccccccc
Confidence 88999988 889999998655569999999999999999999999999999999999999 57899999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch-----------HHHH
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQKY 225 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~-----------~~~~ 225 (465)
...... +.......++..|++||.+.+..++.++||||||+++|||++|..||........ ....
T Consensus 160 ~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 160 PEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 532110 1112223456679999999988999999999999999999999999876432210 1111
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..........+. ...+|.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 236 ~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111111 134578999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=296.22 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=196.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-------ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-------PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-------~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ..+..|+++++.++|+++++.+..+. +....++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-HKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-cCCEEEE
Confidence 589999999999999999999889999999988754322 24567999999999877777666554 4678899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++++++|.+++......+++..+..++.||+.||.|||++|++|+||+|+|||+ +.++.++|+|||++.......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999997533479999999999999999999999999999999999999 588999999999998764421
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM------ 233 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~------ 233 (465)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||.+...... +.++.....
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (298)
T cd07841 157 R-------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEEN 226 (298)
T ss_pred c-------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhh
Confidence 1 1123356888999998865 4578999999999999999999888876443222 222111100
Q ss_pred -----------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 -----------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 -----------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+........+.++.++|..||..+|.+||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 01111122345788999999999999999999776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=289.86 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=198.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----------ccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----------PQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----------~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+|.+...||.|+||.||+|.+..+++.||+|.+...... ..+..|+.++..+.|++++..+. +..+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLG-SSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEE-EEEeCC
Confidence 588999999999999999999889999999987643221 24678899999998877666554 455566
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+.+++++++ +++|.+++.. ...+++..+..++.|++.+|+|||+.|++|+||+|+|||+ ++++.++|+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 788899988 8899999975 4678999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
......... .........|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .+.+..+.....
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~-- 229 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGENAS-- 229 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhccCC--
Confidence 653211110 11122345689999999999988899999999999999999999999987432 222222222111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
......++.++.++|.+||+.+|.+||++.+|.+
T Consensus 230 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 230 --PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1122457899999999999999999999877754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=292.79 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=195.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHc-CCCCCceeEEEeEe-----CcEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQ-GGTGVPHLKWFGVE-----GEYN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~-~~~~i~~l~~~~~~-----~~~~ 78 (465)
.++|++.+.||.|+||.||+|.+..+++.|++|++..... ...+..|+.+++.+. |++++..+..+... +...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5899999999999999999999988999999999875543 356888999999995 55555555554332 3467
Q ss_pred EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
+++|+++ +++|.+++... +..+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccce
Confidence 8999998 78999988643 3679999999999999999999999999999999999999 578999999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
....... ......|+..|+|||++.. ..++.++||||||+++|+|++|..||..... ......+.
T Consensus 162 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 231 (275)
T cd06608 162 QLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---MRALFKIP 231 (275)
T ss_pred ecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---HHHHHHhh
Confidence 6543211 1234568999999998754 3467899999999999999999999976432 22222222
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....... .....++.++.+++.+||..||++||++.+|.+
T Consensus 232 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2211111 011236789999999999999999999877754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=291.75 Aligned_cols=252 Identities=21% Similarity=0.250 Sum_probs=194.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.++|++.+.||+|+||.||+|.+..++..||||++...... ..+.+|+.++..+.|++++ .+..+...+...++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEe-EEEEEEecCCeEEEEE
Confidence 36899999999999999999999999999999998654322 2567899999999887655 4455556677889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++++++|.+.+......+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCC-
Confidence 999889988876545678999999999999999999999999999999999999 5889999999999975432111
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc--------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM-------- 233 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (465)
......+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ..+.+..+.....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 159 ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred ------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhh
Confidence 12234578999999998764 478899999999999999999999986542 1222222111000
Q ss_pred -----------------cCcHHHHh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 -----------------LTPIEVLC--KSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 -----------------~~~~~~~~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
........ -..++++.+++.+|+..||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 00000000 12357899999999999999999977654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=296.48 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=198.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
.+|++.+.||.|+||.||+|++..+++.||||.+.... ....+..|+.++..++|++++..+..+ ..+...++++++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF-LVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeE-ecCceEEEEEEe
Confidence 57999999999999999999999999999999886543 234577899999999988777666555 456678889998
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++. ...+++.++..++.|++.+|+|||+.|++|+||||+||++ +.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 98 LAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred cCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhcccccc--
Confidence 8 889999887 4569999999999999999999999999999999999999 5789999999999876543221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+.... .....+.... .+.......
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~~~~~--~~~~~~~~~ 240 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNG--TPELQNPEK 240 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcC--CcccCCccc
Confidence 122456889999999999888999999999999999999999999774321 1111111111 111112245
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+++.+.++|.+||..||.+||++.+|.
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 789999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=295.45 Aligned_cols=254 Identities=20% Similarity=0.327 Sum_probs=199.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
-.++|++++.||.|+||.||+|.+.. ++..||||++..... ...+..|+.++..+.|++++..+. ++..+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~-~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLG-VCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEE-EEcCCC
Confidence 45789999999999999999998743 678999998875432 245788999999998876666555 445566
Q ss_pred EEEEEEecc-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN---------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 134 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~---------------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NI 134 (465)
..+++++++ +++|.+++.... ..+++.+++.++.|++.+|.|||.++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 778999988 789999986321 2478899999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCC
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPW 213 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf 213 (465)
|+ +.++.++|+|||++..+..... +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 162 l~---~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 162 LV---GENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred Ee---cCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99 5889999999999876532211 111223345678999999998899999999999999999998 88999
Q ss_pred CCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 214 QGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
.+... .+....+....... ....+|.++.+|+.+||..+|++||++.+|.+.|+
T Consensus 234 ~~~~~---~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAH---EEVIYYVRDGNVLS----CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCH---HHHHHHHhcCCCCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 76543 23333333222211 12356899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=293.70 Aligned_cols=255 Identities=20% Similarity=0.255 Sum_probs=197.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+++++.+.|++++..+..+ ..+...++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-RRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-EECCEEEEEE
Confidence 57999999999999999999999999999999876432 235688999999999987766655554 5577889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+++.+++.+.+......+++.++..++.||+.||.|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPA- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCcc-
Confidence 999767666655545679999999999999999999999999999999999999 5799999999999987654321
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh----------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---------- 231 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (465)
.......++..|+|||++.+. .++.++||||||+++|+|++|..||.+............+...
T Consensus 156 -----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 -----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred -----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 112345688999999999888 7899999999999999999999999864322111111100000
Q ss_pred --------hc-----cCcHH-HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 --------KM-----LTPIE-VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 --------~~-----~~~~~-~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.. ....+ .....++.++.++|..||..+|++||++.+|.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000 111234889999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=293.09 Aligned_cols=247 Identities=17% Similarity=0.272 Sum_probs=191.7
Q ss_pred eeEeeeCceEEEEEEEcCCCc--EEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGE--EVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~--~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|++..++. .+++|.+.... ....+..|++++..+.+|+++..+..++......+++|+++ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999887775 46888776322 22457789999999965555556655666666789999988 8
Q ss_pred CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 87 PSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 87 ~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
++|.+++.... ..+++.++..++.|++.||+|||+.|++|+||||+|||+ +.++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 89999986421 248899999999999999999999999999999999999 588999999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||.+.+. ...+..+..
T Consensus 158 l~~~~~~~--------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 226 (270)
T ss_pred Cccccchh--------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhC
Confidence 98632211 01112234667999999988889999999999999999997 9999977443 222222222
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
... .. ....++.++.+++.+||..+|.+||++.++.+.|..++
T Consensus 227 ~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYR-LE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC-CC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 11 11346789999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=290.34 Aligned_cols=247 Identities=23% Similarity=0.311 Sum_probs=196.9
Q ss_pred eeEeeeCceEEEEEEEcC-CC--cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNVQ-TG--EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~-~~--~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.||+|+||.||+|.+.. .+ ..||||.+..... ...+..|+.++..++|++++..+..+.. ...+++++++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999999755 33 3699998876544 3467889999999999887777766654 7788999988
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||||+|||+ +.++.+||+|||++..+.....
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~--- 152 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNED--- 152 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE---ecCCEEEecccccccccccccc---
Confidence 899999987543 568999999999999999999999999999999999999 5789999999999987644221
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
.+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...... +....+........ ....
T Consensus 153 -~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~~~---~~~~ 225 (257)
T cd05040 153 -HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDKEGERLE---RPEA 225 (257)
T ss_pred -ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCcCC---CCcc
Confidence 1122234567889999999999899999999999999999998 99999764332 22222222111111 1235
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+|..+.+++..||..+|++||++.+|.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 6899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=286.53 Aligned_cols=246 Identities=21% Similarity=0.283 Sum_probs=198.8
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|++++..+..+ ..+...+++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-LEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-ecCCEEEEEEe
Confidence 6999999999999999999999999999999887542 223578899999999987776666544 45667889999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++... ...+++..+..++.|++.+|+|||++|++|+||+|+||++. +.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCc-
Confidence 88 88999999754 34589999999999999999999999999999999999995 345678999999998764321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ......+...... ...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~ 222 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTFA----PIS 222 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCCC----CCC
Confidence 12345688999999999988899999999999999999999999977433 2222222222111 122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+++..||..+|++||++.+|.+
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 457899999999999999999999877654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=298.75 Aligned_cols=248 Identities=21% Similarity=0.340 Sum_probs=197.4
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
..+|++++.||+|+||.||+|.+..+++.||||.+..... ...+..|+.++..+.|++++..+..+ ..+...+++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCEEEEeec
Confidence 4789999999999999999999989999999998875432 24577889999999887766665554 45667889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++. ...+++.++..++.|++.+|.|||+.|++|+||||+|||+ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred ccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCcc-
Confidence 88 899999986 4568999999999999999999999999999999999999 5889999999999976543221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......+++.|+|||.+.+..++.++|+||||+++|++++|..||........ .+. +.... .+......
T Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~~-~~~~~--~~~~~~~~ 239 (297)
T cd06656 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYL-IATNG--TPELQNPE 239 (297)
T ss_pred ------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--eee-eccCC--CCCCCCcc
Confidence 11245688999999999998899999999999999999999999976433111 111 11111 11111123
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.++..+.+++.+||..+|++||++.+|.+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56888999999999999999999766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=297.16 Aligned_cols=254 Identities=18% Similarity=0.293 Sum_probs=198.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-.++|++++.||+|+||+||+|.+..+++.||+|++..... ...+..|++++..+.|++++..+..+ ......++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF-LNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE-ecCCEEEEE
Confidence 35789999999999999999999999999999998765432 24678899999999877666665555 455688999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+||+ +++|.+++.. .+.+++..+..++.+++.+|.|||+ .+++|+||||+||++ +.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 9998 7899888875 4579999999999999999999997 589999999999999 58899999999998654321
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC-----chHHHHHHHhhhhcc
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYDKISEKKML 234 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~~ 234 (465)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||...... ...............
T Consensus 158 ~---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 158 I---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred c---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 1 13457899999999998888999999999999999999999999865432 111111111111000
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRL 272 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (465)
.+.......+|.++.+|+.+||..||++||++.++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000012368899999999999999999998777653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.50 Aligned_cols=255 Identities=22% Similarity=0.318 Sum_probs=200.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+-..+|.+.++||+|+||.||+|... .++..||+|.+.... ....+..|++++..++|++++..+. ++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYG-VCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEE-EEecCC
Confidence 44678999999999999999999743 346789999876432 2346888999999998877666554 455566
Q ss_pred EEEEEEecc-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN--------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~--------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
..+++++++ +++|.+++.... ..+++.++..++.||+.||.|||+.|++|+||||+|||+ ++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV---GQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE---cC
Confidence 788999887 889999987532 248999999999999999999999999999999999999 47
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
++.++|+|||++........ +.......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 230 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-- 230 (280)
T ss_pred CCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--
Confidence 89999999999975533211 112234456789999999999999999999999999999998 9999976433
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
...+..+....... ....+|+.+.+++.+||..||++||++.+|.+.|+
T Consensus 231 -~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 -TEAIECITQGRELE----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred -HHHHHHHHcCccCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 22232222221111 11357899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=291.59 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=197.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ....+..|+++++.++|++++..+..+. ++...+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-EDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-cCCeEE
Confidence 5889999999999999999999999999999887533 1245788999999999988777776654 445667
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++++++ +++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||+|+||++. ..+..++|+|||++..+..
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 777776 8899999875 45799999999999999999999999999999999999994 2334699999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
...... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..............+...... .
T Consensus 157 ~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 230 (268)
T cd06630 157 KGTGAG---EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---P 230 (268)
T ss_pred ccccCC---ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---C
Confidence 321111 1123456899999999999888999999999999999999999999764433222222221111111 1
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....+++++.+++.+||..+|++||++.++.
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 12235688999999999999999999977765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.04 Aligned_cols=259 Identities=20% Similarity=0.222 Sum_probs=197.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEe--------
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVE-------- 74 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~-------- 74 (465)
++++|.+.+.||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.++|++++..+..+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 47899999999999999999999999999999998865433 23578899999999998877766544332
Q ss_pred -----CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEe
Q 012336 75 -----GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149 (465)
Q Consensus 75 -----~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~D 149 (465)
....+++++++.++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||+. ..++.++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 23578999999889988886 45799999999999999999999999999999999999995 3567899999
Q ss_pred cCCccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH
Q 012336 150 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i 228 (465)
||++.......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99997653221111 11123357889999998754 55888999999999999999999999765432211111000
Q ss_pred h----------------------hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 229 S----------------------EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 229 ~----------------------~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. ......+.......++.++.+|+..||..||++||++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 000111112223457889999999999999999999777643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=293.74 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=194.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
-++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+.+++.++|++++..+ .+..++...++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~-~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLH-DIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEE-EEEecCCeEEEEE
Confidence 3689999999999999999999988999999998765432 23467899999999887655544 4556777899999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|++.++|.+++......+++..+..++.|++.||.|||+.||+|+||||+|||+ +.++.++|+|||+++......
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~-- 157 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPS-- 157 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCC--
Confidence 999889999988666689999999999999999999999999999999999999 588999999999987542211
Q ss_pred ccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc--------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM-------- 233 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (465)
.......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+... ..+....+.....
T Consensus 158 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 158 -----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred -----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhh
Confidence 11122346889999999876 4588999999999999999999999976431 1111111110000
Q ss_pred -----------------cCcHHHHhccCc--HHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 -----------------LTPIEVLCKSYP--SEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 -----------------~~~~~~~~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+.......+. .++.+++.+||..+|++||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 000111112334 7889999999999999999977764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=295.74 Aligned_cols=260 Identities=21% Similarity=0.233 Sum_probs=197.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcC--CCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQ--TGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~--~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~ 79 (465)
+|++.+.||+|+||.||+|.+.. +++.||||++... .....+..|+.++..+.|++++..+..+... ....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8999999998762 3345678899999999998877777666543 26889
Q ss_pred EEEeccCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc-CCCCCcEEEEecCCcc
Q 012336 80 MVIDLLGPSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL-GRKSNQVYIIDYGLAK 154 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~-~d~~~~vkL~DFGla~ 154 (465)
+|||+++++|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+.. ++.++.+||+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 999999989988876432 36899999999999999999999999999999999999941 1118999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch------HHHHHH
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYDK 227 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~------~~~~~~ 227 (465)
........ ........+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+...... ...+..
T Consensus 161 ~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 161 LFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 65432211 1223455789999999988764 578999999999999999999999986543320 001111
Q ss_pred Hhhhh--------------------------ccCc----HHHHh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 228 ISEKK--------------------------MLTP----IEVLC--KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 228 i~~~~--------------------------~~~~----~~~~~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.... ...+ ..... ...+.++.+++.+||..||++||++.++.+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000 00011 145678999999999999999999877653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.36 Aligned_cols=266 Identities=17% Similarity=0.187 Sum_probs=203.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEe----EeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFG----VEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~----~~~~~ 77 (465)
|-++||++.+.||+|||+-||++.+..++..||+|.+.... ..+..++|+...++++|++.++.+.... +....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 45789999999999999999999999999999999766543 3456889999999999988777654332 23446
Q ss_pred EEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 78 NVMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
.|+++++. .|+|.+.++.+ +..+++.+++.|+.+++.||++||... +.||||||.|||++ +.+.++|.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEecc
Confidence 78888877 89999998765 346999999999999999999999999 99999999999996 68999999999
Q ss_pred CccccccccCcc--cccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH
Q 012336 152 LAKKYRDLQTHK--HIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 226 (465)
Q Consensus 152 la~~~~~~~~~~--~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~ 226 (465)
.++......... ......-..-..|..|.|||.+.- ...+.++|||||||+||.|+.|.-||......-- ....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-SlaL 253 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLAL 253 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEEE
Confidence 998654322111 000111112346899999999864 3468899999999999999999999953111000 0000
Q ss_pred HHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 227 KISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.+....+..|.. ..+++.+.++|++|++.||..||++.+|...+.++
T Consensus 254 Av~n~q~s~P~~---~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 AVQNAQISIPNS---SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred eeeccccccCCC---CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 011122223322 34799999999999999999999999998887765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.61 Aligned_cols=258 Identities=22% Similarity=0.238 Sum_probs=196.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeC-------
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEG------- 75 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~------- 75 (465)
++|++.+.||+|+||.||+|.+..+++.||||++...... ..+..|+.+++.+.|+++++.+..+....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5799999999999999999999999999999987654322 24567999999999988888877665432
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...+++|++++++|.+++......+++.++..++.|++.||+|||+.|++|+||||+|||+ +.++.+||+|||++..
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARA 168 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCccc
Confidence 4569999999999999887655579999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc-
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM- 233 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (465)
+....... ........++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........+..+.....
T Consensus 169 ~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 169 FSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred ccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 64322111 01123346788999999887643 78899999999999999999999987543222222222111000
Q ss_pred ---------------cCc-------HHHH-hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 ---------------LTP-------IEVL-CKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ---------------~~~-------~~~~-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+ ...+ ....+..+.++|..||..||++||+++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 000 0000 001246788999999999999999977765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=292.66 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=195.2
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-------CccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-------HPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYN 78 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~ 78 (465)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ...+..|+.++..++|+++++.+..+... ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998764321 12477899999999988877777665543 4677
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++++++ +++|.+++.. ...+++..+..++.|++.+|+|||+.+|+|+||||+||++ +.++.++|+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 8899988 7899999875 4568999999999999999999999999999999999999 588899999999997653
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
...... .......++..|+|||.+.+..++.++|||||||++|||++|..||..... .+.+.........
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~~~--- 227 (266)
T cd06651 158 TICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQPTN--- 227 (266)
T ss_pred cccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCCCC---
Confidence 211100 111234688999999999998899999999999999999999999976432 2222222111111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+...+++.+.+++ .||..+|++||++.+|.
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 112234578888888 68889999999977764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=293.62 Aligned_cols=252 Identities=19% Similarity=0.301 Sum_probs=194.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHc-CCCCCceeEEEeEe----CcEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQ-GGTGVPHLKWFGVE----GEYN 78 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~-~~~~i~~l~~~~~~----~~~~ 78 (465)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+. |++++..+..+... +...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3678999999999999999999999999999999886532 2345778999999984 55555545444432 2467
Q ss_pred EEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
+++++++ +++|.+++.. ....+++..+..++.|++.+|+|||+.|++|+||||+||++ +.++.++|+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccch
Confidence 8999988 8899998863 24679999999999999999999999999999999999999 578899999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCC-----CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||..... ...+..+.
T Consensus 177 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~ 246 (291)
T cd06639 177 QLTSTRL-------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIP 246 (291)
T ss_pred hcccccc-------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHh
Confidence 6543211 11234688999999997643 368899999999999999999999987532 22222222
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....... .....++..+.++|.+||..+|++||++.+|.+
T Consensus 247 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2211100 111345778999999999999999999777654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=287.32 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=201.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv~ 82 (465)
+|++++.||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.+.|++++..+..+.. .+...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998865432 2357789999999999888777765554 455778999
Q ss_pred ecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 83 DLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMH-----SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 83 e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLH-----s~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
+++ +++|.+++... ...+++..++.++.||+.+|.||| +.+++|+||+|+||++ +.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE---ecCCCEEEeccccc
Confidence 998 88999998754 467999999999999999999999 8899999999999999 47899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .+....+.....
T Consensus 158 ~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~ 227 (265)
T cd08217 158 KILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLASKIKEGKF 227 (265)
T ss_pred ccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHHHHHhcCCC
Confidence 87643221 02234689999999999998899999999999999999999999987442 222222222222
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .+...++.++.+++.+||..+|++||++.+|.+
T Consensus 228 ~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred C----CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 122467899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=303.09 Aligned_cols=259 Identities=18% Similarity=0.251 Sum_probs=201.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeE---eCcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGV---EGEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~---~~~~ 77 (465)
++++|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.|++++.....|.. ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 5689999999999999999999999999999999887542 23457789999999998777766655543 3457
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.++++++++++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceeec
Confidence 899999998899998864 4569999999999999999999999999999999999999 588999999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH--------
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI-------- 228 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i-------- 228 (465)
...... ........|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.........+...
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 322110 011234578999999999866 45889999999999999999999999775432211111110
Q ss_pred ---------------hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 229 ---------------SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 229 ---------------~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.......+.......+++++.++|..||+.+|++||++.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 000111122233456789999999999999999999966543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=289.36 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=195.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-------CccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-------HPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYN 78 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~ 78 (465)
.+|++.+.||+|+||.||+|.+..++..||||++..... ...+..|+.++..+.|++++..+..+... ....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 689999999999999999999999999999998754321 12467799999999887777766655443 4567
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+++.. ...+++..+..++.|++.+|+|||+++++|+||||+|||+ +.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCccccccc
Confidence 8899998 8899999875 3568999999999999999999999999999999999999 588999999999997653
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
..... ........|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+..........
T Consensus 158 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 228 (265)
T cd06652 158 TICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTNP-- 228 (265)
T ss_pred ccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCCCC--
Confidence 21110 0112345689999999999988899999999999999999999999976422 22222222111111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....++..+.+++..|+ .+|.+||++++|.+
T Consensus 229 -~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 229 -VLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred -CCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 112345678999999999 49999999877654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=288.25 Aligned_cols=244 Identities=18% Similarity=0.280 Sum_probs=192.1
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
+.||+|+||.||+|.. .++..||+|++..... ...+..|+.++..+.|++++..+..+ ......+++||++ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC-TQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE-ecCCccEEEEECCCCCc
Confidence 4689999999999985 5788999998765432 22577899999999887777666655 4555788999987 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
|.+++......+++.++..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||++........ .
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~------~ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIY------S 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceecccccc------c
Confidence 999887655678999999999999999999999999999999999999 5888999999999875432211 1
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
......+++.|+|||++.+..++.++||||||+++|++++ |..||...... .....+.... .. .....++..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~-~~---~~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGY-RM---SCPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC-CC---CCCCCCCHH
Confidence 1122344678999999998889999999999999999998 99999875332 2222222211 11 112356899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 248 FTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=292.55 Aligned_cols=253 Identities=20% Similarity=0.241 Sum_probs=198.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~lv~ 82 (465)
++|...+.||.|++|.||+|.+..+++.||+|++..... ...+.+|++++..+.|++++..+..|... ....+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 579999999999999999999999999999998875432 34688999999999988887777766543 45688999
Q ss_pred ecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 83 DLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 83 e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+++ +++|.+++.. ....+++..+..++.||+.+|.|||+.|++|+||+|+||++ +.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeeccccccccc
Confidence 998 8899988753 24568999999999999999999999999999999999999 5788999999999875432
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC--CchHHHHHHHhhhhccCc
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~ 236 (465)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....+....+........
T Consensus 158 ~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred cc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 11 1244678899999999998999999999999999999999999986532 112222222222111100
Q ss_pred HH--HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IE--VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~--~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.. .....+++++.+++.+||..+|.+||++.+|.+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00 001235688999999999999999999766543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=291.58 Aligned_cols=253 Identities=24% Similarity=0.287 Sum_probs=192.7
Q ss_pred eEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
.||+|+||.||+|.+..+++.||||++...... .....|..++..++ +++++..+..+.......++|||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999899999999987654221 12344544444443 3455666666666777889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
|++|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||+ +.++.++|+|||++......
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~------ 150 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKK------ 150 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCcc------
Confidence 8899988864 5679999999999999999999999999999999999999 57889999999998755321
Q ss_pred cccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 166 PYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.................... .....+
T Consensus 151 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (278)
T cd05606 151 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-----ELPDSF 222 (278)
T ss_pred ---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC-----CCCCcC
Confidence 12245789999999998754 689999999999999999999999987533222222111111111 122346
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 245 PSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+.++.+++.+||..+|.+|| ++.++.+ .++...++|....
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~----------~~~~~~~~~~~~~ 267 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------HPFFRSLDWQMVF 267 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh----------CccccCCCchHhh
Confidence 89999999999999999999 7666643 5666667787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=300.61 Aligned_cols=251 Identities=21% Similarity=0.243 Sum_probs=200.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+.++|++++.||.|+||.||+|.+..+++.||||.+.... ....+..|++++..+.|++++..+..|...+...++
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 6889999999999999999999999999999999875422 234677899999999998888877777666777889
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
++++++++|.+++. ...+++..+..++.||+.||.|||+++|+|+||+|+|||+ +.++.++|+|||++......
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC-
Confidence 99999999998887 4578999999999999999999999999999999999999 58899999999998754221
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH-----------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI----------- 228 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i----------- 228 (465)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+...
T Consensus 162 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 162 ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 123467889999998766 56899999999999999999999999764321111110000
Q ss_pred ------------hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 229 ------------SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 229 ------------~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.......+....+..+++++.++|.+||..+|++||++.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000111223334456789999999999999999999976653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.55 Aligned_cols=253 Identities=17% Similarity=0.221 Sum_probs=188.4
Q ss_pred EEeeEeee--CceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 11 LGRKIGSG--SFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 11 l~~~LG~G--~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++++||+| +|++||++.+..+++.||||++..... ...+..|+.+++.++|++++..+..| ..+...++|+++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-IADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-EECCEEEEEEec
Confidence 56789999 789999999999999999999875432 23467789999999887777765554 556678899998
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 85 L-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 85 ~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE---ecCCcEEEcccchhhcccccccc
Confidence 8 88999998643 3569999999999999999999999999999999999999 57889999999876543321110
Q ss_pred ccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML------ 234 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------ 234 (465)
............++..|+|||++.+ ..++.++|||||||++|||++|..||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCcccccccc
Confidence 0000011223457788999999976 4589999999999999999999999986443211 1111110000
Q ss_pred -CcH----------------------------------HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 -TPI----------------------------------EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 -~~~----------------------------------~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+. ......+++++.+|+..||..||++||++++|.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 000 001123567899999999999999999977654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=292.82 Aligned_cols=248 Identities=19% Similarity=0.319 Sum_probs=198.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.+.|++++..+..+ ......+++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF-YNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheee-ecCCEEEEEEE
Confidence 478899999999999999999999999999998876532 24578899999999977766655554 44577889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++......+++..+..++.|++.+|+|||+ .|++|+||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHh
Confidence 98 599999998655789999999999999999999999 999999999999999 4788999999999876543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC--CchHHHHHHHhhhhccCcHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 239 (465)
....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ....+....+.........
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 225 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP-- 225 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC--
Confidence 126788999999999998999999999999999999999999976431 1122222222222111111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+++++.++|..||..+|++||++.+|.
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 226 -SGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred -hhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 112688999999999999999999977664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=293.06 Aligned_cols=282 Identities=19% Similarity=0.253 Sum_probs=233.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+|.+++.||.|+|+.|.+++.+.|.+.||+|+++++ ...+..+.|..++.+-.+++.+..+..|+.....+|+|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 6899999999999999999999999999999987754 33445788999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
.||+ ||+|--.+.+ +++++++.+..+..+|+.+|+|||++|||+||||.+|+|+ |..|++||.|||+++..-...
T Consensus 330 ieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC
Confidence 9998 8888877765 6889999999999999999999999999999999999999 799999999999998643322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCC-----CCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~-----~~~~~~~~~~i~~~~~~~ 235 (465)
..+.+++|||.|.|||++.+.+|+..+|||+||++++||+.|+.||.-.. ..+..-.+..|.+.....
T Consensus 406 -------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 406 -------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred -------cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 34578999999999999999999999999999999999999999995322 223344455566666665
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCCCCCC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRSRPSG 308 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~ 308 (465)
| ..++.....+++..|.+||.+|.... ..--|. .-.+++++..+||..+.+.+...+-.|...+
T Consensus 479 p-----rslsvkas~vlkgflnkdp~erlgc~-~~~g~~---dik~h~ffr~idwd~leqk~v~ppf~p~i~~ 542 (593)
T KOG0695|consen 479 P-----RSLSVKASHVLKGFLNKDPKERLGCR-PQTGFS---DIKSHAFFRSIDWDLLEQKQVLPPFQPQITD 542 (593)
T ss_pred c-----ceeehhhHHHHHHhhcCCcHHhcCCC-cccchh---hhhcchhhhhCCHHHHhhcccCCCCCCcccc
Confidence 5 45677888899999999999996421 000122 2356788888999999877776666655443
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=290.97 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=210.4
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc--cHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCH
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP--QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSL 89 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~--~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (465)
+.||+|+|+.|--++.+.++.+||||++.+...+. ++.+|++++..+++|.+|..+..|++++..+|+|||-+ ||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 57999999999999999999999999998876554 68999999999999988888888888888889999988 9999
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccC
Q 012336 90 EDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169 (465)
Q Consensus 90 ~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (465)
...+.. .+.|++.++..+..+|+.||.|||.+||.||||||+|||....+.-.-||||||.|.........-....--.
T Consensus 164 LshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 164 LSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 988875 5679999999999999999999999999999999999999755555678999999975433221111111122
Q ss_pred CCCcccccccccccccc---C--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc------------hHHHHHHHhhhh
Q 012336 170 NKNLTGTARYASVNTHL---G--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYDKISEKK 232 (465)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~---~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~------------~~~~~~~i~~~~ 232 (465)
.-+.+|...|||||+.. + .-|++++|.||||||||-||.|.+||.+....+ ....+..|++++
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 34568999999999854 2 238999999999999999999999998855422 355677788888
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
+..|...+ ..++.+.++++..++..|+.+|..+.++
T Consensus 323 YeFPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 323 YEFPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred CcCChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 88876554 5789999999999999999999885443
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=296.24 Aligned_cols=257 Identities=21% Similarity=0.293 Sum_probs=201.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
....+|++.+.||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.++|++++.....+ ......
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~-~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCY-LREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-EeCCeE
Confidence 345679999999999999999999988999999998764322 13577899999999887666655544 556678
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 79 VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|++++.++|.+++......+++..+..++.|++.+|.|||+.||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence 8999999999999887666789999999999999999999999999999999999999 5889999999999865432
Q ss_pred ccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.....++..|+|||++. ...++.++||||||+++|||++|..||.+... ......+.......
T Consensus 168 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~ 233 (307)
T cd06607 168 -----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPT 233 (307)
T ss_pred -----------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCC
Confidence 22456888999999874 35588899999999999999999999976432 11111222111111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQF 284 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~ 284 (465)
.....++.++.+++..||..+|++||++.+|. .+.|.....+.
T Consensus 234 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il---~~~~~~~~~~~ 276 (307)
T cd06607 234 ---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL---KHRFVLRERPP 276 (307)
T ss_pred ---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHh---cChhhcccCCc
Confidence 11124678999999999999999999977764 44444443333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=290.11 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=194.5
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||.|+||.||+|.+..+++.||||++..... ...+..|..++....+++++..+..+...+...++++|++ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 578999999999999988999999998864321 1234455555544434455555555566777889999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+|||+ +.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~-------- 149 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNGLE-------- 149 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEeecccceeccc--------
Confidence 899999975 4579999999999999999999999999999999999999 5788999999999875432
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
.....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+. .+.+..+.......+. .....+++
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~ 222 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINWPE-EVKEFCSP 222 (260)
T ss_pred ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCCCC-cccccCCH
Confidence 2345688999999999988899999999999999999999999976433 3333333332222221 12235789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 247 EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
++.+++.+||..+|++||++..+.++|.+.|.
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 99999999999999999988778888876654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=290.56 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=189.2
Q ss_pred eeEeeeCceEEEEEEEc--CCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNV--QTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|... .++..+|+|.+...... ..+.+|+.+++.++|++++..+..+ .+....++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-TEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCCcEEEEECCCC
Confidence 46899999999999854 34568999987654322 3577899999999988877666554 4556678999998 7
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 87 PSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 87 ~sL~~ll~~~~----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++|.+++.... ..+++..+..++.|++.+|+|||+.+++|+||||+|||+ +.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEECCccccccccCcce-
Confidence 99999986422 246778888999999999999999999999999999999 5789999999999975432211
Q ss_pred ccccccCCCCccccccccccccccCC-------CCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGV-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-------~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
+.......++..|+|||++.+. .++.++||||||+++|||++ |..||......... ...+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHhhcccCC
Confidence 1122345678899999998643 35789999999999999996 99999875432221 1122222233
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
.+.+......++.+.+++..|| .+|++||++.+|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3333344467889999999999 68999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=301.51 Aligned_cols=256 Identities=18% Similarity=0.198 Sum_probs=198.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeC----c
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----E 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~ 76 (465)
+.++|++.+.||.|+||.||+|++..++..||||.+... .....+..|+.++..++|++++..+..+.... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 578999999999999999999999999999999987642 12335678999999999888777766554332 3
Q ss_pred EEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
..++++++++++|.+++.. ...+++..+..++.|++.||.|||+++++|+||||+|||+ +.++.++|+|||++...
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCcccccc
Confidence 5799999999999988874 4679999999999999999999999999999999999999 57899999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh----
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK---- 231 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 231 (465)
..... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 159 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 159 SEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 43211 1234467899999998875 45889999999999999999999999764321111111110000
Q ss_pred -------------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 -------------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 -------------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
............+++++.+++.+||..+|++||++.++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 0001112223467899999999999999999999665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.61 Aligned_cols=265 Identities=17% Similarity=0.285 Sum_probs=202.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+|++.+.||.|+||.||+|.+. .++..||+|++.... ....+..|+.++..+.++++|..+..++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999874 478999999886432 1235678999999998778888887777777888
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++++++ +++|.+++.. ...+++..+..++.|++.+|.|||+.|++||||+|+|||+ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999998 7899998875 4678999999999999999999999999999999999999 578999999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH-HHHhhhhcc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISEKKML 234 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~ 234 (465)
.... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||...........+ ..+......
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 157 EDEV------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230 (290)
T ss_pred cccc------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC
Confidence 3221 112245689999999998763 4678999999999999999999999753222221222 111111111
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
....+++.+.+++.+||..+|++||+.. .+.+++. .++...+.|....
T Consensus 231 -----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~-------~~~~~~~~~~~~~ 280 (290)
T cd05613 231 -----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK-------HPFFQKINWDDLA 280 (290)
T ss_pred -----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc-------CcccccCCHHHHh
Confidence 1245688999999999999999998321 1333333 5566667786553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.82 Aligned_cols=264 Identities=19% Similarity=0.288 Sum_probs=205.1
Q ss_pred ceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+|++.+.||.|+||.||+|++. .++..||||++.... ....+..|++++..+.+++++..+......+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467899999876421 2235778999999998767666666666677788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++||+++ +++|.+++.. ...+++..+..++.|++.+|.|||+.+++|+||+|+||++ +.++.++|+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999998 7899988864 4579999999999999999999999999999999999999 578899999999987654
Q ss_pred cccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH-HHHhhhhcc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISEKKML 234 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~ 234 (465)
.... .......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...........+ ..+......
T Consensus 157 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 157 AEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230 (288)
T ss_pred cccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC
Confidence 3211 1123456899999999987765 788999999999999999999999653222111121 111111111
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
....++.++.+++.+||+.+|++||++.++.+.|++ +++...+|...
T Consensus 231 -----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~-------~~~~~~~~~~~ 277 (288)
T cd05583 231 -----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH-------PFFQGIDWDDL 277 (288)
T ss_pred -----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC-------cccccCCHHHH
Confidence 123468899999999999999999999888888775 45556678654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=286.03 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=196.1
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCC----cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTG----EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~----~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
|++.+.||.|+||.||+|.+...+ ..||+|++..... ...+..|+.++..+.|++++..+..+ .+....+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC-TEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE-cCCCeeEEE
Confidence 467899999999999999987766 8999999875543 34788899999999776655555544 445678888
Q ss_pred Eecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~-ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|+++ +++|.+++...... +++.++..++.|++.+|+|||+.+++|+||||+||++ +.++.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 8887 88999999754333 9999999999999999999999999999999999999 57889999999999876543
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+..+........
T Consensus 157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~-- 225 (258)
T smart00219 157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRLPK-- 225 (258)
T ss_pred cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCCCC--
Confidence 2211 112237789999999988889999999999999999998 8899976432 333333332222211
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
...+|.++.+++.+||..+|++||++.++.+.|
T Consensus 226 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 134689999999999999999999988887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=289.39 Aligned_cols=248 Identities=19% Similarity=0.267 Sum_probs=187.2
Q ss_pred eeEeeeCceEEEEEEEcC--CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQ--TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~--~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|.... ....+|+|.+..... ...+.+|+.+++.+.|++++..+..+. .....+++||++ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-ESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCceEEEEEeCCC
Confidence 368999999999996433 345788887654322 235678999999998887777666554 556788999998 8
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 87 PSLEDLFNYCN----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 87 ~sL~~ll~~~~----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDY- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchh-
Confidence 89999987532 235688899999999999999999999999999999999 5889999999999865432111
Q ss_pred ccccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHH-Hhhhhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK-ISEKKM 233 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~-i~~~~~ 233 (465)
+.......+++.|+|||++.. ..++.++|||||||++|||++ |..||...... +.+.. +.....
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~ 228 (269)
T cd05042 156 ----YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQDI 228 (269)
T ss_pred ----eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccCc
Confidence 011233456788999998743 356889999999999999999 88999764322 22222 222223
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
..+.+.....++..+.+++..|| .||++||++.+|.++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 33333445678899999999999 5999999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=288.66 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=196.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------------CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------------HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+|.+.+.||.|+||.||+|.+..+++.||||.+..... ...+..|+.++..+.|++++..+. ++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG-FETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE-EeccC
Confidence 68999999999999999999988999999998753211 124667899999998876665554 55566
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...++|+|++ +++|.+++... ..+++..+..++.|++.+|.|||+++++|+||+|+||++ +.++.++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 7888999988 89999998753 679999999999999999999999999999999999999 588999999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
........ .......|+..|+|||.+.... ++.++|+||||+++|++++|..||..... .+.+..+....
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR 228 (272)
T ss_pred cccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence 64332111 1123456889999999987755 78999999999999999999999965322 22222222111
Q ss_pred -ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 -MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 -~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...........++.++.+++..||..+|++||++.+|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111222334567899999999999999999999777654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=292.58 Aligned_cols=246 Identities=21% Similarity=0.329 Sum_probs=197.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
...|+.++.||.|+||.||+|.+..++..||||++..... ...+..|++++..+.|++++..+. ++..+...++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEE-EEEECCEEEEEE
Confidence 3578899999999999999999988999999998875432 235788999999998765555555 556677899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ +++|.+++. .+.+++.++..++.|++.+|+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE---cCCCCEEEcccccceeccCCcc
Confidence 998 889999886 4579999999999999999999999999999999999999 5788999999999976543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......++..|+|||++.+..++.++|+|||||++|||++|..||....... ....+.... .+...
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~----~~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFLIPKNN----PPTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---HhhhhhcCC----CCCCc
Confidence 1233468889999999998889999999999999999999999998754322 111111111 11122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+|..+.+++..||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 346889999999999999999999877744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=288.65 Aligned_cols=236 Identities=17% Similarity=0.240 Sum_probs=187.0
Q ss_pred eeEeeeCceEEEEEEEcCCC----------cEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 13 RKIGSGSFGELYLGVNVQTG----------EEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~----------~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.||+|+||.||+|.+..++ ..|++|++..... ...+.+|+.+++.+.|++++..+..+.. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEE
Confidence 46899999999999987766 4588887665433 4578889999999998887777766655 556889
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC-------cEEEEecCCc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-------QVYIIDYGLA 153 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~-------~vkL~DFGla 153 (465)
++++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+. ..+ .++|+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9988 8899999886445799999999999999999999999999999999999995 444 7999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...........+. .
T Consensus 156 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~ 221 (259)
T cd05037 156 ITVLS-----------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D 221 (259)
T ss_pred ccccc-----------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence 76432 1234567889999999876 78999999999999999999 688887754322222221 1
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
.. ..+ ......+.+++.+||..+|.+||++.+|.+.|
T Consensus 222 ~~-~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 QH-RLP-----MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CC-CCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11 111 11137899999999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=291.05 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=193.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++++.||+|+||.||+|.+..+++.||+|++..... ...+..|++++..+.|++++..+..+ ..+...++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-RRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-ccCCeEEEEE
Confidence 579999999999999999999988999999998764322 23577899999999887766665554 5667889999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ ++.|.++.. ....+++.++..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 998 555555554 34569999999999999999999999999999999999999 5889999999999976543221
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh---------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--------- 231 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (465)
......++..|+|||++.+. .++.++||||||+++|||++|..||...........+......
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 11234688999999998764 4788999999999999999999999764321111111110000
Q ss_pred --------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 --------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 --------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....+......+++..+.+++..||..+|++||++.+|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0001111223467899999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=295.04 Aligned_cols=255 Identities=20% Similarity=0.210 Sum_probs=197.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~lv 81 (465)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... ..+..|+.+++.+.|++++..+..+... ....+++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 5799999999999999999999889999999988754322 2457899999999987766655554333 2789999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++++.++|.+++......+++..+..++.|++.||+|||++|++|+||||+|||+ +.++.++|+|||++........
T Consensus 85 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 85 MEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred ehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCCcc
Confidence 9999889999998656679999999999999999999999999999999999999 5889999999999986654211
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh--------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK-------- 232 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------- 232 (465)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.......
T Consensus 162 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 162 -------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred -------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 122345788999999987644 6889999999999999999999998754322222211100000
Q ss_pred --cc-------------CcHHHHhcc-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 --ML-------------TPIEVLCKS-YPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 --~~-------------~~~~~~~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.. .....+... +++.+.++|..||..+|++||++.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000011111 4788999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=285.72 Aligned_cols=250 Identities=18% Similarity=0.331 Sum_probs=205.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++.+.+..||+|.-|+||+++...+|...|||.+..... ..+++..+.++......+.|+....|+..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345677889999999999999999999999998875433 33567777777777667777777777777777889999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++..-++.++....+++++..+-.+...++.||.||-.+ ||+|||+||+|||+ |..|++||||||++-.+.+...+
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc
Confidence 999999999998889999999999999999999999864 79999999999999 79999999999999888775543
Q ss_pred ccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
....|-+.|||||.+.- ..|+.++||||||++|+||.||..||.+.+.+ -+.+.++..... |.-.
T Consensus 249 --------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~eP--P~L~ 316 (391)
T KOG0983|consen 249 --------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNEEP--PLLP 316 (391)
T ss_pred --------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhcCC--CCCC
Confidence 34579999999999864 35899999999999999999999999986432 334444444222 2111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...++++.|.+|+..||.+|+.+||.|.+|.+
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 22458999999999999999999999887643
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=298.39 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=199.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC----cEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----EYNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~ 79 (465)
+|++.+.||.|+||.||+|++..+++.||||++.... ....+..|+.+++.+.|++++..+..+.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999998889999999877532 3346888999999999877777666655443 4679
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++|++++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeeccc
Confidence 9999998899988874 4589999999999999999999999999999999999999 57899999999999876543
Q ss_pred cCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc----
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML---- 234 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~---- 234 (465)
.... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... +.+..+......
T Consensus 157 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 157 EDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEE 229 (330)
T ss_pred cccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChh
Confidence 2110 112345688999999999888 7899999999999999999999999875432 222222211100
Q ss_pred ----------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 ----------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ----------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+.......++.++.++|..||.++|++||+++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 011112234688999999999999999999976654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=300.19 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=203.1
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHH-cCCCCCceeEEEeEe-
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLL-QGGTGVPHLKWFGVE- 74 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l-~~~~~i~~l~~~~~~- 74 (465)
++..+.++|++.+.||+|+||.||+|.+..+++.||||.+... .....+..|+.++..+ +|+++++.+..|...
T Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 3567889999999999999999999999889999999977532 2233567899999999 777777777665543
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
....+++++++.++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++.
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~ 155 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLAR 155 (337)
T ss_pred CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchh
Confidence 457899999998899988873 378999999999999999999999999999999999999 589999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh---
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE--- 230 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (465)
......... .........|+..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.........+.....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 764432110 0012234568999999998765 4578899999999999999999999976443222111111100
Q ss_pred --------------------hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 --------------------KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 --------------------~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...........+.++.++.++|..||..+|++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00111122333457899999999999999999999766654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=283.98 Aligned_cols=246 Identities=20% Similarity=0.222 Sum_probs=199.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++.+.||+|+||.||++.+..+++.||||.+.... ....+..|+.+++.++|++++..+ .+.......+++++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ-ESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeE-eeecCCCeEEEEEe
Confidence 6999999999999999999999999999999876432 223678899999999987655544 44566678899999
Q ss_pred cc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++... ...+++.+++.++.|++.+|.|||++|++|+||+|+|||+ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 88 88999988753 3468999999999999999999999999999999999999 5788999999999976543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||... .....+..+....... ..
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08218 157 -------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYPP----VS 222 (256)
T ss_pred -------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCCC----Cc
Confidence 112346889999999999888999999999999999999999999753 2333333333222211 12
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.++|.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 456899999999999999999999777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.92 Aligned_cols=252 Identities=19% Similarity=0.224 Sum_probs=194.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++.+.||.|+||+||+|.+..+++.||||++..... ...+..|+++++.+.|++++..+. +...+...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD-VVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEE-EEecCCeEEEEE
Confidence 579999999999999999999988999999998765422 245788999999998866555554 445667899999
Q ss_pred eccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++++++|.+++.... ..+++..+..++.||+.||+|||+++++|+||+|+|||+. +.++.+||+|||++.......
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCc-
Confidence 999889988886433 3368899999999999999999999999999999999994 345689999999997643321
Q ss_pred cccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh-h-------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-K------- 232 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-~------- 232 (465)
.......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... ..+.++... .
T Consensus 158 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~---~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 158 ------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI---DELFKIFRILGTPNEETW 228 (294)
T ss_pred ------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChhhc
Confidence 112334678999999988764 4788999999999999999999999764321 122111110 0
Q ss_pred ----------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 ----------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ----------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...........+++++.+++.+||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111223457889999999999999999999777654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.20 Aligned_cols=255 Identities=20% Similarity=0.279 Sum_probs=201.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||.|+||+||+|.+..++..||+|++.... ....+..|+++++.+.|++++..+.. .......+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS-FVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEE-EeeCCEEEEEEe
Confidence 57999999999999999999998899999999987543 23468889999999988776665544 455677889999
Q ss_pred cc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 84 LL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 84 ~~-g~sL~~ll~~~--~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
++ +++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||+|+||++ ++++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 88 88999998753 2468999999999999999999999999999999999999 578899999999998766533
Q ss_pred CcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc-CcHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML-TPIE 238 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~ 238 (465)
... ........|+..|+|||++... .++.++|+||||+++|+|++|+.||....... .+......... ....
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQNDPPSLETG 230 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcCCCCCcCCc
Confidence 211 0123455789999999998877 78999999999999999999999998754322 22222222111 1111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....+++++.+++..||..||++||++.+|.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111367899999999999999999999776653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=283.31 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=198.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..+|++.+.||.|+||.||+|.+. .+..+|+|++..... ...+..|+++++.+.|++++..+.. .......++++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~~v~e~ 80 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGV-CTERSPICLVFEF 80 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEE-EccCCceEEEEEc
Confidence 458999999999999999999874 477899998765432 3578899999999998776665554 4455577889998
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++......+++..+..++.|++.+|+|||+.+++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE---cCCCeEEECCCcceeecccCcc--
Confidence 7 889999987655678999999999999999999999999999999999999 4788999999999876533211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+........ ..
T Consensus 156 ----~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~~----~~ 224 (256)
T cd05112 156 ----TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRLYK----PR 224 (256)
T ss_pred ----cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCCCC----CC
Confidence 11123345678999999998889999999999999999998 9999976432 233333222211111 12
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
..+.++.+++.+||..+|++||++.++.+.|
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3589999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=294.13 Aligned_cols=252 Identities=19% Similarity=0.317 Sum_probs=197.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
--++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+..++++..+..++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 45789999999999999999999988899999999875432 224566777777776555566666666677789999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|++++++|.+++......+++..+..++.|++.+|.|||+ .||+||||+|+|||+ +.++.++|+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCCC
Confidence 9999999999988766789999999999999999999997 599999999999999 588999999999997654322
Q ss_pred CcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||..... ..+.+..+........
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~ 239 (296)
T cd06618 170 A--------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPSL 239 (296)
T ss_pred c--------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCCC
Confidence 1 12335788999999987654 78899999999999999999999975322 1222222222211111
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. ....++.++.+|+.+||..||++||++.++.+
T Consensus 240 ~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 240 P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 11246899999999999999999999877654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.10 Aligned_cols=253 Identities=20% Similarity=0.314 Sum_probs=199.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|++++.||.|+||.||+|+... +.+.|++|.+...... ..+..|++++..+.|++++..+. +..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG-LCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEE-EECCCCc
Confidence 4789999999999999999999654 3568999987654332 46888999999998876655444 5556677
Q ss_pred EEEEEecc-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN--------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~--------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
.++||+++ +++|.+++.... ..+++..+..++.|++.+|.|||+.+|+|+||||+|||+ +..+.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV---SSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE---eCCCcEEEc
Confidence 89999998 789999987532 158999999999999999999999999999999999999 478899999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (465)
|||++....... +.......+++.|+|||.+.+..++.++||||||+++|++++ |..||..... ...+..
T Consensus 160 ~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNR 230 (275)
T ss_pred ccccccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHH
Confidence 999987543211 112234456788999999988889999999999999999998 8899976433 223333
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+.......+. ...+|..+.+++.+||..+|++||++.++...|.
T Consensus 231 ~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3322222221 2457899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=289.25 Aligned_cols=250 Identities=20% Similarity=0.232 Sum_probs=195.3
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++++.||.|+||.||+|++..+++.||||++..... ...+..|++++..++|++++..+..+ .++...+++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-ccCCcEEEEee
Confidence 48999999999999999999999999999998765432 23578899999999987766666554 56668899999
Q ss_pred ccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++.++|.+++... ...+++..+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 9988999888754 3568999999999999999999999999999999999999 5889999999999876532211
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh-hc-------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-KM------- 233 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~------- 233 (465)
......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ...+... ..
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWP 226 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCChhhhh
Confidence 112335788999999887654 58899999999999999999999976432111 1111110 00
Q ss_pred ----------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 ----------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 ----------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..........+++++.++|.+||..||.+||+++++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00011122356788999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=289.67 Aligned_cols=251 Identities=20% Similarity=0.329 Sum_probs=196.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHc---CCCCCceeEEEeEeCcEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~---~~~~i~~l~~~~~~~~~~~lv 81 (465)
.|++.+.||.|+||.||+|.+..+++.||||++..... ...+..|+.++..+. |++++..+. ++..+...+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~-~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYG-SYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEee-eeeeCCEEEEE
Confidence 58889999999999999999999999999998865422 345778999999997 555555444 45567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. ..+++..+..++.|++.+|.|||+.||+|+||+|+||++ +.++.++|+|||++..+....
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCc
Confidence 9988 8899998863 479999999999999999999999999999999999999 478999999999998765432
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+... ...+..+... .+...
T Consensus 156 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~---~~~~~~~~~~---~~~~~ 222 (277)
T cd06917 156 S-------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---FRAMMLIPKS---KPPRL 222 (277)
T ss_pred c-------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh---hhhhhccccC---CCCCC
Confidence 1 1234468999999999865 4478999999999999999999999976432 2222111111 11111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....++.++.+++..||..||++||++.++.. +.|.+.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~---~~~~~~ 260 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK---SKWIKA 260 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh---ChHhhc
Confidence 11237899999999999999999999777643 444433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=287.84 Aligned_cols=242 Identities=25% Similarity=0.292 Sum_probs=197.8
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|++++..++|++++..+.. ..++...++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS-FQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHh-hcCCCeEEEEE
Confidence 5899999999999999999998899999999887542 23467889999999988766655544 45667889999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++.. ...+++..+..++.||+.+|.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 80 DLLLGGDLRYHLSQ-KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred eCCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCc-
Confidence 988 8999999875 3589999999999999999999999999999999999999 588999999999987654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.........+........ .....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~ 222 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA-----DVLYP 222 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc-----cccCc
Confidence 123456889999999999888999999999999999999999999876543233222222211 11222
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYS 267 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~ 267 (465)
..+|.++.++|.+||..||.+||+..
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 45789999999999999999999973
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=286.50 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=196.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-------CCccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-------KHPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYN 78 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~ 78 (465)
.+|++.+.||+|+||.||+|.+..++..||+|++.... ....+..|+++++.++|++++..+..+... ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 58999999999999999999999999999999875321 113577899999999988877777665443 4567
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++++++ +++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||||+||++ +.++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECccccccccc
Confidence 7888888 8899999874 3568999999999999999999999999999999999999 578899999999998653
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
...... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||..... ...+..+.. ....
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~---~~~~ 227 (264)
T cd06653 158 TICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIAT---QPTK 227 (264)
T ss_pred cccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHc---CCCC
Confidence 211100 112245689999999999998899999999999999999999999976422 222222211 1112
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+.+...+++++.+++.+||. +|..||+..++.
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 23446778999999999999 579999977654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=283.02 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=202.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++.+.||.|+||.||+|.+..+++.|+||++..... ...+..|+..+..++|++++..+. +.......+++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-AFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEE-EEccCCeEEEEEE
Confidence 479999999999999999999999999999998876543 456889999999999766555444 4455578889998
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++.. ...+++..++.++.|++.+|.|||+ .+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 88 6999999985 3679999999999999999999999 999999999999999 5899999999999986643221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........+....+...... ...
T Consensus 156 -------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~ 224 (264)
T cd06623 156 -------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP----SLP 224 (264)
T ss_pred -------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCC----CCC
Confidence 112456889999999999988999999999999999999999999876432333444333322221 122
Q ss_pred cc-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KS-YPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.. ++..+.+++..||..+|++||++.+|.+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 33 7899999999999999999999776654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=317.00 Aligned_cols=262 Identities=18% Similarity=0.185 Sum_probs=186.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCC-cEEEEE------------------Eee-cCCCCccHHHHHHHHHHHcCCC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTG-EEVAVK------------------LES-VKTKHPQLHYESKLYMLLQGGT 63 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~-~~vAvK------------------i~~-~~~~~~~~~~E~~il~~l~~~~ 63 (465)
.+.++|++++.||+|+||+||+|...... ..+++| .+. .......+.+|+.++..+.|++
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 35678999999999999999998754322 222222 111 0111235778999999999877
Q ss_pred CCceeEEEeEeCcEEEEEEeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~sL~~ll~~~----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~ 139 (465)
++..+..+ ......++++++++++|.+++... ........+..|+.||+.||.|||++|||||||||+|||+
T Consensus 225 Iv~l~~~~-~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--- 300 (501)
T PHA03210 225 ILKIEEIL-RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--- 300 (501)
T ss_pred cCcEeEEE-EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence 76665554 556678899999988888877532 1234567788999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCCCC
Q 012336 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP-WQGLKA 218 (465)
Q Consensus 140 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~P-f~~~~~ 218 (465)
+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|..+ |.....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKERE------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred CCCCCEEEEeCCCceecCcccc------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 5889999999999987643221 112346799999999999999999999999999999999998754 443322
Q ss_pred CchHHHHHHHhhhh-----c---------------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012336 219 GTKKQKYDKISEKK-----M---------------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRL 272 (465)
Q Consensus 219 ~~~~~~~~~i~~~~-----~---------------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (465)
....+....+.... . ..+.......++..+.+++.+||..||.+||++.++
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el--- 451 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL--- 451 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH---
Confidence 22222221111000 0 000011112467788999999999999999997665
Q ss_pred HHHHHH
Q 012336 273 FRDLFI 278 (465)
Q Consensus 273 L~~~~~ 278 (465)
|.+.|.
T Consensus 452 L~hp~f 457 (501)
T PHA03210 452 LALPLF 457 (501)
T ss_pred hhChhh
Confidence 444443
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=286.88 Aligned_cols=253 Identities=22% Similarity=0.249 Sum_probs=195.1
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+|++.+.||.|++|.||+|++..+++.||||++.... ....+..|+.+++.++|++++.. ..++......+++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~-~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeee-eeeEeeCCcEEEEEec
Confidence 5899999999999999999999999999999887543 23457789999999987665554 4455566778999999
Q ss_pred cCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 85 LGPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 85 ~g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+.++|.+++.... ..+++..+..++.|++.+|.|||++|++|+||||+||++ +.++.++|+|||++.......
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~-- 154 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPV-- 154 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCc--
Confidence 9889999887533 468999999999999999999999999999999999999 588999999999997553321
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc--------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM-------- 233 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (465)
.......+++.|++||.+.+. .++.++||||||+++|+|++|..||.+.........+........
T Consensus 155 -----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 155 -----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred -----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 112234578899999988664 578899999999999999999999987543322222111100000
Q ss_pred ----------c---CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 ----------L---TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 ----------~---~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .........++.++.+++..||+.||.+||++.+|.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 0001112345788999999999999999999777653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=296.00 Aligned_cols=251 Identities=19% Similarity=0.287 Sum_probs=197.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|++++.||+|+||.||+|.+..++..||||++..... ...+..|+.+++.+.|++++..+..+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 67899999999999999999999999999999998764322 235778999999999988887777665443
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++++|++++++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccccc
Confidence 2468999999999998887 4679999999999999999999999999999999999999 4788999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh---
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--- 231 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (465)
.... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.+.........+..+...
T Consensus 168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 168 TDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 4321 123467899999999876 35889999999999999999999999864332111111110000
Q ss_pred --------------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 --------------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 --------------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
............+++++.++|..|+..||.+||++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000001112245678899999999999999999976654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=292.02 Aligned_cols=261 Identities=21% Similarity=0.233 Sum_probs=202.0
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEe---
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVE--- 74 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~--- 74 (465)
+.+.-++|++.+.||.|+||.||+|.+..+++.||||++..... ...+..|+++++.++|++++..+..+...
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 35667899999999999999999999998999999999875432 23567899999999988877776655432
Q ss_pred ------CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 75 ------GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 75 ------~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
....+++++++.++|.+++......+++..+..++.|++.||.|||+.||+|+||||+||++ +.++.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence 23789999999889988887545579999999999999999999999999999999999999 588999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
|||++..+..... .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+..
T Consensus 159 dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 159 DFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999986643221 111233567889999988653 468899999999999999999999976433222222222
Q ss_pred Hhhhhcc----------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 228 ISEKKML----------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 228 i~~~~~~----------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....... ......+..+|..+.+++..||..+|.+||++.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111000 0011123457899999999999999999999877754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.78 Aligned_cols=248 Identities=19% Similarity=0.328 Sum_probs=203.2
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+.|.++..||.|+||.||+|.++.++-..|.|++..+.. ...++.|+.||..+.|+.++..+..|..++..+ |+.+|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw-iliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW-ILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE-EEEee
Confidence 457888999999999999999998888889998776543 347889999999999988888888877777655 55566
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
| ||-....+-..++.|++.++..+.+|++.+|.|||+++|||||||+.|||++ .+|.++|+|||.+.......
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~--- 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTR--- 184 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHH---
Confidence 6 7777777777789999999999999999999999999999999999999996 78999999999987654321
Q ss_pred cccccCCCCccccccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 164 HIPYRENKNLTGTARYASVNTH-----LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~-----~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
....++.|||.|||||+. ...+|++++||||||++|.||..+.+|-..+++. ..+.++..... |.-
T Consensus 185 ----qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM---RVllKiaKSeP--PTL 255 (1187)
T KOG0579|consen 185 ----QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSEP--PTL 255 (1187)
T ss_pred ----hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH---HHHHHHhhcCC--Ccc
Confidence 234678999999999975 4677999999999999999999999999887653 33333333222 211
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....++..|.+|+..||.+||+.||++.+|.
T Consensus 256 lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 256 LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred cCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 22245688999999999999999999987664
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=283.42 Aligned_cols=245 Identities=27% Similarity=0.379 Sum_probs=196.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+|+..+.||+|+||.||+|.+..++..|++|++.... ....+..|+.++..+.|++++.... +...+...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG-TEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheee-eEecCCeEEE
Confidence 5888999999999999999998899999999876543 2245788999999998876666554 4556667888
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+++++ +++|.+++.. ...+++..+..++.||+.+|.|||+.|++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99998 7899999875 4568999999999999999999999999999999999999 58899999999998765432
Q ss_pred cCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
. ......|+..|++||.+.... ++.++|+||||+++|+|++|..||.... .......+...... .
T Consensus 156 ~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~---~ 221 (258)
T cd06632 156 S--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKEL---P 221 (258)
T ss_pred c--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---HHHHHHHHHhcccC---C
Confidence 2 123456899999999988776 8999999999999999999999997643 22222222211111 1
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....+++.+.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 122456899999999999999999999777653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=294.02 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=192.1
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCC--CcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEe----EeCcE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQT--GEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFG----VEGEY 77 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~--~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~----~~~~~ 77 (465)
+|++.+.||+|+||.||+|++..+ +..||||.+.... ....+..|+.+++.+.+|++|..+..+. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8999999876432 2335778999999996444444443332 22345
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.++++++++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||+ +.++.++|+|||++..+.
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 789999999999998864 5679999999999999999999999999999999999999 588999999999998664
Q ss_pred cccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH-----------
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY----------- 225 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~----------- 225 (465)
...... ........|+..|+|||.+.+ ..++.++||||||+++|++++|..||...+.....+..
T Consensus 157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 322110 011234578999999998766 46899999999999999999999999764421111110
Q ss_pred -HHHhh-----------hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 226 -DKISE-----------KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 226 -~~i~~-----------~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
..+.. .............++.++.+++.+||..||.+||++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00000 000111122234567899999999999999999997665
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.44 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=195.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEe-----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVE----- 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (465)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..++|++++..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 36789999999999999999999998999999999886432 123577899999999998888777665432
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
....++++++++++|.+++. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEecccccc
Confidence 23478899999999998886 3569999999999999999999999999999999999999 588899999999987
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ +..+.....
T Consensus 169 ~~~~----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~ 235 (345)
T cd07877 169 HTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVG 235 (345)
T ss_pred cccc----------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence 5432 1234568899999999876 4688999999999999999999999976433221 111111100
Q ss_pred c--------------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 L--------------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ~--------------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ..........++++.++|..|+..||.+||++.++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 0 000111124578899999999999999999966543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=294.05 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=197.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+.|+..+.||+|+||.||+|.+..++..||+|++..... ...+..|+.++..+.|+++++.+..+ ..+...++|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY-LKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccc-ccCCceEEEE
Confidence 3467788899999999999999988999999998774432 23578899999999887666655544 5566789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ +++|.+++. .+.+++..+..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 82 EYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE---eCCCCEEEccccccccccCcch
Confidence 999 789988886 4679999999999999999999999999999999999999 4789999999999976543211
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|+..|+|||.+.+..++.++|+||||+++|||++|..||.......... .+..... ....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~~~~----~~~~ 222 (277)
T cd06642 157 -------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LIPKNSP----PTLE 222 (277)
T ss_pred -------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hhhcCCC----CCCC
Confidence 1223468899999999999899999999999999999999999997644322211 1111111 1122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+++..||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 356889999999999999999999877765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=285.79 Aligned_cols=242 Identities=19% Similarity=0.266 Sum_probs=187.1
Q ss_pred CceEEEeeE--eeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKI--GSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~L--G~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++|.+.+.+ |+|+||.||++.+..++..+|+|++....... .|......+.+++++..+..++......++|||+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 567777776 99999999999999999999999987543221 2333444444455666666665666788999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC-cEEEEecCCccccccccCc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~-~vkL~DFGla~~~~~~~~~ 162 (465)
+ +++|.+++.. ...+++.++..++.||+.||.|||+.|++||||||+||++. .++ .++|+|||++......
T Consensus 91 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 91 IKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred CCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC---
Confidence 8 8999999985 34899999999999999999999999999999999999994 555 8999999998765321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
....|+..|+|||++.+..++.++||||||+++|+|++|..||......... ...+.... ... ....+
T Consensus 164 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~-~~~-~~~~~ 231 (267)
T PHA03390 164 --------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQ-QKK-LPFIK 231 (267)
T ss_pred --------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHHhh-ccc-CCccc
Confidence 2346899999999999989999999999999999999999999864432211 11111111 111 11224
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPD-YSYLK 270 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt-~~~l~ 270 (465)
.+++.+.++|..||+.+|.+||+ +++|+
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 67899999999999999999995 46654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=285.46 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=197.8
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||.|+||.||+|++..+++.||+|++.... ....+..|++++..+.|++++..+..+ .++...+++++++ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-KDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-EcCCccEEEEecCCCCc
Confidence 689999999999998889999999987532 224588899999999887766666644 5666788999987 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~-------- 147 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQ-------- 147 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCccc--------
Confidence 9999875 4568999999999999999999999999999999999999 578999999999998764421
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEF 248 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l 248 (465)
......|++.|++||.+.+..++.++|+||||+++|+|++|..||...... ....+..+......... ....++++
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~ 223 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-PMEIYNDILKGNGKLEF---PNYIDKAA 223 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-HHHHHHHHhccCCCCCC---CcccCHHH
Confidence 122346889999999998888999999999999999999999999875431 22333333211111111 12347899
Q ss_pred HHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCcccccc
Q 012336 249 TSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWT 291 (465)
Q Consensus 249 ~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~ 291 (465)
.++|..||..+|++||+ +.++.+ ++|+..++|.
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~----------~~~~~~~~~~ 261 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK----------HKWFNGFDWE 261 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc----------ChhhhCCCCC
Confidence 99999999999999999 454433 5666667785
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=283.07 Aligned_cols=245 Identities=21% Similarity=0.320 Sum_probs=192.8
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
++||.|+||.||+|.+.. ++.||+|++..... ...+..|+++++.+.|++++..+ .+.......+++++++ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI-GVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEE-EEEecCCCeEEEEEcCCCCc
Confidence 479999999999999876 99999998775433 24678899999999887655544 4455666778899987 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
|.+++......+++..+..++.+++.+|.|||+++++||||||+|||+ +.++.++|+|||++......... .
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~-----~ 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYT-----V 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCcce-----e
Confidence 999987655678999999999999999999999999999999999999 58899999999999765421110 0
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||.........+. +... ...+ ....+|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~---~~~~-~~~~---~~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER---IESG-YRMP---APQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH---HhcC-CCCC---CCccCCHH
Confidence 1112234677999999998889999999999999999999 8999987543222222 2111 1111 12356899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 248 FTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
+.+++.+||..+|.+||++.+|.+.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=287.60 Aligned_cols=249 Identities=20% Similarity=0.229 Sum_probs=195.3
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
|++.+.||.|++|.||+|.+..++..||||++..... ...+..|++++..++|++++..+..+ .++...++++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-HSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-ccCCeEEEEEec
Confidence 6789999999999999999999999999998875432 23577899999999987776666554 456788999999
Q ss_pred cCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 LGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++++|.+++.... ..+++.++..++.|++.+|+|||+++++|+||+|+|||+ +.++.++|+|||++.......
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCcEEEeecccccccCCCc---
Confidence 9889999987533 369999999999999999999999999999999999999 478999999999997543221
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh-----------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK----------- 231 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (465)
.......++..|+|||++.+. .++.++||||||+++|+|++|..||........ +..+...
T Consensus 154 ----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 154 ----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ---LFRIFRTLGTPDEDVWPG 226 (283)
T ss_pred ----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhh
Confidence 111233568899999988764 478899999999999999999999976432111 1111110
Q ss_pred -------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 -------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 -------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
............++.++.+++.+||+.+|.+||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0001112234567889999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=287.45 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=197.2
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEEEEEEe
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYNVMVID 83 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~lv~e 83 (465)
|++.+.||.|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.|++++..+..+... ....+++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999899999999987653 223577899999999988877777666554 378899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++..+..++.||+.||+|||+.|++|+||+|+|||+ +.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCc--
Confidence 99889999987544689999999999999999999999999999999999999 5899999999999987654321
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc---------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM--------- 233 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (465)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...........+........
T Consensus 156 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 156 ----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred ----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 01123356888999998765 4578999999999999999999999986543221111111100000
Q ss_pred -------------cCcHHHHhcc-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 234 -------------LTPIEVLCKS-YPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 234 -------------~~~~~~~~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.......... +++++.+++..||..+|.+||++.++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000111122 3889999999999999999999877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=284.56 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=192.3
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHc---CCCCCceeEEEeEeCc----E
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQ---GGTGVPHLKWFGVEGE----Y 77 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~---~~~~i~~l~~~~~~~~----~ 77 (465)
|++.+.||.|+||.||+|++..+++.||||++...... ..+..|+.++..+. |++++..+..+..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999998754322 24567888887775 6555555555443322 4
Q ss_pred EEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++.++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+|||+ +.++.++|+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 88999999889999887643 369999999999999999999999999999999999999 57899999999999776
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh----
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---- 232 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (465)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||.+..... .+.++....
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 226 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD---QLDKIFDVIGLPS 226 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---HHHHHHHHcCCCC
Confidence 43211 123357889999999999899999999999999999999999998754322 222221110
Q ss_pred ------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...........+++.+.+++..||..||.+||++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 00111122234568899999999999999999977765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=311.94 Aligned_cols=250 Identities=21% Similarity=0.341 Sum_probs=210.4
Q ss_pred EEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec------CCCCccHHHHHHHHHHHcCCCCCceeEE-EeEeCcEEEEEE
Q 012336 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV------KTKHPQLHYESKLYMLLQGGTGVPHLKW-FGVEGEYNVMVI 82 (465)
Q Consensus 10 ~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~------~~~~~~~~~E~~il~~l~~~~~i~~l~~-~~~~~~~~~lv~ 82 (465)
+....||+|+|=+||+|.+..+|.+||.-.++. ....+++..|+++|+.|+|+|+|..+.. ....+....+++
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 566789999999999999999999999754332 2223578999999999999999988854 444566777888
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|++ .|+|..+++. -+++..+.+..|+.||+.||.|||++. |||||||.+||+|. ...|.|||.|+|||+.....
T Consensus 123 EL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhcc
Confidence 888 9999999986 568999999999999999999999986 99999999999997 57799999999999987653
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ...+.|||.|||||++. ..|+..+||||||+|++||+|+..||... ....|+|.++..+..+..
T Consensus 200 ~---------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC--~n~AQIYKKV~SGiKP~s--- 264 (632)
T KOG0584|consen 200 H---------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC--TNPAQIYKKVTSGIKPAA--- 264 (632)
T ss_pred c---------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh--CCHHHHHHHHHcCCCHHH---
Confidence 3 24589999999999998 67999999999999999999999999875 457888888777654433
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
+.+--.+++++||.+|+.. ..+||+ ++++|.+.|....
T Consensus 265 l~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred hhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 3333479999999999999 999999 6667888876553
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=285.95 Aligned_cols=257 Identities=21% Similarity=0.244 Sum_probs=196.0
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||+|+||+||+|.+..+++.||+|++.... ....+..|+++++.++|++++..+..+ ......+++++++ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-ETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-ecCCeEEEEEecCCCCc
Confidence 689999999999999999999999876432 223467899999999876666655555 4556788999988 789
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccc
Q 012336 89 LEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167 (465)
Q Consensus 89 L~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (465)
|.+++.... ..+++..+..++.|++.+|.|||+.|++|+||+|+|||+ +.++.++|+|||++.......
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCC-------
Confidence 999887533 369999999999999999999999999999999999999 588999999999987654311
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
......++..|+|||++.+..++.++||||||+++|+|++|+.||...........+.. ..... .......++++
T Consensus 150 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~ 224 (277)
T cd05577 150 -KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTLEM-AVEYPDKFSPE 224 (277)
T ss_pred -ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---ccccc-cccCCccCCHH
Confidence 12345678899999999988899999999999999999999999977543222222211 11111 11122456899
Q ss_pred HHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCccccccccC
Q 012336 248 FTSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+.++|.+||+.+|.+||++.+ +.+++. +++...++|...+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~~~~~~ll~-------h~~~~~~~~~~~~ 266 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRGGSADEVRE-------HPLFKDLNWRRLE 266 (277)
T ss_pred HHHHHHHHccCChhHccCCCcccHHHHHh-------ChhhhcCChhhhh
Confidence 999999999999999994333 222233 4555567787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=281.32 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=197.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.|++++..+.. .......+++++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~-~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV-EVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeee-EecCCEEEEEEe
Confidence 69999999999999999999988999999999876543 3467889999999988766655554 456678889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCc
Confidence 98 8999999875 4568999999999999999999999999999999999999 47899999999999876543221
Q ss_pred ccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-ccCcHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK-MLTPIE 238 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-~~~~~~ 238 (465)
.. .......+++.|+|||.+.+.. ++.++||||||+++|++++|..||..... .......+.... ...+
T Consensus 156 ~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~-- 228 (264)
T cd06626 156 MG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIP-- 228 (264)
T ss_pred cc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCCCCCCC--
Confidence 10 0022456889999999998766 88999999999999999999999976532 122221122111 1111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....+++.+.+++..||..+|++||++.++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 229 -DSLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred -cccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1124588999999999999999999987764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=287.44 Aligned_cols=258 Identities=17% Similarity=0.210 Sum_probs=208.7
Q ss_pred cCCceEEE-eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE----eCcEEE
Q 012336 5 IGGKFKLG-RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV----EGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~-~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~----~~~~~~ 79 (465)
+.++|.+- ++||-|-.|.|-.+.++.|++.+|+|++. ..+...+|+++.....+|++|+.+..... ...++.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 45566654 57999999999999999999999999876 34567889999888887776666544332 456788
Q ss_pred EEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
||||++ ||.|...+...+ ..|++.++..|+.||+.||.|||+.+|.||||||+|+|......+..+||+|||+|+.-.
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999998 999999998643 569999999999999999999999999999999999999877788999999999998754
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch-HHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~ 236 (465)
... ...+.+-||.|.|||++....|++.+|+|||||++|-||+|.+||+....... .....+|....+..|
T Consensus 216 ~~~--------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 216 EPG--------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred CCc--------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 321 23456789999999999999999999999999999999999999987543221 223344555666666
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.+.+ ..+++..+++|+.+|..+|.+|.|+++ .+.+.|
T Consensus 288 ~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~---~m~hpw 324 (400)
T KOG0604|consen 288 EPEW-SCVSEAAKDLIRKLLKTEPTERLTIEE---VMDHPW 324 (400)
T ss_pred ChhH-hHHHHHHHHHHHHHhcCCchhheeHHH---hhcCch
Confidence 5544 357899999999999999999999554 455444
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=297.87 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=197.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.|++++..+..+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 5789999999999999999999999999999999876431 2235678999999998888777665554332
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++|+++++++|.+++. ...+++..+..++.|++.+|.|||+.||+|+||||+||++ +.++.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEcccccccc
Confidence 3589999999999999987 4579999999999999999999999999999999999999 4789999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.... .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||.+... ...+..+......
T Consensus 168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~ 234 (343)
T cd07851 168 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGT 234 (343)
T ss_pred cccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Confidence 5431 234467889999999865 3678999999999999999999999976433 2222222211100
Q ss_pred C--------------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 T--------------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ~--------------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ........+++++.++|..||..+|++||++.+|.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 0 01112234688999999999999999999977764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=290.94 Aligned_cols=246 Identities=22% Similarity=0.305 Sum_probs=196.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
....|...+.||+|+||.||+|++..++..||||++..... ...+..|+.+++.++|++++..+.. ...+...+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~ 101 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGC-YLREHTAW 101 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEE-EeeCCeEE
Confidence 34568899999999999999999988999999998864322 1357789999999988766665554 45566789
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++|+++.++|.+++......+++.++..++.|++.+|.|||+.||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASP- 177 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCC-
Confidence 999999889998887656779999999999999999999999999999999999999 5789999999999865432
Q ss_pred cCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.....|++.|+|||.+. +..++.++|||||||++|+|++|..||..... ......+........
T Consensus 178 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~ 244 (317)
T cd06635 178 ----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPTL 244 (317)
T ss_pred ----------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCCC
Confidence 23456889999999974 45588999999999999999999999976432 222222222211111
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....+++.+.+++.+||..+|.+||++.+|.+
T Consensus 245 ---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 276 (317)
T cd06635 245 ---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276 (317)
T ss_pred ---CCccccHHHHHHHHHHccCCcccCcCHHHHHh
Confidence 12346789999999999999999999777654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=286.56 Aligned_cols=246 Identities=21% Similarity=0.337 Sum_probs=191.6
Q ss_pred eeEeeeCceEEEEEEEcCCC------cEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 13 RKIGSGSFGELYLGVNVQTG------EEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~------~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+.||+|+||.||+|++.... +.||||.+.... ....+.+|+.++..+.|++++..+..+ ......+++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC-LLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeee-cCCCCeEEEEe
Confidence 36899999999999876443 689999876432 234678899999999988777766655 45556889999
Q ss_pred cc-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC-----cEEEEecC
Q 012336 84 LL-GPSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-----QVYIIDYG 151 (465)
Q Consensus 84 ~~-g~sL~~ll~~~------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~-----~vkL~DFG 151 (465)
++ +++|.+++... ...+++.+++.++.|++.+|.|||+++++|+||||+|||+. .++ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVS---EKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEe---cCCCCCCcceEECCcc
Confidence 87 89999998642 23488999999999999999999999999999999999995 444 89999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+..
T Consensus 157 ~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~ 228 (269)
T cd05044 157 LARDIYKSDY-----YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTA 228 (269)
T ss_pred cccccccccc-----cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhc
Confidence 9976543211 111223456788999999999999999999999999999998 9999976433 222222222
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
..... ....+|..+.+++.+||..+|.+||++.+|.+.|.
T Consensus 229 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GGRLQ----KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCccC----CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21111 11356899999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=286.38 Aligned_cols=245 Identities=21% Similarity=0.323 Sum_probs=196.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+-|++.+.||.|+||.||+|.+..++..||||+...... ...+..|+.++..+.|++++..+.. ...+...++|++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS-YLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEE-EEeCCeEEEEEE
Confidence 347889999999999999999988999999998764322 2457789999999988766655554 456678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++. +..+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchh-
Confidence 98 779998886 4579999999999999999999999999999999999999 5788999999999876543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ......+..... .....
T Consensus 157 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 223 (277)
T cd06641 157 ------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNNP----PTLEG 223 (277)
T ss_pred ------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCCC----CCCCc
Confidence 11234688999999999988899999999999999999999999976433 222222221111 11224
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.++.++.+++..||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 57899999999999999999999877766
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=285.03 Aligned_cols=249 Identities=21% Similarity=0.316 Sum_probs=194.2
Q ss_pred ceEEEeeEeeeCceEEEEEEEcC-CCcEEEEEEeecCCC------------CccHHHHHHHHHH-HcCCCCCceeEEEeE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQ-TGEEVAVKLESVKTK------------HPQLHYESKLYML-LQGGTGVPHLKWFGV 73 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~-~~~~vAvKi~~~~~~------------~~~~~~E~~il~~-l~~~~~i~~l~~~~~ 73 (465)
.|++.+.||+|+||.||+|.+.. +++.+|||.+..... ...+..|+.++.. +.|++++..+. +..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~-~~~ 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK-TFL 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe-eEc
Confidence 48899999999999999999877 688999998753211 1235667777765 45555555444 445
Q ss_pred eCcEEEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEE
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
.+...+++||++ +++|.+++.. ....+++..++.++.|++.+|.|||+ .+++|+||+|+|||+ +.++.++|+
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~ 156 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTIT 156 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEe
Confidence 667889999987 8899988753 24569999999999999999999996 789999999999999 588999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i 228 (465)
|||++....... ......|+..|++||.+.+..++.++|+||||+++|+|++|..||..... ......+
T Consensus 157 dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~ 225 (269)
T cd08528 157 DFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKI 225 (269)
T ss_pred cccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHH
Confidence 999997654321 12345689999999999988899999999999999999999999976432 2222233
Q ss_pred hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
......... ...+++++.++|.+||..||++||++.++...+.
T Consensus 226 ~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 226 VEAVYEPLP---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hhccCCcCC---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 222222111 1346899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=284.84 Aligned_cols=253 Identities=17% Similarity=0.286 Sum_probs=194.9
Q ss_pred eEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeC-----c
Q 012336 9 FKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEG-----E 76 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~-----~ 76 (465)
|++.+.||+|+||.||+|.+. .+++.||||++..+.. ..++..|++++..+.|++++..+..+.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 3578999998875432 235778999999999887777666554322 1
Q ss_pred EEEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEec
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~-----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
..+++++++ +++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+|||+ +.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcc
Confidence 336677776 88998876421 1247899999999999999999999999999999999999 57899999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (465)
|+++....... +.......+++.|++||.+.+..++.++||||||+++|+|++ |..||.+... ...+..+.
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI 229 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Confidence 99986533211 112223456678999999998889999999999999999999 8999976433 22222222
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...... ....++..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 230 ~~~~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 221111 1134678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=288.03 Aligned_cols=240 Identities=17% Similarity=0.232 Sum_probs=182.3
Q ss_pred eeEeeeCceEEEEEEEcCCCc-------EEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 13 RKIGSGSFGELYLGVNVQTGE-------EVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~-------~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+.||.|+||.||+|.+...+. .||+|++..... ...+..|..++..+.|++++..+..+. .+...+++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-CGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-eCCCcEEEEe
Confidence 468999999999998765544 488888754322 245778889999998877776665554 4556788999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC-----CCCcEEEEecCCccccc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-----KSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d-----~~~~vkL~DFGla~~~~ 157 (465)
++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+..++ ....++++|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 88 8899999886556789999999999999999999999999999999999995211 11237999999986543
Q ss_pred cccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCC-CCCCCCCCCchHHHHHHHhhhhccC
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|. .||........ . .........
T Consensus 160 ~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~-~~~~~~~~~ 224 (258)
T cd05078 160 P-----------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L-QFYEDRHQL 224 (258)
T ss_pred C-----------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H-HHHHccccC
Confidence 2 2345688899999999864 4789999999999999999984 66655332111 1 111111111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
....+.++.+++..||+.+|++||++.+|.+.|
T Consensus 225 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 -----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred -----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 123467899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=294.35 Aligned_cols=248 Identities=20% Similarity=0.295 Sum_probs=194.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|.+.+.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.|++++..+..+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 56899999999999999999999989999999998764321 234778999999999988887776664432
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...+++++++..+|..++ ...+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||+++.
T Consensus 93 ~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 93 QDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLARH 166 (342)
T ss_pred ceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcC
Confidence 346899999988877665 3469999999999999999999999999999999999999 5889999999999875
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh--
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK-- 232 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (465)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+....
T Consensus 167 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~---~~~~~~~~~~~~ 233 (342)
T cd07879 167 ADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGV 233 (342)
T ss_pred CCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCC
Confidence 4321 124467899999999876 45889999999999999999999999874321 1111111100
Q ss_pred ------------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 ------------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ------------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...........+++++.++|..||..||++||++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000111112356788999999999999999999777643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=286.57 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=198.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+..|.+++..+..++++..+..+...+...+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999887532 2345788899999998334444444445566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEecCCccccccCCcc
Confidence 9999 9999999985 4579999999999999999999999999999999999999 478899999999998664432
Q ss_pred Cccc-------------ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 161 THKH-------------IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 161 ~~~~-------------~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
.... ........+.++..|+|||.+.+..++.++|+||||+++|++++|..||.... ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHH
Confidence 1100 01123345678999999999998889999999999999999999999998753 2333333
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDY 266 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (465)
+.......+ ..+++.+.+++..||..+|.+||++
T Consensus 234 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 234 ILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCc
Confidence 332222222 4568999999999999999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=278.08 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=198.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
+|.+.+.||+|+||.||+|.+..+++.|++|++.... ....+..|+.++..+.|++++..+. +.......+++++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEE-EEecCCeEEEEEecC
Confidence 5899999999999999999998899999999987654 4457889999999999766555444 445557788899988
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++......+++..+..++.|++.+|.|||..|++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---ccCCeEEEeecccccccccccc---
Confidence 699999988644689999999999999999999999999999999999999 4789999999999976644221
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... +.......... +.......+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~--~~~~~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGP--PGLRNPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhcCC--CCcCccccc
Confidence 23557899999999999888999999999999999999999999874322 22222221111 111111224
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.++.+++..||..||.+||++.++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 889999999999999999999877653
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=279.48 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=200.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|.+.+.||.|+||.||++.+..++..||+|++..... ...+..|+++++.++|++.+..+..+. .+...+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-EKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-cCCEEEEEEE
Confidence 68999999999999999999988999999999876532 345788999999999877666665554 4478889999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 84 LL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 84 ~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++ +++|.+++... ...+++..+..++.+++.||.|||+.|++|+||+|+||++ +.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE---cCCCcEEECCccceeecccC
Confidence 88 78999998764 3679999999999999999999999999999999999999 47899999999999876443
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+........... .
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYP----P 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCCCC----C
Confidence 21 1234578999999999999889999999999999999999999997643 22333332222211 1
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+...++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22367899999999999999999999777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=305.39 Aligned_cols=240 Identities=21% Similarity=0.347 Sum_probs=202.8
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEeccCCC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPS 88 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~s 88 (465)
+.||+|.||+||-|++..+|+.||||++.+. ....++.+|+.||..+.| ++|..+...++..+..|+|||-+.|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcch
Confidence 6799999999999999999999999998754 344689999999999965 67778888888888999999999776
Q ss_pred HHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccc
Q 012336 89 LEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167 (465)
Q Consensus 89 L~~ll~-~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (465)
..+++- ...++|++.....++.||+.+|.|||-++|+|+||||+|||+...+.--++||||||+|+.......
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF------ 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF------ 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh------
Confidence 666654 4467899999999999999999999999999999999999998766677999999999998766432
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
..+++|||.|.|||++.+..|.+.-|+||.|||+|--|.|-.||... ..+.+.|+......|...+ +.++++
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQNAaFMyPp~PW-~eis~~ 794 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQNAAFMYPPNPW-SEISPE 794 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhhccccccCCCch-hhcCHH
Confidence 35789999999999999999999999999999999999999999652 2233444444444443332 578999
Q ss_pred HHHHHHHHhcCCCCCCCCHH
Q 012336 248 FTSYFHYCRSLRFEDKPDYS 267 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~ 267 (465)
+.+||..+|+..-.+|.+.+
T Consensus 795 AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHHHHHHHHHHHHHHhcchH
Confidence 99999999999999999854
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.59 Aligned_cols=250 Identities=20% Similarity=0.252 Sum_probs=206.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.++.++.++||+|.||.||+|.|..- .-.||||++..+. ..+.|++|+.+|.+|+|++.|..++..-. ....
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~m 186 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAM 186 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhh
Confidence 45677889999999999999998643 2479999987654 34689999999999999887776665443 5678
Q ss_pred EEEecc-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~-~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
||+|++ .|+|.+.+.. ....|....+..|+.||+.|+.||.++++|||||..+|+|+. ....|||+||||.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccC
Confidence 999999 9999999986 356699999999999999999999999999999999999996 78999999999999876
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
..... |.......-...|+|||.+....++.++|||+|||+||||++ |+.||.+... .+++..+. .....+
T Consensus 264 ~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---~qIL~~iD-~~erLp 335 (1039)
T KOG0199|consen 264 ENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---IQILKNID-AGERLP 335 (1039)
T ss_pred CCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---HHHHHhcc-ccccCC
Confidence 54332 222334445678999999999999999999999999999999 9999999665 44554444 333334
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+. .+|+.++++++.||..+|+|||++..|.+
T Consensus 336 RPk---~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RPK---YCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCC---CChHHHHHHHHHhccCCccccccHHHHHH
Confidence 333 34999999999999999999999999874
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=294.06 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=199.6
Q ss_pred CCCccCCceEE-EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----------------ccHHHHHHHHHHHcCCC
Q 012336 1 MDHVIGGKFKL-GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----------------PQLHYESKLYMLLQGGT 63 (465)
Q Consensus 1 ~~~i~~~~y~l-~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----------------~~~~~E~~il~~l~~~~ 63 (465)
|..-+.++|.. .+.||.|+||+||+|++..+++.||||++...... ..+..|+.++..+.|++
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 55667889975 57799999999999999999999999987643221 13678999999999877
Q ss_pred CCceeEEEeEeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~ 143 (465)
++..+..+ ..+.+.+++||++.++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+|||+ +.++
T Consensus 82 iv~~~~~~-~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 82 IMGLVDVY-VEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred eeeeeEEE-ecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 76666554 56678899999998899999874 5579999999999999999999999999999999999999 5888
Q ss_pred cEEEEecCCccccccccCcccc-------cccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCC
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHI-------PYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQG 215 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~-------~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~ 215 (465)
.++|+|||++..+......... .........+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999766421110000 001112335688999999987654 68999999999999999999999987
Q ss_pred CCCCchHHHHHHHhhhhc--------------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 216 LKAGTKKQKYDKISEKKM--------------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~--------------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.........+........ ...........+.++.+++..||..+|++||+++++.
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 543222211111110000 0001112234578899999999999999999976664
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=287.63 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=199.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
..+.|++...||+|+||.||+|.+..++..|++|++..... ...+..|++++..+.|++++..+. +.......+++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEE-EEEECCEEEEEEe
Confidence 35679999999999999999999988899999999875543 456888999999998865555444 4555678889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++......+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchh-
Confidence 98 699999998644489999999999999999999999999999999999999 5888999999999876543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......++..|++||++.+..++.++|+||||+++|+|++|..||...+.. .....+......... ...
T Consensus 172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~--~~~ 240 (286)
T cd06614 172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTKGIPPLK--NPE 240 (286)
T ss_pred ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCCCc--chh
Confidence 113345788999999999888999999999999999999999999764332 222222221111111 113
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.++.++.++|.+||+.+|.+||++.+|.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 4789999999999999999999977664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=304.00 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=205.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc----cHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~----~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
--+.|.+.+.||+|.|+.|.+|++..++..||||++++..... .+.+|+++|+.|.|+++|..+.... .....|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-TEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-ecceeEE
Confidence 3578999999999999999999999999999999988764433 3689999999999988777666554 4446789
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||||+ ++.+.+++.. .+.+.+..+..++.|++.+++|||+++|+|||||++|||+ +.+.++||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeeccc
Confidence 99998 9999999986 4566669999999999999999999999999999999999 68899999999999887643
Q ss_pred cCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
. ...+++|++.|+|||++.+.+| ++++|+||||++||-|+.|.+||.+.. ..+.-.+....++..+
T Consensus 209 ~--------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~---lk~Lr~rvl~gk~rIp-- 275 (596)
T KOG0586|consen 209 L--------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN---LKELRPRVLRGKYRIP-- 275 (596)
T ss_pred c--------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc---cccccchheeeeeccc--
Confidence 2 2467899999999999999886 689999999999999999999999833 3333344444555444
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
-.++.+..++|++++.++|.+|+++++|.
T Consensus 276 ---~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 276 ---FYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ---ceeechhHHHHHHhhccCccccCCHHHhh
Confidence 24567899999999999999999966554
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=286.53 Aligned_cols=249 Identities=22% Similarity=0.258 Sum_probs=197.4
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+..|+++++.+.|++++..+..+ ..+...++++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-RHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-ccCCCEEEEEec
Confidence 6788999999999999999988999999998765432 24678899999999976666655544 455788999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 85 LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 85 ~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+.++|.+++......+++..+..++.|++.+|.|||+.+|+|+||||+||++ +.++.++|+|||.+.......
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~---- 152 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPV---- 152 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCc----
Confidence 9889999988756789999999999999999999999999999999999999 578999999999997765432
Q ss_pred ccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-----------
Q 012336 165 IPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK----------- 232 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (465)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+ .+..+....
T Consensus 153 ---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 153 ---RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred ---ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccc
Confidence 112234678899999998877 78999999999999999999999997643321 111111110
Q ss_pred --------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 --------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 --------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...........++.++.++|..||..||.+||++.+|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 001111223456889999999999999999999777653
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.60 Aligned_cols=292 Identities=21% Similarity=0.243 Sum_probs=218.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
..-|..++.||-|+||+|.+++...|...||+|.+.+. +....+..|..||..-.+ ++|+.|++.+.+.+.+|+
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEeccCCceEE
Confidence 45689999999999999999999999999999977643 222345667777776654 677777777788888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||+|+ ||++-.++.+ -+.|.+..+..++.++.++|+++|.+|||||||||+|||| |.+|++||.|||||+-++..
T Consensus 707 VMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceec
Confidence 99998 9999999886 4679999999999999999999999999999999999999 79999999999999865432
Q ss_pred cCcc------cc---------------------c--------ccCCCCccccccccccccccCCCCCCcchHHHHHHHHH
Q 012336 160 QTHK------HI---------------------P--------YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLM 204 (465)
Q Consensus 160 ~~~~------~~---------------------~--------~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ 204 (465)
...+ +. . ....-.++||+.|+|||++....|+.-+||||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 1100 00 0 00123468999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 012336 205 YFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQF 284 (465)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~ 284 (465)
||+.|..||....+...+.++..+... .--..|.+++.+..++|.+++. ++++|.--. ..+ .-..++|
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~----l~~~~~~~ls~e~~~li~kLc~-sad~RLGkn-g~d------~vKaHpf 930 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNF----LHIPYQGNLSKEALDLIQKLCC-SADSRLGKN-GAD------QVKAHPF 930 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhc----cccccccccCHHHHHHHHHHhc-Chhhhhccc-chh------hhhcCcc
Confidence 999999999876665554444322211 1122467788999988876553 566675311 111 1134789
Q ss_pred Ccccccccc-CCCCCCCCCCCCCCCCCCCCC
Q 012336 285 DYVFDWTIL-KYPQTGSSSRSRPSGKPNLNP 314 (465)
Q Consensus 285 ~~~~dw~~~-~~~~~~~~~~~~~~~~~~~~~ 314 (465)
+...||..+ +++..-.+....|.+..++.|
T Consensus 931 FkgIDfsslRkq~ApYIP~ItHptDTSNFdp 961 (1034)
T KOG0608|consen 931 FKGIDFSSLRKQRAPYIPRITHPTDTSNFDP 961 (1034)
T ss_pred ccccchHhhhhccCCcCccccCCCccccCCc
Confidence 999999875 333333444444555555544
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=276.98 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=201.6
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeC-cEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEG-EYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~-~~~~lv~ 82 (465)
+|++.+.||+|+||.||+|.+..++..|++|++..... ...+..|++++.++.|+++++.+..+.... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58999999999999999999988999999999876543 456889999999999877776665554431 6788999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEcccccEEecccccc
Confidence 998 99999999863 489999999999999999999999999999999999999 4789999999999987654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
. .......++..|+|||.+.+..++.++||||||+++|+|++|..||.... ........+....... ...
T Consensus 157 ~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~---~~~ 226 (260)
T cd06606 157 G-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPP---EIP 226 (260)
T ss_pred c-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCc---CCC
Confidence 1 01234578899999999998889999999999999999999999998754 1222222222111111 122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+++.+|+..+|++||++.++.+
T Consensus 227 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 227 EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 345899999999999999999999776653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=291.21 Aligned_cols=247 Identities=19% Similarity=0.308 Sum_probs=195.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..|.....||.|+||.||+|.+..+++.||||++.... ....+..|+.++..+.|++++..+..+ ..+...++++++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY-LVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhe-eeCCeEEEEEec
Confidence 34556678999999999999998899999999986532 234577899999999887666655554 456677889988
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|..++. ...+++..+..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||++........
T Consensus 100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhcccccc--
Confidence 7 789988876 4579999999999999999999999999999999999999 5889999999999875543211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..... .+.+..+...... .......
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~ 242 (297)
T cd06659 173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPP--KLKNAHK 242 (297)
T ss_pred -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCC--CccccCC
Confidence 12345789999999999998999999999999999999999999976432 2233222221111 1112245
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
++.++.+++..||..+|.+||++.+|.+
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 7889999999999999999999777655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=291.48 Aligned_cols=247 Identities=19% Similarity=0.309 Sum_probs=195.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+.|.....||+|+||.||++.+..++..||||.+.... ....+..|+.++..++|++++..+..+ ..+...+++|++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY-LVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-ecCCeEEEEEeC
Confidence 45666778999999999999998899999999876432 233577899999999887777666554 456688999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++. ...+++.++..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence 8 788988876 4569999999999999999999999999999999999999 5789999999999876533211
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
......|+..|+|||++.+..++.++||||||+++|||++|..||..... .+.+..+... .... ......
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~-~~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDN-LPPR-VKDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CCCc-cccccc
Confidence 12345689999999999988999999999999999999999999986432 2222222211 1111 111234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
++..+.+++..||..+|.+||++.++.+
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6889999999999999999999776654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=280.90 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=190.8
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.....||+|+||.||+|++..++..||+|.+..... ...+..|+.++..++|++++..+.. +..+...+++++++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS-DSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeee-eccCCEEEEEEecCC
Confidence 3345689999999999999988999999998765432 3367889999999998877765554 45566788999887
Q ss_pred CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 86 GPSLEDLFNYCNRKF--SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 86 g~sL~~ll~~~~~~l--s~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+++|.+++......+ ++..+..++.||+.||.|||++||+||||||+|||+. ..++.++|+|||++........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~-- 164 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP-- 164 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC--
Confidence 899999987544455 8899999999999999999999999999999999994 3367999999999876532111
Q ss_pred cccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|++.|+|||++.+.. ++.++||||||+++|+|++|..||........ ........... ..+.
T Consensus 165 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~---~~~~ 234 (268)
T cd06624 165 -----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKIH---PEIP 234 (268)
T ss_pred -----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhccC---CCCC
Confidence 122346889999999987644 78899999999999999999999976432111 11111110111 1122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+++++.+++.+||..+|.+||++.+|.+
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 456889999999999999999999777653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.75 Aligned_cols=247 Identities=22% Similarity=0.307 Sum_probs=197.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|.+.+.||.|+||.||+|.+..++..||+|.+... .....+..|+++++.+.|++++..+..+ ......+++++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-QENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-ccCCeEEEEEe
Confidence 689999999999999999999999999999988654 2334678899999999987777766544 55667889999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++.... ..+++..+..++.|++.+|.|||+.+++|+||||+||++. +.+..++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 88 889999987532 3589999999999999999999999999999999999994 2335679999999977643221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .+.+..+...... ...
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~ 223 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYFA----PIS 223 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccCC----CCC
Confidence 11234689999999999888899999999999999999999999976432 2223222222211 122
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+++.+||..+|++||++.+|.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 456889999999999999999999777653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=282.25 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=200.3
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||.|+||.||+|++..+++.|++|++.... ....+..|+.++..+.|++++..+. +...+...+++++++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY-SFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHH-heecCcEEEEEEecCCCCc
Confidence 689999999999998889999999886542 2346788899999998776666544 445677788999998 789
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc-cccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK-HIPY 167 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~-~~~~ 167 (465)
|.+++... ..+++..+..++.||+.+|.|||++|++|+||+|+|||+ +.++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 99999863 479999999999999999999999999999999999999 588999999999987643321100 0000
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
.......++..|++||.+.+..++.++||||||+++|++++|..||.... ..+.+..+.......+.. ..++..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~---~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWPED---VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCCcc---ccCCHH
Confidence 12234568899999999998889999999999999999999999997643 333333333322222211 125899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccc
Q 012336 248 FTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDW 290 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw 290 (465)
+.+++..||..+|.+||++..+.++|.+ ++...++|
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~-------~~~~~~~~ 265 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNH-------PFFKGIDW 265 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcC-------ccccCCCC
Confidence 9999999999999999999777777764 44445555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.74 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=194.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.+.|...+.||+|+||+||+|++..+++.|+||++...... ..+..|+.+++.++|++++..+.. +.+....++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~l 98 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGC-YLKEHTAWL 98 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEE-EEeCCEEEE
Confidence 34577888999999999999999899999999988754221 346789999999988766665554 456678899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+|+++.++|.+++......+++.++..++.||+.+|.|||++|++|+||+|+||++ +.++.++|+|||++....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccC---
Confidence 99999889999887666779999999999999999999999999999999999999 578899999999986432
Q ss_pred CcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
......|+..|+|||.+. ...++.++||||||+++|+|++|..||........ ...+..... .
T Consensus 173 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~~~~---~ 238 (313)
T cd06633 173 --------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNDS---P 238 (313)
T ss_pred --------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCC---C
Confidence 123457899999999984 35588899999999999999999999977543221 112211111 1
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
......++..+.+++.+||+.+|.+||++.++.
T Consensus 239 ~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 239 TLQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 112245678899999999999999999977664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.58 Aligned_cols=239 Identities=17% Similarity=0.211 Sum_probs=180.5
Q ss_pred eEeeeCceEEEEEEEcCC------------------------CcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCce
Q 012336 14 KIGSGSFGELYLGVNVQT------------------------GEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPH 67 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~------------------------~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~ 67 (465)
.||+|+||.||+|....+ ...|++|++..... ...+..|..++..+.|++++..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 699999999999975322 23688888764322 2346777888888888666655
Q ss_pred eEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC----CCC
Q 012336 68 LKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG----RKS 142 (465)
Q Consensus 68 l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~----d~~ 142 (465)
+.. +......++||||+ +++|..++....+.+++.++..++.||+.||+|||++||+||||||+|||+... ...
T Consensus 82 ~~~-~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 82 HGV-CVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEE-EEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 554 55666788999998 888988887656779999999999999999999999999999999999999521 112
Q ss_pred CcEEEEecCCccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHh-cCCCCCCCCCCCc
Q 012336 143 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 220 (465)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~ell-tG~~Pf~~~~~~~ 220 (465)
..++|+|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|..||.......
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999998643221 12357788999998875 56899999999999999985 6999998754332
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
....+ ......+ ...++++.++|.+||..+|++||++.+|.+.|
T Consensus 230 ~~~~~----~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFY----EKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH----HhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 22211 1111111 23457899999999999999999998887765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=282.92 Aligned_cols=240 Identities=15% Similarity=0.189 Sum_probs=180.2
Q ss_pred eeEeeeCceEEEEEEEcC------------CCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 13 RKIGSGSFGELYLGVNVQ------------TGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~------------~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+.||.|+||.||+|+... ....|++|++..... ...+..|..++..+.|++++..+..+ ......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~-~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVC-VRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCCC
Confidence 468999999999998532 233689998765432 22567788888889887766655554 455667
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC----CCCcEEEEecCCc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR----KSNQVYIIDYGLA 153 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d----~~~~vkL~DFGla 153 (465)
+++|+++ +++|..++......+++.+++.++.||+.||.|||+++|+||||||+|||+.... ....++++|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 8999998 7788888775556799999999999999999999999999999999999995211 1123899999998
Q ss_pred cccccccCcccccccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHh-cCCCCCCCCCCCchHHHHHHHhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~k~DiwSLGviL~ell-tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||........ ......
T Consensus 160 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~ 224 (262)
T cd05077 160 ITVLS-----------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERFYEG 224 (262)
T ss_pred ccccC-----------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHHHhc
Confidence 65432 12346788999999886 466899999999999999998 58999876432211 111111
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
... .....++++.++|.+||..||++||++.+|.+.|
T Consensus 225 ~~~-----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QCM-----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Ccc-----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 111 1123467899999999999999999998887754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.20 Aligned_cols=246 Identities=20% Similarity=0.302 Sum_probs=196.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
....|...+.||.|+||.||+|++..+++.||||.+..... ...+..|+++++.++|+++++.+..+ ......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEE-EcCCeeE
Confidence 34568889999999999999999999999999998764311 23567899999999887777766554 4566789
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+|++++.++|.+++......+++.++..++.|++.+|.|||+.+++|+||+|+|||+ +.++.++|+|||++.....
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---CCCCcEEECCcccceeecC-
Confidence 999999889988887656779999999999999999999999999999999999999 4789999999999875432
Q ss_pred cCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.....|++.|+|||.+. ...++.++|||||||++|+|++|..||....... ....+.......
T Consensus 168 ----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~- 233 (308)
T cd06634 168 ----------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPA- 233 (308)
T ss_pred ----------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHhhcCCCC-
Confidence 23456889999999975 3457889999999999999999999997753321 111222211111
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....++.++.++|.+||..+|++||++.++.+
T Consensus 234 --~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 --LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred --cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 112356889999999999999999999777654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=280.04 Aligned_cols=249 Identities=18% Similarity=0.255 Sum_probs=185.9
Q ss_pred eeEeeeCceEEEEEEEcCC--CcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 13 RKIGSGSFGELYLGVNVQT--GEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~--~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+.||+|+||.||+|..... ...+++|.+.... ....+..|+.++..++|++++..+..+. .....+++||++ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-EAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-CCCccEEEEecCCC
Confidence 3699999999999975433 3456677655432 2346888999999998888777776654 456789999998 7
Q ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 87 PSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 87 ~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++|.+++... ...+++..+..++.||+.||+|||+.+++||||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence 8999998753 2346778889999999999999999999999999999999 5889999999999854221110
Q ss_pred cccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHh-hhhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKIS-EKKML 234 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~-~~~~~ 234 (465)
........++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.+..+. .....
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccc
Confidence 012234568899999998753 345789999999999999997 6788876433 23333322 22222
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
...+.....+++.+.+++..|| .+|++||++.+|.+.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2223334567899999999999 68999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=286.69 Aligned_cols=247 Identities=22% Similarity=0.324 Sum_probs=195.2
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.... ....+..|+.+++.++|++++..+.. .......+++++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~-~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS-YLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhhe-eeeCCcEEEEEe
Confidence 478999999999999999999988899999999876432 23457889999999987666555544 445667889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++. ...+++..+..++.|++.+|.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred cCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---cCCCCEEEccCcceeccccccc-
Confidence 88 889999987 3568999999999999999999999999999999999999 4788999999999876543221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......|++.|++||.+.+..++.++|+||||+++|++++|..||...... .....+.... .+......
T Consensus 171 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~---~~~~~~~~~~--~~~~~~~~ 239 (293)
T cd06647 171 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNG--TPELQNPE 239 (293)
T ss_pred ------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh---hheeehhcCC--CCCCCCcc
Confidence 123456889999999999888999999999999999999999999764321 1111111111 11111113
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.++..+.+++..||..+|++||++.+|.
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 4678899999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=273.94 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=198.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|.+.+.||+|+||.||+|++..+++.|++|.+..... ...+..|++++..+.|++++..+.. .......+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~-~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS-IETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEE-EEeCCEEEEEEe
Confidence 58999999999999999999988999999998875532 3467889999999988766554444 455678889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||++. .++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~- 154 (254)
T cd06627 80 YAENGSLRQIIKK-FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSK- 154 (254)
T ss_pred cCCCCcHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCcc-
Confidence 88 7899999875 36799999999999999999999999999999999999994 689999999999987654221
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......++..|+|||.+.+..++.++|||+||+++|+|++|..||..... ............. ....
T Consensus 155 ------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 221 (254)
T cd06627 155 ------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDHP----PLPE 221 (254)
T ss_pred ------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCCC----CCCC
Confidence 12345689999999999888889999999999999999999999986542 2222222211111 1224
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+++++.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 56899999999999999999999877653
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=280.15 Aligned_cols=249 Identities=20% Similarity=0.224 Sum_probs=195.9
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
|++.+.||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.|++++.....+ ......++++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-HTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-hcCCceEEEecC
Confidence 678899999999999999999999999999887643 234577899999999876666555444 455788999999
Q ss_pred cCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 85 LGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 85 ~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
++++|.+++......+++..+..++.|++.+|.|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence 9889999998654679999999999999999999999999999999999999 5789999999999976543211
Q ss_pred ccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-----------
Q 012336 165 IPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK----------- 232 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (465)
......++..|+|||.+.+. .++.++||||||+++||+++|..||...... ..+..+....
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhh
Confidence 11234567889999998876 7899999999999999999999999774322 2221111100
Q ss_pred -------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 -------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 -------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...........++..+.+++..||..+|++||++.++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000111222345789999999999999999999777653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=281.48 Aligned_cols=251 Identities=23% Similarity=0.282 Sum_probs=192.0
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHc-CCCCCceeEEEeEeCcEEEEEEec
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQ-GGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~-~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
|++.+.||.|+||+||+|+...+++.|+||.+..... ......|+..+..+. |++++..+..+ ..+...+++|++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVF-RENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHh-hcCCcEEEEEec
Confidence 7889999999999999999988899999998765432 123456888899998 65555555444 447788999999
Q ss_pred cCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 LGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++++|.+++.... ..+++.++..++.|++.+|.|||++|++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 80 MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC--
Confidence 9999999887543 478999999999999999999999999999999999999 5899999999999976543211
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh----------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------- 232 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (465)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...................
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 155 ------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 123468889999998754 457899999999999999999999997754322221111110000
Q ss_pred ------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 ------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
............+..+.+++..||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000111112234688999999999999999999777643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=274.93 Aligned_cols=244 Identities=18% Similarity=0.257 Sum_probs=196.6
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+|++.+.||.|+||.||++.+..+++.||||.+.... ....+..|+++++.++|++++... .+.......+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK-EAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhh-hhhccCCEEEEEeh
Confidence 5899999999999999999999999999999877532 223567889999999876655544 44455678899999
Q ss_pred cc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 84 LL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 84 ~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
++ +++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++. .++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 88 88999988642 35689999999999999999999999999999999999995 6889999999999876542
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .....+++.|++||.+.+..++.++|+||||+++|+|++|..||..... ......+.......
T Consensus 157 ~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~---- 220 (256)
T cd08530 157 M---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYPP---- 220 (256)
T ss_pred C---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCC----
Confidence 1 1234578999999999998899999999999999999999999987543 22222222222211
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....++.++.+++.+||..+|++||++.++.+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 12356899999999999999999999877654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=282.57 Aligned_cols=245 Identities=20% Similarity=0.288 Sum_probs=195.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
.|...+.||+|+||.||++.+..+++.|++|.+..... ...+.+|+.+++.+.|++++..+..+ ..+...+++++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~-~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY-LVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEE-EcCCeEEEEEecc
Confidence 56777899999999999999988999999998764332 23577899999999887666655544 4566788899988
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++.. ..+++..+..++.|++.+|+|||++|++||||+|+||++ +.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCc---
Confidence 8899999874 579999999999999999999999999999999999999 5889999999998875433211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... .+.+..+........ .....+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~--~~~~~~ 241 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPKL--KNLHKV 241 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCCC--cccccC
Confidence 12345689999999999988899999999999999999999999976332 233333332211111 111236
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+..+.+++.+||..+|++||++.+|.
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHc
Confidence 88999999999999999999976664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.57 Aligned_cols=143 Identities=24% Similarity=0.433 Sum_probs=124.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|+++++||.|+||.||+|.+..+++.||||++..... ...+..|+.++..++|++++..+ .+.....+.|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~-~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEE-EEEEECCEEEEE
Confidence 689999999999999999999999999999999875432 24577889999988887766655 455667788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
|+|+ +++|.+++.. .+.+++..++.|+.||+.||.|||.++|+||||||+|||+ +.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9998 8999999875 4578999999999999999999999999999999999999 578999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=283.72 Aligned_cols=243 Identities=19% Similarity=0.266 Sum_probs=191.6
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CC
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GP 87 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (465)
...+||+|+||.||++.+..+++.||||.+.... ....+..|+.+++.+.|++++..+.. +..++..+++||++ ++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-YLVGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeE-EEeCCEEEEEEecCCCC
Confidence 3467999999999999999999999999875432 23357889999999988666655554 45667889999998 77
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccc
Q 012336 88 SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167 (465)
Q Consensus 88 sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (465)
+|.+++. ...+++..+..++.|++.+|+|||+.|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 103 ~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~------- 170 (292)
T cd06657 103 ALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEV------- 170 (292)
T ss_pred cHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceeccccc-------
Confidence 8888775 4578999999999999999999999999999999999999 578899999999987654321
Q ss_pred cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 168 ~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+... .+....+...... ... ....++..
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~~~~-~~~-~~~~~~~~ 245 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLPP-KLK-NLHKVSPS 245 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhCCc-ccC-CcccCCHH
Confidence 112345688999999999888899999999999999999999999986432 2222222221111 110 11356889
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 248 FTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.+++.+||..+|.+||++.++.+
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 999999999999999999776544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=287.99 Aligned_cols=265 Identities=18% Similarity=0.250 Sum_probs=205.0
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-CCCccHHHHHHHHHHHcCC-----CCCceeEEEeEeC
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-TKHPQLHYESKLYMLLQGG-----TGVPHLKWFGVEG 75 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~-----~~i~~l~~~~~~~ 75 (465)
++.+.++|.++..||+|.||.|-.+.+..++..|||||++.- ...+...-|++++.++... +-+..+..+++..
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 567899999999999999999999999999999999998754 3345577899999999532 2334444556667
Q ss_pred cEEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC--------------
Q 012336 76 EYNVMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-------------- 140 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d-------------- 140 (465)
.+.|||+|++|.++.+++... -.+|+..++..|+.|++.+++|||+.+++|-||||+|||+...+
T Consensus 164 ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 164 GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 789999999999999999853 35799999999999999999999999999999999999995321
Q ss_pred ---CCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCC
Q 012336 141 ---KSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (465)
Q Consensus 141 ---~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~ 217 (465)
.+..|+|+|||.|+.-.... ..++-|-.|.|||++.+-+++..+||||+||||+|+.+|...|+...
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 25578999999998644321 35678999999999999999999999999999999999999999866
Q ss_pred CCchHHHHHHHhhhhccC-----------------------------------cHHHHhcc---CcHHHHHHHHHHhcCC
Q 012336 218 AGTKKQKYDKISEKKMLT-----------------------------------PIEVLCKS---YPSEFTSYFHYCRSLR 259 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~-----------------------------------~~~~~~~~---~p~~l~~li~~cl~~d 259 (465)
..+.......+....... +....... --.++.+|++.||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 544333333333211000 00000000 1135889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHH
Q 012336 260 FEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 260 p~~RPt~~~l~~~L~~~~~~ 279 (465)
|.+|+|+ .+.|.+.|..
T Consensus 394 P~~RiTl---~EAL~HpFF~ 410 (415)
T KOG0671|consen 394 PARRITL---REALSHPFFA 410 (415)
T ss_pred ccccccH---HHHhcCHHhh
Confidence 9999994 4556655544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=293.70 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=210.6
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---------CccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---------HPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---------~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
..++++|-++..||.|||++||+|.+...++.||||+-..... +....+|..|.+.|.|+.+|..+..|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 4578899999999999999999999999999999998554322 2345678999999999999999999999
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEec
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
+.+.+|.|+||| |.+|.-+++. .+-++++++..|+.||+.+|.||.... |||-||||.|||+-.+...|.+||.||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999999 6666666654 678999999999999999999999764 999999999999976667899999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCC----CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 226 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~ 226 (465)
||++.+.++..+...-...+....||.+|++||.+.-. ..+.|+||||+|||+|.++.|+.||.... ..+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq---sQQd-- 692 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ---SQQD-- 692 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch---hHHH--
Confidence 99999887765543334456678899999999998643 36889999999999999999999997622 1221
Q ss_pred HHhhhhccCcHHHHh---ccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 227 KISEKKMLTPIEVLC---KSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 227 ~i~~~~~~~~~~~~~---~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.+.+..+....+... +.++++...||++||+..-++|.+..+|
T Consensus 693 ILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 693 ILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred HHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 122222222222221 2357899999999999999999995554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=298.18 Aligned_cols=241 Identities=20% Similarity=0.268 Sum_probs=201.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+...|.+...||.|+|+.|..+.+..+++.+++|++... ..+...|+.++....+|+++..+.....++...++||++
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 567899999999999999999999999999999999866 456777888999999888888888888888899999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ |+-|.+.+.. ...+. .++..|+.+|+.++.|||.+|||||||||+|||+. +..++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~-~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 398 LDGGELLRRIRS-KPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred ccccHHHHHHHh-cchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchh----
Confidence 9 5555555542 33334 78888999999999999999999999999999994 38899999999999877653
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
..+.+-|..|.|||+....+|+.++||||||++||+||+|+.||.....+ .+....+...... ..
T Consensus 470 ------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~ 534 (612)
T KOG0603|consen 470 ------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------EC 534 (612)
T ss_pred ------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------cc
Confidence 12346689999999999999999999999999999999999999886554 2333222222221 56
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
++.++++|+.+||+.||.+||++.++.
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhc
Confidence 789999999999999999999977764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=304.79 Aligned_cols=258 Identities=17% Similarity=0.283 Sum_probs=214.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCC---cEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTG---EEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~---~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
|-.....+.+.||.|-||+||+|+.+..+ ..||||.++.-. ....|+.|..||-++.|+|+|..-+ .......
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEG-VVTks~P 704 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEG-VVTKSKP 704 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEE-EEecCce
Confidence 33456789999999999999999987665 479999988643 3346999999999999877665544 4455566
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+|+.||+ +|+|..++....+.|+..++..+++.|+.|+.||-.+|+|||||.++|||+ +.+-.+|++||||++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeec
Confidence 77788887 999999999877889999999999999999999999999999999999999 69999999999999987
Q ss_pred ccccCcccccccCCCCccc--cccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 157 RDLQTHKHIPYRENKNLTG--TARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~G--t~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.++.. ....+..| .++|.|||.+....++.++||||+|++|||.++ |+.||.++.. |...+..+..+
T Consensus 782 edd~~------~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----QdVIkaIe~gy 851 (996)
T KOG0196|consen 782 EDDPE------AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVIKAIEQGY 851 (996)
T ss_pred ccCCC------ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----HHHHHHHHhcc
Confidence 66431 11122222 479999999999999999999999999999888 9999998654 33444455666
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..|+++.| |..+.+||..||++|...||.+.+|+..|..+..
T Consensus 852 RLPpPmDC---P~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 852 RLPPPMDC---PAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCCCCC---cHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 66666655 9999999999999999999999999999988753
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.21 Aligned_cols=252 Identities=17% Similarity=0.231 Sum_probs=183.2
Q ss_pred eeEeee--CceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSG--SFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G--~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
..||.| +||+||+|.+..+++.||||++..... ...+..|+.+++.++|++++..+..| ..+...+++++++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-TTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-ecCCceEEEEeccc
Confidence 456666 999999999999999999999875432 23567788888888887766655554 4566788999988
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCcccc
Confidence 78999988753 3469999999999999999999999999999999999999 4788999999987644322111111
Q ss_pred ccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC-------
Q 012336 165 IPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT------- 235 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~------- 235 (465)
..+.......++..|+|||++.+. .++.++|||||||++|||++|..||....... .....+.......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 111112223456789999999764 47899999999999999999999997643211 1111111000000
Q ss_pred ----------------------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 ----------------------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ----------------------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
........+++++.+|+..||..||++|||+.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00001123567899999999999999999976654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=300.22 Aligned_cols=273 Identities=21% Similarity=0.264 Sum_probs=204.2
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec---CCCCccHHHHHHHHHHHcCCCCCceeEEEeE-----eCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV---KTKHPQLHYESKLYMLLQGGTGVPHLKWFGV-----EGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~---~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~~~ 77 (465)
++-|...+.||+|+||.||+|+++.+|+.||||.++. ....+....|++++++|.|+|+|..+..-.. ....
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 4567888999999999999999999999999998775 3445678899999999997776665533222 1346
Q ss_pred EEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC-CCCcEEEEecCCc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KSNQVYIIDYGLA 153 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d-~~~~vkL~DFGla 153 (465)
.+++|+|| ||+|...++... ..|++.+++.++.+++.||.|||.+||+||||||.||++..+. .....||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 68999999 999999998542 4699999999999999999999999999999999999996543 3446689999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC-chHHHHHHHhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDKISEK 231 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~-~~~~~~~~i~~~ 231 (465)
+.+.+.. ...+++||..|.+||++.. ..|+..+|.|||||++|+++||..||--.-.. ...+....+.-+
T Consensus 172 rel~d~s--------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 172 RELDDNS--------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred ccCCCCC--------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 9887643 2457899999999999995 77999999999999999999999999543221 111222222111
Q ss_pred hcc--------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcCCCCCc
Q 012336 232 KML--------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKP--DYSYLKRLFRDLFIREGYQFDY 286 (465)
Q Consensus 232 ~~~--------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RP--t~~~l~~~L~~~~~~~~~~~~~ 286 (465)
+.. +.+-.++.++-..+...+..+|..+|.+|. .+.+.-..+.+++...-...+.
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhiFs 320 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHIFS 320 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEEEe
Confidence 100 001112222234456667778888888888 6666666777776655444333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=292.49 Aligned_cols=264 Identities=17% Similarity=0.227 Sum_probs=207.7
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
++-.....++++||+|-||+|.+|.- ..+..||||++..... ...|..|+++|.+|+|+++|..++.|..++ .++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-Pic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chH
Confidence 34466788999999999999999983 4569999999875532 246999999999999988888888876665 456
Q ss_pred EEEecc-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~-ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|++||+ +|+|.+++.....+ +.-+....|+.||+.|++||.+.+||||||.+.|||+ |.++++||+|||+++.+.
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccc
Confidence 677776 99999999865333 3556677899999999999999999999999999999 699999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.... |+.....+-.++|||+|.+...+++.++|+|+||+++||+++ ...||..+.++...+....+....-..
T Consensus 689 sg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence 3332 233455677899999999999999999999999999999775 889998865543333222222221111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.......-+|.++.++|..||..+-.+||++++|...|.+.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111234599999999999999999999999999888764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=269.82 Aligned_cols=239 Identities=23% Similarity=0.288 Sum_probs=192.9
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
||.|+||.||++.+..+++.||+|++..... ...+..|+.+++.+.|+++++.+.. ...+...+++|+++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA-FQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHH-eecCCeeEEEEecCCCCc
Confidence 6899999999999988899999998875432 2367889999999998766665544 45677889999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
|.+++.. ...+++..+..++.|++.+|.|||+.+++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL---DADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---cCCCcEEEeecCcceecccCCC-------
Confidence 9999975 4579999999999999999999999999999999999999 4788999999999977543211
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEF 248 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l 248 (465)
......++..|++||.+.+...+.++|+||||+++|++++|..||..... .+.+..+...... ....++..+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-----~~~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLR-----FPEFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCC-----CCCCCCHHH
Confidence 12345688999999999988899999999999999999999999976432 3333333332222 224458999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 249 TSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
.+++..||..||++||++.++.+++
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~~~~l~ 245 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGGAEEIK 245 (250)
T ss_pred HHHHHHHhcCCHhhCCCcccHHHHH
Confidence 9999999999999999985433333
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.65 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=204.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.-+|+-..+||.|.||.||-|.+..+|+-.|||-+... ...+.+..|..++..|.|++.|..++ ..+..+..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyG-VEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYG-VEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCc-eeecHHHHHHH
Confidence 34677888999999999999999999999999966543 33457889999999999977666544 45566678899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||| +|+|.+++.. ++-.++.....+..|++.||.|||+.|||||||||.||++ +.+|.+|++|||.|.......
T Consensus 1313 MEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCch
Confidence 9999 9999999985 6668888889999999999999999999999999999999 689999999999998876542
Q ss_pred CcccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
. ..| .+-....||+.|||||++.+.. ...++|||||||++.||+||+.||..++. ..++.-++..+..+..+
T Consensus 1389 ~--~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1389 Q--TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred h--cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHHHhHHhccCCCCCc
Confidence 1 111 3445778999999999998644 56799999999999999999999988753 22333233322222222
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..++++-.+|+.+||..||..|.++. ++|++.|.
T Consensus 1464 ----~~ls~~g~dFle~Cl~~dP~~Rw~~~---qlle~~f~ 1497 (1509)
T KOG4645|consen 1464 ----ERLSSEGRDFLEHCLEQDPKMRWTAS---QLLEHAFG 1497 (1509)
T ss_pred ----hhhhHhHHHHHHHHHhcCchhhhHHH---HHHHhhcc
Confidence 23789999999999999999998855 44555443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.85 Aligned_cols=245 Identities=23% Similarity=0.282 Sum_probs=191.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-------CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-------TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-------~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+|.+.+.||+|+||.||++.+..++..+++|+++.. ....++..|+.++..++|++++..+..+ .+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-LERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-hcCCceEE
Confidence 699999999999999999999888777777765531 1122466788899999887777665554 44556788
Q ss_pred EEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 81 VIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
+++++ +++|.+++.. ....+++.++..++.|++.||.|||+.|++|+||+|+||++. ++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99987 8899988864 245799999999999999999999999999999999999993 467999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
..... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ........+......
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~-- 223 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPTP-- 223 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHcCCCC--
Confidence 43221 123456889999999998888999999999999999999999999653 222333222222111
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....++.++.++|.+||..+|++||++.++.+
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 122466899999999999999999999777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=297.79 Aligned_cols=256 Identities=20% Similarity=0.366 Sum_probs=209.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-ccHHHHHHHHHHHcCCCCCceeEEEeE-----eCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-PQLHYESKLYMLLQGGTGVPHLKWFGV-----EGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~~~~~ 79 (465)
.+.|++++.||.|.+|.||+++++.+++.+|+||+...... ..+..|..+++.+.+|++++.++.++. .++.++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 46799999999999999999999999999999998876544 467889999999999988888765543 456889
Q ss_pred EEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+||||| ||+..|+++.. +..+.|..+..|+..++.||.+||...++|||||-.|||++ .++.|||+|||.+..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeeee
Confidence 999999 99999999854 57799999999999999999999999999999999999996 99999999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
... ....++.||+.|||||++...+ |+.++|+||||++..||.-|.+|+.++-+ ...+..|...
T Consensus 175 sT~-------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---mraLF~IpRN- 243 (953)
T KOG0587|consen 175 STV-------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN- 243 (953)
T ss_pred ccc-------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---hhhhccCCCC-
Confidence 422 3346789999999999987543 67899999999999999999999988644 2222222222
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
++|.-.....++.+|.+||..||.+|.+.||... ++|++.|+.
T Consensus 244 -PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~---~ll~hpFi~ 286 (953)
T KOG0587|consen 244 -PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTE---ELLKHPFIT 286 (953)
T ss_pred -CCccccchhhHHHHHHHHHHHHHhhccccCcchh---hhccCCccc
Confidence 1222222356789999999999999999999954 445555544
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=277.25 Aligned_cols=252 Identities=18% Similarity=0.253 Sum_probs=184.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHH
Q 012336 19 SFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLF 93 (465)
Q Consensus 19 ~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll 93 (465)
++|.||+++...+++.||||++.... ....+..|+.+++.++|++++..+..+ .+....+++|+++ +++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-IVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-ecCCeEEEEEeccCCCCHHHHH
Confidence 45566666667799999999987542 224688999999999988777766654 4556778899988 78999998
Q ss_pred HHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCC
Q 012336 94 NYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172 (465)
Q Consensus 94 ~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 172 (465)
... ...+++..+..++.|++.||+|||+++|+|+||||+|||+ +.++.++|+|||.+..+................
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE---ecCCceEEecCccceeecccccccccccccccc
Confidence 753 4568999999999999999999999999999999999999 478999999999987654322211111122234
Q ss_pred ccccccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh---------------c--
Q 012336 173 LTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK---------------M-- 233 (465)
Q Consensus 173 ~~Gt~~Y~APE~~~~~--~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------------~-- 233 (465)
..++..|+|||++... .++.++|+|||||++|||++|..||...... ......+.... .
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchhhhcCCcCc
Confidence 5678899999998763 5889999999999999999999999864321 11111111000 0
Q ss_pred -----------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 234 -----------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 234 -----------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
..........++.++.+++..||..||++||++.++ |++.|.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l---l~~p~~~ 299 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQL---LNHSFFK 299 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHH---hcCchHh
Confidence 000001112345789999999999999999996655 4555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=274.38 Aligned_cols=253 Identities=19% Similarity=0.307 Sum_probs=200.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCC-CCCceeEEEeEeCcEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGG-TGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~-~~i~~l~~~~~~~~~~~lv 81 (465)
.++.+-+..||.|+||+|++-.++.+|+..|||.+..... ..+++.|....++-... ++|..++.++.+++ .+|.
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cWiC 141 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CWIC 141 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-eeee
Confidence 4556667889999999999999999999999998775433 45788888887776654 44555566666665 4689
Q ss_pred EeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 82 IDLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~----~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
||++..+|..+.++. ...+++..+-.|+...+.||+||-. ..||||||||+|||+ |..|.|||||||++-.+
T Consensus 142 MELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhH
Confidence 999999999887643 5679999999999999999999985 589999999999999 79999999999999877
Q ss_pred ccccCcccccccCCCCccccccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGV--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.+... ...-.|-..|||||.+... .|+.++||||||++|||+.||..||.+.+. ..+.+..+..+..+
T Consensus 219 v~SiA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp 288 (361)
T KOG1006|consen 219 VDSIA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPP 288 (361)
T ss_pred HHHHH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCC
Confidence 65432 2345788999999998743 489999999999999999999999988643 33333333333222
Q ss_pred -CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012336 235 -TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRL 272 (465)
Q Consensus 235 -~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (465)
......|-.++..+..||..|+.+|-.+||.|.+|++.
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22233345688999999999999999999999888653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=285.82 Aligned_cols=207 Identities=22% Similarity=0.293 Sum_probs=176.3
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-CCCccHHHHHHHHHHHcC-----CCCCceeEEEeEe
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-TKHPQLHYESKLYMLLQG-----GTGVPHLKWFGVE 74 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~-----~~~i~~l~~~~~~ 74 (465)
++.++.++|.+....|+|-|++|..|.+..-|+.|||||+... ..+..=+.|+++|++|+. ..|+..+.-.+..
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 4678999999999999999999999999999999999998754 345567889999999984 2344444444556
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~--~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
.+++|||+|.+.-+|.++++..++ .|..+.+..|+.||..+|..|-..||+|.||||+||||. .....+||||||.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcc
Confidence 778999999999999999986543 488999999999999999999999999999999999996 5678899999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~ 218 (465)
|...... ...| ..-.-.|.|||++.|.+|+...|+||.||+||||.||+..|+|...
T Consensus 584 A~~~~en---eitP------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 584 ASFASEN---EITP------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccccccc---cccH------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 9766542 2222 2456689999999999999999999999999999999999998544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.82 Aligned_cols=259 Identities=20% Similarity=0.289 Sum_probs=201.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.++..+.+.||+|.||+||+|.... ....||||.++.... ...+..|+++|+.+.+|+++..+..++...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3455677799999999999997431 146899998775443 356899999999998665555554444446
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~ 139 (465)
...++++|++ .|+|.+++..+. ..++...++.++.||+.|++||+++.+|||||.++|||++
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~-- 452 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT-- 452 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec--
Confidence 6677777777 999999998654 2499999999999999999999999999999999999995
Q ss_pred CCCCcEEEEecCCccccccccCcccccccCCCCcc--ccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCC
Q 012336 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 216 (465)
Q Consensus 140 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~--Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~ 216 (465)
.+..+||+|||+++........ . .+... -...|||||.+....|+.++||||||++|||+++ |..||.+.
T Consensus 453 -~~~~~kIaDFGlar~~~~~~~y-----~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 453 -KNKVIKIADFGLARDHYNKDYY-----R-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred -CCCEEEEccccceeccCCCCce-----E-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 8889999999999865443321 1 11112 2456999999999999999999999999999999 99999985
Q ss_pred CCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 217 KAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
... ...+..+.. ......+.. +++++.++|+.||..+|++||++.++.+.|...+..
T Consensus 526 ~~~--~~l~~~l~~-G~r~~~P~~---c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 526 PPT--EELLEFLKE-GNRMEQPEH---CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred CcH--HHHHHHHhc-CCCCCCCCC---CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 421 222333333 333333333 489999999999999999999999999999986544
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=265.79 Aligned_cols=205 Identities=23% Similarity=0.300 Sum_probs=176.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
..|+++..||+|.||.||+|....++. .+|||.++... ......+|+.+++.++|+|.|.....|-..+...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468999999999999999997655543 78999888663 3346889999999999999999888888778889
Q ss_pred EEEEeccCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-CCCCcEEEEecCCc
Q 012336 79 VMVIDLLGPSLEDLFNYC----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKSNQVYIIDYGLA 153 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~~----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~-d~~~~vkL~DFGla 153 (465)
+|+++|..-+|+..+... .+.++...+..|+.||+.|+.|||++=|+||||||.|||+..+ ...|.|||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 999999999999999864 3469999999999999999999999999999999999999522 23499999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCC
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQG 215 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~ 215 (465)
+.+.... .|......++-|++|.|||.+.|.. |+++.|||+.|||+.|||+-++-|.+
T Consensus 184 R~~~~pl----kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 184 RLFNNPL----KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHhhccc----cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9987643 2444566788999999999999865 99999999999999999999888876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=271.23 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=202.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHH--HHcCCCCCceeEEEeEeC---cE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM--LLQGGTGVPHLKWFGVEG---EY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~--~l~~~~~i~~l~~~~~~~---~~ 77 (465)
+-+....++.+.||+|.||+||+|.+ -|+.||||++.... +..+.+|.+|+. .|+|.|++.++..--.+. ..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd-E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD-ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc-hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 44678899999999999999999998 68999999998554 456777877776 578988888775433222 24
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceeeccCCCCCcEEEE
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------GFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~--------givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
++||.+|- .|+|.|++.. ..++.+..++++..++.||++||.. .|.|||||..|||+ .+++.+-|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEe
Confidence 67777775 9999999994 7899999999999999999999963 39999999999999 599999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCC------CCCcchHHHHHHHHHHHhcC----------CCC
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE------QSRRDDLESLGYVLMYFLRG----------SLP 212 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~k~DiwSLGviL~elltG----------~~P 212 (465)
|+|||...........+ ....-+||.+|||||++...- .-+.+||||||.++||++.. .+|
T Consensus 359 DLGLAv~h~~~t~~idi---~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDI---PPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred eceeeEEecccCCcccC---CCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 99999887665433322 244568999999999987533 23478999999999999852 688
Q ss_pred CCCCCCCch--HHHHHHHhhhhccCcHHHHhccCc--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 213 WQGLKAGTK--KQKYDKISEKKMLTPIEVLCKSYP--SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 213 f~~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
|.+.-+.+. .+...-+...+..+..+...+..| ..+.++|+.||..+|.-|-|+-.|++.|.++.
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 887655443 222222222223222222222222 45889999999999999999999999998875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.27 Aligned_cols=258 Identities=22% Similarity=0.256 Sum_probs=191.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEE-Ee--------
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKW-FG-------- 72 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~-~~-------- 72 (465)
.-.+|+.++.||+||||.||+|+++-+|..||||.+.... ....+.+|+.++.+|+|+|+|.++.. ..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467888999999999999999999999999999887653 23458889999999999877665410 00
Q ss_pred -----------------------------------------------E--------------------------------
Q 012336 73 -----------------------------------------------V-------------------------------- 73 (465)
Q Consensus 73 -----------------------------------------------~-------------------------------- 73 (465)
.
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred e----------------------C--------cEEEEEEeccCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHC
Q 012336 74 E----------------------G--------EYNVMVIDLLGPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSR 122 (465)
Q Consensus 74 ~----------------------~--------~~~~lv~e~~g~sL~~ll~~~~~~l-s~~~~~~ia~qi~~gL~yLHs~ 122 (465)
+ . .++||-|+||..+|...+...+... .....++++.+|++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 0 3568899999776666665434333 4778899999999999999999
Q ss_pred CccccCCCCCceeeccCCCCCcEEEEecCCccccc---c-----cc--Cccccccc-CCCCccccccccccccccCCC--
Q 012336 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR---D-----LQ--THKHIPYR-ENKNLTGTARYASVNTHLGVE-- 189 (465)
Q Consensus 123 givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~---~-----~~--~~~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-- 189 (465)
|||||||||.||++ |.++.|||+|||+|+... . .. .....+-. .....+||..|+|||.+.+..
T Consensus 717 giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999 699999999999998722 0 00 11111111 234568999999999998765
Q ss_pred -CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012336 190 -QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSY 268 (465)
Q Consensus 190 -~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~ 268 (465)
|+.|+|+||||||++||+. ||.. ..+....+..+.....+.+ ..+..+--+.-..+|+++++.||.+|||+.+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999994 5643 2334444444443444433 2222333355678999999999999999887
Q ss_pred HHH
Q 012336 269 LKR 271 (465)
Q Consensus 269 l~~ 271 (465)
|.+
T Consensus 868 LL~ 870 (1351)
T KOG1035|consen 868 LLN 870 (1351)
T ss_pred Hhh
Confidence 654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.29 Aligned_cols=252 Identities=18% Similarity=0.154 Sum_probs=166.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCC----CcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEE-----eEeC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQT----GEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWF-----GVEG 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~----~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~-----~~~~ 75 (465)
-.++|.+.+.||+|+||.||+|++..+ +..||||.+...........| .+....+......+..+ ...+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 357899999999999999999999888 899999987643322211111 11111111111111111 2355
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcee
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRK-------------------FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 135 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~-------------------ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NIL 135 (465)
...+++++|+ +++|.+++...... .....+..++.||+.||+|||+++|+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 6788999998 78899988643211 123456689999999999999999999999999999
Q ss_pred eccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCC----------------------CCCCc
Q 012336 136 MGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV----------------------EQSRR 193 (465)
Q Consensus 136 l~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~----------------------~~s~k 193 (465)
+. +.++.+||+|||+++.+..... .....+.+++.|+|||.+... .++.+
T Consensus 288 l~--~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 288 FS--EGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred Ee--CCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 94 3467999999999986543222 123456889999999965432 23456
Q ss_pred chHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC----------cHHH------HhccCcHHHHHHHHHHhc
Q 012336 194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT----------PIEV------LCKSYPSEFTSYFHYCRS 257 (465)
Q Consensus 194 ~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----------~~~~------~~~~~p~~l~~li~~cl~ 257 (465)
+|||||||+||||+++..|+.. ...+....+....... .... ..........+|+..||.
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 7999999999999998777543 1111111111111000 0000 000112345689999999
Q ss_pred CCCCCCCCHHHHH
Q 012336 258 LRFEDKPDYSYLK 270 (465)
Q Consensus 258 ~dp~~RPt~~~l~ 270 (465)
.||++||++.++.
T Consensus 436 ~dP~kR~ta~e~L 448 (566)
T PLN03225 436 FKGRQRISAKAAL 448 (566)
T ss_pred CCcccCCCHHHHh
Confidence 9999999966654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=260.05 Aligned_cols=219 Identities=15% Similarity=0.147 Sum_probs=171.0
Q ss_pred eCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHc
Q 012336 18 GSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYC 96 (465)
Q Consensus 18 G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~ 96 (465)
|.||.||+|++..+++.||+|.+..... ...|...+....|+ ++..+..++......+++||++ +++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~~~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHCVP-NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcCCC-ceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 8899999999999999999998875432 33344444444444 4444555556677889999998 7899998875
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCcccc
Q 012336 97 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 176 (465)
Q Consensus 97 ~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt 176 (465)
...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+|||++....... ....++
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~----------~~~~~~ 145 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSC----------DGEAVE 145 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhcccccc----------ccCCcC
Confidence 4569999999999999999999999999999999999999 588899999999886553311 233457
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHh
Q 012336 177 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCR 256 (465)
Q Consensus 177 ~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl 256 (465)
..|+|||.+.+..++.++||||||+++|||++|..||...... +... .... ....+++.+.+++.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~~-~~~~---~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INTH-TTLN---IPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------cccc-cccC---CcccCCHHHHHHHHHHc
Confidence 7899999998888999999999999999999999988642210 0000 0000 11346889999999999
Q ss_pred cCCCCCCCCH
Q 012336 257 SLRFEDKPDY 266 (465)
Q Consensus 257 ~~dp~~RPt~ 266 (465)
+.||++||++
T Consensus 214 ~~dp~~R~~~ 223 (237)
T cd05576 214 QFNPTERLGA 223 (237)
T ss_pred cCCHHHhcCC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=283.19 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=209.8
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
..+..++||+|+||+||+|.+...++ +||||++..... ...++.|..+|..|.|++.+..+.++-... ..|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHH
Confidence 35567899999999999999877654 788998765543 346899999999999999988888775444 567
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|++|+ +|.|.|++......+..+..+.|..||++|+.|||.+.++||||..+|||+ ...+.+||.|||+++.+..+
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCcc
Confidence 77777 999999999877889999999999999999999999999999999999999 58999999999999988765
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
...-.. ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+... +.+.....+.+
T Consensus 852 ~~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d----lle~geRLsqP 922 (1177)
T KOG1025|consen 852 EKEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD----LLEKGERLSQP 922 (1177)
T ss_pred cccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH----HHhccccCCCC
Confidence 443221 23345678999999999999999999999999999999 999999977644433 33333333333
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..| +.++.-++.+||..|+..||++.++...|..+..
T Consensus 923 piC---tiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 923 PIC---TIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCc---cHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 333 8899999999999999999999999998887654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=261.94 Aligned_cols=258 Identities=24% Similarity=0.257 Sum_probs=201.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeE-------
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGV------- 73 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~------- 73 (465)
..+.|.-+.+||+|.||+||+|+...+++.||+|+.-.++. ....++|+.++..|+|++.+..+..|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 35678888999999999999999999999999996544322 2357899999999999988887755532
Q ss_pred eCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 74 EGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 74 ~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
+...+++|+.+|..+|..++.....+|+..++..++.++..||.|+|...|+|||+||.|+|| +.++.+||+|||++
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI---t~dgilklADFGla 171 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI---TKDGILKLADFGLA 171 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---cCCceEEeeccccc
Confidence 223479999999999999998766789999999999999999999999999999999999999 58999999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
+.+.......... -.+-+-|.+|.+||.+.|. +|++..|||.-|||+.||+++.+-+++. +..+.+..|..-.
T Consensus 172 r~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn---teqqql~~Is~Lc 245 (376)
T KOG0669|consen 172 RAFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN---TEQQQLHLISQLC 245 (376)
T ss_pred cceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC---hHHHHHHHHHHHh
Confidence 8776543322111 2344569999999999876 5899999999999999999999999883 3333333333211
Q ss_pred cc-----CcH------------H-----------HHhc--cCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 ML-----TPI------------E-----------VLCK--SYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ~~-----~~~------------~-----------~~~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
-. +|. + ...+ .-.++..+|+..++..||.+|++++++..
T Consensus 246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00 000 0 0000 11357889999999999999999876543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=264.54 Aligned_cols=137 Identities=31% Similarity=0.542 Sum_probs=117.5
Q ss_pred CCCccC-CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-ccHHHHHHHHHHHcCCC-------CCc-eeEE
Q 012336 1 MDHVIG-GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-PQLHYESKLYMLLQGGT-------GVP-HLKW 70 (465)
Q Consensus 1 ~~~i~~-~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~-------~i~-~l~~ 70 (465)
++++|. ++|.+.++||.|.|++||+|.+..+.+.||||+.+....+ +..+.|+++|+++..+. +|. .+..
T Consensus 71 IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 71 IGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 467787 9999999999999999999999999999999998865433 45788999999987432 333 3444
Q ss_pred E---eEeCcEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeec
Q 012336 71 F---GVEGEYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMG 137 (465)
Q Consensus 71 ~---~~~~~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~ 137 (465)
| +.++.+.|||+|++|.+|..++.+++ +.++...+..|+.||+.||.|||. .||||-||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 4 45788999999999999999999765 679999999999999999999996 5899999999999993
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=302.81 Aligned_cols=248 Identities=13% Similarity=0.146 Sum_probs=186.1
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
.|.....||+|+||.||+|++..++..||||.+..... ....|++++.+++|+++|..++.| .+....++||||+ +
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv~~~~~~-~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIVKLIGLC-RSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcceEEEEE-EcCCCCEEEEeCCCC
Confidence 46667889999999999999988999999998764322 334578899999887777766665 4556778999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH---SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH---s~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++|.+++. .+++..+..|+.|++.||+||| +.+|+||||||+|||+ +.++.+++. ||.......
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-ecccccccc-----
Confidence 99999986 3899999999999999999999 6699999999999999 466676665 665543221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc--hHHHHHHHhhhh----ccCcH
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKYDKISEKK----MLTPI 237 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~--~~~~~~~i~~~~----~~~~~ 237 (465)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+......... ...+.
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 123368899999999999999999999999999999999999995432211 111111000000 00000
Q ss_pred H----HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 238 E----VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 238 ~----~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
. ........++.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 0 000011346788999999999999999999999998764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=235.81 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=199.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+|.-.++||+|.||+||+|++..+++.||+|....+... ...++|+-+++.++|.++|..+.. ...+...-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-lhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-LHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-hccCceeEEeH
Confidence 3577789999999999999999999999999987765433 358999999999999776665544 44555678999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++|..+|..++..+++.+..+.+..++.|++.||.|+|+.+++||||||+|.|+ ..+|.+||+|||+++.+...
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgip--- 154 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIP--- 154 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCc---
Confidence 999999999999999999999999999999999999999999999999999999 59999999999999977542
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc--cCc--
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM--LTP-- 236 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~--~~~-- 236 (465)
.+....-+-|.+|.+|.++.+.. |+...|+||-|||+.|+.. |.+.|++.+..+....+........ .+|
T Consensus 155 ----vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 155 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ----eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 23334456799999999999876 7889999999999999998 8888888544333322222221100 000
Q ss_pred -----------------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 237 -----------------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 237 -----------------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+-+.+...=.++++.++.-+|..|.+++...
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 0011122334467889999999999999977543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=251.61 Aligned_cols=265 Identities=18% Similarity=0.285 Sum_probs=205.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCC-CCCceeEEEeEeCcEEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGG-TGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~-~~i~~l~~~~~~~~~~~lv~ 82 (465)
+.+.|.+.+.||+|.||.+-+|++..+++.+++|-+.... ....|.+|...--.|.+| ++|..+...+...+++++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4678999999999999999999999999999999877553 344688887765556554 55555666666777899999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ .|+|..-+. ...+.+.....++.|++.||.|||++++||||||.+||||... +...|||||||+.+......
T Consensus 102 E~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred ccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCcee-
Confidence 998 888887776 4678999999999999999999999999999999999999743 34599999999998654321
Q ss_pred cccccccCCCCccccccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCc-hHHHHHHHhhhhccC
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYDKISEKKMLT 235 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~ 235 (465)
.....+..|.+||...... ..+.+|+|.||+++|++|||++||+.....+ ....+......+. +
T Consensus 178 ---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~-~ 247 (378)
T KOG1345|consen 178 ---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN-P 247 (378)
T ss_pred ---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC-c
Confidence 1223466789998765432 4678899999999999999999998532222 2222333333333 3
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
..+...+.+++.+..++++-|..+|++|--..+.++...+.|++..+.
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~ 295 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIK 295 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhc
Confidence 344455778999999999999999999988788888888888776553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=263.63 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=191.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHH--HcCCCCCceeEEEeE---eCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYML--LQGGTGVPHLKWFGV---EGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~--l~~~~~i~~l~~~~~---~~~~~~lv 81 (465)
...++.+.||+|.||.||+|.. +++.||||++.... .+.++.|..|+.. ++|++++.++..-.. ....+.||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~-kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE-KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH-HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3467888999999999999975 67999999988543 4678888888874 667777766543211 12355677
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR---------GFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~---------givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
++|- .|+|.+++. ...++|....+|+..|+.||+|||+. .|+|||||.+|||+ +.+++..|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 7775 999999998 57899999999999999999999973 59999999999999 599999999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCC-C-----CCcchHHHHHHHHHHHhcCC------------CCC
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-Q-----SRRDDLESLGYVLMYFLRGS------------LPW 213 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~-----s~k~DiwSLGviL~elltG~------------~Pf 213 (465)
||..+...... ...-..+||.+|||||++.+.- + =.+.||||+|.+|||+++.. +||
T Consensus 362 LAl~~~p~~~~-----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKPQ-----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCCC-----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 99988643322 2233468999999999998643 2 24789999999999999642 233
Q ss_pred CCCC--CCchHHHHHHHhhhhc--cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 214 QGLK--AGTKKQKYDKISEKKM--LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 214 ~~~~--~~~~~~~~~~i~~~~~--~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...- ..+..+....+..++. ..+....+.....-+.+.+..||+.|++.|.|+.-+.+.+..+
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l 503 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL 503 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence 2100 0112222222333332 3333344444557799999999999999999999888887665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=243.17 Aligned_cols=236 Identities=25% Similarity=0.326 Sum_probs=186.2
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHHH
Q 012336 19 SFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFN 94 (465)
Q Consensus 19 ~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~ 94 (465)
+||.||+|++..+++.||+|++..... ...+..|++.+..++|.++++.+.. .......+++++++ +++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~-~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDV-FEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhh-eeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999988899999999876544 4578899999999977665555444 44556788999998 449999987
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCcc
Q 012336 95 YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174 (465)
Q Consensus 95 ~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 174 (465)
.. ..+++..+..++.+++.+|.|||+.+++|+||+|+||++ +.++.++|+|||++....... ......
T Consensus 80 ~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~--------~~~~~~ 147 (244)
T smart00220 80 KR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DEDGHVKLADFGLARQLDPGG--------LLTTFV 147 (244)
T ss_pred hc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCCCcEEEccccceeeecccc--------cccccc
Confidence 53 338999999999999999999999999999999999999 477999999999998765421 123456
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHH
Q 012336 175 GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHY 254 (465)
Q Consensus 175 Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~ 254 (465)
++..|++||.+.+..++.++|||+||+++|++++|..||..... .......+......... ....++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPFPP--PEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCCcc--ccccCCHHHHHHHHH
Confidence 88899999999988899999999999999999999999976322 12222222222221111 111178999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 012336 255 CRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 255 cl~~dp~~RPt~~~l~~ 271 (465)
||..+|++||++.++.+
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999877754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=256.24 Aligned_cols=262 Identities=20% Similarity=0.267 Sum_probs=210.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC-----CcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~-----~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+-..|+++...+-+|.||.||.|.+... .+.|-+|.++..... ..++.|.-++..+.|++..+.++.+.++.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3467899999999999999999976543 345666655433222 24666777777778889999999988888
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN-------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYI 147 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~-------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL 147 (465)
...++.+.+. .++|..++..|. +.++..++..++.|++.|++|||+.|+||.||..+|++| |+.-+|||
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkl 437 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKL 437 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEe
Confidence 8888888887 789999998552 347888999999999999999999999999999999999 68899999
Q ss_pred EecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHH
Q 012336 148 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYD 226 (465)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~ 226 (465)
+|=.+++.+.....+.. ..+-..+..||+||.+.+..|+.++|+||||++||||+| |+.||...++.+. ..
T Consensus 438 tDsaLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---~~ 509 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---EH 509 (563)
T ss_pred ccchhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH---HH
Confidence 99999998766544321 223345678999999999999999999999999999999 9999998766333 33
Q ss_pred HHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 227 KISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+.++... ..+ -++|+++..+|..||..+|++||++++++..|.+...+.
T Consensus 510 ylkdGyRl-aQP---~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 510 YLKDGYRL-AQP---FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HHhcccee-cCC---CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 33333222 222 356999999999999999999999999999999987654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=264.20 Aligned_cols=255 Identities=18% Similarity=0.186 Sum_probs=174.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc----------------CCCcEEEEEEeecCCC----------------CccHHH
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV----------------QTGEEVAVKLESVKTK----------------HPQLHY 51 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~----------------~~~~~vAvKi~~~~~~----------------~~~~~~ 51 (465)
.-.++|.+.++||+|+||.||+|... ..++.||||.+..... ......
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34679999999999999999999752 2346799998764321 112334
Q ss_pred HHHHHHHHcCCCCC-----ceeEEEeE-------eCcEEEEEEecc-CCCHHHHHHHcC---------------------
Q 012336 52 ESKLYMLLQGGTGV-----PHLKWFGV-------EGEYNVMVIDLL-GPSLEDLFNYCN--------------------- 97 (465)
Q Consensus 52 E~~il~~l~~~~~i-----~~l~~~~~-------~~~~~~lv~e~~-g~sL~~ll~~~~--------------------- 97 (465)
|+.++.+++|++++ ..+.+|.. +....++|++|+ +++|.+++....
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 66677777776542 22333322 234578999998 889998886421
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccc
Q 012336 98 --RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175 (465)
Q Consensus 98 --~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~G 175 (465)
..+++..+..++.|++.+|.|||+++|+||||||+|||+ +.++.++|+|||++........ .......+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~------~~~~~g~~ 372 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGIN------FNPLYGML 372 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCc------cCccccCC
Confidence 124567889999999999999999999999999999999 5788999999999975432211 01112345
Q ss_pred cccccccccccCCCC----------------------CCcchHHHHHHHHHHHhcCCC-CCCCCCCCch-HH-------H
Q 012336 176 TARYASVNTHLGVEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTK-KQ-------K 224 (465)
Q Consensus 176 t~~Y~APE~~~~~~~----------------------s~k~DiwSLGviL~elltG~~-Pf~~~~~~~~-~~-------~ 224 (465)
|+.|+|||.+..... ..+.||||+||++|+|++|.+ ||.+...... .. .
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 889999998764321 134799999999999999886 7764321111 01 1
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCC---CCCCCHHHHH
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRF---EDKPDYSYLK 270 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp---~~RPt~~~l~ 270 (465)
...+.......+ .....++..++|+..||..+| .+|+++.+++
T Consensus 453 ~r~~~~~~~~~~---~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 453 WRMYKGQKYDFS---LLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred HHhhcccCCCcc---cccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 111111111111 123467899999999999876 6899965543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=260.66 Aligned_cols=194 Identities=21% Similarity=0.358 Sum_probs=167.3
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----------CCccHHHHHHHHHHHc---CCCCCceeEEEeEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----------KHPQLHYESKLYMLLQ---GGTGVPHLKWFGVE 74 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~---~~~~i~~l~~~~~~ 74 (465)
+|..++.||.|+||.||+|.++.+..+|+||.+.++. .-..+..|++||..|. |+|++. +..|+++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlK-lLdfFEd 640 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILK-LLDFFED 640 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhh-hhheeec
Confidence 5999999999999999999999999999999876542 2234678999999998 555444 4455677
Q ss_pred CcEEEEEEecc--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 75 GEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 75 ~~~~~lv~e~~--g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
++++||+|+-- |-+|.+++.. ...+++.++..|+.|++.|+++||++||||||||-+|+.+ |.+|.+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccc
Confidence 77889999987 6688888886 5679999999999999999999999999999999999999 7999999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCC
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQG 215 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~ 215 (465)
+..... .....++||..|+|||++.|..| ++.-|||+||++||.++....||++
T Consensus 717 aa~~ks---------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYTKS---------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhhcC---------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 975433 12357899999999999999887 7788999999999999999999975
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-32 Score=250.46 Aligned_cols=248 Identities=18% Similarity=0.273 Sum_probs=188.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCc----EEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE----YNV 79 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~----~~~ 79 (465)
+.+-.+.||.|+||.||.+.+..+|+.||+|.+..- .....+.+|++++..++|.|.+..+........ ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344567899999999999999999999999976532 123468899999999999888777665544221 346
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+++|++..+|...+-. .+.++.+.+.-+++||+.||.|||+.+|+||||||.|.|+ +.|..+||||||+++....+
T Consensus 134 V~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchh
Confidence 8889999999988874 6789999999999999999999999999999999999999 58999999999999876543
Q ss_pred cCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. +-...-+-|..|.|||++.|.. |+.++||||.|||+.|||..+..|+...+- +.++.|.+-.-.+..+
T Consensus 210 ~~------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi---qQL~lItdLLGTPs~E 280 (449)
T KOG0664|consen 210 DR------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI---EQLQMIIDLLGTPSQE 280 (449)
T ss_pred hh------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH---HHHHHHHHHhCCCcHH
Confidence 32 1112335688999999998864 899999999999999999999999875543 3333322211111111
Q ss_pred ---HHhc--------------------------cCcHHHHHHHHHHhcCCCCCCCCHHH
Q 012336 239 ---VLCK--------------------------SYPSEFTSYFHYCRSLRFEDKPDYSY 268 (465)
Q Consensus 239 ---~~~~--------------------------~~p~~l~~li~~cl~~dp~~RPt~~~ 268 (465)
..|. ....+...++..++..||+.|.+.++
T Consensus 281 aMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~ 339 (449)
T KOG0664|consen 281 AMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE 339 (449)
T ss_pred HHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh
Confidence 1111 11235677888889999999988443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=232.84 Aligned_cols=211 Identities=21% Similarity=0.305 Sum_probs=167.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCcee-EEEeEeCcEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHL-KWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l-~~~~~~~~~~~lv 81 (465)
.+....+..||+|++|.|-+-++..+|+..|+|.+...- ...++++|+.+.++....+.+.++ +.+..++ ...+.
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-dvwIc 123 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-DVWIC 123 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-cEEEe
Confidence 345566788999999999999999999999999876542 234677788887776655554443 3333344 46788
Q ss_pred EeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 82 IDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 82 ~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
||.+..+|..+... .+..+++..+-+||..++.||.|||++ .+||||+||.|||+ +..|+|||||||++-.+.
T Consensus 124 ME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeeh
Confidence 99999999888753 367899999999999999999999976 79999999999999 699999999999998776
Q ss_pred cccCcccccccCCCCccccccccccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLG----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
+... .....|-..|||||.+.. ..|+-++||||||+++.||.+++.||... .+.-+.+..+.+
T Consensus 201 dSiA--------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVe 267 (282)
T KOG0984|consen 201 DSIA--------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVE 267 (282)
T ss_pred hhhH--------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhc
Confidence 6432 223578899999999864 35899999999999999999999999765 344444444444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=272.70 Aligned_cols=244 Identities=22% Similarity=0.266 Sum_probs=187.7
Q ss_pred EeeEeeeCce-EEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEeccCCCHH
Q 012336 12 GRKIGSGSFG-ELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLE 90 (465)
Q Consensus 12 ~~~LG~G~fG-~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~sL~ 90 (465)
.+.+|.|+-| .||+|.. .++.||||.+-.. ......+|++.++.-..|++|..++....+..+.||..|+|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e-~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE-FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH-hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 4568899887 5799986 7889999965422 2346789999999998888887777777788899999999999999
Q ss_pred HHHHHcCCCCC---HHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC--CCCcEEEEecCCccccccccCcccc
Q 012336 91 DLFNYCNRKFS---LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 91 ~ll~~~~~~ls---~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d--~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
|+++.....+. -...+.++.|++.||++||+.+||||||||.||||...+ ....++|+|||+++++.....
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s---- 666 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS---- 666 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc----
Confidence 99985311111 134577889999999999999999999999999997432 345789999999999876443
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc-cCcHHHHhcc
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM-LTPIEVLCKS 243 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~ 243 (465)
.+.......||-+|+|||++.....+..+|||||||++|+.++ |..||..... .-..|..... .......
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----R~~NIl~~~~~L~~L~~~--- 738 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----RQANILTGNYTLVHLEPL--- 738 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-----hhhhhhcCccceeeeccC---
Confidence 3455678899999999999999998999999999999999999 5999976322 2112222211 1111100
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
-..++.+||.+|+..+|..||++.++.
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 012899999999999999999977664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=221.91 Aligned_cols=207 Identities=28% Similarity=0.434 Sum_probs=176.2
Q ss_pred EeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHH
Q 012336 15 IGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLE 90 (465)
Q Consensus 15 LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~ 90 (465)
||+|.+|.||++....+++.++||++...... ..+.+|++.+..+.+. ++..+..+.......+++++++ +++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~-~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHP-NIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCC-CeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999998778999999998876553 6799999999999884 4555555555567889999999 49999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC-CCcEEEEecCCccccccccCcccccccC
Q 012336 91 DLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-SNQVYIIDYGLAKKYRDLQTHKHIPYRE 169 (465)
Q Consensus 91 ~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~-~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (465)
+++......++...+..++.+++.+|.+||+.|++|+||+|.||++. . ++.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 99986445799999999999999999999999999999999999994 5 78999999999986644221 1
Q ss_pred CCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHH
Q 012336 170 NKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEF 248 (465)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l 248 (465)
.....+...|++||.+... .++.+.|+|+||++++++ ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 2345678899999999887 788999999999999998 568
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHH
Q 012336 249 TSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+++..|+..+|++||++.++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~ 213 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILE 213 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhh
Confidence 89999999999999999877764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=225.16 Aligned_cols=249 Identities=17% Similarity=0.294 Sum_probs=185.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEe--CcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVE--GEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~--~~~~~lv~e 83 (465)
.++|++++++|.|-+++||.|++..+++.++||+++.- ....+.+|+++|..|.++++|..+.....+ .....+++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 47899999999999999999999999999999998743 245789999999999977777666555443 334567777
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+. +.+...+.. .|+...+..++.+++.||.|+|++||+|||+||.|+|+. .....++|+|+|+|..+......
T Consensus 116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eY 189 (338)
T KOG0668|consen 116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEY 189 (338)
T ss_pred hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCcee
Confidence 77 666555543 688899999999999999999999999999999999995 45678999999999887653321
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCC-CCCchHHHHHHHh----------h
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGL-KAGTKKQKYDKIS----------E 230 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~-~~~~~~~~~~~i~----------~ 230 (465)
..-+.+-.|--||.+.... |+..-|+|||||+|..|+..+.||... +..+..-++.++. .
T Consensus 190 --------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 190 --------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred --------eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 1223455667799987654 788999999999999999999887543 2222111111111 1
Q ss_pred hhccCcHH--------------HHh-----ccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 231 KKMLTPIE--------------VLC-----KSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 231 ~~~~~~~~--------------~~~-----~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
-.+..++. .+. .-.++++.+|+..+|..|..+|+|+.|.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEa 319 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEA 319 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHH
Confidence 11111111 000 1145899999999999999999997654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=239.98 Aligned_cols=260 Identities=22% Similarity=0.357 Sum_probs=200.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcC---CCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~---~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.+.|.++.+||.|.|+.||++.+.. .+..||+|-+........+..|+++|..+.+..+|..+..|...++..++|
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv 113 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV 113 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence 46789999999999999999999877 788999999888777888999999999999999999999999999999999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++. .....+++. .++...+..++..++.||.++|++|||||||||.|||.. ...+.-.|+|||+|..+....
T Consensus 114 lp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred ecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhhh
Confidence 9998 556666655 578999999999999999999999999999999999996 567888999999998322111
Q ss_pred ------C-----cc--------------------------cccccCCCCccccccccccccccCCC-CCCcchHHHHHHH
Q 012336 161 ------T-----HK--------------------------HIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYV 202 (465)
Q Consensus 161 ------~-----~~--------------------------~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGvi 202 (465)
. .. .......-+..||++|.|||++...+ ++.++||||.|+|
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 0 00 00001122356999999999988755 8999999999999
Q ss_pred HHHHhcCCCCCCCCCCCc--hHHHHH-----------HHhhh-------h----------ccC--------------cHH
Q 012336 203 LMYFLRGSLPWQGLKAGT--KKQKYD-----------KISEK-------K----------MLT--------------PIE 238 (465)
Q Consensus 203 L~elltG~~Pf~~~~~~~--~~~~~~-----------~i~~~-------~----------~~~--------------~~~ 238 (465)
+.-++++..||....+.. ..+... ..... . +.. ..+
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 999999999997644322 111110 00000 0 000 000
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....+|..+.+|+.+|+..||.+|.++++.+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 11123566899999999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=230.34 Aligned_cols=247 Identities=20% Similarity=0.237 Sum_probs=195.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+..+|.-++.+|.|.- .|..+.+...+++||+|.+... ....+..+|..++..+.|.++|..+..|....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4568999999999999 8899999999999999976543 33456889999999999999999988886533
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...|+|||++..+|...+. -.++-+++..|+.|++.|+.|||+.||+||||||+||++ ..+..+||+|||+++.
T Consensus 94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence 3568999999999998887 357889999999999999999999999999999999999 5899999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
-..+ ......+.|-.|.|||++.+..+...+||||+||++.||++|..-|.+.+- ...+.++.+..-..
T Consensus 168 e~~~--------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~---idQ~~ki~~~lgtp 236 (369)
T KOG0665|consen 168 EDTD--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH---IDQWNKIIEQLGTP 236 (369)
T ss_pred cCcc--------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH---HHHHHHHHHHhcCC
Confidence 5432 123455789999999999999999999999999999999999999987332 22222222211111
Q ss_pred cH-------------------------HHHh------------ccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 236 PI-------------------------EVLC------------KSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 236 ~~-------------------------~~~~------------~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.. .... +.-+..+.+++.+||..+|++|.+.+++
T Consensus 237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da 307 (369)
T KOG0665|consen 237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA 307 (369)
T ss_pred CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH
Confidence 00 0000 0112458899999999999999995544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=255.80 Aligned_cols=250 Identities=18% Similarity=0.266 Sum_probs=206.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|.++..+|+|.||.||+++++.+++..|+|+++.+.. ..-+..|+-+++.++|+++|.+++.|-... ...+.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEE
Confidence 5789999999999999999999999999999999887643 345788999999999999999988876544 4578999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|| |++|.+...- .+++++.++....+..+.||+|||++|-+|||||-.|||++ +.+.+|++|||.+..+....
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhh--
Confidence 99 8888888763 67899999999999999999999999999999999999995 89999999999998776533
Q ss_pred ccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 163 KHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
...+.+.||+.|||||+.. ...|..++|||++|++..|+---..|-... ..++...-+....+..+...
T Consensus 167 -----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl---hpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 167 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL---HPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred -----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc---chHHHHHHhhccCCCCCccc
Confidence 3457889999999999853 456899999999999999988877775543 23444444444444444433
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....+.+.|.+|++.|+.++|.+||+++.+.
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 3446788999999999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-26 Score=213.97 Aligned_cols=197 Identities=29% Similarity=0.426 Sum_probs=164.3
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
|.+.+.||.|++|.||+|.+..+++.||||.+.... ....+..|++.+..+.|.+.+..+.. .......+++++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~-~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGV-FEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheee-eecCCceEEEEecc
Confidence 678899999999999999998889999999987654 34578889999999987665555554 45556778888888
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++......+++..+..++.+++.+|.+||+.+++|+||+|.||++ +.++.++|+|||++..+.....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~--- 153 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---GMDGLVKLADFGLARFIHRDLA--- 153 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeeCceeeEecCccc---
Confidence 559999998533228999999999999999999999999999999999999 4779999999999987654320
Q ss_pred ccccCCCCccccccccccccc-cCCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q 012336 165 IPYRENKNLTGTARYASVNTH-LGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~-~~~~~s~k~DiwSLGviL~elltG~~Pf~~ 215 (465)
.......++..|++||.+ ....++.++|+|+||+++|+|++|+.||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=210.05 Aligned_cols=166 Identities=16% Similarity=0.171 Sum_probs=127.2
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
|+|.+++...+..+++.+++.|+.|++.||.|||+++ ||+|||+ +.++.+++ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPE------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeeccc-------
Confidence 6899999865667999999999999999999999998 9999999 58888998 9998765431
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH--HHhccC
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE--VLCKSY 244 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 244 (465)
...||+.|||||++.+..++.++|||||||++|||++|+.||...... .+.+..+.......... .....+
T Consensus 63 -----~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 63 -----QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred -----cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 125889999999999999999999999999999999999999764321 12222222111111000 001122
Q ss_pred cH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 245 PS--EFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 245 p~--~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
+. ++.+++..||..+|++||++.++.+.+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 33 6999999999999999999888877665543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=257.53 Aligned_cols=187 Identities=16% Similarity=0.207 Sum_probs=133.3
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc----------------C
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL----------------G 139 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~----------------~ 139 (465)
...++++|+++.+|.+++......+++.+++.|+.||+.||+|||++||+||||||+||||.. .
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 456778888899999999865567999999999999999999999999999999999999941 0
Q ss_pred CCCCcEEEEecCCcccccccc--------Ccccccc-cCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCC
Q 012336 140 RKSNQVYIIDYGLAKKYRDLQ--------THKHIPY-RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 210 (465)
Q Consensus 140 d~~~~vkL~DFGla~~~~~~~--------~~~~~~~-~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~ 210 (465)
+.++.+||+|||+++...... .....++ .......||+.|||||++.+..++.++|||||||+||||++|.
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 234556666777665421100 0000000 0111246899999999999999999999999999999999998
Q ss_pred CCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 211 LPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.|+... ...+..+.... ..+ . ... ..++...++..||..+|.+||++.+|.+
T Consensus 213 ~~~~~~-----~~~~~~~~~~~-~~~-~-~~~-~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 213 SSREEK-----SRTMSSLRHRV-LPP-Q-ILL-NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CchhhH-----HHHHHHHHHhh-cCh-h-hhh-cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 887532 11222222111 111 1 111 1355678999999999999999887753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=218.81 Aligned_cols=172 Identities=19% Similarity=0.211 Sum_probs=132.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcC-CCcEEEEEEeecCC-------CCccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEVAVKLESVKT-------KHPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~-~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
+.+.++|.+.+.||+|+||+||+|++.. +++.||||++.... ....+.+|++++..+.|+++++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4678899999999999999999998876 67888999865321 123488999999999999988876553
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCceeeccCCCCCcEEEEecCC
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI-KPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDL-KP~NILl~~~d~~~~vkL~DFGl 152 (465)
...++||||+ |++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||+ +.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence 2468999998 777862 21 111 1467889999999999999999999 9999999 4778999999999
Q ss_pred ccccccccCccccc-ccCCCCccccccccccccccCCC
Q 012336 153 AKKYRDLQTHKHIP-YRENKNLTGTARYASVNTHLGVE 189 (465)
Q Consensus 153 a~~~~~~~~~~~~~-~~~~~~~~Gt~~Y~APE~~~~~~ 189 (465)
++.+........+. +..-.+..+++.|+|||++...+
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 99776543322211 11113677899999999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-22 Score=196.98 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=189.7
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+..|..++..+.+++.+..+..+.......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999976 8899998776543 34588899999999998645555444455555788888
Q ss_pred cc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC-cEEEEecCCccccccc
Q 012336 84 LL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDL 159 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~-~vkL~DFGla~~~~~~ 159 (465)
++ +++|.+++.... ..++......++.|++.+|.|+|+.+++||||||+|||+ +..+ .++++|||++..+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCC
Confidence 88 888887776432 279999999999999999999999999999999999999 4666 7999999999855443
Q ss_pred cCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC-chHHHHHHHhhhhccC
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDKISEKKMLT 235 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 235 (465)
....... .......|+..|++||.+.+ ..++...|+|++|++++++++|..||...... ...+....+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 2211000 12356789999999999988 57889999999999999999999998765431 1222222222222110
Q ss_pred cHHHHhccC----cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSY----PSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~----p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
......... ...+.+++..|+..+|..|.+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 000000111 257899999999999999998665443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-23 Score=224.53 Aligned_cols=235 Identities=22% Similarity=0.350 Sum_probs=168.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
..+|..++.|..|+||.||+++++.+.+.+|+|+ ++++. +++. ++. |. ++ .++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l---ilRn--ilt-------------~a-~n--pfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL---ILRN--ILT-------------FA-GN--PFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch---hhhc--ccc-------------cc-CC--ccee----
Confidence 5689999999999999999999999999999964 22221 1111 111 10 01 1112
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc--
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK-- 163 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~-- 163 (465)
|+-..+++. -++++.. ++.+++|||+.||+|||+||+|.||+ .-|++|+.|||+++......+..
T Consensus 136 -gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhh
Confidence 444555553 2334432 37899999999999999999999995 88999999999997643221110
Q ss_pred ------cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 164 ------HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 164 ------~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
..-....+.++||+.|.|||++..+.|++.+|||++|+|+||++.|..||.+. +..+.+..+......++.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd---tpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC---CHHHHHhhhhhhhccccc
Confidence 00112356689999999999999999999999999999999999999999984 444555555554444554
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT 291 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~ 291 (465)
. ...+|+++++++.++|..+|.+|---.- .+.-....++..+||.
T Consensus 280 ~--dea~p~Ea~dli~~LL~qnp~~Rlgt~g-------a~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 E--DEALPPEAQDLIEQLLRQNPLCRLGTGG-------ALEVKQHGFFQLLDWK 324 (1205)
T ss_pred c--CcCCCHHHHHHHHHHHHhChHhhcccch-------hhhhhhccceeecccc
Confidence 4 3567999999999999999999962211 1222335677778888
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=194.46 Aligned_cols=231 Identities=24% Similarity=0.284 Sum_probs=149.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcC-----------CCCCcee---
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQG-----------GTGVPHL--- 68 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~-----------~~~i~~l--- 68 (465)
.+...+.||.|+|+.||.+++..|++++|||+....... .++.+|.-....+.+ .-.++.-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 467788999999999999999999999999987655422 223333322222111 0111110
Q ss_pred ----EEEeEeC---cE-----EEEEEeccCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 012336 69 ----KWFGVEG---EY-----NVMVIDLLGPSLEDLFNYC---NRK---FSLKTVLMLADQLINRVEYMHSRGFLHRDIK 130 (465)
Q Consensus 69 ----~~~~~~~---~~-----~~lv~e~~g~sL~~ll~~~---~~~---ls~~~~~~ia~qi~~gL~yLHs~givHrDLK 130 (465)
..+.... .. .+++|+.+.++|.+++... ... +.....+.+..|++..+++||..|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 0011111 11 3678888899999887632 221 3344456677899999999999999999999
Q ss_pred CCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccC--------CCCCCcchHHHHHHH
Q 012336 131 PDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--------VEQSRRDDLESLGYV 202 (465)
Q Consensus 131 P~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--------~~~s~k~DiwSLGvi 202 (465)
|+|||+ +.+|.++|.||+.......... ....+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 6899999999988876543211 0233577899997643 247889999999999
Q ss_pred HHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCC
Q 012336 203 LMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDK 263 (465)
Q Consensus 203 L~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~R 263 (465)
||.|+||..||........... .-..|..+|+.++.||..+|+.+|++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986533221110 223577899999999999999999987
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-23 Score=221.92 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=191.1
Q ss_pred EEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC---CCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK---TKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 10 ~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~---~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.....+|.|++|.|+.+......+.++.|....+ ... ..+..|+.+-..|.|++++..+..+.........
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~- 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS- 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh-
Confidence 5677899999998888887777776666654321 100 1134455555567777776666555444333333
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
||||..+|..++.. ...++...+-.++.|++.||+|||+.||.||||||+|+|+. .++.+||+|||.+..+.....
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence 99995599988874 34799999999999999999999999999999999999994 888999999999987654322
Q ss_pred cccccccCCCCccccccccccccccCCCCCC-cchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH-HHhhhhccCcHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD-KISEKKMLTPIEV 239 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~-k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~-~i~~~~~~~~~~~ 239 (465)
.. ......++|...|+|||++.+.+|.+ ..||||.|++++.|.+|+.||.-........... ...+.........
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 11 13456788999999999999999975 6899999999999999999997654433321111 1112222333444
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+...+|.+.+.+|.++|+++|..|.|+++ .|++.|.+.
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~---i~~d~W~~~ 590 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQ---ILNDEWIRS 590 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHH---HhhChHhhh
Confidence 45677999999999999999999999554 456666544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=184.64 Aligned_cols=172 Identities=17% Similarity=0.215 Sum_probs=127.1
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCcc-----------HHHHHHHHHHHcCCCCCceeE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQ-----------LHYESKLYMLLQGGTGVPHLK 69 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~-----------~~~E~~il~~l~~~~~i~~l~ 69 (465)
|+.++.++|++++.||.|+||.||++.. ++..||||++.......+ +..|++.+.++.|+. ++.+.
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G-I~~~~ 101 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG-LASLN 101 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC-CCcce
Confidence 3567899999999999999999999754 577899999874422211 467888899997754 44444
Q ss_pred EEeE-e-------CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC
Q 012336 70 WFGV-E-------GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 140 (465)
Q Consensus 70 ~~~~-~-------~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d 140 (465)
.+.. . ....+++||++ |.+|.++.. +++ ....+++.+|..||..|++||||||.|||+.
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~--- 169 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS--- 169 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---
Confidence 4432 2 23578999999 678877632 333 2456999999999999999999999999994
Q ss_pred CCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHh
Q 012336 141 KSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL 207 (465)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ell 207 (465)
.++ ++|+|||.......... ...+.....+..++|+|+|||++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 566 99999999876533211 011344445667899999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=208.60 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=192.4
Q ss_pred EeeeCceEEEEEEE---cCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-C
Q 012336 15 IGSGSFGELYLGVN---VQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-G 86 (465)
Q Consensus 15 LG~G~fG~Vyla~~---~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (465)
+|+|.||.|++++. ...+.-+|+|++.+... ......|..++..++.++.+..+...+......++++++. |
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999999763 33577899998775432 1245568888888887777777777776666666777766 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 87 PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 87 ~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
+.|...+.. ...+.+.....+...++.+++++|+.+++|||+|++||++ +.+|++++.|||+++......
T Consensus 82 g~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~------ 151 (612)
T KOG0603|consen 82 GDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEK------ 151 (612)
T ss_pred chhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhh------
Confidence 787776653 5678899999999999999999999999999999999999 799999999999998765432
Q ss_pred ccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcH
Q 012336 167 YRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~ 246 (465)
..+||..|||||++. .....+|+||||++++||++|-.||.. +....|.......| ..+..
T Consensus 152 -----~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p-----~~l~~ 212 (612)
T KOG0603|consen 152 -----IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMP-----RELSA 212 (612)
T ss_pred -----hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCc-----hhhhH
Confidence 228999999999998 566789999999999999999999987 33333444344344 34467
Q ss_pred HHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCccccccccCCCCCCCC
Q 012336 247 EFTSYFHYCRSLRFEDKPDY--SYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSS 301 (465)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~--~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (465)
.+.+++.+++..+|..|.-. .-+.+. ....+....||+.+...+....
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~~~~~~ei-------k~h~f~~~i~~~~l~~r~~~~~ 262 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAGPDGVDEI-------KQHEFFQSIDWNELEARSRPPP 262 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccCcchhHHH-------hccchheeeeHhhHhhcCCCCC
Confidence 88999999999999999643 222222 2356777889997654444333
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-21 Score=207.82 Aligned_cols=253 Identities=22% Similarity=0.337 Sum_probs=185.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC---CceeEEEeEeCcEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG---VPHLKWFGVEGEYNVM 80 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~---i~~l~~~~~~~~~~~l 80 (465)
+-+.+|.+.+.||.|+||.||+|.... ++.||||+.+-..-+ .|.-=.+++.+|+ +.. +-.+..+....+-.++
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W-EfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW-EFYICLQVMERLK-PQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce-eeeehHHHHHhhc-hhhhcchHHHHHHHccCCccee
Confidence 347899999999999999999999755 999999987654433 2333344555554 221 2222222233344567
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc----CCCCCcEEEEecCCccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL----GRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~----~d~~~~vkL~DFGla~~ 155 (465)
|++|. .|+|.++++ ..+.+++..+..++.||+..|+.||..+|||+||||+|+||.. +.+...++|+|||.+..
T Consensus 772 v~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred eeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 88877 999999998 4778999999999999999999999999999999999999964 23467899999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
+...... ......++|-.+-.+|+..|.++++.+|.|.|+-+++-||.|+.- + ...+....
T Consensus 851 m~lfp~~-----~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q----~~~g~~~~ 911 (974)
T KOG1166|consen 851 MKLFPDG-----TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E----VKNGSSWM 911 (974)
T ss_pred eeEcCCC-----cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H----hcCCccee
Confidence 6543322 123456789999999999999999999999999999999987432 1 11110000
Q ss_pred cHHHHhccC--cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 236 PIEVLCKSY--PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 236 ~~~~~~~~~--p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+ +.+ -+-+.+|+..+|..|-..=|...+|...|+..|.+.
T Consensus 912 ~~~~~-~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 912 VKTNF-PRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ccccc-hhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 00000 011 134778999999977777789999999999888765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.9e-21 Score=177.94 Aligned_cols=136 Identities=19% Similarity=0.225 Sum_probs=103.4
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----------CccH-----------------HHHHHHHHHHcCCC
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----------HPQL-----------------HYESKLYMLLQGGT 63 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----------~~~~-----------------~~E~~il~~l~~~~ 63 (465)
...||+|+||.||+|.+. +|+.||||++..... ...+ ..|.+++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999976 899999999865421 1122 24889999997643
Q ss_pred CCceeEEEeEeCcEEEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCceeeccCCC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLLGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYM-HSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~-sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yL-Hs~givHrDLKP~NILl~~~d~ 141 (465)
. +....+.... .+||||++++ +|...... ...++...+..++.|++.+|.|| |+.||+||||||+|||+.
T Consensus 81 v-~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 81 I-PCPEPILLKS--HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred C-CCCcEEEecC--CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 3 2222222222 3799999954 44433222 46799999999999999999999 799999999999999993
Q ss_pred CCcEEEEecCCcccc
Q 012336 142 SNQVYIIDYGLAKKY 156 (465)
Q Consensus 142 ~~~vkL~DFGla~~~ 156 (465)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.6e-20 Score=172.38 Aligned_cols=192 Identities=15% Similarity=0.094 Sum_probs=137.4
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc------cHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP------QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~------~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+.+...|++|+||+||++.. .+..|+.+.+....... .+.+|+++|.+|.|+++++.+..+ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 45678999999999998864 77888877666544322 367899999999988888888654 2358999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI-KPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDL-KP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ |.+|...... ....++.|++.+|.++|.+||+|||| ||.|||+ +.++.++|+|||++.......
T Consensus 78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE---cCCCCEEEEECCCceecCCcc
Confidence 997 7777644321 12457889999999999999999999 7999999 477899999999998543211
Q ss_pred Cc------ccccccCCCCccccccccccccccCC-CCC-CcchHHHHHHHHHHHhcCCCCCCCCC
Q 012336 161 TH------KHIPYRENKNLTGTARYASVNTHLGV-EQS-RRDDLESLGYVLMYFLRGSLPWQGLK 217 (465)
Q Consensus 161 ~~------~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s-~k~DiwSLGviL~elltG~~Pf~~~~ 217 (465)
.. .........-...++.|++|+...-- ..+ ...+|++.|+-+|.++|+..|+.+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00 00000000011256778888754322 222 56799999999999999999876543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=170.50 Aligned_cols=136 Identities=21% Similarity=0.267 Sum_probs=104.5
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----------------------------ccHHHHHHHHHHHcCCC
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----------------------------PQLHYESKLYMLLQGGT 63 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----------------------------~~~~~E~~il~~l~~~~ 63 (465)
.+.||+|+||+||+|.+. +|+.||||++...... ..+..|...+.++.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999976 8999999998754210 01246788888888754
Q ss_pred CCceeEEEeEeCcEEEEEEeccCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLLGPS-LE-DLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGR 140 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~s-L~-~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d 140 (465)
. .....+... ..+||||++++. +. ..+. ...++...+..++.|++.+|.+||+ .||+||||||+|||+ +
T Consensus 81 i-~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~ 152 (190)
T cd05145 81 V-PVPEPILLK--KNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H 152 (190)
T ss_pred C-CCceEEEec--CCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E
Confidence 3 222222222 247999999543 33 2333 4568889999999999999999999 999999999999999 3
Q ss_pred CCCcEEEEecCCccccc
Q 012336 141 KSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 141 ~~~~vkL~DFGla~~~~ 157 (465)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 6899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.6e-21 Score=204.67 Aligned_cols=249 Identities=17% Similarity=0.126 Sum_probs=180.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+|...+.||++.|=.|.+|++ ..|. |+||++-++.. ..+.+.|++ +..++++|.+|..++ .+.....|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHH
Confidence 789999999999999999985 3444 89999876532 234555666 666778787777666 3445567888
Q ss_pred EeccCCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLLGPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~-ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
-+|...+|.|.+. .++ +..-+...|+-|++.||..+|..||+|||||.+|||++ .-+-++|+||..-+...-..
T Consensus 100 RqyvkhnLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHHHhhhhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCC
Confidence 8999999999987 455 57778899999999999999999999999999999996 88999999998775432211
Q ss_pred CcccccccCCCCccccccccccccccCCC-----------CCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVE-----------QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-----------~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (465)
++..-.-....+-..-.+|.|||.+.... .+++-||||+||++.||++ |.+||.- .|.+..
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aY- 247 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAY- 247 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhH-
Confidence 11100000111222346899999876421 4678899999999999999 8888842 333322
Q ss_pred hhhhccCcHHHHhccC-cHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 229 SEKKMLTPIEVLCKSY-PSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
..+. ....+.....+ ...+++++..|++.||..|.++++..+.-
T Consensus 248 r~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred hccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 2222 23333333343 45799999999999999999998877653
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=176.48 Aligned_cols=190 Identities=18% Similarity=0.226 Sum_probs=140.5
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC-CcEEEEecCCc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS-NQVYIIDYGLA 153 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~-~~vkL~DFGla 153 (465)
+...|+||.-...+|.+++- .+..+..+...|+.|+++++.|||++||.|||||.+|||+.++|+. -.+.|+|||.+
T Consensus 315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 44678999999999999986 6778889999999999999999999999999999999999887544 46678999988
Q ss_pred cccccccCcccccccC-CCCccccccccccccccCCCC------CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH
Q 012336 154 KKYRDLQTHKHIPYRE-NKNLTGTARYASVNTHLGVEQ------SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 226 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~------s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~ 226 (465)
-.- +...-..||.. .....|+...||||+....+- -.|+|.|+.|.+.||+++...||++........ .
T Consensus 393 LAd--~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--r 468 (598)
T KOG4158|consen 393 LAD--DNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--R 468 (598)
T ss_pred eec--cccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--h
Confidence 432 12122233322 223468889999999875431 238999999999999999999998733222111 1
Q ss_pred HHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 227 KISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
...+.. .++ +...+|+.+.+++..+|+.||.+|++..-....|.
T Consensus 469 ~Yqe~q-LPa---lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 469 TYQESQ-LPA---LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred hhhhhh-CCC---CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 112222 222 22456999999999999999999998765555443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.9e-20 Score=173.56 Aligned_cols=245 Identities=12% Similarity=0.150 Sum_probs=186.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+...++.+|.....|+.|+|++ .|..+++|+++... ....|..|.-.++.+.|+++++.+..|....+...|..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 3456778899999999999998 45667788887653 33468889999999999999999999988876666666
Q ss_pred eccCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEE--ecCCccccc
Q 012336 83 DLLGPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYII--DYGLAKKYR 157 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~-~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~--DFGla~~~~ 157 (465)
++..++|..++..... ..+..++.+++.+|+.|+.|||+.. |..--|....+++ |++.+.+|. |--++-.
T Consensus 268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeee--
Confidence 6669999999985433 4788899999999999999999975 4445688888999 566666653 3322211
Q ss_pred cccCcccccccCCCCccccccccccccccCCCC---CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~---s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
...-.-.|.||+||.+...+- -+.+|+|||+++||||.|...||....+.+...++ .-....
T Consensus 343 ------------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki---aleglr 407 (448)
T KOG0195|consen 343 ------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI---ALEGLR 407 (448)
T ss_pred ------------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh---hhcccc
Confidence 112234688999999987653 45899999999999999999999987764433222 211111
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
. .+.++++..+.+++.-|+..||.+||.+..|+-.|+.+
T Consensus 408 v---~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 408 V---HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred c---cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1 12257788999999999999999999999999888765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3e-18 Score=164.09 Aligned_cols=141 Identities=23% Similarity=0.263 Sum_probs=108.4
Q ss_pred ceEEEeeEeeeCceEEEEEE-EcCCCcEEEEEEeecCCCC--------------------------ccHHHHHHHHHHHc
Q 012336 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKH--------------------------PQLHYESKLYMLLQ 60 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~-~~~~~~~vAvKi~~~~~~~--------------------------~~~~~E~~il~~l~ 60 (465)
-|.+.+.||+|+||.||+|. +..+|+.||||++...... ..+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 6779999999988753210 12457999999997
Q ss_pred CCCCCceeEEEeEeCcEEEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCceeecc
Q 012336 61 GGTGVPHLKWFGVEGEYNVMVIDLLGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG-FLHRDIKPDNFLMGL 138 (465)
Q Consensus 61 ~~~~i~~l~~~~~~~~~~~lv~e~~g~-sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g-ivHrDLKP~NILl~~ 138 (465)
+ .++.....+... ..++|||++++ +|...+.. ...+...++..++.|++.+|.+||+.| |+||||||+|||+
T Consensus 109 ~-~~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli-- 182 (237)
T smart00090 109 E-AGVPVPKPIAWR--RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV-- 182 (237)
T ss_pred h-cCCCCCeeeEec--CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE--
Confidence 5 233332222222 24799999854 56554322 345667778899999999999999999 9999999999999
Q ss_pred CCCCCcEEEEecCCcccc
Q 012336 139 GRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~ 156 (465)
+ ++.++|+|||++...
T Consensus 183 -~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 -H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred -E-CCCEEEEEChhhhcc
Confidence 3 778999999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2e-17 Score=155.11 Aligned_cols=136 Identities=15% Similarity=0.199 Sum_probs=100.5
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHc-----CCCCCceeEEEeEeC--cE-EEEE
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQ-----GGTGVPHLKWFGVEG--EY-NVMV 81 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~-----~~~~i~~l~~~~~~~--~~-~~lv 81 (465)
.+.||+|+||.||. +..++.. +||++.... ....+.+|+.+++.+. |++++..++++..+. .+ +.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999995 5666665 699876532 2346899999999995 455555555554442 23 3478
Q ss_pred EeccC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCceeeccCC-CCCcEEEEecCCcc
Q 012336 82 IDLLG---PSLEDLFNYCNRKFSLKTVLMLADQLINRV-EYMHSRGFLHRDIKPDNFLMGLGR-KSNQVYIIDYGLAK 154 (465)
Q Consensus 82 ~e~~g---~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL-~yLHs~givHrDLKP~NILl~~~d-~~~~vkL~DFGla~ 154 (465)
++++| ++|.+++.. ..+++. ..++.|++.++ +|||+++|+||||||+|||++..+ .+..++|+||+.+.
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99865 899999974 356666 35678888877 999999999999999999996322 34589999955543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.7e-17 Score=152.01 Aligned_cols=131 Identities=25% Similarity=0.410 Sum_probs=103.4
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+.||+|++|.||+|.+ .+..|+||+...... ...+.+|+.++..+.+.++... ..+.......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p-~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVP-AVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCC-eEEEEeCCCCEEEE
Confidence 6799999999999986 778899997653321 1246678889998887554333 33333445667899
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+++ |++|.+++.... . ....++.+++.+|.+||+.|++|+|++|.|||+ + ++.++|+|||++..
T Consensus 79 e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~---~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL---S-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE---E-CCCEEEEECCcccC
Confidence 988 889999987421 2 888999999999999999999999999999999 3 78899999999865
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.5e-18 Score=171.80 Aligned_cols=173 Identities=25% Similarity=0.346 Sum_probs=129.8
Q ss_pred cEEEEEEecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~--~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
.+.+|.|.+| ..+|++++... ....++...+.++.|++.+++| ++.+|+|+||.||++. .+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 3678999999 88999999732 3457888999999999999999 9999999999999995 667999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
.+......+. ..++.......||..||+||.+.+..|+.++||||||++|+|++. =..+|.. ......+...
T Consensus 403 ~ts~~~~~~~-~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~~d~r~g 475 (516)
T KOG1033|consen 403 VTSQDKDETV-APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATLTDIRDG 475 (516)
T ss_pred eeecccCCcc-cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhhhhhhcC
Confidence 9877654411 111223345679999999999999999999999999999999997 3333322 1112122222
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCC
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD 265 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt 265 (465)
..++.....+| +-..|+.+++...|.+||+
T Consensus 476 ---~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 476 ---IIPPEFLQDYP-EEYTLLQQLLSPSPEERPS 505 (516)
T ss_pred ---CCChHHhhcCc-HHHHHHHHhcCCCcccCch
Confidence 11222223444 3468999999999999994
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=167.39 Aligned_cols=213 Identities=15% Similarity=0.193 Sum_probs=158.6
Q ss_pred HHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCce
Q 012336 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF-LHRDIKPDNF 134 (465)
Q Consensus 57 ~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~gi-vHrDLKP~NI 134 (465)
+.+.|.|..+.++.+. ++...+++-++| -|+|.|.+......+++.-...++.+|+.||+|||.-.| .|+.|+..|+
T Consensus 2 ~~l~h~n~~~f~g~~~-~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASV-DGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccchhhhhhheeeEe-cCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3456666555555544 446677777887 999999998766778888999999999999999998765 9999999999
Q ss_pred eeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCC-------CCCcchHHHHHHHHHHHh
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-------QSRRDDLESLGYVLMYFL 207 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-------~s~k~DiwSLGviL~ell 207 (465)
++ |....+||.|||+......... +.......-...|.|||.+.+.. .+.+.||||||++++|++
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~-----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAE-----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred ee---eeeEEEEechhhhccccccccc-----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99 7999999999999876643111 11122233557899999988742 367799999999999999
Q ss_pred cCCCCCCCCCCCch-HHHHHHHhhhhc---cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 208 RGSLPWQGLKAGTK-KQKYDKISEKKM---LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 208 tG~~Pf~~~~~~~~-~~~~~~i~~~~~---~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
+.+.||........ .+.+..+..... .+..... ..+++++..++..||..+|++||+++++...++.+...
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELL-NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred hccCccccccccCChHHHHHHHHhcCCCCcCcchhhh-hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99999987332221 334444333122 1122211 25677899999999999999999999999988877654
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=148.44 Aligned_cols=134 Identities=22% Similarity=0.320 Sum_probs=102.7
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------------------------CccHHHHHHHHHHHcCCC-
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------------------------HPQLHYESKLYMLLQGGT- 63 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------------------------~~~~~~E~~il~~l~~~~- 63 (465)
|.+.+.||.|+||.||+|.+ .+++.||||++..... ......|..++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88999999999999999986 4899999998664320 012466788888887653
Q ss_pred CCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
.++.... ....+++|+++ |++|..+.. ......++.+++.++.++|..||+|+||||.|||+ +.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence 2222222 12457899988 667765432 13456788999999999999999999999999999 578
Q ss_pred CcEEEEecCCccccc
Q 012336 143 NQVYIIDYGLAKKYR 157 (465)
Q Consensus 143 ~~vkL~DFGla~~~~ 157 (465)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-16 Score=145.91 Aligned_cols=128 Identities=24% Similarity=0.400 Sum_probs=99.0
Q ss_pred eEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.||+|+||.||+|.. ++..|++|+...... ..++.+|++++..+.+.+ ++....+.......+++|+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 379999999999984 678899998543221 134567999999998754 2333333344555678999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
++ |++|.+++.... . .++.+++.+|.+||+.|++|+|++|.|||+ + ++.++++|||++...
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcCC
Confidence 98 889998876311 1 889999999999999999999999999999 3 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-15 Score=163.52 Aligned_cols=133 Identities=21% Similarity=0.371 Sum_probs=102.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
..|...+.||+|+||+||+|.+.. ..+++|+...+. ....+.+|.+++..+++++++. ...+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~-p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT-PVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe-eEEEEEeCC
Confidence 345668899999999999998643 344444322111 1134778999999998866443 334444455
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++||++ |++|.+++. ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999998 889998875 346789999999999999999999999999999 467899999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.7e-15 Score=137.89 Aligned_cols=135 Identities=24% Similarity=0.353 Sum_probs=95.1
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----cc----------------------HHHHHHHHHHHcCCC-C
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQ----------------------LHYESKLYMLLQGGT-G 64 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~----------------------~~~E~~il~~l~~~~-~ 64 (465)
.+.||+|+||.||+|.+. +++.||||++...... .. ...|...+..+.+.. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999975 8999999987643210 01 134566666665432 2
Q ss_pred CceeEEEeEeCcEEEEEEeccCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCC
Q 012336 65 VPHLKWFGVEGEYNVMVIDLLGP-SLE-DLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~g~-sL~-~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~ 141 (465)
++....+ ...+++|+++.+ .+. ..+.... .. ..+..++.+++.++.++|. .||+|+||||+|||+ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-
Confidence 3333322 135899999844 221 1122111 11 6778999999999999999 999999999999999 3
Q ss_pred CCcEEEEecCCcccccc
Q 012336 142 SNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~ 158 (465)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-14 Score=136.52 Aligned_cols=132 Identities=17% Similarity=0.248 Sum_probs=97.7
Q ss_pred eeEe-eeCceEEEEEEEcCCCcEEEEEEeecCC---------------CCccHHHHHHHHHHHcCCCC-CceeEEE-eEe
Q 012336 13 RKIG-SGSFGELYLGVNVQTGEEVAVKLESVKT---------------KHPQLHYESKLYMLLQGGTG-VPHLKWF-GVE 74 (465)
Q Consensus 13 ~~LG-~G~fG~Vyla~~~~~~~~vAvKi~~~~~---------------~~~~~~~E~~il~~l~~~~~-i~~l~~~-~~~ 74 (465)
..|| .|+.|+||.+.. .+..++||.+.... ....+.+|+.++..|.+..+ ++....+ ...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 899999999975 47889999765311 12356789999999987553 3333322 222
Q ss_pred CcE---EEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEe
Q 012336 75 GEY---NVMVIDLL-G-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149 (465)
Q Consensus 75 ~~~---~~lv~e~~-g-~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~D 149 (465)
... .+++++++ | .+|.+++. ...++... +.+++.+|.+||..||+|+||||.|||+ +.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~--~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv---~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQ--EAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL---DPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHh--cCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE---cCCCCEEEEE
Confidence 222 24888887 4 58988886 34566554 5688999999999999999999999999 4677999999
Q ss_pred cCCccc
Q 012336 150 YGLAKK 155 (465)
Q Consensus 150 FGla~~ 155 (465)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=126.07 Aligned_cols=132 Identities=21% Similarity=0.313 Sum_probs=105.7
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCC-CCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGG-TGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~-~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
+++.||.|.++.||++... +..++||..........+..|..++..+.+. ..++.+..+.......+++++++ +..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4678999999999999863 4789999876543345789999999999876 45666655555556788999988 444
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 89 LEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR---GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 89 L~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~---givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+..+ +......++.+++.+|.+||.. +++|+||+|.|||+. ..+.++++|||++..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 4433 5567788899999999999985 699999999999994 678999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-16 Score=169.88 Aligned_cols=254 Identities=25% Similarity=0.322 Sum_probs=186.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcC-CCcEEEEEEeecCCC-C---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQ-TGEEVAVKLESVKTK-H---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~-~~~~vAvKi~~~~~~-~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
...|.+.+.||+|+|+.|-+..... ....+|+|.+..... . .+...|..+...+..|.++...........+.++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4568899999999999999987643 344677776554431 1 1234466777777745566666666667778888
Q ss_pred EEecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCceeeccCCCCC-cEEEEecCCcccc
Q 012336 81 VIDLL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKY 156 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~-~ls~~~~~~ia~qi~~gL~yLH-s~givHrDLKP~NILl~~~d~~~-~vkL~DFGla~~~ 156 (465)
.+++. |+++.+.+..... ..+...+..++.|+..+|.|+| ..++.|+||||+|.++ +..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL---DESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh---ccCCCcccCCCchhhccc
Confidence 88887 8888887732232 6788888999999999999999 9999999999999999 4777 9999999999988
Q ss_pred cc-ccCcccccccCCCCccc-cccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 157 RD-LQTHKHIPYRENKNLTG-TARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~G-t~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.. .... +.....+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..||....... +.+........
T Consensus 176 ~~~~g~~-----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAE-----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcc-----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 76 3322 22234467 99999999999854 4678999999999999999999997654322 22222222211
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ........+.....+++.+++..+|..|.+.+++.
T Consensus 249 ~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 R-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred c-cccCccccCChhhhhcccccccCCchhcccccccc
Confidence 1 01112356788899999999999999999966554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-14 Score=150.62 Aligned_cols=255 Identities=17% Similarity=0.135 Sum_probs=191.3
Q ss_pred ccCCceEEEeeEee--eCceEEEEEEE--cCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGS--GSFGELYLGVN--VQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~--G~fG~Vyla~~--~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+...|.+...+|. |.+|.||.+.. ..++..+|+|.-+... ....-.+|....+++..+..+..........
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 45667888899999 99999999987 7889999999633222 1223455666666665555555545556678
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCceeeccCCCC-CcEEEEec
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLIN----RVEYMHSRGFLHRDIKPDNFLMGLGRKS-NQVYIIDY 150 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~----gL~yLHs~givHrDLKP~NILl~~~d~~-~~vkL~DF 150 (465)
...|+-+|+++.+|..+......-++...++.+..++.. ||.++|+.+++|-|+||.||++. .+ ..++++||
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDF 267 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCc
Confidence 899999999999999998866666899999999999999 99999999999999999999996 55 89999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
|+...+........ +.......|...|++||...+ -++..+|+++||.++.+..++..+...... ....+
T Consensus 268 ~~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------~~W~~ 337 (524)
T KOG0601|consen 268 GLVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-------SSWSQ 337 (524)
T ss_pred ceeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-------CCccc
Confidence 99988776543221 122234467889999998765 578899999999999998887655433110 00111
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.........+|.+.+.++...+..+++.++-.|++.+.+..
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11112445677788888888999999999999998765544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.7e-12 Score=133.56 Aligned_cols=138 Identities=20% Similarity=0.305 Sum_probs=96.9
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC------------------------------------------ccHH
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH------------------------------------------PQLH 50 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~------------------------------------------~~~~ 50 (465)
+.||+|++|+||+|+. .+|+.||||+....... -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 58999999986432100 0233
Q ss_pred HHHHHHHHHc----CCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHHCCc
Q 012336 51 YESKLYMLLQ----GGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN-RVEYMHSRGF 124 (465)
Q Consensus 51 ~E~~il~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~-gL~yLHs~gi 124 (465)
+|...+.++. +.+.+..-..|.......++||||+ |.+|.++.......+. ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4444444443 4444444444544445578999999 8888887653222232 3445666655 4788999999
Q ss_pred cccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 125 vHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+|+|++|.|||+ +.++.++|+|||++..+.
T Consensus 279 ~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 999999999999 478899999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.9e-12 Score=114.68 Aligned_cols=127 Identities=19% Similarity=0.245 Sum_probs=96.6
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCH
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSL 89 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (465)
++.|+.|.++.||++.. .+..|+||+..... ....+..|..++..+.+...+|.+..+... ..+++|+++ |.++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCcc
Confidence 56789999999999985 47899999876443 234578899999999877777777655432 346889988 5555
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 90 EDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF-----LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 90 ~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~gi-----vHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.+. ......++.+++.+|..||..++ +|+|++|.|||+. ++.++|+|||.+..
T Consensus 79 ~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEecccccC
Confidence 432 01123456789999999999885 9999999999993 56899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=6.4e-11 Score=125.19 Aligned_cols=140 Identities=19% Similarity=0.273 Sum_probs=93.3
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------------------------------------------
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------------------------------------------ 45 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------------------------------------------ 45 (465)
.|.. +.||+|++|+||+|+...+|+.||||+......
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 789999999999999877799999998753210
Q ss_pred CccHHHHHHHHHHHc----CCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHH
Q 012336 46 HPQLHYESKLYMLLQ----GGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRK-----FSLKTVLMLADQLINR 115 (465)
Q Consensus 46 ~~~~~~E~~il~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~-----ls~~~~~~ia~qi~~g 115 (465)
+-++..|...+.++. +.+.+..-..|.......+||||++ |+.+.++-...... +....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 012344544444443 3333333344444455678999999 88887753211222 3333334444444
Q ss_pred HHHHHHCCccccCCCCCceeeccCCCCC----cEEEEecCCcccccc
Q 012336 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSN----QVYIIDYGLAKKYRD 158 (465)
Q Consensus 116 L~yLHs~givHrDLKP~NILl~~~d~~~----~vkL~DFGla~~~~~ 158 (465)
+..|++|+|++|.||++. .++ .++++|||++..+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEECCH
Confidence 468999999999999994 555 999999999976643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=114.43 Aligned_cols=135 Identities=15% Similarity=0.198 Sum_probs=97.2
Q ss_pred eeEeeeCceEEEEEEEcC------CCcEEEEEEeecCC------------C--------C----ccH----HHHHHHHHH
Q 012336 13 RKIGSGSFGELYLGVNVQ------TGEEVAVKLESVKT------------K--------H----PQL----HYESKLYML 58 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~------~~~~vAvKi~~~~~------------~--------~----~~~----~~E~~il~~ 58 (465)
..||.|--+.||.|.... .+..+|||+..... . . ..+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 35799999754210 0 0 012 378888888
Q ss_pred HcCC-CCCceeEEEeEeCcEEEEEEeccCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCce
Q 012336 59 LQGG-TGVPHLKWFGVEGEYNVMVIDLLGPS-LE-DLFNYCNRKFSLKTVLMLADQLINRVEYM-HSRGFLHRDIKPDNF 134 (465)
Q Consensus 59 l~~~-~~i~~l~~~~~~~~~~~lv~e~~g~s-L~-~ll~~~~~~ls~~~~~~ia~qi~~gL~yL-Hs~givHrDLKP~NI 134 (465)
+... -.+|....+ ...+|||++++++ +. ..+. ...++..++..+..+++.+|..| |..|+||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8753 334444433 4578999999753 21 1222 22456677788899999999999 899999999999999
Q ss_pred eeccCCCCCcEEEEecCCccccc
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+ .++.++|+|||.+....
T Consensus 157 L~----~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LW----HDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE----ECCcEEEEECCCceeCC
Confidence 99 45789999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=8.7e-13 Score=143.09 Aligned_cols=270 Identities=19% Similarity=0.179 Sum_probs=193.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEE---eEeCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWF---GVEGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~---~~~~~ 76 (465)
-.+.+.+++-+-+|.|+.++.+.-..++...++|+...... ......+..++ .++..+.+..+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~----i~p~~P~v~~~~~s~~~rs 877 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNIL----ITPRSPAVVRSFPSFPCRS 877 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcc----ccCCCCceecccCCCCCCC
Confidence 45677888899999999999998777787777776443211 12222222222 11222332211 23455
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++++++ +++|...+.. ....+.+-...++..+...++|||+..++|+|++|.|+|.. .++..++.|||....
T Consensus 878 P~~L~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSK 953 (1205)
T ss_pred CcchhhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCccccccc
Confidence 677888888 7788877774 34577777788888899999999999999999999999994 899999999984432
Q ss_pred cccc---cCc---------------------ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCC
Q 012336 156 YRDL---QTH---------------------KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSL 211 (465)
Q Consensus 156 ~~~~---~~~---------------------~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~ 211 (465)
.... ... .....+......||+.|.+||...+......+|||++|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 2110 000 0001123456789999999999999999999999999999999999999
Q ss_pred CCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012336 212 PWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT 291 (465)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~ 291 (465)
||.. .+..+.+..+....+.++.-. ...+.++++++...+..++..|..+.-- ....+..++...||.
T Consensus 1034 p~na---~tpq~~f~ni~~~~~~~p~g~--~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1034 PFNA---ETPQQIFENILNRDIPWPEGP--EEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWE 1101 (1205)
T ss_pred CCCC---cchhhhhhccccCCCCCCCCc--cccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCcc
Confidence 9976 556777777776666555322 3458899999999999999999874311 123568889999999
Q ss_pred ccC
Q 012336 292 ILK 294 (465)
Q Consensus 292 ~~~ 294 (465)
.+.
T Consensus 1102 ~l~ 1104 (1205)
T KOG0606|consen 1102 NLA 1104 (1205)
T ss_pred ccc
Confidence 764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-10 Score=104.30 Aligned_cols=142 Identities=17% Similarity=0.264 Sum_probs=105.4
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeec-CCCCc---------cHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESV-KTKHP---------QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~-~~~~~---------~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.+..|-+|+-+.|+++.+ .|+.+.||.-.. .-.++ +...|..++.++.-- +|+.-..+..+....+|
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 677889999999999986 789999995332 22222 456788888877643 44444445555556778
Q ss_pred EEeccCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 81 VIDLLGP--SLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 81 v~e~~g~--sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+||+..+ ++.+++... ...........++.+|=..|.-||..+++|+||..+|||+..++....+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999966 888887643 33334444478899999999999999999999999999997544555669999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2e-10 Score=103.34 Aligned_cols=128 Identities=23% Similarity=0.389 Sum_probs=95.8
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecC-CCC---------ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVK-TKH---------PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-~~~---------~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
..+++|+-+.||.+.+ -|..+++|.-..+ -.+ .+..+|..++.++.. .+|+.-..|..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 3578999999999966 4455788853322 112 235678888888765 36666666667777778999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
++. |..|.+.+... ...++..+=.-+.-||..||+|+||.++||++ .++.++++||||+..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCCcEEEEECCcccc
Confidence 998 66777788742 25566677777888999999999999999999 456699999999964
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.4e-11 Score=125.79 Aligned_cols=242 Identities=16% Similarity=0.093 Sum_probs=166.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEc-CCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNV-QTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~-~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.-++|.++..||.|.|+.|+.+... .++..|++|-..... ....-+.|+.+...+..+.+++.+..-.......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3568999999999999999998754 578899999544321 11123556666666665555555322223333445
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+-.|+| ++++.... .....+.+...+.+..|++.++.++|++.++|+|+||+||++.. ..+..++.|||.++.+.-
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhccccccccccce
Confidence 888888 66665554 44667899999999999999999999999999999999999952 228889999999875321
Q ss_pred ccCcccccccCCCCcccccccc--ccccccCCCCCCcchHHHHHHHHHHHhcCC-CCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYA--SVNTHLGVEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~--APE~~~~~~~s~k~DiwSLGviL~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
....+.+.-+++ +++.....++..+.|+++||..+.+.++|. +++.+... + .+.......
T Consensus 420 ----------~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~------~-~i~~~~~p~ 482 (524)
T KOG0601|consen 420 ----------SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS------L-TIRSGDTPN 482 (524)
T ss_pred ----------ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccc------e-eeecccccC
Confidence 112333444455 555666677889999999999999999976 44443211 1 111111111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..+...++..+.+.+...++..||.+.++..
T Consensus 483 -----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 483 -----LPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -----CCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 1233467888888888899999998665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-09 Score=101.85 Aligned_cols=137 Identities=21% Similarity=0.290 Sum_probs=98.6
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCC-CceeEEEeEeC---cEEEEEEecc
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTG-VPHLKWFGVEG---EYNVMVIDLL 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~~---~~~~lv~e~~ 85 (465)
+.|+.|.++.||++.. .+|..++||+..... ....+..|.+++..+.+... ++.+..+.... ...+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5789999999999985 346899999876543 24578999999999987432 55554444442 2457899988
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS------------------------------------------- 121 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs------------------------------------------- 121 (465)
|.++.+.+. ...+++.....++.+++..|..||+
T Consensus 83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 655655432 1346666667777777777777763
Q ss_pred -------------CCccccCCCCCceeeccCCC--CCcEEEEecCCccc
Q 012336 122 -------------RGFLHRDIKPDNFLMGLGRK--SNQVYIIDYGLAKK 155 (465)
Q Consensus 122 -------------~givHrDLKP~NILl~~~d~--~~~vkL~DFGla~~ 155 (465)
..++|+|+.|.|||+. . ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEecccccc
Confidence 2369999999999994 4 56789999998854
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.3e-08 Score=107.04 Aligned_cols=170 Identities=17% Similarity=0.170 Sum_probs=126.3
Q ss_pred EE-EEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEeccCCCHHHHHHHcCCC
Q 012336 23 LY-LGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK 99 (465)
Q Consensus 23 Vy-la~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~sL~~ll~~~~~~ 99 (465)
+| .|..+.++.+|.|...+.... .....+-++.++.|+|++++.++..+..++ ..|||+|-+-+ |...++.
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~P-l~~~lk~---- 100 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVRP-LETVLKE---- 100 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeecccc-HHHHHHH----
Confidence 45 466678899999999887766 345677788899999999888887776666 77888888754 4445553
Q ss_pred CCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCcccccc
Q 012336 100 FSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178 (465)
Q Consensus 100 ls~~~~~~ia~qi~~gL~yLH-s~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~ 178 (465)
++...+...+.||+.||.||| ..+++|++|.-+.|++ +..|..||.+|.++........ ......--..
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s 170 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNA-------PAKSLYLIES 170 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCc-------ccccchhhhc
Confidence 336777888999999999998 5679999999999999 5999999999998865433221 0111222234
Q ss_pred ccccccccCCCCCCcchHHHHHHHHHHHhcCC
Q 012336 179 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGS 210 (465)
Q Consensus 179 Y~APE~~~~~~~s~k~DiwSLGviL~elltG~ 210 (465)
|..|+.+...++ ..|.|-|||+++|++.|.
T Consensus 171 ~~~P~~~~~s~~--s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 171 FDDPEEIDPSEW--SIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccChhhcCcccc--chhhhhHHHHHHHHhCcc
Confidence 566665543332 369999999999999993
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.4e-09 Score=105.17 Aligned_cols=177 Identities=11% Similarity=0.133 Sum_probs=116.6
Q ss_pred EEEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEec
Q 012336 77 YNVMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
..++..+|+ .++|..++++ +...+..+.+.+|..||+.||.|||+.. |+|+++..+-|++. .++.+||.
T Consensus 146 rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig-- 220 (458)
T KOG1266|consen 146 RVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIG-- 220 (458)
T ss_pred ceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEec--
Confidence 445555665 9999999874 4567999999999999999999999985 99999999999994 78888863
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
....-..........-.+...-.+.++|.+||.=.....+-.+|||+||++..+|..+..--... ......-..+..
T Consensus 221 -~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tns--eS~~~~ee~ia~ 297 (458)
T KOG1266|consen 221 -SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNS--ESKVEVEENIAN 297 (458)
T ss_pred -ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCC--cceeehhhhhhh
Confidence 22110000000000012233345778999999877666777999999999999999877653221 111111111111
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
..... -..--..++..|+.-.|..||++..+
T Consensus 298 ~i~~l--------en~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 298 VIIGL--------ENGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred heeec--------cCccccCcCcccccCCCCCCcchhhh
Confidence 11100 01223467889999999999997654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.6e-08 Score=95.21 Aligned_cols=131 Identities=21% Similarity=0.190 Sum_probs=91.9
Q ss_pred EEEEEEEcCCCcEEEEEEeecCCC-----------Cc--cHHHHHHHHHHHcC--CCCCceeEEEeEe-----CcEEEEE
Q 012336 22 ELYLGVNVQTGEEVAVKLESVKTK-----------HP--QLHYESKLYMLLQG--GTGVPHLKWFGVE-----GEYNVMV 81 (465)
Q Consensus 22 ~Vyla~~~~~~~~vAvKi~~~~~~-----------~~--~~~~E~~il~~l~~--~~~i~~l~~~~~~-----~~~~~lv 81 (465)
.|+.+.. .|+.|.||....... .+ ...+|...+.+|.. .+.+..+ .+++. ....++|
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pV-a~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGV-AFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCee-EEEEecCCCccceeEEE
Confidence 3555543 677899996532220 11 36789998888853 3333223 23332 2346789
Q ss_pred EeccCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC----CCCCcEEEEecCCcc
Q 012336 82 IDLLGP--SLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG----RKSNQVYIIDYGLAK 154 (465)
Q Consensus 82 ~e~~g~--sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~----d~~~~vkL~DFGla~ 154 (465)
++++++ +|.+++... ....+......++.+++..+.-||..||+|+||++.|||+..+ +.+..++|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 998854 799998643 3456777888999999999999999999999999999999521 235789999999885
Q ss_pred c
Q 012336 155 K 155 (465)
Q Consensus 155 ~ 155 (465)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 3
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.6e-09 Score=98.39 Aligned_cols=124 Identities=25% Similarity=0.370 Sum_probs=79.5
Q ss_pred EEEEEEEcCCCcEEEEEEeecC--------------CC--------------CccHHHHHHHHHHHcCCC-CCceeEEEe
Q 012336 22 ELYLGVNVQTGEEVAVKLESVK--------------TK--------------HPQLHYESKLYMLLQGGT-GVPHLKWFG 72 (465)
Q Consensus 22 ~Vyla~~~~~~~~vAvKi~~~~--------------~~--------------~~~~~~E~~il~~l~~~~-~i~~l~~~~ 72 (465)
.||.|.. ..+..+|||+.... .. .....+|...|.++.... .+|....+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899985 67889999975421 00 012567899999988653 36655444
Q ss_pred EeCcEEEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCceeeccCCCCCcEEEEe
Q 012336 73 VEGEYNVMVIDLLG--PSLEDLFNYCNRKFSLKTVLMLADQLINRVEY-MHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149 (465)
Q Consensus 73 ~~~~~~~lv~e~~g--~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~y-LHs~givHrDLKP~NILl~~~d~~~~vkL~D 149 (465)
. ..+||||+++ |.....+.. ..++......++.+++..+.. +|..|++|+||.+.|||+. ++.++|+|
T Consensus 79 -~--~~~ivME~I~~~G~~~~~l~~--~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 79 -N--RNVIVMEYIGEDGVPLPRLKD--VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp -E--TTEEEEE--EETTEEGGCHHH--CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred -e--CCEEEEEecCCCccchhhHHh--ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 2 3579999997 543333332 122245567777888885555 5799999999999999993 44999999
Q ss_pred cCCcccc
Q 012336 150 YGLAKKY 156 (465)
Q Consensus 150 FGla~~~ 156 (465)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.2e-08 Score=98.02 Aligned_cols=258 Identities=14% Similarity=0.203 Sum_probs=159.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCce-eEE-----EeEe-CcEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH-LKW-----FGVE-GEYN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~-l~~-----~~~~-~~~~ 78 (465)
+.-..+.+.||+|+-+.+|-.-. -...+.|+.....-..+ ...+..|...-.++.+.. +.| ++.+ +...
T Consensus 10 ge~i~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 10 GEPIPPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CcccCCCccccCCccceeeecch---hhchhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 33445678899999999997532 23345677664432111 111222222222233322 211 2222 3335
Q ss_pred EEEEeccCC--CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 79 VMVIDLLGP--SLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 79 ~lv~e~~g~--sL~~ll~~~-----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
-++|+.+.+ ...+++.-. -..+.|.-+++.+..++.+...||..|.+-+|++++|||++ +++.|.|+|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEccc
Confidence 567777633 333443311 12478899999999999999999999999999999999996 78888888754
Q ss_pred CccccccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcC-CCCCCCCCCC----ch
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG----TK 221 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG-~~Pf~~~~~~----~~ 221 (465)
.-....+.. .--..+|...|.+||... +.+-+...|.|.||++++++|.| ..||.+.... ..
T Consensus 163 sfqi~~ng~--------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p 234 (637)
T COG4248 163 SFQINANGT--------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP 234 (637)
T ss_pred ceeeccCCc--------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc
Confidence 332221111 112457899999999755 44567789999999999999985 9999874421 11
Q ss_pred HH-HHH-----HH--h-hhhccCcHHHHhccCcHHHHHHHHHHhcCC--CCCCCCHHHHHHHHHHHHH
Q 012336 222 KQ-KYD-----KI--S-EKKMLTPIEVLCKSYPSEFTSYFHYCRSLR--FEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 222 ~~-~~~-----~i--~-~~~~~~~~~~~~~~~p~~l~~li~~cl~~d--p~~RPt~~~l~~~L~~~~~ 278 (465)
.+ .+. .. . ......|.+.-..-+|+.+..++.+|+..- +.-||+.+.....|..+-.
T Consensus 235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 11 000 00 0 111122222222346899999999999763 5689999877776655543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.2e-07 Score=90.71 Aligned_cols=210 Identities=18% Similarity=0.213 Sum_probs=146.9
Q ss_pred eEEEEEEEcCCCcEEEEEEeecCCCC--ccHHHHHHHHHHHcCCCCCceeEEEeE---eCcEEEEEEecc--CCCHHHHH
Q 012336 21 GELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTGVPHLKWFGV---EGEYNVMVIDLL--GPSLEDLF 93 (465)
Q Consensus 21 G~Vyla~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~i~~l~~~~~---~~~~~~lv~e~~--g~sL~~ll 93 (465)
.+.|++....+|..|++|.+...... .....-++.++++.|.++|+.-..|.. .+.-.++|++|. .++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899999999999999988543221 133445788999999998887655542 334567888876 66777764
Q ss_pred HHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 94 NYC--------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 94 ~~~--------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
-.. +.+.++..++.|+.|+..||.++|+.|+..+-|.|.+||+. ....++|..-|+......+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecCC
Confidence 211 23578899999999999999999999999999999999994 6668888877776554332
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. +.+. .-.+-|.-.||.+++.|.||..- |... ..+.. ...
T Consensus 447 ~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d----~~~~s----------~~~ 488 (655)
T KOG3741|consen 447 PT---------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTD----STQSS----------HLT 488 (655)
T ss_pred CC---------------------cchh---HHhhhhHHHHHHHHHHHhhccccccccc----chHHH----------HHH
Confidence 10 1111 12367999999999999998543 3221 11111 112
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRL 272 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (465)
.+...++.++.+++.++...++++ -+++++...
T Consensus 489 ~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 489 RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 233456788999999999999986 355555443
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8e-09 Score=108.88 Aligned_cols=153 Identities=12% Similarity=0.185 Sum_probs=106.0
Q ss_pred HHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccC--CCCccccccccccccccC
Q 012336 111 QLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE--NKNLTGTARYASVNTHLG 187 (465)
Q Consensus 111 qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~--~~~~~Gt~~Y~APE~~~~ 187 (465)
+++.||.|+|. .++||++|.|++|.+ +.++.+||+.|+++..........-..|.. .....-...|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45599999995 589999999999999 599999999999987654422211111211 122335678999999999
Q ss_pred CCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCH
Q 012336 188 VEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDY 266 (465)
Q Consensus 188 ~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (465)
...+.++|+||||+.+|.+.. |+.-+.... ......+. ........-.....+|+++.+-+.+++..+..-||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-~~~~~~~~---~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANG-GLLSYSFS---RNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccC-Ccchhhhh---hcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 888999999999999998885 444443321 12211111 1111112222236789999999999999999999976
Q ss_pred HHHH
Q 012336 267 SYLK 270 (465)
Q Consensus 267 ~~l~ 270 (465)
..+.
T Consensus 260 ~~l~ 263 (700)
T KOG2137|consen 260 DLLL 263 (700)
T ss_pred hhhh
Confidence 5443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.8e-07 Score=83.22 Aligned_cols=135 Identities=13% Similarity=0.113 Sum_probs=99.2
Q ss_pred eeeCceEEEEEEEcCCCcEEEEEEeec--------CCCCccHHHHHHHHHHHcCCCC-CceeEEEeEe----CcEEEEEE
Q 012336 16 GSGSFGELYLGVNVQTGEEVAVKLESV--------KTKHPQLHYESKLYMLLQGGTG-VPHLKWFGVE----GEYNVMVI 82 (465)
Q Consensus 16 G~G~fG~Vyla~~~~~~~~vAvKi~~~--------~~~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~----~~~~~lv~ 82 (465)
|.||.+.|+.... .|+.+-+|.-.. ....+.+.+|...+..|....+ +|...++... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4589999999764 444688885331 2234579999999999874322 4444443322 22467888
Q ss_pred eccC--CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc--EEEEecCCccc
Q 012336 83 DLLG--PSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ--VYIIDYGLAKK 155 (465)
Q Consensus 83 e~~g--~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~--vkL~DFGla~~ 155 (465)
+-++ .+|.+++.... .+.+......++.+|+..|.-||..|+.|+|+.+.|||+ +.++. +.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll---~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV---KTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee---cCCCCeeEEEEEhhccch
Confidence 8776 78998886422 346788888999999999999999999999999999999 33445 99999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=8.2e-07 Score=83.21 Aligned_cols=110 Identities=19% Similarity=0.290 Sum_probs=79.8
Q ss_pred CccHHHHHHHHHHHcCCC-CCceeEEEeEeC----cEEEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 012336 46 HPQLHYESKLYMLLQGGT-GVPHLKWFGVEG----EYNVMVIDLL-G-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118 (465)
Q Consensus 46 ~~~~~~E~~il~~l~~~~-~i~~l~~~~~~~----~~~~lv~e~~-g-~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~y 118 (465)
.....+|...+..|.... -+|....++... ...+++++.+ + .+|.+++.... .++......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHH
Confidence 346788888888876421 122233333321 2347788877 3 37999988532 37778889999999999999
Q ss_pred HHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 119 LHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
||..||+|+|+++.|||+..++....+.|+||+-+...
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999953333348999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-06 Score=82.18 Aligned_cols=139 Identities=18% Similarity=0.277 Sum_probs=91.3
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc-----------cHHHHHHHHHHHcCC--CCCcee
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP-----------QLHYESKLYMLLQGG--TGVPHL 68 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~-----------~~~~E~~il~~l~~~--~~i~~l 68 (465)
+.++.++|.+++.+-.....-|.+-. .++..+++|....+.... ...+++..+..+... .....+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 45788999999999998877777764 478999999765432211 122333333334321 111111
Q ss_pred EEEe-----EeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 69 KWFG-----VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 69 ~~~~-----~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
.... ......+|+|||+ |..|.++.. +++ .++..+...|.-||+.|++|+|+.|.|+++ .+
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV----SN 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE----EC
Confidence 1111 1223557899998 766766543 222 355677788999999999999999999999 46
Q ss_pred CcEEEEecCCccc
Q 012336 143 NQVYIIDYGLAKK 155 (465)
Q Consensus 143 ~~vkL~DFGla~~ 155 (465)
+.++++||+..+.
T Consensus 171 ~~i~iID~~~k~~ 183 (229)
T PF06176_consen 171 NGIRIIDTQGKRM 183 (229)
T ss_pred CcEEEEECccccc
Confidence 6699999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-06 Score=81.86 Aligned_cols=134 Identities=22% Similarity=0.297 Sum_probs=92.4
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC--------------------------ccHHHHHHHHHHHcCCC-CC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--------------------------PQLHYESKLYMLLQGGT-GV 65 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~--------------------------~~~~~E~~il~~l~~~~-~i 65 (465)
..|.+|--+.||+|.. .++..||||++...... .....|..-|+++.... -+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3666777889999984 67899999987643110 01345777777765421 12
Q ss_pred ceeEEEeEeCcEEEEEEeccCCCH--HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCC
Q 012336 66 PHLKWFGVEGEYNVMVIDLLGPSL--EDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 66 ~~l~~~~~~~~~~~lv~e~~g~sL--~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~ 142 (465)
|.-..+ ..++++|+++|... .-.+. .-.+..+....+..+++..+.-|-. .++||+||..=|||+ ..
T Consensus 133 P~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~----~~ 202 (268)
T COG1718 133 PEPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV----HD 202 (268)
T ss_pred CCceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----EC
Confidence 221111 24689999997651 01111 1124444788889999999999987 899999999999999 58
Q ss_pred CcEEEEecCCccccc
Q 012336 143 NQVYIIDYGLAKKYR 157 (465)
Q Consensus 143 ~~vkL~DFGla~~~~ 157 (465)
+.++|+|||.+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 999999999997644
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.1e-06 Score=77.12 Aligned_cols=129 Identities=25% Similarity=0.432 Sum_probs=98.8
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CC
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GP 87 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (465)
.++.+.|+.|.+|.||+|.+ .|.++|+|+-..+.....+..|.+++..+++...-|.+..++.+. +.|++. |.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~ 97 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGR 97 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCc
Confidence 45677899999999999987 567999999888888889999999999999999999998887544 448888 66
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CC-ceeeccCCCCCcEEEEecCCccc
Q 012336 88 SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIK-PD-NFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 88 sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLK-P~-NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.|.++.... ..+++..+ +..---|-..||-|+.|. |. ||++ .++.++|+||..|+.
T Consensus 98 ~L~~~~~~~----~rk~l~~v----lE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG----DRKHLLRV----LEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc----cHHHHHHH----HHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 888776521 33444433 333333556799999886 44 5555 555999999999873
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.2e-06 Score=81.92 Aligned_cols=134 Identities=22% Similarity=0.369 Sum_probs=95.3
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec----------------CCCCc--------cHHHHHHHHHHHcCC-C
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV----------------KTKHP--------QLHYESKLYMLLQGG-T 63 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~----------------~~~~~--------~~~~E~~il~~l~~~-~ 63 (465)
+.+..+||-|--+.||.|.+ ..|.++|||.-.. ...+. ...+|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678999999999999985 5899999995221 00111 246788899988754 2
Q ss_pred CCceeEEEeEeCcEEEEEEeccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLLGP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~-sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
-||.-. ..+.+++||++..| -|..+ ++..+..-.++..|+.-+.-+-..|+||+|+.+=|||+ +.+
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV---~~d 238 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV---TED 238 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE---ecC
Confidence 333321 23467899999954 33222 22455566667777777777778999999999999999 488
Q ss_pred CcEEEEecCCcccc
Q 012336 143 NQVYIIDYGLAKKY 156 (465)
Q Consensus 143 ~~vkL~DFGla~~~ 156 (465)
|.++++||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999877543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.5e-06 Score=77.86 Aligned_cols=71 Identities=17% Similarity=0.091 Sum_probs=55.0
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEEEeEeCcEEEEEEeccCC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKWFGVEGEYNVMVIDLLGP 87 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~g~ 87 (465)
..||.|..+.||+. .+..+++|+............|.+++..+..... +|....++.......++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2556889987765555568999999999986555 67777777777677789999844
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.7e-06 Score=89.79 Aligned_cols=140 Identities=21% Similarity=0.301 Sum_probs=93.3
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecC------------------------C---C---------------CccHH
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVK------------------------T---K---------------HPQLH 50 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~------------------------~---~---------------~~~~~ 50 (465)
..|+.++-|+||.|+. .+|+.||||+..-. . . +-++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4678999999999995 56999999974321 0 0 00123
Q ss_pred HHHHHHHHH----cCCCCCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 012336 51 YESKLYMLL----QGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125 (465)
Q Consensus 51 ~E~~il~~l----~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~giv 125 (465)
.|..-+.++ .+.+.+..-..|.+-....+|+||++ |-.+.+...-....++.+.+.....++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 344444433 34444444455555566779999999 7677777432245566555544444333 2333347999
Q ss_pred ccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 126 HrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|.|..|.||++ +.++.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 99999999999 5889999999999976543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.6e-05 Score=74.70 Aligned_cols=140 Identities=17% Similarity=0.238 Sum_probs=81.3
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEEEeE---eCcEEEEEEecc-C
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKWFGV---EGEYNVMVIDLL-G 86 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~~~~---~~~~~~lv~e~~-g 86 (465)
++.|+.|..+.||++.... ..+++|+.........+..|..++..+....+ +|.+..+.. .....+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999998533 59999987654334568889999999886544 555555332 334568888887 6
Q ss_pred CCHHH----------------HHH---HcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHHH-
Q 012336 87 PSLED----------------LFN---YCN---RKFSLKT---------VLML------------ADQLIN-RVEYMHS- 121 (465)
Q Consensus 87 ~sL~~----------------ll~---~~~---~~ls~~~---------~~~i------------a~qi~~-gL~yLHs- 121 (465)
..+.. .+. ... ..+.... .... ...+.. .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 55555 111 110 1111000 0000 111222 2333332
Q ss_pred ------CCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 122 ------RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 122 ------~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|+|+.|.|||+. +.++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccceE
Confidence 3599999999999994 3567778999988743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.9e-05 Score=74.37 Aligned_cols=74 Identities=15% Similarity=0.211 Sum_probs=52.8
Q ss_pred eEeeeCc-eEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHH
Q 012336 14 KIGSGSF-GELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLE 90 (465)
Q Consensus 14 ~LG~G~f-G~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~ 90 (465)
.|-.|.. ..||++.. .+..+.||+..... ...+..|++++..+.....+|.+..+...+...+++|+++ |.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 78999864 34788899876543 4568889999999986656667776666656678889987 65555
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00018 Score=66.58 Aligned_cols=124 Identities=19% Similarity=0.288 Sum_probs=85.4
Q ss_pred CceEEEeeEeeeCc-eEEEEEEEcCCCcEEEEEEeec---C--------------------CCCccHHHHHHHHHHHcCC
Q 012336 7 GKFKLGRKIGSGSF-GELYLGVNVQTGEEVAVKLESV---K--------------------TKHPQLHYESKLYMLLQGG 62 (465)
Q Consensus 7 ~~y~l~~~LG~G~f-G~Vyla~~~~~~~~vAvKi~~~---~--------------------~~~~~~~~E~~il~~l~~~ 62 (465)
.+++.++.||.|.- |.||+++. .|+.||||++.. . ....-|..|...+-+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999985 788999998221 0 1112477888888888854
Q ss_pred CC-----CceeEEEeEe-----------------CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 012336 63 TG-----VPHLKWFGVE-----------------GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120 (465)
Q Consensus 63 ~~-----i~~l~~~~~~-----------------~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH 120 (465)
.. +...+|+.-. ...+.||.++....- .+. ..-+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 33 3333443221 112345665542211 122 233567888889999
Q ss_pred HCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 121 s~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
..||+-+|+++.|..=+ +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccCC--------EEEecccC
Confidence 99999999999998654 89999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00039 Score=64.64 Aligned_cols=129 Identities=19% Similarity=0.274 Sum_probs=88.2
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC------------------CCccHHHHHHHHHHHc-C----CCCCcee
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT------------------KHPQLHYESKLYMLLQ-G----GTGVPHL 68 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~------------------~~~~~~~E~~il~~l~-~----~~~i~~l 68 (465)
...||+|+.-.||. ...+....||+..... ...+...|+..+..+. . ..+++.+
T Consensus 6 ~~~i~~G~~R~cy~---HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ---HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE---CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999887 3456677899877554 2456778888888777 2 2345555
Q ss_pred EEEeEeCcEEEEEEecc-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 69 KWFGVEGEYNVMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-------g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
..+.+.+.-.-+|+|.. ..+|.+++. ...++. .+... +-.-..||-..+|+.+||+|.||++...+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 55555554455666654 347888886 445666 33333 334456788899999999999999986555
Q ss_pred CC-cEEEEe
Q 012336 142 SN-QVYIID 149 (465)
Q Consensus 142 ~~-~vkL~D 149 (465)
.. .++|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 55 788887
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00011 Score=70.01 Aligned_cols=73 Identities=22% Similarity=0.215 Sum_probs=45.4
Q ss_pred EeeEeeeCce-EEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCC--CCceeEEEeEeC---cEEEEEEecc
Q 012336 12 GRKIGSGSFG-ELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGT--GVPHLKWFGVEG---EYNVMVIDLL 85 (465)
Q Consensus 12 ~~~LG~G~fG-~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~--~i~~l~~~~~~~---~~~~lv~e~~ 85 (465)
++.|+.|+.. .||+. +..+++|+.........+..|.+++..+...- -+|.+...+... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567877776 58975 24577897665434457899999999987532 244443333321 2346778877
Q ss_pred -CCCH
Q 012336 86 -GPSL 89 (465)
Q Consensus 86 -g~sL 89 (465)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 5444
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=3.9e-06 Score=88.14 Aligned_cols=184 Identities=11% Similarity=0.012 Sum_probs=130.2
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEeccCCC--H
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPS--L 89 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~s--L 89 (465)
..-+++|+++.+++.+...+...+ .+++... ....-++++|.+++|++-......-...+.+..++++++++. -
T Consensus 247 fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 344678889999998765444333 5554422 345668899999999882222222234456778899998443 2
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccC
Q 012336 90 EDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169 (465)
Q Consensus 90 ~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (465)
........-.|.+-+...+...-+.+|++||+--=+|+| ||+. .++..+..||+....+.... .
T Consensus 323 ~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~--------~ 386 (829)
T KOG0576|consen 323 ALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM--------K 386 (829)
T ss_pred cccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc--------c
Confidence 222221122344455566667778899999998778998 8888 67899999999987765432 2
Q ss_pred CCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q 012336 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (465)
Q Consensus 170 ~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~ 215 (465)
..+..+|+.++|||+..+..+....|+|++|+-..++.-|-+|-..
T Consensus 387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 4567899999999999999999999999999877777777777543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00022 Score=75.36 Aligned_cols=141 Identities=21% Similarity=0.270 Sum_probs=88.6
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---------------------------------------CCccHHHHH
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---------------------------------------KHPQLHYES 53 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---------------------------------------~~~~~~~E~ 53 (465)
+.||..+.|+||+|+. .+|+.||||+-+..- .+=+|..|.
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5789999999999995 559999999743210 001234443
Q ss_pred HHHHH----HcCCC-----CCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 012336 54 KLYML----LQGGT-----GVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123 (465)
Q Consensus 54 ~il~~----l~~~~-----~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g 123 (465)
+-..+ +.+-+ .||.+ |.......+|+|||+ |..+.|+-.-....++...+..-+.++..- .|=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~V--y~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKV--YWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCee--hhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhcC
Confidence 33332 33333 13333 334445678999999 655554433224567766555544444332 233468
Q ss_pred ccccCCCCCceeeccC-CCCCcEEEEecCCcccccc
Q 012336 124 FLHRDIKPDNFLMGLG-RKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 124 ivHrDLKP~NILl~~~-d~~~~vkL~DFGla~~~~~ 158 (465)
++|+|=.|.||++... +.+..+.+.|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999521 2478899999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00073 Score=76.32 Aligned_cols=77 Identities=13% Similarity=0.155 Sum_probs=50.6
Q ss_pred EEeeEeeeCceEEEEEEEcCCC--cEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCC--ceeEEEeEeC---cEEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQTG--EEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGV--PHLKWFGVEG---EYNVM 80 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~--~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i--~~l~~~~~~~---~~~~l 80 (465)
-++.|+.|.+..+|+......+ ..+++|+..... ....+.+|..++..+..+..+ |.+..++.+. ...|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678899999999998754322 467888754322 223688999999999743334 4444443332 35689
Q ss_pred EEeccCC
Q 012336 81 VIDLLGP 87 (465)
Q Consensus 81 v~e~~g~ 87 (465)
||+++.|
T Consensus 122 VME~v~G 128 (822)
T PLN02876 122 IMEYLEG 128 (822)
T ss_pred EEEecCC
Confidence 9999844
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.002 Score=61.12 Aligned_cols=74 Identities=19% Similarity=0.161 Sum_probs=48.7
Q ss_pred EeeEeeeCceEEEEEEEcC-CCcEEEEEEeecCCCC-ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 12 GRKIGSGSFGELYLGVNVQ-TGEEVAVKLESVKTKH-PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~-~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
++.|..|-...+|++.... .+..|++|+....... -....|..++..+.....+|.+..+... .++|+++ |.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence 4677788888999987432 2578999976543221 2345799999999766667776544322 3688887 444
Q ss_pred H
Q 012336 89 L 89 (465)
Q Consensus 89 L 89 (465)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 3
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00043 Score=69.12 Aligned_cols=139 Identities=19% Similarity=0.266 Sum_probs=96.8
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----------------------CCc------cHHHHHHHHHHHcCC
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----------------------KHP------QLHYESKLYMLLQGG 62 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----------------------~~~------~~~~E~~il~~l~~~ 62 (465)
+-..|..|--+.||.|. ..+|..+||||++... ..+ ....|..-|++|...
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44577889999999998 5788899999865310 001 134567777777642
Q ss_pred CCCceeEEEeEeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCceeeccCCC
Q 012336 63 TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH-s~givHrDLKP~NILl~~~d~ 141 (465)
+||.-.-... ..++|||+++|.+=+-.=.-....++...+..+-.|++.-+.-|. ..++||.||.-=|+|+ .
T Consensus 227 -GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 227 -GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred -CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 3443222111 236899999976533221111445788888888888988888886 4679999999999999 7
Q ss_pred CCcEEEEecCCccccc
Q 012336 142 SNQVYIIDYGLAKKYR 157 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~ 157 (465)
+|.++|+|-+.+....
T Consensus 300 dG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHD 315 (520)
T ss_pred CCEEEEEEccccccCC
Confidence 9999999999886543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0047 Score=63.59 Aligned_cols=74 Identities=20% Similarity=0.280 Sum_probs=51.4
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeec------C---CCCccHHHHHHHHHHHcC--CCCCceeEEEeEeCcEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESV------K---TKHPQLHYESKLYMLLQG--GTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~------~---~~~~~~~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~ 79 (465)
-.+.||.|.+..||++.....++.|+||.-.. + ....+...|.+.|..+.. +..+|.+..+.. ...+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCE
Confidence 35689999999999999753335899997321 1 123456788888887653 356777776644 4467
Q ss_pred EEEeccC
Q 012336 80 MVIDLLG 86 (465)
Q Consensus 80 lv~e~~g 86 (465)
+||+++.
T Consensus 108 lVME~L~ 114 (401)
T PRK09550 108 TVMEDLS 114 (401)
T ss_pred EEEecCC
Confidence 8999874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.027 Score=57.03 Aligned_cols=70 Identities=20% Similarity=0.245 Sum_probs=46.3
Q ss_pred eEeeeCceEEEEEEEcCCCcEEEEEEee----c-----CCCCccHHHHHHHHHHHcC--CCCCceeEEEeEeCcEEEEEE
Q 012336 14 KIGSGSFGELYLGVNVQTGEEVAVKLES----V-----KTKHPQLHYESKLYMLLQG--GTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~~~~vAvKi~~----~-----~~~~~~~~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.||.|....||++.+...++.|+||.-. . .....+...|...|+.... +..+|.++.| +....+++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 5799999999999974333689999521 1 1123356778888877653 3456666555 444566888
Q ss_pred ecc
Q 012336 83 DLL 85 (465)
Q Consensus 83 e~~ 85 (465)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 877
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0032 Score=62.60 Aligned_cols=141 Identities=20% Similarity=0.266 Sum_probs=79.8
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEE------EeEeCcEEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKW------FGVEGEYNVMV 81 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~------~~~~~~~~~lv 81 (465)
..-++.++.|.-..+|++.. ++..+++|+.........+..|..++..|..... ++.+.. +...+...+++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 33466777777789999863 3446889987654334566778888888864222 222211 11224456788
Q ss_pred EeccCC-CH-----H------HHH---HHcCCCCC--------HHHHH---------------HHHHHHHHHHHHHHH--
Q 012336 82 IDLLGP-SL-----E------DLF---NYCNRKFS--------LKTVL---------------MLADQLINRVEYMHS-- 121 (465)
Q Consensus 82 ~e~~g~-sL-----~------~ll---~~~~~~ls--------~~~~~---------------~ia~qi~~gL~yLHs-- 121 (465)
++++.| .+ . ..+ ......++ ..... .....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 888733 21 1 111 11111110 01000 011123344555543
Q ss_pred -----CCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 122 -----RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 122 -----~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
.+++|+|+.+.||++. .++.+.|+||+.+.
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 5799999999999994 55667899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0072 Score=60.27 Aligned_cols=73 Identities=16% Similarity=0.109 Sum_probs=43.8
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeE------EEeEeCcEEEEEEec
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLK------WFGVEGEYNVMVIDL 84 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~------~~~~~~~~~~lv~e~ 84 (465)
++.|+.|....+|+... ++..+++|+.. ......+..|..++..|..... ++... .+.......++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 45677777789999874 33478899876 3334456667777777753221 22221 122234456788888
Q ss_pred cCC
Q 012336 85 LGP 87 (465)
Q Consensus 85 ~g~ 87 (465)
+.|
T Consensus 104 l~G 106 (319)
T PRK05231 104 LEG 106 (319)
T ss_pred cCC
Confidence 733
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0081 Score=57.98 Aligned_cols=132 Identities=17% Similarity=0.184 Sum_probs=77.5
Q ss_pred eEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC--ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHH
Q 012336 14 KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLE 90 (465)
Q Consensus 14 ~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~ 90 (465)
.+..|-...+|+.. .++..+++|+....... -....|..++..+......|.+..+.. ..++++++ |..+.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 34567778999886 46778999975543222 246889999999987656666655432 25788887 43332
Q ss_pred --------------HHHHHc------CCCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCccccCCCCC
Q 012336 91 --------------DLFNYC------NRKFSLK-TVLMLADQL---------INRVEYMHS--------RGFLHRDIKPD 132 (465)
Q Consensus 91 --------------~ll~~~------~~~ls~~-~~~~ia~qi---------~~gL~yLHs--------~givHrDLKP~ 132 (465)
.++... ..+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 111111 1112222 112222111 111222221 24899999999
Q ss_pred ceeeccCCCCCcEEEEecCCccc
Q 012336 133 NFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 133 NILl~~~d~~~~vkL~DFGla~~ 155 (465)
|||++ +++ ++|+||..+..
T Consensus 157 Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEe---CCC-CEEEeccccCc
Confidence 99994 444 78999998854
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0041 Score=70.15 Aligned_cols=202 Identities=15% Similarity=0.090 Sum_probs=125.9
Q ss_pred HHHHHHHHHHcCCCCCceeEEEeEeCcEE---EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 012336 50 HYESKLYMLLQGGTGVPHLKWFGVEGEYN---VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125 (465)
Q Consensus 50 ~~E~~il~~l~~~~~i~~l~~~~~~~~~~---~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~giv 125 (465)
..|...+..+.|.+....+.+-....... .+..+++ .-++..++.. -...+..+++.+..+++.||.|+|+....
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 44566666777766655554433222111 1222334 5566666653 45789999999999999999999998666
Q ss_pred ccCCCCCceeeccCCCCCcEEEE--ecCCccccccccCcccccccCCCCccccccccccccccCCCCCC--cchHHHHHH
Q 012336 126 HRDIKPDNFLMGLGRKSNQVYII--DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSR--RDDLESLGY 201 (465)
Q Consensus 126 HrDLKP~NILl~~~d~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~--k~DiwSLGv 201 (465)
|.-|...-..-...+..+.+.+. ||+..+.+.+... .....-+..|.++|........+ ..|+|.||.
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--------SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCccc--------chhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 55554442222112456667666 9998887665322 11223455677888777666554 479999999
Q ss_pred HHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 202 VLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 202 iL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+..+..|..+-... ..+...++.....+..++...|+.-+.++|+...+ ++.+.|.+.
T Consensus 381 l~~~~~~~~~i~~~~-----------------~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~---ll~~~f~~~ 439 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS-----------------AVPVSLLDVLSTSELLDALPKCLDEDSEERLSALE---LLTHPFLRF 439 (1351)
T ss_pred HHhhhhhcCcccccc-----------------cchhhhhccccchhhhhhhhhhcchhhhhccchhh---hhhchhccc
Confidence 999888875542110 01112222223347888899999999999999554 455555544
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0018 Score=59.76 Aligned_cols=97 Identities=26% Similarity=0.303 Sum_probs=69.9
Q ss_pred HHHHHHHHHHcCCCCCcee-EEEeEeCcEEEEEEeccC-CCHHHH----HHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-
Q 012336 50 HYESKLYMLLQGGTGVPHL-KWFGVEGEYNVMVIDLLG-PSLEDL----FNYCNRKFSLKTVLMLADQLINRVEYMHSR- 122 (465)
Q Consensus 50 ~~E~~il~~l~~~~~i~~l-~~~~~~~~~~~lv~e~~g-~sL~~l----l~~~~~~ls~~~~~~ia~qi~~gL~yLHs~- 122 (465)
..|.-+++.+++..++|.+ +.|+ .+++.|+.+ +++... .. --..+|..+..||.+++..+++|+..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3477888888886555554 4443 245666664 444321 11 12368999999999999999999973
Q ss_pred --CccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 123 --GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 123 --givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+.-.|++|+||-+. +++.+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 467799999999994 7789999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.012 Score=58.29 Aligned_cols=70 Identities=14% Similarity=0.088 Sum_probs=46.9
Q ss_pred EeeEeeeCceEEEEEEEcC------CCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 12 GRKIGSGSFGELYLGVNVQ------TGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~------~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++.|..|--..||++.... .++.|++|+...... ......|..++..+......|.+..+...+ +++++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~~----~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPNG----RIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCCC----chhhe
Confidence 4566666677999987432 257899999665432 246788999999998766666666555422 45666
Q ss_pred c
Q 012336 85 L 85 (465)
Q Consensus 85 ~ 85 (465)
+
T Consensus 79 i 79 (302)
T cd05156 79 I 79 (302)
T ss_pred e
Confidence 5
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.008 Score=59.20 Aligned_cols=140 Identities=17% Similarity=0.169 Sum_probs=80.5
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEE------EeEeCcEEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKW------FGVEGEYNVMV 81 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~------~~~~~~~~~lv 81 (465)
..-++.|..|....+|++.. .+..+++|+... .....+..|..++..+..... ++.... +...+...+++
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l 92 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAAL 92 (296)
T ss_pred hhheecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEE
Confidence 33466777888889999863 445789998764 334567788888888865321 233211 12233456788
Q ss_pred Eecc-CCCHH-----------HHH---HHcCCCCCH--------HHHH------------HHHHHHHHHHHHHHH-----
Q 012336 82 IDLL-GPSLE-----------DLF---NYCNRKFSL--------KTVL------------MLADQLINRVEYMHS----- 121 (465)
Q Consensus 82 ~e~~-g~sL~-----------~ll---~~~~~~ls~--------~~~~------------~ia~qi~~gL~yLHs----- 121 (465)
++++ |..+. ..+ +.....+.. .... .....+...+.++..
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 8877 44321 111 110111100 0000 011122334444443
Q ss_pred --CCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 122 --RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 122 --~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
.+++|+|+.|.|||+. .++.+.|+||+.+.
T Consensus 173 ~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 173 LPRGVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred CCCcCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 3699999999999993 55666899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.031 Score=56.62 Aligned_cols=140 Identities=14% Similarity=0.173 Sum_probs=81.2
Q ss_pred eEEEeeEeeeCceEEEEEEEcC----CCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQ----TGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~----~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
..-+..|-.|-.-.+|++.... .++.|++|+...... .-....|..++..+....+-|.+..+...+ .+++
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 3344566567788999986432 246899998764332 113477999999998877777776655443 3455
Q ss_pred cc-CCCHHH-----------H---HHH---cC----C-CCCHHHHHHHHHHH-----------------HHHHHHHH---
Q 012336 84 LL-GPSLED-----------L---FNY---CN----R-KFSLKTVLMLADQL-----------------INRVEYMH--- 120 (465)
Q Consensus 84 ~~-g~sL~~-----------l---l~~---~~----~-~ls~~~~~~ia~qi-----------------~~gL~yLH--- 120 (465)
|+ +.+|.. + +.. .. . ...+..+..+..++ ...+..|.
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 55 444321 1 110 01 0 11123333332221 11122221
Q ss_pred -----HCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 121 -----SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 121 -----s~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...++|+|+++.|||+. +.++.++|+||..+.
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 12589999999999995 335789999998875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0015 Score=64.45 Aligned_cols=132 Identities=20% Similarity=0.360 Sum_probs=89.4
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec----------CC------CCc--------cHHHHHHHHHHHcCC-C
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV----------KT------KHP--------QLHYESKLYMLLQGG-T 63 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~----------~~------~~~--------~~~~E~~il~~l~~~-~ 63 (465)
+.++.+||-|--+.||.+-+ ..|++.++|+-.. +. ... ...+|...|+.|..+ .
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56788999999999999985 6789999995211 00 000 235688888888753 2
Q ss_pred CCceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
-||... +....|+||+++ |-.|...-. .....++. ..+..-|--|-..|+||+|..-=|||+ +++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d~~~ly---~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH----VEDPPTLY---DDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee----cCChHHHH---HHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 333332 334678999988 545543322 22333333 344444556778999999999999999 478
Q ss_pred CcEEEEecCCccc
Q 012336 143 NQVYIIDYGLAKK 155 (465)
Q Consensus 143 ~~vkL~DFGla~~ 155 (465)
+.++++||-.+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999987654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0085 Score=58.77 Aligned_cols=51 Identities=10% Similarity=0.055 Sum_probs=31.7
Q ss_pred EeeEeeeCceEEEEEEE--cCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCC
Q 012336 12 GRKIGSGSFGELYLGVN--VQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGG 62 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~--~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~ 62 (465)
...++.|.-|..+.+.. ...|..+++|.-........+.+|.+++..+...
T Consensus 13 ~~~~~~~~~g~~~~v~~i~~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 13 PETLSLNESGLDFQVVFAKDTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceecCCcceeEEEEEEcCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 34444555444333332 2357899999765433345688999999999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.028 Score=56.62 Aligned_cols=141 Identities=16% Similarity=0.180 Sum_probs=79.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCCC-ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTKH-PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
...+ +.|..|=.-.+|++..... +..|++|+....... -....|..+++.+....+-|.+..+...+ ++.+
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 3444 4444466778998864332 348999987643321 13467999999998777767766554333 3555
Q ss_pred cc-CCCHH--------------HHHHHc-CCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 012336 84 LL-GPSLE--------------DLFNYC-NRK------F-SLKTVLMLADQL----------------------INRVEY 118 (465)
Q Consensus 84 ~~-g~sL~--------------~ll~~~-~~~------l-s~~~~~~ia~qi----------------------~~gL~y 118 (465)
++ |..|. ..+... ... + .+..+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 55 33321 111110 111 1 122333332222 112222
Q ss_pred HH----HC----CccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 119 MH----SR----GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 119 LH----s~----givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
+. .. -++|.|+.+.|||+. ++++.++++||..|..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~--~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence 22 11 279999999999995 3457899999998853
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.011 Score=61.65 Aligned_cols=164 Identities=20% Similarity=0.178 Sum_probs=95.9
Q ss_pred CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 012336 44 TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123 (465)
Q Consensus 44 ~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g 123 (465)
....+++-..++++.++|.+...++..........++|++.++-+|++.+.... +-.....
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~~----------------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESLL----------------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhhc-----------------
Confidence 334467778888999999887777766554455689999999999999987422 1111111
Q ss_pred ccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHH
Q 012336 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVL 203 (465)
Q Consensus 124 ivHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL 203 (465)
.|+=+ +-|+ ++++| -+.+.+ ....| +|+|||++|.++
T Consensus 85 -~~~~~-~~~~----------~~~td-~~~t~~--------------~~~~~----------------pKsdVwsl~~i~ 121 (725)
T KOG1093|consen 85 -AHGVL-HLNI----------IYITD-HFLTKY--------------PSPIG----------------PKSDVWSLGFII 121 (725)
T ss_pred -ccccc-eehh----------hhccc-cccccC--------------CCCCC----------------cchhhhhHHHHH
Confidence 22211 1222 22333 111110 01111 399999999999
Q ss_pred HHHhcCCCCCCCCCCCchHHHHHHHhhhhc---cCcHH-HHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 204 MYFLRGSLPWQGLKAGTKKQKYDKISEKKM---LTPIE-VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~~~-~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.++.-|..-|......+....+.+...... ....+ .+...++..+.++...|+-..|..||...++
T Consensus 122 ~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 122 LELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 999999888876433222222211111000 00001 1223457888999999999999999865544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.00059 Score=78.35 Aligned_cols=130 Identities=10% Similarity=-0.042 Sum_probs=96.4
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceeeccCCCCCcE
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEYMHSRG-----FLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~---ls~~~~~~ia~qi~~gL~yLHs~g-----ivHrDLKP~NILl~~~d~~~~v 145 (465)
....+.++.++ +|.+.+.+.....+ +...-+.....+.+....-+|+.. .+|++||+-|.++ ..+..+
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v 1379 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYNV 1379 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCcc
Confidence 33446677776 88888887643222 333344444444467777777642 7999999999999 689999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCC
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~ 214 (465)
|+.++|+.+....... ..+...+++.|+.+++.....++.++|+|.+|+-+|+...|..+|-
T Consensus 1380 ~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1380 KLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 9999999983332221 2345678889999999999999999999999999999888888873
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.052 Score=55.67 Aligned_cols=72 Identities=22% Similarity=0.282 Sum_probs=49.1
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEe----ecC----CCCccHHHHHHHHHHHcC--CCCCceeEEEeEeCcEEEEE
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLE----SVK----TKHPQLHYESKLYMLLQG--GTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~----~~~----~~~~~~~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~lv 81 (465)
.+.||.|.-..||++.+...+.-|+||.- ... -...+...|...|+.+.. +..+|.+..|.. ...++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~--e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS--VMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc--HHhhHH
Confidence 67899999999999997433567999942 211 122356788888887653 456777766643 345677
Q ss_pred Eecc
Q 012336 82 IDLL 85 (465)
Q Consensus 82 ~e~~ 85 (465)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 7776
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.21 Score=49.21 Aligned_cols=74 Identities=18% Similarity=0.225 Sum_probs=51.6
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEEEEEEecc
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
.+-.+.|+.|....+|... .+++.+.||+-. ......+..|.+-|+.|. ..-.+|....++......|+++|++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4556788989999999986 678899999877 445567999999999994 5566777777777666778999997
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.11 Score=51.47 Aligned_cols=107 Identities=14% Similarity=0.095 Sum_probs=72.6
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCC--CCceeEEEeE---eCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGT--GVPHLKWFGV---EGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~--~i~~l~~~~~---~~~~~~lv~ 82 (465)
.-.-.+.||.|..+.||.... .+..+.+|+.+.......+..|...++.|.... -||.+..++. .....++||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 455677899999999999863 233577787543223458999999999998643 3455544333 235578999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~ 122 (465)
+++ |.++.+. .........+..+++.+|.-||+.
T Consensus 93 E~i~G~~~~~~------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 998 5555541 123445566777888999999975
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.27 Score=50.77 Aligned_cols=73 Identities=15% Similarity=0.263 Sum_probs=48.8
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEee-----cCC----CCccHHHHHHHHHHHcC--CCCCceeEEEeEeCcEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLES-----VKT----KHPQLHYESKLYMLLQG--GTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~-----~~~----~~~~~~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~ 79 (465)
..+.||.|....||++.+ .+..|+||.-. ... ...+...|...|..+.. +..+|.+..++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 477889999999999886 34568999633 111 33455667777766652 346776666655 4467
Q ss_pred EEEeccCC
Q 012336 80 MVIDLLGP 87 (465)
Q Consensus 80 lv~e~~g~ 87 (465)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78998844
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.3 Score=50.20 Aligned_cols=74 Identities=15% Similarity=0.120 Sum_probs=45.1
Q ss_pred EEeeEeeeCceEEEEEEEcCC-CcE-----EEEEEeecC-CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 11 LGRKIGSGSFGELYLGVNVQT-GEE-----VAVKLESVK-TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~-~~~-----vAvKi~~~~-~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++.|..|-...+|++..... +.. |.+++.... ...-.-..|.+++..+....+-|.+..++.. .++++
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 445665688889999874322 122 444442211 1111346789999999988888888666543 36777
Q ss_pred cc-CCC
Q 012336 84 LL-GPS 88 (465)
Q Consensus 84 ~~-g~s 88 (465)
++ |..
T Consensus 130 fIeGr~ 135 (383)
T PTZ00384 130 WVEGNT 135 (383)
T ss_pred Eecccc
Confidence 76 443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.051 Score=54.67 Aligned_cols=74 Identities=20% Similarity=0.269 Sum_probs=61.0
Q ss_pred EeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 73 VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 73 ~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
.++.+.|++|++-|++|.-.- --..++++.|+.+++..|.-+..+ .+=|||+.-+|||| ++|+|-|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEee
Confidence 456788899999888876332 235788899999998888877765 58999999999999 49999999999
Q ss_pred Cccc
Q 012336 152 LAKK 155 (465)
Q Consensus 152 la~~ 155 (465)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.33 Score=48.69 Aligned_cols=69 Identities=14% Similarity=0.101 Sum_probs=40.4
Q ss_pred eCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCC--CCCcee----EEEeEeCcEEEEEEeccCC
Q 012336 18 GSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGG--TGVPHL----KWFGVEGEYNVMVIDLLGP 87 (465)
Q Consensus 18 G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~--~~i~~l----~~~~~~~~~~~lv~e~~g~ 87 (465)
+.-..||+.. ..++..+++|+..... ....+..|+..+..|... +.+..+ ..+...+.+.+.++++++|
T Consensus 36 s~eN~vy~v~-~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFG-DEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEe-cCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 3445789886 3566789999875332 344677888888877642 211112 1112234466777777743
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.2 Score=49.95 Aligned_cols=32 Identities=22% Similarity=0.428 Sum_probs=26.9
Q ss_pred CccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 123 givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.++|+|+.+.||++. .++-+=++||+++..-.
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEeccccccCC
Confidence 489999999999994 56668899999997643
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.082 Score=53.99 Aligned_cols=59 Identities=24% Similarity=0.237 Sum_probs=44.2
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCceeec
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKPDNFLMG 137 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH-s~givHrDLKP~NILl~ 137 (465)
..+|+.++. |-++..++. ....+++....++.-.+++|--|- -.+++|.|+.|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~--~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVK--WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhh--cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 456777777 878888887 344566677777777777665443 56899999999999995
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.6 Score=54.16 Aligned_cols=47 Identities=9% Similarity=0.116 Sum_probs=32.0
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcC
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQG 61 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~ 61 (465)
+.|+ |..-.+|+.. ..++..+++|+.+..........|.+++..|..
T Consensus 31 ~~L~-s~~d~nf~v~-~~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLT-TDDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEE-eCCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 4567889986 456778999998865444455666777776653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.51 Score=47.44 Aligned_cols=131 Identities=18% Similarity=0.229 Sum_probs=73.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCce-----eE--EEeEeC--cEEEEEEecc-CCC
Q 012336 19 SFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH-----LK--WFGVEG--EYNVMVIDLL-GPS 88 (465)
Q Consensus 19 ~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~-----l~--~~~~~~--~~~~lv~e~~-g~s 88 (465)
.--.||+... .+ ..+++|+........++..|...+.-|....+... +. ....-. .+.+-+.+++ |..
T Consensus 37 ~eN~~f~~~~-~~-g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQT-ED-GRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEe-cC-CCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 4456888864 33 44499998876555678888888888764332221 11 111122 2566666666 554
Q ss_pred HHH------------HH---HHcCCC-----------CCHHH----H---------HHHHHHHHHHHHHHHHC-------
Q 012336 89 LED------------LF---NYCNRK-----------FSLKT----V---------LMLADQLINRVEYMHSR------- 122 (465)
Q Consensus 89 L~~------------ll---~~~~~~-----------ls~~~----~---------~~ia~qi~~gL~yLHs~------- 122 (465)
+.. ++ ....+. ..+.. . .....++...+..+...
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 441 11 110111 11210 0 01233444555555542
Q ss_pred -C--ccccCCCCCceeeccCCCCC-cEEEEecCCcc
Q 012336 123 -G--FLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAK 154 (465)
Q Consensus 123 -g--ivHrDLKP~NILl~~~d~~~-~vkL~DFGla~ 154 (465)
+ +||+|+.|+||++. .+. .+-++||+-+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 3 99999999999993 444 48899999774
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.53 E-value=1.2 Score=46.64 Aligned_cols=71 Identities=14% Similarity=-0.009 Sum_probs=45.9
Q ss_pred EEeeEeeeCceEEEEEEEcC--------CCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQ--------TGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~--------~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-++.|..|-.-.+|++.... .++.|.+++...... .-....|..++..+....+-+.+..... ...+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 56677677777899987432 146899998754322 1245679999999987777666654432 2345
Q ss_pred Eecc
Q 012336 82 IDLL 85 (465)
Q Consensus 82 ~e~~ 85 (465)
.+|+
T Consensus 185 ~efi 188 (442)
T PTZ00296 185 EEWL 188 (442)
T ss_pred EEee
Confidence 6666
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.21 E-value=0.29 Score=46.19 Aligned_cols=85 Identities=18% Similarity=0.204 Sum_probs=54.1
Q ss_pred cHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--CCcc
Q 012336 48 QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS--RGFL 125 (465)
Q Consensus 48 ~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs--~giv 125 (465)
.+..+..++.++.+ |..+. ..++..+-++.|.|..---.+.+ ++..=+..|.-.|+ .+.+
T Consensus 104 ~y~nky~v~ArmhG---ilrL~--NDn~~~yGvIlE~Cy~~~i~~~N-------------~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 104 LYFNKYRVFARMHG---ILRLK--NDNNYKYGVILERCYKIKINFSN-------------FITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhHHHHhhh---eeEee--cCCCceeEEEEeeccCcccchhH-------------HHHHhHHHHHHhhccCCCee
Confidence 45667777777744 44443 22444445666666432111111 11112567888894 4699
Q ss_pred ccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 126 HrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
|+|..|+|||. |..|.+||.|-+.-
T Consensus 166 HGD~np~NiM~---D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMC---DKFGYLKLVDPVCL 190 (308)
T ss_pred cCCCChhheee---cCCCCEEecChhhh
Confidence 99999999999 79999999998754
|
The function of this family is unknown. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.01 E-value=0.19 Score=49.68 Aligned_cols=29 Identities=41% Similarity=0.810 Sum_probs=24.5
Q ss_pred CCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 122 ~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
.+++|+|+.+.|||+. . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 4789999999999993 3 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.20 E-value=0.19 Score=50.01 Aligned_cols=62 Identities=23% Similarity=0.254 Sum_probs=37.6
Q ss_pred EEEEEEeccCCCHHHHHHH--cCCCC--CHHHHHHHHHHHHHHHHHHHH----CCccccCCCCCceeecc
Q 012336 77 YNVMVIDLLGPSLEDLFNY--CNRKF--SLKTVLMLADQLINRVEYMHS----RGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~--~~~~l--s~~~~~~ia~qi~~gL~yLHs----~givHrDLKP~NILl~~ 138 (465)
-.++++++.-++-..+-.. ..-.| -.+-+..++.||+.-.-.+.. .+++|-||||+|||+-.
T Consensus 249 GnIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 318 (444)
T PHA03111 249 GNIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFD 318 (444)
T ss_pred CcEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEec
Confidence 3578888875543332210 01111 234566777787765544433 35999999999999973
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.02 E-value=0.32 Score=48.72 Aligned_cols=79 Identities=20% Similarity=0.293 Sum_probs=44.1
Q ss_pred EEEEEeccCCCHHHHHHHcCCC--C--CHHHHHHHHHHHHHHHHHHHH----CCccccCCCCCceeeccCCC--------
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRK--F--SLKTVLMLADQLINRVEYMHS----RGFLHRDIKPDNFLMGLGRK-------- 141 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~--l--s~~~~~~ia~qi~~gL~yLHs----~givHrDLKP~NILl~~~d~-------- 141 (465)
.++++++.-++-..+-...-.. | -..-+..++.||+.-.--+.. .+++|-||||+|||+-..+.
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 4688888755544332211111 1 223455566666543311222 35999999999999963222
Q ss_pred -------CCcEEEEecCCcccc
Q 012336 142 -------SNQVYIIDYGLAKKY 156 (465)
Q Consensus 142 -------~~~vkL~DFGla~~~ 156 (465)
.-.++|.||.++..-
T Consensus 326 ~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 326 RNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred eEEEecccceeeecccCHHHhc
Confidence 124456777777643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 465 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-157 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-140 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-139 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-138 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-102 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-101 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-101 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-101 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 9e-99 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 8e-95 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 8e-95 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 5e-29 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 5e-29 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 7e-29 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-26 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 8e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 7e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 7e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-05 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-05 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 9e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 618 bits (1596), Expect = 0.0
Identities = 288/470 (61%), Positives = 346/470 (73%), Gaps = 7/470 (1%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KLE+VKTKHPQL YESK+Y +LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GGTG+P+++WFGVEG+YNV+V+DLLGPSLEDLFN+C+RK SLKTVLMLADQ+INRVE++H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR++NQVYIID+GLAKKYRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
SVNTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY+KISEKK+ T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300
C+ YP+EF SYFHYCRSLRF+DKPDYSYLKRLFRDLFIREG+QFDYVFDWTILKY Q+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 SSRSRPSGKPNLNPAG--PSAERVERPSGQEVRDRFAGGIEAFARRNTSGHGLHGDHSRH 358
+S + P+G P A + +R SG + R +G RR G ++
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQNDRQSGVD-EGRTSGWSSMDRRRAPPPIASVGTLAKQ 359
Query: 359 KSSDDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGGRPSSSGDHSDNRSGRLV--SGSG 416
K+ +S +P L R+S S +R +S R D S+ R S
Sbjct: 360 KAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASPGA 419
Query: 417 SGRLSTTQRAQP--GYESKSSSFSRGAATRSGRDDALRSFELLTIGSGKR 464
R S Q++ P E K SS +R ++ + AL+ E L +R
Sbjct: 420 FRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDER 469
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 567 bits (1463), Expect = 0.0
Identities = 176/327 (53%), Positives = 239/327 (73%), Gaps = 4/327 (1%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGT 63
++G F++G+KIG G+FGEL LG N+ T E VA+KLE +K++ PQLH E + Y L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
G+P + +FG G+YN MV++LLGPSLEDLF+ C+R FSLKTVLM+A QLI+R+EY+HS+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 124 FLHRDIKPDNFLMGLG--RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
++RD+KP+NFL+G + ++IID+ LAK+Y D +T KHIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y KI + K TPIEVLC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSS 301
+++P E +Y Y R L F +KPDY YL++LF DLF R+GY FDY +DW + P +
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 302 SRSRPSGKPNLNPAGPSAERVERPSGQ 328
+ P+ N A +++++ Q
Sbjct: 305 VQQDPALSSN-REAHQHRDKMQQSKNQ 330
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 556 bits (1435), Expect = 0.0
Identities = 218/294 (74%), Positives = 267/294 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ GEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P ++W G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 555 bits (1433), Expect = 0.0
Identities = 161/295 (54%), Positives = 213/295 (72%), Gaps = 2/295 (0%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
++V+G +K+GR+IG GSFG ++ G N+ ++VA+K E ++ PQL E + Y LL
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
G TG+P++ +FG EG +NV+VIDLLGPSLEDL + C RKFS+KTV M A Q++ RV+ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SRGFLHRDIKPDNFLMGL--GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+ ++RDIKPDNFL+G + +N +Y++D+G+ K YRD T +HIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238
Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKY++I EKK TP+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293
LC +P EF Y HY R+L F+ PDY YL+ LF + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 511 bits (1317), Expect = 0.0
Identities = 88/335 (26%), Positives = 148/335 (44%), Gaps = 29/335 (8%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEVAVKLESVKTKHPQLHYESKL 55
+ + +K+G IG G FG +YL +V + VK+E + + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86
Query: 56 YMLLQ--------------GGTGVPHLKWFGVEG----EYNVMVIDLLGPSLEDLFNYCN 97
Y GVP G+ Y M++D G L+ ++
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
++FS KTVL L+ ++++ +EY+H ++H DIK N L+ +QVY++DYGLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205
Query: 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
HK + GT + S++ H GV SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AGTKKQKYDKISEKKMLTPIEVLC---KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274
K + KI ++ + + C + P E Y + L + +KP Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFIREGYQFDYVFDWTILKYPQTGSSSRSRPSGK 309
G + D D ++++ + + ++
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAA 360
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 490 bits (1262), Expect = e-173
Identities = 89/314 (28%), Positives = 140/314 (44%), Gaps = 29/314 (9%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-TKHPQLHYESKLYMLL 59
+D + G ++ LG+KIGSG FG +YL E+ A + V+ ++ L E K Y +
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 60 QGGT--------------GVPHLKWFGV----EGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
G+P G+ Y MV++ LG L+ + N F
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
TVL L ++++ +EY+H ++H DIK N L+G +QVY+ DYGL+ +Y
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPNGN 208
Query: 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 218
HK K GT + S++ H GV SRR D+E LGY ++ +L G LPW+
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 219 GTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278
+ K + + E S E + SL +++KP+Y LK++ I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328
Query: 279 REGYQFDYVFDWTI 292
G D++
Sbjct: 329 PLGP-----LDFST 337
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 474 bits (1221), Expect = e-167
Identities = 73/317 (23%), Positives = 128/317 (40%), Gaps = 33/317 (10%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTG--------EEVAVKLESVKT----------- 44
G ++KL + G LY T ++ ++KL++
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 45 --KHPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNVMVIDLLGPSLEDLFNYCNRK-F 100
K Q++ KLY +P FGV + +Y +V+ LG SL+ + +
Sbjct: 99 AAKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156
Query: 101 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160
S ++VL +A +L++ +E++H ++H ++ +N + + +QV + YG A +Y
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCP-- 213
Query: 161 THKHIPYRENKN--LTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ KH+ Y E G + S++ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
Query: 219 GTKKQKYDKISEKKMLTPIEVLCKSY---PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275
T+ K P C + Y +L +E+KP Y+ L+
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333
Query: 276 LFIREGYQFDYVFDWTI 292
L +
Sbjct: 334 LLQDLRVSPYDPIGLPM 350
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 55/298 (18%), Positives = 104/298 (34%), Gaps = 59/298 (19%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQ 60
+ L +G G+ ++ G + +TG+ A+K+ S E ++ L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 61 GGTGVPH---LKWFGVE----GEYNVMVIDLL--GPSLEDLFNYCNRK-----FSLKTVL 106
H +K F +E + V++++ G L+ L
Sbjct: 66 ------HKNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFL 115
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVY-IIDYGLAKKYRDLQTHKHI 165
++ ++ + ++ G +HR+IKP N + +G VY + D+G A++ D
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------- 168
Query: 166 PYRENKNLT---GTARYAS--------VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPW 213
++ GT Y + + DL S+G V Y GSLP+
Sbjct: 169 ----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPF 223
Query: 214 QGLKAG-TKKQKYDKISEKKMLTPIEVLCKS------YPSEFTSYFHYCRSLRFEDKP 264
+ + K+ KI K I + K+ + + R L+ P
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 38/268 (14%), Positives = 79/268 (29%), Gaps = 54/268 (20%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--------------------KHP 47
K KL + G ++L +V+ E+ A+K+ ++
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 48 ---QLHYESKLYMLLQGGTGVPHLKWFGVEGEYN-------VMVIDLLGPSLEDLFNYCN 97
+ +L + + + + ++++ LE LF+ +
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 98 R------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151
+ + +L QLI + S+G +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 152 LAKKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMY-FLR 208
K + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 209 GSLPWQGLKAGTKKQKYDKISEKKMLTP 236
LP+ GL K + + S + T
Sbjct: 289 LFLPF-GLVTPGIKGSWKRPSLRVPGTD 315
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/299 (18%), Positives = 104/299 (34%), Gaps = 59/299 (19%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLL 59
+ L +G G+ ++ G + +TG+ A+K+ S E ++ L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 60 QGGTGVPH---LKWFGVE----GEYNVMVIDLL--GPSLEDLFNYCNRK-----FSLKTV 105
H +K F +E + V++++ G L+
Sbjct: 65 N------HKNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEF 114
Query: 106 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVY-IIDYGLAKKYRDLQTHKH 164
L++ ++ + ++ G +HR+IKP N + +G VY + D+G A++ D
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED------ 168
Query: 165 IPYRENKNLT---GTARYAS--------VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 212
++ GT Y + + DL S+G V Y GSLP
Sbjct: 169 -----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLP 222
Query: 213 WQGLKAG-TKKQKYDKISEKKMLTPIEVLCKS------YPSEFTSYFHYCRSLRFEDKP 264
++ + K+ KI K I + K+ + + R L+ P
Sbjct: 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 46/240 (19%), Positives = 89/240 (37%), Gaps = 47/240 (19%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKH-PQLHYESKLYMLL 59
V G + + ++IGSG +++ +N + + A+K LE + E L
Sbjct: 25 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 83
Query: 60 QGGTGVPH---LKWFGV-EGEYNVMVIDLLGPSLE----DLFNYCNRK--FSLKTVLMLA 109
Q ++ + + + ++ +E DL ++ +K
Sbjct: 84 QQ----HSDKIIRLYDYEITDQYIYMV------MECGNIDLNSWLKKKKSIDPWERKSYW 133
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
++ V +H G +H D+KP NFL+ + +ID+G+A + + T
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK---- 185
Query: 170 NKNLTGTARYAS-----------VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 217
+ GT Y N + S + D+ SLG ++Y G P+Q +
Sbjct: 186 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII 243
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-23
Identities = 53/233 (22%), Positives = 94/233 (40%), Gaps = 46/233 (19%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKT-----KHPQLHYESKLYML 58
+++LG +G G FG ++ G + +VA+K+ V E L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 59 LQGGTGVPH----LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVL--MLADQL 112
+ G G P L WF + + ++V++ P+ +DLF+Y K L Q+
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSRCFFGQV 148
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD--LQTHKHIPYREN 170
+ +++ HSRG +HRDIK +N L + + +ID+G D
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYTD--------- 197
Query: 171 KNLTGTARYAS---VNTHL--GVEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ ++ H + + SLG Y ++ G +P++
Sbjct: 198 --FDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 49/262 (18%), Positives = 93/262 (35%), Gaps = 53/262 (20%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKH-PQLHYESKLYMLL 59
V G + + ++IGSG +++ +N + + A+K LE + E L
Sbjct: 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL 64
Query: 60 QGGTGVPH---LKWFGV-EGEYNVMVIDLLGPSLE----DLFNYCNRK--FSLKTVLMLA 109
Q ++ + + + ++ +E DL ++ +K
Sbjct: 65 QQ----HSDKIIRLYDYEITDQYIYMV------MECGNIDLNSWLKKKKSIDPWERKSYW 114
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
++ V +H G +H D+KP NFL+ + +ID+G+A + + T
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK---- 166
Query: 170 NKNLTGTARYAS-----------VNTHLGVEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
+ GT Y N + S + D+ SLG Y + Y G P+Q
Sbjct: 167 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQ 222
Query: 216 LKAGTKKQKYDKISEKKMLTPI 237
+ + K I +
Sbjct: 223 II--NQISKLHAIIDPNHEIEF 242
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-23
Identities = 44/198 (22%), Positives = 73/198 (36%), Gaps = 30/198 (15%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--------LESVKT--------KHPQLHY 51
F+ +G G+FG++ N A+K L ++ + H Y
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ---Y 63
Query: 52 ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLAD 110
+ Y + + ++ +L DL + N L
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD----LQTHKHIP 166
Q++ + Y+HS+G +HRD+KP N + +S V I D+GLAK L+
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 167 YRENKNLT---GTARYAS 181
+ NLT GTA Y +
Sbjct: 181 PGSSDNLTSAIGTAMYVA 198
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 41/257 (15%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKH-PQLHYESKLYML 58
V G + + ++IGSG +++ +N + + A+K LE + E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 59 LQG-GTGVPHLKWFGVEGEYNVMVIDLLGPSLE----DLFNYCNRK--FSLKTVLMLADQ 111
LQ + L + + +Y MV +E DL ++ +K
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMV-------MECGNIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 112 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENK 171
++ V +H G +H D+KP NFL+ + +ID+G+A + + T
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----D 214
Query: 172 NLTGTARYAS-----------VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
+ G Y N + S + D+ SLG +L Y G P+Q +
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--N 272
Query: 221 KKQKYDKISEKKMLTPI 237
+ K I +
Sbjct: 273 QISKLHAIIDPNHEIEF 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 29/246 (11%), Positives = 64/246 (26%), Gaps = 42/246 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL-----------------ESVKTKH---- 46
G +G + +TGE V + E ++ +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 47 ---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN-------VMVIDLLGPSLEDLFNY- 95
Q + K V + + + +L+
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 96 -----CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150
++ L L Q+I + +H G +H ++P + ++ + V++ +
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250
Query: 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRG 209
+ E L S + + D +LG +++Y
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309
Query: 210 SLPWQG 215
LP
Sbjct: 310 DLPITK 315
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 3e-22
Identities = 50/318 (15%), Positives = 107/318 (33%), Gaps = 61/318 (19%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYES------------ 53
G +++ ++G+G FG + ++ TGE+VA+K + + +
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 54 --KLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK-----FSLKTVL 106
+ G + + ++ ++ DL Y N+ +
Sbjct: 74 VVSAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENCCGLKEGPIR 124
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166
L + + + Y+H +HRD+KP+N ++ G + IID G AK+
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------- 176
Query: 167 YRENKNLT---GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
+ T GT +Y + + + D S G + + G P+ +
Sbjct: 177 ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP---NWQPV 230
Query: 224 KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDK-PDYSYLKRLFRDL---FIR 279
++ +K I V Y +++F P ++L + +++
Sbjct: 231 QWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279
Query: 280 EGYQFDYVFDWTILKYPQ 297
+ T + P
Sbjct: 280 CMLMWHQRQRGTDPQNPN 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 58/299 (19%), Positives = 106/299 (35%), Gaps = 72/299 (24%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--------------LESVKT------ 44
+ K+ L IG GS+G + + + QT A+K +E +KT
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 45 --KHP---QLH--YESK--LYM---LLQGG--------------TGVPHLKWFGVEGEYN 78
HP +L+ YE + + + L GG
Sbjct: 84 KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 79 VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138
+ + S+ + K + + Q+ + + Y+H++G HRDIKP+NFL
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF-S 202
Query: 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDL 196
KS ++ ++D+GL+K++ L ++ GT + + V + D
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 197 ESLGYVLMYF-LRGSLP-W----QGLKAGTKKQKYD-------KISE------KKMLTP 236
S G VL++ L G++P + +K +S +L
Sbjct: 260 WSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNR 317
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 53/235 (22%), Positives = 100/235 (42%), Gaps = 44/235 (18%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--ESVKTKHPQLHYESKLYM--- 57
+ ++++G +GSG FG +Y G+ V VA+K + + +L +++ M
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 58 -LLQGGTGVPH----LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVL--MLAD 110
L + +G L WF + V++++ P +DLF++ + +L+ L
Sbjct: 99 LLKKVSSGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELARSFFW 156
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD--LQTHKHIPYR 168
Q++ V + H+ G LHRDIK +N L + ++ +ID+G +D
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDF------ 208
Query: 169 ENKNLTGTARYAS---VNTHL--GVEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ + H G + SLG Y ++ G +P++
Sbjct: 209 -----DGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-21
Identities = 66/286 (23%), Positives = 95/286 (33%), Gaps = 88/286 (30%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK----------LESVKT------ 44
M + L + +G G++GE+ L VN T E VAVK E++K
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 45 --KHP---QLHYE-----SKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN 94
H + Y + Y+ L+ +G GE LF+
Sbjct: 61 MLNHENVVKF-YGHRREGNIQYLFLEYCSG----------GE---------------LFD 94
Query: 95 YC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
+ QL+ V Y+H G HRDIKP+N L L + N + I D+GL
Sbjct: 95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGL 151
Query: 153 AKKYRDLQTHKHIPYRENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLGYVLMYFL 207
A +R + + + GT Y D+ S G VL L
Sbjct: 152 ATVFRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAML 202
Query: 208 RGSLPWQG-----------LKAGTKKQKYDKISE------KKMLTP 236
G LPW + T + KI K+L
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-21
Identities = 64/260 (24%), Positives = 104/260 (40%), Gaps = 71/260 (27%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKT--------------KH 46
F++GR +G G FG +YL Q+ +A+K LE +H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 47 P---QLHY----ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR- 98
P +L+ +++Y++L+ + G ++ +
Sbjct: 69 PNILRLYGYFHDATRVYLILE----------YAPLGT---------------VYRELQKL 103
Query: 99 -KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
KF + +L N + Y HS+ +HRDIKP+N L+G + ++ I D+G +
Sbjct: 104 SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS---- 156
Query: 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGL 216
H P +L GT Y G + DL SLG VL Y FL G P++
Sbjct: 157 -----VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE-- 208
Query: 217 KAGTKKQKYDKISEKKMLTP 236
A T ++ Y +IS + P
Sbjct: 209 -ANTYQETYKRISRVEFTFP 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 66/286 (23%), Positives = 95/286 (33%), Gaps = 88/286 (30%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK----------LESVKT------ 44
M + L + +G G++GE+ L VN T E VAVK E++K
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 45 --KHP---QLHYE-----SKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN 94
H + Y + Y+ L+ +G GE LF+
Sbjct: 61 MLNHENVVKF-YGHRREGNIQYLFLEYCSG----------GE---------------LFD 94
Query: 95 YC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
+ QL+ V Y+H G HRDIKP+N L L + N + I D+GL
Sbjct: 95 RIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGL 151
Query: 153 AKKYRDLQTHKHIPYRENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLGYVLMYFL 207
A +R + + + GT Y D+ S G VL L
Sbjct: 152 ATVFRYNNRERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAML 202
Query: 208 RGSLPWQG-----------LKAGTKKQKYDKISE------KKMLTP 236
G LPW + T + KI K+L
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 61/287 (21%), Positives = 106/287 (36%), Gaps = 96/287 (33%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK----------LESVKT--------KH 46
I F RK+GSG+FG+++L +G E +K +E ++ H
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 47 P---QLH--YESKLYM-----LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLF--- 93
P ++ +E M +GG +L
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGG----------------------------ELLERI 111
Query: 94 ---NYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150
+ S V L Q++N + Y HS+ +H+D+KP+N L + + IID+
Sbjct: 112 VSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLGYVLMYF- 206
GLA+ ++ + N GTA Y + + + D+ S G V+MYF
Sbjct: 172 GLAELFKSDEHS--------TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFL 218
Query: 207 LRGSLP-W----QGLKAGTKKQKYD------KISE------KKMLTP 236
L G LP + ++ ++ + ++ K+MLT
Sbjct: 219 LTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTK 265
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 70/268 (26%), Positives = 112/268 (41%), Gaps = 59/268 (22%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQG 61
++K R +G GSFGE+ L + TG+E AVK VK K + ++ +L Q
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ- 82
Query: 62 GTGVPH---LKWFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQL 112
+ H +K + E + +V ++ G +LF+ + FS + Q+
Sbjct: 83 ---LDHPNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQV 135
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172
++ + YMH +HRD+KP+N L+ K + IID+GL+ + + K
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK------- 188
Query: 173 LTGTARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLP-W----QGLKAGTK 221
GTA Y + E D+ S G V++Y L G P + +
Sbjct: 189 -IGTAYYIA------PEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNGANEYDILKKVE 240
Query: 222 KQKYD-------KISE------KKMLTP 236
K KY K+SE +KMLT
Sbjct: 241 KGKYTFELPQWKKVSESAKDLIRKMLTY 268
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 27/262 (10%), Positives = 67/262 (25%), Gaps = 58/262 (22%)
Query: 1 MDHVIGGK---FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLES---------------- 41
++ +G + G +G + +TGE V +
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128
Query: 42 -------VKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN--------VMVIDLLG 86
K+ + ++ P K + +
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 87 PSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 140
+L+ ++ L L Q+I + +H G +H ++P + ++
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--- 245
Query: 141 KSNQVYIIDYGLAKKY-RDLQTHKHIPYRENKNLTGTARYAS-----VNTHLGVEQSRRD 194
+ V++ + + + + + H +
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAF 298
Query: 195 DLESLGYVLMYF-LRGSLPWQG 215
D +LG + +Y+ LP
Sbjct: 299 DTWTLG-LAIYWIWCADLPNTD 319
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 58/260 (22%), Positives = 96/260 (36%), Gaps = 71/260 (27%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVK--------------TKH 46
F +GR +G G FG +YL Q +A+K LE +H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 47 P---QLHY----ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR- 98
P +++ ++Y++L+ F GE L+ +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLE----------FAPRGE---------------LYKELQKH 108
Query: 99 -KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
+F + ++L + + Y H R +HRDIKP+N LMG ++ I D+G +
Sbjct: 109 GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWS---- 161
Query: 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGL 216
H P + + GT Y G + DL G VL Y FL G P+
Sbjct: 162 -----VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD-- 213
Query: 217 KAGTKKQKYDKISEKKMLTP 236
+ + + + +I + P
Sbjct: 214 -SPSHTETHRRIVNVDLKFP 232
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 34/203 (16%), Positives = 72/203 (35%), Gaps = 60/203 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--------ESVKT--------KHP- 47
+ K+ + +G G FG ++ V + + K VK +H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62
Query: 48 --QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYC---NR 98
LH +ES + VM+ + + D+F
Sbjct: 63 ILHLHESFESMEEL---------------------VMIFEFISGL----DIFERINTSAF 97
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+ + + ++ Q+ ++++HS H DI+P+N + R+S+ + II++G A++ +
Sbjct: 98 ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLKP 156
Query: 159 LQTHKHIPYRENKNLTGTARYAS 181
+ L Y +
Sbjct: 157 GDNF--------RLLFTAPEYYA 171
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 43/218 (19%), Positives = 87/218 (39%), Gaps = 20/218 (9%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
F +G G+ G + + +VAVK + E +L L+ P+
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVK-RILPECFSFADREVQL---LRESDEHPN 79
Query: 68 -LKWFGVE--GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+++F E ++ + I+L +L++ + + L Q + + ++HS
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139
Query: 125 LHRDIKPDNFLMGLGRKSNQ--VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS- 181
+HRD+KP N L+ + + I D+GL KK + + + GT + +
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTEGWIAP 195
Query: 182 --VNTHLGVEQSRRDDLESLGYVLMYFL--RGSLPWQG 215
++ + D+ S G + Y++ GS P+
Sbjct: 196 EMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 102/294 (34%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------------LESVKT--- 44
+ ++ + + +GSG+ GE+ L +T ++VA+K +V+T
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 45 -----KHP---QLH--YESK-LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLE 90
HP ++ ++++ Y+ L++GG
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG---------------------------- 99
Query: 91 DLFNY-CNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148
+LF+ + T + Q++ V+Y+H G +HRD+KP+N L+ + + I
Sbjct: 100 ELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT 159
Query: 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDLE----SLGYV 202
D+G +K + + L GT Y + V L + + SLG V
Sbjct: 160 DFGHSKILGETSLM--------RTLCGTPTYLAPEV---LVSVGTAGYNRAVDCWSLG-V 207
Query: 203 LMYF-LRGSLP-W-----QGLKAGTKKQKY-------DKISE------KKMLTP 236
+++ L G P LK KY ++SE KK+L
Sbjct: 208 ILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 40/230 (17%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKLYMLLQ 60
GK+ +G +G GS+G++ ++ +T AVK L + + E +L L+
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 61 GGTGVPHLK-----WFGVEGEYNVMVIDLLGPSLEDLFNY-CNRKFSLKTVLMLADQLIN 114
++ + E + MV++ ++++ + ++F + QLI+
Sbjct: 65 H----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174
+EY+HS+G +H+DIKP N L L + I G+A+ P+ +
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH--------PFAADDTCR 169
Query: 175 ---GTARYAS------VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
G+ + ++T G + D+ S G L G P++G
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEG 215
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 56/250 (22%), Positives = 89/250 (35%), Gaps = 51/250 (20%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKL 55
D ++ GR +G G F + + + T E A K L + ++ E +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68
Query: 56 YMLLQGGTGVPH-LKWFGV-EGEYNVMVIDLLGPSLE-----DLFNYC--NRKFSLKTVL 106
+ L H + + G E V V+ LE L + +
Sbjct: 69 HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 118
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166
Q++ +Y+H +HRD+K N L V I D+GLA K + +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKV-EYDGERK-- 172
Query: 167 YRENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 220
K L GT Y S H S D+ S+G +MY L G P++
Sbjct: 173 ----KVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSC 219
Query: 221 KKQKYDKISE 230
K+ Y +I +
Sbjct: 220 LKETYLRIKK 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 58/276 (21%), Positives = 107/276 (38%), Gaps = 68/276 (24%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG 64
+ ++ + + +GSG+ GE+ L +T ++VA++ + + G+
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIR--IISKRK------------FAIGSA 178
Query: 65 VPHLKWFGVEGEYNVM-------VIDLLG----PS----LE-----DLFNY--CNRKFSL 102
VE E ++ +I + LE +LF+ N++
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE 238
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
T + Q++ V+Y+H G +HRD+KP+N L+ + + I D+G +K +
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 163 KHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLGYVLMYF-LRGSLP-W---- 213
+ L GT Y + + + +R D SLG V+++ L G P
Sbjct: 299 --------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRT 349
Query: 214 -QGLKAGTKKQKY-------DKISE------KKMLT 235
LK KY ++SE KK+L
Sbjct: 350 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLV 385
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 40/180 (22%), Positives = 71/180 (39%), Gaps = 25/180 (13%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTG 64
+ +G G++G +Y G ++ +A+K + LH E L+ L+
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK---- 77
Query: 65 VPH---LKWFGVEGEYNVMVIDL---LGPSLEDLFNYCNRKFSLK--TVLMLADQLINRV 116
H +++ G E + I + G SL L T+ Q++ +
Sbjct: 78 --HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGL 135
Query: 117 EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 176
+Y+H +HRDIK DN L + S + I D+G +K+ + + TGT
Sbjct: 136 KYLHDNQIVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 62/265 (23%), Positives = 115/265 (43%), Gaps = 54/265 (20%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG 64
+ ++ +K+GSG++GE+ L + T E A+K ++ SKL +
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIK--IIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 65 VPH---LKWFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINR 115
+ H +K + E + N +V++ G +LF+ + F+ ++ Q+++
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
V Y+H +HRD+KP+N L+ K + I+D+GL+ + + + K G
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER--------LG 200
Query: 176 TARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLPW-----QGLKAGTKKQK 224
TA Y + E R+ D+ S+G V+++ L G P+ Q + +K K
Sbjct: 201 TAYYIA------PEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGK 253
Query: 225 YD-------KISE------KKMLTP 236
Y +SE K+ML
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQF 278
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 51/236 (21%), Positives = 92/236 (38%), Gaps = 37/236 (15%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG 64
+ + +G GS G + G VAVK + E KL L
Sbjct: 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVK-RMLIDFCDIALMEIKL---LTESDD 67
Query: 65 VPH-LKWFGVE--GEYNVMVIDLLGPSLEDL------FNYCNRKFSLKTVLMLADQLINR 115
P+ ++++ E + + ++L +L+DL + + + L Q+ +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 116 VEYMHSRGFLHRDIKPDNFL----------MGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165
V ++HS +HRD+KP N L G ++ ++ I D+GL KK Q+
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 166 PYRENKNLTGTARYA-------SVNTHLGVEQSRRDDLESLGYVLMYFL--RGSLP 212
N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 188 NL---NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 53/178 (29%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--------ESVK--------TKHP--- 47
++ + IGSG+FG L + T E VAVK E+V+ +HP
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 48 QLHYE-----SKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY-CNR-KF 100
+ E + L ++++ +G GE L+ CN +F
Sbjct: 80 RF-KEVILTPTHLAIIMEYASG----------GE---------------LYERICNAGRF 113
Query: 101 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
S QL++ V Y HS HRD+K +N L+ G + ++ I D+G +K
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 40/221 (18%), Positives = 80/221 (36%), Gaps = 21/221 (9%)
Query: 4 VIGG-KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQ 60
+I + +K+G G F + L + G A+K + + E+ ++ L
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN 84
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLL----GPSLEDLFNYC---NRKFSLKTVLMLADQLI 113
+ + + E LL +L + + +L L +
Sbjct: 85 HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 114 NRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL--QTHKHIPYRENK 171
+E +H++G+ HRD+KP N L+G Q ++D G + + + + ++
Sbjct: 145 RGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 172 NLTGTARYAS---VNTHLGVEQSRRDDLESLG---YVLMYF 206
T Y + + R D+ SLG Y +M+
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 36/155 (23%), Positives = 61/155 (39%), Gaps = 15/155 (9%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKL---YMLLQGGTG 64
F+ ++G GS+GE++ + + G AVK S+ KL + G
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK-RSMSPFRGPKDRARKLAEVGSHEKVG-- 114
Query: 65 VPH-----LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
H L+ EG + +L GPSL+ V + + ++
Sbjct: 115 -QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL 173
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
HS+G +H D+KP N +G + + D+GL
Sbjct: 174 HSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 3e-19
Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 52/252 (20%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKLYMLLQ 60
FK+G +G GSF +Y ++ TG EVA+K + ++ E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69
Query: 61 GGTGVPH-LKWFGV-EGEYNVMVIDLLGPSLE-----DLFNYC---NRKFSLKTVLMLAD 110
P L+ + E V ++ LE ++ Y + FS
Sbjct: 70 H----PSILELYNYFEDSNYVYLV------LEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYREN 170
Q+I + Y+HS G LHRD+ N L+ ++ + I D+GLA +
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHE 167
Query: 171 KNLT--GTARYAS---VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQK 224
K+ T GT Y S D+ SLG + Y L G P+ T K
Sbjct: 168 KHYTLCGTPNYISPEIAT---RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNT 220
Query: 225 YDKISEKKMLTP 236
+K+ P
Sbjct: 221 LNKVVLADYEMP 232
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 61/204 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---------ESVKT--------KHP 47
+ + + ++G+G+FG ++ TG A K E+V+ +HP
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 48 ---QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRK- 99
LH +E M VM+ + + G +LF +
Sbjct: 215 TLVNLHDAFEDDNEM---------------------VMIYEFMSGG----ELFEKVADEH 249
Query: 100 --FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
S + Q+ + +MH ++H D+KP+N + ++SN++ +ID+GL
Sbjct: 250 NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD 308
Query: 158 DLQTHKHIPYRENKNLTGTARYAS 181
P + K TGTA +A+
Sbjct: 309 --------PKQSVKVTTGTAEFAA 324
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 3e-19
Identities = 59/283 (20%), Positives = 96/283 (33%), Gaps = 92/283 (32%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---------LESVKT--------KHP 47
I + L IG GS+GE+ + V T A K ++ K HP
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 48 ---QLH--YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
+L+ +E +Y+ L GG +LF
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGG----------------------------ELFERVV 98
Query: 98 RK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
K F + +++ V Y H HRD+KP+NFL + + +ID+GLA +
Sbjct: 99 HKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 156 YRDLQTHKHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLGYVLMYF-LRGSL 211
++ + + GT Y S + G E D S G V+MY L G
Sbjct: 159 FKPGKMM--------RTKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYP 205
Query: 212 P-W----QGLKAGTKKQKYD-------KISE------KKMLTP 236
P + ++ + +S +++LT
Sbjct: 206 PFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 47/241 (19%), Positives = 82/241 (34%), Gaps = 43/241 (17%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLES----VKTKHPQLHYESKLYMLLQGG 62
++ L +IG GS+G + L N A+K+ S ++ + GG
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 63 TGVPHLKWFGVEGEYNVM-------------VIDLLGPS-----LE-----DLFNYCNR- 98
P V E ++ V+D E +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
S LI +EY+H + +HRDIKP N L+G + + I D+G++ +++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKG 189
Query: 159 LQTHKHIPYRENKNLTGTARYAS----VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 214
N GT + + T + D+ ++G L F+ G P+
Sbjct: 190 SDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFM 241
Query: 215 G 215
Sbjct: 242 D 242
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 68/267 (25%), Positives = 110/267 (41%), Gaps = 58/267 (21%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQ-LHYESKLYMLLQ 60
++ + +G GSFGE+ + T +E AVK S K K + E +L L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGTGVPH-LKWFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLI 113
P+ +K F + E + +V +L G +LF+ ++ FS + Q+
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 114 NRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 173
+ + YMH +HRD+KP+N L+ K + IID+GL+ ++ K
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR-------- 183
Query: 174 TGTARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLP-W----QGLKAGTKK 222
GTA Y + E R D+ S G V++Y L G+ P + + +
Sbjct: 184 IGTAYYIA------PEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVET 236
Query: 223 QKYD-------KISE------KKMLTP 236
KY IS+ +KMLT
Sbjct: 237 GKYAFDLPQWRTISDDAKDLIRKMLTF 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 49/204 (24%), Positives = 79/204 (38%), Gaps = 61/204 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---------ESVKT--------KHP 47
+ + + ++GSG+FG ++ V TG K +VK HP
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 48 ---QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRK- 99
LH +E K M V++++ L G +LF+ +
Sbjct: 109 KLINLHDAFEDKYEM---------------------VLILEFLSGG----ELFDRIAAED 143
Query: 100 --FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
S V+ Q +++MH +H DIKP+N + +K++ V IID+GLA K
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN 202
Query: 158 DLQTHKHIPYRENKNLTGTARYAS 181
P K T TA +A+
Sbjct: 203 --------PDEIVKVTTATAEFAA 218
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 55/252 (21%), Positives = 88/252 (34%), Gaps = 55/252 (21%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKL 55
D ++ GR +G G F + + + T E A K L + ++ E +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94
Query: 56 YMLLQGGTGVPH-LKWFGV-EGEYNVMVIDLLGPSLE-----DLFNYC--NRKFSLKTVL 106
+ L H + + G E V V+ LE L + +
Sbjct: 95 HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 144
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166
Q++ +Y+H +HRD+K N L V I D+GLA K +
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------VE 192
Query: 167 YRENKNLT--GTARYA-----SVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 218
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 243
Query: 219 GTKKQKYDKISE 230
K+ Y +I +
Sbjct: 244 SCLKETYLRIKK 255
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 8e-19
Identities = 51/272 (18%), Positives = 90/272 (33%), Gaps = 56/272 (20%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKTKHPQLHYES 53
++ +G G + ++ T +E AVK E V+ E
Sbjct: 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 74
Query: 54 KLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLA 109
+ + G + LK + +V DL+ G +LF+Y K S K +
Sbjct: 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIM 130
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
L+ + +H +HRD+KP+N L+ + + D+G + + +
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKL------- 180
Query: 170 NKNLTGTARYAS--VNTHLGVEQSRRDDLE----SLGYVLMYF-LRGSLP-W----QGLK 217
+ + GT Y + + + E S G V+MY L GS P W +
Sbjct: 181 -REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFWHRKQMLML 238
Query: 218 AGTKKQKYD-------KISE------KKMLTP 236
Y S+ + L
Sbjct: 239 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVV 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-19
Identities = 51/237 (21%), Positives = 93/237 (39%), Gaps = 52/237 (21%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----------ESVKTKHPQLHYESKLY 56
K+ +GSG+FG ++ V+ + +EV VK K ++ E +
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 57 MLLQGGTGVPH-LKWFGV-EGEYNV-MVIDLLGPSLEDLFNYCNRKFSLKTVL--MLADQ 111
++ + +K + E + +V++ G L+ LF + +R L L + Q
Sbjct: 84 SRVEH----ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFRQ 138
Query: 112 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD---LQTHKHIPYR 168
L++ V Y+ + +HRDIK +N + + + +ID+G A T
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLERGKLFYTF------ 189
Query: 169 ENKNLTGTARYA-----SVNTHLGVEQSRRDDLESLG---YVLMYFLRGSLPWQGLK 217
GT Y N + G E ++ SLG Y L++ P+ L+
Sbjct: 190 -----CGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPFCELE 234
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 61/295 (20%), Positives = 95/295 (32%), Gaps = 100/295 (33%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--------------LESVKT--- 44
D + ++L IG G F + +N +TG++ AVK E +K
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 45 -----KHP---QLH--YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSL 89
KHP +L Y S LYM + G
Sbjct: 79 ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA--------------------------- 111
Query: 90 EDLFNYCNRKFSLKTVLMLAD------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143
DL ++ V A Q++ + Y H +HRD+KP L+ S
Sbjct: 112 -DLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA 170
Query: 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS----VNTHLGVEQSRRDDLESL 199
V + +G+A + + GT + + G D+
Sbjct: 171 PVKLGGFGVAIQLGE-------SGLVAGGRVGTPHFMAPEVVKREPYGKPV----DVWGC 219
Query: 200 GYVLMYF-LRGSLP-W---QGLKAGTKKQKYD-------KISE------KKMLTP 236
G V+++ L G LP + + L G K KY ISE ++ML
Sbjct: 220 G-VILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLML 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 63/284 (22%), Positives = 102/284 (35%), Gaps = 92/284 (32%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKT--------K 45
++ + +G GSFGE+ + T +E AVK ++
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 46 HP---QLH--YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY 95
HP +L E Y+ L GG +LF+
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGG----------------------------ELFDE 111
Query: 96 CNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
++ FS + Q+ + + YMH +HRD+KP+N L+ K + IID+GL+
Sbjct: 112 IIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 154 KKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMYF-LRGS 210
++ K GTA Y + V L + D+ S G V++Y L G+
Sbjct: 172 TCFQQNTKMKDR--------IGTAYYIAPEV---LRGTYDEKCDVWSAG-VILYILLSGT 219
Query: 211 LP-W----QGLKAGTKKQKYD-------KISE------KKMLTP 236
P + + + KY IS+ +KMLT
Sbjct: 220 PPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-18
Identities = 42/205 (20%), Positives = 81/205 (39%), Gaps = 66/205 (32%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---------------LESVKT-------- 44
+++G ++GSG F + TG+E A K E ++
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 45 KHP---QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCN 97
+HP LH +E+K + V++++L+ G +LF++
Sbjct: 66 RHPNIITLHDIFENKTDV---------------------VLILELVSGG----ELFDFLA 100
Query: 98 RK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKSNQVYIIDYGLAK 154
K + Q+++ V Y+HS+ H D+KP+N ++ + ++ +ID+G+A
Sbjct: 101 EKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160
Query: 155 KYRDLQTHKHIPYRENKNLTGTARY 179
K KN+ GT +
Sbjct: 161 KIEAGNEF--------KNIFGTPEF 177
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 42/187 (22%), Positives = 65/187 (34%), Gaps = 46/187 (24%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKT---------KHP---QLH--- 50
++G GSFGE++ + QTG + AVK LE + P L+
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 51 -YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLA 109
+ + + E L G SL L L
Sbjct: 120 REGPWVNIFM----------------EL------LEGGSLGQLIKQM-GCLPEDRALYYL 156
Query: 110 DQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
Q + +EY+H+R LH D+K DN L L ++ + D+G A + K +
Sbjct: 157 GQALEGLEYLHTRRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG- 213
Query: 170 NKNLTGT 176
+ GT
Sbjct: 214 -DYIPGT 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 57/256 (22%), Positives = 101/256 (39%), Gaps = 74/256 (28%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKT--------KHP 47
G ++L + IG G+F ++ L ++ TG EVA+K L+ + HP
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 48 ---QLH----YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY--CNR 98
+L E LY++++ +G GE +F+Y +
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASG----------GE---------------VFDYLVAHG 109
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+ K Q+++ V+Y H + +HRD+K +N L L N + I D+G + ++
Sbjct: 110 RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV 166
Query: 159 ---LQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQ 214
L G YA+ G + D+ SLG +L + GSLP+
Sbjct: 167 GGKLDAF-----------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
Query: 215 GLKAGTKKQKYDKISE 230
G K+ +++
Sbjct: 216 G---QNLKELRERVLR 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 60/187 (32%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KH 46
G + LG +G G+FG++ +G + TG +VAVK + +K +H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 47 P---QLH----YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC--N 97
P +L+ + +M+++ +G GE LF+Y +
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSG----------GE---------------LFDYICKH 105
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
+ L Q+++ V+Y H +HRD+KP+N L L N I D+GL+
Sbjct: 106 GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMS 162
Query: 158 D---LQT 161
D L+T
Sbjct: 163 DGEFLRT 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 43/211 (20%), Positives = 76/211 (36%), Gaps = 72/211 (34%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---------------LESVKT----- 44
+ + +G ++GSG F + TG E A K E ++
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 45 ---KHP---QLH--YESKLYM-----LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLED 91
H LH YE++ + L+ GG +
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGG----------------------------E 101
Query: 92 LFNYCNRKFSL--KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKSNQVYII 148
LF++ +K SL + Q+++ V Y+H++ H D+KP+N ++ + +I
Sbjct: 102 LFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
D+GLA + D KN+ GT +
Sbjct: 162 DFGLAHEIEDGVEF--------KNIFGTPEF 184
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-18
Identities = 39/198 (19%), Positives = 70/198 (35%), Gaps = 30/198 (15%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKT----------KHP 47
+D G FK IGSG FG+++ + G+ +K + K H
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHV 64
Query: 48 QL--HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRK-FSLK 103
+ + + + + + ++ +LE +
Sbjct: 65 NIVHYNGC--WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163
L L +Q+ V+Y+HS+ ++RD+KP N + + QV I D+GL ++
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRT 179
Query: 164 HIPYRENKNLTGTARYAS 181
GT RY S
Sbjct: 180 RS--------KGTLRYMS 189
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 64/277 (23%), Positives = 105/277 (37%), Gaps = 67/277 (24%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKLYML 58
IG + RK+GSG++GE+ L E A+K + + + E +
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 59 ------LQGGTGVPH---LKWFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLK 103
L+ + H +K F V E + +V + G +LF + F
Sbjct: 94 YNEISLLKS---LDHPNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHKFDEC 146
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163
+ Q+++ + Y+H +HRDIKP+N L+ + I+D+GL+ + +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRD-----DLESLGYVLMYF-LRGSLP-W--- 213
GTA Y + E ++ D+ S G V+MY L G P
Sbjct: 207 DR--------LGTAYYIA------PEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQN 251
Query: 214 -QGLKAGTKKQKYD-------KISE------KKMLTP 236
Q + +K KY IS+ K MLT
Sbjct: 252 DQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTY 288
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 7e-18
Identities = 61/288 (21%), Positives = 99/288 (34%), Gaps = 99/288 (34%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKT--------K 45
+ + ++G G+F + V+ TG E A K + ++ +
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 46 HP---QLH--YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY 95
HP +LH + + Y+ L+ GG +LF
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGG----------------------------ELFED 95
Query: 96 -CNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
R +S Q++ + Y HS G +HR++KP+N L+ K V + D+GLA
Sbjct: 96 IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
Query: 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRD------DLESLGYVLMYF- 206
+ D + GT Y S E ++D D+ + G V++Y
Sbjct: 156 IEVNDSEAW--------HGFAGTPGYLS------PEVLKKDPYSKPVDIWACG-VILYIL 200
Query: 207 LRGSLP-W----QGLKAGTKKQKYD-------KISE------KKMLTP 236
L G P W L A K YD ++ MLT
Sbjct: 201 LVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 66/208 (31%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---------------LESVKT----- 44
+ + G ++GSG F + TG + A K E ++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 45 ---KHP---QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFN 94
+HP LH YE+K + +++++L+ G +LF+
Sbjct: 69 KEIQHPNVITLHEVYENKTDV---------------------ILILELVAGG----ELFD 103
Query: 95 YCNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG-LGRKSNQVYIIDYG 151
+ K + + Q++N V Y+HS H D+KP+N ++ ++ IID+G
Sbjct: 104 FLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 152 LAKKYRDLQTHKHIPYRENKNLTGTARY 179
LA K KN+ GT +
Sbjct: 164 LAHKIDFGNEF--------KNIFGTPEF 183
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-18
Identities = 29/179 (16%), Positives = 67/179 (37%), Gaps = 21/179 (11%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEVAVKLESVKTKHPQLHYESKLYM 57
+ + +G G+F ++Y + + ++ +K++ + + ++L
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLME 119
Query: 58 LLQGGT--GVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFN----YCNRKFSLKTVLMLAD 110
L+ + +V+V +L +L + N + V+ A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMG--------LGRKSNQVYIIDYGLAKKYRDLQT 161
+++ +E +H +H DIKPDNF++G S + +ID G + +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 41/189 (21%), Positives = 75/189 (39%), Gaps = 65/189 (34%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KH 46
G + + +G GSFG++ L + +T ++VA+K V+ +H
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 47 P---QLH--YESK--LYMLLQ--GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC- 96
P +L+ + + M+++ GG +LF+Y
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYAGG----------------------------ELFDYIV 100
Query: 97 -NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
++ + Q+I +EY H +HRD+KP+N L+ + V I D+GL+
Sbjct: 101 EKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD---DNLNVKIADFGLSNI 157
Query: 156 YRD---LQT 161
D L+T
Sbjct: 158 MTDGNFLKT 166
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 1e-17
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 51/180 (28%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---------ESVKT--------KHP 47
I F +GSG+F E++L TG+ A+K S++ KH
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66
Query: 48 ---QLH--YESK--LYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY-CNR- 98
L YES Y+++Q +G GE LF+ R
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSG----------GE---------------LFDRILERG 101
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
++ K ++ Q+++ V+Y+H G +HRD+KP+N L +++++ I D+GL+K ++
Sbjct: 102 VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 57/271 (21%), Positives = 96/271 (35%), Gaps = 55/271 (20%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYML----- 58
K+ IG G + V+ TG E AVK +E + E
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 59 -LQGGTGVPH-LKWFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLAD 110
L+ G PH + E + +V DL+ G +LF+Y K S K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYREN 170
L+ V ++H+ +HRD+KP+N L+ + Q+ + D+G + +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKL-------- 256
Query: 171 KNLTGTARYAS--VNTHLGVEQSRRDDLE----SLGYVLMYF-LRGSLP-W----QGLKA 218
+ L GT Y + + E E + G V+++ L GS P W +
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHRRQILMLR 315
Query: 219 GTKKQKYD-------KISE------KKMLTP 236
+ +Y S ++L
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQV 346
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 52/214 (24%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 8 KFKLGRK-IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYML--LQGGTG 64
++L +G G+ + +N+ T +E AVK+ + H + ++ ML QG
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRN 72
Query: 65 VPHLK-WFGVEGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEY 118
V L +F E E +V + + G + ++ +++ F+ ++ + + +++
Sbjct: 73 VLELIEFF--EEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+H++G HRD+KP+N L + + V I D+ L + I E G+A
Sbjct: 127 LHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 179 YAS--VNTHLGVEQSRRD---DLESLGYVLMYFL 207
Y + V E S D DL SLG V++Y L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 66/205 (32%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---------------LESVKT-------- 44
+ +G ++GSG F + TG E A K E ++
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 45 KHP---QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCN 97
HP LH YE++ + V++++L+ G +LF++
Sbjct: 73 LHPNIITLHDVYENRTDV---------------------VLILELVSGG----ELFDFLA 107
Query: 98 RKFSL--KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKSNQVYIIDYGLAK 154
+K SL + Q+++ V Y+H++ H D+KP+N ++ + +ID+GLA
Sbjct: 108 QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 155 KYRDLQTHKHIPYRENKNLTGTARY 179
+ D KN+ GT +
Sbjct: 168 EIEDGVEF--------KNIFGTPEF 184
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 38/185 (20%), Positives = 68/185 (36%), Gaps = 59/185 (31%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKT--------K 45
+ + ++G G+F + V+ TG E A K + ++ +
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 46 HP---QLH--YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY 95
HP +LH + + Y+ L+ GG +LF
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGG----------------------------ELFED 118
Query: 96 CNRK--FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+ +S Q++ + Y HS G +HR++KP+N L+ K V + D+GLA
Sbjct: 119 IVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 154 KKYRD 158
+ D
Sbjct: 179 IEVND 183
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 36/181 (19%), Positives = 75/181 (41%), Gaps = 26/181 (14%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM---LLQGGTGVPH 67
+++G G F + ++ TG+E A K +K + +++ +L+ P
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 68 L-KWFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK----FSLKTVLMLADQLINRVEY 118
+ V E + ++++ G ++F+ C + S V+ L Q++ V Y
Sbjct: 91 VINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+H +H D+KP N L+ + I+D+G+++K + + GT
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--------REIMGTPE 198
Query: 179 Y 179
Y
Sbjct: 199 Y 199
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 62/288 (21%), Positives = 97/288 (33%), Gaps = 98/288 (34%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKT--------K 45
+++L ++G G+F + V V G+E A + ++ K
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 46 HP---QLH--YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY 95
HP +LH + Y+ L+ GG +LF
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGG----------------------------ELFED 100
Query: 96 -CNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
R +S Q++ V + H G +HR++KP+N L+ K V + D+GLA
Sbjct: 101 IVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
Query: 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRD------DLESLGYVLMYF- 206
+ + GT Y S E R+D DL + G V++Y
Sbjct: 161 IEVEG-------EQQAWFGFAGTPGYLS------PEVLRKDPYGKPVDLWACG-VILYIL 206
Query: 207 LRGSLP-W----QGLKAGTKKQKYD-------KISE------KKMLTP 236
L G P W L K YD ++ KMLT
Sbjct: 207 LVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTI 254
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 60/285 (21%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYE--------SKLY--- 56
+ +G++IGSGSFG +Y G +VAVK+ +V PQ K
Sbjct: 25 QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 57 -MLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN 114
+L G + P L +V G SL + KF +K ++ +A Q
Sbjct: 82 ILLFMGYSTAPQL----------AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174
++Y+H++ +HRD+K +N + + N V I D+GLA + + + + L+
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLS 183
Query: 175 GTARYAS---VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231
G+ + + + S + D+ + G VL + G LP+ + + Q + +
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRG 241
Query: 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+ + + + P C + +++P + + +L
Sbjct: 242 SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 60/187 (32%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KH 46
G + LG +G G+FG++ +G + TG +VAVK + ++ +H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 47 P---QLH--YESK--LYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC--N 97
P +L+ + ++M+++ +G GE LF+Y N
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSG----------GE---------------LFDYICKN 110
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
+ K L Q+++ V+Y H +HRD+KP+N L L N I D+GL+
Sbjct: 111 GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMS 167
Query: 158 D---LQT 161
D L+T
Sbjct: 168 DGEFLRT 174
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 45/201 (22%), Positives = 82/201 (40%), Gaps = 63/201 (31%)
Query: 8 KFKLGRK--IGSGSFGELYLGVNVQTGEEVAVKL---------ESVKT--------KHP- 47
+ + + +G G FG+++ TG ++A K+ E VK H
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 48 --QLH--YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRK-- 99
QL+ +ESK + V+V++ + G +LF+ +
Sbjct: 148 LIQLYDAFESKNDI---------------------VLVMEYVDGG----ELFDRIIDESY 182
Query: 100 -FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+ ++ Q+ + +MH LH D+KP+N L + R + Q+ IID+GLA++Y+
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK- 240
Query: 159 LQTHKHIPYRENKNLTGTARY 179
P + K GT +
Sbjct: 241 -------PREKLKVNFGTPEF 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 52/185 (28%), Positives = 79/185 (42%), Gaps = 25/185 (13%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLL- 59
+ ++ L RK+G G F ++L ++ VA+K + K E KL +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 60 ------QGGTGVPH----LKWF---GVEGEYNVMVIDLLGPSLEDLF-NYCNRKFSLKTV 105
+ G H L F G G + VMV ++LG +L L Y +R L V
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 106 LMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVY---IIDYGLA-----KKY 156
++ QL+ ++YMH R G +H DIKP+N LM + + I D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 157 RDLQT 161
+QT
Sbjct: 194 NSIQT 198
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 41/229 (17%), Positives = 82/229 (35%), Gaps = 31/229 (13%)
Query: 5 IGG-KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQG 61
+G + ++ R + G F +Y +V +G E A+K + + E L G
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG 84
Query: 62 ---------GTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD 110
+ + + E+ +++ +L L + S TVL +
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEF-LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 111 QLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD-----LQTHK 163
Q V++MH + +HRD+K +N L+ + + D+G A +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 164 HIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLG---YVLMYF 206
E T Y + ++ + + D+ +LG Y+L +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 61/267 (22%), Positives = 106/267 (39%), Gaps = 65/267 (24%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH-LK 69
+ +G GSF V+ ++ + AVK+ S K E L +G P+ +K
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGH---PNIVK 70
Query: 70 WFGV-EGEYNV-MVIDLL--GPSLEDLFNYCNRK--FSLKTVLMLADQLINRVEYMHSRG 123
V + + +V++LL G +LF +K FS + +L++ V +MH G
Sbjct: 71 LHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT---GTARYA 180
+HRD+KP+N L + ++ IID+G A+ +N+ L T YA
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLHYA 176
Query: 181 S--VNTHLGVEQSRRD---DLESLGYVLMYFL-------------RGSLPWQGLKAGTKK 222
+ + + Q+ D DL SLG V++Y + + KK
Sbjct: 177 APEL-----LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230
Query: 223 QKYD-------KISE------KKMLTP 236
+ +S+ + +LT
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLLTV 257
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 59/257 (22%), Positives = 95/257 (36%), Gaps = 80/257 (31%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVK---------TKHP---QLH 50
+++ IG GS+ ++ T E AVK +HP L
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLK 82
Query: 51 --YESK--LYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK--FS 101
Y+ +Y+ L++GG +L + R+ FS
Sbjct: 83 DVYDDGKYVYVVTELMKGG----------------------------ELLDKILRQKFFS 114
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM-GLGRKSNQVYIIDYGLAKKYRDLQ 160
+ + + VEY+H++G +HRD+KP N L + I D+G AK+ R
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-- 172
Query: 161 THKHIPYRENKNLT---GTARYAS--VNTHLGVEQSRRD---DLESLGYVLMYF-LRGSL 211
EN L TA + + V +E+ D D+ SLG VL+Y L G
Sbjct: 173 --------ENGLLMTPCYTANFVAPEV-----LERQGYDAACDIWSLG-VLLYTMLTGYT 218
Query: 212 PWQGLKAGTKKQKYDKI 228
P+ T ++ +I
Sbjct: 219 PFANGPDDTPEEILARI 235
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 32/198 (16%), Positives = 66/198 (33%), Gaps = 51/198 (25%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ + ++IG G FG ++ G V+ VA+K + + K +
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR------- 72
Query: 68 LKWFGVEGEYNVM-------VIDLLGPSLE------------DLFNY---CNRKFSLKTV 105
E +M ++ L G DL++
Sbjct: 73 --------EVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 106 LMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVY--IIDYGLAKKYRDLQT 161
L L + +EYM ++ +HRD++ N + ++ V + D+GL+++ +
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184
Query: 162 HKHIPYRENKNLTGTARY 179
L G ++
Sbjct: 185 ----------GLLGNFQW 192
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 31/150 (20%), Positives = 66/150 (44%), Gaps = 9/150 (6%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKW 70
+ +G G G++ N +T E+ A+K ++ P+ E +L+ + +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK--MLQ-DCPKARREVELHWRASQCPHIVRIVD 78
Query: 71 F---GVEGEYNV-MVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
G + +V++ L G + + ++ F+ + + + ++Y+HS
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
HRD+KP+N L R + + + D+G AK
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 44/202 (21%), Positives = 67/202 (33%), Gaps = 43/202 (21%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGG 62
+F KIGSG FG ++ V G A+K L + L +L Q
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ-- 69
Query: 63 TGVPH-LKWFGVEGEYNVMVIDL---LGPSLEDLFNYCNRK---FSLKTVLMLADQLINR 115
H +++F E + M+I G SL D + R F + L Q+
Sbjct: 70 --HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 116 VEYMHSRGFLHRDIKPDN-FLMGLGRKSNQVYII---------------DYGLAKKYRDL 159
+ Y+HS +H DIKP N F+ + D G +
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187
Query: 160 QTHKHIPYRENKNLTGTARYAS 181
Q G +R+ +
Sbjct: 188 QV-----------EEGDSRFLA 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 60/283 (21%), Positives = 102/283 (36%), Gaps = 85/283 (30%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP- 47
FK G+ +G GSF + L + T E A+K + V HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
+L++ + KLY L + G +L Y +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNG----------------------------ELLKYIRK 123
Query: 99 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
F ++++ +EY+H +G +HRD+KP+N L+ + + I D+G AK
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVL 180
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
+ GTA+Y S + DL +LG ++Y + G P+
Sbjct: 181 SPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF-- 232
Query: 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSL 258
+AG + + KI + + +P +F R L
Sbjct: 233 -RAGNEYLIFQKIIKLEY---------DFPEKFFP---KARDL 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 52/263 (19%), Positives = 103/263 (39%), Gaps = 57/263 (21%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKW 70
+ +G G G++ N +T E+ A+K ++ P+ E +L+ + +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK--MLQ-DCPKARREVELHWRASQCPHIVRIVD 122
Query: 71 F---GVEGEYNV-MVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
G + +V++ L G + + ++ F+ + + + ++Y+HS
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT---GTARYAS 181
HRD+KP+N L R + + + D+G AK+ + +LT T Y +
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKE-----------TTSHNSLTTPCYTPYYVA 231
Query: 182 --VNTHLGVEQSRRD---DLESLGYVLMYFL----------RGSLPWQGLKAGTKKQKYD 226
V + + D D+ SLG V+MY L G G+K + +Y+
Sbjct: 232 PEV-----LGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 227 -------KISE------KKMLTP 236
++SE + +L
Sbjct: 286 FPNPEWSEVSEEVKMLIRNLLKT 308
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-16
Identities = 51/266 (19%), Positives = 104/266 (39%), Gaps = 57/266 (21%)
Query: 8 KFKLGRK-IGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
++L ++ +G G G++ + +TG++ A+K + P+ E + GG +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGGPHIV 85
Query: 67 HLKWF---GVEGEYNV-MVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
+ G+ + ++++ + G + ++ F+ + + + ++++H
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD--LQTHKHIPYRENKNLTGTAR 178
S HRD+KP+N L K + + D+G AK+ LQT T
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-----------PCYTPY 194
Query: 179 YAS--VNTHLGVEQSRRD---DLESLGYVLMYFL----------RGSLPWQGLKAGTKKQ 223
Y + V + + D D+ SLG V+MY L G G+K +
Sbjct: 195 YVAPEV-----LGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248
Query: 224 KYD-------KISE------KKMLTP 236
+Y ++SE + +L
Sbjct: 249 QYGFPNPEWSEVSEDAKQLIRLLLKT 274
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 42/293 (14%), Positives = 94/293 (32%), Gaps = 59/293 (20%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
+++ R + G F ++ L + A+K K+ + +K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYE-KSLLEKKRDFTKSNNDKISIKSKY 87
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLED---------------LFNY--------- 95
+ E ++ + G + + + +
Sbjct: 88 D----DFKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDK 142
Query: 96 -CNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
++ + + ++N Y+H+ + HRD+KP N LM K+ +V + D+G +
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGES 199
Query: 154 KKYRDLQTHKHIPYRENKNLTGTARYAS--VNTHLGVEQSRRDDLESLGYVLMY-FLRGS 210
+ D + GT + ++ + D+ SLG + +Y
Sbjct: 200 EYMVDKKIKG---------SRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNV 249
Query: 211 LPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDK 263
+P+ + + ++ I K + P++ YP L ED
Sbjct: 250 VPFSL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI 300
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 38/196 (19%), Positives = 70/196 (35%), Gaps = 25/196 (12%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTG 64
F+ + +G G FG ++ N A+K L + + ++ E K L+
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSL---------EDLFNYCNRK-----FSLKTVLMLAD 110
V + + + + L E+L ++ N + L +
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL 125
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYREN 170
Q+ VE++HS+G +HRD+KP N + V + D+GL + + +
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 171 KNLT-----GTARYAS 181
GT Y S
Sbjct: 183 AYARHTGQVGTKLYMS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 54/280 (19%), Positives = 99/280 (35%), Gaps = 86/280 (30%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL-------ESVKT--------KHP-- 47
+ F++ ++G G+ +Y T + A+K+ + V+T HP
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNI 110
Query: 48 -QLH--YESK--LYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY-CNR-KF 100
+L +E+ + ++L+ TG GE LF+ + +
Sbjct: 111 IKLKEIFETPTEISLVLELVTG----------GE---------------LFDRIVEKGYY 145
Query: 101 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160
S + Q++ V Y+H G +HRD+KP+N L + I D+GL+K
Sbjct: 146 SERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205
Query: 161 THKHIPYRENKNLTGTARYAS----VNTHLGVEQSRRDDLESLGYVLMYFL-------RG 209
K + GT Y + G E D+ S+G ++ Y L
Sbjct: 206 LM--------KTVCGTPGYCAPEILRGCAYGPEV----DMWSVG-IITYILLCGFEPFYD 252
Query: 210 SLPWQGLKAGTKKQKY-------DKISE------KKMLTP 236
Q + +Y D++S +K++
Sbjct: 253 ERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVL 292
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 38/166 (22%), Positives = 76/166 (45%), Gaps = 26/166 (15%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGG 62
+ ++++ + IG GSFG++ + + + VA+K + + K H Q E ++ L+
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRI---LE-- 148
Query: 63 TGVPHLKWFGVEGEYNV--------------MVIDLLGPSLEDLFNYCN-RKFSLKTVLM 107
HL+ + NV M +LL +L +L + FSL V
Sbjct: 149 ----HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK 204
Query: 108 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
A ++ ++ +H +H D+KP+N L+ + + + +ID+G +
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 33/188 (17%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH-- 67
L IG G FGE++ G GEEVAVK+ S + + E+++Y + + H
Sbjct: 45 VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR-EAEIYQTVM----LRHEN 97
Query: 68 -LKWFGVEGEYNVMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
L + + + N L SL D N +++ ++ LA + + ++
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHL 155
Query: 120 HSR--------GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENK 171
H HRD+K N L+ +K+ I D GLA ++ I
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PN 209
Query: 172 NLTGTARY 179
+ GT RY
Sbjct: 210 HRVGTKRY 217
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------LESVKTKHPQLHYESKLYMLLQ 60
F++ +KIG G F E+Y + G VA+K L K + E L L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINRV 116
+ + F +E +V++L L + + ++ +TV QL + +
Sbjct: 91 HPNVIKYYASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 117 EYMHSRGFLHRDIKPDN-FLMGLGRKSNQVYIIDYGLAKK 155
E+MHSR +HRDIKP N F+ + V + D GL +
Sbjct: 150 EHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRF 185
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 35/176 (19%), Positives = 64/176 (36%), Gaps = 52/176 (29%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LES------------VKT----KHPQ 48
K++ KIG GS+G ++ N TG+ VA+K ++ KHP
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63
Query: 49 L-------HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
L + +L++ V + ++ + R
Sbjct: 64 LVNLLEVFRRKRRLHL-----------------------VFEYCDHTVLHELDRYQRGVP 100
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
V + Q + V + H +HRD+KP+N L+ K + + + D+G A+
Sbjct: 101 EHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLT 153
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 59/264 (22%), Positives = 96/264 (36%), Gaps = 76/264 (28%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP- 47
F++ R IG GSFG++ + T + A+K + +V +HP
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 48 --QLHY----ESKLYM---LLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN--YC 96
L Y E ++M LL GG DL
Sbjct: 77 LVNLWYSFQDEEDMFMVVDLLLGG----------------------------DLRYHLQQ 108
Query: 97 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
N F +TV + +L+ ++Y+ ++ +HRD+KPDN L+ + V+I D+ +A
Sbjct: 109 NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAML 165
Query: 157 RDLQTHKHIPYRENKNLTGTARYAS---VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 212
+ GT Y + ++ G S D SLG V Y LRG P
Sbjct: 166 PRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRP 216
Query: 213 WQGLKAGTKKQKYDKISEKKMLTP 236
+ + + K+ + P
Sbjct: 217 YHIRSSTSSKEIVHTFETTVVTYP 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 18/158 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKH-PQLHYESKLYMLLQGGT 63
K+ +KIG GSFG+ L + + G + +K + + +K + E + ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 64 GVPHLKWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRK----FSLKTVLMLADQLINRVE 117
V + + F E +V+D G DLF N + F +L Q+ ++
Sbjct: 85 IVQYRESF-EENGSLYIVMDYCEGG----DLFKRINAQKGVLFQEDQILDWFVQICLALK 139
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
++H R LHRDIK N + K V + D+G+A+
Sbjct: 140 HVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARV 174
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 42/175 (24%), Positives = 73/175 (41%), Gaps = 52/175 (29%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVK-----T-----------KHPQ 48
K++ KIG G++G ++ N +T E VA+K L+ + KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 49 -------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
LH + KL ++ E+ DL + F+ CN
Sbjct: 63 IVRLHDVLHSDKKLTLVF----------------EF--CDQDL-----KKYFDSCNGDLD 99
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ V QL+ + + HSR LHRD+KP N L+ ++ ++ + ++GLA+ +
Sbjct: 100 PEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAF 151
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 7e-15
Identities = 49/235 (20%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQL----HYESKLY 56
+ +I ++K+ K+G G +YL + +VA+K +
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFE 59
Query: 57 MLLQGGTGVPHLKW-----FGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLAD 110
+ + + H E + +V++ + GP+L + + S+ T + +
Sbjct: 60 REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTN 118
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL---QTHKHIPY 167
Q+++ +++ H +HRDIKP N L+ + + I D+G+AK + QT+
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQTN----- 170
Query: 168 RENKNLTGTARYASVNTHLGVEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
++ GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 171 ----HVLGTVQYFS------PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 74.6 bits (183), Expect = 9e-15
Identities = 39/209 (18%), Positives = 81/209 (38%), Gaps = 14/209 (6%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQ-- 60
+ G++ + RK+G G F ++L ++Q + VA+K ++S + E +L ++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93
Query: 61 -----GGTGVPHLK-WF---GVEGEYNVMVIDLLGPSLEDL-FNYCNRKFSLKTVLMLAD 110
V L F GV G + MV ++LG L + L V +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 111 QLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
Q++ ++Y+H++ +H DIKP+N L+ + + + + ++
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 170 NKNLTGTARYASVNTHLGVEQSRRDDLES 198
+ + + DL +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 45/190 (23%), Positives = 78/190 (41%), Gaps = 33/190 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ ++ ++IG G +GE+++G GE+VAVK+ + E+++Y + H
Sbjct: 38 QIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFR-ETEIYQT----VLMRH 90
Query: 68 ---LKWFGVEGEYNVMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
L + + + L SL D + K++L LA ++ +
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLC 148
Query: 118 YMHSRGF--------LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRE 169
++H+ F HRD+K N L+ +K+ I D GLA K+ IP
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP--- 202
Query: 170 NKNLTGTARY 179
GT RY
Sbjct: 203 PNTRVGTKRY 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 41/181 (22%), Positives = 77/181 (42%), Gaps = 29/181 (16%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ ++ +G G+FG + ++VA+K ++++ + + +L L + V H
Sbjct: 9 EIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQ--IESESERKAFIVELRQL----SRVNH 60
Query: 68 ---LKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS 121
+K +G +V++ G SL ++ + ++ + Q V Y+HS
Sbjct: 61 PNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 122 R---GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+HRD+KP N L L + I D+G A D+QTH N G+A
Sbjct: 121 MQPKALIHRDLKPPNLL--LVAGGTVLKICDFGTA---CDIQTHM-------TNNKGSAA 168
Query: 179 Y 179
+
Sbjct: 169 W 169
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 41/194 (21%), Positives = 75/194 (38%), Gaps = 60/194 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVA---VKLESVK----------------TKHP- 47
K++ KIG G+FGE++ + +TG++VA V +E+ K KH
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 48 --------------QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLF 93
+ +Y++ ++ DL G L
Sbjct: 78 VVNLIEICRTKASPYNRCKGSIYLVF----------------DF--CEHDLAG-----LL 114
Query: 94 NYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+ KF+L + + L+N + Y+H LHRD+K N L+ + + + D+GLA
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLA 171
Query: 154 KKYRDLQTHKHIPY 167
+ + + + Y
Sbjct: 172 RAFSLAKNSQPNRY 185
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 39/187 (20%), Positives = 77/187 (41%), Gaps = 26/187 (13%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHP-QLHYESKLYMLLQGGTGVP 66
G +G G FG+ + +TGE + +K L + E K+ L+
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE------ 65
Query: 67 H---LKWFGV---EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
H LK+ GV + N + + + G +L + + ++ + A + + + Y+
Sbjct: 66 HPNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD-------LQTHKHIPYRENKN 172
HS +HRD+ N L+ ++ V + D+GLA+ D L++ K ++
Sbjct: 125 HSMNIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 LTGTARY 179
+ G +
Sbjct: 182 VVGNPYW 188
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 39/174 (22%), Positives = 66/174 (37%), Gaps = 51/174 (29%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LES-----------VKT----KHPQ- 48
+ K+G G++ +Y G + T VA+K LE V KH
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 49 ------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSL 102
+H E L ++ EY + DL + + C ++
Sbjct: 63 VTLHDIIHTEKSLTLVF----------------EY--LDKDL-----KQYLDDCGNIINM 99
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
V + QL+ + Y H + LHRD+KP N L+ + ++ + D+GLA+
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAK 150
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 36/177 (20%), Positives = 62/177 (35%), Gaps = 52/177 (29%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LES------------VKT----KHPQ 48
K++ +G GS+G + N TG VA+K +K +H
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 49 L-------HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
L + + Y++ E+ + +L
Sbjct: 86 LVNLLEVCKKKKRWYLVF----------------EF--VDHTILD-----DLELFPNGLD 122
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+ V Q+IN + + HS +HRDIKP+N L+ +S V + D+G A+
Sbjct: 123 YQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAA 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 41/231 (17%), Positives = 80/231 (34%), Gaps = 44/231 (19%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYE--------SKLY----M 57
++G IG G FG++Y G EVA++L ++ + + +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 58 LLQGG-TGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
L G PHL ++ L G +L + + +A +++
Sbjct: 93 LFMGACMSPPHL----------AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK-KYRDLQTHKHIPYRENKNLT 174
+ Y+H++G LH+D+K N + +V I D+GL + R
Sbjct: 143 MGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGVLQAGRREDKLRIQ---N 195
Query: 175 GTARY---------ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
G + + + S+ D+ +LG + P++
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 41/224 (18%), Positives = 75/224 (33%), Gaps = 40/224 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
KL IG G +G +Y G VAVK+ S + E +Y + + H
Sbjct: 14 NLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQ-NFINEKNIYRV----PLMEH 66
Query: 68 ---LKWFGVEGEYNV-------MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRV 116
++ + +V++ SL + + LA + +
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRGL 124
Query: 117 EYMHS---------RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
Y+H+ HRD+ N L+ + I D+GL+ + + +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 168 -RENKNLTGTARY-------ASVNTHLGVEQSRRDDLESLGYVL 203
+ GT RY +VN ++ D+ +LG +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 41/170 (24%), Positives = 80/170 (47%), Gaps = 30/170 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
++L RK+G G + E++ +N+ E+V VK L+ VK K ++ E K+ L+GG +
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGPNII 94
Query: 67 HLKWFGVEGEYNVMVIDLLGPSLED----LFNYCN--------RKFSLKTVLMLADQLIN 114
L D++ + +F + N + + + +++
Sbjct: 95 TL-------------ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK 141
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164
++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y Q +
Sbjct: 142 ALDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNV 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 7e-14
Identities = 43/176 (24%), Positives = 69/176 (39%), Gaps = 53/176 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVK-----T-----------KHPQ 48
F+ KIG G++G +Y N TGE VA+K L++ T HP
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 49 -------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN-RKF 100
+H E+KLY++ E+ + DL + +
Sbjct: 64 IVKLLDVIHTENKLYLVF----------------EF--LHQDL-----KKFMDASALTGI 100
Query: 101 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
L + QL+ + + HS LHRD+KP N L+ + + D+GLA+ +
Sbjct: 101 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAF 153
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 45/174 (25%), Positives = 70/174 (40%), Gaps = 46/174 (26%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LES-----------VKT----KHPQ- 48
+FK K+G+G++ +Y G+N TG VA+K L+S + KH
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 49 ------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSL 102
+H E+KL ++ E+ M DL R L
Sbjct: 66 VRLYDVIHTENKLTLVF----------------EF--MDNDLKKYMDSRTVGNTPRGLEL 107
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
V QL+ + + H LHRD+KP N L+ K Q+ + D+GLA+ +
Sbjct: 108 NLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAF 158
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 50/233 (21%), Positives = 83/233 (35%), Gaps = 42/233 (18%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+L G FG ++ E VAVK+ ++ K + E ++Y L G+ H
Sbjct: 25 PLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFPIQDKQSWQN-EYEVYSL----PGMKH 77
Query: 68 ---LKWFGVEGEYNVMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
L++ G E + +DL SL D S + +A+ + +
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLA 135
Query: 118 YMHSRGF----------LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
Y+H HRDIK N L+ + + I D+GLA K+ ++
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAG---- 188
Query: 168 RENKNLTGTARY-----ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ GT RY + + R D+ ++G VL G
Sbjct: 189 -DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 54/245 (22%), Positives = 96/245 (39%), Gaps = 63/245 (25%)
Query: 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQL----------HYE 52
+ +++LG +G G E++L +++ +VAVK+ L E
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRRE 62
Query: 53 SKLYMLL--------------QGGTGVPHLKWFGVEGEYNVM-VIDLLGPSLEDLFNYCN 97
++ L + G Y VM +D G +L D+ +
Sbjct: 63 AQNAAALNHPAIVAVYDTGEAETPAGPLP---------YIVMEYVD--GVTLRDIVHT-E 110
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
+ K + + + + H G +HRD+KP N ++ +N V ++D+G+A+
Sbjct: 111 GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIA 167
Query: 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSR------RDDLESLGYVLMY-FLRGS 210
D + + GTA+Y S EQ+R R D+ SLG ++Y L G
Sbjct: 168 DSGN----SVTQTAAVIGTAQYLS------PEQARGDSVDARSDVYSLG-CVLYEVLTGE 216
Query: 211 LPWQG 215
P+ G
Sbjct: 217 PPFTG 221
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 35/180 (19%), Positives = 66/180 (36%), Gaps = 59/180 (32%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVA---VKLESVKT-------------------K 45
+++ +G G F +Y + T + VA +KL
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 46 HP---QL----HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
HP L ++S + ++ ++ M DL E + +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVF----------------DF--METDL-----EVIIKDNSL 107
Query: 99 KFSLKTV--LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ + ML + +EY+H LHRD+KP+N L+ ++ + + D+GLAK +
Sbjct: 108 VLTPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSF 162
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 1e-13
Identities = 44/175 (25%), Positives = 68/175 (38%), Gaps = 53/175 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVK-----T-----------KHPQ 48
K+ KIG G++G +Y N GE A+K LE T KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 49 -------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
+H + +L ++ E+ + DL + L + C
Sbjct: 62 IVKLYDVIHTKKRLVLVF----------------EH--LDQDL-----KKLLDVCEGGLE 98
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
T QL+N + Y H R LHRD+KP N L+ + ++ I D+GLA+ +
Sbjct: 99 SVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAF 150
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 43/188 (22%), Positives = 69/188 (36%), Gaps = 33/188 (17%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH-- 67
L +G G +GE++ G GE VAVK+ S + + E++LY + + H
Sbjct: 11 TLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFR-ETELYNTVM----LRHEN 63
Query: 68 -LKWFGVEGEYNVMVIDLL-------GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYM 119
L + + L SL D + L + + + + ++
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHL 121
Query: 120 HSRGF--------LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENK 171
H F HRD+K N L+ +K+ Q I D GLA + + N
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG---NN 175
Query: 172 NLTGTARY 179
GT RY
Sbjct: 176 PRVGTKRY 183
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 34/169 (20%), Positives = 59/169 (34%), Gaps = 29/169 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKH-PQLHYESKLYMLLQGGT 63
+++ IG+GS+G G+ + K S+ L E L L+
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLE-----DLFNY------CNRKFSLKTVLMLADQL 112
V + + ++ +E DL + + + VL + QL
Sbjct: 67 IVRYYDRIIDRTNTTLYIV------MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 113 INRVEYMHSRGF-----LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
++ H R LHRD+KP N + V + D+GLA+
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARIL 166
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 58/180 (32%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LES------------VKT----KHPQ 48
+++ K+G G++GE+Y ++ T E VA+K LE V +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 49 -------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLE-DLFNYCNR-- 98
+H+ +L+++ EY E DL Y ++
Sbjct: 95 IIELKSVIHHNHRLHLIF----------------EY-----------AENDLKKYMDKNP 127
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN--QVYIIDYGLAKKY 156
S++ + QLIN V + HSR LHRD+KP N L+ + S + I D+GLA+ +
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 43/237 (18%), Positives = 83/237 (35%), Gaps = 60/237 (25%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEVAVKL-------ESVKT----------- 44
++ G++++ I G G +YL ++ G V +K E+
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 45 KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLK 103
HP + +++ V H G Y VM + + G SL+ +K +
Sbjct: 137 VHPSI---VQIF------NFVEHTDRHGDPVGYIVM--EYVGGQSLKRSKG---QKLPVA 182
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163
+ +++ + Y+HS G ++ D+KP+N ++ Q+ +ID G +
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSRINSFGY-- 236
Query: 164 HIPYRENKNLTGTARYASVNTHLGVEQSR-----RDDLESLGYVLMYFLRGSLPWQG 215
L GT + + E R D+ ++G L G
Sbjct: 237 ---------LYGTPGFQA------PEIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 39/177 (22%), Positives = 65/177 (36%), Gaps = 48/177 (27%)
Query: 10 KLGRKIGSGSFGELYLGVN--VQTGEEVAVK---LESVKT------------KHP----- 47
G K+G G++G +Y + ++ A+K + KHP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISL 83
Query: 48 ----QLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLG---PSLEDLFNYCNRKF 100
H + K+++L +Y DL N +
Sbjct: 84 QKVFLSHADRKVWLLF----------------DY--AEHDLWHIIKFHRASKANKKPVQL 125
Query: 101 SLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL-MGLGRKSNQVYIIDYGLAKKY 156
V L Q+++ + Y+H+ LHRD+KP N L MG G + +V I D G A+ +
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 53/226 (23%), Positives = 88/226 (38%), Gaps = 39/226 (17%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQL----------HYESKLY 56
G ++L R +G G G++Y + VA+KL L E++
Sbjct: 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTRMQREARTA 88
Query: 57 MLLQGGTGVPHLKW---FGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL 112
LQ PH+ FG + + L+ G L + + + + Q+
Sbjct: 89 GRLQE----PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQI 143
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL---QTHKHIPYRE 169
+ ++ H+ G HRD+KP+N L+ + Y++D+G+A D Q
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLG------- 193
Query: 170 NKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
N GT Y + + R D+ +L VL L GS P+QG
Sbjct: 194 --NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 4e-13
Identities = 37/175 (21%), Positives = 65/175 (37%), Gaps = 53/175 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVK-----T-----------KHPQ 48
K++ K+G G++G +Y + G VA+K L++ T HP
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 49 -------LHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
+H E L ++ E+ M DL + + +
Sbjct: 81 IVSLIDVIHSERCLTLVF----------------EF--MEKDL-----KKVLDENKTGLQ 117
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ + QL+ V + H LHRD+KP N L+ + + D+GLA+ +
Sbjct: 118 DSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAF 169
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 27/171 (15%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK----LESVKTKHPQLHYESKLYMLLQGGTG 64
K +IG GSF +Y G++ +T EVA + K++ + E+++ LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ---- 83
Query: 65 VPHL-------KWFGVEGEYNVMVIDL---LGPSLEDLFNYCNRKFSLKTVLMLADQLIN 114
H W +V+ +L+ + +K + Q++
Sbjct: 84 --HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILK 140
Query: 115 RVEYMHSRG--FLHRDIKPDN-FLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
++++H+R +HRD+K DN F+ G + V I D GLA R
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 38/168 (22%), Positives = 72/168 (42%), Gaps = 28/168 (16%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGG 62
++++ IG GSFG++ + E VA+K +++ K Q E + LL+
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVR---LLE-- 105
Query: 63 TGVPHLKWFGVEGEYNV--------------MVIDLLGPSLEDLF-NYCNRKFSLKTVLM 107
+ E +Y + +V ++L +L DL N R SL
Sbjct: 106 ----LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRK 161
Query: 108 LADQLINRVEYMHSR--GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
A Q+ + ++ + +H D+KP+N L+ K + + I+D+G +
Sbjct: 162 FAQQMCTALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS 208
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 34/177 (19%), Positives = 66/177 (37%), Gaps = 44/177 (24%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+++ +IG G++G +Y + +G VA+K + + GG G+P
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALK----SVR---VPNGG------GGGGGLPI 56
Query: 68 --------LKWFGVEGEYNV-----MVIDLLGPSLEDL---FNYC------------NRK 99
L+ NV + + F +
Sbjct: 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 100 FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+T+ L Q + ++++H+ +HRD+KP+N L+ V + D+GLA+ Y
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIY 170
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 64/279 (22%), Positives = 92/279 (32%), Gaps = 87/279 (31%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK----------------------LESVKT-K 45
F + R IG G FGE+Y TG+ A+K L V T
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 46 HP---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN- 94
P + Y KL +L GG DL
Sbjct: 251 CPFIVCMSYAFHTPDKLSFILDLMNGG----------------------------DLHYH 282
Query: 95 -YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+ FS + A ++I +E+MH+R ++RD+KP N L+ + V I D GLA
Sbjct: 283 LSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLA 339
Query: 154 KKYRDLQTHKHIPYRENKNLTGTARY-ASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSL 211
+ + H GT Y A GV D SLG +++ LRG
Sbjct: 340 CDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRGHS 389
Query: 212 PWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTS 250
P++ K K + + P F+
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAV---------ELPDSFSP 419
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 17/155 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGV-- 65
F R+IG GSFG +Y +V+ E VA+K S K ++ +
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-----DIIKEVRFLQ 109
Query: 66 ----PHL-KWFG--VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
P+ ++ G + +V++ S DL + + + + + Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+HS +HRD+K N L+ + V + D+G A
Sbjct: 170 LHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 32/170 (18%), Positives = 73/170 (42%), Gaps = 49/170 (28%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----------------KHP--- 47
+++ ++G G+FG++Y N +TG A K+ K+ HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV 79
Query: 48 QLH----YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLK 103
+L ++ KL++++ E+ G +++ + +R +
Sbjct: 80 KLLGAYYHDGKLWIMI----------------EF------CPGGAVDAIMLELDRGLTEP 117
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+ ++ Q++ + ++HS+ +HRD+K N LM L + + D+G++
Sbjct: 118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL---EGDIRLADFGVS 164
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 29/143 (20%), Positives = 62/143 (43%), Gaps = 14/143 (9%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQ-- 60
++ F + RK+G G+FG + L ++ + AVK + ++K E+ + +Q
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 61 --GGTGVPHLK-WFGVEGEYN---VMVIDLLGPSLEDLF-NYCNRKFSLKTVLMLADQLI 113
+ F Y ++ + LGPSL ++ F ++ + + +++
Sbjct: 92 DINNNNIVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL 147
Query: 114 NRVEYMHSRGFLHRDIKPDNFLM 136
+ Y+ H D+KP+N L+
Sbjct: 148 KALNYLRKMSLTHTDLKPENILL 170
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 44/191 (23%), Positives = 78/191 (40%), Gaps = 42/191 (21%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYE--------SKLY-- 56
+ KIG+GSFG ++ + G +VAVK+ + H + E +L
Sbjct: 38 DLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 57 --MLLQGG-TGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLF--NYCNRKFSLKTVLMLAD 110
+L G T P+L +V + L SL L + + + L +A
Sbjct: 95 NIVLFMGAVTQPPNL----------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAY 144
Query: 111 QLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168
+ + Y+H+R +HR++K N L+ K V + D+GL++ K +
Sbjct: 145 DVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRL-------KASTFL 194
Query: 169 ENKNLTGTARY 179
+K+ GT +
Sbjct: 195 SSKSAAGTPEW 205
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-12
Identities = 60/260 (23%), Positives = 92/260 (35%), Gaps = 77/260 (29%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLES--------------------VKTKHP- 47
+++ + IG G+FGE+ L + T + A+KL S P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 48 --QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
QL Y + LYM+++ GG DL N +
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG----------------------------DLVNLMSN 162
Query: 99 -KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157
K +++ ++ +HS GF+HRD+KPDN L+ KS + + D+G K
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMN 219
Query: 158 DLQTHKHIPYRENKNLTGTARYAS----VNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 212
+ GT Y S + R D S+G V +Y L G P
Sbjct: 220 KEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTP 272
Query: 213 WQGLKAGTKKQKYDKISEKK 232
+ A + Y KI K
Sbjct: 273 F---YADSLVGTYSKIMNHK 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-12
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 32/166 (19%)
Query: 10 KLGRKIGSGSFGELYLGV-NVQTGEEVAVKL------ESVKTKHPQLHYESKLYMLLQGG 62
L IG G FG++Y G+EVAVK E + + E+KL+ +L+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-- 64
Query: 63 TGVPH---LKWFGV--EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRV 116
H + GV + +V++ G L + + ++ ++ A Q+ +
Sbjct: 65 ----HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGM 118
Query: 117 EYMHSRG---FLHRDIKPDNFLMGLGRKSNQVY-----IIDYGLAK 154
Y+H +HRD+K N L+ ++ + I D+GLA+
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 12/104 (11%)
Query: 86 GPSLEDLFNYCNRKFSL--KTVLMLADQLINRVEYMHSRGFLHRDIKPDN-FLMGLGRKS 142
+L+D N L + Q+ VE++HS+G +HRD+KP N F
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 200
Query: 143 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT-----GTARYAS 181
+ V + D+GL + + + T GT Y S
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 41/182 (22%), Positives = 69/182 (37%), Gaps = 48/182 (26%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT-KHP- 47
D + + IG+GSFG +Y +GE VA+K L+ ++ H
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCN 108
Query: 48 --QLHY----------ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY 95
+L Y E L ++L +Y + + + ++
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVL----------------DY--VPETVY--RVARHYSR 148
Query: 96 CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + V + QL + Y+HS G HRDIKP N L L + + + D+G AK+
Sbjct: 149 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQ 206
Query: 156 YR 157
Sbjct: 207 LV 208
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 25/161 (15%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGV 65
++L IGSG+ + E+VA+K LE +T +L E +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH----- 71
Query: 66 PH---LKWFG--VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQL--INR-- 115
H + ++ V + +V+ LL G S+ D+ + K K+ ++ + I R
Sbjct: 72 -HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 116 ---VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
+EY+H G +HRD+K N L+G + V I D+G++
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 59/310 (19%), Positives = 104/310 (33%), Gaps = 103/310 (33%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLES--------------------VKTKHP- 47
F++ + IG G+F E+ + QTG+ A+K+ + V
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 48 --QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY--- 95
QLH+ E+ LY++++ GG DL
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGG----------------------------DLLTLLSK 154
Query: 96 CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + +++ ++ +H G++HRDIKPDN L+ + + + D+G
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCL- 210
Query: 156 YRDLQTHKHIPYRENKNLT--GTARYAS--VNTHLGVEQSRRD-----DLESLGYVLMY- 205
K ++L GT Y S + +G D +LG V Y
Sbjct: 211 -------KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYE 262
Query: 206 FLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD 265
G P+ A + + Y KI K + ++ + P E R
Sbjct: 263 MFYGQTPFY---ADSTAETYGKIVHYKEHLSLPLVDEGVPEE-------ARDF------- 305
Query: 266 YSYLKRLFRD 275
++RL
Sbjct: 306 ---IQRLLCP 312
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 41/187 (21%), Positives = 64/187 (34%), Gaps = 40/187 (21%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--LESVKTK-----------HPQ----LH 50
K+ LG+ +G+GSFG + ++++G+ A+K L+ + K H +
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 51 YESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN------------- 97
Y P V Y N
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 98 -RKFSLKTVLMLAD-------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149
+ F + + QL V ++HS G HRDIKP N L + K N + + D
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLKLCD 185
Query: 150 YGLAKKY 156
+G AKK
Sbjct: 186 FGSAKKL 192
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 33/170 (19%), Positives = 65/170 (38%), Gaps = 47/170 (27%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---------------KHPQL--- 49
F + K+G GS+G +Y ++ +TG+ VA+K V++ P +
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 50 ----HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTV 105
+ L++++ EY S+ D+ N+ + +
Sbjct: 90 YGSYFKNTDLWIVM----------------EY------CGAGSVSDIIRLRNKTLTEDEI 127
Query: 106 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + +EY+H +HRDIK N L+ + D+G+A +
Sbjct: 128 ATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQ 174
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 58/308 (18%), Positives = 103/308 (33%), Gaps = 101/308 (32%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLES--------------------VKTKHP- 47
F++ + IG G+FGE+ + + A+K+ + V
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 48 --QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
LHY ++ LY+++ GG DL ++
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGG----------------------------DLLTLLSK 167
Query: 99 ---KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + +++ ++ +H ++HRDIKPDN LM + + + D+G
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCL- 223
Query: 156 YRDLQTHKHIPYRENKNLT--GTARYAS---VNTHLGVEQ--SRRDDLESLGYVLMY-FL 207
K + ++ GT Y S + G + D SLG V MY L
Sbjct: 224 -------KLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEML 275
Query: 208 RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS 267
G P+ A + + Y KI K +P++ T + L
Sbjct: 276 YGETPFY---AESLVETYGKIMNHKERFQ-------FPTQVTDVSENAKDL--------- 316
Query: 268 YLKRLFRD 275
++RL
Sbjct: 317 -IRRLICS 323
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 49/183 (26%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT-KHP---QLHY 51
+ + IG+GSFG ++ V++ E VA+K L+ ++ KHP L
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 52 ----------ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFS 101
E L ++L EY + + + +
Sbjct: 100 FFYSNGDKKDEVFLNLVL----------------EY--VPETVY--RASRHYAKLKQTMP 139
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
+ + + QL+ + Y+HS G HRDIKP N L L S + +ID+G AK +
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEP 197
Query: 162 HKH 164
+
Sbjct: 198 NVS 200
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 33/171 (19%), Positives = 74/171 (43%), Gaps = 36/171 (21%)
Query: 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----------------KHPQ 48
G F+L +G+G++G++Y G +V+TG+ A+K+ V H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 49 L--HYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYC-NRKFSLKT 104
+ +Y + ++ L W +V++ S+ DL +
Sbjct: 83 IATYYGA--FIKKNPPGMDDQL-W---------LVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 105 VLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + +++ + ++H +HRDIK N L+ ++ +V ++D+G++ +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQ 178
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 16/154 (10%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGV 65
F KIG GSFGE++ G++ +T + VA+K LE + + + E +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 66 PHL-KWFG--VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
P++ K++G ++ ++++ L G S DL + + +++ ++Y+HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKGLDYLHS 137
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+HRDIK N L+ + +V + D+G+A +
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQ 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 30/181 (16%), Positives = 68/181 (37%), Gaps = 42/181 (23%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGV-NVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQG 61
+ ++++ +G G+FG++ + + + +VA+K + +V E + L+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINV---LK- 71
Query: 62 GTGVPHLKWFGVEGEYNV--------------MVIDLLGPSLEDLF-NYCNRKFSLKTVL 106
+K E ++ + +LLG + + + + L V
Sbjct: 72 -----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 126
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLM----------------GLGRKSNQVYIIDY 150
+A QL + + ++H H D+KP+N L K+ + + D+
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 151 G 151
G
Sbjct: 187 G 187
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 36/181 (19%), Positives = 69/181 (38%), Gaps = 42/181 (23%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTG-EEVAVK-LESVKTKHPQLHYESKLYMLLQG 61
V+ ++++ +G G+FG++ ++ + G VAVK +++V E ++ L+
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQV---LE- 66
Query: 62 GTGVPHLKWFGVEGEYNV--------------MVIDLLGPSLEDLFNYCNRK-FSLKTVL 106
HL + +V +LLG S D F L +
Sbjct: 67 -----HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLM----------------GLGRKSNQVYIIDY 150
+A Q+ V ++HS H D+KP+N L + + ++D+
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 151 G 151
G
Sbjct: 182 G 182
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 39/172 (22%), Positives = 73/172 (42%), Gaps = 51/172 (29%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----------------KHPQL- 49
K+ KIG G+ G +Y ++V TG+EVA++ +++ K+P +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 50 -HYES-----KLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLK 103
+ +S +L++++ EY L G SL D+
Sbjct: 81 NYLDSYLVGDELWVVM----------------EY------LAGGSLTDV--VTETCMDEG 116
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + + + +E++HS +HRDIK DN L+G+ V + D+G +
Sbjct: 117 QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQ 165
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/273 (20%), Positives = 89/273 (32%), Gaps = 75/273 (27%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP- 47
F+ R +G G FGE+ TG+ A K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 48 --QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
L Y + L ++L GG LK+ +++
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGG----DLKF--------------------HIYHMGQA 281
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
F + A ++ +E +H ++RD+KP+N L+ + I D GLA +
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPE 338
Query: 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 217
QT K GT Y + + D +LG L+Y + G P+Q K
Sbjct: 339 GQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRK 389
Query: 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTS 250
KK K +++ P E Y F+
Sbjct: 390 ---KKIKREEVERLVKEVPEE-----YSERFSP 414
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 70/309 (22%), Positives = 116/309 (37%), Gaps = 101/309 (32%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTK----------------HP- 47
F + +G+GSFG + L + ++G A+K+ + VK K P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY--C 96
+L + S LYM++ GG ++F++
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG----------------------------EMFSHLRR 134
Query: 97 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+FS A Q++ EY+HS ++RD+KP+N L+ + + + D+G AK+
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV 191
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
+ +T L GT + L ++ D +LG VL+Y G P+
Sbjct: 192 KG-RTW---------TLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF-- 238
Query: 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF-R 274
A Q Y+KI K+ +PS F+S + L L+ L
Sbjct: 239 -FADQPIQIYEKIVSGKV---------RFPSHFSS---DLKDL----------LRNLLQV 275
Query: 275 DLFIREGYQ 283
DL R G
Sbjct: 276 DLTKRFGNL 284
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 33/170 (19%), Positives = 72/170 (42%), Gaps = 32/170 (18%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQ-TGEEVA---VKLESVKTKHP-----------QLHYE 52
+++ +IG G++G+++ +++ G VA V++++ + P L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 53 S-----KLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKF-SLKTVL 106
+L+ + K +V + + L + +T+
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTETIK 123
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ QL+ ++++HS +HRD+KP N L+ S Q+ + D+GLA+ Y
Sbjct: 124 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIY 170
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 3e-10
Identities = 39/184 (21%), Positives = 72/184 (39%), Gaps = 67/184 (36%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK----------------------LESVKTKH 46
F++ R +G+GSFG ++L + G A+K L V H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT--H 65
Query: 47 P---QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYC 96
P ++ +++M++ +GG +LF+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGG----------------------------ELFSLL 97
Query: 97 NR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+ +F A ++ +EY+HS+ ++RD+KP+N L+ K+ + I D+G AK
Sbjct: 98 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAK 154
Query: 155 KYRD 158
D
Sbjct: 155 YVPD 158
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 36/172 (20%), Positives = 71/172 (41%), Gaps = 51/172 (29%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----------------KHPQL- 49
KIG GS G + L +G +VAVK+ ++ +H +
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV 105
Query: 50 -HYES-----KLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLK 103
Y+S +L++L+ E+ L G +L D+ + + +
Sbjct: 106 EMYKSYLVGEELWVLM----------------EF------LQGGALTDI--VSQVRLNEE 141
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ + + ++ + Y+H++G +HRDIK D+ L+ L +V + D+G +
Sbjct: 142 QIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQ 190
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 34/171 (19%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--LESVKTKHPQLHYESKLYMLLQGGTGV 65
+F++ R G G+FG + LG TG VA+K ++ + ++ +L ++Q +
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-------QIMQDLAVL 76
Query: 66 PH-----LKWF-------GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD--- 110
H L+ + Y +V++ + + L C + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 111 ---QLINRVEYMH--SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
QLI + +H S HRDIKP N L + + + D+G AKK
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-10
Identities = 18/188 (9%), Positives = 48/188 (25%), Gaps = 40/188 (21%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYE--------SKLY-- 56
+ K+ GEL+ G G ++ VK+ V+ + +
Sbjct: 11 QLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67
Query: 57 --MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLED-LFNYCNRKFSLKTVLMLADQLI 113
+ + G P + + + SL + L N + A +
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHW------MPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 114 NRVEYMHSRGF--LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENK 171
+ ++H+ + + ++ + I + ++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF------------SFQSP 166
Query: 172 NLTGTARY 179
+
Sbjct: 167 GRMYAPAW 174
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 41/202 (20%), Positives = 72/202 (35%), Gaps = 60/202 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
I F+L +G G++G + + TGE VA+K ++ L+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREI 60
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD---- 110
+L+ H K E + + ++ P + FN Y + LM D
Sbjct: 61 KILK------HFK-----HENIITIFNIQRPDSFENFNEVY------IIQELMQTDLHRV 103
Query: 111 ----------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLA 153
Q + V+ +H +HRD+KP N L+ SN + + D+GLA
Sbjct: 104 ISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLA 159
Query: 154 KKYRDLQTHKHIPYRENKNLTG 175
+ + P + +
Sbjct: 160 RIIDESAADNSEPTGQQSGMVE 181
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 78/276 (28%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP- 47
F R +G G FGE++ TG+ A K +
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 48 --QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
L Y ++ L +++ GG H+ + N
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDED----------------------NP 284
Query: 99 KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
F + Q+++ +E++H R ++RD+KP+N L+ V I D GLA
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLA----- 336
Query: 159 LQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
+ + K GT + + LG E D +LG V +Y + P++
Sbjct: 337 ----VELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRA 391
Query: 216 LKAGTKKQK-YDKISEKKMLTPIEVLCKSYPSEFTS 250
+ ++ ++ E+ + +YP +F+
Sbjct: 392 RGEKVENKELKQRVLEQAV---------TYPDKFSP 418
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 39/185 (21%), Positives = 77/185 (41%), Gaps = 53/185 (28%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ + +GSG++G + ++ ++GE+VA+K K P ++S+++
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRP---FQSEIFAKRAYREL 74
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 110
+LL+ H++ V G +V + D + L M D
Sbjct: 75 LLLK------HMQHENVIGLLDVFTPASSLRNFYDFY--------LVMPFMQTDLQKIMG 120
Query: 111 -------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKY 156
Q++ ++Y+HS G +HRD+KP N + + ++ I+D+GLA+
Sbjct: 121 LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHA 176
Query: 157 RDLQT 161
T
Sbjct: 177 DAEMT 181
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 37/173 (21%), Positives = 73/173 (42%), Gaps = 19/173 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTG 64
LG +IG G+FGE++ G VAVK + E+++
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH--- 171
Query: 65 VPHL-KWFGV--EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
P++ + GV + + +V++L+ G + +KT+L + +EY+
Sbjct: 172 -PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK-----KYRDLQTHKHIPYR 168
S+ +HRD+ N L+ + N + I D+G+++ Y + +P +
Sbjct: 231 SKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 64/179 (35%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F L R IG GS+ ++ L +T A+K ++ V+T HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
LH ES+L+ +++ GG DL +
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 102
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
R K + + ++ + Y+H RG ++RD+K DN L+ + + DYG+ K
Sbjct: 103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCK 158
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 37/183 (20%), Positives = 67/183 (36%), Gaps = 57/183 (31%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+G ++ + +G G G ++ V+ + VA+K ++
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---------KIVLTDPQSVKHALREI 59
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVM-VIDLLGPSLEDLFNYCNRKFSLKTV-----LMLAD 110
+++ L N++ V ++LGPS L + L +V M D
Sbjct: 60 KIIR------RLD------HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD 107
Query: 111 --------------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150
QL+ ++Y+HS LHRD+KP N + + + I D+
Sbjct: 108 LANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDF 165
Query: 151 GLA 153
GLA
Sbjct: 166 GLA 168
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 35/178 (19%), Positives = 65/178 (36%), Gaps = 12/178 (6%)
Query: 7 GKFKLGRKIGSG--SFGELYLGVNVQTGEEVAVK---LESVKTKHPQ-LHYESKLYMLLQ 60
G ++L IG G + L TGE V V+ LE+ + L E + L
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLF-NYCNRKFSLKTVLMLADQLINRVEY 118
VP+ F + E V V + S +DL + + + + ++ ++Y
Sbjct: 85 HPNIVPYRATFIADNELWV-VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGT 176
+H G++HR +K + L+ +VY+ + + + K
Sbjct: 144 IHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 39/179 (21%), Positives = 67/179 (37%), Gaps = 64/179 (35%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F L R IG GS+ ++ L +T A++ ++ V+T HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
LH ES+L+ +++ GG DL +
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 145
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
R K + + ++ + Y+H RG ++RD+K DN L+ + + DYG+ K
Sbjct: 146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCK 201
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 20/159 (12%)
Query: 8 KFKLGRKIGSGSFGELYLGV----NVQTGEEVAVKL--ESVKTKHPQ-LHYESKLYMLLQ 60
K R +G G FG++ L N TGE VAVK +H E + L
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 61 GGTGVPHL-KWFGV---EGEYNVMVIDLLGPSLEDLFNY-CNRKFSLKTVLMLADQLINR 115
H+ K+ G G ++ ++ P L L +Y L +L+ A Q+
Sbjct: 92 H----EHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRHSIGLAQLLLFAQQICEG 146
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+ Y+H++ ++HRD+ N L+ V I D+GLAK
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 63/178 (35%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP- 47
F + +G G+FG++ L TG A+K + T +HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 48 --QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
L Y +L +++ GG +LF + +R
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 98
Query: 99 --KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
F+ + ++++ +EY+HSR ++RDIK +N ++ K + I D+GL K
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCK 153
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 5e-09
Identities = 38/179 (21%), Positives = 69/179 (38%), Gaps = 64/179 (35%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F L + +G GSFG+++L +T + A+K +E +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
+ + L+ +++ GG DL +
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGG----------------------------DLMYHIQ 110
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
KF L A ++I ++++HS+G ++RD+K DN L+ K + I D+G+ K
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCK 166
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 54/266 (20%), Positives = 93/266 (34%), Gaps = 84/266 (31%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F +G GSFG++ L T E AVK +E K P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
QLH +LY +++ GG DL +
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 113
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ +F + A ++ + ++ S+G ++RD+K DN ++ + I D+G+ K+
Sbjct: 114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKE 170
Query: 156 --YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGS 210
+ + T T GT Y + + D + G VL+Y L G
Sbjct: 171 NIWDGVTTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQ 218
Query: 211 LPWQGLKAGTKKQKYDKISEKKMLTP 236
P++G + + + I E + P
Sbjct: 219 APFEG---EDEDELFQSIMEHNVAYP 241
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 40/157 (25%), Positives = 65/157 (41%), Gaps = 19/157 (12%)
Query: 10 KLGRKIGSGSFGELYLGV----NVQTGEEVAVK-LESVKTKHPQ-LHYESKLYMLLQGGT 63
K ++G G+FG + L TG VAVK L+ + E ++ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-- 83
Query: 64 GVPHL-KWFGV---EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
+ K+ GV G ++ ++ P L D + +L+ + Q+ +E
Sbjct: 84 --DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
Y+ SR +HRD+ N L+ V I D+GLAK
Sbjct: 142 YLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 52/185 (28%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ +++ +GSG++G + + +TG VAVK K P ++S ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRP---FQSIIHAKRTYREL 79
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 110
LL+ H+K V G +V D++ L T LM AD
Sbjct: 80 RLLK------HMKHENVIGLLDVFTPARSLEEFNDVY--------LVTHLMGADLNNIVK 125
Query: 111 --------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
Q++ ++Y+HS +HRD+KP N + + ++ I+D+GLA+
Sbjct: 126 CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 182
Query: 157 RDLQT 161
D T
Sbjct: 183 ADEMT 187
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 57/267 (21%), Positives = 92/267 (34%), Gaps = 80/267 (29%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F + IG GSFG++ L + AVK + + + KHP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
LH+ KLY +L GG +LF +
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGG----------------------------ELFYHLQ 131
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
R F A ++ + + Y+HS ++RD+KP+N L+ + + D+GL K
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCK- 187
Query: 156 YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 212
++I + + T GT Y + R D LG ++Y L G P
Sbjct: 188 -------ENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLPP 238
Query: 213 WQGLKAGTKKQKYDKISEKKMLTPIEV 239
+ + YD I K + +
Sbjct: 239 FYS---RNTAEMYDNILNKPLQLKPNI 262
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 64/179 (35%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F+ R +G GSFG++ L +TG+ AVK +E T HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
QL +L+ +++ GG DL +
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQ 116
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+ +F A ++I+ + ++H +G ++RD+K DN L+ + D+G+ K
Sbjct: 117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCK 172
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 41/186 (22%), Positives = 77/186 (41%), Gaps = 54/186 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ ++ + +GSG++G + V+ +TG +VA+K K P ++S+L+
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK----KLYRP---FQSELFAKRAYREL 75
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 110
LL+ H++ V G +V D D + L M D
Sbjct: 76 RLLK------HMRHENVIGLLDVFTPDETLDDFTDFY--------LVMPFMGTDLGKLMK 121
Query: 111 --------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKK 155
Q++ + Y+H+ G +HRD+KP N + + ++ I+D+GLA++
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQ 177
Query: 156 YRDLQT 161
T
Sbjct: 178 ADSEMT 183
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 38/181 (20%), Positives = 66/181 (36%), Gaps = 60/181 (33%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ + + IG GS+G +YL + T + VA+K K +E +
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK----KVNRM---FEDLIDCKRILREI 76
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD---- 110
+L LK +Y + + DL+ P F+ Y + + +D
Sbjct: 77 TILN------RLK-----SDYIIRLYDLIIPDDLLKFDELY------IVLEIADSDLKKL 119
Query: 111 -----------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGL 152
L+ ++H G +HRD+KP N L+ + V + D+GL
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGL 175
Query: 153 A 153
A
Sbjct: 176 A 176
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 20/159 (12%)
Query: 9 FKLGRKIGSGSFGELYLGV----NVQTGEEVAVKL--ESVKTKHPQ-LHYESKLYMLLQG 61
K R +G G FG++ L TGE+VAVK H L E ++ L
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 62 GTGVPHL-KWFGV---EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINR 115
++ K+ G+ +G + +I P SL++ K +LK L A Q+
Sbjct: 83 ----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
++Y+ SR ++HRD+ N L+ +QV I D+GL K
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 54/267 (20%), Positives = 93/267 (34%), Gaps = 80/267 (29%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT---------KHP 47
F +G GSFG++ L T E AVK +E K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 48 ---QLHY----ESKLYMLLQ---GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCN 97
QLH +LY +++ GG DL +
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 434
Query: 98 R--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+ +F + A ++ + ++ S+G ++RD+K DN ++ + I D+G+ K
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCK- 490
Query: 156 YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 212
++I T GT Y + + D + G VL+Y L G P
Sbjct: 491 -------ENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAP 541
Query: 213 WQGLKAGTKKQKYDKISEKKMLTPIEV 239
++G + + + I E + P +
Sbjct: 542 FEG---EDEDELFQSIMEHNVAYPKSM 565
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 42/157 (26%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 10 KLGRKIGSGSFGELYLGV----NVQTGEEVAVKL--ESVKTKHPQLHYESKLYMLLQGGT 63
K +++G G+FG + + TGE VAVK S + E ++ LQ
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 101
Query: 64 GVPHL-KWFGV---EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
++ K+ GV G N+ +I P SL D + +L Q+ +E
Sbjct: 102 --DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
Y+ ++ ++HRD+ N L+ N+V I D+GL K
Sbjct: 160 YLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 31/155 (20%), Positives = 73/155 (47%), Gaps = 15/155 (9%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGV 65
+ ++GSG+ G+++ +TG +AVK K ++ ++ + L ++L+
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD--LDVVLK-SHDC 83
Query: 66 PHL-KWFG---VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
P++ + FG + + ++L+G E L + + + ++ + Y+
Sbjct: 84 PYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 122 -RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
G +HRD+KP N L+ + Q+ + D+G++ +
Sbjct: 143 KHGVIHRDVKPSNILLD---ERGQIKLCDFGISGR 174
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 24/217 (11%), Positives = 53/217 (24%), Gaps = 45/217 (20%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGG 62
+ G+++L G + + ++ +VA+ ++ + E+ L
Sbjct: 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSR 87
Query: 63 TGVPHLKW---FGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
P + ++V + + G SL+++ + S + L +
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRAMQSLAAAADA 144
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
H G P + G
Sbjct: 145 AHRAGVALSIDHPSRVRVS-----------IDGDVV-------------------LAYPA 174
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+DD+ +G L L P
Sbjct: 175 TMPDANP-------QDDIRGIGASLYALLVNRWPLPE 204
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 19/159 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGV----NVQTGEEVAVKL--ESVKTKHPQLHYESKLYMLLQG 61
K +++G G+FG + + TGE VAVK S + E ++ LQ
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH 70
Query: 62 GTGVPHL-KWFGV---EGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINR 115
++ K+ GV G N+ +I P SL D + +L Q+
Sbjct: 71 ----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I D+GL K
Sbjct: 127 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 35/180 (19%), Positives = 73/180 (40%), Gaps = 53/180 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ +++ + IGSG+ G + + VA+K K P ++++ +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRP---FQNQTHAKRAYREL 112
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 110
+L++ + + NV +D++ L LM A+
Sbjct: 113 VLMK------CVNHKNIISLLNVFTPQKTLEEFQDVY--------LVMELMDANLCQVIQ 158
Query: 111 -------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKY 156
Q++ ++++HS G +HRD+KP N ++ KS+ + I+D+GLA+
Sbjct: 159 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 46/174 (26%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
I ++++ IG+GS+G + + VA+K K +E +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----KILRV---FEDLIDCKRILREI 103
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN--YCNRKF---SLKTVLM---- 107
+L L ++ V V+D++ P + F+ Y + K +
Sbjct: 104 AILN------RLN-----HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVY 152
Query: 108 LAD--------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
L + L+ V+Y+HS G LHRD+KP N L+ + V + D+GLA
Sbjct: 153 LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLA 203
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 42/169 (24%), Positives = 64/169 (37%), Gaps = 43/169 (25%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
FK + +GSG+FG +Y G+ + GE+V + + ++K L+ T
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKE--------------LREATSPKAN 61
Query: 69 KWFGVEGEYNVM-------VIDLLGPSLED-------------LFNY---CNRKFSLKTV 105
K E VM V LLG L L +Y + +
Sbjct: 62 KEI--LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 106 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
L Q+ + Y+ R +HRD+ N L+ V I D+GLAK
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 33/176 (18%), Positives = 71/176 (40%), Gaps = 51/176 (28%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ +++ + IGSG+ G + + VA+K K P ++++ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK----KLSRP---FQNQTHAKRAYREL 75
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLAD------ 110
+L++ + + G NV +D++ + LM A+
Sbjct: 76 VLMK------CVNHKNIIGLLNVFTPQKSLEEFQDVY--------IVMELMDANLCQVIQ 121
Query: 111 -------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153
Q++ ++++HS G +HRD+KP N ++ + + I+D+GLA
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA 174
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 61/283 (21%), Positives = 117/283 (41%), Gaps = 41/283 (14%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGV 65
+L K+G G FGE+++G N T VA+K L+ E+++ L+
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 66 PHL-KWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHS 121
L + + V E + ++ SL D K+ L ++ +A Q+ + + Y+
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD----LQTHKHIPYRENKNLTGTA 177
++HRD++ N L+G ++ + D+GLA+ D + P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK-KML 234
A++ + + D+ S G +L+ +G +P+ G+ ++ D++ +M
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQVERGYRMP 401
Query: 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
P C P C E++P + YL+ D F
Sbjct: 402 CP--PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 61/180 (33%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-------- 56
+ K++L +K+G G++G ++ ++ +TGE VAVK K +++
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK----KIFDA---FQNSTDAQRTFREI 59
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVM-VIDLLGP-SLEDLFNYCNRKFSLKTVLMLAD---- 110
M+L L G N++ ++++L + D++ L M D
Sbjct: 60 MILT------ELS-----GHENIVNLLNVLRADNDRDVY--------LVFDYMETDLHAV 100
Query: 111 ----------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLA 153
QLI ++Y+HS G LHRD+KP N L+ + V + D+GL+
Sbjct: 101 IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 53/267 (19%), Positives = 98/267 (36%), Gaps = 80/267 (29%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK------------LESVKT--------KHP- 47
F+ + +G G+FG++ L TG A+K + T +HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 48 --QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR 98
L Y +L ++ GG +LF + +R
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 241
Query: 99 --KFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
FS ++++ ++Y+HS + ++RD+K +N ++ K + I D+GL K
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK- 297
Query: 156 YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRGSLP 212
+ I T GT Y + + R D LG V+MY + G LP
Sbjct: 298 -------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLP 348
Query: 213 WQGLKAGTKKQKYDKISEKKMLTPIEV 239
+ ++ ++ I +++ P +
Sbjct: 349 FYN---QDHEKLFELILMEEIRFPRTL 372
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 52/176 (29%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV--KTKHPQLHY-ESKLYMLLQG 61
+G ++ IG G++G + + VA+K S + Q E K+
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI------ 78
Query: 62 GTGVPHLKWFGVEGEYNVM-VIDLLGPSLEDLFN--YCNRKFSLKTVLMLAD-------- 110
L F E N++ + D++ + Y + LM D
Sbjct: 79 ------LLRFRHE---NIIGINDIIRAPTIEQMKDVY------IVQDLMETDLYKLLKTQ 123
Query: 111 ------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLA 153
Q++ ++Y+HS LHRD+KP N L+ + + I D+GLA
Sbjct: 124 HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 5e-08
Identities = 63/272 (23%), Positives = 100/272 (36%), Gaps = 87/272 (31%)
Query: 9 FKLGRKIGSGSFGELYL---GVNVQTGEEVAVK-------------LESVKT-------- 44
F+L R +G G +G+++ TG+ A+K K
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 45 KHP---QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN 94
KHP L Y KLY++L GG +LF
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGG----------------------------ELFM 110
Query: 95 YCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
R F T ++ + ++H +G ++RD+KP+N ++ V + D+GL
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGL 167
Query: 153 AKK--YRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FL 207
K+ + TH T GT Y + + +R D SLG LMY L
Sbjct: 168 CKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYDML 215
Query: 208 RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239
G+ P+ G +K+ DKI + K+ P +
Sbjct: 216 TGAPPFTG---ENRKKTIDKILKCKLNLPPYL 244
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 18/157 (11%)
Query: 9 FKLGRKIGSGSFGELYLGV-NVQTGEE--VAVK-LESVKTKHPQLHY----ESKLYMLLQ 60
+L K+G GSFG + G + +G+ VAVK L+ P+ E L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 61 GGTGVPHL-KWFGVEGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
+L + +GV + ++ L P SL D F L T+ A Q+ +
Sbjct: 80 H----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
Y+ S+ F+HRD+ N L+ + V I D+GL +
Sbjct: 136 YLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 7e-08
Identities = 43/240 (17%), Positives = 68/240 (28%), Gaps = 73/240 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---------------------------- 39
K + KIG G FGE++ + VA+K+
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 40 ------ESVKTKHPQLHY----------------ESKLYMLLQGGTGVPHLKWFGVEGEY 77
V + ++ + G+ +F + +
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFL- 135
V+ + G LE + SL T + QL + + F HRD+ N L
Sbjct: 139 IVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 136 ----------MGLGRKSN------QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
G+ S QV IIDY L++ RD + TG Y
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDY 255
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 39/188 (20%), Positives = 61/188 (32%), Gaps = 59/188 (31%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--LESVKTKHPQLHYESKLY--- 56
H + + + R I SGS+G + GV+ G VA+K +V
Sbjct: 17 LHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 57 -----MLLQGGTGVPHLKWFGVEGEYNVM-VIDLLGPSLEDLFN--YCNRKFSLKTVLML 108
LL H N++ + D+ E + Y L T LM
Sbjct: 76 VLREIRLLN------HFH------HPNILGLRDIFVHFEEPAMHKLY------LVTELMR 117
Query: 109 AD----------------------QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QV 145
D ++ + +H G +HRD+ P N L+ N +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173
Query: 146 YIIDYGLA 153
I D+ LA
Sbjct: 174 TICDFNLA 181
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 59/289 (20%), Positives = 118/289 (40%), Gaps = 39/289 (13%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ K+G G +GE+Y GV + VAVK L+ + + E+ + ++ P
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 276
Query: 67 HL-KWFGV--EGEYNVMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+L + GV ++ + + +L D L ++ S +L +A Q+ + +EY+
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD----LQTHKHIPYRENKNLTGTA 177
+ F+HR++ N L+G +++ V + D+GL++ P + TA
Sbjct: 337 KNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------TA 387
Query: 178 RYASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISE-KKML 234
+ S + D+ + G VL++ G P+ G+ Q Y+ + + +M
Sbjct: 388 PESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSPYPGI---DLSQVYELLEKDYRME 439
Query: 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283
P C P + C D+P ++ + + F +F
Sbjct: 440 RP--EGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 9e-08
Identities = 65/267 (24%), Positives = 107/267 (40%), Gaps = 85/267 (31%)
Query: 9 FKLGRKIGSGSFGELYL---GVNVQTGEEVAVK---------------------LESVKT 44
F+L + +G GSFG+++L + A+K L V
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN- 84
Query: 45 KHP---QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFN 94
HP +LHY E KLY++L +GG DLF
Sbjct: 85 -HPFIVKLHYAFQTEGKLYLILDFLRGG----------------------------DLFT 115
Query: 95 --YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
F+ + V +L ++++HS G ++RD+KP+N L+ + + + D+GL
Sbjct: 116 RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGL 172
Query: 153 AKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQSRRDDLESLGYVLMY-FLRG 209
+K + I + E K + GT Y + ++ D S G VLM+ L G
Sbjct: 173 SK--------ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTG 222
Query: 210 SLPWQGLKAGTKKQKYDKISEKKMLTP 236
+LP+QG +K+ I + K+ P
Sbjct: 223 TLPFQG---KDRKETMTMILKAKLGMP 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 58/274 (21%), Positives = 109/274 (39%), Gaps = 83/274 (30%)
Query: 9 FKLGRKIGSGSFGELYL---GVNVQTGEEVAVK-------------LESVKT-------- 44
F+L + +G+G++G+++L TG+ A+K E +T
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 45 -KHP---QLHY----ESKLYMLL---QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLF 93
+ P LHY E+KL+++L GG +LF
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGG----------------------------ELF 147
Query: 94 N--YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151
+F+ V + +++ +E++H G ++RDIK +N L+ + V + D+G
Sbjct: 148 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFG 204
Query: 152 LAKKYRDLQTHKHIPYRENKNLT--GTARYASVNTHLGVEQ--SRRDDLESLGYVLMY-F 206
L+K + + + GT Y + + G + + D SLG VLMY
Sbjct: 205 LSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG-VLMYEL 255
Query: 207 LRGSLPWQGLKAG-TKKQKYDKISEKKMLTPIEV 239
L G+ P+ ++ + +I + + P E+
Sbjct: 256 LTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 60/289 (20%), Positives = 117/289 (40%), Gaps = 39/289 (13%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+L K+G G FGE+++G VA+K L+ E+++ L+
Sbjct: 268 SLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH----E 322
Query: 67 HL-KWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRKF-SLKTVLMLADQLINRVEYMHSR 122
L + + V E + ++ SL D K+ L ++ +A Q+ + + Y+
Sbjct: 323 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD----LQTHKHIPYRENKNLTGTAR 178
++HRD++ N L+G ++ + D+GLA+ D + P + TA
Sbjct: 383 NYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAP 433
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYDKISEK-KMLT 235
A++ + + D+ S G +L+ +G +P+ G+ ++ D++ +M
Sbjct: 434 EAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPC 485
Query: 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQF 284
P C P C E++P + YL+ D F Q+
Sbjct: 486 P--PEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 55/317 (17%), Positives = 116/317 (36%), Gaps = 66/317 (20%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGV 65
F+ ++G+G+ G ++ + +G +A K LE Q+ E L +L +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE--LQVLHE--CNS 90
Query: 66 PHL-KWFG---VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
P++ ++G +GE + ++ + G SL+ + R + + ++ +I + Y+
Sbjct: 91 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 121 SRGF-LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARY 179
+ +HRD+KP N L+ ++ + D+G++ + D + + GT Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196
Query: 180 ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW------------------------QG 215
S G S + D+ S+G L+ G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 216 LKAGTKKQKYDKISEKKMLTPIEVLCK------------SYPSEFTSYFHYCRSLRFEDK 263
+ + + + + E+L + EF + + C ++
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 316
Query: 264 PDYSYLKRLFRDLFIRE 280
D K+L FI+
Sbjct: 317 ADL---KQLMVHAFIKR 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 34/154 (22%), Positives = 69/154 (44%), Gaps = 17/154 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+++G+G FG + G + +VA+K ++ + E+K+ M L
Sbjct: 25 DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH----E 79
Query: 67 HL-KWFGV--EGEYNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMH 120
L + +GV + ++ + + + L NY +F + +L + + +EY+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 137
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
S+ FLHRD+ N L+ V + D+GL++
Sbjct: 138 SKQFLHRDLAARNCLVN---DQGVVKVSDFGLSR 168
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 27/173 (15%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ KL + IG G FG++ LG G +VAVK E+ + L+ +
Sbjct: 22 ELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 75
Query: 68 L-KWFGV--EGEYNVMVIDLLGPSLE-----DLFNY----CNRKFSLKTVLMLADQLINR 115
L + GV E + + ++ E L +Y +L + +
Sbjct: 76 LVQLLGVIVEEKGGLYIV------TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168
+EY+ F+HRD+ N L+ + N + D+GL K+ Q +P +
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 46/175 (26%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ +LGR IG G FG+++ G+ +AV ++KT + T
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAV---AIKT--------------CKNCTSDS 58
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLE-------------DLFNY---CNRKFSLK 103
+ F E M ++ L+G E +L ++ L
Sbjct: 59 VREKF--LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLA 116
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
++++ A QL + Y+ S+ F+HRDI N L+ ++ V + D+GL++ D
Sbjct: 117 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 168
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 40/167 (23%), Positives = 69/167 (41%), Gaps = 15/167 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ KL + IG G FG++ LG G +VAVK E+ + L+ +
Sbjct: 194 ELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 247
Query: 68 L-KWFGV--EGEYNVMVIDLLGP--SLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
L + GV E + + ++ SL D L + +L + + +EY+
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168
F+HRD+ N L+ + N + D+GL K+ Q +P +
Sbjct: 308 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 2e-07
Identities = 35/157 (22%), Positives = 69/157 (43%), Gaps = 17/157 (10%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPH 67
++IGSG FG ++LG ++VA+K + E+++ M L P
Sbjct: 10 LTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH----PK 64
Query: 68 L-KWFGV--EGEYNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHS 121
L + +GV E +V + + L +Y F+ +T+L + + + Y+
Sbjct: 65 LVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+HRD+ N L+G ++ + + D+G+ + D
Sbjct: 123 ACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQ-LHYESKLYMLLQGGTGVP 66
+ K+G G +GE+Y GV + VAVK T + E+ + ++ P
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 69
Query: 67 HL-KWFGV--EGEYNVMVIDLLGPSLEDLFNY---CNRK-FSLKTVLMLADQLINRVEYM 119
+L + GV ++ + + + +L +Y CNR+ S +L +A Q+ + +EY+
Sbjct: 70 NLVQLLGVCTREPPFYIITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
+ F+HRD+ N L+G +++ V + D+GL++
Sbjct: 128 EKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 49/177 (27%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
L R +G G FGE+Y GV GE++ V +VKT ++K +
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINV---AVKTCKKDCTLDNKEKFM-------- 61
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLE-------------DLFNY---CNRKFSLK 103
E +M ++ L+G E +L +Y +
Sbjct: 62 --------SEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVL 113
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160
T+++ + Q+ + Y+ S +HRDI N L+ V + D+GL+ R ++
Sbjct: 114 TLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS---RYIE 164
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 42/169 (24%), Positives = 64/169 (37%), Gaps = 43/169 (25%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
FK + +GSG+FG +Y G+ + GE+V + + ++K L+ T
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKE--------------LREATSPKAN 61
Query: 69 KWFGVEGEYNVM-------VIDLLGPSLE-------------DLFNY---CNRKFSLKTV 105
K E VM V LLG L L +Y + +
Sbjct: 62 KEI--LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 119
Query: 106 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
L Q+ + Y+ R +HRD+ N L+ V I D+GLAK
Sbjct: 120 LNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 34/176 (19%), Positives = 72/176 (40%), Gaps = 47/176 (26%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ + +G+G FGE+ G + + +E++V ++KT L+ G
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISV---AIKT--------------LKVGYTEK 88
Query: 67 HLKWFGVEGEYNVM-------VIDLLG------P-----------SLEDLFNYCNRKFSL 102
+ F GE ++M +I L G P SL+ + +F++
Sbjct: 89 QRRDF--LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV 146
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
++ + + + ++Y+ G++HRD+ N L+ + + D+GL + D
Sbjct: 147 IQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 26/135 (19%), Positives = 65/135 (48%), Gaps = 16/135 (11%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGVPHL-K 69
+IG G++G + V+ +G+ +AVK + + QL + L ++++ + P++ +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD--LDVVMR-SSDCPYIVQ 85
Query: 70 WFG---VEGEYNVMVIDLLGPSLEDL----FNYCNRKFSLKTVLMLADQLINRVEYMHS- 121
++G EG+ + ++L+ S + ++ + + + + + + ++
Sbjct: 86 FYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 122 RGFLHRDIKPDNFLM 136
+HRDIKP N L+
Sbjct: 145 LKIIHRDIKPSNILL 159
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 32/159 (20%), Positives = 64/159 (40%), Gaps = 21/159 (13%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKTKHPQLHY-----ESKLYML 58
+ + + +GSG FG ++ GV + GE V +K ++ K + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIK--VIEDKSGRQSFQAVTDHMLAIGS 71
Query: 59 LQGGTGVPHL-KWFGVEGEYNVMVIDLLGP--SLEDLFNYCNRKFSLKTVLMLADQLINR 115
L H+ + G+ ++ ++ P SL D + +L Q+
Sbjct: 72 LDH----AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+ Y+ G +HR++ N L+ +QV + D+G+A
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGV 65
KL +K+G+G FGE+++ N T +VAVK ++ E+ + LQ
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 66 PHL-KWFGVEGEYNVMVIDLLGP--SLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
L K V + + +I SL D L + K L ++ + Q+ + ++
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
R ++HRD++ N L+ S I D+GLA+ D
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLARVIED 336
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 29/134 (21%), Positives = 62/134 (46%), Gaps = 15/134 (11%)
Query: 14 KIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTGVPHL-K 69
++G G++G + +V +G+ +AVK + +L + L + ++ P
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD--LDISMR-TVDCPFTVT 70
Query: 70 WFG---VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLA---DQLINRVEYMHS-R 122
++G EG+ + ++L+ SL+ + K +L ++ +E++HS
Sbjct: 71 FYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 123 GFLHRDIKPDNFLM 136
+HRD+KP N L+
Sbjct: 130 SVIHRDVKPSNVLI 143
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 37/160 (23%), Positives = 70/160 (43%), Gaps = 20/160 (12%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ L +++GSG FG + LG + +VAVK ++ + E++ M L P
Sbjct: 9 EITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH----P 63
Query: 67 HL-KWFGV--EGEYNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMH 120
L K++GV + +V + + S L NY + +L + + + ++
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160
S F+HRD+ N L+ + V + D+G+ R +
Sbjct: 122 SHQFIHRDLAARNCLVD---RDLCVKVSDFGMT---RYVL 155
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 35/168 (20%), Positives = 59/168 (35%), Gaps = 47/168 (27%)
Query: 11 LGRKIGSGSFGELYLGV-NVQTGE-EVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
+++GSG+FG + G ++ VAVK +L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVK------------------ILKNEANDPALK 62
Query: 69 KWFGVEGEYNVM-------VIDLLGPSLE-------------DLFNY--CNRKFSLKTVL 106
E NVM ++ ++G L Y NR K ++
Sbjct: 63 DEL--LAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
L Q+ ++Y+ F+HRD+ N L+ + I D+GL+K
Sbjct: 121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 31/181 (17%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEE---VAVKLESVKTKHPQLHYESKLY-MLLQGGTGV 65
IG G FG +Y G + + AVK S+ L ++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 66 PH-LKWFGV--EGEYNVMVIDLLGPSLE-----DLFNY---CNRKFSLKTVLMLADQLIN 114
P+ L G+ E + +V+ L DL N+ ++K ++ Q+
Sbjct: 86 PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 139
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174
++Y+ S+ F+HRD+ N ++ + V + D+GLA RD+ + Y +
Sbjct: 140 GMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDM--YDKEYYSVHNKTG 191
Query: 175 G 175
Sbjct: 192 A 192
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 39/175 (22%), Positives = 71/175 (40%), Gaps = 46/175 (26%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ +LGR IG G FG+++ G+ +AV ++KT + T
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAV---AIKT--------------CKNCTSDS 433
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLE-------------DLFNY---CNRKFSLK 103
+ F E M ++ L+G E +L ++ L
Sbjct: 434 VREKF--LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLA 491
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
++++ A QL + Y+ S+ F+HRDI N L+ ++ V + D+GL++ D
Sbjct: 492 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 29/174 (16%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEE---VAVKLESVKTKHPQLHYESKLY-MLLQGGTGV 65
IG G FG +Y G + + AVK S+ L ++
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK--SLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 66 PH-LKWFGV--EGEYNVMVIDLLGPSLE-----DLFNY---CNRKFSLKTVLMLADQLIN 114
P+ L G+ E + +V+ L DL N+ ++K ++ Q+
Sbjct: 150 PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK 203
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168
++++ S+ F+HRD+ N ++ + V + D+GLA RD+ +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDMYDKEFDSVH 251
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 39/159 (24%), Positives = 71/159 (44%), Gaps = 27/159 (16%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGV 65
KL ++G+G FGE+++G N T +VAVK L+ E+ L LQ
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 66 PHL-KWFGVEGEYNVMVIDLLGPSLE-----DLFNY----CNRKFSLKTVLMLADQLINR 115
L + + V + + +I E L ++ K ++ +L +A Q+
Sbjct: 68 QRLVRLYAVVTQEPIYII------TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
+ ++ R ++HRD++ N L+ + I D+GLA+
Sbjct: 122 MAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLAR 157
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 32/175 (18%), Positives = 63/175 (36%), Gaps = 47/175 (26%)
Query: 9 FKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ + IGSG GE+ G V +V V ++K L+ G
Sbjct: 51 IHIEKIIGSGDSGEVCYGRLRVPGQRDVPV---AIKA--------------LKAGYTERQ 93
Query: 68 LKWFGVEGEYNVM-------VIDLLG------P--------SLEDLFNY---CNRKFSLK 103
+ F E ++M +I L G L + + +F++
Sbjct: 94 RRDF--LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
++ + + + Y+ G++HRD+ N L+ + + D+GL++ D
Sbjct: 152 QLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 39/191 (20%), Positives = 73/191 (38%), Gaps = 55/191 (28%)
Query: 10 KLGRKIGSGSFGELYLGVNVQTGEE---VAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
R IG G FG +Y G + + A+K S+ E+ L+
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIK--SLSRITEMQQVEA----FLR------ 71
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLE---------------DLFNY---CNRKFS 101
E +M V+ L+G L DL + R +
Sbjct: 72 ---------EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
+K ++ Q+ +EY+ + F+HRD+ N ++ +S V + D+GLA RD+
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLA---RDILD 176
Query: 162 HKHIPYRENKN 172
++ +++++
Sbjct: 177 REYYSVQQHRH 187
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 28/164 (17%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEE---VAVKL---ESVKTKHPQLHYESKLYMLLQ 60
+ IG+G FGE+Y G+ +G++ VA+K + + E+ +
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 61 GGTGVPHL-KWFGV--EGEYNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLIN 114
++ + GV + + +++ + + L + + +FS+ ++ + +
Sbjct: 105 H----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158
++Y+ + ++HRD+ N L+ + + D+GL++ D
Sbjct: 159 GMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 40/191 (20%), Positives = 66/191 (34%), Gaps = 60/191 (31%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
+F LGR +G G FG + + G V V +VK + S + L+
Sbjct: 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKV---AVKMLKADIIASSDIEEFLR------ 74
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLE--------------------DLFNY---- 95
E M V L+G SL DL +
Sbjct: 75 ---------EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 96 ----CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151
L+T++ + +EY+ SR F+HRD+ N ++ + V + D+G
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFG 182
Query: 152 LAKKYRDLQTH 162
L+ R + +
Sbjct: 183 LS---RKIYSG 190
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 29/181 (16%), Positives = 62/181 (34%), Gaps = 27/181 (14%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGE-------EVAVK-LESVKTKHPQ-LHYESKLYML 58
+G G+F +++ GV + G+ EV +K L+ + + + +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 59 LQGGTGVPHL-KWFGV--EGEYNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQL 112
L HL +GV G+ N++V + + L Y ++ L +A QL
Sbjct: 69 LSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 113 INRVEYMHSRGFLHRDIKPDNFL-----MGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
+ ++ +H ++ N L + + D G++ +
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ-ERI 181
Query: 168 R 168
Sbjct: 182 P 182
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 40/187 (21%), Positives = 65/187 (34%), Gaps = 59/187 (31%)
Query: 8 KFKLGRKIGSGSFGELYLGV-NVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
LG+ +G G FG + G + G + V +VKT + ++ L
Sbjct: 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKV---AVKTMKLDNSSQREIEEFLS------ 85
Query: 67 HLKWFGVEGEYNVM-------VIDLLGPSLE-------------------DLFNY----- 95
E M VI LLG +E DL Y
Sbjct: 86 ---------EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR 136
Query: 96 ---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
+ L+T+L + +EY+ +R FLHRD+ N ++ V + D+GL
Sbjct: 137 LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGL 193
Query: 153 AKKYRDL 159
+ + +
Sbjct: 194 S---KKI 197
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 32/152 (21%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEE--VAVKL---ESVKTKHPQLHYESKLYMLLQGGTGV 65
++G G+FG + GV ++ VA+K+ + K ++ E+++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PHL-KWFGVEGEYNVMVIDLL--GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
P++ + GV +M++ + G L + + V L Q+ ++Y+ +
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
F+HR++ N L+ + I D+GL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 32/169 (18%), Positives = 66/169 (39%), Gaps = 42/169 (24%)
Query: 8 KFKLGR-KIGSGSFGELYLGV-NVQTGE-EVAVK--------------LESVKT----KH 46
+ ++G G+FG + GV ++ + +VA+K + + +
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 47 PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTV 105
P + +L GV + E ++V+++ G L + + V
Sbjct: 70 PYI---VRLI-------GV-------CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 112
Query: 106 LMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
L Q+ ++Y+ + F+HRD+ N L+ + I D+GL+K
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/201 (18%), Positives = 65/201 (32%), Gaps = 61/201 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGV--NVQTGEE---VAVKLESVKTKHPQLHYESKLYMLLQGG 62
L R +G G+FGE+Y G + VAVK ++ E L
Sbjct: 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCS----EQDELDFLM-- 82
Query: 63 TGVPHLKWFGVEGEYNVM-------VIDLLGPSLE--------------DLFNY------ 95
E ++ ++ +G SL+ DL ++
Sbjct: 83 -------------EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRP 129
Query: 96 ---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
++ +L +A + +Y+ F+HRDI N L+ I D+G+
Sbjct: 130 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189
Query: 153 AKK-----YRDLQTHKHIPYR 168
A+ Y +P +
Sbjct: 190 ARDIYRASYYRKGGCAMLPVK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 2e-05
Identities = 39/253 (15%), Positives = 77/253 (30%), Gaps = 51/253 (20%)
Query: 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142
D+L ED F F K V + ++++ E H L K
Sbjct: 20 DIL-SVFEDAFV---DNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 143 NQVYI--------IDYG-----LAKKYRD--LQTHKHIPYRENKNLTGTARYA--SVNTH 185
++ I+Y + + R + T +I R ++ +A +V+
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR-DRLYNDNQVFAKYNVSRL 134
Query: 186 LGVEQSRRDDLESL---GYVLMYFLRGS----LPWQGLKA-GTKKQKYDKI--------- 228
+ R L L VL+ + GS + + + + KI
Sbjct: 135 QPYLK-LRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF------RDLFIREGY 282
S + +L ++ L +TS + +++ + L+RL L +
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV---- 249
Query: 283 QFDYVFDWTILKY 295
V +
Sbjct: 250 -LLNVQNAKAWNA 261
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 3e-04
Identities = 47/307 (15%), Positives = 88/307 (28%), Gaps = 100/307 (32%)
Query: 28 NVQTGEEVAVKLESVKTKHPQLHYESKLYML-------LQG--GTGVPHLKWFGVEGEYN 78
+ +V K +V P L L L + G G+G K
Sbjct: 118 RLYNDNQVFAKY-NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG----KT-------- 164
Query: 79 VMVID-LLGPSLEDLFNY---------CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRD 128
+ +D L ++ ++ CN +TVL + +L+ +++ + H
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSP---ETVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 129 IKPDNFLMGLGRKSNQVYIIDYGLAKKY-------RDLQTHKHIPYREN--KNLTGTARY 179
+ +K Y ++Q K K L T R+
Sbjct: 222 NIKLRIHSIQAELRRLL------KSKPYENCLLVLLNVQNAKAWNAFNLSCKILL-TTRF 274
Query: 180 ASVNTHLGVEQSRRDDL----------ESLGYVLMYFLR---GSLPWQGLK--------- 217
V L + L E +L+ +L LP + L
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKS-LLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 218 AGTKK------QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271
A + + + ++ K+ T IE SL + +Y ++
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIES-----------------SLNVLEPAEY---RK 373
Query: 272 LFRDLFI 278
+F L +
Sbjct: 374 MFDRLSV 380
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 37/201 (18%), Positives = 65/201 (32%), Gaps = 61/201 (30%)
Query: 8 KFKLGRKIGSGSFGELYLGV--NVQTGEE---VAVKLESVKTKHPQLHYESKLYMLLQGG 62
L R +G G+FGE+Y G + VAVK ++ E L
Sbjct: 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVK--TLPEVCS----EQDELDFLM-- 123
Query: 63 TGVPHLKWFGVEGEYNVM-------VIDLLGPSLE--------------DLFNY------ 95
E ++ ++ +G SL+ DL ++
Sbjct: 124 -------------EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 170
Query: 96 ---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152
++ +L +A + +Y+ F+HRDI N L+ I D+G+
Sbjct: 171 RPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230
Query: 153 AKK-----YRDLQTHKHIPYR 168
A+ Y +P +
Sbjct: 231 ARDIYRAGYYRKGGCAMLPVK 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 38/176 (21%), Positives = 82/176 (46%), Gaps = 31/176 (17%)
Query: 8 KFKLGRKIGSGSFGELYLGV--NVQTGEE---VAVK-LESVKTKHPQLHYESKLYMLLQG 61
K + R++G GSFG +Y GV V E VA+K + + ++ + ++ ++ +
Sbjct: 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 85
Query: 62 GTGVPHL-KWFGV--EGEYNVMVI------DLL------GPSLEDLFNYCNRKFSLKTVL 106
H+ + GV +G+ ++++ DL P++ + N SL ++
Sbjct: 86 NC--HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLAPPSLSKMI 141
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
+A ++ + + Y+++ F+HRD+ N ++ + V I D+G+ RD+
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMT---RDIYET 191
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 41/212 (19%), Positives = 72/212 (33%), Gaps = 76/212 (35%)
Query: 8 KFKLGRKIGSGSFGELYLG--VNVQTGEE---VAVKLESVKTKHPQLHYESKLYMLLQGG 62
+ G+ +G+G+FG++ + + VAVK +K E+ L+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK--MLKPSAHLTEREA----LMS-- 75
Query: 63 TGVPHLKWFGVEGEYNVM--------VIDLLG------PSL---E-----DLFNY----- 95
E V+ +++LLG P+L E DL N+
Sbjct: 76 -------------ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122
Query: 96 ---------------CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 140
L+ +L + Q+ + ++ S+ +HRD+ N L+
Sbjct: 123 DSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT--- 179
Query: 141 KSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172
I D+GLA RD+ Y N
Sbjct: 180 HGRITKICDFGLA---RDI--KNDSNYVVKGN 206
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 36/179 (20%)
Query: 10 KLGRKIGSGSFGELYLGV--NVQTGEE---VAVKL--ESVKTKHPQLHYESKLYMLLQGG 62
L R++G G+FG+++L N+ ++ VAVK + E++L LQ
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH- 76
Query: 63 TGVPHL-KWFGV--EGEYNVMVI------DLL------GPSLEDLFNYCNR----KFSLK 103
H+ K++GV +G+ +MV DL GP L + R + L
Sbjct: 77 ---EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 104 TVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
+L +A Q+ + + Y+ S+ F+HRD+ N L+G + V I D+G++ RD+ +
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---RDVYST 186
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 39/196 (19%), Positives = 70/196 (35%), Gaps = 70/196 (35%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEE-----VAVKLESVKTKHPQLHYESKLYMLLQGG 62
+ G+ +G+G+FG++ G+E VAVK +K+ E+ L+
Sbjct: 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVK--MLKSTAHADEKEA----LMS-- 98
Query: 63 TGVPHLKWFGVEGEYNVM--------VIDLLGPSLE--------------DLFNY----- 95
E +M +++LLG DL N+
Sbjct: 99 -------------ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKS 145
Query: 96 -----------CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ 144
N S + +L + Q+ + ++ S+ +HRD+ N L+ +
Sbjct: 146 RVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHV 202
Query: 145 VYIIDYGLAKKYRDLQ 160
I D+GLA RD+
Sbjct: 203 AKIGDFGLA---RDIM 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 40/178 (22%), Positives = 72/178 (40%), Gaps = 38/178 (21%)
Query: 8 KFKLGRKIGSGSFGELYLG--VNVQTGEE---VAVKLESVKTKHPQLHYE---SKLYMLL 59
+ KLG+ +G G+FG++ + VAVK +K + S+L +L+
Sbjct: 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVK--MLKEGATHSEHRALMSELKILI 85
Query: 60 QGGTGVPH---LKWFGV--EGEYNVMVI-------DLL----------GPSLEDLFNYCN 97
G H + G + +MVI +L P +
Sbjct: 86 HIG---HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 98 RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155
+L+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D+GLA+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARD 197
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 31/173 (17%)
Query: 10 KLGRKIGSGSFGELYLGV--NVQTGEE---VAVKLESVKTKHPQLHYESKLYMLLQGGTG 64
L ++G G+FG+++L N+ ++ VAVK ++ + ++ + +L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH- 102
Query: 65 VPHL-KWFGV--EGEYNVMVI------DLL---------GPSLEDLFNYCNRKFSLKTVL 106
H+ ++FGV EG +MV DL L + L +L
Sbjct: 103 -QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 107 MLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159
+A Q+ + Y+ F+HRD+ N L+G + V I D+G++ RD+
Sbjct: 162 AVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVVKIGDFGMS---RDI 208
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 64/187 (34%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
F IG G FG++Y GV ++ G +VA+K + ES QG +
Sbjct: 41 FDHKFLIGHGVFGKVYKGV-LRDGAKVALK---------RRTPESS-----QG------I 79
Query: 69 KWFGVEGEYNVMVIDLLG----PSLEDLFNYCNRKFSLKTV--LM----LADQLINRV-- 116
+ F E I+ L P L L +C+ + + + M L L
Sbjct: 80 EEFETE-------IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 117 --------------------EYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
Y+H+R +HRD+K N L+ ++ I D+G++KK
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD---ENFVPKITDFGISKKG 189
Query: 157 RDL-QTH 162
+L QTH
Sbjct: 190 TELDQTH 196
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 8e-04
Identities = 39/190 (20%), Positives = 71/190 (37%), Gaps = 38/190 (20%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEE--VAVKLESVKTKHPQLHYE---SKLYMLLQGG 62
K IG G+FG++ + G A+K +K + + +L +L + G
Sbjct: 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK--RMKEYASKDDHRDFAGELEVLCKLG 83
Query: 63 TGVPH---LKWFGV--EGEYNVMVI------DLL----------GPSLEDLFNYCNRKFS 101
H + G Y + I +LL + N S
Sbjct: 84 ---HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK---YRD 158
+ +L A + ++Y+ + F+HRD+ N L+G ++ I D+GL++ Y
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYV- 196
Query: 159 LQTHKHIPYR 168
+T +P R
Sbjct: 197 KKTMGRLPVR 206
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 465 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.6 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.46 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.85 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.55 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.14 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.64 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.51 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.68 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-74 Score=601.99 Aligned_cols=460 Identities=62% Similarity=0.997 Sum_probs=278.4
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
|+.+++++|+++++||+|+||.||+|++..+++.||||++.......++..|++++..|+|+++++.+.+++.+..+.+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 78999999999999999999999999999999999999999888888999999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++++++|.+++..+.+.+++.+++.|+.||+.||+|||++||+||||||+||||+.++.++.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999878899999999999999999999999999999999999999655578999999999999887766
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....++.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.......+.+..+.........+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 66666777778899999999999999999999999999999999999999999999888888999998888888888889
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCCCCCCC-CCCC-CCCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRSRPSGK-PNLN-PAGPS 318 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~ 318 (465)
+..+|+++.+||..||..+|++||++.+|.++|++++.+.+++++..+||+..+..+......+..... ...+ +..+.
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~~~ 320 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLAPP 320 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCCCc
Confidence 999999999999999999999999999999999999999999999999999987665443332221111 1111 11122
Q ss_pred cccCCCCC-ccccccccCcccccccccCCCCCCcCCCCCCCCCC--CCCCCCCCCCCCCCCCCccccCCcccccccccCC
Q 012336 319 AERVERPS-GQEVRDRFAGGIEAFARRNTSGHGLHGDHSRHKSS--DDVPSSKDVQPDSERPRSLSRNSSSLKRAIMSGG 395 (465)
Q Consensus 319 ~~~~~~~~-~~~~~~~~~G~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (465)
...+++++ .++. +.+|....-.++..+...++|..+++++| .+++.+++.+.++ +....|+.|++|+.++|+|
T Consensus 321 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 396 (483)
T 3sv0_A 321 ALQNDRQSGVDEG--RTSGWSSMDRRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISA--SNFLGRSSGSSRRPAVSSS 396 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccCccccc--cccCCcccccccCCcccccccccccccCCCCCCccccccccccc--cccccccCCcccccccccc
Confidence 22333333 3333 33343332356666777888899999998 6667788887777 6667899999999999999
Q ss_pred CCCCCCCCCC-CCCcccccCCCC-CCCCCCcccCCC--CCCccccccCCCCCCCCccccccccccccccCCCC
Q 012336 396 RPSSSGDHSD-NRSGRLVSGSGS-GRLSTTQRAQPG--YESKSSSFSRGAATRSGRDDALRSFELLTIGSGKR 464 (465)
Q Consensus 396 ~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (465)
|++..++..+ +++++..+++|+ .|.+++||.+|. +++|+++++|++++++|||++||+||+|+|++|+|
T Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (483)
T 3sv0_A 397 RDVMPIDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDER 469 (483)
T ss_dssp -------------------------------------------------------------------------
T ss_pred ccccCCCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccccHHHHhhhhhhcccCCchH
Confidence 9985554455 778888888888 788888999887 69999999999999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=429.58 Aligned_cols=267 Identities=21% Similarity=0.309 Sum_probs=225.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.++|++++.||+|+||+||+|++..+++.||||++... .....+.+|+++++.|+|+++|..+..| .+....||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCEEEE
Confidence 46799999999999999999999999999999998743 3345689999999999987766666555 56678899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||||+ ||+|.+++.. .+.|++.++..|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 8899999985 4679999999999999999999999999999999999999 58899999999999876543
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
... ....+++||+.|||||++.+..|+.++|||||||+||||++|..||.+. +..+.+..+.......+
T Consensus 186 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~p--- 254 (311)
T 4aw0_A 186 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYDFP--- 254 (311)
T ss_dssp TTC-----CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCC---
T ss_pred CCc-----ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC---
Confidence 221 2345679999999999999999999999999999999999999999873 45566666666555444
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++++.+||.+||.+||++||+++++. ...+. ..++|+..+||..+.
T Consensus 255 --~~~s~~~~dli~~lL~~dp~~R~t~~e~~---~~~~i-~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 255 --EKFFPKARDLVEKLLVLDATKRLGCEEME---GYGPL-KAHPFFESVTWENLH 303 (311)
T ss_dssp --TTCCHHHHHHHHHHSCSSGGGSTTSGGGT---CHHHH-HTSGGGTTCCCTTGG
T ss_pred --cccCHHHHHHHHHHccCCHhHCcChHHHc---CCHHH-HCCCCcCCCCHHHhc
Confidence 46799999999999999999999977653 22222 237888899999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=409.61 Aligned_cols=294 Identities=74% Similarity=1.340 Sum_probs=261.1
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+..|+.++..+.|+++++.+..+...+...++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 56778999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+|++++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+..++.++.+||+|||+++......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998777889999999999999999999999999999999999999544578899999999999877665
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 55555566667889999999999999999999999999999999999999999987776666777777777777888888
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+..+|+++.+++..||+.||++||++.+|.+.|++++.+.+..+++.+||+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 889999999999999999999999999999999999999999999999999764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=411.69 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=201.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|+++|..+..+ .+....|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-KSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EECCEEEEE
Confidence 68999999999999999999999999999999987542 223588999999999987766666554 566788999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|||++++|.+++.. .+.+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 92 mEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 92 IEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCC-
Confidence 99999999999976 5689999999999999999999999999999999999999 588999999999998754322
Q ss_pred cccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
...+.+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+. ...+.+..+.......+
T Consensus 167 -------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~~p---- 232 (275)
T 3hyh_A 167 -------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYTLP---- 232 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCCC----
T ss_pred -------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCCC----
Confidence 2345789999999999998886 58999999999999999999999873 44555556655554433
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
..+++++.+||.+||+.||++|||+++ +|++.|.+...+
T Consensus 233 -~~~s~~~~~li~~~L~~dP~~R~s~~e---il~hpw~k~~~p 271 (275)
T 3hyh_A 233 -KFLSPGAAGLIKRMLIVNPLNRISIHE---IMQDDWFKVDLP 271 (275)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHH---HHHCHHHHTTCC
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHH---HHcCcccccCCC
Confidence 457999999999999999999999555 567888776543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-52 Score=406.22 Aligned_cols=294 Identities=74% Similarity=1.340 Sum_probs=266.6
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
|+..++++|++++.||+|+||.||+|++..+++.||||++........+..|+.++..+.|+++++.+..+...+...++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 56778999999999999999999999999999999999998877778899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+|++++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++..+.++.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998777789999999999999999999999999999999999999655578899999999998877655
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....++.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.......+.+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 54445555667788999999999999999999999999999999999999999987766666666777777777777788
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
+..+|+++.+++..||+.||++||++.+|.+.|++++.+.+.+.+..+||+.++
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGCC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 889999999999999999999999999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=423.40 Aligned_cols=253 Identities=18% Similarity=0.271 Sum_probs=210.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++|+++|..+..| .+.+..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEEeC
Confidence 56999999999999999999999999999999987543 345689999999999987766666555 566788999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
| ||+|.+++.. ..+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 8899999974 579999999999999999999999999999999999999 5889999999999987654321
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
...+++||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+........ .....
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~~--~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRL--KNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCCC--SCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCC--Ccccc
Confidence 235678999999999999999999999999999999999999999874 33444544444322111 12246
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+++++.+||..||..||++||++++| |++.|.+.
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~---l~Hp~~~~ 329 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAEL---LKHPFLAK 329 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH---TTCGGGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH---hcCHhhcC
Confidence 79999999999999999999996655 55555443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-53 Score=421.44 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=213.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
+.|++.++||+|+||+||+|++..+|+.||||+++.+. ...+|+.++..|+|+++|..+..| .++...||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~---~~~~E~~il~~l~HpnIV~l~~~~-~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSSPRIVPLYGAV-REGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCTHHHHTTTTCCCTTBCCEEEEE-EETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH---hHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEEeccC
Confidence 57999999999999999999999999999999998653 235799999999987777766554 5677889999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC-cEEEEecCCccccccccCccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~-~vkL~DFGla~~~~~~~~~~~ 164 (465)
|++|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+||||+ .++ .+||+|||+|+.+.......
T Consensus 134 gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~- 208 (336)
T 4g3f_A 134 GGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGK- 208 (336)
T ss_dssp TCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCccc-
Confidence 8999999986 46799999999999999999999999999999999999994 565 69999999998765432211
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
.......++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.........+ .... .+...+...+
T Consensus 209 -~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~~~~--~~~~~~~~~~ 282 (336)
T 4g3f_A 209 -SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI---ASEP--PPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH---HHSC--CGGGGSCTTS
T ss_pred -ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH---HcCC--CCchhcCccC
Confidence 112234578999999999999999999999999999999999999999886655544333 2222 1222334578
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
++++.+||.+||.+||++||++.+|.+.|...+...+
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999888776654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=413.51 Aligned_cols=287 Identities=60% Similarity=1.074 Sum_probs=260.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+++++|++++.||+|+||.||+|++..+++.||||++........+..|+.+++.+.+|++|+.+..++..+...++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46789999999999999999999999999999999999877777789999999999966677777777778888999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc-----EEEEecCCccccc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ-----VYIIDYGLAKKYR 157 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~-----vkL~DFGla~~~~ 157 (465)
++++++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||+. .++. +||+|||+++.+.
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999997778899999999999999999999999999999999999994 5555 9999999999877
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
........++.......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 66555555666667889999999999999999999999999999999999999999998878888888888887777888
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
+..+..+| ++.+++..||..||.+||++.+|.+.|++++.+.+...+..+||...
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 296 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGK 296 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTTS
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCCC
Confidence 88888888 99999999999999999999999999999999999999999999843
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=424.94 Aligned_cols=253 Identities=22% Similarity=0.243 Sum_probs=206.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.|+|+++|..+..| .+....||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-EENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-EECCEEEEEE
Confidence 5899999999999999999999999999999998765432 3588999999999987777666555 5677889999
Q ss_pred ecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||| ||+|.+++.... ..+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 899999997543 458999999999999999999999999999999999999 588999999999998764321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. ...+.+..+........
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~~---- 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPPV---- 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCC----
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCC----
Confidence 1 123568999999999999999999999999999999999999999874 44555555555443221
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+|+++.+||.+||.+||++||++++| |++.|...
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~~ 282 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIAK 282 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHH---hcCHHhhc
Confidence 24679999999999999999999996655 56666554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=418.53 Aligned_cols=263 Identities=22% Similarity=0.336 Sum_probs=210.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
.++|++++.||+|+||+||+|++. .+++.||||+++... ....+..|+.++..++|+++|..+..| .+....
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-QTEGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-EETTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-EECCEE
Confidence 468999999999999999999974 367899999987532 233578899999999887766666555 566788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
||||||+ ||+|.+++.. .+.+++.++..|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 102 ~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC--
T ss_pred EEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceecc
Confidence 9999999 8999999985 5689999999999999999999999999999999999999 588999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ....+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+..+.......+
T Consensus 178 ~~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~p- 246 (304)
T 3ubd_A 178 DHE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLGMP- 246 (304)
T ss_dssp ----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC-
T ss_pred CCC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCCCC-
Confidence 322 1234678999999999999999999999999999999999999999874 44555555555544433
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
..+++++.+||.+||..||++||++. .+.++++ ++|+..+||..+..
T Consensus 247 ----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~-------Hp~f~~idw~~l~~ 295 (304)
T 3ubd_A 247 ----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR-------HSFFSTIDWNKLYR 295 (304)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT-------SGGGTTCCHHHHHT
T ss_pred ----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc-------CccccCCCHHHHHh
Confidence 45799999999999999999999852 1333333 66777789987653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=427.01 Aligned_cols=253 Identities=18% Similarity=0.270 Sum_probs=211.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++|+++++||+|+||.||+|++..+|+.||||++.... ....+.+|+.+|+.|+|+++|..+..| .+.+.+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY-LVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEE-EECCEEEEEEeC
Confidence 57999999999999999999999999999999987543 334688999999999987777666665 456688999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
| ||+|.+++.. +.+++.++..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 8899999974 579999999999999999999999999999999999999 5889999999999987654321
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
...+++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.. ..+.+..+........ .....
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~~--~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPRL--KNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCC--SCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCCC--ccccc
Confidence 2356789999999999999999999999999999999999999998743 3444444444322111 12246
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+++++.+||..||..||++||++.+| |++.|...
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~el---l~Hp~~~~ 406 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAEL---LKHPFLAK 406 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH---TTCGGGGG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH---hcCHHhcC
Confidence 79999999999999999999996654 55555444
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=398.18 Aligned_cols=291 Identities=55% Similarity=0.988 Sum_probs=260.8
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.+++++|++++.||+|+||.||+|++..+++.||||++........+..|+.++..+.++++++.+..++......+++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 56889999999999999999999999999999999999987777788999999999998778888888888888999999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC--CCCCcEEEEecCCccccccc
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG--RKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~--d~~~~vkL~DFGla~~~~~~ 159 (465)
|++++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+..+ +....+||+|||++......
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999999999999777789999999999999999999999999999999999999521 12234999999999987765
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
......++.......||+.|+|||++.+..++.++||||||+++|||++|..||.+.......+.+..+.......+...
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 55444555566778899999999999999999999999999999999999999999877777777777777777777777
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTI 292 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 292 (465)
.+..+|+++.+++..||..||++||++.+|.+.|++++.+.+...+..+||+.
T Consensus 245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 88899999999999999999999999999999999999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=411.26 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=214.8
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+|-.++|.+.+.||+|+||+||+|++. .++..||||+++.... ...+.+|++++.+|+|+|+|..++.|. ++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-EG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-eC
Confidence 455689999999999999999999875 3578999999875432 246889999999999888777777664 45
Q ss_pred cEEEEEEecc-CCCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYC------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
...+|||||+ +|+|.+++... ...|++.+++.|+.||+.||+|||+++||||||||+|||+ +.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCC
Confidence 6788999999 99999999753 2469999999999999999999999999999999999999 588
Q ss_pred CcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCch
Q 012336 143 NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (465)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~ 221 (465)
+.+||+|||+|+....... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus 165 ~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--- 236 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--- 236 (299)
T ss_dssp GCEEECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred CcEEECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 9999999999987644322 122345679999999999999999999999999999999998 9999988543
Q ss_pred HHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 222 KQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+.+..+........ ...+|+++.+||..||+.||++||++.+|.+.|+++....
T Consensus 237 ~~~~~~i~~~~~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 237 NEVIECITQGRVLQR----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 455555554433222 1457999999999999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=406.56 Aligned_cols=248 Identities=21% Similarity=0.294 Sum_probs=204.1
Q ss_pred cCCce-EEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEe---Cc
Q 012336 5 IGGKF-KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVE---GE 76 (465)
Q Consensus 5 ~~~~y-~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~---~~ 76 (465)
..++| ++.++||+|+||+||+|++..++..||||++...... ..+.+|+.+++.|+|+|+|..+..|... ..
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 34566 7889999999999999999999999999998754322 3588999999999999988888877542 45
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
..||||||+ ||+|.+++.. .+.+++..+..|+.||+.||+|||++| ||||||||+|||+. +.++.+||+|||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla 179 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence 689999999 8999999985 568999999999999999999999998 99999999999994 24789999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
+..... ...+.+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.. ...+.+..+.....
T Consensus 180 ~~~~~~---------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~ 247 (290)
T 3fpq_A 180 TLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVK 247 (290)
T ss_dssp GGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCC
T ss_pred EeCCCC---------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCC
Confidence 754321 2345789999999999875 69999999999999999999999997643 23344444443322
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ......+++++.+||..||..||++||++.+|.
T Consensus 248 ~---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 248 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred C---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2 122355789999999999999999999976653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=410.24 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=204.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
|-.++|++.++||+|+||+||+|++. ..||||+++..... ..+.+|+.++.+++|+|+|..++++. + ...+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~-~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K-DNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-SSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C-CeEE
Confidence 34578999999999999999999853 46999998754322 35889999999999999888776553 3 3468
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|||||+ +|+|.+++......+++.+++.|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceeccc
Confidence 999999 899999998666789999999999999999999999999999999999999 5889999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.... ......+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+.. ......+.......
T Consensus 185 ~~~~-----~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p 257 (307)
T 3omv_A 185 WSGS-----QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASP 257 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCC
T ss_pred CCcc-----eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCC
Confidence 2211 123456899999999999743 5899999999999999999999999875432 22222222322222
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
........+|+++.+||..||+.||++||++.+|.+.|+.+
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22333456799999999999999999999999999888754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=409.72 Aligned_cols=259 Identities=22% Similarity=0.309 Sum_probs=206.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+-..+|.+.++||+|+||+||+|++. .+++.||||+++.... ...|.+|++++.+|+|+|+|..+++|. +..
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-~~~ 116 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-EGR 116 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECC
Confidence 34578999999999999999999865 3688999999875432 246899999999999888777776654 556
Q ss_pred EEEEEEecc-CCCHHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC--------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~--------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
..+|||||+ +|+|.+++... ..++++.+++.|+.||+.||+|||+++||||||||+|||+ +.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence 789999999 99999998743 2459999999999999999999999999999999999999 58
Q ss_pred CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCc
Q 012336 142 SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (465)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~ 220 (465)
++.+||+|||+++....... ........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+...
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-- 266 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-- 266 (329)
T ss_dssp TTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--
T ss_pred CCcEEEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH--
Confidence 99999999999987643322 122345689999999999999999999999999999999999 9999988543
Q ss_pred hHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+.+..+........ ...+|+++.+|+..||+.||++||++.+|.+.|+.+..
T Consensus 267 -~~~~~~i~~g~~~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 267 -TEAIDCITQGRELER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp -HHHHHHHHHTCCCCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 444555544432211 14579999999999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=404.33 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=211.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
++--.+++++++||+|+||+||+|++. .+++.||||+++.... ...|.+|+.++.+++|+|+|..++.|. +
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-K 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-E
Confidence 344578999999999999999999864 3678999999875432 246899999999999988888777765 4
Q ss_pred CcEEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
....+|||||+ +|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl-- 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-- 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence 55678999999 99999999642 2359999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
+.++.+||+|||+++....... +.......||+.|||||++.+..|+.++|||||||+||||+| |..||.+..
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred -CCCCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 5889999999999987654322 123456789999999999999999999999999999999998 899998854
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
. .+.+..+...... +.+ ..+|+++.+|+..||+.||++||++.+|.+.|+.
T Consensus 253 ~---~~~~~~i~~~~~~-~~p---~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 253 N---QDVVEMIRNRQVL-PCP---DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp H---HHHHHHHHTTCCC-CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred H---HHHHHHHHcCCCC-CCc---ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 3 4444444444332 211 4579999999999999999999999999998863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=410.49 Aligned_cols=262 Identities=20% Similarity=0.289 Sum_probs=213.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCC-----cEEEEEEeecCCC---CccHHHHHHHHHHHcCCC-CCceeEEEeEeC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTG-----EEVAVKLESVKTK---HPQLHYESKLYMLLQGGT-GVPHLKWFGVEG 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~-----~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~-~i~~l~~~~~~~ 75 (465)
-.++|++++.||+|+||+||+|++..++ +.||||++..... ...+..|+.++..+.||+ +|..++.|...+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 3578999999999999999999976543 6899999875433 235889999999999876 455555666667
Q ss_pred cEEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG 139 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~ 139 (465)
...+|||||| +|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--- 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---
Confidence 7789999999 99999999753 2348999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCC
Q 012336 140 RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (465)
Q Consensus 140 d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~ 218 (465)
+.++.+||+|||+|+....... +.......||+.|||||++.+..|+.++|||||||+||||+| |..||.+...
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 5889999999999987644322 123356789999999999999999999999999999999998 9999988654
Q ss_pred CchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 219 GTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.. .....+..... .+.+ ..+|+++.++|..||+.||++||++.+|.+.|+.++...
T Consensus 294 ~~--~~~~~i~~g~~-~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 294 DE--EFCRRLKEGTR-MRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp SH--HHHHHHHHTCC-CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH--HHHHHHHcCCC-CCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 32 22223333222 2211 356899999999999999999999999999999887644
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=407.72 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=208.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeE-----eC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGV-----EG 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~ 75 (465)
++++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++|+.|+|+++|..+..+.. +.
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 568999999999999999999999999999999998754332 357789999999999888887776543 33
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...||||||++++|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 132 ~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 132 KSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARG 207 (398)
T ss_dssp CCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred CEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceeee
Confidence 57899999999999999974 5789999999999999999999999999999999999999 5899999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
+....... .....+.+||+.|||||++.+.. ++.++|||||||++|||++|+.||.+.+. .+.+..+......
T Consensus 208 ~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~~~g~ 281 (398)
T 4b99_A 208 LCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMMVLGT 281 (398)
T ss_dssp C----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred cccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 64322111 12345679999999999988764 69999999999999999999999988543 3333333222111
Q ss_pred --------------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 235 --------------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 235 --------------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+.......+++++.+||.+||..||.+|||+.++ |++.|.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~---L~Hp~f 348 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA---LRHPFL 348 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH---TTSGGG
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH---hcCHhh
Confidence 11223345678999999999999999999996654 454443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=393.67 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=187.8
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCc-------
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGE------- 76 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~------- 76 (465)
++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..|+|+++|..+..|...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4699999999999999999999999999999998754432 357899999999999998888887765432
Q ss_pred ----EEEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEe
Q 012336 77 ----YNVMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149 (465)
Q Consensus 77 ----~~~lv~e~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~D 149 (465)
+.||||||| +++|.+++.... ....+..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEcc
Confidence 578999999 899999998532 235667789999999999999999999999999999999 5889999999
Q ss_pred cCCccccccccCccc-----ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHH
Q 012336 150 YGLAKKYRDLQTHKH-----IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (465)
Q Consensus 150 FGla~~~~~~~~~~~-----~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~ 224 (465)
||+|+.+........ .........+||+.|||||++.+..|+.++|||||||++|||++ ||.... .....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence 999987654322110 01122345689999999999999999999999999999999996 885421 11222
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+..+.... .+. .....++.+.+||..||+.||++||++.+|.+
T Consensus 237 ~~~~~~~~--~p~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDVRNLK--FPP--LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHTTC--CCH--HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhcCC--CCC--CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222222 121 11234577889999999999999999777643
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=423.33 Aligned_cols=268 Identities=24% Similarity=0.296 Sum_probs=218.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~ 78 (465)
-++|++++.||+|+||+||+|++..+|+.||||++.+. ........|..++..+. +|++|..+..++.+...+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 46899999999999999999999999999999998743 22234556655555554 345555666666777889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
||||||+ ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||| +.+|.+||+|||+|+.+.
T Consensus 268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence 9999999 8999999986 5679999999999999999999999999999999999999 689999999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.. ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.......+.+..+.......+
T Consensus 344 ~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 344 KK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp SC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred CC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence 42 2346789999999999974 5799999999999999999999999987665555555555554444333
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccCCCCCCCC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSS 301 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (465)
..+++++.+||..||..||.+|++ +++|+ .++|+..+||..+.......+
T Consensus 415 -----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~----------~HpfF~~idW~~l~~~~~~pP 469 (689)
T 3v5w_A 415 -----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK----------ESPFFRSLDWQMVFLQKYPPP 469 (689)
T ss_dssp -----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT----------TSGGGTTCCHHHHHTTCSCCS
T ss_pred -----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh----------cCccccCCCHHHHHcCCCCcC
Confidence 467999999999999999999998 45553 378888999998754443333
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=395.27 Aligned_cols=267 Identities=22% Similarity=0.230 Sum_probs=201.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHH--HHHHHHHcCCCCCceeEEEeEeC---cEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYE--SKLYMLLQGGTGVPHLKWFGVEG---EYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E--~~il~~l~~~~~i~~l~~~~~~~---~~~~ 79 (465)
|..+|.+.++||+|+||+||+|++ +|+.||||+++.... ..+..| +..+..++|+|+|..+..+..++ ...+
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 456899999999999999999987 689999999875432 334444 44445678988888888877654 3679
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceeeccCCCCCcEEEEec
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------GFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~--------givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
|||||+ +|+|.+++.. ..+++..+..++.|++.||+|||++ +||||||||+|||+ +.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeC
Confidence 999999 8999999984 5799999999999999999999987 89999999999999 68999999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHhcCCCCCCCCC-------
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRGSLPWQGLK------- 217 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~k~DiwSLGviL~elltG~~Pf~~~~------- 217 (465)
|+++......... .......+||+.|||||++.+. .++.++|||||||+||||+||..||....
T Consensus 153 Gla~~~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 153 GLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEE---SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CCCccccCCCCce---eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 9998765432211 1123456899999999999765 36779999999999999999977654321
Q ss_pred ---CC--chHHHHHHHhhhhccCcHHHHh--ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 218 ---AG--TKKQKYDKISEKKMLTPIEVLC--KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 218 ---~~--~~~~~~~~i~~~~~~~~~~~~~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
.. ...+....+......+..+... ...+..+.+|+..||..||++|||+.+|.+.|+.+..+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 11 1222333333333222221111 12356799999999999999999999999999998776654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=391.34 Aligned_cols=288 Identities=29% Similarity=0.494 Sum_probs=222.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC-----CcEEEEEEeecCCCCccHHHHHHHHHHHc---------------CCC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT-----GEEVAVKLESVKTKHPQLHYESKLYMLLQ---------------GGT 63 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~-----~~~vAvKi~~~~~~~~~~~~E~~il~~l~---------------~~~ 63 (465)
+..++|++++.||+|+||.||+|.+..+ ++.||||++.... ..+..|++++..+. |++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 4567999999999999999999998664 5899999987543 34556666655544 455
Q ss_pred CCceeEEEeEe---CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC
Q 012336 64 GVPHLKWFGVE---GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 140 (465)
Q Consensus 64 ~i~~l~~~~~~---~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d 140 (465)
++..+..+... ..+.+|||++++++|.+++......+++.+++.|+.||+.||.|||++||+||||||+|||+.. +
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 55555554443 2568999999999999999876678999999999999999999999999999999999999941 1
Q ss_pred CCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc
Q 012336 141 KSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (465)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~ 220 (465)
.++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 67899999999998776544333222233456679999999999999999999999999999999999999998643322
Q ss_pred hHHHHHHHhhhhccCcHHHHh---ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 221 KKQKYDKISEKKMLTPIEVLC---KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~---~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
....................| ..+|+++.+++..||..+|++||++.+|.+.|++++...+...+..+||....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 269 KYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 221111111111111111112 56799999999999999999999999999999999999999999999999755
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=388.43 Aligned_cols=258 Identities=21% Similarity=0.289 Sum_probs=199.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.++|+++++||+|+||+||+|++. .+++.||||++.......++.+|++++..+.+|++|..+..++.+.++.|||
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 6789999999999999999999874 4678999999877666667899999999997777777777777788899999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ |++|.+++. .+++.++..|+.||+.||+|||++||+||||||+|||+. .+.+.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcc
Confidence 9999 889999884 599999999999999999999999999999999999995 344899999999998654322
Q ss_pred Cccc---------------------ccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCC
Q 012336 161 THKH---------------------IPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (465)
Q Consensus 161 ~~~~---------------------~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~ 218 (465)
.... .........+||+.|||||++.+.. |+.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 1100 0001123457999999999998764 89999999999999999999999965432
Q ss_pred CchHHHHHHHhhh--------------------------------------hccCc-----------HHHHhccCcHHHH
Q 012336 219 GTKKQKYDKISEK--------------------------------------KMLTP-----------IEVLCKSYPSEFT 249 (465)
Q Consensus 219 ~~~~~~~~~i~~~--------------------------------------~~~~~-----------~~~~~~~~p~~l~ 249 (465)
..+.+..+... ....+ .......+++++.
T Consensus 253 --~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 253 --DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp --HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred --HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 11111111110 00000 0011235789999
Q ss_pred HHHHHHhcCCCCCCCCHHHHH
Q 012336 250 SYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 250 ~li~~cl~~dp~~RPt~~~l~ 270 (465)
+||.+||..||.+|||++++.
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHCcCChhHCcCHHHHh
Confidence 999999999999999966553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=404.98 Aligned_cols=250 Identities=19% Similarity=0.261 Sum_probs=209.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+|..|+|+++|..+..| .+....||+|||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-ECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEEEEEEee
Confidence 689999999999999999999999999999999876432 34578899999999987766655554 567788999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ ||+|.+++......|++.++..|+.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+|+.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~-- 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-- 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE--
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc--
Confidence 9 89999998755668999999999999999999999999999999999999952 2358999999999987654221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+.......+. .....
T Consensus 313 ------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~ 382 (573)
T 3uto_A 313 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMDD-SAFSG 382 (573)
T ss_dssp ------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCCS-GGGTT
T ss_pred ------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCCCc-ccccC
Confidence 23568999999999999999999999999999999999999999874 345555555554443332 23357
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
+++++.+||..||..||.+||++.+++
T Consensus 383 ~s~~~~dli~~~L~~dp~~R~t~~e~l 409 (573)
T 3uto_A 383 ISEDGKDFIRKLLLADPNTRMTIHQAL 409 (573)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 899999999999999999999977664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.67 Aligned_cols=281 Identities=23% Similarity=0.389 Sum_probs=223.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC--------CcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCc-----------
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT--------GEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP----------- 66 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~--------~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~----------- 66 (465)
+++|++++.||+|+||.||+|++..+ ++.||||++... ..+..|+.++..++|++++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 68999999999999999999998874 889999998754 57899999999998855443
Q ss_pred ---eeEEEeE-eCcEEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC
Q 012336 67 ---HLKWFGV-EGEYNVMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK 141 (465)
Q Consensus 67 ---~l~~~~~-~~~~~~lv~e~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~ 141 (465)
.+..++. .+...++|||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+. .
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---P 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---T
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---C
Confidence 2334444 47889999999999999999864 36799999999999999999999999999999999999994 6
Q ss_pred CC--cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC
Q 012336 142 SN--QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (465)
Q Consensus 142 ~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~ 219 (465)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 66 8999999999876543322211112234568999999999999999999999999999999999999999875422
Q ss_pred chHHHHHHHhh-hhccCcHH---HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 220 TKKQKYDKISE-KKMLTPIE---VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 220 ~~~~~~~~i~~-~~~~~~~~---~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
.. ........ ........ .....+|+++.+++..||..||++||++.+|.+.|+.++...+...+..+||...
T Consensus 275 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 351 (352)
T 2jii_A 275 TE-DIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPMV 351 (352)
T ss_dssp HH-HHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC-
T ss_pred HH-HHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcCC
Confidence 21 11111111 11111100 0113568999999999999999999999999999999999999999999999853
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=370.60 Aligned_cols=269 Identities=19% Similarity=0.264 Sum_probs=217.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|..+..++......
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999998753 23345788999999886666677777777778889
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 100 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 9999999 8899999975 4679999999999999999999999999999999999999 588999999999997543
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+
T Consensus 176 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~p- 244 (353)
T 3txo_A 176 CNG-------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVVYP- 244 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC-
T ss_pred cCC-------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC-
Confidence 221 1234668999999999999989999999999999999999999999874 34555555555544443
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCH------HHHHHHHHHHHHHcCCCCCccccccccCCCCCCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDY------SYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSS 301 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~------~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (465)
..+++++.++|..||..||.+||++ ++|+ + ++|+..+||..+...+...+
T Consensus 245 ----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il---~-------hp~f~~~~w~~l~~~~~~~p 300 (353)
T 3txo_A 245 ----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL---R-------HPFFKEIDWAQLNHRQIEPP 300 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH---T-------SGGGTTCCHHHHHTTCSCCS
T ss_pred ----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh---h-------CCcccCCCHHHHhcCcCCCC
Confidence 3468999999999999999999997 4433 2 67777889998754444333
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=369.91 Aligned_cols=272 Identities=19% Similarity=0.255 Sum_probs=220.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
-++|++++.||+|+||.||+|++..+++.||||++.... ....+..|..++..+.+|++|..+..++......++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999987542 234578899999988656666666666777888999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|||++ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence 99999 8899999875 4679999999999999999999999999999999999999 68999999999999853321
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC------chHHHHHHHhhhhc
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYDKISEKKM 233 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~ 233 (465)
. ......+||+.|+|||++.+..++.++|||||||++|||++|..||...... .....+..+.....
T Consensus 207 ~-------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 G-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp T-------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred C-------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 1 2235678999999999999999999999999999999999999999754221 22233444444444
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCccccccccCCCCCCC
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS---YLKRLFRDLFIREGYQFDYVFDWTILKYPQTGS 300 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~ 300 (465)
..+ ..+++++.+||..||..||.+||++. .+.++++ ++|+..+||..+...+...
T Consensus 280 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~-------Hpff~~i~w~~l~~~~~~p 337 (396)
T 4dc2_A 280 RIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG-------HPFFRNVDWDMMEQKQVVP 337 (396)
T ss_dssp CCC-----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH-------STTTTTCCHHHHHTTCSCC
T ss_pred CCC-----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc-------CccccCCCHHHHHcCCCCC
Confidence 333 45789999999999999999999852 3344443 6788889999875444433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=366.79 Aligned_cols=270 Identities=19% Similarity=0.234 Sum_probs=221.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|..+..+.......
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4457999999999999999999999999999999998753 23345778888888887778888888888888899
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+|||++ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 97 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence 9999999 8899999985 4579999999999999999999999999999999999999 588999999999998643
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+
T Consensus 173 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~p- 241 (353)
T 2i0e_A 173 WDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVAYP- 241 (353)
T ss_dssp CTT-------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC-
T ss_pred cCC-------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCCCC-
Confidence 211 1234678999999999999999999999999999999999999999874 34455555555544433
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccCCCCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILKYPQTG 299 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~ 299 (465)
..+++++.+||..||..||.+||++. .+.++++ ++|+..+||..+......
T Consensus 242 ----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~-------h~~f~~~~w~~l~~~~~~ 294 (353)
T 2i0e_A 242 ----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-------HAFFRYIDWEKLERKEIQ 294 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT-------SGGGTTCCHHHHHTTCSC
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc-------CccccCCCHHHHHhCCCC
Confidence 46799999999999999999999641 2233332 667777899987544333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.98 Aligned_cols=262 Identities=20% Similarity=0.341 Sum_probs=211.2
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
++.++.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..+.|++++..+.. +...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~-~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDV-DEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE-EECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEe-eeeC
Confidence 5788999999999999999999999999999999999988654322 357789999999988766665554 5667
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...++|||++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence 7889999999 8899999985 4579999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
....... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.. ..............
T Consensus 160 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~~~ 230 (294)
T 4eqm_A 160 ALSETSL------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET---AVSIAIKHIQDSVP 230 (294)
T ss_dssp TC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC---HHHHHHHHHSSCCC
T ss_pred ccccccc------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhhccCC
Confidence 7643221 22345679999999999999999999999999999999999999998743 23333333333333
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKP-DYSYLKRLFRDL 276 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~~ 276 (465)
.........+|+.+.++|.+||..||.+|| +++++.+.|..+
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 333445567899999999999999999999 888888877654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=361.00 Aligned_cols=262 Identities=20% Similarity=0.258 Sum_probs=216.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
--++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+. +.......+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~-~~~~~~~~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY-AFQTHDRLC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEE-EEECSSEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEE-EEEeCCEEE
Confidence 357899999999999999999999999999999998753 23346788999999998766555544 455667889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||++ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhccc
Confidence 999999 8899999875 5679999999999999999999999999999999999999 5889999999999986432
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+.......+
T Consensus 158 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p-- 225 (337)
T 1o6l_A 158 DG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFP-- 225 (337)
T ss_dssp TT-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC--
T ss_pred CC-------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCCCC--
Confidence 21 12346789999999999999999999999999999999999999998743 3444444444443333
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..+++++.++|..||..||.+|| ++.+|++ ++++..+||..+...
T Consensus 226 ---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~----------h~~f~~~~~~~~~~~ 275 (337)
T 1o6l_A 226 ---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME----------HRFFLSINWQDVVQK 275 (337)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHTT
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc----------CCCcCCCCHHHHHhC
Confidence 45789999999999999999999 7666643 677778899876533
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=372.91 Aligned_cols=268 Identities=19% Similarity=0.240 Sum_probs=217.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec-----CCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV-----KTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~-----~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+..++|++++.||+|+||+||+|++..+++.||||++.. ......+..|..++..+.|++++..+ .++.+....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~-~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE-EEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE-EEEeeCCEE
Confidence 446899999999999999999999999999999999874 23344588999999998776555544 455667788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 9999998 999999998656789999999999999999999999999999999999999 689999999999998765
Q ss_pred cccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
.... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.+. ...+.+..+....
T Consensus 227 ~~~~------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~ 297 (437)
T 4aw2_A 227 EDGT------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHK 297 (437)
T ss_dssp TTSC------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHH
T ss_pred cCCC------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhcc
Confidence 4322 1234568999999999997 556899999999999999999999999874 3444555554332
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
.....+.....+++++.+||..||..+|+. ||++++|++ ++|+..+||..+.
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~----------Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK----------HPFFSGIDWDNIR 351 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT----------SGGGTTCCTTTGG
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC----------CCccCCCCHHHHh
Confidence 211111222457999999999999988887 899776643 6788889999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=364.07 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=217.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|..+..+..+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3458999999999999999999999999999999998753 23345788999999885556666666666777789
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++|||++ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 94 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 9999999 8899999985 4579999999999999999999999999999999999999 588999999999997643
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+.......+
T Consensus 170 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 170 LGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPFYP- 238 (345)
T ss_dssp CTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-
T ss_pred cCC-------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCCCC-
Confidence 211 12346789999999999999999999999999999999999999998743 3444555544433332
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccCCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILKYPQ 297 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 297 (465)
..+++++.++|..||..||.+||++. +|+ .++++..+||..+....
T Consensus 239 ----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~----------~hp~f~~~~w~~l~~~~ 285 (345)
T 1xjd_A 239 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR----------QHPLFREINWEELERKE 285 (345)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG----------GSGGGTTCCHHHHHTTC
T ss_pred ----cccCHHHHHHHHHHhcCCHhHcCCChHHHH----------cCccccCCCHHHHhhCC
Confidence 45789999999999999999999975 432 36777788998775433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=359.18 Aligned_cols=274 Identities=20% Similarity=0.275 Sum_probs=218.7
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
|+.+--++|++++.||+|+||.||+|++..+++.||||++...... ..+..|..++..+.+|++|..+..+....
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 4456678999999999999999999999999999999998765322 24678999998885555566666666777
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...++|||++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence 8899999999 8899999875 4679999999999999999999999999999999999999 588999999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC------CchHHHHHHH
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYDKI 228 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~------~~~~~~~~~i 228 (465)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+..+
T Consensus 159 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 159 EGLRPG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CSCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred cccCCC-------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 543211 123466899999999999999999999999999999999999999975322 1222333344
Q ss_pred hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCccccccccCCCC
Q 012336 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS---YLKRLFRDLFIREGYQFDYVFDWTILKYPQ 297 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 297 (465)
.......+ ..+++++.++|..||..||.+||++. .+.+++ .++|+..+||..+...+
T Consensus 232 ~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~-------~hp~f~~~~w~~~~~~~ 291 (345)
T 3a8x_A 232 LEKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ-------GHPFFRNVDWDMMEQKQ 291 (345)
T ss_dssp HHCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHH-------TSGGGTTCCHHHHHTTC
T ss_pred HcCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHh-------cCCccCCCCHHHHHhCC
Confidence 44333333 46789999999999999999999852 233333 36777788998765433
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=360.08 Aligned_cols=260 Identities=20% Similarity=0.290 Sum_probs=217.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+.-++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+ .+..+....
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEE-EEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEE-EEEEcCCEE
Confidence 3457999999999999999999999999999999998643 2334678899999999776655554 445567788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++|||++ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence 9999999 8999999985 4579999999999999999999999999999999999999 588999999999998654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+
T Consensus 193 ~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~p- 258 (350)
T 1rdq_E 193 GR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFP- 258 (350)
T ss_dssp SC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC-
T ss_pred CC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCCCC-
Confidence 31 23568999999999999999999999999999999999999999874 34555555555544433
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..+++++.++|..||..||.+||+ +++|++ ++|+..+||..+...
T Consensus 259 ----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~----------h~~f~~~~w~~~~~~ 308 (350)
T 1rdq_E 259 ----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAIYQR 308 (350)
T ss_dssp ----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHHHTT
T ss_pred ----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh----------CcCcCCCCHHHHhhc
Confidence 467999999999999999999998 565543 677778899876533
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=367.96 Aligned_cols=266 Identities=23% Similarity=0.284 Sum_probs=216.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeec-----CCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESV-----KTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~-----~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+..++|++++.||+|+||+||+|++..+++.||||++.. ......+..|..++..++|++++..+.. +.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA-FQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE-EECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE-EEECCEE
Confidence 345799999999999999999999999999999999864 2334568899999999987666655544 4567789
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++||||+ |++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence 9999999 9999999974 579999999999999999999999999999999999999 689999999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK- 232 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~----~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (465)
.... ......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+. .....+..+....
T Consensus 220 ~~~~------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~ 290 (410)
T 3v8s_A 220 KEGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKN 290 (410)
T ss_dssp TTSE------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHH
T ss_pred cCCc------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhccc
Confidence 3221 1234678999999999998766 789999999999999999999999874 3445555554432
Q ss_pred -ccCcHHHHhccCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCccccccccCCCC
Q 012336 233 -MLTPIEVLCKSYPSEFTSYFHYCRSLRFED--KPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQ 297 (465)
Q Consensus 233 -~~~~~~~~~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 297 (465)
...+. ...+++++.+||..||..+|.+ ||++++|++ ++|+..+||......+
T Consensus 291 ~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~----------Hp~f~~~~w~~~~~~~ 345 (410)
T 3v8s_A 291 SLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR----------HLFFKNDQWAWETLRD 345 (410)
T ss_dssp HCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT----------SGGGCCSSCCSTTGGG
T ss_pred cccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc----------CccccCCCHHHHhhcc
Confidence 12221 1467999999999999988888 999877754 6777778887654333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.56 Aligned_cols=263 Identities=19% Similarity=0.265 Sum_probs=217.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------CccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------HPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
..+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+..| .+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-EN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-Ee
Confidence 4567899999999999999999999999999999999876532 23578999999999987766665554 56
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC----cEEEEe
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN----QVYIID 149 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~----~vkL~D 149 (465)
....++|||++ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. .++ .+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence 67889999999 8999999974 56799999999999999999999999999999999999994 444 799999
Q ss_pred cCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 150 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+.
T Consensus 163 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~ 231 (361)
T 2yab_A 163 FGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANIT 231 (361)
T ss_dssp CSSCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHH
T ss_pred cCCceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Confidence 99998765421 124567999999999999999999999999999999999999999874 3445555555
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccc
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTI 292 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 292 (465)
......+. .....+++++.+||..||..||.+||++.++.+ ++|....+|..
T Consensus 232 ~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~~~~~~~~~ 283 (361)
T 2yab_A 232 AVSYDFDE-EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR----------HPWITPVDTQQ 283 (361)
T ss_dssp TTCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT----------STTTSCSSHHH
T ss_pred hcCCCCCc-hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc----------CcCcCCCchhh
Confidence 55444443 334678999999999999999999999776643 56665566653
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=354.99 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=215.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.|++++..+.. ..+....+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~-~~~~~~~~ 82 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-FQDAQQIF 82 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-EECSSEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEE-EEeCCEEE
Confidence 347899999999999999999999999999999998753 233457789999999887766665554 45667889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||++ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSS
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCC
Confidence 999999 8899999985 5679999999999999999999999999999999999999 5889999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+
T Consensus 159 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~~p-- 223 (318)
T 1fot_A 159 ----------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELRFP-- 223 (318)
T ss_dssp ----------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCCCC--
T ss_pred ----------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC--
Confidence 123568999999999999999999999999999999999999999874 33455555555444333
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccCC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
..+++++.++|..||..||.+|| ++++|++ ++|+..++|..+..
T Consensus 224 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~----------hp~f~~~~~~~~~~ 272 (318)
T 1fot_A 224 ---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN----------HPWFKEVVWEKLLS 272 (318)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT----------SGGGSSCCHHHHHT
T ss_pred ---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc----------CccccCCCHHHHHh
Confidence 45789999999999999999999 6665543 67777889987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=348.43 Aligned_cols=256 Identities=17% Similarity=0.235 Sum_probs=202.4
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-------CccHHHHHHHHHHHc---CCCCCceeEE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-------HPQLHYESKLYMLLQ---GGTGVPHLKW 70 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~---~~~~i~~l~~ 70 (465)
++.++.++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+. |++++..+..
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 367889999999999999999999999999999999999874321 235778888888876 7777777766
Q ss_pred EeEeCc----EEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 71 FGVEGE----YNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 71 ~~~~~~----~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
+..... ..+++|++++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~ 159 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTV 159 (308)
T ss_dssp EEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCE
T ss_pred eeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCE
Confidence 655433 678999999999999998543 349999999999999999999999999999999999999 588999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~ 225 (465)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+
T Consensus 160 kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~ 228 (308)
T 3g33_A 160 KLADFGLARIYSYQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQL 228 (308)
T ss_dssp EECSCSCTTTSTTCC--------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHH
T ss_pred EEeeCccccccCCCc--------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 999999998654321 224567999999999999999999999999999999999999999875433 333
Q ss_pred HHHhhhhc----------------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 226 DKISEKKM----------------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 226 ~~i~~~~~----------------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+..... ..+.......+++++.+||..||..||++||++.++.
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 33222111 1112233456889999999999999999999976654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=367.05 Aligned_cols=267 Identities=20% Similarity=0.286 Sum_probs=214.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+..++|++++.||+|+||+||+|++..+++.||||++... .....+..|..++..+.|++++. +..++.+....
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~-l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCC-EEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeee-EEEEEeeCCEE
Confidence 4468999999999999999999999999999999998742 23456889999999987755554 45555667789
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+||||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 9999999 999999998766689999999999999999999999999999999999999 688999999999998765
Q ss_pred cccCcccccccCCCCcccccccccccccc-------CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHL-------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-------~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
.... ......+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+ ..+.+..+..
T Consensus 214 ~~~~------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~ 284 (412)
T 2vd5_A 214 ADGT------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVH 284 (412)
T ss_dssp TTSC------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHT
T ss_pred CCCc------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHh
Confidence 4322 1123568999999999997 3568999999999999999999999998743 3444555444
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCC---CCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDK---PDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~R---Pt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
.......+.....+|+++.+||.+||. +|.+| |++++|++ ++|+..+||..+.
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~----------Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT----------HPFFFGLDWDGLR 340 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT----------SGGGTTCCSTTST
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc----------CCCcCCCCHHHHh
Confidence 322111122335789999999999999 99998 47666543 6778888999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.74 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=220.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.+.-++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+..| .+...
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-QDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeCCE
Confidence 45568999999999999999999999999999999998643 2334678999999999887766665554 45667
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++||+++ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 89999998 8899999974 5679999999999999999999999999999999999999 58999999999999875
Q ss_pred ccccCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.........+.+..+.....
T Consensus 166 ~~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 166 PRET--------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237 (384)
T ss_dssp CTTC--------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred cCCC--------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence 4321 2346789999999999974 4589999999999999999999999987666666666555554443
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPD-YSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..+ ..+++++.+||..||..||.+||+ +++|. .++++..++|..+...
T Consensus 238 ~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~----------~hp~f~~~~w~~~~~~ 286 (384)
T 4fr4_A 238 TYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ----------NFPYMNDINWDAVFQK 286 (384)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHH----------TSGGGTTCCHHHHHTT
T ss_pred CCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHH----------cChhhhcCCHHHHHhC
Confidence 333 457899999999999999999998 55443 3678888899876543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=349.77 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=203.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
..++|++++.||+|+||+||+|++..+++.||||++.... ....+..|+.++..+.|++++..+..+ ..+...++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEE-EECCEEEEEE
Confidence 3578999999999999999999999999999999987543 234578899999999887777666655 4566789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 998 9999999984 479999999999999999999999999999999999999 5889999999999987654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ......+........ ...
T Consensus 172 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~--~~~ 239 (297)
T 3fxz_A 172 -------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPEL--QNP 239 (297)
T ss_dssp -------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCC--SCG
T ss_pred -------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCCC--CCc
Confidence 23456799999999999999999999999999999999999999987433 222222222211111 112
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+++.+.+|+..||..||++||++.++.
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 46789999999999999999999976654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.44 Aligned_cols=246 Identities=21% Similarity=0.336 Sum_probs=206.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
..-++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+ ......+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-ETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCEEE
Confidence 3457899999999999999999999999999999998765332 3577899999999987766666554 5666789
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence 999999 8899999875 4679999999999999999999999999999999999999 5889999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s-~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.. .....+||+.|+|||++.+..+. .++|||||||++|+|++|..||.+.+ ..+....+.......+
T Consensus 167 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~p- 234 (328)
T 3fe3_A 167 GG--------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYRIP- 234 (328)
T ss_dssp SC--------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC-
T ss_pred CC--------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-
Confidence 21 12456799999999999988875 79999999999999999999998743 3444444444444333
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+++++.+|+..||..||.+|||++++.
T Consensus 235 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 235 ----FYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp ----TTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred ----CCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 34689999999999999999999976654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=358.16 Aligned_cols=270 Identities=30% Similarity=0.450 Sum_probs=203.1
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcC---CCcEEEEEEeecCCC-------------CccHHHHHHHHHHHcCCCCC
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEVAVKLESVKTK-------------HPQLHYESKLYMLLQGGTGV 65 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~---~~~~vAvKi~~~~~~-------------~~~~~~E~~il~~l~~~~~i 65 (465)
+.+.+++|++++.||+|+||.||+|++.. ++..||||++..... ...+..|+.++..+.|++++
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~ 111 (345)
T 2v62_A 32 DDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIP 111 (345)
T ss_dssp ECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCC
T ss_pred ccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcc
Confidence 34567899999999999999999999987 788999998875431 12345566667777787777
Q ss_pred ceeEEEeEe---CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCC
Q 012336 66 PHLKWFGVE---GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 66 ~~l~~~~~~---~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~ 142 (465)
..+..+... ....++|||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+. .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~ 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YK 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SS
T ss_pred eeecccccccCCCcEEEEEEeccCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cC
Confidence 777666553 6789999999999999998753 4899999999999999999999999999999999999995 45
Q ss_pred C--cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc
Q 012336 143 N--QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (465)
Q Consensus 143 ~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~ 220 (465)
+ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 5 99999999998775433222111122245689999999999999999999999999999999999999996532222
Q ss_pred hHHHHHHHhhhhccCcHH--HHhc--cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 221 KKQKYDKISEKKMLTPIE--VLCK--SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~--~~~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.. ............+.. .... .+|+++.++|..||..||++||++.+|.+.|+.+
T Consensus 268 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VA-VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HH-HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HH-HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 11 111111111111211 1111 6899999999999999999999999999988753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=347.40 Aligned_cols=256 Identities=18% Similarity=0.244 Sum_probs=205.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
..+.++|++++.||+|+||+||+|++. +++.||||++...... ..+.+|+.++..++|++++..+..+ ......
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-HSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-CCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-ccCCEE
Confidence 346789999999999999999999984 6899999998754332 3578999999999887766666555 456678
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 79 VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|||++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTS
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCC
Confidence 9999999889999998666679999999999999999999999999999999999999 5889999999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc----
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM---- 233 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---- 233 (465)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 172 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 172 PV-------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CC-------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred Cc-------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 21 12234578999999999876 5689999999999999999999999998766555444433222111
Q ss_pred ------------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 ------------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ------------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+.......+++++.+||..||..||++||++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 1112233456789999999999999999999977664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=361.60 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=209.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHH-HHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLY-MLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il-~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+..++|++++.||+|+||.||+|++..+++.||||++..... ...+..|..++ ..+.|++ |..+..++.....
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~-Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF-LVGLHFSFQTADK 113 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTT-BCCEEEEEECSSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCC-CCCEEEEEEeCCE
Confidence 345789999999999999999999999999999999875432 23455566653 3455544 5555555566778
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.|+||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGG
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCcccccc
Confidence 99999999 8899999875 4679999999999999999999999999999999999999 58899999999999864
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+
T Consensus 190 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~~ 259 (373)
T 2r5t_A 190 IEHN-------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQLK 259 (373)
T ss_dssp BCCC-------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCCCC
T ss_pred ccCC-------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccCCC
Confidence 3221 1235678999999999999999999999999999999999999999874 34555555555443332
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSY-LKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..+++++.+||..||..||.+||++.+ +.++ ..++|+..+||..+...
T Consensus 260 -----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i-------~~h~~f~~~~w~~l~~~ 308 (373)
T 2r5t_A 260 -----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI-------KSHVFFSLINWDDLINK 308 (373)
T ss_dssp -----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH-------HTSGGGTTCCHHHHHTT
T ss_pred -----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH-------hCCccccCCCHHHHHhC
Confidence 467899999999999999999998742 2222 23677778899876433
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=354.41 Aligned_cols=261 Identities=19% Similarity=0.257 Sum_probs=211.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-------CCccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.++.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++|++++..+..+ .+.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-SSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-EET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-EeC
Confidence 467889999999999999999999999999999999986421 234688999999999887777666655 556
Q ss_pred cEEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
...++|||++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+..++....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 7889999999 79998877542 3459999999999999999999999999999999999999643344569999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ..+.+..+...
T Consensus 179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~ 247 (351)
T 3c0i_A 179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKG 247 (351)
T ss_dssp TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHT
T ss_pred ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcC
Confidence 9987654221 123557999999999999999999999999999999999999999863 23444444444
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
...... .....+++++.+||..||..||++||++.++ |++.|..
T Consensus 248 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~ 291 (351)
T 3c0i_A 248 KYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEA---LNHPWLK 291 (351)
T ss_dssp CCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred CCCCCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcChhhc
Confidence 443333 2335789999999999999999999996655 4555543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=386.44 Aligned_cols=274 Identities=19% Similarity=0.229 Sum_probs=228.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
--++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.++++|..+..+..+....|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999999999999999998743 344567889999988888888998888888888999
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|||||+ |++|.+++.. .+.|++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+++....
T Consensus 419 lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecccc
Confidence 999999 8899999986 4679999999999999999999999999999999999999 6899999999999986432
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|..||.+. ...+.+..+.......+
T Consensus 495 ~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p-- 562 (674)
T 3pfq_A 495 DG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVAYP-- 562 (674)
T ss_dssp TT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCCCC--
T ss_pred CC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCCCC--
Confidence 21 1235678999999999999999999999999999999999999999874 44556666666555444
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCccccccccCCCCCCCCCCC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDY--SYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSSSRS 304 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 304 (465)
..+++++.+||..||..||++||++ ..+.+++ .++|+..+||..+...+...+-.+
T Consensus 563 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~-------~h~ff~~i~w~~l~~~~~~pp~~p 620 (674)
T 3pfq_A 563 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK-------EHAFFRYIDWEKLERKEIQPPYKP 620 (674)
T ss_dssp ---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH-------SSGGGSSCCHHHHTTTCSCCSCCC
T ss_pred ---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh-------cCccccCCCHHHHHhCCCCCCCCC
Confidence 4679999999999999999999986 1112222 377888899998765544443333
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=350.96 Aligned_cols=259 Identities=18% Similarity=0.257 Sum_probs=214.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+.++|++++.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+.|++++..+..+ .+....+++||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-ESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-EETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEE-ecCCEEEEEEE
Confidence 67899999999999999999999999999999999875432 23578899999999887766666555 56678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||++..+.....
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc-
Confidence 99 78999999765567999999999999999999999999999999999999941 1278999999999987643211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+.......+. ....
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~~~-~~~~ 228 (321)
T 1tki_A 160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFDE-EAFK 228 (321)
T ss_dssp -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCCH-HHHT
T ss_pred -------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHHHcCCCCCCh-hhhc
Confidence 13457899999999999988999999999999999999999999874 344555555555544443 3346
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+++++.+|+..||..||.+||++.++ |++.|...
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~ 263 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLKQ 263 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHH---hcChhhcc
Confidence 789999999999999999999996654 56666654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=345.48 Aligned_cols=249 Identities=18% Similarity=0.186 Sum_probs=200.1
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+.++.++|+++++||+|+||+||+|++..+++.||||++...... .....|+..+..+.+|++|..+..++.++..
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 345678999999999999999999999999999999987654322 2355666666667555666666666678889
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.++|||+++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecc
Confidence 99999999999999998777789999999999999999999999999999999999999 588999999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......||+.|+|||++.+ .++.++|||||||++|||++|..||.+. .....+.... ..
T Consensus 209 ~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~---~~ 270 (311)
T 3p1a_A 209 TAG--------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGY---LP 270 (311)
T ss_dssp --------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTC---CC
T ss_pred cCC--------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccC---CC
Confidence 322 1234569999999999886 7999999999999999999997666541 2222222221 12
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
......+++++.++|..||..||++||++.+|.+
T Consensus 271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 2344678999999999999999999999776643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.49 Aligned_cols=264 Identities=18% Similarity=0.263 Sum_probs=211.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.++..++|++++..+..+ .++...++||+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-YKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-ecCCeeEEEEE
Confidence 589999999999999999999999999999999875432 234588999999999987766666555 46677889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++......+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence 98 889999998767789999999999999999999999999999999999999 58899999999999876543221
Q ss_pred ccc-------cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHH--HHHHHhhhhc
Q 012336 163 KHI-------PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYDKISEKKM 233 (465)
Q Consensus 163 ~~~-------~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~ 233 (465)
... .........||+.|+|||++.+..++.++||||||+++|||++|..||.......... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~--- 241 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD--- 241 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH---
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc---
Confidence 100 0011225679999999999999999999999999999999999999997644322110 0000000
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
......+|+++.+++..||+.||++||++.+|.+.|+.+....
T Consensus 242 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 242 ----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1112467899999999999999999999999999999887543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=354.69 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=214.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.+.++|++++.||+|+||.||+|++..+++.||||++.... .....|++++.++.+|++|..+..++.++...++|||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~--~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT--CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc--CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 46788999999999999999999999999999999987553 3467899999999655666666666678889999999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC-CCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d-~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+...+ ..+.+||+|||+++.......
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99 8899999874 56799999999999999999999999999999999999985211 124699999999987654221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+.......+. ...
T Consensus 176 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~~ 247 (342)
T 2qr7_A 176 -------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG-GYW 247 (342)
T ss_dssp -------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS-TTT
T ss_pred -------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc-ccc
Confidence 123567999999999999888999999999999999999999999876555666666666655444332 223
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+++++.+||..||..||++||++.++ |++.|.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~ 281 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI 281 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence 5679999999999999999999996654 555554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=352.18 Aligned_cols=262 Identities=17% Similarity=0.271 Sum_probs=211.5
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.+..++|++.+.||+|+||.||+|++..+++ .||||++..... ...+..|+.++..++|++++..+.++ .++.
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-TRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeCC
Confidence 4567899999999999999999999876555 599999875432 23588899999999887766666554 5666
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRV 200 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCcccc
Confidence 788999999 889999998656789999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
+....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+... .+....+......
T Consensus 201 ~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~ 273 (325)
T 3kul_A 201 LEDDPDAA----YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRL 273 (325)
T ss_dssp CC----CC----EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC
T ss_pred cccCccce----eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCC
Confidence 65432211 11233456889999999999899999999999999999999 9999987543 3333333333221
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
+ ....+|+++.++|..||..||++||++.+|.+.|+.+...
T Consensus 274 -~---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 -P---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -C---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1 1246799999999999999999999999999999988653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=348.56 Aligned_cols=265 Identities=21% Similarity=0.288 Sum_probs=206.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCC------CCccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKT------KHPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~------~~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
.+..++|++++.||+|+||.||+|++. .+++.||||++.... ....+..|+.++..+.|++++..+..+ .
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF-Q 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-E
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-E
Confidence 456789999999999999999999985 689999999987542 234577899999999987776666555 5
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
.....++|||++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL 167 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence 566789999998 8899999975 4679999999999999999999999999999999999999 5889999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+.+..+....
T Consensus 168 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCK 237 (327)
T ss_dssp C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC
T ss_pred ccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCC
Confidence 976433211 2245679999999999999999999999999999999999999998743 344444444444
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
...+ ..+++++.++|..||..||.+||++. .+.+++. ++|+..++|....
T Consensus 238 ~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~-------hp~f~~~~~~~~~ 289 (327)
T 3a62_A 238 LNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA-------HPFFRHINWEELL 289 (327)
T ss_dssp CCCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH-------SGGGSSCCHHHHH
T ss_pred CCCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc-------CCcccCCCHHHHh
Confidence 3333 35789999999999999999999432 2344444 4556667888654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=346.82 Aligned_cols=265 Identities=20% Similarity=0.253 Sum_probs=207.5
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHH--HcCCCCCceeEEEeEe---C
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYML--LQGGTGVPHLKWFGVE---G 75 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~--l~~~~~i~~l~~~~~~---~ 75 (465)
|++++.++|++++.||+|+||+||+|++ +++.||||++.... ...+..|.+++.. +.|++++..+..+... .
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 6789999999999999999999999987 78999999987542 3456678888877 6787777777665442 3
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCceeeccCCCCCcEE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH--------SRGFLHRDIKPDNFLMGLGRKSNQVY 146 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH--------s~givHrDLKP~NILl~~~d~~~~vk 146 (465)
...++||+++ +++|.+++. ...+++..++.++.||+.||.||| ++||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence 5678999999 789999996 567999999999999999999999 9999999999999999 5889999
Q ss_pred EEecCCccccccccCcccccccCCCCccccccccccccccCC------CCCCcchHHHHHHHHHHHhcC----------C
Q 012336 147 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV------EQSRRDDLESLGYVLMYFLRG----------S 210 (465)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~------~~s~k~DiwSLGviL~elltG----------~ 210 (465)
|+|||+++.......... .......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 154 l~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLD---VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp ECCCTTCEEEETTTTEEE---CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeeCCCeeeccccccccc---ccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 999999987654322111 123345799999999999877 455799999999999999999 8
Q ss_pred CCCCCCCCCc-hHHHHHHHhh-h--hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 211 LPWQGLKAGT-KKQKYDKISE-K--KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 211 ~Pf~~~~~~~-~~~~~~~i~~-~--~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.||....... ....+..... . ....+.......+++++.+++..||+.||++||++.+|.+.|+.+
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 9997654332 1222222221 1 112222223334578999999999999999999999999998864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=363.25 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=210.7
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
..+.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ .+....
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-SEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-ECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-EECCEE
Confidence 3567899999999999999999999999999999999876542 23578999999999887766665554 566788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++|||++ |++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+.....++.+||+|||++....
T Consensus 86 ~lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp EEEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999 8899999875 5679999999999999999999999999999999999999644357899999999997665
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+.......+.
T Consensus 165 ~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~ 234 (444)
T 3soa_A 165 GEQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPS 234 (444)
T ss_dssp TTCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCT
T ss_pred CCCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCc
Confidence 4221 123567999999999999999999999999999999999999999874 344555555555444333
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+ ....+++++.+||..||..||.+||++.++.+
T Consensus 235 ~-~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 P-EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2 22467999999999999999999999766544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.45 Aligned_cols=267 Identities=19% Similarity=0.228 Sum_probs=208.9
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEE----EcCCCcEEEEEEeecCCCC--ccHHHHHHHHHHHcCCCCCceeEEEeEe-
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGV----NVQTGEEVAVKLESVKTKH--PQLHYESKLYMLLQGGTGVPHLKWFGVE- 74 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~----~~~~~~~vAvKi~~~~~~~--~~~~~E~~il~~l~~~~~i~~l~~~~~~- 74 (465)
..+..++|++++.||+|+||.||+|+ +..+++.||||++...... ..+.+|+.++..++|++++..+..+...
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 35678999999999999999999998 5668999999998754322 4578999999999998888877776543
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
....++||+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLT 161 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCSC
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE---cCCCeEEEccCccc
Confidence 34678999998 889999998766679999999999999999999999999999999999999 47899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc---------hH--
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---------KK-- 222 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~---------~~-- 222 (465)
......... ........++..|+|||.+.+..++.++||||||+++|||++|..||....... ..
T Consensus 162 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp C-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred ccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 876543211 122334568889999999999999999999999999999999999986532100 00
Q ss_pred --HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 223 --QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 223 --~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.....+.... ..+ ....+|+++.+++..||..||++||++.+|.+.|+.+...
T Consensus 238 ~~~~~~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 238 VFHLIELLKNNG-RLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHTTC-CCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccC-cCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111 111 1246789999999999999999999999999999988654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=352.18 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=203.3
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHc----CCCCCceeEEEeEeCc
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQ----GGTGVPHLKWFGVEGE 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~----~~~~i~~l~~~~~~~~ 76 (465)
+.++.++|+++++||+|+||.||+|++..+++.||||++.... ....+..|..++..+. .|++|..+..++....
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 4678999999999999999999999999999999999986432 2345778999999997 2444555555556777
Q ss_pred EEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC----------------
Q 012336 77 YNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG---------------- 139 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~---------------- 139 (465)
..++||++++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+...
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 899999999999999998643 459999999999999999999999999999999999999410
Q ss_pred ------CCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q 012336 140 ------RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213 (465)
Q Consensus 140 ------d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf 213 (465)
..++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 12789999999999764331 23567999999999999999999999999999999999999999
Q ss_pred CCCCCCchHHHHHHHhhhhccCcHHHH-----------------------------------------hccCcHHHHHHH
Q 012336 214 QGLKAGTKKQKYDKISEKKMLTPIEVL-----------------------------------------CKSYPSEFTSYF 252 (465)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~-----------------------------------------~~~~p~~l~~li 252 (465)
.+.... +.+..+.......+.... ....++.+.+||
T Consensus 260 ~~~~~~---~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 260 RTHEHM---EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CCSSHH---HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCcHH---HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 875432 233222222222221110 111247788999
Q ss_pred HHHhcCCCCCCCCHHHHH
Q 012336 253 HYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 253 ~~cl~~dp~~RPt~~~l~ 270 (465)
..||+.||++||++.++.
T Consensus 337 ~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 337 YSILQIDPTLRPSPAELL 354 (360)
T ss_dssp HHHCCSSGGGSCCHHHHT
T ss_pred HHHhcCChhhCCCHHHHh
Confidence 999999999999977664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=355.96 Aligned_cols=260 Identities=18% Similarity=0.315 Sum_probs=209.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEeE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFGV 73 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~~ 73 (465)
..++|++++.||+|+||.||+|++.. ++..||||++..... ...+..|+.++..+ .|++++..+. ++.
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~-~~~ 157 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG-ACT 157 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE-EEC
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE-EEc
Confidence 45799999999999999999998753 456899999875532 23578999999999 5655555554 445
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeec
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMG 137 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~ 137 (465)
.....++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 566788999998 889999998642 358999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCC
Q 012336 138 LGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGL 216 (465)
Q Consensus 138 ~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~ 216 (465)
+.++.+||+|||+++....... +.......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --CCCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 5889999999999986644221 122344567899999999999999999999999999999999 99999886
Q ss_pred CCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 217 KAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..... +..+...... . ....+++++.++|..||..||++||++.+|.+.|+.++...
T Consensus 310 ~~~~~---~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 310 PVEEL---FKLLKEGHRM-D---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp CGGGH---HHHHHTTCCC-C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHH---HHHHhcCCCC-C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 54332 2223222211 1 12456899999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=352.71 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=210.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+.. ..+....+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~-~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-IQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE-EEeCCEEE
Confidence 4567899999999999999999999999999999998765432 357889999999988776666555 45667889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++.....
T Consensus 105 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999998 7899998874 56799999999999999999999999999999999999996433456799999999987653
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+ ..+.+..+.......+..
T Consensus 184 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 184 SE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCTT
T ss_pred Cc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCcc
Confidence 21 1235679999999999999999999999999999999999999998743 344444555444433322
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
....+++++.+||..||..||++||++.++ |++.|.
T Consensus 253 -~~~~~~~~~~~li~~~L~~dP~~R~t~~e~---l~hp~~ 288 (362)
T 2bdw_A 253 -EWDTVTPEAKSLIDSMLTVNPKKRITADQA---LKVPWI 288 (362)
T ss_dssp -GGGGSCHHHHHHHHHHSCSSGGGSCCHHHH---TTSHHH
T ss_pred -cccCCCHHHHHHHHHHcCCChhhCcCHHHH---hcCccc
Confidence 224679999999999999999999996655 444443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=364.84 Aligned_cols=263 Identities=19% Similarity=0.244 Sum_probs=207.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+..++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+.. +......
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~-~~~~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-FQTHDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEE-EEETTEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEE-EeeCCEE
Confidence 3457899999999999999999999999999999998743 223457788888888887766555544 4566788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
++|||++ +++|.+++.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||+ +.++.+||+|||+++..
T Consensus 224 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceec
Confidence 9999999 8899999875 4689999999999999999999998 999999999999999 58899999999999764
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+
T Consensus 300 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 300 IKDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIRFP 369 (446)
T ss_dssp CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC
T ss_pred cCCC-------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCCCC
Confidence 3321 12345789999999999999999999999999999999999999998743 3444444444433333
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
..+++++.+||..||..||.+|| ++.+|.+ ++|+..++|......
T Consensus 370 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~----------hp~f~~~~~~~~~~~ 419 (446)
T 4ejn_A 370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ----------HRFFAGIVWQHVYEK 419 (446)
T ss_dssp -----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT----------SGGGTTCCHHHHHTT
T ss_pred -----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh----------CccccCCCHHHHhhC
Confidence 45789999999999999999999 8766643 677777899876533
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=355.44 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=210.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEE-----EcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcC-CCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQG-GTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~-----~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~-~~~i~~l~~~~~~ 74 (465)
+..++|++++.||+|+||.||+|+ +..+++.||||++...... ..+..|++++..+.+ ++++..+..+...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 457899999999999999999998 4556789999998754332 358899999999955 5555556666655
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCC-------------------------------------------------------
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNR------------------------------------------------------- 98 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~------------------------------------------------------- 98 (465)
+...+++|+++ +++|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 66789999999 8899999975322
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccccc
Q 012336 99 ----------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYR 168 (465)
Q Consensus 99 ----------~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (465)
.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~-----~~ 250 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPD-----YV 250 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTT-----CE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeeccccc-----ch
Confidence 18999999999999999999999999999999999999 5788999999999986543222 12
Q ss_pred CCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHH
Q 012336 169 ENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSE 247 (465)
Q Consensus 169 ~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~ 247 (465)
......||+.|+|||++.+..++.++||||||+++|||++ |..||.+...... ....+...... . ....++++
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~~-~---~~~~~~~~ 324 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEGTRM-R---APDYTTPE 324 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHTCCC-C---CCTTCCHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcCCCC-C---CCCCCCHH
Confidence 2345678999999999999999999999999999999998 9999987554322 22222222111 1 11456899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 248 FTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
+.+++..||..||.+||++.+|.+.|+.++..
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=346.00 Aligned_cols=251 Identities=19% Similarity=0.268 Sum_probs=208.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+ ...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~ 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-ENK 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-ECS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EeC
Confidence 466789999999999999999999999999999999875432 23588999999999987766665554 566
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC----cEEEEec
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN----QVYIIDY 150 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~----~vkL~DF 150 (465)
...++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. .++ .+||+||
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~---~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL---DRNVPKPRIKIIDF 162 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES---CSSSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe---cCCCCCCCEEEEEC
Confidence 7789999998 8899999974 56799999999999999999999999999999999999995 444 8999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+..
T Consensus 163 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~ 231 (326)
T 2y0a_A 163 GLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231 (326)
T ss_dssp TTCEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHH
T ss_pred CCCeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHh
Confidence 9998764321 1235679999999999999999999999999999999999999998743 3444444444
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....+ ......+++++.+||..||..||++||++.++.+
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 232 VNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp TCCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 443333 3344578999999999999999999999777654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=349.59 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=205.7
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
|..-+-++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+.. +.++..
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~-~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-RREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEE-EECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEE-EecCCe
Confidence 566788999999999999999999999999999999999875432 3568899999999988776665554 556778
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence 89999999 7899988864 4579999999999999999999999999999999999999 58899999999999866
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .+..........
T Consensus 156 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL 228 (323)
T ss_dssp EETTEE-----CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTTCTTS
T ss_pred ccCCcc-----cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhcccccC
Confidence 432211 12245689999999999988775 7899999999999999999999987544322 222222222222
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.. ...+++++.+|+..||..||++||++.+|.
T Consensus 229 ~~---~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 229 NP---WKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp TT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred Cc---cccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11 246789999999999999999999977664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=344.88 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=201.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
.+..++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.++..++|++++..+..+ ......
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-TQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCce
Confidence 35578999999999999999999986 6899999998755432 3578899999999987777666555 455567
Q ss_pred EEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 79 VMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
++||+++ +++|.+++.... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCC
Confidence 8999998 889999997432 13999999999999999999999999 9999999999999 58899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
+...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .+....+.....
T Consensus 187 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~ 256 (309)
T 3p86_A 187 RLKASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCK 256 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCC
T ss_pred ccccccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCC
Confidence 7543321 123456799999999999999999999999999999999999999987543 333333322221
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
... ....+++++.++|..||..||.+||++.+|.+.|+.++..
T Consensus 257 ~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 RLE---IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 2246799999999999999999999999999999987643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=352.04 Aligned_cols=256 Identities=18% Similarity=0.224 Sum_probs=194.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
..+.++|++.+.||+|+||.||+|++..+++.||||++........+..|+.++..+.|++++..+..+ ......++||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~ 127 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF-ETPTEISLVL 127 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEE-ECSSEEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeE-ecCCeEEEEE
Confidence 346788999999999999999999999999999999998766667788999999999987766666555 5566789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++......
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 205 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV- 205 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence 998 8899999874 4679999999999999999999999999999999999999643458999999999998654321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+..+.......+ ....
T Consensus 206 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~~-~~~~ 275 (349)
T 2w4o_A 206 -------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYFI-SPWW 275 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCCC-TTTT
T ss_pred -------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCccC-Cchh
Confidence 12356799999999999999999999999999999999999999976432 2223334443333222 2233
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..++.++.+||..||..||++||++.++.+
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 567999999999999999999999766543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=356.45 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=194.5
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHc-CCCCCceeEEEeEe-
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQ-GGTGVPHLKWFGVE- 74 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~-~~~~i~~l~~~~~~- 74 (465)
++..+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+. |++++..+..+..+
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 356678999999999999999999999999999999998754322 235778999999998 65656655555443
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
....|+|||+++++|.+++.. +.+++..+..++.||+.||+|||+.||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 347899999999999999984 579999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcc-c-------------ccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC
Q 012336 155 KYRDLQTHK-H-------------IPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (465)
Q Consensus 155 ~~~~~~~~~-~-------------~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~ 219 (465)
.+....... . .........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~- 236 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST- 236 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 654311100 0 00112234689999999999987 6789999999999999999999999988543
Q ss_pred chHHHHHHHhhhhccCcHHHH------------------------------------------hccCcHHHHHHHHHHhc
Q 012336 220 TKKQKYDKISEKKMLTPIEVL------------------------------------------CKSYPSEFTSYFHYCRS 257 (465)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~------------------------------------------~~~~p~~l~~li~~cl~ 257 (465)
...+..+......+..+.. ...+++++.+|+.+||.
T Consensus 237 --~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 237 --MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp --HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred --HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 2333333221111111100 01568899999999999
Q ss_pred CCCCCCCCHHHHH
Q 012336 258 LRFEDKPDYSYLK 270 (465)
Q Consensus 258 ~dp~~RPt~~~l~ 270 (465)
.||++|||+.++.
T Consensus 315 ~dP~~R~t~~e~l 327 (388)
T 3oz6_A 315 FNPNKRISANDAL 327 (388)
T ss_dssp SSGGGSCCHHHHT
T ss_pred cCcccCCCHHHHh
Confidence 9999999976654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=347.26 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=199.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeC--
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEG-- 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~-- 75 (465)
..+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..+.|++++..+..+....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 46789999999999999999999999999999999998765332 24678888898998888888777665543
Q ss_pred -cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 76 -EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 76 -~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
...++|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC
T ss_pred CcccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE---cCCCCEEEeeccCc
Confidence 2458999999 8899999975 4679999999999999999999999999999999999999 48899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
..+...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+... .......... .
T Consensus 164 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~-~ 235 (311)
T 3ork_A 164 RAIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVRE-D 235 (311)
T ss_dssp ----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHC-C
T ss_pred ccccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcC-C
Confidence 876543211 1223456799999999999999999999999999999999999999987433 2222222222 2
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS 267 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~ 267 (465)
..+.......+++++.++|.+||..||++||+..
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~ 269 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTA 269 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhH
Confidence 3344445567899999999999999999999743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=342.84 Aligned_cols=267 Identities=20% Similarity=0.263 Sum_probs=202.6
Q ss_pred CccCCceEEE-eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 3 HVIGGKFKLG-RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 3 ~i~~~~y~l~-~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
..+.++|++. +.||+|+||.||+|++..+++.||||++..... ...+.+|+.++.++.+|++|..+..+..+....+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4578899996 789999999999999999999999999876533 3468899999999765555656656666778899
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||++ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+..++....+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999 7999999975 46799999999999999999999999999999999999995322234599999999976543
Q ss_pred ccCcccccccCCCCccccccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc------------h
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-----VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------K 221 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~------------~ 221 (465)
................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22111111112234569999999999875 457899999999999999999999998754322 2
Q ss_pred HHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 222 KQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...+..+.......+.. ....+++++.+||..||..||.+||++.++.+
T Consensus 247 ~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 23344444444433332 33568999999999999999999999777654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=345.77 Aligned_cols=265 Identities=18% Similarity=0.192 Sum_probs=209.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeC-cEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG-EYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~-~~~ 78 (465)
.+++++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|++++..++|++++..+..+.... ...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 467899999999999999999999999999999999987533 2345779999999999888887777665543 377
Q ss_pred EEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-CCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~-d~~~~vkL~DFGla~ 154 (465)
++|||++ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999 899999998533 239999999999999999999999999999999999998322 356789999999998
Q ss_pred ccccccCcccccccCCCCcccccccccccccc--------CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc-hHHHH
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHL--------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKY 225 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~--------~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~-~~~~~ 225 (465)
....... .....||+.|+|||++. +..++.++|||||||++|||++|..||....... ..+.+
T Consensus 165 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 165 ELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred ecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 7654321 23457999999999986 5678999999999999999999999997644322 23333
Q ss_pred HHHhhhhcc--------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 226 DKISEKKML--------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 226 ~~i~~~~~~--------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
..+...... .....+...+++.+.+++..||+.||++||++.++.+...+
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 333322211 00011123456789999999999999999998887766554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=342.31 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=202.0
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.+..++|++.+.||+|+||.||+|++..+ +..||||++..... ...+..|+.++..+.|++++..+..+ ...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TEN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--ccC
Confidence 35678999999999999999999998654 45799998765332 23578899999999988877777665 344
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++||+++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE---CCCCCEEECccccccc
Confidence 578999998 779999998756679999999999999999999999999999999999999 4789999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....... ..+......
T Consensus 166 ~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~~~ 236 (281)
T 1mp8_A 166 MEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERL 236 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC
T ss_pred cCcccc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCCCC
Confidence 644221 12234467889999999998899999999999999999996 99999886544332 222222211
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+ ....+|+++.+++..||..||++||++.+|.+.|+.++..+
T Consensus 237 -~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 -P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp -C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -C---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 22467999999999999999999999999999999988654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=342.56 Aligned_cols=249 Identities=20% Similarity=0.281 Sum_probs=200.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----------------------------CccHHHHHHH
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----------------------------HPQLHYESKL 55 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----------------------------~~~~~~E~~i 55 (465)
+.-++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 456899999999999999999999999999999999875421 2458899999
Q ss_pred HHHHcCCCCCceeEEEeE-eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 012336 56 YMLLQGGTGVPHLKWFGV-EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDN 133 (465)
Q Consensus 56 l~~l~~~~~i~~l~~~~~-~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~N 133 (465)
++.++|++++..+..+.. .....++|||++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999998888887777665 356889999999 778877654 4679999999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHhcCC
Q 012336 134 FLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGS 210 (465)
Q Consensus 134 ILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~k~DiwSLGviL~elltG~ 210 (465)
||+ +.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|.
T Consensus 168 il~---~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 168 LLV---GEDGHIKIADFGVSNEFKGSDA-------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSSSC-------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred EEE---CCCCCEEEecCCCccccccccc-------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999 5889999999999987653221 123457999999999998765 378899999999999999999
Q ss_pred CCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 211 LPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.||.+.. .......+.......+. ...+++++.++|..||..||++||++.+|.
T Consensus 238 ~pf~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 238 CPFMDER---IMCLHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp CSSCCSS---HHHHHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCcc---HHHHHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 9998743 23333333333322221 246789999999999999999999966653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=338.47 Aligned_cols=251 Identities=19% Similarity=0.214 Sum_probs=201.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..++|++++..+.. ..++...++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-LHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEE-EEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeE-EEeCCEEEEEE
Confidence 5899999999999999999999999999999998755432 357789999999988776665555 45677889999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|++.++|.+.+......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-- 155 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCC--
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCcc--
Confidence 999999999888777889999999999999999999999999999999999999 588999999999998764321
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH----
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI---- 237 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---- 237 (465)
.......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... .....+..+.........
T Consensus 156 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred -----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence 2234567899999999998766 7999999999999999999888864322 222333333221111100
Q ss_pred --------------------HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 --------------------EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 --------------------~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
......+++++.+|+..||..||++||+++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 011235789999999999999999999976654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=354.90 Aligned_cols=264 Identities=19% Similarity=0.291 Sum_probs=211.0
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEE-----EcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~-----~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
..+..++|++++.||+|+||.||+|+ +..++..||||++..... ...+..|+.++..++|++++..+..+ .
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-L 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-e
Confidence 34667899999999999999999999 445778999999864322 23578899999999887777766665 4
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEE
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCN------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVY 146 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vk 146 (465)
.....++|||++ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+..+..+..+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 555678999998 889999998643 3599999999999999999999999999999999999995333455799
Q ss_pred EEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHH
Q 012336 147 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (465)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~ 225 (465)
|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.. ..+.+
T Consensus 225 L~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVL 296 (367)
T ss_dssp ECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHH
T ss_pred ECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHH
Confidence 999999986543221 123345678999999999999999999999999999999998 999998743 33444
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+........ ...+|+++.+|+..||+.||++||++.+|.+.|+.+..
T Consensus 297 ~~i~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 297 EFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 44433332222 24678999999999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=339.83 Aligned_cols=254 Identities=18% Similarity=0.277 Sum_probs=206.1
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---------ccHHHHHHHHHHHcCCCCCceeEEEe
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---------PQLHYESKLYMLLQGGTGVPHLKWFG 72 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---------~~~~~E~~il~~l~~~~~i~~l~~~~ 72 (465)
..+..++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..++|++++..+..+.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 356789999999999999999999999999999999998654322 46788999999998877777766653
Q ss_pred EeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCc-----
Q 012336 73 VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQ----- 144 (465)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~----- 144 (465)
... +++|+++ +++|.+++......+++..++.++.|++.||.|||++| |+||||||+|||+. .++.
T Consensus 94 ~~~---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~ 167 (287)
T 4f0f_A 94 NPP---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVC 167 (287)
T ss_dssp TTT---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCC
T ss_pred CCC---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCcee
Confidence 322 6899998 79999988765678999999999999999999999999 99999999999994 4444
Q ss_pred EEEEecCCccccccccCcccccccCCCCcccccccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH
Q 012336 145 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL--GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222 (465)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~--~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~ 222 (465)
+||+|||+++..... .....||+.|+|||++. ...++.++||||||+++|+|++|..||........
T Consensus 168 ~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~- 236 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI- 236 (287)
T ss_dssp EEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-
T ss_pred EEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-
Confidence 999999999754321 23457999999999984 45578999999999999999999999987654333
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
.....+........ ....+|+++.+++..||..||++||++.+|.+.|++
T Consensus 237 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 237 KFINMIREEGLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHhccCCCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 22222333222222 224679999999999999999999999999998864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=349.11 Aligned_cols=271 Identities=19% Similarity=0.254 Sum_probs=215.0
Q ss_pred ccCCceEEE-eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLG-RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~-~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
.|.++|.+. +.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.++++|..+..++......
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 467889998 899999999999999999999999999875432 236788999999998877777777777788889
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 79 VMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
++|||++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+.....++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 9999998 77999887532 367999999999999999999999999999999999999953223789999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+.+..+.......+
T Consensus 185 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 253 (327)
T 3lm5_A 185 GHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED---NQETYLNISQVNVDYS 253 (327)
T ss_dssp -----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCC
T ss_pred CCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHHHhcccccC
Confidence 4322 1234679999999999999999999999999999999999999998743 3344444443333322
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
. .....+++++.++|..||..||++||++.+|.+ .+|...++|.....+
T Consensus 254 ~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~----------h~~~~~~~~~~~~~~ 302 (327)
T 3lm5_A 254 E-ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS----------HSWLQQWDFENLFHP 302 (327)
T ss_dssp T-TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT----------CGGGCCCCTTCC---
T ss_pred c-hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC----------CHhhcccccccccCc
Confidence 2 223567999999999999999999999777643 566666777765543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.35 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=214.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+-.++|++++.||+|+||.||+|.+ .++.||||+++.......+..|+.+++.++|++++..+..+.......++|||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3457899999999999999999987 47899999998777777899999999999999888888887766667899999
Q ss_pred cc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~-~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCccccccc--
Confidence 98 8899999986543 47999999999999999999999999999999999999 58899999999999854321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....+++.|+|||++.+..++.++||||||+++|||++ |..||.+.........+ .... ..+.
T Consensus 343 --------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~~-~~~~--- 407 (450)
T 1k9a_A 343 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGY-KMDA--- 407 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---HTTC-CCCC---
T ss_pred --------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC-CCCC---
Confidence 123357889999999999999999999999999999998 99999987655443332 2221 1111
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
...+|+++.++|..||..||++||++.+|.+.|+++...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 246799999999999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=349.41 Aligned_cols=265 Identities=18% Similarity=0.316 Sum_probs=213.9
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCC-------CcEEEEEEeecCCCC---ccHHHHHHHHHHH-cCCCCCceeEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQT-------GEEVAVKLESVKTKH---PQLHYESKLYMLL-QGGTGVPHLKWF 71 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~-------~~~vAvKi~~~~~~~---~~~~~E~~il~~l-~~~~~i~~l~~~ 71 (465)
.+..++|++++.||+|+||.||+|++..+ +..||||++...... ..+..|++++..+ +|++++..+. +
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~-~ 143 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG-A 143 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE-E
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhee-e
Confidence 35678999999999999999999997543 358999998765332 3578999999999 5555555544 4
Q ss_pred eEeCcEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcee
Q 012336 72 GVEGEYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFL 135 (465)
Q Consensus 72 ~~~~~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NIL 135 (465)
+......++|||++ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 55666788999999 889999998643 35999999999999999999999999999999999999
Q ss_pred eccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCC
Q 012336 136 MGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (465)
Q Consensus 136 l~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~ 214 (465)
+ +.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 224 l---~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 224 V---TEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp E---CTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred E---cCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9 5889999999999986643221 122345568899999999999999999999999999999999 999998
Q ss_pred CCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 215 GLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
+... .+....+........ ...+++++.+++..||..||++||++.+|.+.|+.+......+
T Consensus 296 ~~~~---~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 296 GVPV---EELFKLLKEGHRMDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp TCCH---HHHHHHHHTTCCCCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred CCCH---HHHHHHHHcCCCCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 7543 333333333322211 2467899999999999999999999999999999998766444
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=334.80 Aligned_cols=257 Identities=20% Similarity=0.278 Sum_probs=211.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+-.++|++++.||+|+||.||+|++. +++.||||++.... ....+.+|+.++..++|++++..+..+ .+....+++|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 84 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVF 84 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCceEEEE
Confidence 34689999999999999999999975 57889999987654 345689999999999987766666555 4556688999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc
Confidence 998 889999998666779999999999999999999999999999999999999 5788999999999986543221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+....+........
T Consensus 162 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~~~---- 228 (269)
T 4hcu_A 162 ------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRLYK---- 228 (269)
T ss_dssp ------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCCC----
T ss_pred ------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccCCC----
Confidence 22344567889999999999999999999999999999999 9999987433 334433333322211
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
...+++++.+++..||..||++||++.++.+.|+.+..
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 13468999999999999999999999999999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.00 Aligned_cols=258 Identities=19% Similarity=0.298 Sum_probs=201.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCC-CCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGG-TGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~-~~i~~l~~~~~~~~~~ 78 (465)
+.+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.++..++|+ ++|..+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 4688999999999999999999986 57899999998765433 3578899999999874 6677777777788899
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 79 VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|||+.+++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+ .++.+||+|||+++....
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----ECCcEEEeecccccccCc
Confidence 99999889999999986 5689999999999999999999999999999999999999 467899999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccC-----------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-----------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....+..
T Consensus 160 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~ 232 (343)
T 3dbq_A 160 DTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred cccc-----ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence 3221 12235679999999999865 6688999999999999999999999976432 2222222
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+........ .....+.++.+|+..||..||.+||++.++ |++.|...
T Consensus 233 ~~~~~~~~~---~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~ 279 (343)
T 3dbq_A 233 IIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQI 279 (343)
T ss_dssp HHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHS
T ss_pred HhcCCcccC---CcccCCHHHHHHHHHHcCCChhHCCCHHHH---HhCccccc
Confidence 222111111 113457899999999999999999996555 55666553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.43 Aligned_cols=277 Identities=17% Similarity=0.173 Sum_probs=196.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEe----C
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVE----G 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~----~ 75 (465)
.+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+... .
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 457899999999999999999999999999999998865322 23578999999999988888887776443 2
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...|+|||+++++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 130 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred ceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchh
Confidence 56899999999999999974 5679999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccc--------------------cccCCCCccccccccccccc-cCCCCCCcchHHHHHHHHHHHhc------
Q 012336 156 YRDLQTHKHI--------------------PYRENKNLTGTARYASVNTH-LGVEQSRRDDLESLGYVLMYFLR------ 208 (465)
Q Consensus 156 ~~~~~~~~~~--------------------~~~~~~~~~Gt~~Y~APE~~-~~~~~s~k~DiwSLGviL~ellt------ 208 (465)
.......... ........+||+.|+|||++ .+..++.++|||||||+||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6432211000 00123456789999999986 45669999999999999999998
Q ss_pred -----CCCCCCCCCCCc-----------------hHHHHHHHhhhhcc--------------------------CcHHHH
Q 012336 209 -----GSLPWQGLKAGT-----------------KKQKYDKISEKKML--------------------------TPIEVL 240 (465)
Q Consensus 209 -----G~~Pf~~~~~~~-----------------~~~~~~~i~~~~~~--------------------------~~~~~~ 240 (465)
|+++|.+..... ....+..+....-. ......
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 677776633100 01111111111000 111112
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
...+++++.+||.+||..||++||++++++ + ++|+..+.|....
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L---~-------Hp~f~~~~~~~~e 409 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECL---A-------HPFFKEVRIAEVE 409 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHH---H-------SGGGTTTCCGGGC
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHh---c-------CHhhhhcCCCccC
Confidence 245689999999999999999999976654 3 4555556666543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=355.45 Aligned_cols=259 Identities=19% Similarity=0.277 Sum_probs=212.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.+.|++++..+..+ ......++|
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv 190 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIV 190 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-CSSSSCEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ecCCCcEEE
Confidence 45789999999999999999999988999999999875422 23688899999999988777766665 455567899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSE
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCc
Confidence 9998 899999998656679999999999999999999999999999999999999 588999999999997643321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+... .+....+.... ..+.
T Consensus 268 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~-~~~~-- 336 (377)
T 3cbl_A 268 YA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGG-RLPC-- 336 (377)
T ss_dssp EE-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTC-CCCC--
T ss_pred ee-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC-CCCC--
Confidence 10 11123346788999999998889999999999999999998 9999988543 23332222222 2221
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
...+|+++.++|..||..||++||++.+|.+.|+.+..+
T Consensus 337 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 -PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 135689999999999999999999999999999988654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=339.31 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=198.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++++.||+|+||.||+|++ .+++.||||++..... ...+.+|+.+++.++|++++..+..+ ......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-ccCCeEEEEE
Confidence 5899999999999999999998 6899999999865432 34678999999999887766666555 5566789999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCccc--
Confidence 999889999998766789999999999999999999999999999999999999 588999999999998654321
Q ss_pred ccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh---------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 232 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (465)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+.......
T Consensus 155 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 155 -----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 112345789999999999764 58999999999999999999999998754322222221111100
Q ss_pred ------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+.+.....+++++.+||..||..||++||++.++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00111223356789999999999999999999976654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=332.14 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=211.9
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
..+.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++|++++..+..+ ......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-EcCCEE
Confidence 46889999999999999999999999999999999998765432 3577899999999887766655554 566778
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+..++.++.+||+|||++....
T Consensus 81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999998 7899888875 4679999999999999999999999999999999999999643345569999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+....+.......+.
T Consensus 160 ~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS 228 (284)
T ss_dssp SSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT
T ss_pred cCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc
Confidence 322 1234679999999999999999999999999999999999999998743 34444444444333332
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+ ....+++++.+++..||..||++||++.++ |++.|...
T Consensus 229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (284)
T 3kk8_A 229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQA---LKVPWICN 267 (284)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHH---TTSHHHHS
T ss_pred h-hhcccCHHHHHHHHHHcccChhhCCCHHHH---hcCccccC
Confidence 2 224679999999999999999999996655 55666544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.95 Aligned_cols=259 Identities=17% Similarity=0.282 Sum_probs=211.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+-.++|++++.||+|+||.||+|.+. ++..||||++.... ....+..|+.++..++|++++..+..+ .+....++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-ecCCCeEEEE
Confidence 45679999999999999999999864 67889999987654 345688999999999987766666555 5566788999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc
Confidence 998 899999998656779999999999999999999999999999999999999 5888999999999986643221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+........
T Consensus 176 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~~~---- 242 (283)
T 3gen_A 176 ------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLYR---- 242 (283)
T ss_dssp ------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCCC----
T ss_pred ------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCCCC----
Confidence 12334567889999999998899999999999999999998 9999987543 333333333322211
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+++++.+++..||..||++||++.+|.+.|.+++.++
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1346899999999999999999999999999999988654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=353.87 Aligned_cols=256 Identities=18% Similarity=0.295 Sum_probs=200.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcC-CCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQG-GTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~-~~~i~~l~~~~~~~~~~~ 79 (465)
.+.+|++++.||+|+||.||+|.+. +++.||||++...... ..+.+|+.++..+.| +++|..+..++......+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3567999999999999999999975 4899999998765432 457899999999986 567777777777788899
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+|||+.+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||+ .++.+||+|||+++.+...
T Consensus 133 lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 133 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC---
T ss_pred EEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccCC
Confidence 9999889999999986 4589999999999999999999999999999999999999 3588999999999876432
Q ss_pred cCcccccccCCCCccccccccccccccC-----------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLG-----------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i 228 (465)
... .......||+.|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..+
T Consensus 208 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~ 280 (390)
T 2zmd_A 208 TTS-----VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI 280 (390)
T ss_dssp -----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHH
T ss_pred Ccc-----ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHH
Confidence 211 12245679999999999876 3688999999999999999999999976432 22233333
Q ss_pred hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
........ .....+.++.+||..||..||.+||++.+| |++.|..
T Consensus 281 ~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~el---l~hp~~~ 325 (390)
T 2zmd_A 281 IDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 325 (390)
T ss_dssp HCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred hCccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHH---hhCcCcc
Confidence 32222111 113347899999999999999999996655 5566654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=348.70 Aligned_cols=265 Identities=18% Similarity=0.279 Sum_probs=210.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecC------CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVK------TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~------~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.++|++++.||+|+||.||+|++. .+++.||||++... .....+..|+.++..+.++++|..+..+.....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999984 48999999987643 233457789999999987777777777777788
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 899999999 7899999975 4579999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH-HHHHHHhhhh
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYDKISEKK 232 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~-~~~~~i~~~~ 232 (465)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||......... .....+....
T Consensus 209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 6432221 1234679999999999986 34789999999999999999999999865433322 2222222222
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccCC
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
.. ....+++.+.+||..||..||.+|| ++.++.+ .+++..++|..+..
T Consensus 283 ~~-----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~----------h~~f~~~~~~~l~~ 335 (355)
T 1vzo_A 283 PP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE----------HLFFQKINWDDLAA 335 (355)
T ss_dssp CC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT----------SGGGTTCCHHHHHT
T ss_pred CC-----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc----------CcchhcCChhHhhh
Confidence 21 1246789999999999999999999 7665543 45556678887653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=341.03 Aligned_cols=261 Identities=21% Similarity=0.385 Sum_probs=200.6
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++.+++|++.+.||+|+||.||+|++ ...||||++...... ..+.+|+.+++.++|++++..+.+ . ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-S-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-E-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-c-cCCc
Confidence 468899999999999999999999985 346999998765433 357889999999998887776663 3 3445
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEEccceecccc
Confidence 67888888 799999997666789999999999999999999999999999999999999 47899999999999765
Q ss_pred ccccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
...... .......||+.|+|||++. +..++.++||||||+++|+|++|..||.+... ..+....+.....
T Consensus 171 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~ 243 (289)
T 3og7_A 171 SRWSGS-----HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSL 243 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSC
T ss_pred cccccc-----ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhccccc
Confidence 432111 1223467999999999987 56688899999999999999999999987543 2333333334444
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
..........+|+++.+++..||..||++||++.+|.+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 44444445678999999999999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.85 Aligned_cols=255 Identities=17% Similarity=0.229 Sum_probs=209.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+-.++|++++.||+|+||.||+|.+. ++..||||++.... ....+..|+.++..++|++++..+..+ ......++||
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 82 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-SKEYPIYIVT 82 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCceEEEE
Confidence 55789999999999999999999864 67789999987654 345688999999999987766666555 5566788999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 83 EYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCE
T ss_pred EccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhhh
Confidence 998 889999998766679999999999999999999999999999999999999 5889999999999986544321
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..... .+....+........
T Consensus 160 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~~---- 226 (268)
T 3sxs_A 160 ------VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLYR---- 226 (268)
T ss_dssp ------EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCCC----
T ss_pred ------hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCCC----
Confidence 12234567888999999999899999999999999999999 9999987443 333333333322221
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...+++++.+++..||..||.+||++.+|.+.|+.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (268)
T 3sxs_A 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262 (268)
T ss_dssp CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 134689999999999999999999999999988765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.47 Aligned_cols=260 Identities=17% Similarity=0.205 Sum_probs=196.0
Q ss_pred CCceEEE-eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCce-eEEEeE---eCcEEEE
Q 012336 6 GGKFKLG-RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH-LKWFGV---EGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~-~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~-l~~~~~---~~~~~~l 80 (465)
-++|.+. +.||.|+||+||+|++..+++.||||++.. ...+.+|+.++.++.+|++|.. +..|.. ...+.||
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 3566666 799999999999999999999999999863 3567889998876655444444 444433 2567899
Q ss_pred EEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 81 VIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|||++ |++|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999 789999998532 4699999999999999999999999999999999999995332378999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch-HHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~ 237 (465)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ......+.......+.
T Consensus 217 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 217 HN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp ------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred CC--------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 21 12356799999999999999999999999999999999999999987543221 1122223333332222
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
. ....+++++.+||..||..||++||++.+ +|++.|...
T Consensus 289 ~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~e---il~hp~~~~ 327 (400)
T 1nxk_A 289 P-EWSEVSEEVKMLIRNLLKTEPTQRMTITE---FMNHPWIMQ 327 (400)
T ss_dssp T-TTTTSCHHHHHHHHTTSCSSGGGSCCHHH---HHHSHHHHT
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHH---HhcCccccC
Confidence 1 22467999999999999999999999655 456666544
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=351.18 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=208.1
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
....-++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++|++++..+..+ ....
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~ 82 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-TTPT 82 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-ECSS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCC
Confidence 345668999999999999999999999999999999998643 2345688999999999987766666554 5566
Q ss_pred EEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
..++|||+++++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTT
T ss_pred EEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceec
Confidence 7899999999999998875 4679999999999999999999999999999999999999 58899999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........ .+......
T Consensus 159 ~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---~i~~~~~~- 226 (336)
T 3h4j_B 159 TDGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---KVNSCVYV- 226 (336)
T ss_dssp TTSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC---CCCSSCCC-
T ss_pred cCCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH---HHHcCCCC-
Confidence 4322 2245679999999999998876 789999999999999999999998754322211 11111111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
....+++++.+||..||..||.+||++.+| +++.|...+
T Consensus 227 ----~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~~ 265 (336)
T 3h4j_B 227 ----MPDFLSPGAQSLIRRMIVADPMQRITIQEI---RRDPWFNVN 265 (336)
T ss_dssp ----CCTTSCHHHHHHHHTTSCSSGGGSCCHHHH---TTCHHHHTT
T ss_pred ----CcccCCHHHHHHHHHHcCCChhHCcCHHHH---HhChhhccC
Confidence 123568999999999999999999996554 566666543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=338.79 Aligned_cols=252 Identities=19% Similarity=0.292 Sum_probs=208.9
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------CccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------HPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
..+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+..+ .+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-EN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-EC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-ec
Confidence 3467889999999999999999999999999999999876432 23588999999999987766655554 56
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC----cEEEEe
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN----QVYIID 149 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~----~vkL~D 149 (465)
....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. .++ .++|+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~D 162 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEcc
Confidence 67889999999 8899999974 56799999999999999999999999999999999999994 555 799999
Q ss_pred cCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 150 YGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+.+..+.
T Consensus 163 fg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANIT 231 (321)
T ss_dssp CTTCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHH
T ss_pred CccceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH
Confidence 99998765421 1235579999999999999999999999999999999999999998743 344444444
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
......+ ......+++++.++|..||..||++||++.++.+
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSYDFD-EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCCCC-HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccccC-hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4433333 3344678999999999999999999999777654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=343.23 Aligned_cols=257 Identities=17% Similarity=0.248 Sum_probs=203.3
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCC-cEEEEEEeecCC-CCccHHHHHHHHHHHcCCCC-----CceeEEEeE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTG-EEVAVKLESVKT-KHPQLHYESKLYMLLQGGTG-----VPHLKWFGV 73 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~-~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~-----i~~l~~~~~ 73 (465)
++.++.++|++++.||+|+||.||+|++..++ +.||||++.... ....+..|+.++..+.|++. +..+..+..
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 46788999999999999999999999998776 799999987432 23457789999999987553 444555666
Q ss_pred eCcEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-------------
Q 012336 74 EGEYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG------------- 139 (465)
Q Consensus 74 ~~~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~------------- 139 (465)
.....++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+...
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 777899999999999998887643 579999999999999999999999999999999999999422
Q ss_pred ---CCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCC
Q 012336 140 ---RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGL 216 (465)
Q Consensus 140 ---d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~ 216 (465)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 25789999999999764321 23567999999999999999999999999999999999999999875
Q ss_pred CCCchHHHHHHHhhhhccCcHHHH-----------------------------h----------ccCcHHHHHHHHHHhc
Q 012336 217 KAGTKKQKYDKISEKKMLTPIEVL-----------------------------C----------KSYPSEFTSYFHYCRS 257 (465)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~-----------------------------~----------~~~p~~l~~li~~cl~ 257 (465)
........+..+ ....+.... | ...++++.+||..||.
T Consensus 243 ~~~~~~~~~~~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENREHLVMMEKI---LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHHHHHHHHHHH---HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHHH---cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 432222222221 111111100 0 1124689999999999
Q ss_pred CCCCCCCCHHHHH
Q 012336 258 LRFEDKPDYSYLK 270 (465)
Q Consensus 258 ~dp~~RPt~~~l~ 270 (465)
.||++||++.++.
T Consensus 320 ~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 320 FDPAQRITLAEAL 332 (355)
T ss_dssp SSTTTSCCHHHHT
T ss_pred CChhhCcCHHHHh
Confidence 9999999977664
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=354.45 Aligned_cols=275 Identities=15% Similarity=0.198 Sum_probs=204.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeC----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEG---- 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (465)
.+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4689999999999999999999999999999999998754322 36789999999999988888777765543
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...|+|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCccc
Confidence 56899999999999999974 5679999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccc---------------cccCCCCccccccccccccc-cCCCCCCcchHHHHHHHHHHHhcCCCC-------
Q 012336 156 YRDLQTHKHI---------------PYRENKNLTGTARYASVNTH-LGVEQSRRDDLESLGYVLMYFLRGSLP------- 212 (465)
Q Consensus 156 ~~~~~~~~~~---------------~~~~~~~~~Gt~~Y~APE~~-~~~~~s~k~DiwSLGviL~elltG~~P------- 212 (465)
.......... ........+||+.|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543211000 00112467899999999986 455699999999999999999985444
Q ss_pred ----CCCCCCCc--------------hHHHHHHHhhh--------------------------hccCcHHHHhccCcHHH
Q 012336 213 ----WQGLKAGT--------------KKQKYDKISEK--------------------------KMLTPIEVLCKSYPSEF 248 (465)
Q Consensus 213 ----f~~~~~~~--------------~~~~~~~i~~~--------------------------~~~~~~~~~~~~~p~~l 248 (465)
|.+..... ....+..+.+. ....+.......+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 43322100 01111111110 01111222335689999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccc
Q 012336 249 TSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTI 292 (465)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 292 (465)
.+||..||..||++||+++++++ ++|...+.|..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~----------Hp~f~~~~~~~ 372 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALD----------HPYLKDVRKKK 372 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHT----------CGGGTTTCCTT
T ss_pred HHHHHHHhcCCcccCCCHHHHhc----------ChhhhhccCcc
Confidence 99999999999999999766543 45555555543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=346.24 Aligned_cols=255 Identities=23% Similarity=0.274 Sum_probs=188.9
Q ss_pred cCCceEEE---eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLG---RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~---~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
|-++|.+. +.||+|+||.||+|++..+++.||||++... ....+..|+.+++.+.+|++|..+..++.+....++|
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 45678886 7899999999999999999999999998754 3456788999999998556666666666777888999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||+..++.+..+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999 7899999986 5679999999999999999999999999999999999999633334489999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC----CchHHHHHHHhhhhccCc
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~ 236 (465)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ....+.+..+.......+
T Consensus 164 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 164 Q-------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred C-------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 1 12355789999999999999999999999999999999999999987443 223444555554444333
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.+ ....+++++.+||..||..||.+||++.++
T Consensus 237 ~~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 268 (325)
T 3kn6_A 237 GE-AWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268 (325)
T ss_dssp SH-HHHTSCHHHHHHHHHHHCCCTTTCCCTTTS
T ss_pred cc-cccCCCHHHHHHHHHHCCCChhHCCCHHHH
Confidence 22 235689999999999999999999997665
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.64 Aligned_cols=260 Identities=19% Similarity=0.258 Sum_probs=202.0
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEE----EEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEV----AVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~v----AvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+..++|++++.||+|+||+||+|++..+++.| |+|.+.... ....+..|+.++..++|++++..+..+.. +
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-S
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-C
Confidence 355789999999999999999999988887754 777664332 23468899999999998877777766654 4
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++++++.+++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE---CCCCCEEEccCcceeE
Confidence 4444445555999999998767789999999999999999999999999999999999999 4889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ .... .
T Consensus 167 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~-~ 237 (327)
T 3poz_A 167 LGAEEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGE-R 237 (327)
T ss_dssp HTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTC-C
T ss_pred ccCCccc-----ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH---HcCC-C
Confidence 6543221 12234467889999999999999999999999999999999 99999886554333222 2221 1
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+. ...++.++.+++..||..||++||++.+|.+.|+.+..
T Consensus 238 ~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 LPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 13468999999999999999999999999999887753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=345.45 Aligned_cols=253 Identities=18% Similarity=0.230 Sum_probs=196.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+ ......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII-HTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEE-ECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEE-eeCCEEEEEec
Confidence 589999999999999999999999999999998865432 22466799999999887766655554 56677899999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~--- 154 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT--- 154 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCc---
Confidence 99999999998877789999999999999999999999999999999999999 588999999999997654321
Q ss_pred cccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc--------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML-------- 234 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (465)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.........
T Consensus 155 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 ----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 12234578999999999887 56899999999999999999999999885443322222221111000
Q ss_pred --------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 --------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 --------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.........+++++.+||..||..||.+||++.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 001122235789999999999999999999976654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.96 Aligned_cols=259 Identities=20% Similarity=0.321 Sum_probs=210.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+..++|++++.||+|+||.||+|++. .+++.||||++..... ...+.+|+.++..++|++++..+..+ ...
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~ 122 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-AVG 122 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ccC
Confidence 45689999999999999999999986 3458999999875432 23578899999999887766666655 456
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN-----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~-----------------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP 131 (465)
...++|||++ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp 202 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 202 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 6788999998 789999997632 5799999999999999999999999999999999
Q ss_pred CceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CC
Q 012336 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GS 210 (465)
Q Consensus 132 ~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~ 210 (465)
+|||+ +.++.+||+|||++........ +.......||+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 203 ~NIl~---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 203 RNCLV---GENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp GGEEE---CGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEE---CCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999 5888999999999987643221 122345678999999999999899999999999999999999 99
Q ss_pred CCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 211 LPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.||.+... .+....+....... ....+|+++.+++..||..||++||++.+|.+.|+.+..
T Consensus 275 ~p~~~~~~---~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 275 QPYYGMAH---EEVIYYVRDGNILA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CTTTTSCH---HHHHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CcCCCCCh---HHHHHHHhCCCcCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 99987443 33333333333221 124678999999999999999999999999999988754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=345.87 Aligned_cols=256 Identities=19% Similarity=0.217 Sum_probs=206.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC----cEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG----EYN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~~~ 78 (465)
+++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|++++..++|++++..+..+.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 58999999999999999999999999999999998743322 45789999999999988888777765433 468
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 79 VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++||++++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 106 ~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCC
Confidence 99999999999999974 579999999999999999999999999999999999999 5889999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh------
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK------ 231 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~------ 231 (465)
..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 181 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 181 DHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp GGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred CCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 32211 11245689999999998764 45899999999999999999999999886554443333221110
Q ss_pred -----------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 -----------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 -----------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....+.......+++++.+||..||..||++||++.++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 011122333456789999999999999999999966553
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.82 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=212.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC--CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK--TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~--~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-+.++|++.+.||+|+||.||+|.+..++..||+|++... .....+..|+.+++.++|++++..+.. +......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-FEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEE-EECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEE-EecCCeEEEE
Confidence 3578999999999999999999999999999999998754 234568899999999988776665555 4567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+..++.++.++|+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 8899998875 5679999999999999999999999999999999999999655678999999999998764322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
......||+.|+|||++.+. ++.++||||||+++|+|++|..||.... ..+....+.......+.. .
T Consensus 164 --------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~-~ 230 (277)
T 3f3z_A 164 --------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFPEK-D 230 (277)
T ss_dssp --------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCHH-H
T ss_pred --------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCch-h
Confidence 22355799999999998765 8999999999999999999999998743 344444455544444433 3
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+++++.+++..||..||++||++.++ |++.|.+.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~---l~h~~~~~ 267 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQA---LEHEWFEK 267 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHHHH
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHH---hcCHHHhc
Confidence 34789999999999999999999996655 55555443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=359.45 Aligned_cols=249 Identities=19% Similarity=0.234 Sum_probs=196.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|++++..+..+....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4689999999999999999999999999999999987542 2235788999999999988888887775433
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++|||++.++|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence 4679999999888888775 359999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. ...+..+.......
T Consensus 214 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 214 AGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTP 282 (464)
T ss_dssp ---CC--------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSC
T ss_pred cCCCc--------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 54321 22456899999999999999999999999999999999999999988543 22333322211111
Q ss_pred cHHH-------------------------Hh------------ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 PIEV-------------------------LC------------KSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ~~~~-------------------------~~------------~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+. .. ...++++.+||.+||..||++|||++++.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1100 00 01156799999999999999999966654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=348.07 Aligned_cols=262 Identities=17% Similarity=0.221 Sum_probs=202.2
Q ss_pred cCCceEEEeeEeee--CceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 5 IGGKFKLGRKIGSG--SFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 5 ~~~~y~l~~~LG~G--~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
-+++|++++.||+| +||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+ ......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-IADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE-EECCEE
Confidence 46899999999999 9999999999999999999998765432 3467799999999987777766555 466688
Q ss_pred EEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 79 VMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
++||+++ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999998 89999999764 3679999999999999999999999999999999999999 58899999999998765
Q ss_pred ccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh---
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--- 231 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (465)
..................||+.|+|||++.+ ..++.++|||||||++|||++|..||.+................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 4322111111122344579999999999988 57899999999999999999999999875543322111100000
Q ss_pred -----------------------------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 -----------------------------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 -----------------------------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
....+.......+++++.+||..||..||++||++.++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000001112345789999999999999999999977654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=363.69 Aligned_cols=271 Identities=20% Similarity=0.235 Sum_probs=217.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+-.++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..++|++++..+. +.......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY-AFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE-EEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEE-EEeeCCEE
Confidence 4458899999999999999999999999999999998753 22346788999999998766655554 45566788
Q ss_pred EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
|+||+++ |++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 89999998753 2469999999999999999999999999999999999999 589999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC-chHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~ 233 (465)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...+....+.....
T Consensus 338 ~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQT-------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCC-------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCc-------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 7643221 123568999999999999999999999999999999999999999875432 23344444444333
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCccccccccCCCC
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSY--LKRLFRDLFIREGYQFDYVFDWTILKYPQ 297 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~~~~~~~~~~~~~~dw~~~~~~~ 297 (465)
..+ ..+++++.+||..||..||.+||++.+ +.+++ .++|+..++|..+....
T Consensus 411 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~-------~Hpff~~i~w~~l~~~~ 464 (543)
T 3c4z_A 411 TYP-----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR-------THPLFRDISWRQLEAGM 464 (543)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH-------TSGGGTTCCHHHHHTTC
T ss_pred CCC-----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH-------cCccccCCCHHHHHcCC
Confidence 333 467999999999999999999997532 12222 36777788998765433
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=342.77 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=187.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+.|++++..+..+ ......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-HTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-CCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-EECCeEEEEE
Confidence 5789999999999999999999999999999999875432 34688999999999887766666554 4566889999
Q ss_pred eccCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 83 DLLGPSLEDLFNYCN-----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 83 e~~g~sL~~ll~~~~-----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999999999987532 469999999999999999999999999999999999999 588999999999998754
Q ss_pred cccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc--
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML-- 234 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (465)
... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+.........
T Consensus 160 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 321 122345789999999999864 5899999999999999999999999875443222222211110000
Q ss_pred -------------------C-c----HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 -------------------T-P----IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 -------------------~-~----~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. . .......+++++.+||..||..||++||++.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 0 0 0011125788999999999999999999976653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.61 Aligned_cols=252 Identities=20% Similarity=0.264 Sum_probs=201.5
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCC-----CCCceeEEEeEeCc
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGG-----TGVPHLKWFGVEGE 76 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~-----~~i~~l~~~~~~~~ 76 (465)
..+.++|++++.||+|+||+||+|++..+++.||||++..... ...+..|+.++..+.+. ++|..+..++....
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4577899999999999999999999999999999999875432 34677899999998753 24445555566778
Q ss_pred EEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc--EEEEecCCc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ--VYIIDYGLA 153 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~--vkL~DFGla 153 (465)
..++||++++++|.+++.... ..+++..+..|+.||+.||.|||++||+||||||+|||+. .++. +||+|||++
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTC
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccc
Confidence 899999999999999998643 4599999999999999999999999999999999999994 5655 999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
..... ......||+.|+|||++.+..++.++|||||||+||||++|..||.+.... +.+..+.+...
T Consensus 250 ~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~---~~l~~i~~~~~ 316 (429)
T 3kvw_A 250 CYEHQ----------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG---DQLACMIELLG 316 (429)
T ss_dssp EETTC----------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHC
T ss_pred eecCC----------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcC
Confidence 75432 123567999999999999999999999999999999999999999885432 22222222111
Q ss_pred cCcHH------------------------------------------------------HHhccCcHHHHHHHHHHhcCC
Q 012336 234 LTPIE------------------------------------------------------VLCKSYPSEFTSYFHYCRSLR 259 (465)
Q Consensus 234 ~~~~~------------------------------------------------------~~~~~~p~~l~~li~~cl~~d 259 (465)
..+.. .+....++++.+||..||..|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 11111 111123788999999999999
Q ss_pred CCCCCCHHHHH
Q 012336 260 FEDKPDYSYLK 270 (465)
Q Consensus 260 p~~RPt~~~l~ 270 (465)
|++|||+.++.
T Consensus 397 P~~Rpta~e~L 407 (429)
T 3kvw_A 397 PAVRMTPGQAL 407 (429)
T ss_dssp TTTSCCHHHHH
T ss_pred hhhCCCHHHHh
Confidence 99999977664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=345.09 Aligned_cols=260 Identities=21% Similarity=0.226 Sum_probs=199.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
..++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++..+..+ ......++||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEE-eeCCEEEEEEE
Confidence 4689999999999999999999999999999999987643 345688999999999987766665554 56667899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC--cEEEEecCCcccccccc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN--QVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~--~vkL~DFGla~~~~~~~ 160 (465)
++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+. .++ .+||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~---~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEEC---SSSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCceEEEeecCcccccccc-
Confidence 99 8899999875 45799999999999999999999999999999999999994 444 4999999999753321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCc-chHHHHHHHHHHHhcCCCCCCCCCCCc-hHHHHHHHhhhhccCcHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k-~DiwSLGviL~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~ 238 (465)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..... ....+..+.......+..
T Consensus 172 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 172 -------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred -------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 12235579999999999998887655 899999999999999999998755432 233333333333332221
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
..+++++.+||.+||..||.+||++.+ +|++.|.....+
T Consensus 245 ---~~~s~~~~~li~~~L~~dP~~Rps~~e---ll~hp~f~~~~~ 283 (361)
T 3uc3_A 245 ---IRISPECCHLISRIFVADPATRISIPE---IKTHSWFLKNLP 283 (361)
T ss_dssp ---SCCCHHHHHHHHHHSCSCTTTSCCHHH---HHTSHHHHTTCC
T ss_pred ---CCCCHHHHHHHHHHccCChhHCcCHHH---HHhCcchhcCCc
Confidence 356899999999999999999999655 566777665443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=350.57 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=201.3
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcC--------CCCCceeEEE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQG--------GTGVPHLKWF 71 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~--------~~~i~~l~~~ 71 (465)
++.++.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+.+ ++++..+..|
T Consensus 31 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 31 IGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 35788999999999999999999999999999999999987442 23467889999999974 3355555555
Q ss_pred eE---eCcEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCC----
Q 012336 72 GV---EGEYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKS---- 142 (465)
Q Consensus 72 ~~---~~~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~---- 142 (465)
.. .+...++||++++++|.+.+.... ..+++..++.|+.||+.||.|||++ ||+||||||+|||+. .+
T Consensus 111 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~---~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS---VNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEEC---CCHHHH
T ss_pred eecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEe---ccchhh
Confidence 43 456889999999999988887543 5799999999999999999999998 999999999999995 33
Q ss_pred ---------------------------------------------CcEEEEecCCccccccccCcccccccCCCCccccc
Q 012336 143 ---------------------------------------------NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 177 (465)
Q Consensus 143 ---------------------------------------------~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~ 177 (465)
..+||+|||++...... .....||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~gt~ 257 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQTR 257 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCSCG
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCCCC
Confidence 37999999999865432 23457999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch---HHHHHHHhhhhccCcHHH---------------
Q 012336 178 RYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK---KQKYDKISEKKMLTPIEV--------------- 239 (465)
Q Consensus 178 ~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~---~~~~~~i~~~~~~~~~~~--------------- 239 (465)
.|+|||++.+..++.++|||||||+||||++|..||........ ...+..+.......+...
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 337 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTS
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcc
Confidence 99999999999999999999999999999999999987554321 122222221111111110
Q ss_pred ----------------------HhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 240 ----------------------LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 240 ----------------------~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....++++.+||..||..||++||++.+|.
T Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 390 (397)
T 1wak_A 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390 (397)
T ss_dssp SBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHH
T ss_pred ccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 0122356789999999999999999977664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=345.05 Aligned_cols=257 Identities=18% Similarity=0.230 Sum_probs=205.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcE----EEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEE----VAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~----vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+-.++|++++.||+|+||.||+|++..+++. ||+|++.... ....+..|+.++..+.|++++..+.++. . .
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G-S 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B-S
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C-C
Confidence 3468999999999999999999999888876 7777765432 2346788999999999888777777653 3 3
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++||+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 466777777 899999998655689999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
+...... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+......... +......
T Consensus 165 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~~~~~ 236 (325)
T 3kex_A 165 LPPDDKQ-----LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERL 236 (325)
T ss_dssp SCCCTTC-----CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---HHTTCBC
T ss_pred cCccccc-----ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---HHcCCCC
Confidence 6543221 12235568889999999999999999999999999999999 9999988654333322 2222221
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.. ...++.++.+++..||..||.+||++.+|.+.|+.+.
T Consensus 237 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 AQ----PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CC----CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CC----CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 1345788999999999999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=365.65 Aligned_cols=269 Identities=20% Similarity=0.188 Sum_probs=217.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.+..++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..+.|++++..+.. ..+...
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~-~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA-YETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEE-EECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEE-EeeCCE
Confidence 35578899999999999999999999999999999998643 233457889999999988766665544 456678
Q ss_pred EEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.++|||++ |++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence 89999999 899999987533 349999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch-HHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (465)
...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+...... .+....+......
T Consensus 336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~ 407 (576)
T 2acx_A 336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407 (576)
T ss_dssp CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC
T ss_pred cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc
Confidence 643221 1345899999999999999999999999999999999999999987654332 2333333332222
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccCCCCC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQT 298 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 298 (465)
.+ ..+++++.+||..||..||.+|| ++++|++ ++|+..+||..+.....
T Consensus 408 ~p-----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~----------HpfF~~i~w~~l~~~~~ 461 (576)
T 2acx_A 408 YS-----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE----------HPLFKKLNFKRLGAGML 461 (576)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT----------SGGGTTCCHHHHHTTCS
T ss_pred CC-----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh----------ChhhccCCHHHHhcCCC
Confidence 22 46799999999999999999999 5555433 57777789987654333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=344.81 Aligned_cols=263 Identities=18% Similarity=0.188 Sum_probs=205.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeC---cEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEG---EYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~---~~~~lv 81 (465)
.++|++++.||+|+||+||+|++ .++.||||++..... ......|+.++..++|++++..+..+.... ...++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 57899999999999999999987 489999999875432 224556788888899988888888776653 357899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCceeeccCCCCCcEEEEec
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR----------GFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~----------givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
||++ +++|.+++.. +.+++..+..++.||+.||.|||+. ||+||||||+|||+ +.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccC
Confidence 9999 8899999974 5699999999999999999999999 99999999999999 58899999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCC-----CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc-----
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----- 220 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~----- 220 (465)
|+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.....
T Consensus 176 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 176 GLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp TTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999876543221 123446799999999999873 45678899999999999999999998744321
Q ss_pred --------hHHHHHHHhhhhccCcHHHH--hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 221 --------KKQKYDKISEKKMLTPIEVL--CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 221 --------~~~~~~~i~~~~~~~~~~~~--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.......+............ ....++++.+||..||+.||++||++.+|.+.|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111112121111111111 1123567999999999999999999999999999886554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=338.62 Aligned_cols=265 Identities=22% Similarity=0.254 Sum_probs=209.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEE----EcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe-
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGV----NVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE- 74 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~----~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~- 74 (465)
.+...+|++++.||+|+||.||+|+ +..+++.||||++..... ...+..|+.++..++|++++..+..+...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 4456789999999999999999998 567899999999875432 24688999999999988888777776654
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
....+++|+++ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDFGLT 173 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE---cCCCCEEECccccc
Confidence 35678999998 889999997667789999999999999999999999999999999999999 47889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC-----------CchH
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------GTKK 222 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~-----------~~~~ 222 (465)
......... ........||..|+|||++.+..++.++||||||+++|+|++|..||..... ....
T Consensus 174 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 174 KAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp EECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred ccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 876543221 1223456789999999999999999999999999999999999998753210 0011
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
..+..........+ ....+|+++.+++..||..||.+||++.+|.+.|+.++
T Consensus 250 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111111111 12467899999999999999999999999999998875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=336.55 Aligned_cols=263 Identities=18% Similarity=0.270 Sum_probs=211.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEE-----cCCCcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVN-----VQTGEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~-----~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~~~ 74 (465)
+..++|++.+.||+|+||.||+|++ ..+++.||||++..... ...+.+|+.++..+ .|++++..+ .++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~-~~~~~ 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL-GACTI 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE-EEECS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEE-EEEec
Confidence 4568999999999999999999985 35678999999875532 24588999999999 555555544 44555
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceee
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNR-----------------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 136 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~-----------------~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl 136 (465)
....+++||++ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 66778999998 7799999986432 48999999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCC
Q 012336 137 GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 215 (465)
Q Consensus 137 ~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~ 215 (465)
+.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 179 ---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 179 ---THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp ---ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ---cCCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 48899999999999876543221 12334568899999999999999999999999999999999 9999987
Q ss_pred CCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
....... ........... ....+|+++.+++..||..||.+||++.+|.+.|+.++....
T Consensus 251 ~~~~~~~---~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 251 MPVDSKF---YKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CCSSHHH---HHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ccchhHH---HHHhccCCCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 6543222 22222222111 124578999999999999999999999999999999887653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=342.80 Aligned_cols=256 Identities=22% Similarity=0.237 Sum_probs=203.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEe-------
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVE------- 74 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~------- 74 (465)
-++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4789999999999999999999999999999998865433 23578999999999998888887776553
Q ss_pred CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
....++|||++.++|.+.+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence 45789999999999999988666789999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.+....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ...+.....
T Consensus 173 ~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~ 246 (351)
T 3mi9_A 173 AFSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCG 246 (351)
T ss_dssp ECCCCSSSS---CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred ccccccccc---ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhC
Confidence 765322211 122345678999999999876 4589999999999999999999999988543322 222222111
Q ss_pred cCcHHH---------------------------HhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 LTPIEV---------------------------LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 ~~~~~~---------------------------~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+... .....++++.+||..||..||++||++.++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 111100 0001367899999999999999999966554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=332.59 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=199.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.++|++.+.||+|+||.||+|.+..++..||||++..... ...+..|+++++.++|++++..+..+ ......++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-ecCCeEEEE
Confidence 56889999999999999999999999999999999876542 25688999999999987766666555 566678999
Q ss_pred Eecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 82 IDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
||++ +++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9998 78999988542 4679999999999999999999999999999999999999644456889999999997654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+... .+....+........
T Consensus 179 ~~~--------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~~- 245 (285)
T 3is5_A 179 SDE--------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNYA- 245 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCC-
T ss_pred Ccc--------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCcccc-
Confidence 322 123567999999999986 4689999999999999999999999987543 222222222222211
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+..+++++.+|+..||..||++||++.+|.
T Consensus 246 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 246 -VECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp -C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred -cccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 12345789999999999999999999976664
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=336.04 Aligned_cols=256 Identities=18% Similarity=0.243 Sum_probs=202.4
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEE-cCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCC-----CCceeEEEeEe
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVN-VQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGT-----GVPHLKWFGVE 74 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~-~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~-----~i~~l~~~~~~ 74 (465)
+.++.++|++++.||+|+||.||+|.+ ..+++.||||++.... ....+..|+.++..+.|++ .+..+..+...
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 678899999999999999999999998 5578999999986432 2346788999999998754 34455555667
Q ss_pred CcEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC------------
Q 012336 75 GEYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK------------ 141 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~------------ 141 (465)
....++|||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+...+.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 77899999999999999998643 36999999999999999999999999999999999999952111
Q ss_pred ----CCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCC
Q 012336 142 ----SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (465)
Q Consensus 142 ----~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~ 217 (465)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999764321 235679999999999999999999999999999999999999998754
Q ss_pred CCchHHHHHHHhhhhccCcHHHH---------------------------------------hccCcHHHHHHHHHHhcC
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVL---------------------------------------CKSYPSEFTSYFHYCRSL 258 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~---------------------------------------~~~~p~~l~~li~~cl~~ 258 (465)
.......+..+. ...+.... ....++++.+||..||..
T Consensus 239 ~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 SKEHLAMMERIL---GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp HHHHHHHHHHHH---CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred hHHHHHHHHHHh---CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 432222222211 11111100 012357899999999999
Q ss_pred CCCCCCCHHHHH
Q 012336 259 RFEDKPDYSYLK 270 (465)
Q Consensus 259 dp~~RPt~~~l~ 270 (465)
||.+||++.++.
T Consensus 316 dP~~Rpt~~ell 327 (339)
T 1z57_A 316 DPAKRITLREAL 327 (339)
T ss_dssp STTTSCCHHHHT
T ss_pred CcccccCHHHHh
Confidence 999999977664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=343.98 Aligned_cols=261 Identities=18% Similarity=0.246 Sum_probs=206.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCC---CCccHHHHHHHHHHH-cCCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKT---KHPQLHYESKLYMLL-QGGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l-~~~~~i~~l~~~~~~ 74 (465)
+-.++|++++.||+|+||.||+|++. .++..||||++.... ....+..|+.++..+ .|++++..+. ++..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~-~~~~ 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG-ACTL 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE-EECS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEE-EEee
Confidence 34679999999999999999999973 456789999987542 345688999999999 5555555444 4555
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNR----------------------KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~----------------------~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP 131 (465)
....++||+++ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 66788999998 8899999975432 379999999999999999999999999999999
Q ss_pred CceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CC
Q 012336 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GS 210 (465)
Q Consensus 132 ~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~ 210 (465)
+|||+ +.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 201 ~NIll---~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 201 RNVLV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp GGEEE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred hhEEE---cCCCcEEeCCCccCcccccCccc-----eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 99999 48899999999999876543221 12345568899999999999999999999999999999998 99
Q ss_pred CCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 211 LPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.||.+...... +............ ...+++++.+++..||..||.+||++.+|.+.|+.++..
T Consensus 273 ~p~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 273 NPYPGIPVDAN---FYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSSTTCCCSHH---HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCcccCCcHHH---HHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 99988654322 2222222222221 135689999999999999999999999999999887654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=341.17 Aligned_cols=265 Identities=22% Similarity=0.219 Sum_probs=202.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.-++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+.. ...+...++
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV-IHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEE-EEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEE-EecCCEEEE
Confidence 45789999999999999999999999999999999875432 2357789999999988776665555 456778899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC--CCCCcEEEEecCCcccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG--RKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~--d~~~~vkL~DFGla~~~~~ 158 (465)
|||++.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||++.....
T Consensus 111 v~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 111 IFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999999999999985 5579999999999999999999999999999999999999532 2455699999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC--
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT-- 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-- 235 (465)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... ...+..+.......
T Consensus 190 ~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 190 PI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE---IDQLFKIFEVLGLPDD 259 (329)
T ss_dssp -----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCT
T ss_pred cc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH---HHHHHHHHHHhCCCch
Confidence 21 1223457899999999998754 89999999999999999999999987443 22332222211110
Q ss_pred -----------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012336 236 -----------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT 291 (465)
Q Consensus 236 -----------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~ 291 (465)
........+++++.+||..||..||++||++.++.+ ++|+...+|.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~----------hp~f~~~~~~ 328 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE----------HPYFSHNDFD 328 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT----------SGGGSSSCSC
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC----------CcccCCCCCC
Confidence 011122337899999999999999999999776643 5666666675
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.63 Aligned_cols=248 Identities=19% Similarity=0.303 Sum_probs=197.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 578999999999999999999999999999999998654322 35778999999999988888877776543
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++||++++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccc
Confidence 34689999999999999984 679999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+. ...+..+......
T Consensus 178 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 178 ADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGT 244 (367)
T ss_dssp CCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCC
T ss_pred cccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 5431 234578999999999987 6799999999999999999999999987543 2233322221111
Q ss_pred Cc--------------------------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 TP--------------------------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ~~--------------------------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+ .......+++++.+|+.+||..||.+||++.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l 306 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence 11 1112245689999999999999999999976654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=343.72 Aligned_cols=260 Identities=19% Similarity=0.261 Sum_probs=201.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEE----EEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEV----AVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~v----AvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+..++|++++.||+|+||.||+|++..+++.| |+|.+.... ....+..|+.++..+.|++++..+..+.. .
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-S
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-C
Confidence 355789999999999999999999998888765 566554322 23468889999999998877777766654 4
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++++++.+++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKL 166 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCTTC---
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE---cCCCCEEEccCcceeE
Confidence 4444444455999999998777789999999999999999999999999999999999999 4789999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.......+.+ .... .
T Consensus 167 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~~~-~ 237 (327)
T 3lzb_A 167 LGAEEKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGE-R 237 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---HTTC-C
T ss_pred ccCcccc-----ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCC-C
Confidence 6443221 11234457889999999999999999999999999999999 99999886554433222 2222 1
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+. ...++.++.+++..||..||.+||++.+|.+.|+.+..
T Consensus 238 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 13568999999999999999999999999999988763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=351.36 Aligned_cols=252 Identities=20% Similarity=0.215 Sum_probs=205.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+.++|++++.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..++|++++..+..+ .+....++||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE-EeCCEEEEEE
Confidence 35789999999999999999999999999999999875432 23578899999999887766666554 5667889999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+++.......
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence 998 88999998754557999999999999999999999999999999999999941 1357899999999987643221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+. ...
T Consensus 207 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~-~~~ 274 (387)
T 1kob_A 207 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFDE-DAF 274 (387)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCCS-STT
T ss_pred --------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc-ccc
Confidence 123479999999999999999999999999999999999999998743 33444444433322221 223
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+++++.+||..||..||++||++.++.
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 46799999999999999999999977664
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.68 Aligned_cols=262 Identities=17% Similarity=0.281 Sum_probs=194.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+..++|++++.||+|+||.||+|++..++. .||||++.... ....+.+|+.+++.++|++++..+..+.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 457899999999999999999999877665 89999987542 22468899999999988887777776654332
Q ss_pred E-----EEEEEecc-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 77 Y-----NVMVIDLL-GPSLEDLFNYCN-----RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 77 ~-----~~lv~e~~-g~sL~~ll~~~~-----~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
. .+++|+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCCE
Confidence 2 38888888 889999986432 259999999999999999999999999999999999999 588999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~ 224 (465)
||+|||+++....... ........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+......
T Consensus 177 kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--- 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--- 248 (323)
T ss_dssp EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---
T ss_pred EEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---
Confidence 9999999987644221 122234567889999999999999999999999999999999 9999988654333
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+........ ...+++++.+++..||..||++||++.+|.+.|++++...
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 YNYLIGGNRLKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHHTTCCCCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHhcCCCCCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 222332222111 2467899999999999999999999999999999887544
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=339.01 Aligned_cols=256 Identities=20% Similarity=0.249 Sum_probs=198.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
.+-++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..|....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 355789999999999999999999999999999999875432 246889999999999988888887764432
Q ss_pred ---------------------------------------------------cEEEEEEecc-CCCHHHHHHHcC--CCCC
Q 012336 76 ---------------------------------------------------EYNVMVIDLL-GPSLEDLFNYCN--RKFS 101 (465)
Q Consensus 76 ---------------------------------------------------~~~~lv~e~~-g~sL~~ll~~~~--~~ls 101 (465)
.+.+++||++ +++|.+++.... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2479999999 889999998532 2366
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc-----cccCCCCcccc
Q 012336 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI-----PYRENKNLTGT 176 (465)
Q Consensus 102 ~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~Gt 176 (465)
+..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........... .+.......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 77899999999999999999999999999999999 58899999999999876543211100 01233456799
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHh
Q 012336 177 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCR 256 (465)
Q Consensus 177 ~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl 256 (465)
+.|+|||++.+..++.++||||||+++|||++|..|+.. ..+....+.... .+ ......++++.++|..||
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~--~~--~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK--FP--LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC--CC--HHHHHHCHHHHHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC--CC--cccccCChhHHHHHHHHc
Confidence 999999999999999999999999999999998777632 122222222211 11 122345788999999999
Q ss_pred cCCCCCCCCHHHHHH
Q 012336 257 SLRFEDKPDYSYLKR 271 (465)
Q Consensus 257 ~~dp~~RPt~~~l~~ 271 (465)
+.||++||++.++.+
T Consensus 311 ~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 311 SPSPTERPEATDIIE 325 (332)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCCCcCCCHHHHhh
Confidence 999999999777654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=334.47 Aligned_cols=262 Identities=17% Similarity=0.240 Sum_probs=209.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCC---cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTG---EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~---~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
..+|++.+.||+|+||.||+|++..++ ..||||++..... ...+..|+.+++.++|++++..+.++.......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 457999999999999999999975443 3689998775433 2457889999999999888888888777777888
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999998 779999998656779999999999999999999999999999999999999 5889999999999987644
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... .........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+.......... ........
T Consensus 181 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 253 (298)
T 3f66_A 181 KEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLLQ- 253 (298)
T ss_dssp GGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---HTTCCCCC-
T ss_pred cchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hcCCCCCC-
Confidence 3211 1122345578899999999999999999999999999999999 66777765543333222 22222111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+|+++.+++..||..||++||++.+|.+.|+.++...
T Consensus 254 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1456899999999999999999999999999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=335.14 Aligned_cols=245 Identities=20% Similarity=0.291 Sum_probs=202.0
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
.|...+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++..++|++++..+..+. .....++|||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL-VGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-ECCEEEEEEecC
Confidence 48899999999999999999988999999999875433 345889999999998877776666554 566789999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 -GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 -g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
+++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~--- 196 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVP--- 196 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC---
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCcc---
Confidence 889999987 4679999999999999999999999999999999999999 5889999999999987644221
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+.+..+........ .....+
T Consensus 197 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~--~~~~~~ 267 (321)
T 2c30_A 197 ----KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKL--KNSHKV 267 (321)
T ss_dssp ----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCCC--TTGGGS
T ss_pred ----ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCc--CccccC
Confidence 2245679999999999999999999999999999999999999998743 2333333333222111 112457
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
++++.+++..||..||++||++.++.
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell 293 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELL 293 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHh
Confidence 89999999999999999999977654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=339.42 Aligned_cols=264 Identities=20% Similarity=0.281 Sum_probs=211.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcC-CCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTKH---PQLHYESKLYMLLQG-GTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~-~~~i~~l~~~~~~ 74 (465)
+..++|++++.||+|+||.||+|++. .+++.||||++...... ..+..|+.++..+.+ ++++..+..+...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 45689999999999999999999853 46789999998755332 357889999999954 5555555566656
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRK---------------FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~---------------ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
+...+++|+++ +++|.+++...... +++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~-- 181 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 181 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE--
Confidence 66789999999 78999999854322 8999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
+.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 182 -~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 182 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCCEEECCCccccccccCccc-----eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 57889999999999865432211 12235568899999999999999999999999999999998 999998754
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
.... ....+...... . ....+++++.+++..||..||.+||++.+|.+.|+.++....
T Consensus 256 ~~~~--~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 256 IDEE--FCRRLKEGTRM-R---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CSHH--HHHHHHHTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hhHH--HHHHhccCccC-C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 3322 22222222211 1 123568999999999999999999999999999999887654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=340.96 Aligned_cols=269 Identities=17% Similarity=0.187 Sum_probs=195.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHc-CCCCCceeEEEe-------Ee
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQ-GGTGVPHLKWFG-------VE 74 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~-~~~~i~~l~~~~-------~~ 74 (465)
...+|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+. |++++..+..+. ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 45689999999999999999999999999999998754432 245788999999997 666666665553 34
Q ss_pred CcEEEEEEeccCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEec
Q 012336 75 GEYNVMVIDLLGPSLEDLFNY--CNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 75 ~~~~~lv~e~~g~sL~~ll~~--~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
....+++|++++++|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+||
T Consensus 106 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Df 182 (337)
T 3ll6_A 106 QAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDF 182 (337)
T ss_dssp SEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCC
T ss_pred CceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecC
Confidence 456899999999999999875 2456999999999999999999999999 9999999999999 58889999999
Q ss_pred CCccccccccCcccc-----cccCCCCccccccccccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchH
Q 012336 151 GLAKKYRDLQTHKHI-----PYRENKNLTGTARYASVNTH---LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222 (465)
Q Consensus 151 Gla~~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~APE~~---~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~ 222 (465)
|+++........... .........||+.|+|||++ .+..++.++||||||+++|+|++|..||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876543221100 00112245699999999998 5667899999999999999999999999763221
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCc
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDY 286 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~ 286 (465)
. +.......+. ...++..+.+|+..||..||++||++.++.+.|+.+..........
T Consensus 260 ~----~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 260 R----IVNGKYSIPP---HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ----------CCCCT---TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred H----hhcCcccCCc---ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 1 1111222221 1355788999999999999999999999999999998777655444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.10 Aligned_cols=258 Identities=19% Similarity=0.237 Sum_probs=207.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+..++|++.+.||+|+||.||+|++... +..||||++..... ...+.+|+.++..++|++++..+..+. + ..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-~~ 86 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-E-EP 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-S-SS
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-C-CC
Confidence 4578999999999999999999986543 44699999875432 346788999999999888877777654 2 34
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV---ASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---EETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE---CCCCcEEeCccCCCccc
Confidence 57888888 789999998766779999999999999999999999999999999999999 47889999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+ .......
T Consensus 164 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~~~~~~ 234 (281)
T 3cc6_A 164 EDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EKGDRLP 234 (281)
T ss_dssp ---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HHTCCCC
T ss_pred ccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hcCCCCC
Confidence 44221 12234567889999999998899999999999999999998 99999875544333322 2222111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
. ...+|+.+.+++..||..||++||++.+|.+.|++++..
T Consensus 235 ~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 235 K----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 1 135689999999999999999999999999999988753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=329.53 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=209.7
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE-------
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV------- 73 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~------- 73 (465)
++..++++|++++.||+|+||.||+|++..+++.||||++.... ..+.+|+.++..++|++++..+..+..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 35678899999999999999999999999899999999987543 578899999999999888887766543
Q ss_pred --------eCcEEEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC
Q 012336 74 --------EGEYNVMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143 (465)
Q Consensus 74 --------~~~~~~lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~ 143 (465)
.....+++||++ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||+ +.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCC
Confidence 245679999999 67999999754 3679999999999999999999999999999999999999 4888
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~ 223 (465)
.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||... ..
T Consensus 160 ~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~ 226 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SK 226 (284)
T ss_dssp EEEECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HH
T ss_pred CEEECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HH
Confidence 99999999998765422 123456999999999999999999999999999999999999998531 12
Q ss_pred HHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 224 KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
....+.... ....++.++.+++..||..||.+||++.++.+.|..+
T Consensus 227 ~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 222222211 1245789999999999999999999999998888754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=353.62 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=198.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----------CCccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----------KHPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+..|+.+++.++|++++..+.++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-- 209 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-- 209 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE--
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence 35689999999999999999999999999999999987532 123578999999999988877766664
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
+....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.+..+||+|||+
T Consensus 210 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 210 DAEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp ESSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred ecCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 334468999998 8899888764 56799999999999999999999999999999999999996444556799999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ....+.
T Consensus 289 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i~ 358 (419)
T 3i6u_A 289 SKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 358 (419)
T ss_dssp TTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHHH
T ss_pred ceecCCCc--------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHHh
Confidence 98764321 2245679999999999864 5678899999999999999999999987543322 222223
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....... ......+++++.+||..||..||++||++.++.+
T Consensus 359 ~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 SGKYNFI-PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCCC-chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 3333322 3344678999999999999999999999766543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.62 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=205.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+..++|++++.||+|+||.||+|.+ +++.||||++........+..|+.++..++|++++..+..+.......+++|+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4468999999999999999999986 58999999998776667899999999999998888888877666667899999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccccc--
Confidence 99 669999997533 238999999999999999999999999999999999999 58899999999999765432
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |..||........ ...+...... ..
T Consensus 171 --------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~~~----~~ 235 (278)
T 1byg_A 171 --------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYKM----DA 235 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTTTCCC----CC
T ss_pred --------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcCCCC----CC
Confidence 123467889999999999999999999999999999998 9999987544332 2222222111 12
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+|+++.+++..||..||++||++.+|.+.|+++....
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 2467999999999999999999999999999999886543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=341.85 Aligned_cols=251 Identities=20% Similarity=0.313 Sum_probs=205.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..++|++++..+..+ ......++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LREHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCeEEE
Confidence 45699999999999999999999999999999998754322 3578999999999987777666554 56678899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||++.++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 132 v~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 132 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS--
T ss_pred EEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC--
Confidence 99999999999987667789999999999999999999999999999999999999 4889999999999976532
Q ss_pred CcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.....||+.|+|||++. +..++.++|||||||++|||++|..||.+... ...+..+........
T Consensus 207 ---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~- 273 (348)
T 1u5q_A 207 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL- 273 (348)
T ss_dssp ---------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC-
T ss_pred ---------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC-
Confidence 23457999999999985 46689999999999999999999999987532 233333333222111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+++.+.+||..||..||++||++.+| |++.|...
T Consensus 274 --~~~~~~~~l~~li~~~l~~dP~~Rps~~~l---l~h~~~~~ 311 (348)
T 1u5q_A 274 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL---LKHRFVLR 311 (348)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH---TTCHHHHS
T ss_pred --CCCCCCHHHHHHHHHHcccChhhCcCHHHH---hhChhhhc
Confidence 124578999999999999999999996665 44555544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=334.76 Aligned_cols=259 Identities=19% Similarity=0.308 Sum_probs=205.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
....++|++++.||+|+||.||+|++..+++.||||++........+..|+.++..+.|++++..+..+ ......+++|
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSY-FKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-EeCCEEEEEe
Confidence 346789999999999999999999999999999999998877777899999999999887766666555 4566789999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|.+++......+++..+..++.||+.||.|||+.|++|+||||+|||+ +.++.++|+|||++........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence 999 679999998667789999999999999999999999999999999999999 5889999999999987644221
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ......+....... ....
T Consensus 181 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~ 248 (314)
T 3com_A 181 -------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPT--FRKP 248 (314)
T ss_dssp -------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--CSSG
T ss_pred -------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCcc--cCCc
Confidence 22355799999999999999999999999999999999999999987432 22222222221111 0112
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..+++++.++|..||..||.+||++.++ |++.|...
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~l---l~~~~~~~ 284 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQL---LQHPFVRS 284 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHH---TTSHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHH---HhCHHHhc
Confidence 4568999999999999999999996655 55666554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=330.10 Aligned_cols=259 Identities=22% Similarity=0.367 Sum_probs=211.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++++.||+|+||.||+|.+ .++..||||++.... ....+..|++++..++|++++..+..+. ....+++|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~ 86 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIIT 86 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc--CCCcEEEE
Confidence 5678999999999999999999996 467789999887543 3356889999999999888777776654 33478899
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
+++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCcc
Confidence 998 89999998642 2369999999999999999999999999999999999999 588999999999998764322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+... .+.+..+.......
T Consensus 164 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~~~---- 230 (279)
T 1qpc_A 164 Y------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYRMV---- 230 (279)
T ss_dssp E------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCC----
T ss_pred c------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccCCC----
Confidence 1 12334567889999999998889999999999999999999 9999987443 33333333221111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
....+|+++.+++..||..||++||++.+|.+.|++++....
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 124678999999999999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.59 Aligned_cols=251 Identities=21% Similarity=0.220 Sum_probs=198.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEe-----CcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVE-----GEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-----~~~~~ 79 (465)
...+|++++.||+|+||.||+|++..+++.||||++.... ....+|+++++.++|++++..+.+|... ..+.+
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3457999999999999999999999999999999886543 2345799999999998888887776542 23567
Q ss_pred EEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 80 MVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
+||+++.++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+. .+.+.+||+|||+++.+
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhc
Confidence 9999998888877653 356799999999999999999999999999999999999994 24567899999999875
Q ss_pred ccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.... ..+..+.......
T Consensus 208 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p 276 (420)
T 1j1b_A 208 VRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTP 276 (420)
T ss_dssp CTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSC
T ss_pred ccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCC
Confidence 4321 12356789999999999775 6999999999999999999999999885432 2222222110000
Q ss_pred c------------------------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 P------------------------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ~------------------------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ...+...+++++.+||.+||..||.+||++.++.
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 0 0112235689999999999999999999976654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=355.15 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=210.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+.++|++++.||+|+||+||+|++..+++.||||++... .....+.+|+.+++.+.|++++..+..+ ......++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-EcCCEEEE
Confidence 568999999999999999999999999999999998642 2345688999999999887766666554 56678899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||+++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++.+...
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99998 8899998875 467999999999999999999999999999999999999964446678999999999866432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+.+
T Consensus 178 ~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~- 244 (486)
T 3mwu_A 178 T--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP- 244 (486)
T ss_dssp ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSG-
T ss_pred C--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCc-
Confidence 1 1234579999999999986 59999999999999999999999998743 344555555544433322
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+++++.+||..||..||.+||++.+ +|++.|.+.
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~---~l~hp~~~~ 282 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQ---CLEHPWIQK 282 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHH---HHHCHHHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHH---HhcCHhhcc
Confidence 23567999999999999999999999655 566777654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=358.64 Aligned_cols=260 Identities=24% Similarity=0.360 Sum_probs=212.8
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.|++++..+..+ .....
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-EDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeCCE
Confidence 467789999999999999999999999999999999987542 234588999999999887766666554 55678
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++||+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||+++.+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 89999988 8999998874 567999999999999999999999999999999999999954446789999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.......+
T Consensus 180 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFE 247 (484)
T ss_dssp CCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC
T ss_pred ccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCC
Confidence 54221 124579999999999987 69999999999999999999999998743 3445555555444333
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+ ....+++++.+||..||..||.+||++.+ +|++.|.+.
T Consensus 248 ~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e---~l~h~~~~~ 287 (484)
T 3nyv_A 248 LP-QWKKVSESAKDLIRKMLTYVPSMRISARD---ALDHEWIQT 287 (484)
T ss_dssp SG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHH---HHTSHHHHH
T ss_pred Cc-ccccCCHHHHHHHHHHCCCChhHCcCHHH---HhhChhhcc
Confidence 22 22467999999999999999999999655 456666543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=332.11 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=207.8
Q ss_pred cCCceEEEe-eEeeeCceEEEEEEE--cCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 5 IGGKFKLGR-KIGSGSFGELYLGVN--VQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 5 ~~~~y~l~~-~LG~G~fG~Vyla~~--~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
-.++|++.+ .||+|+||.||+|.+ ..+++.||||++..... ...+..|+.++..+.|++++..+.++ ....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~ 91 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAES 91 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ESSS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--CCCC
Confidence 357899999 999999999999954 55678999999875532 23578899999999988877777766 4556
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++...
T Consensus 92 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE---eCCCcEEEccCCcceee
Confidence 78999998 7899999986 5679999999999999999999999999999999999999 47889999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+... .+....+.......
T Consensus 168 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 168 RADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERMG 240 (291)
T ss_dssp CTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCCC
T ss_pred ccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCCC
Confidence 4432211 12233457789999999998889999999999999999999 9999987543 23333332222111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+|+++.+++..||..||.+||++.+|.+.|++++...
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 12467999999999999999999999999999999998643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=358.95 Aligned_cols=256 Identities=21% Similarity=0.351 Sum_probs=210.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++.+.||+|+||+||+|.+. ++..||||++.... ....+..|+.+++.++|++++..+..+. ....++||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~ 261 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIIT 261 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEE
Confidence 45678999999999999999999974 57889999987543 3456899999999999988887776654 45678999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCc
Confidence 998 88999999743 2468999999999999999999999999999999999999 588999999999998764321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......+|+.|+|||++....++.++|||||||+||||++ |..||.+... .+.+..+..... .+.
T Consensus 339 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~-~~~-- 406 (454)
T 1qcf_A 339 Y------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYR-MPR-- 406 (454)
T ss_dssp H------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCC-CCC--
T ss_pred e------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-CCC--
Confidence 1 12234457889999999998899999999999999999999 9999987543 333333333222 221
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
...+|+++.++|..||..||++||++.+|.+.|++++.
T Consensus 407 -~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 407 -PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred -CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 14579999999999999999999999999999987643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.67 Aligned_cols=261 Identities=18% Similarity=0.320 Sum_probs=208.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-------CCCcEEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-------QTGEEVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFG 72 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-------~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~ 72 (465)
+..++|++++.||+|+||.||+|++. .++..||||++..... ...+..|+.++..+ .|++++..+ .++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~-~~~ 110 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL-GAC 110 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE-EEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE-EEE
Confidence 45689999999999999999999975 3567899999875432 23578899999999 555555444 445
Q ss_pred EeCcEEEEEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceee
Q 012336 73 VEGEYNVMVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLM 136 (465)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl 136 (465)
......++||+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 5666788999998 789999997532 248999999999999999999999999999999999999
Q ss_pred ccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCC
Q 012336 137 GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQG 215 (465)
Q Consensus 137 ~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~ 215 (465)
+.++.+||+|||++........ ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---cCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 5889999999999986654221 112334567899999999998889999999999999999999 9999987
Q ss_pred CCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
... .+....+....... ....+++++.+++..||..||.+||++.+|.+.|+.++...
T Consensus 263 ~~~---~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 263 IPV---EELFKLLKEGHRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CCH---HHHHHHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCH---HHHHHHHhcCCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 532 33333333322211 12467899999999999999999999999999999998754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=341.74 Aligned_cols=206 Identities=24% Similarity=0.323 Sum_probs=175.4
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCC-----CceeEEEeEeC
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTG-----VPHLKWFGVEG 75 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~-----i~~l~~~~~~~ 75 (465)
+..+.++|++++.||+|+||+||+|++..+++.||||++..... ...+..|+.++..+.+++. +..+..+....
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34567899999999999999999999999999999999874322 2456778999999986653 55566666677
Q ss_pred cEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMH--SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLH--s~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
...++|||+++++|.+++.... ..+++..+..++.||+.||.||| ..||+||||||+|||+.. +.++.+||+|||+
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTT
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccC
Confidence 8999999999999999998654 56999999999999999999999 579999999999999942 2467899999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCC
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~ 218 (465)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+...
T Consensus 208 a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 208 SCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9876431 2356799999999999999999999999999999999999999987543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=330.80 Aligned_cols=263 Identities=20% Similarity=0.308 Sum_probs=213.6
Q ss_pred cCCceEEEe-eEeeeCceEEEEEEEc--CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 5 IGGKFKLGR-KIGSGSFGELYLGVNV--QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 5 ~~~~y~l~~-~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
-.++|.+.+ .||+|+||.||+|.+. .++..||||++..... ...+..|+.++..++|++++..+..+ .....
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~ 84 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEAL 84 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ESSSE
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--cCCCc
Confidence 367888887 9999999999999854 4678899999876432 23578999999999988877777766 44557
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
++||+++ +++|.+++......+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE---cCCCCEEECcccceeeec
Confidence 8999998 779999997656679999999999999999999999999999999999999 478999999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
..... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+.......
T Consensus 162 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~i~~~~~~~- 233 (287)
T 1u59_A 162 ADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRME- 233 (287)
T ss_dssp TCSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCC-
T ss_pred cCcce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHhcCCcCC-
Confidence 33221 122334567899999999998889999999999999999998 9999987544 22333333322111
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
....+|+++.++|..||..||++||++.+|.+.|+.++...+.+
T Consensus 234 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 234 ---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred ---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 12467999999999999999999999999999999998866554
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.50 Aligned_cols=262 Identities=16% Similarity=0.269 Sum_probs=200.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.+..++|.+.+.||+|+||.||+|++. .++..||||++..... ...+.+|+.++..++|++++..+..+ ....
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-TKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCC
Confidence 345678999999999999999999876 4677899999875432 23588999999999887766666554 5566
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|||++ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 788999999 899999998656679999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||.+... .+....+......
T Consensus 197 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~ 269 (373)
T 2qol_A 197 LEDDPEAA----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRL 269 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEEC
T ss_pred cccCCccc----eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC
Confidence 65432111 11123346788999999999999999999999999999998 9999987543 3333333332222
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.. ...+|.++.+++..||..||++||++.+|.+.|+.+...
T Consensus 270 ~~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 PP----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CC----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11 135689999999999999999999999999999988753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.68 Aligned_cols=260 Identities=17% Similarity=0.248 Sum_probs=209.5
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.|.+.+.||+|+||+||+|++..++. .||+|++...... ..+.+|+.+++.++|++++..+.++...+...+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 56778999999999999999766554 7999998754332 35788999999999988888888877666666788
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence 8887 999999998656789999999999999999999999999999999999999 588899999999998654422
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCC-CCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. .........+|+.|+|||.+.+..++.++||||||+++|+|++|. +||........ ...+........
T Consensus 179 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~--- 249 (298)
T 3pls_A 179 YY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL---THFLAQGRRLPQ--- 249 (298)
T ss_dssp GG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH---HHHHHTTCCCCC---
T ss_pred cc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH---HHHhhcCCCCCC---
Confidence 11 112334567899999999999999999999999999999999955 45554333222 222222221111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+++++.+++..||..||.+||++.++.+.|+.++...
T Consensus 250 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 250 -PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 2456899999999999999999999999999999998765
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.82 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=203.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-CCCcEEEEEEeecCC----CCccHHHHHHHHHHH---cCCCCCceeEEEeE--
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-QTGEEVAVKLESVKT----KHPQLHYESKLYMLL---QGGTGVPHLKWFGV-- 73 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l---~~~~~i~~l~~~~~-- 73 (465)
.+.++|++++.||+|+||.||+|++. .+++.||||++.... ....+.+|+.+++.+ .|++++..+..+..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35689999999999999999999985 678999999887532 234678899998888 57666666665542
Q ss_pred --eCcEEEEEEeccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEec
Q 012336 74 --EGEYNVMVIDLLGPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 74 --~~~~~~lv~e~~g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
.....++||+++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecC
Confidence 456789999999999999998643 459999999999999999999999999999999999999 58899999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... ...+..+..
T Consensus 165 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~ 233 (326)
T 1blx_A 165 GLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILD 233 (326)
T ss_dssp CSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred cccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Confidence 9997654321 12356789999999999999999999999999999999999999987543 223333222
Q ss_pred hhc----------------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 231 KKM----------------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 231 ~~~----------------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
... ..+.......+++++.+|+..||..||++||++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111 0112233456899999999999999999999977664
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.34 Aligned_cols=262 Identities=19% Similarity=0.283 Sum_probs=209.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCc-----EEEEEEeecCCC---CccHHHHHHHHHHH-cCCCCCceeEEEeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE-----EVAVKLESVKTK---HPQLHYESKLYMLL-QGGTGVPHLKWFGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~-----~vAvKi~~~~~~---~~~~~~E~~il~~l-~~~~~i~~l~~~~~~ 74 (465)
+..++|++.+.||+|+||.||+|.+..+++ .||||++..... ...+..|+.++..+ .|++++..+. ++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~-~~~~ 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG-ACTH 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE-EECS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEE-EEec
Confidence 446889999999999999999999877664 799999875432 24578999999999 5655555554 4455
Q ss_pred CcEEEEEEecc-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYC-------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR 140 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~-------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d 140 (465)
....++||+++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL---T 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE---E
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE---C
Confidence 66788999998 77999998743 3468999999999999999999999999999999999999 4
Q ss_pred CCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCC
Q 012336 141 KSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 219 (465)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~ 219 (465)
.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred CCCeEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 7889999999999866443211 12345568899999999999899999999999999999998 99999875543
Q ss_pred chHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 220 TKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
... ..+......... ...+|+++.+++..||..||.+||++.+|.+.|+++....
T Consensus 274 ~~~---~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 274 SKF---YKLVKDGYQMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHH---HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHH---HHHHhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 222 222222222211 1346899999999999999999999999999999887643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=331.09 Aligned_cols=254 Identities=21% Similarity=0.257 Sum_probs=194.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..++|++++..+..+ ......++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-RRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-ecCCeEEEE
Confidence 47899999999999999999999999999999988655432 3467899999999987776666655 566778999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++. ..+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 81 FEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 9999 555666655 36779999999999999999999999999999999999999 588999999999998764322
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK------- 232 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (465)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+.......
T Consensus 157 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 D-------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 1 1234578999999999986 568999999999999999999999998854432222222111100
Q ss_pred ----------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 233 ----------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 233 ----------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...+.......+++++.+|+..||..||++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001122233568899999999999999999999776643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.50 Aligned_cols=252 Identities=19% Similarity=0.258 Sum_probs=199.9
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.+-.++|++.+.||+|+||.||+|++ .++.||||++........+..|+.++..++|++++..+..+. +..++||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEE
Confidence 34568999999999999999999987 578999999876665667899999999999888777765544 3468999
Q ss_pred ecc-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCceeeccCCCCC-cEEEEecCCccc
Q 012336 83 DLL-GPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHS---RGFLHRDIKPDNFLMGLGRKSN-QVYIIDYGLAKK 155 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~--~ls~~~~~~ia~qi~~gL~yLHs---~givHrDLKP~NILl~~~d~~~-~vkL~DFGla~~ 155 (465)
|++ +++|.+++..... .++...++.++.||+.||.|||+ +||+||||||+|||+. .++ .+||+|||++..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACD 155 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC---
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccccc
Confidence 998 8899999985332 48899999999999999999999 8999999999999995 555 489999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.... .....||+.|+|||++.+..++.++||||||+++|||++|..||........ .....+......
T Consensus 156 ~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~- 223 (307)
T 2eva_A 156 IQTH----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIMWAVHNGTRP- 223 (307)
T ss_dssp -------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHHHHHHTTCCC-
T ss_pred cccc----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHHHHHhcCCCC-
Confidence 5432 1234689999999999999999999999999999999999999986543222 222222222111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.....+|+++.+++..||..||++||++.+|.+.|+.+.
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 224 ---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 122567999999999999999999999999999998874
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=332.93 Aligned_cols=263 Identities=19% Similarity=0.304 Sum_probs=217.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+..++|++.+.||+|+||.||+|.+..++..||||++..... ...+..|+.+++.++|++++..+..+ ......++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCCEEEE
Confidence 4567899999999999999999999999999999999875543 34688999999999987777666655 455667899
Q ss_pred Eecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 82 IDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCC
Confidence 9998 789999998643 459999999999999999999999999999999999999 57889999999999876533
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.......+.+ ...... .
T Consensus 165 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~---~~~~~~-~-- 232 (288)
T 3kfa_A 165 TY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EKDYRM-E-- 232 (288)
T ss_dssp SS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HTTCCC-C--
T ss_pred cc------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---hccCCC-C--
Confidence 21 12234567889999999999999999999999999999999 99999886543333322 222111 1
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
....+|+++.+++..||..||.+||++.+|.+.|+.++.+...
T Consensus 233 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~~ 275 (288)
T 3kfa_A 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275 (288)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 1146789999999999999999999999999999999876543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=344.35 Aligned_cols=268 Identities=21% Similarity=0.234 Sum_probs=211.4
Q ss_pred Ccc-CCceEEEeeEeeeCceEEEEEE----EcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeE-e
Q 012336 3 HVI-GGKFKLGRKIGSGSFGELYLGV----NVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGV-E 74 (465)
Q Consensus 3 ~i~-~~~y~l~~~LG~G~fG~Vyla~----~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~-~ 74 (465)
+++ .++|++++.||+|+||.||+|+ +..+++.||||++..... ...+.+|++++..++|++++..+..+.. .
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 344 5899999999999999999998 467899999999875432 2348899999999988877777766543 5
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
....++||+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADFGLA 174 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCGGGC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE---CCCCCEEEcccccc
Confidence 66789999999 999999998756679999999999999999999999999999999999999 58899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc-----------hH
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-----------KK 222 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~-----------~~ 222 (465)
......... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ..
T Consensus 175 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3lxl_A 175 KLLPLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL 250 (327)
T ss_dssp EECCTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH
T ss_pred eecccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH
Confidence 876433221 122345578999999999999889999999999999999999999997532110 00
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.............+ ....+++++.+++..||..||++||++.+|.+.|+.++...
T Consensus 251 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 251 SRLLELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111111111111 12467899999999999999999999999999998876433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=338.91 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=205.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----------CccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----------HPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----------~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
+.++|++.+.||.|+||.||+|++..+|+.||||++..... ...+..|+.++..+.++++|..+..++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 34689999999999999999999988999999999875432 23467899999999544555555566677
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 78899999999 7899999875 4679999999999999999999999999999999999999 58899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccC------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....+..
T Consensus 248 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~ 316 (365)
T 2y7j_A 248 CHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRM 316 (365)
T ss_dssp EECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred cccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHH
Confidence 8765322 1235679999999999863 358899999999999999999999998743 3444444
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+.......+.+. ...+++++.++|..||..||++||++.++.+
T Consensus 317 i~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQFSSPE-WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCCCCHHH-HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCcc-cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 444444433332 3577899999999999999999999776643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=353.47 Aligned_cols=260 Identities=21% Similarity=0.316 Sum_probs=209.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---------------CCccHHHHHHHHHHHcCCCCCcee
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---------------KHPQLHYESKLYMLLQGGTGVPHL 68 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---------------~~~~~~~E~~il~~l~~~~~i~~l 68 (465)
.+.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+.|++++..+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 46789999999999999999999999999999999987532 224578899999999887766655
Q ss_pred EEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEE
Q 012336 69 KWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYI 147 (465)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL 147 (465)
.++ .+....++||+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+........+||
T Consensus 113 ~~~-~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 113 DVF-EDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEE-ECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEE-EcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 554 5677889999999 8899998875 467999999999999999999999999999999999999953222347999
Q ss_pred EecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 148 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
+|||++..+.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..
T Consensus 191 ~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKK 258 (504)
T ss_dssp CCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred EECCCCEEcCCCC--------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH
Confidence 9999998765422 1235579999999999874 68999999999999999999999998743 3455555
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
+.......+.+ ....+++++.+||..||..||.+||++.+ +|++.|.+..
T Consensus 259 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e---~l~h~~~~~~ 308 (504)
T 3q5i_A 259 VEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEE---ALNSRWIKKY 308 (504)
T ss_dssp HHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHH---HHTSHHHHHT
T ss_pred HHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHH---HhcCHhhhhc
Confidence 55555444433 33578999999999999999999999555 5667776553
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=336.26 Aligned_cols=263 Identities=16% Similarity=0.241 Sum_probs=205.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCC----cEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTG----EEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
.+..++|++.+.||+|+||.||+|.+..++ ..||||++...... ..+..|+.++..+.|++++..+..+ ...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-ecC
Confidence 466789999999999999999999976553 46999998754322 3578899999999887776666555 456
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 6788999999 779999998766789999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
......... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+... .+....+.....
T Consensus 196 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~ 268 (333)
T 1mqb_A 196 VLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFR 268 (333)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCC
T ss_pred hhccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCc
Confidence 765422111 11223456889999999999999999999999999999999 9999987543 333333333222
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
. +. ...+|+++.+++..||..||++||++.+|.+.|+.++...
T Consensus 269 ~-~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 269 L-PT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp C-CC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred C-CC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 11 2457899999999999999999999999999999887643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.27 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=200.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE----------
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV---------- 73 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~---------- 73 (465)
...++|++++.||+|+||.||+|++..+++.||||++..... ...+|+++++.++|++++..+.+|..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 467899999999999999999999999999999998865432 34579999999999888888877643
Q ss_pred ---------------------------eCcEEEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 012336 74 ---------------------------EGEYNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRG 123 (465)
Q Consensus 74 ---------------------------~~~~~~lv~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~g 123 (465)
...+.++|||++.++|.+.+.. ....+++..+..++.||+.||.|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 2345889999999998888763 3567999999999999999999999999
Q ss_pred ccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHH
Q 012336 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYV 202 (465)
Q Consensus 124 ivHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGvi 202 (465)
|+||||||+|||+. ..++.+||+|||+++.+.... ......||+.|+|||++.+.. ++.++|||||||+
T Consensus 162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999994 257899999999998764322 223557899999999988754 8999999999999
Q ss_pred HHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc------------------------HHHHhccCcHHHHHHHHHHhcC
Q 012336 203 LMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP------------------------IEVLCKSYPSEFTSYFHYCRSL 258 (465)
Q Consensus 203 L~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~p~~l~~li~~cl~~ 258 (465)
+|||++|..||.+.... ..+..+........ ...+...+|+++.+||..||..
T Consensus 232 l~ell~g~~pf~~~~~~---~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSI---DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 99999999999885432 22222222111110 1112235789999999999999
Q ss_pred CCCCCCCHHHHHH
Q 012336 259 RFEDKPDYSYLKR 271 (465)
Q Consensus 259 dp~~RPt~~~l~~ 271 (465)
||.+||++.++.+
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999776643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=325.98 Aligned_cols=251 Identities=19% Similarity=0.294 Sum_probs=204.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------CccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------HPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
++.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+ ...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-ENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-ECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-cCC
Confidence 577899999999999999999999999999999999875432 24588999999999987766655554 556
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC----cEEEEec
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN----QVYIIDY 150 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~----~vkL~DF 150 (465)
...+++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. .++ .++|+||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~~~~kl~df 156 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL---DKNVPNPRIKLIDF 156 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES---CSSSSSCCEEECCC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe---cCCCCCCceEEEec
Confidence 7789999998 8999999975 46799999999999999999999999999999999999995 444 8999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
|++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.. ..+....+..
T Consensus 157 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~ 225 (283)
T 3bhy_A 157 GIAHKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISA 225 (283)
T ss_dssp TTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHT
T ss_pred ccceeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHh
Confidence 99986543221 234569999999999999999999999999999999999999998743 3344444443
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.....+ ......+++++.+++..||..||++||++.++.+
T Consensus 226 ~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYDFD-EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCCCC-HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCc-chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 333333 3344678999999999999999999999776654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=336.56 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=204.4
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHH--cCCCCCceeEEEeEeC---cE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLL--QGGTGVPHLKWFGVEG---EY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l--~~~~~i~~l~~~~~~~---~~ 77 (465)
..+.++|++++.||+|+||.||+|++ +++.||||++.... ......|.+++..+ .|++++..+..+.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 45678999999999999999999987 48999999986443 33455666666654 6666666665554432 67
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceeeccCCCCCcEEEE
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------GFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~--------givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
.++|||++ +++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEE
Confidence 89999999 7899999974 5799999999999999999999999 99999999999999 588999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCCCCc------chHHHHHHHHHHHhcC----------CCC
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRR------DDLESLGYVLMYFLRG----------SLP 212 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k------~DiwSLGviL~elltG----------~~P 212 (465)
|||+++.+........ .......||+.|+|||++.+..+... +|||||||++|||++| ..|
T Consensus 185 Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVD---IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eCCCceeecccccccc---CCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 9999977654322111 11235679999999999988776665 9999999999999999 788
Q ss_pred CCCCCCCch-HHHHHHHhh-hh--ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 213 WQGLKAGTK-KQKYDKISE-KK--MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 213 f~~~~~~~~-~~~~~~i~~-~~--~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
|........ ......... .. ...+.......+++++.+++..||..||.+||++.+|.+.|+.+......
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 876543322 122222111 11 11222222234578899999999999999999999999999998766543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=353.33 Aligned_cols=270 Identities=18% Similarity=0.194 Sum_probs=213.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeC-cEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG-EYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~-~~~ 78 (465)
.+++++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|++++..++|++++..+..+.... ...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 467899999999999999999999999999999999987542 2345779999999999988888777665543 477
Q ss_pred EEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-CCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~-d~~~~vkL~DFGla~ 154 (465)
++|||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999 889999987532 239999999999999999999999999999999999998332 356779999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccC--------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC-chHHHH
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKY 225 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~-~~~~~~ 225 (465)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||...... ...+.+
T Consensus 165 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 165 ELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 7654321 234679999999999875 45788999999999999999999999764432 223333
Q ss_pred HHHhhhhccC--------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 226 DKISEKKMLT--------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 226 ~~i~~~~~~~--------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..+....... ....+...++..+.+++..||..||++||++.++.+.+.+++.+.
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 3333322110 001112345678999999999999999999999999988876443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=338.02 Aligned_cols=264 Identities=17% Similarity=0.193 Sum_probs=204.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe----C
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE----G 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~----~ 75 (465)
..+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+... .
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4578999999999999999999999999999999999864332 23567899999999988877777665443 3
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...+++|++++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecccccc
Confidence 67899999999999999884 579999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCccccc---ccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 156 YRDLQTHKHIP---YRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 156 ~~~~~~~~~~~---~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
..........+ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65322111000 011234579999999998765 67899999999999999999999999875432211111111000
Q ss_pred ------------------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 ------------------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 ------------------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....+.......+++++.+||..||..||.+||++.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0011223334578999999999999999999999776543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=334.50 Aligned_cols=252 Identities=17% Similarity=0.266 Sum_probs=202.6
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCC-------cEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEe
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTG-------EEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFG 72 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~-------~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~ 72 (465)
..+..++|++.+.||+|+||.||+|++..++ ..||+|++.... ....+..|+.++..++|++++..+..+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4677899999999999999999999988777 479999986543 2346889999999999877776666554
Q ss_pred EeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc-------
Q 012336 73 VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ------- 144 (465)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~------- 144 (465)
.....++|||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+. .++.
T Consensus 83 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~ 158 (289)
T 4fvq_A 83 -CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPP 158 (289)
T ss_dssp -CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCC
T ss_pred -eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccc
Confidence 456678999999 7899999987555699999999999999999999999999999999999995 4444
Q ss_pred -EEEEecCCccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcC-CCCCCCCCCCch
Q 012336 145 -VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTK 221 (465)
Q Consensus 145 -vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG-~~Pf~~~~~~~~ 221 (465)
+||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|||++| .+||.....
T Consensus 159 ~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--- 224 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--- 224 (289)
T ss_dssp EEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---
T ss_pred eeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---
Confidence 999999999754321 23468899999999988 6789999999999999999995 455554322
Q ss_pred HHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 222 KQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
.... .........+ ..+++++.+++..||+.||++||++.+|.+.|+.++
T Consensus 225 ~~~~-~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 225 QRKL-QFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp HHHH-HHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred HHHH-HHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 2222 1122222111 345788999999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=354.90 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=205.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+.++|++++.||+|+||+||+|++..++..||||++.... ....+.+|+.+++.+.|++++..+..| ......++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-EeCCEEEE
Confidence 4568999999999999999999999999999999987542 345688999999999987777666655 56667899
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||+++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99998 8899988875 467999999999999999999999999999999999999964444677999999999876542
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+.+
T Consensus 193 ~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~- 259 (494)
T 3lij_A 193 K--------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDSP- 259 (494)
T ss_dssp B--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCSG-
T ss_pred c--------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCch-
Confidence 2 123567999999999986 469999999999999999999999998743 345555555554443322
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
....+++++.+||..||..||.+||++.++ |++.|.
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~---l~hp~~ 295 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQA---LEHPWI 295 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTCHHH
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHH---hcCccc
Confidence 235789999999999999999999997665 444544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=334.77 Aligned_cols=260 Identities=15% Similarity=0.270 Sum_probs=210.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+..++|++.+.||+|+||.||+|.+. .++..||||++...... ..+..|+.++..++|++++..+..+ ...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~ 98 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQD 98 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-ecC
Confidence 45789999999999999999999874 45589999998754322 3578899999999887776666655 455
Q ss_pred cEEEEEEecc-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCN-----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKP 131 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~-----------------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP 131 (465)
...+++|+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 6678999998 799999998632 2389999999999999999999999999999999
Q ss_pred CceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CC
Q 012336 132 DNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GS 210 (465)
Q Consensus 132 ~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~ 210 (465)
+|||+ +.++.+||+|||++........ ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 179 ~NIli---~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 179 RNILV---AEGRKMKISDFGLSRDVYEEDS-----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp GGEEE---ETTTEEEECCCTTCEECTTTSC-----EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred heEEE---cCCCCEEEcccccccccccccc-----ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999 4889999999999986644222 112344567899999999999889999999999999999999 99
Q ss_pred CCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 211 LPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.||.+........ .+....... ....+++++.+++..||..||++||++.+|.+.|+.++.+
T Consensus 251 ~p~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 251 NPYPGIPPERLFN---LLKTGHRME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CSSTTCCGGGHHH---HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHHHHH---HhhcCCcCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9998865433322 222222111 1246799999999999999999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=340.38 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=209.1
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
.+..++|++.+.||+|+||.||+|++. .+++.||||++...... ..+.+|+.+++.+.|++++..+..+ ..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-CS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-cc
Confidence 356789999999999999999999876 35789999998754322 2478899999999887766666555 55
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCN---------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQ 144 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~---------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~ 144 (465)
....+++|+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCe
Confidence 56778999998 789999987432 457999999999999999999999999999999999999 58899
Q ss_pred EEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHH
Q 012336 145 VYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (465)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~ 223 (465)
+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+... .+
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~ 248 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQ 248 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HH
T ss_pred EEECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HH
Confidence 999999999865433211 12234567899999999999999999999999999999999 8999987533 33
Q ss_pred HHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 224 KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
....+....... ....+|+++.+++..||..||++||++.++.+.|+..+
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 249 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 333333332221 12467899999999999999999999999999887653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=325.77 Aligned_cols=250 Identities=19% Similarity=0.180 Sum_probs=198.6
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
|...+.++|++++.||+|+||.||+|++..+++.||||++..... ...+..|+..+..+.+|++|..+..+..+..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 456678999999999999999999999999999999999875432 2357788888988844444555555556777
Q ss_pred EEEEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC------------
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR------------ 140 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d------------ 140 (465)
..++|||++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+..+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 889999999 78999999753 26799999999999999999999999999999999999995221
Q ss_pred ----CCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCC
Q 012336 141 ----KSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQG 215 (465)
Q Consensus 141 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~ 215 (465)
....++|+|||++...... ....||+.|+|||++.+. .++.++||||||+++|+|++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSP-----------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCS-----------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCc-----------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 4458999999999865431 234599999999999876 566899999999999999999887754
Q ss_pred CCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .....+....... ....+++++.+++..||..||++||++.++.+
T Consensus 234 ~------~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 234 G------DQWHEIRQGRLPR----IPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp S------HHHHHHHTTCCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h------hHHHHHHcCCCCC----CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 2 1222233322211 22467899999999999999999999776643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=338.50 Aligned_cols=266 Identities=20% Similarity=0.257 Sum_probs=210.1
Q ss_pred CccCCce-EEEeeEeeeCceEEEEEEE----cCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 3 HVIGGKF-KLGRKIGSGSFGELYLGVN----VQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 3 ~i~~~~y-~l~~~LG~G~fG~Vyla~~----~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
.++.++| ++++.||+|+||+||+|.. ..+++.||||++..... ...+.+|+.+++.++|++++..+.++...
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 4677787 9999999999999988764 34789999999886532 23578999999999988888777777654
Q ss_pred -CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 75 -GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 75 -~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
....++||+++ +++|.+++.. ..+++..++.++.||+.+|.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGL 180 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGG
T ss_pred CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCccc
Confidence 46789999999 7899999973 469999999999999999999999999999999999999 5889999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc--------hHH-
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--------KKQ- 223 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~--------~~~- 223 (465)
+......... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....... ...
T Consensus 181 a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 181 AKAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp CEECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred cccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 9876543211 122345568899999999999899999999999999999999999997532110 000
Q ss_pred --HHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 224 --KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 224 --~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
............+ ....+|+++.+||..||..||++||++.+|.+.|+.+..+.
T Consensus 257 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 257 VLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0111111111111 12467899999999999999999999999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=333.14 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=198.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.-++|++.+.||+|+||.||+|++..+++.||||++...... ..+..|+.++..++|++++..+.++ ......+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-~~~~~~~ 110 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-EIDGQLY 110 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-eeCCeEE
Confidence 347899999999999999999999999999999998754321 4578899999999887766655554 5567889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 111 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC------
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCccccc
Confidence 999998 6799999985 4679999999999999999999999999999999999999 5789999999999976544
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+... . .+....... .....
T Consensus 187 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~~~~~~~-~~~~~ 255 (309)
T 2h34_A 187 EKL------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMGAHINQA-IPRPS 255 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHHHHHHSC-CCCGG
T ss_pred ccc------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHHHHhccC-CCCcc
Confidence 221 122345799999999999999999999999999999999999999987432 1 221211211 12223
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKP-DYSYLKRLFRDLF 277 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~~~ 277 (465)
.....+|+++.++|..||..||++|| +++++.+.|+..+
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 34467899999999999999999999 9999999887654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=333.42 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=202.7
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEe--------
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFG-------- 72 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~-------- 72 (465)
..++++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++++..+..+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 4678999999999999999999999999999999998875432 245788999999999988888877663
Q ss_pred -----EeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEE
Q 012336 73 -----VEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYI 147 (465)
Q Consensus 73 -----~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL 147 (465)
.+....+++|+++.++|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||+. ..++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEE
T ss_pred ccccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEE
Confidence 3446789999999889999987 56799999999999999999999999999999999999994 35679999
Q ss_pred EecCCccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH
Q 012336 148 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 226 (465)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~ 226 (465)
+|||++.......... .......+|..|+|||.+.+ ..++.++||||||+++|||++|..||.+... .+.+.
T Consensus 163 ~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~ 235 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQ 235 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH
T ss_pred ccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence 9999998764321111 12234567999999998876 6789999999999999999999999987543 22222
Q ss_pred HHhhhh-------------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 227 KISEKK-------------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 227 ~i~~~~-------------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+.... ...+.......+++++.+||..||..||++||++.++ |++.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~ 310 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA---LSHPYMS 310 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH---HTSHHHH
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH---hCCcccc
Confidence 222211 1122233445689999999999999999999996655 5555544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=339.55 Aligned_cols=262 Identities=21% Similarity=0.346 Sum_probs=203.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-------CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-------TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-------~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+.++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..++|++++..+..+ .+...
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-EDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-ECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-ccCCe
Confidence 467899999999999999999999999999999998643 2224688899999999887766666555 56778
Q ss_pred EEEEEecc-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 012336 78 NVMVIDLL-GPSLEDLFNYC---------------------------------------NRKFSLKTVLMLADQLINRVE 117 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~---------------------------------------~~~ls~~~~~~ia~qi~~gL~ 117 (465)
.++|||++ +++|.+++... ...+++..+..++.||+.||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 89999999 99999988410 112467889999999999999
Q ss_pred HHHHCCccccCCCCCceeeccCCCCC--cEEEEecCCccccccccCcccccccCCCCccccccccccccccC--CCCCCc
Q 012336 118 YMHSRGFLHRDIKPDNFLMGLGRKSN--QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRR 193 (465)
Q Consensus 118 yLHs~givHrDLKP~NILl~~~d~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k 193 (465)
|||++||+||||||+|||+. .++ .+||+|||++..+....... ........||+.|+|||++.+ ..++.+
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~---~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFS---TNKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHTTEECCCCCGGGEEES---CSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHCCccccCCChhhEEEe---cCCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999994 444 89999999998764422211 112345679999999999975 678999
Q ss_pred chHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 012336 194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLF 273 (465)
Q Consensus 194 ~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (465)
+||||||+++|||++|..||.+... .+.+..+.......+.+ ....+++++.++|..||..||.+||++.++ |
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l 329 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRA---L 329 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---H
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHH---h
Confidence 9999999999999999999987543 33444444433332222 224579999999999999999999996554 6
Q ss_pred HHHHHHc
Q 012336 274 RDLFIRE 280 (465)
Q Consensus 274 ~~~~~~~ 280 (465)
++.|...
T Consensus 330 ~hp~~~~ 336 (345)
T 3hko_A 330 QHPWISQ 336 (345)
T ss_dssp HSHHHHT
T ss_pred cChhhcc
Confidence 6666544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.16 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=211.4
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+.+.-++|.+++.||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.++|++++..+..+ ....
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-~~~~ 89 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-STPS 89 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSS
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECC
Confidence 3466789999999999999999999999999999999987532 234688999999999987766666554 5566
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|||++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEE
T ss_pred EEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhh
Confidence 789999999 8999999874 5679999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
..... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.. ....+..+......
T Consensus 166 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~ 234 (476)
T 2y94_A 166 MSDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFKKICDGIFY 234 (476)
T ss_dssp CCTTC--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHHHHHTTCCC
T ss_pred ccccc--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCcC
Confidence 64321 1235679999999999998775 789999999999999999999998743 33444455444433
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
.+ ..+++++.+||..||..||.+||++.+| +++.|....
T Consensus 235 ~p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~ei---l~hp~~~~~ 273 (476)
T 2y94_A 235 TP-----QYLNPSVISLLKHMLQVDPMKRATIKDI---REHEWFKQD 273 (476)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHH---HTCHHHHTT
T ss_pred CC-----ccCCHHHHHHHHHHcCCCchhCcCHHHH---HhCHHhhhc
Confidence 32 3568999999999999999999996655 556666543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=330.57 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=209.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++|++++..+.. .......+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-YESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEE-EECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhh-cccCCEEEEE
Confidence 46789999999999999999999999999999999987543 23458899999999988776665555 4566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+...+.++.++|+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 85 MQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp ECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred EEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9998 7899999875 457999999999999999999999999999999999999954457889999999999754321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ....+..+.......+. ..
T Consensus 163 --------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~-~~ 230 (304)
T 2jam_A 163 --------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEFES-PF 230 (304)
T ss_dssp --------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCCCT-TT
T ss_pred --------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCc-cc
Confidence 1123468999999999999999999999999999999999999998743 33444444444333222 23
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+++++.++|..||..||++||++.++ |++.|...
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKA---LSHPWIDG 267 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHHHS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCccccC
Confidence 35679999999999999999999996654 55666544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=327.03 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=204.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
..-++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.++..++|++++..+.. +.+....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY-FHDATRV 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEE-EECSSEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhhe-EecCCEE
Confidence 3457999999999999999999999999999999988643 223468889999999998766665554 4566788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCC
Confidence 9999998 7899999875 4679999999999999999999999999999999999999 588999999999986543
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+.......+
T Consensus 161 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~- 227 (279)
T 3fdn_A 161 SS---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFTFP- 227 (279)
T ss_dssp ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-
T ss_pred cc---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCCCC-
Confidence 31 1235578999999999999999999999999999999999999998743 3344444444333322
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..+++++.+||..||..||.+||++.+| |++.|...
T Consensus 228 ----~~~~~~~~~li~~~l~~~p~~Rps~~e~---l~h~~~~~ 263 (279)
T 3fdn_A 228 ----DFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWITA 263 (279)
T ss_dssp ----TTSCHHHHHHHHHHCCSSGGGSCCHHHH---HHCHHHHH
T ss_pred ----CcCCHHHHHHHHHHhccChhhCCCHHHH---hhCccccC
Confidence 4568999999999999999999996555 55666544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=345.95 Aligned_cols=251 Identities=19% Similarity=0.265 Sum_probs=186.3
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEe-----C
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVE-----G 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~-----~ 75 (465)
+.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+..+... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 56899999999999999999999999999999999865422 23577899999999998888887777543 2
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++++++++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence 56799999999999999873 679999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh---
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--- 231 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (465)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+......
T Consensus 182 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 5432 234579999999999987 67899999999999999999999999885432222222111100
Q ss_pred --------------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 --------------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 --------------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
............+++++.+||.+||..||.+||++.++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 001112233346789999999999999999999966553
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=335.27 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=210.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
...++|++++.||+|+||.||+|++..+++.||+|++..... ...+..|+.+++.+.|++++..+.++ .+....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-EDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCCeE
Confidence 457899999999999999999999999999999999875432 23578899999999887766665554 566788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 117 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence 9999999 7899998875 4679999999999999999999999999999999999999 588999999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+.+..+.......+
T Consensus 193 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~- 261 (335)
T 2owb_A 193 YDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYSIP- 261 (335)
T ss_dssp STTC-------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-
T ss_pred cCcc-------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCCCC-
Confidence 3221 1235679999999999999999999999999999999999999998743 3344444443333322
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
..+++++.++|..||..||++||++.+| |++.|...+.
T Consensus 262 ----~~~~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~~ 299 (335)
T 2owb_A 262 ----KHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSGY 299 (335)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTSC
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHH---hcCccccCCC
Confidence 4578999999999999999999996554 5666666544
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=345.12 Aligned_cols=261 Identities=17% Similarity=0.239 Sum_probs=202.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCC---cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTG---EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~---~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
..|++.+.||+|+||.||+|++..++ ..||||++..... ...+..|+.+++.++|++++..+..+.......++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35889999999999999999875443 4689998865432 23578899999999998888888877766677889
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccccc
Confidence 99998 789999998656679999999999999999999999999999999999999 58899999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.........+ ........
T Consensus 246 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~~~~-- 317 (373)
T 3c1x_A 246 EFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRLLQ-- 317 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCCCCC--
T ss_pred cccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCCCCC--
Confidence 2111 112234567889999999999999999999999999999999 78889876654443322 22222111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+|+++.+++..||..||++||++.+|.+.|+.++...
T Consensus 318 --p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 318 --PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1356899999999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=361.19 Aligned_cols=256 Identities=19% Similarity=0.324 Sum_probs=212.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
-..+|++.+.||+|+||.||+|++..++..||||++.... ....+..|+.+++.++|++++..+..+. .....++|||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-cCCcEEEEEE
Confidence 4568999999999999999999999889999999987553 3356899999999999887777766654 4556789999
Q ss_pred cc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 84 LL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
++ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCC-
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCc-
Confidence 98 799999998643 569999999999999999999999999999999999999 588999999999998764322
Q ss_pred cccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
+.......+++.|+|||++.+..++.++|||||||+||||++ |..||.+.......+. +... .....
T Consensus 373 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---~~~~-~~~~~--- 440 (495)
T 1opk_A 373 -----YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKD-YRMER--- 440 (495)
T ss_dssp -----EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTT-CCCCC---
T ss_pred -----eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcC-CCCCC---
Confidence 122334567889999999999899999999999999999999 9999998655433322 2222 11111
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
...+|+++.+||..||..||++||++.+|.+.|+.++
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 2467999999999999999999999999999988654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.48 Aligned_cols=266 Identities=19% Similarity=0.290 Sum_probs=211.0
Q ss_pred CCceEEEe-eEeeeCceEEEEEEEc--CCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGR-KIGSGSFGELYLGVNV--QTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~-~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.++|.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+|+.++..++|++++..+.++.. ...+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~ 411 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALM 411 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeE
Confidence 45667776 8999999999999875 356689999987543 23468899999999999888887777643 4578
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+|||++ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccC
Confidence 999998 889999997656679999999999999999999999999999999999999 4889999999999987643
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.... +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+........
T Consensus 489 ~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~~~- 560 (613)
T 2ozo_A 489 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRMEC- 560 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCCCC-
T ss_pred CCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 2211 112233456789999999999999999999999999999998 99999986543 33333333322111
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYV 287 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~ 287 (465)
...+|+++.++|..||..||++||++.+|.+.|++++...+...+..
T Consensus 561 ---p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~ 607 (613)
T 2ozo_A 561 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607 (613)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCS
T ss_pred ---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCc
Confidence 14579999999999999999999999999999999998776655443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=326.53 Aligned_cols=251 Identities=17% Similarity=0.191 Sum_probs=204.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----------CccHHHHHHHHHHHcCCCCCceeEEEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----------HPQLHYESKLYMLLQGGTGVPHLKWFG 72 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----------~~~~~~E~~il~~l~~~~~i~~l~~~~ 72 (465)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.+|++|..+..+.
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 357899999999999999999999999999999999875431 235678999999997455555555566
Q ss_pred EeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 73 VEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
......++||+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEeccc
Confidence 7778899999999 7899999975 4679999999999999999999999999999999999999 588999999999
Q ss_pred CccccccccCcccccccCCCCcccccccccccccc------CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL------GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~------~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~ 225 (465)
++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.... .....
T Consensus 170 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML 238 (298)
T ss_dssp TCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred chhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH
Confidence 998754321 123457899999999985 4568899999999999999999999998743 33334
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+.......+.+ ....+++++.+++..||..||++||++.++.
T Consensus 239 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 239 RMIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 4444433332221 2246799999999999999999999977664
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=353.83 Aligned_cols=255 Identities=20% Similarity=0.346 Sum_probs=204.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++.+.||+|+||.||+|.+.. +..||||++..... ...+.+|+.+++.++|++++..+..+.. ...++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEe
Confidence 446789999999999999999999754 56799999876442 3568999999999999888887766543 5578999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|++ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCc
Confidence 998 88999999743 3569999999999999999999999999999999999999 578899999999998764322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+... .+....+..... .+.
T Consensus 335 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~-~~~-- 402 (452)
T 1fmk_A 335 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR-MPC-- 402 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC-CCC--
T ss_pred e------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-CCC--
Confidence 1 12234567889999999999899999999999999999999 9999987543 333333333221 111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
...+|+++.++|..||..||++||++.+|.+.|++++
T Consensus 403 -~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 1457999999999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=343.74 Aligned_cols=258 Identities=19% Similarity=0.274 Sum_probs=206.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----------CCccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----------KHPQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
+.++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++|++++..+..+ .+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~-~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF-EN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE-EC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-ee
Confidence 5679999999999999999999999999999999987653 334678899999999887766666555 56
Q ss_pred CcEEEEEEecc-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 75 GEYNVMVIDLL-GP-SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 75 ~~~~~lv~e~~-g~-sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
....++||+++ ++ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 66788999977 44 99999874 5579999999999999999999999999999999999999 5889999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
+....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||..... ....
T Consensus 177 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~ 239 (335)
T 3dls_A 177 AAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEA 239 (335)
T ss_dssp CEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTT
T ss_pred ceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhh
Confidence 98764322 1234579999999999998876 8899999999999999999999976321 1111
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
....+ ..+++++.+||..||..||++||++.+| |++.|...... ...++|...
T Consensus 240 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~el---l~hp~~~~~~~-~~~~~~~~~ 292 (335)
T 3dls_A 240 AIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKL---VTDPWVTQPVN-LADYTWEEV 292 (335)
T ss_dssp CCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHH---HHCTTTTCCCC-GGGCCHHHH
T ss_pred ccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHH---hcCccccCCcc-ccccCHHHH
Confidence 11111 3468999999999999999999996555 55555543222 234566654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=338.92 Aligned_cols=253 Identities=18% Similarity=0.211 Sum_probs=198.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-------CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-------KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-------~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
..++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..+.|++++..+..+ .....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-eeCCc
Confidence 3578999999999999999999999999999999886432 124678999999999987777666665 45667
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.++||+++.++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 88999999889999988655679999999999999999999999999999999999999 588999999999998764
Q ss_pred cccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc--
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML-- 234 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (465)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 164 ~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT 233 (346)
T ss_dssp SCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred CCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence 322 122356789999999999764 489999999999999999999999987543 3333333222111
Q ss_pred ---------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 ---------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 ---------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+.......+++++.+||..||..||++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 1122233567899999999999999999999766543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.44 Aligned_cols=262 Identities=20% Similarity=0.311 Sum_probs=201.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC---CCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ---TGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~---~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+..++|++.+.||+|+||.||+|.+.. ++..||||++...... ..+..|+.++..++|++++..+..+.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 346899999999999999999998765 4568999998755332 357889999999999888888877765432
Q ss_pred ----EEEEEEecc-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEE
Q 012336 77 ----YNVMVIDLL-GPSLEDLFNYC-----NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVY 146 (465)
Q Consensus 77 ----~~~lv~e~~-g~sL~~ll~~~-----~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vk 146 (465)
..+++|+++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEE
Confidence 458899988 78999998532 3569999999999999999999999999999999999999 5888999
Q ss_pred EEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHH
Q 012336 147 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (465)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~ 225 (465)
|+|||++........ +.......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+...... .
T Consensus 188 l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~ 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---Y 259 (313)
T ss_dssp ECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H
T ss_pred EeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---H
Confidence 999999987643221 122334567889999999999999999999999999999999 9999987554333 2
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..+....... ....+++++.+++..||..||.+||++.+|.+.|+.++...
T Consensus 260 ~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 260 DYLLHGHRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHHHTTCCCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHcCCCCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 2222222111 12467899999999999999999999999999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=331.81 Aligned_cols=251 Identities=18% Similarity=0.287 Sum_probs=195.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEe--CcEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVE--GEYNVMV 81 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~--~~~~~lv 81 (465)
...++|++++.||+|+||.||+|++..+++.||||++... ....+.+|+.++..+.+|++|..+..+... ....+++
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3468999999999999999999999999999999998743 345789999999999855555555555444 5678899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++. .+++..+..++.||+.||.|||++||+||||||+|||+. ..+..+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCC
Confidence 9998 789888875 489999999999999999999999999999999999994 233489999999998654322
Q ss_pred CcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh---------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE--------- 230 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~--------- 230 (465)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .......+..
T Consensus 186 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 186 --------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp --------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHH
T ss_pred --------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhh
Confidence 1234578999999999987 6689999999999999999999999965322 1111111111
Q ss_pred ----hhccCcH-------------------HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 ----KKMLTPI-------------------EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 ----~~~~~~~-------------------~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....... ......+++++.+||..||..||++||++.++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011237899999999999999999999776643
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.02 Aligned_cols=255 Identities=18% Similarity=0.249 Sum_probs=196.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 467999999999999999999999999999999998754322 35778999999999988888877776543
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...++|||++.++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccc
Confidence 3789999999999998886 469999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ...+..+.......
T Consensus 177 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 177 AGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP 245 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCC
T ss_pred ccccc--------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 54321 12346799999999999999999999999999999999999999987533 22333222211110
Q ss_pred cHHH-------------------------------------HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 236 PIEV-------------------------------------LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 236 ~~~~-------------------------------------~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+. .....++++.+||..||..||.+||++.+ +|++.|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e---~l~hp~~ 322 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE---ALQHPYI 322 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHH---HHHSHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHH---HhCCcch
Confidence 0000 00112578999999999999999999555 5667776
Q ss_pred H
Q 012336 279 R 279 (465)
Q Consensus 279 ~ 279 (465)
.
T Consensus 323 ~ 323 (371)
T 2xrw_A 323 N 323 (371)
T ss_dssp H
T ss_pred h
Confidence 5
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=336.71 Aligned_cols=254 Identities=22% Similarity=0.314 Sum_probs=201.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----------CCccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----------KHPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----------~~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+.++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 46789999999999999999999999999999999986432 12358899999999998887777666543
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
.. .++||+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+...+.+..+||+|||+
T Consensus 87 -~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 -ED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -SS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -Cc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 33 78999998 7799998874 56799999999999999999999999999999999999996333345699999999
Q ss_pred ccccccccCcccccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
+........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||........ ....+.
T Consensus 164 ~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 164 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp CEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred ceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 986543211 12356899999999974 56689999999999999999999999987544322 122222
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...... .+.....+++++.+++..||..||++||++.++.+
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYNF-IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCcccc-CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 332222 23344678999999999999999999999877653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=322.18 Aligned_cols=256 Identities=20% Similarity=0.275 Sum_probs=210.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
-.++|++++.||+|+||.||+|.+. +++.||||++.... ....+.+|+.++..++|++++..+..+ ......+++|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 83 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVTE 83 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSCEEEEC
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCCeEEEEe
Confidence 3679999999999999999999975 67899999987654 335688999999999887766666555 45567889999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
++ +++|.+++......+++..+..++.|++.||.|||++|++|+||||+|||+ +.++.++|+|||++........
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc-
Confidence 98 789999998766779999999999999999999999999999999999999 5788999999999986543211
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.......+++.|+|||++.+..++.++||||||+++|+|++ |..||.... ..+....+........ .
T Consensus 160 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~~~----~ 227 (267)
T 3t9t_A 160 -----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRLYK----P 227 (267)
T ss_dssp -----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCCCC----C
T ss_pred -----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcCCC----C
Confidence 12234567889999999998899999999999999999999 999998743 2333333333322111 1
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+++++.+++..||..||++||++.++.+.|+.+..
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3568999999999999999999999999999998764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=334.24 Aligned_cols=259 Identities=17% Similarity=0.255 Sum_probs=207.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEE--EEEEeecC---CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEV--AVKLESVK---TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~v--AvKi~~~~---~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
-.++|++.+.||+|+||.||+|++..++..+ |||.+... .....+..|+.++..+.+|++|..+..+.......+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 3579999999999999999999998888865 99987643 234568899999999944455555555556777899
Q ss_pred EEEecc-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC
Q 012336 80 MVIDLL-GPSLEDLFNYCN---------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~---------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~ 143 (465)
+|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCC
Confidence 999999 889999997432 469999999999999999999999999999999999999 5788
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~ 222 (465)
.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.. ..
T Consensus 180 ~~kL~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~ 248 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY--------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CA 248 (327)
T ss_dssp CEEECCTTCEESSCEE--------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HH
T ss_pred eEEEcccCcCcccccc--------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc---HH
Confidence 9999999999743321 11234467889999999998889999999999999999998 999998743 33
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
+.+..+....... ....+++++.+++..||..||.+||++.++.+.|..++.+..
T Consensus 249 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 249 ELYEKLPQGYRLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHHHGGGTCCCC----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHhhcCCCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 3443333322111 123568999999999999999999999999999999887654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.82 Aligned_cols=253 Identities=19% Similarity=0.242 Sum_probs=197.8
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeC-----c
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEG-----E 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~-----~ 76 (465)
+.....+|++++.||+|+||.||+|++..+++ ||+|.+..... ...+|+++++.++|++++..+.+|...+ .
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 34567789999999999999999999876665 88887654332 3447999999999988888887775543 3
Q ss_pred EEEEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 77 YNVMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
+.++|||++.++|...+.. ....+++..+..++.||+.||+|||++||+||||||+|||+. ..++.+||+|||++
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCc
Confidence 5789999998887766542 256799999999999999999999999999999999999993 26899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
+.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.... ..+..+....
T Consensus 190 ~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~l~~i~~~~ 258 (394)
T 4e7w_A 190 KILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI---DQLVEIIKVL 258 (394)
T ss_dssp EECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHH
T ss_pred ccccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence 8764322 12356789999999999765 5899999999999999999999999885432 2222222211
Q ss_pred ccC-----------------------c-HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 MLT-----------------------P-IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ~~~-----------------------~-~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
... + ...+...+++++.+||.+||..||.+||++.++.
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 100 0 1112234789999999999999999999976654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.57 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=209.7
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.+++.+.|++++..+..+ .....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~ 89 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-EDNDF 89 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-ccCCE
Confidence 4567899999999999999999999999999999999875432 23577899999999887766655554 56678
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 90 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceec
Confidence 89999999 7899998875 4679999999999999999999999999999999999999 58899999999999875
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (465)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.... ..+.+..+.......+
T Consensus 166 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~ 235 (294)
T 2rku_A 166 EYDGE-------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYSIP 235 (294)
T ss_dssp CSTTC-------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCC
T ss_pred ccCcc-------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccCCCc
Confidence 43221 1234679999999999999899999999999999999999999998743 3334444433333222
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
..+++++.+++..||..||++||++.++ |++.|...+
T Consensus 236 -----~~~~~~~~~li~~~l~~~p~~Rps~~~l---l~~~~~~~~ 272 (294)
T 2rku_A 236 -----KHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 272 (294)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred -----cccCHHHHHHHHHHcccChhhCcCHHHH---hhChheecC
Confidence 4578999999999999999999996655 556665544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=334.86 Aligned_cols=264 Identities=19% Similarity=0.292 Sum_probs=206.4
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEE-----EcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGV-----NVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~-----~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
..+..++|++++.||+|+||.||+|+ +..++..||||++..... ...+..|+.++..+.|++++..+..+ .
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-L 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-c
Confidence 46788999999999999999999998 556788999999864322 23578899999999887766666555 4
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEE
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCN------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVY 146 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vk 146 (465)
.....++||+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+...+.+..++
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 555678999998 899999998643 3499999999999999999999999999999999999995433566799
Q ss_pred EEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHH
Q 012336 147 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (465)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~ 225 (465)
|+|||++........ ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.... ..+..
T Consensus 184 l~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVL 255 (327)
T ss_dssp ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHH
T ss_pred ECccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHH
Confidence 999999976543221 122334568999999999999899999999999999999998 999998743 23333
Q ss_pred HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 226 DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+........ ...+++++.++|..||..||.+||++.+|.+.|..+..
T Consensus 256 ~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 33333322211 24678999999999999999999999999999887654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=327.74 Aligned_cols=252 Identities=18% Similarity=0.272 Sum_probs=184.5
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc---cHHHHHHH-HHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP---QLHYESKL-YMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~---~~~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
++..++|++++.||+|+||+||+|++..+++.||||++....... ....|... ++.+.|++++. +..+.......
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~-~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT-FYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCC-EEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEE-EeeeeeccCCE
Confidence 356789999999999999999999999999999999987543222 23333333 44455555444 44455566778
Q ss_pred EEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
++|||++.++|.+++.. ....+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC----
T ss_pred EEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcc
Confidence 99999998899888764 356799999999999999999999998 99999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTH----LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~----~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
....... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||..... ....+.....
T Consensus 159 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~ 228 (290)
T 3fme_A 159 YLVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVE 228 (290)
T ss_dssp -------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHH
T ss_pred ccccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhc
Confidence 7644221 2344799999999996 566789999999999999999999999976432 2222222222
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...... ....+++++.+++..||..||++||++.++.+
T Consensus 229 ~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 229 EPSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp SCCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 222111 12457899999999999999999999776644
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=323.28 Aligned_cols=253 Identities=20% Similarity=0.365 Sum_probs=195.7
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
.+-.++|++.+.||+|+||.||+|.+ +++.||||++..... ...+..|+.++..++|++++..+..+ ....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-LKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-ecCC
Confidence 35578999999999999999999997 589999998765422 24578899999999987766666555 4556
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCceeeccCC-----CCCcEEE
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG---FLHRDIKPDNFLMGLGR-----KSNQVYI 147 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g---ivHrDLKP~NILl~~~d-----~~~~vkL 147 (465)
..+++||++ +++|.+++. .+.+++..+..++.|++.||.|||++| |+||||||+|||+.... .++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 788999998 899999986 568999999999999999999999999 89999999999995211 2788999
Q ss_pred EecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 148 IDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
+|||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+... ......
T Consensus 158 ~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~ 225 (271)
T 3dtc_A 158 TDFGLAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYG 225 (271)
T ss_dssp CCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHH
T ss_pred ccCCccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHh
Confidence 9999998654321 2245799999999999999999999999999999999999999987532 222222
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
+.......+ ....+|+++.+++..||..||.+||++.++.+.|+.
T Consensus 226 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 VAMNKLALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhcCCCCCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 222222222 224678999999999999999999999999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=339.32 Aligned_cols=260 Identities=19% Similarity=0.302 Sum_probs=205.8
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
++.+..++|++++.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..+.|++++..+..+ ..+..
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 105 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGE 105 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-EETTE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-EECCE
Confidence 356788999999999999999999999999999999999876532 23578899999999887766666554 56678
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.++||+++ +++|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.++|+|||++..
T Consensus 106 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHH
T ss_pred EEEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCcc
Confidence 89999999 7899999985 45799999999999999999999996 99999999999999 5889999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH----------
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY---------- 225 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~---------- 225 (465)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 182 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 182 LIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp HHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred ccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 54321 23457999999999999999999999999999999999999999874432211111
Q ss_pred -----------------------------HHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 226 -----------------------------DKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 226 -----------------------------~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..+...... ......++.++.+||..||..||++||++.++ |++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp 326 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP---KLPSGVFSLEFQDFVNKCLIKNPAERADLKQL---MVHA 326 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCC---CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC---CCCcccccHHHHHHHHHHhhcChhhCCCHHHH---hhCh
Confidence 111111000 00112468899999999999999999996655 5566
Q ss_pred HHHc
Q 012336 277 FIRE 280 (465)
Q Consensus 277 ~~~~ 280 (465)
|.+.
T Consensus 327 ~~~~ 330 (360)
T 3eqc_A 327 FIKR 330 (360)
T ss_dssp HHHH
T ss_pred Hhhc
Confidence 6543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=339.19 Aligned_cols=259 Identities=16% Similarity=0.181 Sum_probs=200.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEE-----EEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcC--CCCCceeEEEeEeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLG-----VNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQG--GTGVPHLKWFGVEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla-----~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~--~~~i~~l~~~~~~~~ 76 (465)
+..++|++.+.||+|+||+||+| .+..+++.||||++... ....+..|..++..+.+ ++++..+..+.....
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 34678999999999999999999 46778999999998744 34567888999988873 233444445555666
Q ss_pred EEEEEEecc-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc--------CCCCC
Q 012336 77 YNVMVIDLL-GPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL--------GRKSN 143 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~----~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~--------~d~~~ 143 (465)
..++||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+|||+.. ++.++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 778999998 8999999975 2467999999999999999999999999999999999999952 11179
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~ 223 (465)
.+||+|||+++.+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 221 ~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~- 294 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKG-----TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK- 294 (365)
T ss_dssp TEEECCCTTCEEGGGSCTT-----EEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-
T ss_pred CEEEeeCchhhhhhccCCC-----ceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-
Confidence 9999999999765432211 1224567999999999999999999999999999999999999999653321100
Q ss_pred HHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHc
Q 012336 224 KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDK-PDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~R-Pt~~~l~~~L~~~~~~~ 280 (465)
..... .....++.+.+++..|+..+|.+| |++.++.+.|++.+...
T Consensus 295 ---------~~~~~--~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 295 ---------PEGLF--RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp ---------ECSCC--TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------echhc--cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00000 001236789999999999999999 58889999999888764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.39 Aligned_cols=258 Identities=19% Similarity=0.346 Sum_probs=198.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHc-CCCCCceeEEEeEe-----Cc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQ-GGTGVPHLKWFGVE-----GE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~-~~~~i~~l~~~~~~-----~~ 76 (465)
...++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+. |++++..+..+... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 35789999999999999999999999999999999987543 3457889999999994 55555555555443 46
Q ss_pred EEEEEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
..++|||++ +++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 789999999 67999999864 3579999999999999999999999999999999999999 588999999999998
Q ss_pred ccccccCcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
...... .......||+.|+|||++. +..++.++||||||+++|+|++|..||.+... ......+.
T Consensus 178 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred ecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 654321 1123457999999999987 56689999999999999999999999977432 22222222
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...... .....+++++.++|..||..||.+||++.+| |++.|...
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~hp~~~~ 292 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQL---MKHPFIRD 292 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH---HTSHHHHC
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHH---hhChHHhh
Confidence 222111 1224678999999999999999999996655 45555543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.39 Aligned_cols=252 Identities=16% Similarity=0.186 Sum_probs=196.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-------------ccHHHHHHHHHHHcCCCCCceeEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-------------PQLHYESKLYMLLQGGTGVPHLKW 70 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-------------~~~~~E~~il~~l~~~~~i~~l~~ 70 (465)
.+.++|++++.||+|+||.||+|.+. +++.||||++...... ..+.+|+.++..++|++++..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 46799999999999999999999974 5999999987643221 457899999999999888888777
Q ss_pred EeEe----CcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEE
Q 012336 71 FGVE----GEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVY 146 (465)
Q Consensus 71 ~~~~----~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vk 146 (465)
+... ....++||+++.++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence 7543 33789999999999999998655679999999999999999999999999999999999999 5889999
Q ss_pred EEecCCccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH
Q 012336 147 IIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (465)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~ 225 (465)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+
T Consensus 175 l~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~ 243 (362)
T 3pg1_A 175 ICDFNLAREDTADA--------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQL 243 (362)
T ss_dssp ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred EEecCccccccccc--------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 99999997543321 1234578999999999987 67899999999999999999999999875432 222
Q ss_pred HHHhhhhcc---------------------------CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 226 DKISEKKML---------------------------TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 226 ~~i~~~~~~---------------------------~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+...... .........+++.+.+||..||..||.+||++.++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 222221111 111223346789999999999999999999966653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=323.50 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=202.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEe---CcE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVE---GEY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~---~~~ 77 (465)
-+..|++.+.||+|+||.||+|.+..++..||+|++...... ..+..|+.+++.++|++++..+..+... ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 356799999999999999999999999999999998754322 3578899999999998888887776543 567
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
.++||+++ +++|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||+. +.++.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 89999999 8899999975 467999999999999999999999999 99999999999994 368899999999997
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..... ..+.+..+......
T Consensus 181 ~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 181 LKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC
T ss_pred ccccc---------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc
Confidence 54332 1234579999999998875 589999999999999999999999987432 23333333322221
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
......+++++.++|..||..||.+||++.+|.+
T Consensus 249 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2233556899999999999999999999776643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.99 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=198.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE---
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY--- 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~--- 77 (465)
+.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 578999999999999999999999999999999998754332 3577899999999998888888777654432
Q ss_pred --EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 --NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 --~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.++||+++.++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC--
T ss_pred eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccc
Confidence 48999999999887764 469999999999999999999999999999999999999 5889999999999986
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... .+.+..+......
T Consensus 194 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 260 (371)
T 4exu_A 194 ADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV 260 (371)
T ss_dssp ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCC
T ss_pred cccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCC
Confidence 5432 234578999999999987 6789999999999999999999999987543 2222222221111
Q ss_pred C--------------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 T--------------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ~--------------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ........+++++.+||..||..||++||++.++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 1 11122345689999999999999999999966554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=336.14 Aligned_cols=262 Identities=16% Similarity=0.215 Sum_probs=177.8
Q ss_pred CccCCceEEEe-eEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHH-HHHcCCCCCceeEEEeEe---CcE
Q 012336 3 HVIGGKFKLGR-KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY-MLLQGGTGVPHLKWFGVE---GEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~-~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il-~~l~~~~~i~~l~~~~~~---~~~ 77 (465)
..+.++|++++ .||+|+||.||+|++..+++.||||++... .....|+..+ ..+.|++++..+..+... +..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 35788999965 699999999999999999999999998643 3344455544 445555656555555431 456
Q ss_pred EEEEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.++|||++ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||+...+.++.+||+|||++..
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 88999999 779999998543 4699999999999999999999999999999999999996444567799999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHH-HHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~ 234 (465)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........... ...+......
T Consensus 181 ~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 181 TTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp C-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 5432 12355789999999999888899999999999999999999999977543222111 1111111111
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+. .....+++++.+||..||..||.+||++.++ |++.|...
T Consensus 252 ~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~~ 293 (336)
T 3fhr_A 252 FPN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQF---MNHPWINQ 293 (336)
T ss_dssp CCT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHHHT
T ss_pred cCc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCccccc
Confidence 111 1224679999999999999999999996655 55666544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=321.03 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=201.2
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+.+..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|++++..+..+ ....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-STPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-ecCC
Confidence 456779999999999999999999999989999999998643 2234678899999999887766665554 5567
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred eEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence 789999998 7899999975 4579999999999999999999999999999999999999 5889999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
..... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||.... ..+.+..+......
T Consensus 161 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~ 229 (276)
T 2h6d_A 161 MSDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFY 229 (276)
T ss_dssp CCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC
T ss_pred cCCCc--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccc
Confidence 54321 1234578999999999988765 689999999999999999999997743 33444444433322
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
.+ ..++.++.+++..||..||++||++.+| +++.|.+...
T Consensus 230 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~---l~h~~~~~~~ 269 (276)
T 2h6d_A 230 IP-----EYLNRSVATLLMHMLQVDPLKRATIKDI---REHEWFKQDL 269 (276)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHH---HHSHHHHTTC
T ss_pred Cc-----hhcCHHHHHHHHHHccCChhhCCCHHHH---HhChhhccCc
Confidence 22 4568999999999999999999996655 5566665533
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.96 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=180.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.++..++|++++..+..+ ......+++
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-EDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-ECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-ccCCeEEEE
Confidence 57999999999999999999999999999999986432 234688899999999887766665554 566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCCC
Confidence 9999 789999998655789999999999999999999999999999999999999 588999999999998654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .+..+.......
T Consensus 167 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~----- 231 (278)
T 3cok_A 167 E-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYEM----- 231 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCCC-----
T ss_pred C-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhcccCC-----
Confidence 1 1234579999999999999899999999999999999999999998754322 222221111111
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...++.++.++|..||..||++||++.++.
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 235689999999999999999999977664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=341.12 Aligned_cols=256 Identities=20% Similarity=0.241 Sum_probs=202.1
Q ss_pred CCceEE--EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 6 GGKFKL--GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l--~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
.+.|.+ .+.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..++|++++..+..+ ......++|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-ESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEEEEE
Confidence 445666 678999999999999999999999999987643 234688999999999887766666554 556678999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||+++.+....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence 9999 88999988765567999999999999999999999999999999999999942 256799999999998764322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.......+.. .
T Consensus 244 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~-~ 311 (373)
T 2x4f_A 244 --------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLEDE-E 311 (373)
T ss_dssp --------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSCSG-G
T ss_pred --------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCChh-h
Confidence 1234579999999999999999999999999999999999999998743 344444444443333222 2
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
...+++++.+||..||..||.+||++.++ |++.|.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~---l~hp~~ 346 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEA---LKHPWL 346 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHH---hcCcCc
Confidence 35689999999999999999999996665 444443
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=323.09 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=206.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+.-++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.++..++|++++..+..+ ......
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-HDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-EcCCEE
Confidence 4458999999999999999999999999999999998643 2234688999999999887766665554 556788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence 9999999 7799999875 4579999999999999999999999999999999999999 588999999999986543
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||.... .......+.......+
T Consensus 166 ~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~- 232 (284)
T 2vgo_A 166 SL---------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVDLKFP- 232 (284)
T ss_dssp SS---------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCCCC-
T ss_pred cc---------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhccccCCC-
Confidence 31 1235679999999999999999999999999999999999999998743 2333333333322222
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
..+++++.++|..||..||.+||++.++ |++.|.+
T Consensus 233 ----~~~~~~~~~li~~~l~~~p~~Rps~~~l---l~h~~~~ 267 (284)
T 2vgo_A 233 ----PFLSDGSKDLISKLLRYHPPQRLPLKGV---MEHPWVK 267 (284)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSCCHHHH---HTCHHHH
T ss_pred ----CcCCHHHHHHHHHHhhcCHhhCCCHHHH---hhCHHHH
Confidence 4578999999999999999999996665 4455543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=331.25 Aligned_cols=252 Identities=21% Similarity=0.219 Sum_probs=189.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCc------EE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGE------YN 78 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~------~~ 78 (465)
-++|++++.||+|+||.||+|++..+++.||||++.... ....+..+++.+..++|++++..+.+|...+. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 468999999999999999999999999999999876543 33467778888888999888888877755332 47
Q ss_pred EEEEeccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 79 VMVIDLLGPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMH--SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLH--s~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
++||+++.++|.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+|||+. ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999998888776653 3567999999999999999999999 99999999999999994 23889999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
....... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+... ...+..+....
T Consensus 180 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~---~~~~~~~~~~~ 248 (360)
T 3e3p_A 180 KKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS---AGQLHEIVRVL 248 (360)
T ss_dssp BCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHH
T ss_pred eecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh---HHHHHHHHHHc
Confidence 8765422 123557899999999987655 89999999999999999999999988543 23333332221
Q ss_pred ccCcHHH-----------------------H----hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 MLTPIEV-----------------------L----CKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ~~~~~~~-----------------------~----~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+.+. . ...+++++.+||..||..||.+||++.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 1111111 0 112568999999999999999999976654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=323.84 Aligned_cols=255 Identities=26% Similarity=0.343 Sum_probs=204.4
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
|..-+-++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..+.|++++..+.. ..+...
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~ 79 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-RREGNI 79 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEE-EEETTE
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeE-EEcCCE
Confidence 445567899999999999999999999999999999999875432 2467889999999988776665554 456778
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCcccc
Confidence 89999998 6799988863 4579999999999999999999999999999999999999 58899999999999865
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
...... .......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||........ .+..+.......
T Consensus 156 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL 228 (276)
T ss_dssp EETTEE-----CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTS
T ss_pred CCCcch-----hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhccccc
Confidence 432211 12245679999999999988775 7899999999999999999999987544322 222222222211
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ....+++++.+++..||..||.+||++.+|.
T Consensus 229 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (276)
T 2yex_A 229 N---PWKKIDSAPLALLHKILVENPSARITIPDIK 260 (276)
T ss_dssp T---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred C---chhhcCHHHHHHHHHHCCCCchhCCCHHHHh
Confidence 1 1246799999999999999999999977664
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=324.51 Aligned_cols=265 Identities=24% Similarity=0.305 Sum_probs=201.0
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
....++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..++|++++..+..+ .....
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~ 106 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-IEDNE 106 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-EETTE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EcCCc
Confidence 3456789999999999999999999999999999999875322 23578899999999887766666555 45667
Q ss_pred EEEEEecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 78 NVMVIDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
.+++|+++ +++|.+++.. ....+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccce
Confidence 88999998 7799999874 24669999999999999999999999999999999999999 58899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.+... ........+.....
T Consensus 184 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~ 255 (310)
T 2wqm_A 184 RFFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDY 255 (310)
T ss_dssp ----------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCS
T ss_pred eeecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccC
Confidence 76543221 12345789999999999999999999999999999999999999976432 22223333332222
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
... ....+++++.+++..||..||++||++.+|.+.|+.+......
T Consensus 256 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 256 PPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 211 1245789999999999999999999999999999998765543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=358.82 Aligned_cols=255 Identities=21% Similarity=0.358 Sum_probs=209.7
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+..++|++.+.||+|+||.||+|.+.. +..||||++..... ...+.+|+.+++.++|++++..+.++.. ...+|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEee
Confidence 456789999999999999999999754 57799999876443 3568999999999999888887766643 5578999
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|++ +++|.+++... ...+++.+++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc
Confidence 998 78999999743 3569999999999999999999999999999999999999 578899999999998764321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
+.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+..... .+.
T Consensus 418 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~-~~~-- 485 (535)
T 2h8h_A 418 ------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR-MPC-- 485 (535)
T ss_dssp ------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCC-CCC--
T ss_pred ------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-CCC--
Confidence 112234567889999999999899999999999999999999 9999987543 333333333221 111
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
...+|+++.+||..||..||++||++.+|.+.|++++
T Consensus 486 -~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 486 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1457999999999999999999999999999998654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=321.50 Aligned_cols=250 Identities=10% Similarity=0.162 Sum_probs=203.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEe-CcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVE-GEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~~~ 78 (465)
+-.++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.++..++|++++..+..+... ....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 4568999999999999999999997 4899999998765322 3578899999999888777777666543 3677
Q ss_pred EEEEecc-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNR-KFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~-~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
+++|+++ +++|.+++..... .+++..++.++.||+.||.|||++| ++||||||+|||+ +.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKF 161 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCC
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEecccee
Confidence 8999998 7899999985433 5999999999999999999999999 9999999999999 588899999999875
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCC---cchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSR---RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~---k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
.... ....||+.|+|||.+.+..++. ++||||||+++|||++|..||.+... .+....+...
T Consensus 162 ~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~ 226 (271)
T 3kmu_A 162 SFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALE 226 (271)
T ss_dssp TTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHS
T ss_pred eecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhc
Confidence 4321 3457899999999998876554 79999999999999999999987543 2333333322
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
..... ....+|+++.+++..||..||++||++.++.+.|+.+
T Consensus 227 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 227 GLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp CCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 22221 2246799999999999999999999999999999876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=323.39 Aligned_cols=247 Identities=21% Similarity=0.328 Sum_probs=203.7
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
..+.|++++.||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.|++++..+..+ ......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-LKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-ecCCeEEEE
Confidence 35679999999999999999999999999999999875532 34688999999999887666665554 556678999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++. .+.+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++.......
T Consensus 99 ~e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9998 779999987 5679999999999999999999999999999999999999 588999999999998765422
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+...... ..
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNPP----TL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCC----CC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCCC----CC
Confidence 1 12456799999999999999999999999999999999999999987433 2222222222111 12
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
...++.++.+++..||..||++||++.+|.+
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 3567999999999999999999999776644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.89 Aligned_cols=258 Identities=19% Similarity=0.307 Sum_probs=205.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC------CCCccHHHHHHHHHHHcCCCCCceeEEEe-EeCc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK------TKHPQLHYESKLYMLLQGGTGVPHLKWFG-VEGE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~------~~~~~~~~E~~il~~l~~~~~i~~l~~~~-~~~~ 76 (465)
.+.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.++..++|++++..+..+. .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 3568999999999999999999999999999999998753 22346889999999999888887777664 3456
Q ss_pred EEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|||++.++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 78999999977788888754 4579999999999999999999999999999999999999 5889999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCC--CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ--SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~--s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
....... .......||+.|+|||++.+... +.++||||||+++|+|++|..||.+.. ..+.+..+.....
T Consensus 159 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAAD-----DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSS-----CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred cCccccc-----cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCC
Confidence 6432211 11234569999999999987543 789999999999999999999998743 3444444444333
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
..+ ..+++++.+++..||..||.+||++.++ +++.|.+.
T Consensus 231 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~~~~~~~ 269 (305)
T 2wtk_C 231 AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQI---RQHSWFRK 269 (305)
T ss_dssp CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHH---HHSHHHHS
T ss_pred CCC-----CccCHHHHHHHHHHccCChhhCCCHHHH---hcCccccc
Confidence 222 4678999999999999999999996665 55555544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=346.15 Aligned_cols=250 Identities=16% Similarity=0.140 Sum_probs=186.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-----CccHHHHHHHHHHHc--CCCCCcee-------EEEe
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-----HPQLHYESKLYMLLQ--GGTGVPHL-------KWFG 72 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-----~~~~~~E~~il~~l~--~~~~i~~l-------~~~~ 72 (465)
.+|++++.||+|+||.||+|++..+++.||||++..... ...+..|+.++..|. |++++..+ ..+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999887543 234677877777776 66655433 2222
Q ss_pred EeC----------------cEEEEEEeccCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHHCCccccCCC
Q 012336 73 VEG----------------EYNVMVIDLLGPSLEDLFNYCNRKFSLKTV------LMLADQLINRVEYMHSRGFLHRDIK 130 (465)
Q Consensus 73 ~~~----------------~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~------~~ia~qi~~gL~yLHs~givHrDLK 130 (465)
..+ ...++|||++.++|.+++...+..+.+..+ ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 221 347999999999999999865555666666 7888999999999999999999999
Q ss_pred CCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhc
Q 012336 131 PDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLR 208 (465)
Q Consensus 131 P~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~ellt 208 (465)
|+|||+ +.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 588999999999998654311 13456799999999987 679999999999999999999
Q ss_pred CCCCCCCCCCCchHHHHHHHh--hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 209 GSLPWQGLKAGTKKQKYDKIS--EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 209 G~~Pf~~~~~~~~~~~~~~i~--~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
|+.||.+....... .+.... ...........+..+|+++.+||..||..||++||++.++.
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999875332111 000000 00000011112357799999999999999999999976664
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=326.95 Aligned_cols=258 Identities=19% Similarity=0.300 Sum_probs=198.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcC-CCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQG-GTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~-~~~i~~l~~~~~~~~~~ 78 (465)
+.+++|++++.||+|+||.||+|.+ .+++.||||++...... ..+.+|+.++..+.| ++++..+..+.......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 4577899999999999999999997 46899999998765432 457889999999986 56666666667777889
Q ss_pred EEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 79 VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 79 ~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+++||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.....
T Consensus 104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCC---
T ss_pred EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----ECCeEEEeeccccccccC
Confidence 99999889999999986 5679999999999999999999999999999999999999 358999999999987644
Q ss_pred ccCcccccccCCCCccccccccccccccC-----------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-----------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-----------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
.... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||..... ....+..
T Consensus 179 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~ 251 (313)
T 3cek_A 179 DTTS-----VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 251 (313)
T ss_dssp ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred cccc-----ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHH
Confidence 3211 11234579999999999876 4688899999999999999999999976432 2222222
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+........ .....++++.+++..||..||.+||++.++ |++.|...
T Consensus 252 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el---l~h~~~~~ 298 (313)
T 3cek_A 252 IIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQI 298 (313)
T ss_dssp HHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHC
T ss_pred HHhcccccC---CcccchHHHHHHHHHHccCCcccCcCHHHH---hcCccccC
Confidence 222211111 123457899999999999999999996554 55555544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=333.22 Aligned_cols=266 Identities=19% Similarity=0.207 Sum_probs=209.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEE----cCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEe-Cc
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVN----VQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVE-GE 76 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~----~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~-~~ 76 (465)
+..++|++++.||+|+||.||+|+. ..+++.||||++..... ...+.+|+.++..++|++++..+..+... ..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 4567899999999999999999984 56899999999875432 23588999999999988888877766543 34
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++||+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGDFGLTKV 194 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEE
T ss_pred ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---cCCCcEEEecCcchhh
Confidence 678999998 789999998766679999999999999999999999999999999999999 4789999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC---------chHH---
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---------TKKQ--- 223 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~---------~~~~--- 223 (465)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||...... ....
T Consensus 195 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 195 LPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred cccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 65432211 1223456788999999999888999999999999999999999998642100 0000
Q ss_pred HHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 224 KYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.+..........+ ....+|+++.++|..||..||++||++.+|.+.|+.+..+
T Consensus 271 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 271 HLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0011111111111 1246789999999999999999999999999999988654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.55 Aligned_cols=261 Identities=20% Similarity=0.234 Sum_probs=197.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
.-++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..+.|++++..+..+ ......++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-KKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-ecCCEEEE
Confidence 357899999999999999999999999999999988655432 2367899999999987766666554 56778899
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||+++.+.+.+.+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCc
Confidence 99999554444444346779999999999999999999999999999999999999 588999999999997654322
Q ss_pred CcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh--------
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK-------- 231 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 231 (465)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 179 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 179 E-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 1 12345789999999999875 6899999999999999999999999875432222111111000
Q ss_pred ---------------hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 232 ---------------KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 232 ---------------~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
....+.......+++++.+||..||..||++||++.+| |++.|..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el---l~hp~f~ 311 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL---LHHDFFQ 311 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHH
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH---hcCchhc
Confidence 01112223334678999999999999999999996655 4455543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=333.73 Aligned_cols=265 Identities=16% Similarity=0.203 Sum_probs=202.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEe---CcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVE---GEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~---~~~~ 78 (465)
+..++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.++..+.|++++..+..+... ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 44679999999999999999999999999999999876532 234578999999999998888887776542 3477
Q ss_pred EEEEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 79 VMVIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
+++|+++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcch
Confidence 8999998 77999998753 5679999999999999999999999999999999999999 588999999999987
Q ss_pred ccccccCccc--ccccCCCCccccccccccccccCCC---CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 155 KYRDLQTHKH--IPYRENKNLTGTARYASVNTHLGVE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 155 ~~~~~~~~~~--~~~~~~~~~~Gt~~Y~APE~~~~~~---~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
.......... ..........||+.|+|||++.+.. ++.++||||||+++|+|++|..||......... ....+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~ 261 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAVQ 261 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHHH
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHhh
Confidence 6532111000 0000011235799999999988654 689999999999999999999999642111100 011111
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.....+ ....+++++.++|..||..||.+||++.+|.+.|+.+
T Consensus 262 -~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 262 -NQLSIP---QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp -CC--CC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -ccCCCC---ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 111111 1245789999999999999999999999999988754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=329.41 Aligned_cols=259 Identities=23% Similarity=0.281 Sum_probs=199.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-CCc--EEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-TGE--EVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-~~~--~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+..++|++++.||+|+||+||+|++.. +++ .||||++.... ....+.+|+.++..++|++++..+.++....
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 456899999999999999999998643 333 69999876442 2246789999999999888777776665433
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
.+++++++ +++|.+++......+++..+..++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.
T Consensus 95 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 95 --MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMR 169 (291)
T ss_dssp --CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCE
T ss_pred --ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---cCCCCEEEccccccc
Confidence 67888887 899999998766779999999999999999999999999999999999999 478899999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+... .+.+..+.....
T Consensus 170 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~ 242 (291)
T 1u46_A 170 ALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGE 242 (291)
T ss_dssp ECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCC
T ss_pred cccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCC
Confidence 765432211 12234567889999999998889999999999999999999 9999987543 334433333322
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
..+ ....+|+++.+++..||..||++||++.+|.+.|+.+.
T Consensus 243 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 RLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 222 12467999999999999999999999999999888764
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.19 Aligned_cols=244 Identities=22% Similarity=0.351 Sum_probs=199.6
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--------CCccHHHHHHHHHHHcC-CCCCceeEEEe
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--------KHPQLHYESKLYMLLQG-GTGVPHLKWFG 72 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--------~~~~~~~E~~il~~l~~-~~~i~~l~~~~ 72 (465)
+..+.++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+.+ ++++..+..+.
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3567899999999999999999999999999999999987543 23567889999999985 45555555555
Q ss_pred EeCcEEEEEEeccC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEec
Q 012336 73 VEGEYNVMVIDLLG--PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 73 ~~~~~~~lv~e~~g--~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
......+++++++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+. ..++.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence 66677888898883 899999875 56799999999999999999999999999999999999993 26789999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS 229 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (465)
|++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|..||.... . +.
T Consensus 195 g~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~----~~ 256 (320)
T 3a99_A 195 GSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E----II 256 (320)
T ss_dssp TTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H----HH
T ss_pred cccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----h----hh
Confidence 9998765321 234579999999999987665 788999999999999999999997521 1 11
Q ss_pred hhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 230 EKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 230 ~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..... ....+++++.++|..||..||++||++.+|.+
T Consensus 257 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 RGQVF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HCCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 12467999999999999999999999777643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=323.65 Aligned_cols=249 Identities=21% Similarity=0.243 Sum_probs=202.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNVM 80 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~l 80 (465)
.++|++++.||+|+||.||+|++..+++.||+|++..... ...+..|+.++..++|++++..+..+.. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4799999999999999999999999999999999875432 2357889999999998888887776654 4568899
Q ss_pred EEecc-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 81 VIDLL-GPSLEDLFNYC---NRKFSLKTVLMLADQLINRVEYMHSRG-----FLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~---~~~ls~~~~~~ia~qi~~gL~yLHs~g-----ivHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
+||++ +++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCc
Confidence 99999 77999998753 345999999999999999999999999 9999999999999 588999999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||..... .+....+...
T Consensus 162 ~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG 231 (279)
T ss_dssp HHHHC---CH-------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHT
T ss_pred hheeeccccc-------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHHhhc
Confidence 9986543211 01234689999999999999999999999999999999999999987542 3333333333
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.... ....+++++.+++..||..||++||++.+|.+
T Consensus 232 ~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 232 KFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp CCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 3221 12467899999999999999999999877754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=349.25 Aligned_cols=239 Identities=14% Similarity=0.109 Sum_probs=184.8
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHH---cCCCCCcee-------EE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLL---QGGTGVPHL-------KW 70 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l---~~~~~i~~l-------~~ 70 (465)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.++..+ .|++++..+ .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998899999999987432 124577898555554 555555444 33
Q ss_pred EeEeCc----------------EEEEEEeccCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHHCCcccc
Q 012336 71 FGVEGE----------------YNVMVIDLLGPSLEDLFNYCNRKFS-------LKTVLMLADQLINRVEYMHSRGFLHR 127 (465)
Q Consensus 71 ~~~~~~----------------~~~lv~e~~g~sL~~ll~~~~~~ls-------~~~~~~ia~qi~~gL~yLHs~givHr 127 (465)
+...+. ..||+||+++++|.+++... +.++ +..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 222211 37899999999999999853 2344 48888999999999999999999999
Q ss_pred CCCCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCC-----------CCCCcchH
Q 012336 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-----------EQSRRDDL 196 (465)
Q Consensus 128 DLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-----------~~s~k~Di 196 (465)
||||+|||+ +.++.+||+|||+++..... .....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 58899999999999853321 234567 999999999987 89999999
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 197 wSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
|||||++|||++|..||.+......... ....+..+|+++.+||..||..||++||++.++.+
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGSEW------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCSGG------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccchhh------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999999976432211110 01112577999999999999999999999877754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=358.68 Aligned_cols=254 Identities=20% Similarity=0.343 Sum_probs=202.0
Q ss_pred eEEE-eeEeeeCceEEEEEEE--cCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 9 FKLG-RKIGSGSFGELYLGVN--VQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 9 y~l~-~~LG~G~fG~Vyla~~--~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.+. +.||+|+||.||+|.+ ..+++.||||+++.... ...+..|+.++..++|++++..+.++. ....++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEE
Confidence 4443 4899999999999965 45678999999876432 246889999999999988888777663 3447799
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++ +++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 448 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCTTHHHHTTC--
T ss_pred EEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE---eCCCCEEEEEcCCccccccCc
Confidence 9998 8899999975 5679999999999999999999999999999999999999 488899999999998765432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... ..
T Consensus 524 ~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~-~~-- 593 (635)
T 4fl3_A 524 NY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM-GC-- 593 (635)
T ss_dssp ---------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC-CC--
T ss_pred cc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC-CC--
Confidence 21 122234457889999999999999999999999999999998 9999988544 3333333332221 11
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
...+|+++.+||..||..||++||++.+|.+.|++++..
T Consensus 594 -p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 594 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 146799999999999999999999999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=343.57 Aligned_cols=263 Identities=17% Similarity=0.203 Sum_probs=189.7
Q ss_pred ccCCceEE-EeeEeeeCceEEEEEEEc--CCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEEE
Q 012336 4 VIGGKFKL-GRKIGSGSFGELYLGVNV--QTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNV 79 (465)
Q Consensus 4 i~~~~y~l-~~~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~ 79 (465)
.+.+.|.+ .++||+|+||+||+|++. .+++.||||++........+.+|+.+++.++|++++..+..+.. .....+
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45677888 458999999999999965 56899999999877667789999999999999888888777754 466889
Q ss_pred EEEeccCCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC-CCCCcEEEEec
Q 012336 80 MVIDLLGPSLEDLFNYC--------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG-RKSNQVYIIDY 150 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~--------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~-d~~~~vkL~DF 150 (465)
+||++++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+... +.++.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99999999999888632 1249999999999999999999999999999999999999532 36789999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc------hHH
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQ 223 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~------~~~ 223 (465)
|+++.+..... +........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... ...
T Consensus 177 g~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 177 GFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred CCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 99987643211 11223456899999999999874 48999999999999999999999997644310 011
Q ss_pred HHHHHhhhhccCcH---------------------------------HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 224 KYDKISEKKMLTPI---------------------------------EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 224 ~~~~i~~~~~~~~~---------------------------------~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+..+......... .......++++.+||..||..||.+|||+.+++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22222111000000 000012267899999999999999999966553
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=333.87 Aligned_cols=269 Identities=23% Similarity=0.283 Sum_probs=209.2
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHH--HcCCCCCceeEEEeEeC---cE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYML--LQGGTGVPHLKWFGVEG---EY 77 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~--l~~~~~i~~l~~~~~~~---~~ 77 (465)
..+.++|++.+.||+|+||.||+|++ +++.||||++.... ...+..|.+++.. +.|++++..+..+.... ..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 34678999999999999999999987 68999999986443 3467889999888 66777776666665544 27
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH--------SRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH--------s~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
.+++|+++ +++|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||+ +.++.+||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~ 189 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 189 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEEC
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEE
Confidence 89999998 7799999974 57999999999999999999999 8999999999999999 588999999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCC------CCCcchHHHHHHHHHHHhcC----------CCC
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE------QSRRDDLESLGYVLMYFLRG----------SLP 212 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~k~DiwSLGviL~elltG----------~~P 212 (465)
|||++........... .......||+.|+|||++.+.. ++.++||||||+++|||++| ..|
T Consensus 190 Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 190 DLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred ECCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999987654322110 1234567999999999998763 34689999999999999999 889
Q ss_pred CCCCCCCc--hHHHHHHHhhhhccC--cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 012336 213 WQGLKAGT--KKQKYDKISEKKMLT--PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGY 282 (465)
Q Consensus 213 f~~~~~~~--~~~~~~~i~~~~~~~--~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~ 282 (465)
|....... .......+....... +.......+++.+.+++..||..||++||++.+|.+.|+.+..+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 97754322 222222222222221 11111223467899999999999999999999999999999876654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.38 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=196.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHc-----------CCCCCceeEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQ-----------GGTGVPHLKWF 71 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~-----------~~~~i~~l~~~ 71 (465)
+..++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+. |++++..+..+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 44689999999999999999999999999999999987432 2345788999999887 44566666665
Q ss_pred eEeC---cEEEEEEeccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccC---CCCC
Q 012336 72 GVEG---EYNVMVIDLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLG---RKSN 143 (465)
Q Consensus 72 ~~~~---~~~~lv~e~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~---d~~~ 143 (465)
...+ ...+++|++++++|.+++... ...+++..+..++.||+.||.|||++ ||+||||||+|||+... +..+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 5432 378999999999999999864 35699999999999999999999998 99999999999999532 1344
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCc---
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--- 220 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~--- 220 (465)
.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.....
T Consensus 176 ~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred eEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 8999999999866432 234578999999999999999999999999999999999999998644221
Q ss_pred hHHHHHHHhhhhccCcHHH-------------------------------------HhccCcHHHHHHHHHHhcCCCCCC
Q 012336 221 KKQKYDKISEKKMLTPIEV-------------------------------------LCKSYPSEFTSYFHYCRSLRFEDK 263 (465)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~-------------------------------------~~~~~p~~l~~li~~cl~~dp~~R 263 (465)
....+..+.......+... +...+++++.+||..||..||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1112222221111111100 012346789999999999999999
Q ss_pred CCHHHHH
Q 012336 264 PDYSYLK 270 (465)
Q Consensus 264 Pt~~~l~ 270 (465)
|++.+|.
T Consensus 326 pt~~ell 332 (373)
T 1q8y_A 326 ADAGGLV 332 (373)
T ss_dssp BCHHHHH
T ss_pred CCHHHHh
Confidence 9976653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=319.91 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=204.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.+.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++..+..+ ......+
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~ 97 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-EDSSSFY 97 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-eCCCeEE
Confidence 45689999999999999999999999999999999986542 234688999999999887766666554 5566788
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
++++++ +++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||+...+.++.+||+|||++.....
T Consensus 98 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 999988 8899988875 45799999999999999999999999999999999999996433456899999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.. ......||+.|+|||.+.+. ++.++||||||+++|+|++|..||.+.. ..+....+.......+.+
T Consensus 177 ~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 177 NT--------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP 244 (287)
T ss_dssp CS--------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCSG
T ss_pred CC--------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCCCch
Confidence 21 12345689999999998764 8999999999999999999999998743 333444444443332222
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
....+++++.+++..||..||++||++.++.+
T Consensus 245 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 -QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 22467999999999999999999999766643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=324.21 Aligned_cols=252 Identities=19% Similarity=0.291 Sum_probs=199.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-+.++|++++.||+|+||.||+|++..+++.||+|++.... ....+..|+.++..+.|++++..+..+. .....++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-HDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-eCCeEEEE
Confidence 46789999999999999999999999999999999987543 2346889999999998877777666654 45577899
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++......+++..+..++.||+.||.|||++|++||||||+|||+ +.++.++|+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9998 889999988767789999999999999999999999999999999999999 578999999999986533211
Q ss_pred CcccccccCCCCccccccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTH-----LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~-----~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.......||+.|+|||++ .+..++.++||||||+++|+|++|..||..... ...+..+.......
T Consensus 172 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 -------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT 241 (302)
T ss_dssp -------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred -------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc
Confidence 112345799999999998 366789999999999999999999999987543 22333322222111
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. .....++.++.+++..||..||++||++.+|.+
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 112457899999999999999999999777643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.29 Aligned_cols=267 Identities=17% Similarity=0.211 Sum_probs=195.3
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHH--HHcCCCCCceeEEEeE----eCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYM--LLQGGTGVPHLKWFGV----EGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~--~l~~~~~i~~l~~~~~----~~~~ 77 (465)
+--++|++++.||+|+||.||+|++ +++.||||++.... ...+..|.+++. .+.|++++..+..+.. ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 4468999999999999999999976 78999999987543 234455555544 4778777777654432 2346
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCceeeccCCCCCcEEE
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR---------GFLHRDIKPDNFLMGLGRKSNQVYI 147 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~---------givHrDLKP~NILl~~~d~~~~vkL 147 (465)
.++|||++ +++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||+ +.++.+||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL 161 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVI 161 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEE
T ss_pred EEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEE
Confidence 78999999 8899999974 4569999999999999999999999 99999999999999 57899999
Q ss_pred EecCCccccccccCccc-ccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC
Q 012336 148 IDYGLAKKYRDLQTHKH-IPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (465)
Q Consensus 148 ~DFGla~~~~~~~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~ 219 (465)
+|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||++|||++|..||......
T Consensus 162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~ 241 (336)
T 3g2f_A 162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241 (336)
T ss_dssp CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence 99999987654221110 00112335579999999999987 35667899999999999999997776442221
Q ss_pred ch--------------HHHHH-HHhhhhccCcHHHHh---ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 220 TK--------------KQKYD-KISEKKMLTPIEVLC---KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 220 ~~--------------~~~~~-~i~~~~~~~~~~~~~---~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.. ..... .+.........+..+ ..+++++.+||..||..||++||++.++.+.|+.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 10 00111 111111111111111 1135689999999999999999999999999998874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=329.92 Aligned_cols=247 Identities=20% Similarity=0.305 Sum_probs=196.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCc----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGE---- 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~---- 76 (465)
+.++|.+.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..++|++++..+..+.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 568999999999999999999999999999999998754332 357789999999999888887777765443
Q ss_pred -EEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 77 -YNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 77 -~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..+++|+++.++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC
T ss_pred eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccC
Confidence 358999999988887764 469999999999999999999999999999999999999 5889999999999976
Q ss_pred cccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+... ...+..+......
T Consensus 176 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 242 (353)
T 3coi_A 176 ADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGV 242 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCB
T ss_pred CCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 5321 234578999999999887 6789999999999999999999999987543 2222222211100
Q ss_pred C--------------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 235 T--------------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 235 ~--------------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ........+++++.+||..||..||++||++.++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0 01112245789999999999999999999976654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=321.62 Aligned_cols=259 Identities=20% Similarity=0.205 Sum_probs=196.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEe--------
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVE-------- 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-------- 74 (465)
.+.++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.|++++..+..+...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 35689999999999999999999999999999999886432 234678899999999998888877766442
Q ss_pred ----CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEe
Q 012336 75 ----GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIID 149 (465)
Q Consensus 75 ----~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~D 149 (465)
....++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence 45789999999 789999998756678999999999999999999999999999999999999 5889999999
Q ss_pred cCCccccccccCccc-------ccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch
Q 012336 150 YGLAKKYRDLQTHKH-------IPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (465)
Q Consensus 150 FGla~~~~~~~~~~~-------~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~ 221 (465)
||++........... ..........||+.|+|||++.+. .++.++||||||+++|+|++ ||... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 999986543211000 001122355799999999999865 68999999999999999998 66431 112
Q ss_pred HHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 222 KQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.+....+.......+ .......++.+.+++..||..||.+||++.++.+
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 222333332222222 2234566888999999999999999999777654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=331.46 Aligned_cols=265 Identities=18% Similarity=0.236 Sum_probs=207.8
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
..++|++.+.||+|+||.||+|++ .+++.||||++..... ...+.+|+.++..++|++++..+..+ ......++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-DERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-CCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCeEEEEE
Confidence 468999999999999999999995 5789999998775433 24678899999999887766666554 4566788999
Q ss_pred ecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 83 DLL-GPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~---~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 998 789999886432 359999999999999999999999999999999999999 5889999999999986543
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHh----hhhcc
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKIS----EKKML 234 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~----~~~~~ 234 (465)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.............. .....
T Consensus 192 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 2211 12234569999999999999999999999999999999999999998755433222111111 10000
Q ss_pred -----CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 235 -----TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 235 -----~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.........++.++.+++..||..||++||++.++.+.|+.+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 001111223467899999999999999999999999999988653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=354.89 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=209.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCC---CcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQT---GEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~---~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+..++|++.+.||+|+||.||+|++..+ +..||||++...... ..+..|+.++..+.|++++..+..+. ...
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCc
Confidence 4567899999999999999999998654 457999987654322 46889999999999988888777653 345
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl---~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE---eCCCCEEEEecCCCeec
Confidence 78999998 799999998656679999999999999999999999999999999999999 47899999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+... .+.+..+.......
T Consensus 542 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~~ 612 (656)
T 2j0j_A 542 EDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERLP 612 (656)
T ss_dssp CC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCCC
T ss_pred CCCcc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCCC
Confidence 44221 12234467889999999999899999999999999999997 9999987543 33333333332211
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+|+++.++|..||..||++||++.+|.+.|+.++..+
T Consensus 613 ----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 12467899999999999999999999999999999988654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=328.95 Aligned_cols=273 Identities=18% Similarity=0.260 Sum_probs=200.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
.+..++|++.+.||+|+||.||+|++.. .||||++.... ....+.+|+.++..++|++++..+..+. .....
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-SPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-CSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-cCCce
Confidence 3557899999999999999999998743 59999887542 2345788999999998877776666554 55568
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+++|+++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +++.++|+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C--CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----eCCCEEEeecCCccccc
Confidence 8999998 789999998655579999999999999999999999999999999999999 36799999999987653
Q ss_pred cccCcccccccCCCCccccccccccccccC---------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLG---------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKI 228 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~---------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i 228 (465)
...... .........||+.|+|||++.+ ..++.++||||||+++|||++|..||..... ......+
T Consensus 181 ~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~ 255 (319)
T 2y4i_B 181 VLQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQM 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHH
T ss_pred cccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHh
Confidence 221111 1122334569999999999875 3478899999999999999999999987432 3333333
Q ss_pred hhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccc
Q 012336 229 SEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWT 291 (465)
Q Consensus 229 ~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~ 291 (465)
........ ....+|.++.+++..||..||++||++.+|.+.|+.+..+..........|.
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 256 GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 32222111 1235789999999999999999999999999999988776655555555554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.31 Aligned_cols=250 Identities=18% Similarity=0.288 Sum_probs=180.4
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCc---cHHHHHH-HHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP---QLHYESK-LYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~---~~~~E~~-il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-++|++++.||+|+||.||+|++..+++.||||++....... ....|.. ++..+.|++ |..+..+.......++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~-i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY-IVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTT-BCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCc-eeeEEEEEecCCcEEEE
Confidence 368999999999999999999999999999999987654322 2333443 444455555 44454555667788999
Q ss_pred EeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++++.+..+.......+++..+..++.||+.||.|||++ ||+|+||||+|||+ +.++.+||+|||++.......
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCc
Confidence 99998888888776677899999999999999999999996 99999999999999 588999999999997654322
Q ss_pred CcccccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
. .....||+.|+|||++. +..++.++||||||+++|+|++|..||..... ..+.+..+.......
T Consensus 180 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 180 A--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL 249 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC
T ss_pred c--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC
Confidence 1 23457999999999994 45688999999999999999999999986432 223333333322211
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.. ....+++++.++|..||..||.+||++.+|.+
T Consensus 250 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11 11357899999999999999999999776654
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=325.42 Aligned_cols=254 Identities=17% Similarity=0.262 Sum_probs=175.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHH-HHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKL-YMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
+..++|++++.||+|+||.||+|.+..+++.||||++...... .++..|... ++.+.|++++ .+..+.......+
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv-~~~~~~~~~~~~~ 97 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV-QFYGALFREGDCW 97 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBC-CEEEEEECSSEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEe-eeeeEEEeCCceE
Confidence 4568999999999999999999999999999999998754322 235556553 3444555544 4444555667889
Q ss_pred EEEeccCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 80 MVIDLLGPSLEDLFNY----CNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~----~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
+|||++.++|.+++.. ....+++..+..++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||++.
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISG 174 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSC
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE---cCCCCEEEccCCCce
Confidence 9999998899988864 256799999999999999999999999 99999999999999 488999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTH----LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE 230 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~----~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (465)
....... .....||+.|+|||++ .+..++.++||||||+++|+|++|..||.+.... .+.+..+..
T Consensus 175 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~ 244 (327)
T 3aln_A 175 QLVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVK 244 (327)
T ss_dssp C--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCC
T ss_pred ecccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhc
Confidence 7643221 2234699999999998 4566899999999999999999999999864321 111111111
Q ss_pred hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 231 ~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.............+++++.+|+..||..||++||++.+|.+
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111112457899999999999999999999777654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=328.93 Aligned_cols=261 Identities=17% Similarity=0.194 Sum_probs=200.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+..++|++.+.||+|+||.||+|+ ..+++.||||++.... ....+..|+.++..+.|++++..+..+. .....++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~l 104 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-TPTERLL 104 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEEC-CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-CSSCCEE
T ss_pred HHhhccccceeEecCCCcEEEEEE-ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-cCCceEE
Confidence 457899999999999999999998 4578999999987543 2336889999999999877777666554 5556689
Q ss_pred EEecc-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 81 VIDLL-GPSLEDLFNYCN---RKFSLKTVLMLADQLINRVEYMHSR---GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~---~~ls~~~~~~ia~qi~~gL~yLHs~---givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
||+++ +++|.+++.... ..+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 181 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence 99998 889999997532 3499999999999999999999999 99999999999999 58899999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCC-----CCchHHHHHHH
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----AGTKKQKYDKI 228 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~-----~~~~~~~~~~i 228 (465)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...........
T Consensus 182 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 182 KLMDYKDT------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp EECCSSSS------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccCcccc------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 87643222 11234569999999999998889999999999999999999999995211 11111111000
Q ss_pred hhhhc-c-----CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 229 SEKKM-L-----TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 229 ~~~~~-~-----~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
..... . ..........+.++.+++..||..||.+||++.+|.+.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00000 0 00001112235789999999999999999999999988864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=316.41 Aligned_cols=244 Identities=23% Similarity=0.306 Sum_probs=192.1
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCC
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
...||+|+||.||+|++..+++.||||++..... ...+..|+.++..+.|++++..+..+ ......+++|+++ +++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF-SENGFIKIFMEQVPGGS 105 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEEEEECCSEEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEE-EeCCcEEEEEEeCCCCC
Confidence 3489999999999999999999999999875432 34688999999999887777766655 5666788999998 899
Q ss_pred HHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccccc
Q 012336 89 LEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIP 166 (465)
Q Consensus 89 L~~ll~~~~~--~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (465)
|.+++..... .+++..+..++.||+.||.|||++||+|+||||+|||+. ..++.++|+|||++........
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~----- 178 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP----- 178 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC--------
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC-----
Confidence 9999986432 467999999999999999999999999999999999995 2388999999999987543211
Q ss_pred ccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 167 YRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 167 ~~~~~~~~Gt~~Y~APE~~~~~~--~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
......||+.|+|||++.+.. ++.++||||||+++|+|++|..||....... ............. .+...+
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~---~~~~~~ 251 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMFKVGMFKVHP---EIPESM 251 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHHHHHHHCCCC---CCCTTS
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHHhhccccccc---cccccC
Confidence 123557999999999997654 8899999999999999999999997643221 1111111111111 122467
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
++++.+++..||..||++||++.++.
T Consensus 252 ~~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 252 SAEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHh
Confidence 89999999999999999999977664
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=319.29 Aligned_cols=242 Identities=20% Similarity=0.323 Sum_probs=188.8
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--------CCccHHHHHHHHHHH----cCCCCCceeEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--------KHPQLHYESKLYMLL----QGGTGVPHLKW 70 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--------~~~~~~~E~~il~~l----~~~~~i~~l~~ 70 (465)
..+.++|++++.||+|+||.||+|++..+++.||||++.... ....+..|+.++..+ .|++++..+.+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 467889999999999999999999999999999999987543 234567899999999 56666665555
Q ss_pred EeEeCcEEEEEEec-c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 71 FGVEGEYNVMVIDL-L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 71 ~~~~~~~~~lv~e~-~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
+ ......++++++ + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+. ..++.++|+
T Consensus 107 ~-~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 182 (312)
T 2iwi_A 107 F-ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLI 182 (312)
T ss_dssp C------CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEEC
T ss_pred E-ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEE
Confidence 5 444566777776 4 8999999986 45799999999999999999999999999999999999994 268899999
Q ss_pred ecCCccccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDK 227 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~ 227 (465)
|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||... .+
T Consensus 183 dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~---- 244 (312)
T 2iwi_A 183 DFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QE---- 244 (312)
T ss_dssp CCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH----
T ss_pred EcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HH----
Confidence 999998765421 235579999999999887665 45899999999999999999999752 11
Q ss_pred HhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 228 ISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 228 i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+....... ...+++++.++|..||..||++||++.++.+
T Consensus 245 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ILEAELHF-----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHTCCCC-----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HhhhccCC-----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222222 2457899999999999999999999777654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=321.79 Aligned_cols=260 Identities=20% Similarity=0.259 Sum_probs=183.2
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC---CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK---TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~---~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
+..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.++..++|++++..+..+ ......++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF-VVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEE-ESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE-eecCCcEE
Confidence 5578999999999999999999998889999999987653 2344678899999999887766666555 45556889
Q ss_pred EEecc-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 81 VIDLL-GPSLEDLFNY-------CNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~-------~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
||+++ +++|.+++.. ....+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccc
Confidence 99998 8899999874 24569999999999999999999999999999999999999 5889999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
+.......... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... .......
T Consensus 168 ~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~ 243 (303)
T 2vwi_A 168 SAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLTLQND 243 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHHHTSS
T ss_pred hheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHHhccC
Confidence 97654321110 0112345679999999999876 56899999999999999999999999875443222 1111111
Q ss_pred hccCc----HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 232 KMLTP----IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 232 ~~~~~----~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
..... .......+++++.+++..||..||.+||++.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11110 11123467899999999999999999999777654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=315.58 Aligned_cols=256 Identities=22% Similarity=0.289 Sum_probs=198.2
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
|...+.||+|+||.||+|.+ +++.||||++..... ...+.+|+.++..++|++++..+..+ ......+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-ecCCceEEEE
Confidence 33448999999999999985 688999998865321 24578999999999887766666555 4556778899
Q ss_pred ecc-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 83 DLL-GPSLEDLFNYC--NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 83 e~~-g~sL~~ll~~~--~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 998 89999998743 3469999999999999999999999999999999999999 58899999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH-
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE- 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~- 238 (465)
... .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+.............
T Consensus 187 ~~~-----~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 187 AQT-----VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp SSC-----EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred ccc-----ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 211 11234679999999998875 58899999999999999999999998765443222221111111100000
Q ss_pred ------HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 239 ------VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 239 ------~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
.....++..+.+++..||..||.+||++.+|.+.|+.+
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 261 IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp SCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 01123467899999999999999999999999999876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=338.31 Aligned_cols=239 Identities=15% Similarity=0.128 Sum_probs=186.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCCCCC----------ceeEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGGTGV----------PHLKWF 71 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~~~i----------~~l~~~ 71 (465)
..|.+.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.++..+.|..++ ..+..+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999987332 234678898888888763211 111110
Q ss_pred -----------eE-----eCcEEEEEEeccCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 012336 72 -----------GV-----EGEYNVMVIDLLGPSLEDLFNYC------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDI 129 (465)
Q Consensus 72 -----------~~-----~~~~~~lv~e~~g~sL~~ll~~~------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDL 129 (465)
.. .....+++|++++++|.+++..+ ...+++..++.++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 12346888999999999999633 345888899999999999999999999999999
Q ss_pred CCCceeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccc----------cCCCCCCcchHHHH
Q 012336 130 KPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH----------LGVEQSRRDDLESL 199 (465)
Q Consensus 130 KP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~----------~~~~~s~k~DiwSL 199 (465)
||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 58889999999998765432 234567 999999999 55568899999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 200 GYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 200 GviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
||++|||++|+.||.+........ ..-..+..+|+++.+||..||..||++||++.++.+
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSE------------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSG------------GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhhHH------------HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999998743321111 001123467999999999999999999999766643
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=331.62 Aligned_cols=260 Identities=21% Similarity=0.217 Sum_probs=188.7
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ...+..|+.++..+.+|++|..+..+.......++|
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 45678899999999999999998764 5689999999887543 346788999999885445555556666777889999
Q ss_pred EeccCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccC----------CCCCcE
Q 012336 82 IDLLGPSLEDLFNYCNRK------FSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLG----------RKSNQV 145 (465)
Q Consensus 82 ~e~~g~sL~~ll~~~~~~------ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~----------d~~~~v 145 (465)
||+++++|.+++...... .++..++.++.||+.||+|||++||+||||||+|||+... +.+..+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999999999999743211 1333457899999999999999999999999999999522 235689
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccC-------CCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG-------VEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-------~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
||+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |..||....
T Consensus 168 kL~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 999999998765432110 011234679999999999976 568999999999999999999 999997643
Q ss_pred CCchHHHHHHHhhhhccCcH--HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 218 AGTKKQKYDKISEKKMLTPI--EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~--~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
.. + ..+.......+. ......+++++.++|..||..||.+||++.+|.+
T Consensus 245 ~~---~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SR---E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TH---H--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hh---H--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 21 1 111122111110 0011234688999999999999999999877653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.90 Aligned_cols=252 Identities=15% Similarity=0.216 Sum_probs=201.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-------------------ccHHHHHHHHHHHcCCC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-------------------PQLHYESKLYMLLQGGT 63 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-------------------~~~~~E~~il~~l~~~~ 63 (465)
.++.++|++++.||+|+||.||+|++ +++.||||++...... ..+.+|+.++..++|++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 45678999999999999999999998 9999999988743211 67889999999999877
Q ss_pred CCceeEEEeEeCcEEEEEEecc-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCce
Q 012336 64 GVPHLKWFGVEGEYNVMVIDLL-GPSLEDL------FNYC-NRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNF 134 (465)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~-g~sL~~l------l~~~-~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NI 134 (465)
++..+..+ .+....++|||++ +++|.++ +... ...+++..+..++.||+.||.|||+ +||+||||||+||
T Consensus 105 i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 105 CLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp BCCCSEEE-ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred cceEEEEE-eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 66666655 4566889999999 6799988 5432 4679999999999999999999999 9999999999999
Q ss_pred eeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCC-CCCC-cchHHHHHHHHHHHhcCCCC
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSR-RDDLESLGYVLMYFLRGSLP 212 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~-k~DiwSLGviL~elltG~~P 212 (465)
|+ +.++.++|+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|..|
T Consensus 184 l~---~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 184 LM---DKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp EE---CTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EE---cCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99 58899999999999875432 12355799999999999887 5665 99999999999999999999
Q ss_pred CCCCCCCchHHHHHHHhhhhccCcH--------------HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 213 WQGLKAGTKKQKYDKISEKKMLTPI--------------EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~--------------~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
|...... .+....+.......+. ......+++++.+|+..||..||.+||++.++.+
T Consensus 252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9875431 3333344333222221 0111467899999999999999999999776644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=332.74 Aligned_cols=264 Identities=17% Similarity=0.181 Sum_probs=192.3
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
..+|.+.+.||+|+||+||.. ...+++.||||++... ....+.+|+.+++.+..|++|..+..+..+....++|||++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 346999999999999997643 3568999999988643 33467889999999954444555555667788899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC--CCCcEEEEecCCccccccccCcc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d--~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+++|.+++......+.+..+..++.||+.||.|||++||+||||||+|||+...+ ....+||+|||+++........
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~- 179 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS- 179 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc-
Confidence 9999999986555677777889999999999999999999999999999995322 2346889999999876532211
Q ss_pred cccccCCCCcccccccccccccc---CCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 164 HIPYRENKNLTGTARYASVNTHL---GVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~---~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
+.......||+.|+|||++. ...++.++|||||||++|||++ |..||..... .+. ..+..... .....
T Consensus 180 ---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~~-~~~~~~~~-~~~~~ 251 (432)
T 3p23_A 180 ---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQA-NILLGACS-LDCLH 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HHH-HHHTTCCC-CTTSC
T ss_pred ---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HHH-HHHhccCC-ccccC
Confidence 12234567999999999998 4567889999999999999999 9999965322 111 11111111 11000
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccc
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDW 290 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw 290 (465)
.....+..+.+||..||..||.+||++.++.+ ++|+..++|
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~----------hp~f~~~~~ 292 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK----------HPFFWSLEK 292 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT----------STTTCCHHH
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh----------CccccChHH
Confidence 01223567899999999999999999877753 556655555
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.99 Aligned_cols=239 Identities=19% Similarity=0.239 Sum_probs=179.3
Q ss_pred cCCceEEE-eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHc-CCCCCceeEEEeE---eCcEEE
Q 012336 5 IGGKFKLG-RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ-GGTGVPHLKWFGV---EGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~-~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~-~~~~i~~l~~~~~---~~~~~~ 79 (465)
+-++|.++ +.||+|+||.||+|.+..+++.||||++.. ...+..|+.++.++. |++++..+..+.. .....+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 44567666 889999999999999999999999999863 456888999986654 4455554544433 256789
Q ss_pred EEEecc-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCN-RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~-~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+||+++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+...+.++.++|+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 999999 779999998643 469999999999999999999999999999999999999633337899999999986532
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH-HHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 236 (465)
. ..++.++|||||||++|||++|..||.+.......... ..+.......+
T Consensus 172 ~-----------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 222 (299)
T 3m2w_A 172 G-----------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 222 (299)
T ss_dssp T-----------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC
T ss_pred c-----------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC
Confidence 1 24567899999999999999999999764321110000 00111111112
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
......+++++.+++..||..||++||++.++ |++.|..
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~---l~hp~~~ 261 (299)
T 3m2w_A 223 -NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 261 (299)
T ss_dssp -HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred -chhcccCCHHHHHHHHHHcccChhhCCCHHHH---hcChhhc
Confidence 22235689999999999999999999996655 5555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=306.48 Aligned_cols=231 Identities=11% Similarity=0.067 Sum_probs=185.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYN 78 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (465)
+++++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..+.|++++..+. ++......
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~-~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD-VVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE-EEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE-EEEECCcE
Confidence 7889999999999999999999999999999999998865433 46888999999998876555554 45566788
Q ss_pred EEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 79 VMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 79 ~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|+||||+ |++|.+++.. + ....++..|+.||+.||+|||++||+||||||+|||+ +.++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll---~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV---SIDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---ETTSCEEECSCC------
T ss_pred EEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE---cCCCCEEEEecc------
Confidence 9999998 7899999852 3 4666789999999999999999999999999999999 478899987443
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
|++ .++.++|||||||++|||++|+.||.+.............. .....+.
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~ 225 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEP 225 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCCh
Confidence 232 36789999999999999999999998755422110000000 1112333
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
......+|+++.++|.+||+.||++| ++.++.+.|+.+.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 44556789999999999999999999 9999999998764
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.80 Aligned_cols=244 Identities=14% Similarity=0.221 Sum_probs=195.1
Q ss_pred CCccCCceEEEeeEeeeCceEEEEEEEcC-CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCc-
Q 012336 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQ-TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE- 76 (465)
Q Consensus 2 ~~i~~~~y~l~~~LG~G~fG~Vyla~~~~-~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~- 76 (465)
+.++.++|++++.||+|+||.||+|++.. +++.||||++..... ...+..|+.++..++|++++..+.++...+.
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 46788999999999999999999999976 789999998864332 2357789999999999888888877766544
Q ss_pred ---EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 77 ---YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 77 ---~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
..|||||++ |++|.+++. ..+++.+++.|+.||+.||.|||++||+||||||+|||+. . +.+||+|||+
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~ 227 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGA 227 (681)
T ss_dssp SCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCTT
T ss_pred CCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEeccc
Confidence 268999999 789988765 3799999999999999999999999999999999999994 3 5899999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.......
T Consensus 228 a~~~~~~-----------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------- 285 (681)
T 2pzi_A 228 VSRINSF-----------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------- 285 (681)
T ss_dssp CEETTCC-----------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------
T ss_pred chhcccC-----------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc----------
Confidence 9865431 345799999999998765 488999999999999999999998763221110
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKP-DYSYLKRLFRDLFI 278 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~~~~ 278 (465)
..... ...++.+.++|.+||..||.+|| +.+++...|..+..
T Consensus 286 -~~~~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 -EDDPV---LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp -TTCHH---HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred -ccccc---cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00111 12367899999999999999999 56677776666543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=307.84 Aligned_cols=239 Identities=19% Similarity=0.151 Sum_probs=181.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----------ccHHHHHHHHHHHc---------CCCCC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----------PQLHYESKLYMLLQ---------GGTGV 65 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~---------~~~~i 65 (465)
..++|++++.||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.++ |++++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357899999999999999999997 7899999998865322 56889999999997 66666
Q ss_pred ceeEEEeE-----------------------------eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHH
Q 012336 66 PHLKWFGV-----------------------------EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINR 115 (465)
Q Consensus 66 ~~l~~~~~-----------------------------~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~g 115 (465)
.....+.. .....++||||+ ++++.+.+. .+.+++..+..|+.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHH
Confidence 55554432 267889999998 665555543 3679999999999999999
Q ss_pred HHHHH-HCCccccCCCCCceeeccCCCCC--------------------cEEEEecCCccccccccCcccccccCCCCcc
Q 012336 116 VEYMH-SRGFLHRDIKPDNFLMGLGRKSN--------------------QVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174 (465)
Q Consensus 116 L~yLH-s~givHrDLKP~NILl~~~d~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 174 (465)
|+||| ++||+||||||+|||+. .++ .+||+|||+++.... ....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------~~~~ 238 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------GIVV 238 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------------TEEE
T ss_pred HHHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCC------------CcEE
Confidence 99999 99999999999999995 444 899999999987643 2347
Q ss_pred ccccccccccccCCCCCCcchHHHHHHH-HHHHhcCCCCCCCCCCCchHHHHHHHhhhhc--cCcHHHHhccCcHHHHHH
Q 012336 175 GTARYASVNTHLGVEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYDKISEKKM--LTPIEVLCKSYPSEFTSY 251 (465)
Q Consensus 175 Gt~~Y~APE~~~~~~~s~k~DiwSLGvi-L~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~p~~l~~l 251 (465)
||+.|+|||++.+.. +.++||||||++ .++++.|..||.+... .......+..... ..........+++++.+|
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHH
Confidence 999999999999876 889999998877 6788889999954100 0111112221111 111122334568999999
Q ss_pred HHHHhcCCCCCCCCHHHHH
Q 012336 252 FHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 252 i~~cl~~dp~~RPt~~~l~ 270 (465)
|.+||..| ++.++.
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 755543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.33 Aligned_cols=257 Identities=17% Similarity=0.242 Sum_probs=192.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeE-----eCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGV-----EGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~~ 76 (465)
..++|++++.||.|+||.||+|.+..+++.||||++..... ...+..|+.++..+.|++++..+..+.. .+.
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 44899999999999999999999999999999998865422 2357889999999998887776665432 256
Q ss_pred EEEEEEecc-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN--RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~--~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
..++||+++ +++|.+++.... ..+++..+..++.||+.||.|||+.||+||||||+|||+..++....+||+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 778999999 899999998533 26999999999999999999999999999999999999964334446999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCch------HHHHHH
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYDK 227 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~------~~~~~~ 227 (465)
....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ......
T Consensus 172 ~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 172 KELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 8764322 12356799999999999999999999999999999999999999965311000 000000
Q ss_pred Hh-----hh-----hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 228 IS-----EK-----KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 228 i~-----~~-----~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
+. .. ........+...+++++.++|..||..||++||++.++
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 00 00 00011111233468899999999999999999997663
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=278.22 Aligned_cols=186 Identities=17% Similarity=0.166 Sum_probs=133.2
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
..++.|++|.+..++....|+.||||++..+.. ..++.+|+++|.++.++++|+.+..+++++...||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 345678888888888788999999999876422 23588999999999888899999999999999999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||||+ |++|.+++.. .++++.. .|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCC
Confidence 99999 9999999985 5677765 478999999999999999999999999999 58899999999999876543
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf 213 (465)
.. ...+.+||+.|||||++.+. +..++|+|++|++++++.++..||
T Consensus 393 ~~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CS-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred Cc-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 22 23457899999999999864 667899999999988877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=242.25 Aligned_cols=188 Identities=18% Similarity=0.144 Sum_probs=139.5
Q ss_pred EEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----------ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----------PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 10 ~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----------~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
...+.||+|+||+||+|. ..+..+++|....+... ..+.+|++++..++|++++... .+.......+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~-~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPY-IFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCC-EEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceE-EEEEeCCccE
Confidence 345689999999999994 46789999976543221 2368999999999987766433 3333555669
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+||||+ |++|.+++.. +..++.||+.+|+|||++||+||||||+|||+. . .+||+|||+++....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence 999999 7999999873 678999999999999999999999999999993 4 999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG--VEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~--~~~s~k~DiwSLGviL~elltG~~Pf~ 214 (465)
........+.....+.||+.|||||++.+ ..|+..+|+|+..+-.++-+.++-+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32111000011235689999999999987 567888999999998888888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=203.81 Aligned_cols=142 Identities=19% Similarity=0.256 Sum_probs=112.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------------------CccHHHHHHHHHHHcCCCCCc
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------------------HPQLHYESKLYMLLQGGTGVP 66 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------------------~~~~~~E~~il~~l~~~~~i~ 66 (465)
..|.+.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.++..+.| +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 4466779999999999999998 8899999999864321 1247899999999982 44
Q ss_pred eeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 67 HLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 67 ~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
....+.. ...++|||++ |++|.+ +. ......++.|++.||.|||++||+||||||+|||+ + ++.+
T Consensus 166 v~~~~~~--~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW--EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI 231 (282)
T ss_dssp SCCEEEE--ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred cCeEEec--cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence 4444433 3458999998 779887 32 13355799999999999999999999999999999 5 8899
Q ss_pred EEEecCCccccccccCcccccccCCCCcccccccccccccc
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~ 186 (465)
||+|||+++. +..|+|||++.
T Consensus 232 kl~DFG~a~~--------------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE--------------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE--------------------TTSTTHHHHHH
T ss_pred EEEECCCCeE--------------------CCCCCHHHHHH
Confidence 9999999963 34468899875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.1e-20 Score=179.96 Aligned_cols=136 Identities=21% Similarity=0.280 Sum_probs=106.9
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcE--EEEEEeecCCCC--------------------------ccHHHHHHHHHHH
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEE--VAVKLESVKTKH--------------------------PQLHYESKLYMLL 59 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~--vAvKi~~~~~~~--------------------------~~~~~E~~il~~l 59 (465)
-|.+.+.||+|+||.||+|.+..+|+. ||||++...... ..+..|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998788999 999986533110 1478899999999
Q ss_pred cCCCC-CceeEEEeEeCcEEEEEEeccCC------CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCC
Q 012336 60 QGGTG-VPHLKWFGVEGEYNVMVIDLLGP------SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH-SRGFLHRDIKP 131 (465)
Q Consensus 60 ~~~~~-i~~l~~~~~~~~~~~lv~e~~g~------sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLH-s~givHrDLKP 131 (465)
.|+++ ++.+..+ ...++||||+++ .|.++... +++..+..++.||+.+|.||| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 87642 3333322 246899999953 67766432 345678899999999999999 99999999999
Q ss_pred CceeeccCCCCCcEEEEecCCcccc
Q 012336 132 DNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 132 ~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.|||+. . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999993 4 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=8.7e-17 Score=162.51 Aligned_cols=136 Identities=17% Similarity=0.271 Sum_probs=97.3
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------C--------cc--------HHHHHHHHHHHcCCCC
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------H--------PQ--------LHYESKLYMLLQGGTG 64 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~--------~~--------~~~E~~il~~l~~~~~ 64 (465)
|.+...||.|+||.||+|.+ .+|+.||||++..... . .. ...|...+.++.+ .+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~-~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE-EG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH-TT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh-cC
Confidence 89999999999999999996 5799999998653210 0 00 1346777777754 44
Q ss_pred CceeEEEeEeCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCC--
Q 012336 65 VPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRK-- 141 (465)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~-- 141 (465)
++....+.... .+|||+|+ |..|..+. .......++.||+.+|.|||+.|||||||||.|||+..+.+
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 44433333333 37999999 55554332 12345678899999999999999999999999999952211
Q ss_pred -----CCcEEEEecCCccc
Q 012336 142 -----SNQVYIIDYGLAKK 155 (465)
Q Consensus 142 -----~~~vkL~DFGla~~ 155 (465)
...++|+||+.+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 01489999998865
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2.3e-11 Score=116.19 Aligned_cols=138 Identities=16% Similarity=0.259 Sum_probs=108.5
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC--CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK--TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~--~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+.|++...++.|+++.||++.. .+..+++|+.... .....+..|..++..+.++..+|.+..+.......+++|++
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4599999999999999999974 4689999998642 23457999999999997666677777777778888999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS------------------------------------------ 121 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs------------------------------------------ 121 (465)
+ |.+|.+.+. +......++.+++..|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 8 777776521 122345788899999999998
Q ss_pred -----------------CCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 122 -----------------RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 122 -----------------~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
..++|+|++|.|||+. ++..+.|+||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhccc
Confidence 4589999999999993 445567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=9.7e-11 Score=110.94 Aligned_cols=134 Identities=13% Similarity=0.061 Sum_probs=96.7
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEEEeEeCcEEEEEEecc-
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~- 85 (465)
.|.+....+.|..+.||++. ..+|..|+||+.... ....+..|..++..+.++.+ ++.+..+...+...+++|+++
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~ 98 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 98 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence 46665554456679999996 456788999987654 34578899999999987654 666666666666789999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC------------------------------------------
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG------------------------------------------ 123 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g------------------------------------------ 123 (465)
|.+|. .. ... ...++.+++..|..||+..
T Consensus 99 G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 99 GQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp SEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred CcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 65663 11 111 2256667777777777643
Q ss_pred ----------------ccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 124 ----------------FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 124 ----------------ivHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
++|+|++|.|||+. +++.+.|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhccc
Confidence 99999999999993 455567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.8e-09 Score=106.60 Aligned_cols=138 Identities=14% Similarity=0.214 Sum_probs=99.6
Q ss_pred EEEeeEeeeCceEEEEEEEcCCCcEEEEEEee--cCC---CCccHHHHHHHHHHHcCCCC-CceeEEEeEeC---cEEEE
Q 012336 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLES--VKT---KHPQLHYESKLYMLLQGGTG-VPHLKWFGVEG---EYNVM 80 (465)
Q Consensus 10 ~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~--~~~---~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~~---~~~~l 80 (465)
.-++.|+.|.++.||++.. .+..+++|+.. ... ....+..|..++..|..... ++.+..++.+. ...|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 3467889999999999874 35688899765 221 23478899999999986332 55555555444 34789
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-------------------------------------- 121 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-------------------------------------- 121 (465)
+|+++ |..+.+. .-..++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99998 5455321 12347888889999999999999997
Q ss_pred --------------------CCccccCCCCCceeeccCCCC--CcEEEEecCCccc
Q 012336 122 --------------------RGFLHRDIKPDNFLMGLGRKS--NQVYIIDYGLAKK 155 (465)
Q Consensus 122 --------------------~givHrDLKP~NILl~~~d~~--~~vkL~DFGla~~ 155 (465)
..++|+|++|.|||+. .+ ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence 3589999999999994 33 3468999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.90 E-value=1e-09 Score=107.37 Aligned_cols=188 Identities=15% Similarity=0.177 Sum_probs=119.2
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC--CceeEEEeEeCc---EEEEEEecc-
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG--VPHLKWFGVEGE---YNVMVIDLL- 85 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~--i~~l~~~~~~~~---~~~lv~e~~- 85 (465)
++.++.|.+..||++. ..++||+.........+..|..++..+..... +|.+..++.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999863 56889986543233568899999999865433 344444433332 347889988
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-------------------------------------------- 121 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-------------------------------------------- 121 (465)
|..|.+... ..++..+...++.+++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 666654332 247788888888888888888886
Q ss_pred --------------CCccccCCCCCceeeccCCC--CCcEEEEecCCccccccccCcccccccCCCCccccc--------
Q 012336 122 --------------RGFLHRDIKPDNFLMGLGRK--SNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA-------- 177 (465)
Q Consensus 122 --------------~givHrDLKP~NILl~~~d~--~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~-------- 177 (465)
..++|+|++|.|||+. . ...+.|+||+.+.......+..... ... ...+..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~---~~~~~~~~~iD~~~~~~~~~~~Dl~~~~-~~~-~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFD---TEKNTICGIIDFGDAAISDPDNDFISLM-EDD-EEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEE---TTTTEEEEECCCTTCEEECTTHHHHTTC-CTT-TSCCHHHHHHHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEe---CCCCCEEEEEeCCCCccCChHHHHHHHH-hhc-cccCHHHHHHHHHH
Confidence 1379999999999994 4 4567899999986542211100000 000 000000
Q ss_pred -cccc-cccccCCCCCCcchHHHHHHHHHHHhcCCCCCC
Q 012336 178 -RYAS-VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (465)
Q Consensus 178 -~Y~A-PE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~ 214 (465)
.+.. |+.... .....+.|+++.++|.+.+|..+|.
T Consensus 252 Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0011 111111 0112589999999999999988873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.4e-06 Score=85.23 Aligned_cols=136 Identities=21% Similarity=0.246 Sum_probs=88.7
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC--CceeEEEeE-eCcEEEEEEecc-CC
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG--VPHLKWFGV-EGEYNVMVIDLL-GP 87 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~--i~~l~~~~~-~~~~~~lv~e~~-g~ 87 (465)
++.++.|....||+. +..++||+-........+..|..++..|.++.. +|....++. .....+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788888899987 577889985322223468899999999987432 455555543 344567999988 65
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 012336 88 SLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR--------------------------------------------- 122 (465)
Q Consensus 88 sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~--------------------------------------------- 122 (465)
.|.+..- ..++......++.++...|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 6554211 1234444455555555555555532
Q ss_pred ---------------CccccCCCCCceeeccCCCCCc-EEEEecCCccc
Q 012336 123 ---------------GFLHRDIKPDNFLMGLGRKSNQ-VYIIDYGLAKK 155 (465)
Q Consensus 123 ---------------givHrDLKP~NILl~~~d~~~~-vkL~DFGla~~ 155 (465)
.++|+|++|.|||+..++.++. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999951111344 58999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=8.1e-06 Score=77.62 Aligned_cols=133 Identities=17% Similarity=0.138 Sum_probs=91.4
Q ss_pred eEeeeCce-EEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CCCHHH
Q 012336 14 KIGSGSFG-ELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLED 91 (465)
Q Consensus 14 ~LG~G~fG-~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ 91 (465)
.+..|..+ .||+......+..++||+-... ....+..|...+..+...--||.+..++.+....++||+++ |.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34455554 6999876667788999986533 23357889999999986545677777777788889999998 666666
Q ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------------
Q 012336 92 LFNYCNRKFSLKTVLMLADQLINRVEYMHSR------------------------------------------------- 122 (465)
Q Consensus 92 ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~------------------------------------------------- 122 (465)
..... ......++.++...|..||..
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 54321 122233444555555555531
Q ss_pred ---------CccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 123 ---------GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 123 ---------givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.++|+|+.|.|||+ +.++.+-|+||+.+..
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~---~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIF---DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEE---ETTEEEEECCCTTCEE
T ss_pred hcccccCCcEEEcCCCCCCeEEE---ECCeEEEEEECccccc
Confidence 27899999999999 3556667999998853
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=1e-05 Score=81.80 Aligned_cols=75 Identities=16% Similarity=0.174 Sum_probs=50.2
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC---------CCCccHHHHHHHHHHHcC--CCCCceeEEEeEeCcEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK---------TKHPQLHYESKLYMLLQG--GTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~---------~~~~~~~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~ 79 (465)
-.+.||.|.++.||++....++..|+||..... .....+..|.+++..+.. +..+|.+..+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 466899999999999975556788999975421 122356889999998865 3455665544 334457
Q ss_pred EEEeccCC
Q 012336 80 MVIDLLGP 87 (465)
Q Consensus 80 lv~e~~g~ 87 (465)
++|+++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 89999854
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=1.2e-05 Score=79.79 Aligned_cols=78 Identities=13% Similarity=0.250 Sum_probs=52.5
Q ss_pred eEEEeeE-eeeCceEEEEEEEc--C----CCcEEEEEEeecCC-----CCccHHHHHHHHHHHcCC--CCCceeEEEeEe
Q 012336 9 FKLGRKI-GSGSFGELYLGVNV--Q----TGEEVAVKLESVKT-----KHPQLHYESKLYMLLQGG--TGVPHLKWFGVE 74 (465)
Q Consensus 9 y~l~~~L-G~G~fG~Vyla~~~--~----~~~~vAvKi~~~~~-----~~~~~~~E~~il~~l~~~--~~i~~l~~~~~~ 74 (465)
....+.| +.|....+|++... . ++..+++|+..... ....+..|..++..|... -.+|.+..+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88888999998642 0 26789999865432 135688999999998754 235555555443
Q ss_pred C---cEEEEEEeccC
Q 012336 75 G---EYNVMVIDLLG 86 (465)
Q Consensus 75 ~---~~~~lv~e~~g 86 (465)
. ...+++|+++.
T Consensus 102 ~~~~g~~~~v~e~l~ 116 (357)
T 3ats_A 102 GDVLGTPFFLMDYVE 116 (357)
T ss_dssp STTTSSCEEEEECCC
T ss_pred CCccCCceEEEEecC
Confidence 3 24578899883
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=4.9e-05 Score=74.43 Aligned_cols=73 Identities=12% Similarity=0.071 Sum_probs=42.0
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCC-CCceeEE------EeEeCcEEEEEEe
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGT-GVPHLKW------FGVEGEYNVMVID 83 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~-~i~~l~~------~~~~~~~~~lv~e 83 (465)
-++.|+.|..+.||++.. .+..+++|+.... ...+..|..++..|.... .++.+.. +.......+++++
T Consensus 36 ~~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHT--DSGAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEEECC----CEEEEEEE--TTEEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred EeeeccccccCcEEEEEe--CCCCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 345666677899999874 3446899988742 234556777777776321 2333221 2234567789999
Q ss_pred ccCC
Q 012336 84 LLGP 87 (465)
Q Consensus 84 ~~g~ 87 (465)
++.|
T Consensus 112 ~i~G 115 (346)
T 2q83_A 112 WIEG 115 (346)
T ss_dssp CCCC
T ss_pred eecC
Confidence 8843
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00036 Score=67.48 Aligned_cols=68 Identities=12% Similarity=0.059 Sum_probs=46.6
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-CC
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GP 87 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (465)
++.|+.|....+|++ ..+++|+...... .-....|..++..+......|.+..+. ....+++++++ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678889999999998 6688998764321 224567999999888766666665543 32345778877 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00031 Score=71.40 Aligned_cols=73 Identities=14% Similarity=0.262 Sum_probs=45.5
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeec-----CC----CCccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESV-----KT----KHPQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~-----~~----~~~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~ 79 (465)
-++.||.|....||++.. ++..++||.... .. .......|.+++..+. .+..+|.+..+. ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 466889999999999963 567899994221 11 1133445655555443 234456655554 45568
Q ss_pred EEEecc-CC
Q 012336 80 MVIDLL-GP 87 (465)
Q Consensus 80 lv~e~~-g~ 87 (465)
+||+++ .+
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 899988 65
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0026 Score=60.95 Aligned_cols=79 Identities=15% Similarity=0.118 Sum_probs=57.5
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.+.+..-++.+|.|..+.||++. ..+|+.|+||+-..... ...+..|...|+.|.....++.-..+..... +++
T Consensus 12 l~G~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~--~lv 88 (288)
T 3f7w_A 12 LTGREVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDR--TLA 88 (288)
T ss_dssp HHCCCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETT--EEE
T ss_pred hcCCCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCc--eEE
Confidence 457788889999999999999998 46889999998654322 2357889999999975544444444444443 567
Q ss_pred Eecc
Q 012336 82 IDLL 85 (465)
Q Consensus 82 ~e~~ 85 (465)
|+++
T Consensus 89 ~e~l 92 (288)
T 3f7w_A 89 MEWV 92 (288)
T ss_dssp EECC
T ss_pred EEee
Confidence 7776
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0019 Score=62.62 Aligned_cols=142 Identities=17% Similarity=0.213 Sum_probs=78.9
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEE------EeEeCcEEEEE
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKW------FGVEGEYNVMV 81 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~------~~~~~~~~~lv 81 (465)
..-++.|+.|....+|++.. . +..+++|+.........+..|..++..|....+ ++.+.. +.......+++
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~-~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-T-KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-S-SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ceEeeccCCCcccceEEEEe-C-CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34466788888899999874 2 337889987754344567889999988875432 333321 11233456788
Q ss_pred EeccCC-CH-----HH------H---HHHcCCCC--------CHHHHHH---------------HHHHHHHHHHHHHH--
Q 012336 82 IDLLGP-SL-----ED------L---FNYCNRKF--------SLKTVLM---------------LADQLINRVEYMHS-- 121 (465)
Q Consensus 82 ~e~~g~-sL-----~~------l---l~~~~~~l--------s~~~~~~---------------ia~qi~~gL~yLHs-- 121 (465)
++++.| .+ .. . +......+ ....... +...+...+++++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 888743 21 11 1 11111111 1111111 01123444555553
Q ss_pred -----CCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 122 -----RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 122 -----~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.+++|+|+.+.|||+. .+..+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 3699999999999993 444557999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0037 Score=57.43 Aligned_cols=124 Identities=13% Similarity=0.111 Sum_probs=79.3
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~ 164 (465)
.-+|.+++...+.++++++++.++.|++..|.-+-. +.-..+=+.|..|++ ..+|.|-+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc----------
Confidence 348999999889999999999999999999877621 111233344678888 3777766543 1110
Q ss_pred ccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 165 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
.....+.+||... ...+.+.=|||||++||..+--.+|=.. ...+
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e-------------------------E~eL 142 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE-------------------------EREL 142 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE-------------------------EECC
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc-------------------------chhh
Confidence 1123456777653 3446688899999999998863333211 1356
Q ss_pred cHHHHHHHHHHhcC
Q 012336 245 PSEFTSYFHYCRSL 258 (465)
Q Consensus 245 p~~l~~li~~cl~~ 258 (465)
++.+.+||..|..-
T Consensus 143 S~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 143 SPPLEQLIDHMANT 156 (229)
T ss_dssp CHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhc
Confidence 88889999888765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0018 Score=63.29 Aligned_cols=141 Identities=17% Similarity=0.128 Sum_probs=71.7
Q ss_pred EeeEeeeCceE-EEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEEEeEeCcEEEEEEeccC-CC
Q 012336 12 GRKIGSGSFGE-LYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKWFGVEGEYNVMVIDLLG-PS 88 (465)
Q Consensus 12 ~~~LG~G~fG~-Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~g-~s 88 (465)
++.|+.|.... +|+.. ..++..+++|...... ...+..|..++..+....+ +|.+..+..... +++|+.++ ..
T Consensus 23 ~~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEE-CTTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEE-cCCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 44565554444 66765 2236778888644321 1567788999888875432 454544433332 67888774 45
Q ss_pred HHHHHHHc---------------------C----CCCCHHHHHH--------H------------HHHHHHHHHHH----
Q 012336 89 LEDLFNYC---------------------N----RKFSLKTVLM--------L------------ADQLINRVEYM---- 119 (465)
Q Consensus 89 L~~ll~~~---------------------~----~~ls~~~~~~--------i------------a~qi~~gL~yL---- 119 (465)
+.+.+... . ..+....... + ...+...+..|
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54333210 0 0122211110 0 00111222333
Q ss_pred --HHCCccccCCCCCceeeccCCC-CCcEEEEecCCcccc
Q 012336 120 --HSRGFLHRDIKPDNFLMGLGRK-SNQVYIIDYGLAKKY 156 (465)
Q Consensus 120 --Hs~givHrDLKP~NILl~~~d~-~~~vkL~DFGla~~~ 156 (465)
+...++|+|+.+.|||+..++. .+.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2246999999999999941100 268999999998653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0018 Score=63.24 Aligned_cols=73 Identities=22% Similarity=0.268 Sum_probs=55.0
Q ss_pred EEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCC--CCCceeEEEeEeCcEEEEEEecc
Q 012336 10 KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGG--TGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 10 ~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~--~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
.-++.|+.|.+..+|+... .+..++||+.... ....+..|...|..|... ..+|....++......+++|+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 4467899999999999873 5678999987643 234678899999988743 44666666666667789999998
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0085 Score=58.16 Aligned_cols=73 Identities=14% Similarity=0.049 Sum_probs=45.8
Q ss_pred eeEeeeCceEEEEEEEcCCCcEEEEEEeecC-CCCccHHHHHHHHHHHcCCCC-CceeEEE-----eEeCcEEEEEEecc
Q 012336 13 RKIGSGSFGELYLGVNVQTGEEVAVKLESVK-TKHPQLHYESKLYMLLQGGTG-VPHLKWF-----GVEGEYNVMVIDLL 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~~~-i~~l~~~-----~~~~~~~~lv~e~~ 85 (465)
..|+ |....||++. ..+|+.+++|+.... .....+..|..++..|....+ ++.+... ...+...+++++++
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 7788999876 345668999987633 233467788888888874322 3322211 12244567889888
Q ss_pred CC
Q 012336 86 GP 87 (465)
Q Consensus 86 g~ 87 (465)
.|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0067 Score=61.84 Aligned_cols=72 Identities=17% Similarity=0.081 Sum_probs=49.5
Q ss_pred EEeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 11 LGRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
-++.|+.|....||++.... .+..|++|+.........+..|..++..|....+.|.+..+.. + .++++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 45678888889999997542 2578999987432111567789999999987666666654432 2 26777
Q ss_pred ccC
Q 012336 84 LLG 86 (465)
Q Consensus 84 ~~g 86 (465)
++.
T Consensus 153 ~l~ 155 (429)
T 1nw1_A 153 YIP 155 (429)
T ss_dssp CCC
T ss_pred EeC
Confidence 773
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0075 Score=60.48 Aligned_cols=140 Identities=16% Similarity=0.182 Sum_probs=80.5
Q ss_pred EeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 12 GRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
++.|..|-...+|++.... ++..|++|+..... ......+|..++..|....+.|.+..+..++ ++|+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 3467778788999987532 35789999853321 2235668999999998777777775554332 7788
Q ss_pred ccCC-CHH--------------HHHHHc-------CCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 012336 84 LLGP-SLE--------------DLFNYC-------NRKFS--LKTVLMLADQLIN-------------------RVEYMH 120 (465)
Q Consensus 84 ~~g~-sL~--------------~ll~~~-------~~~ls--~~~~~~ia~qi~~-------------------gL~yLH 120 (465)
++.| .|. +.+... .+... +.++..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 8733 221 111111 11122 3555555554422 233333
Q ss_pred H--------CCccccCCCCCceeeccC-CCCCcEEEEecCCccc
Q 012336 121 S--------RGFLHRDIKPDNFLMGLG-RKSNQVYIIDYGLAKK 155 (465)
Q Consensus 121 s--------~givHrDLKP~NILl~~~-d~~~~vkL~DFGla~~ 155 (465)
. ..++|+|+.+.|||+..+ +..+.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 248999999999999521 1136899999998854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0081 Score=59.59 Aligned_cols=73 Identities=14% Similarity=-0.023 Sum_probs=43.8
Q ss_pred EEeeEeeeCceEEEEEEEcC--------CCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQ--------TGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~--------~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
-++.|+.|..-.+|++.... .+..|++|+...... ......|..++..+....++|.+.... . .+++
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 35577888888999997532 136899998654321 113578999999887655565554332 2 2577
Q ss_pred EeccCC
Q 012336 82 IDLLGP 87 (465)
Q Consensus 82 ~e~~g~ 87 (465)
++++.|
T Consensus 113 ~e~i~G 118 (369)
T 3c5i_A 113 EEWLYG 118 (369)
T ss_dssp EECCCS
T ss_pred EEEecC
Confidence 888743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.065 Score=55.02 Aligned_cols=71 Identities=14% Similarity=0.049 Sum_probs=46.9
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL 85 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (465)
-++.|+.|-...+|++.....+..|++|+...... .-....|..++..|....+.|.+..++. . .++|+++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 45678888889999998643357899998753221 1123689999999987766676655542 2 2478887
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.64 E-value=0.21 Score=48.86 Aligned_cols=30 Identities=33% Similarity=0.586 Sum_probs=25.9
Q ss_pred CccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 123 givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
.++|+|+.+.|||+. .++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 599999999999993 567899999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.16 Score=51.56 Aligned_cols=73 Identities=11% Similarity=0.046 Sum_probs=48.6
Q ss_pred EEeeEeeeCceEEEEEEEcCC-------CcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 11 LGRKIGSGSFGELYLGVNVQT-------GEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~-------~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
-++.|..|-...+|++..... +..|++|+...... .-...+|..++..+....+.|.+... .. .++++
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~--~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD--FP--EGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE--ET--TEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE--cC--CCEEE
Confidence 455677788889999986421 57899998654321 12457899999999876666766542 22 25778
Q ss_pred eccCC
Q 012336 83 DLLGP 87 (465)
Q Consensus 83 e~~g~ 87 (465)
+++.|
T Consensus 150 efI~G 154 (424)
T 3mes_A 150 EFIDG 154 (424)
T ss_dssp ECCCS
T ss_pred EEeCC
Confidence 88733
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.68 E-value=0.28 Score=49.11 Aligned_cols=32 Identities=25% Similarity=0.494 Sum_probs=26.1
Q ss_pred ccccCCCCCceeeccC---CCCCcEEEEecCCccc
Q 012336 124 FLHRDIKPDNFLMGLG---RKSNQVYIIDYGLAKK 155 (465)
Q Consensus 124 ivHrDLKP~NILl~~~---d~~~~vkL~DFGla~~ 155 (465)
++|+|+.+.|||+..+ +....++++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999421 3567899999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 465 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-93 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-92 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-29 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-28 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-28 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-27 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-27 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-26 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-26 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-25 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-25 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-24 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-24 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-23 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-23 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-23 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-22 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-22 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-22 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-20 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-18 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-17 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-15 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 282 bits (722), Expect = 3e-93
Identities = 218/298 (73%), Positives = 269/298 (90%)
Query: 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
M+ +G +++LGRKIGSGSFG++YLG ++ GEEVA+KLE VKTKHPQLH ESK+Y ++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
GG G+P ++W G EG+YNVMV++LLGPSLEDLFN+C+RKFSLKTVL+LADQ+I+R+EY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIID+GLAKKYRD +TH+HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
S+NTHLG+EQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKY++ISEKKM TPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQT 298
CK YPSEF +Y ++CRSLRF+DKPDYSYL++LFR+LF R+G+ +DYVFDW +LK+ +
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 280 bits (718), Expect = 1e-92
Identities = 161/292 (55%), Positives = 211/292 (72%), Gaps = 2/292 (0%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGT 63
V+G +K+GR+IG GSFG ++ G N+ ++VA+K E ++ PQL E + Y LL G T
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
G+P++ +FG EG +NV+VIDLLGPSLEDL + C RKFS+KTV M A Q++ RV+ +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 124 FLHRDIKPDNFLMGLG--RKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
++RDIKPDNFL+G + +N +Y++D+G+ K YRD T +HIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKY++I EKK TP+ LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293
+P EF Y HY R+L F+ PDY YL+ LF + R D FDW +L
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (299), Expect = 1e-30
Identities = 59/341 (17%), Positives = 121/341 (35%), Gaps = 26/341 (7%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK--LESVKTKHPQLHYESKLYMLL 59
DHV+ + + ++G+G+FG ++ TG A K + ++ + E + +L
Sbjct: 22 DHVLD-HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL 80
Query: 60 QGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
+ + +L + VM+ + + G L + + K S + Q+ + +
Sbjct: 81 RH-PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
MH ++H D+KP+N + ++SN++ +ID+GL Q+ K TGTA
Sbjct: 140 MHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAE 190
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238
+A+ G D+ S+G + L G P+ G + + +
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCD-WNMDD 246
Query: 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDY-----VFDWTIL 293
+ + + + + ++ G +T +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 294 KYPQTGSSSRSRPSGKPNLNPAGPSAERVERPSGQEVRDRF 334
+ P + S+ R RP +RD F
Sbjct: 304 RDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAF 344
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 7e-30
Identities = 59/330 (17%), Positives = 121/330 (36%), Gaps = 26/330 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
K+ + +G G FG ++ V + + K ++ T + E + + + +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 HLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
HL E VM+ + + G + + N + + + ++ Q+ ++++HS
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 185
H DI+P+N + R+S+ + II++G A++ + + + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245
S D+ SLG ++ L G P+ T +Q + I + T E K
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAE-YTFDEEAFKEIS 231
Query: 246 SEFTSYFHYCRSLRFEDKP------DYSYLKRLFRDL---FIREGYQFDYVFDWTILKYP 296
E + + + + +LK+ + IR Y
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLN 291
Query: 297 QTGSSSRSRPSGKPNLNPAGPSAERVERPS 326
S++R G + G S +V+ S
Sbjct: 292 MVVSAARISCGGAIR-SQKGVSVAKVKVAS 320
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 4e-29
Identities = 54/233 (23%), Positives = 90/233 (38%), Gaps = 19/233 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGT 63
F++GR +G G FG +YL Q+ +A+K+ + K
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
+ L + + ++++ KF + +L N + Y HS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
+HRDIKP+N L+G + ++ I D+G + H P L GT Y
Sbjct: 127 VIHRDIKPENLLLG---SAGELKIADFGWS---------VHAPSSRRTTLCGTLDYLPPE 174
Query: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
G + DL SLG + FL G P++ T ++ Y +IS + P
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 114 bits (285), Expect = 9e-29
Identities = 62/338 (18%), Positives = 117/338 (34%), Gaps = 26/338 (7%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--ESVKTKHPQLHYESKLYMLLQGG 62
+ + + ++GSG+FG ++ V TG K + E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH- 85
Query: 63 TGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+ +L + V++++ L G L D + K S V+ Q +++MH
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
+H DIKP+N + +K++ V IID+GLA K + K T TA +A+
Sbjct: 146 HSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAA 196
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
D+ ++G + L G P+ G + + E
Sbjct: 197 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCD-WEFDEDAF 252
Query: 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQTGSS 301
S E + + + +++ G + +Y +
Sbjct: 253 SSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLK-GDHSNLTSRIPSSRYNKIRQK 308
Query: 302 SRSRPSGKPNLNPAGP-----SAERVERPSGQEVRDRF 334
+ + + P PA S+ R RP ++ D +
Sbjct: 309 IKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDSY 346
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 2e-28
Identities = 59/280 (21%), Positives = 118/280 (42%), Gaps = 23/280 (8%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVP 66
G+ +G++IGSGSFG +Y G + +VAVK+ +V PQ K + + T
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 67 HL-KWFGVEGEYNV-MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
++ + G + +V G SL + KF + ++ +A Q ++Y+H++
Sbjct: 65 NILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
+HRD+K +N + + V I D+GLA + + L+G+ + +
Sbjct: 125 IIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSG-----SHQFEQLSGSILWMAPE 176
Query: 184 THLGVEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
++ S + D+ + G VL + G LP+ + + Q + + + +
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDLSKV 234
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYS----YLKRLFRDL 276
+ P C + +++P + ++ L R L
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-28
Identities = 51/238 (21%), Positives = 90/238 (37%), Gaps = 19/238 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGG 62
FK G+ +G GSF + L + T E A+K + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH- 67
Query: 63 TGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
L + + E + L F ++++ +EY+H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLHG 126
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + + I D+G AK + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239
+ DL +LG ++ + G P++ G + + KI + + P +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDFPEKF 233
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-28
Identities = 52/252 (20%), Positives = 100/252 (39%), Gaps = 32/252 (12%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--------ESVKTKHPQLHYESKLY 56
+ ++++G +GSG FG +Y G+ V VA+K ++ E L
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 57 MLLQGG-TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK--FSLKTVLMLADQLI 113
+ G +GV L + + V++++ P DLF++ + + Q++
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVL 120
Query: 114 NRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 173
V + H+ G LHRDIK +N L + ++ +ID+G +D +
Sbjct: 121 EAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKD---------TVYTDF 169
Query: 174 TGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY--DKISE 230
GT Y+ R + SLG +L + G +P++ + + Q + ++S
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 229
Query: 231 ------KKMLTP 236
+ L
Sbjct: 230 ECQHLIRWCLAL 241
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-28
Identities = 43/247 (17%), Positives = 93/247 (37%), Gaps = 22/247 (8%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ-GGTGVPH 67
+++ ++G G+FG++Y N +T A K+ K++ Y ++ +L +
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 68 LKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 126
L ++I+ G +++ + R + + ++ Q ++ + Y+H +H
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186
RD+K N L + + D+G++ K + + GT + + +
Sbjct: 134 RDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPEVVM 183
Query: 187 GVEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
R D+ SLG L+ P L + KI++ + P
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE--PPTLAQP 238
Query: 242 KSYPSEF 248
+ S F
Sbjct: 239 SRWSSNF 245
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 42/264 (15%), Positives = 92/264 (34%), Gaps = 19/264 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTG 64
F+ ++G+G+ G ++ + +G +A K LE Q+ E ++
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPY 65
Query: 65 VPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR- 122
+ + ++ + G SL+ + + + + ++ +I + Y+ +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
+HRD+KP N L+ ++ + D+G++ + D + + GT Y S
Sbjct: 125 KIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMSP 172
Query: 183 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242
G S + D+ S+G L+ G P A + + E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 243 SYPSEFTSYFHYCRSLRFEDKPDY 266
+ + + DY
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDY 256
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 43/253 (16%), Positives = 90/253 (35%), Gaps = 17/253 (6%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQG 61
+ +I + +G G G++ N +T E+ A+K + P+ E +L+
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQ 63
Query: 62 GTGVPHL----KWFGVEGEYNVMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLADQLINR 115
+ + + + ++V++ L G L + + ++ F+ + + +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
++Y+HS HRD+KP+N L R + + + D+G AK+ + Y
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------- 175
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
T Y + + + D+ SLG ++ L G P+
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 236 PIEVLCKSYPSEF 248
E
Sbjct: 236 FPNPEWSEVSEEV 248
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (269), Expect = 3e-27
Identities = 42/253 (16%), Positives = 81/253 (32%), Gaps = 22/253 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----------LESVKTKHPQLHYESKLY 56
++ +G G + ++ T +E AVK E V+ E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
+ G + LK + +V DL+ L D S K + L+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
+ +H +HRD+KP+N L+ + + D+G + + + + + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNYQF 234
Query: 236 PIEVLCKSYPSEF 248
Y
Sbjct: 235 GSPEW-DDYSDTV 246
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-27
Identities = 58/235 (24%), Positives = 89/235 (37%), Gaps = 15/235 (6%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGT 63
+ L + +G G++GE+ L VN T E VAVK ++ + E + +L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 63
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
V EG + ++ + QL+ V Y+H G
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
HRDIKP+N L+ + + + I D+GLA +R + + + GT Y +
Sbjct: 124 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPE 175
Query: 184 THLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237
E + D+ S G VL L G LPW Q+Y EKK
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNP 228
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 3e-27
Identities = 46/234 (19%), Positives = 88/234 (37%), Gaps = 19/234 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGG 62
F + +G G+FG++ L TG A+K + K + ES++ +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 63 TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
F ++ G L + F+ + ++++ +EY+HSR
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSR 124
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
++RDIK +N ++ K + I D+GL K+ GT Y +
Sbjct: 125 DVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEYLAP 174
Query: 183 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
+ R D LG V+ + G LP+ ++ ++ I +++ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 107 bits (267), Expect = 7e-27
Identities = 53/270 (19%), Positives = 107/270 (39%), Gaps = 21/270 (7%)
Query: 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYML 58
+ +++LG +G G E++L +++ +VAVK L + + + E++
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 59 LQGGTGVPHLKWF---GVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLIN 114
L V G +V++ + G +L D+ + + K + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQ 122
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174
+ + H G +HRD+KP N ++ +N V ++D+G+A+ D + +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNS----VTQTAAVI 175
Query: 175 GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234
GTA+Y S G R D+ SLG VL L G P+ G + + + +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQHVREDPI 232
Query: 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKP 264
P + ++ + + E++
Sbjct: 233 PPSA-RHEGLSADLDAVVLKALAKNPENRY 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-26
Identities = 65/284 (22%), Positives = 104/284 (36%), Gaps = 23/284 (8%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHP-QLHYESKLYMLLQG- 61
K++ KIG G+FGE++ + +TG++VA+K +E+ K P E K+ LL+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 62 ------GTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
+ +V D L L + KF+L + + L+N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
+ Y+H LHRD+K N L+ + + + D+GLA R K+ N
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLA---RAFSLAKNSQPNRYTNRVV 183
Query: 176 TARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234
T Y LG DL G ++ S QG T++ + IS+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240
Query: 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR--LFRDL 276
EV E + + + K R DL
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL 284
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 8e-26
Identities = 43/211 (20%), Positives = 93/211 (44%), Gaps = 14/211 (6%)
Query: 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ-GGTGV 65
K+ KIG G+ G +Y ++V TG+EVA++ +++ + + +++ ++ + +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 66 PHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+ + G+ +V++ L G SL D+ + + + + +E++HS
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
+HRDIK DN L+ V + D+G + Q+ + + GT + +
Sbjct: 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPEV 187
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ D+ SLG + + + G P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 9e-26
Identities = 54/272 (19%), Positives = 106/272 (38%), Gaps = 19/272 (6%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+L K+G G FGE+++G T VA+K L+ E+++ L+ V
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 67 HLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 126
E Y V G L+ L + L ++ +A Q+ + + Y+ ++H
Sbjct: 77 LYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH 136
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186
RD++ N L+G ++ + D+GLA+ D + + ++ + L
Sbjct: 137 RDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEAAL 187
Query: 187 GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245
+ + D+ S G +L +G +P+ G+ ++ D++ + P
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----ECP 240
Query: 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
C E++P + YL+ D F
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-25
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 17/213 (7%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGGT 63
F L + +G GSFG+++L +T + A+K + + E ++ L
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 64 GVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ H+ E V++ L G L KF L A ++I ++++HS+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
G ++RD+K DN L+ K + I D+G+ K+ + GT Y +
Sbjct: 123 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAP 172
Query: 183 NTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQG 215
LG + + D S G +L L G P+ G
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (259), Expect = 2e-25
Identities = 49/272 (18%), Positives = 94/272 (34%), Gaps = 29/272 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-----LESVKTKHPQLHYESKLYMLLQGG 62
F R+IG GSFG +Y +V+ E VA+K + K + E + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ + +V++ S DL + + + + + Y+HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
+HRD+K N L+ + V + D+G A + GT + +
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAP 180
Query: 183 NTHLGVEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239
L +++ + D D+ SLG + P + I++ +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQS- 236
Query: 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271
+ F ++ C +D+P L +
Sbjct: 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 103 bits (258), Expect = 2e-25
Identities = 50/277 (18%), Positives = 103/277 (37%), Gaps = 22/277 (7%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
++L RK+G G + E++ +N+ E+V VK+ K ++ E K+ L+GG +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNIIT 94
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 127
L + + + D + + + +++ ++Y HS G +HR
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQL-YQTLTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 187
D+KP N + + + ++ +ID+GLA+ Y Q + + + +
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 188 VEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246
+ D+ SLG +L + P+ + +I++ + Y
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 247 EFTSYFH-------YCRSLRFEDKPDYSYLKRLFRDL 276
E F+ R RF + + D
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-25
Identities = 62/280 (22%), Positives = 100/280 (35%), Gaps = 31/280 (11%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHL 68
+ + IG+GSFG +Y +GE VA+K V + E ++ L V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQIMRKLDHCNIVRLR 79
Query: 69 KWFGVEGE-----YNVMVIDLLGPS-LEDLFNYCNRK--FSLKTVLMLADQLINRVEYMH 120
+F GE Y +V+D + + +Y K + V + QL + Y+H
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH----KHIPYRENKNLTGT 176
S G HRDIKP N L + + + D+G AK+ + + YR + + G
Sbjct: 140 SFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 177 ARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
Y + D+ S G VL L G + G + + +I K + TP
Sbjct: 198 TDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEI-IKVLGTP 242
Query: 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+ +T + K L
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIAL 282
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 5e-25
Identities = 57/272 (20%), Positives = 107/272 (39%), Gaps = 19/272 (6%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
KL ++G+G FGE+++G +VAVK L+ E+ L LQ V
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 67 HLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 126
E Y + G ++ L K ++ +L +A Q+ + ++ R ++H
Sbjct: 73 LYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186
RD++ N L+ + I D+GLA+ D + + ++ +
Sbjct: 133 RDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAPEAIN 183
Query: 187 GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245
+ + D+ S G +L + G +P+ G+ T + + + + + P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD----NCP 236
Query: 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
E C R ED+P + YL+ + D F
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (255), Expect = 6e-25
Identities = 47/255 (18%), Positives = 100/255 (39%), Gaps = 18/255 (7%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQG 61
I + +G+G+F E+ L + +T + VA+K ++++ K + E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 62 GTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMH 120
+ L G + +++ L+ G L D ++ + L Q+++ V+Y+H
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 121 SRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
G +HRD+KP+N L + +++ I D+GL+K GT Y
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYV 176
Query: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
+ S+ D S+G + L G P+ + +++I + +
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYW 233
Query: 241 CKSYPSEFTSYFHYC 255
+ +
Sbjct: 234 -DDISDSAKDFIRHL 247
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (249), Expect = 4e-24
Identities = 49/232 (21%), Positives = 98/232 (42%), Gaps = 20/232 (8%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGTG 64
F++ R +G+GSFG ++L + G A+K+ V+ K + + +L + +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+ + + + M++D + +++F A ++ +EY+HS+
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
++RD+KP+N L+ K+ + I D+G AK D+ L GT Y +
Sbjct: 126 IYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIAPEV 172
Query: 185 HLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
++ D S G ++ L G P+ + Y+KI ++ P
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 221
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 5e-24
Identities = 47/280 (16%), Positives = 91/280 (32%), Gaps = 19/280 (6%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQG 61
+G ++ IG G++G + + VA+K +T + E K+ + +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GTGVPHLKWF----GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVE 117
+ + + +V L+G L L + S + Q++ ++
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLK 123
Query: 118 YMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTA 177
Y+HS LHRD+KP N L+ + + I D+GLA+ H T
Sbjct: 124 YIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----YVATR 176
Query: 178 RYASVN-THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
Y + ++ D+ S+G +L L + G Q + +
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG--KHYLDQLNHILGILGSPSQ 234
Query: 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
++ C + + DL
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (250), Expect = 5e-24
Identities = 63/248 (25%), Positives = 101/248 (40%), Gaps = 25/248 (10%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLLQGGTG- 64
F + R IG G FGE+Y TG+ A+K + +K K + ++ ML TG
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 65 ---VPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+ + + + ++DL+ + FS + A ++I +E+MH+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
R ++RD+KP N L+ + V I D GLA + + H + GT Y +
Sbjct: 126 RFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173
Query: 182 VNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
GV D SLG +L LRG P++ K K + + LT L
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----RMTLTMAVEL 228
Query: 241 CKSYPSEF 248
S+ E
Sbjct: 229 PDSFSPEL 236
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 9e-24
Identities = 55/280 (19%), Positives = 114/280 (40%), Gaps = 26/280 (9%)
Query: 13 RKIGSGSFGELYLGV--NVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQGGTGVP 66
+++GSG+FG + G + + VAVK+ + P +L E+ + L V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 67 HLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLH 126
+ E VM + LG L + NR K ++ L Q+ ++Y+ F+H
Sbjct: 73 MIGICEAESWMLVMEMAELG-PLNK-YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 127 RDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHL 186
RD+ N L+ + I D+GL+K R + + Y+ + ++ +
Sbjct: 131 RDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPECIN 183
Query: 187 GVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245
+ S + D+ S G ++ G P++G+ + + + + + P
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----GCP 236
Query: 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF---IREGY 282
E + C + E++P ++ ++ R+ + + EG+
Sbjct: 237 REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 1e-23
Identities = 47/245 (19%), Positives = 94/245 (38%), Gaps = 24/245 (9%)
Query: 4 VIGGKF-KLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYML 58
G+F K +IG GSF +Y G++ +T EVA + K++ + E+++
Sbjct: 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64
Query: 59 LQGGTGVPHLKWF---GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
LQ V + + V+V +L+ + + +K + Q++
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKG 124
Query: 116 VEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 173
++++H+R +HRD+K DN + + V I D GLA R K +
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAV 173
Query: 174 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233
GT + + + + D+ + G ++ P+ Q Y +++
Sbjct: 174 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVK 230
Query: 234 LTPIE 238
+
Sbjct: 231 PASFD 235
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-23
Identities = 52/275 (18%), Positives = 110/275 (40%), Gaps = 27/275 (9%)
Query: 13 RKIGSGSFGELYLGVNVQTGE--EVAVK---LESVKTKHPQLHYESKLYMLLQGGTGVPH 67
++G G+FG + GV + +VA+K + K ++ E+++ L P+
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 L-KWFGV-EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGF 124
+ + GV + E ++V+++ G L + + V L Q+ ++Y+ + F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNT 184
+HRD+ N L+ + I D+GL+K ++ ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243
+ S R D+ S G + L G P++ + + I + K +
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGKRME----CPPE 236
Query: 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278
P E + C ++ED+PD+ +++ R +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.0 bits (241), Expect = 2e-23
Identities = 53/278 (19%), Positives = 94/278 (33%), Gaps = 31/278 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQGGT 63
+++ IG+GS+G G+ + K + + L E L L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 64 GVPHLKWFGVEGEYNV-MVIDLL-GPSLEDLFNYCNRK---FSLKTVLMLADQLINRVEY 118
V + + +V++ G L + ++ + VL + QL ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 119 MHSRG-----FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNL 173
H R LHRD+KP N + V + D+GLA+ + K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 174 TGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
Query: 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271
Y E +L+ +P +
Sbjct: 232 RRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 97.1 bits (241), Expect = 3e-23
Identities = 53/272 (19%), Positives = 110/272 (40%), Gaps = 17/272 (6%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVP 66
+ K+G G +GE+Y GV + VAVK L+ + + E+ + ++ V
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 67 HLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRK-FSLKTVLMLADQLINRVEYMHSRGFL 125
L E + ++ + +L D CNR+ S +L +A Q+ + +EY+ + F+
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI 137
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 185
HRD+ N L+G +++ V + D+GL++ H + ++ + +
Sbjct: 138 HRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPESL 188
Query: 186 LGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYP 245
+ S + D+ + G +L + Q Y+ + + + E P
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKDYRMERPE----GCP 242
Query: 246 SEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
+ C D+P ++ + + F +F
Sbjct: 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 3e-23
Identities = 53/282 (18%), Positives = 105/282 (37%), Gaps = 30/282 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQT-GEEVAVKLESVKTKHPQLHY----ESKLYMLLQGG 62
+++ +IG G++G+++ +++ G VA+K V+T + E + L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 63 T--------GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLIN 114
V + E + ++ + L +T+ + QL+
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 115 RVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLT 174
++++HS +HRD+KP N L+ S Q+ + D+GLA+ Y +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--------V 176
Query: 175 GTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234
T Y + L + DL S+G + R ++G + + KI +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKI-LDVIG 232
Query: 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
P E + FH + E + + L +DL
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDL 272
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.1 bits (238), Expect = 6e-23
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 29/278 (10%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY----ESKLYMLLQGGT 63
K+ KIG G++G +Y N GE A+K ++ + + E + L+ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
+ L + V+V + L L+ L + C T QL+N + Y H R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH-----KHIPYRENKNLTGTAR 178
LHRD+KP N L+ + ++ I D+GLA+ + + YR L G+ +
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 179 YASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238
Y S D+ S+G + + G+ + G+ ++ + +I + + TP
Sbjct: 178 Y-----------STTIDIWSVGCIFAEMVNGTPLFPGV---SEADQLMRI-FRILGTPNS 222
Query: 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+ ++ + L DL
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.4 bits (241), Expect = 7e-23
Identities = 53/294 (18%), Positives = 105/294 (35%), Gaps = 25/294 (8%)
Query: 2 DHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQ 60
+ ++ L RK+G G F ++L ++ VA+K + K E KL +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGTGVPHLKWFGVEGEYNVMVIDLLG-----PSLEDLFNYCNRKFSLKTV 105
G + L N + + ++ L + Y +R L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQLINRVEYM-HSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKH 164
++ QL+ ++YM G +H DIKP+N L + + +I +A +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 165 IPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 225 YDKISE-KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277
D I++ ++L + ++F+ LR K + L+ + + +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 8e-23
Identities = 61/286 (21%), Positives = 98/286 (34%), Gaps = 24/286 (8%)
Query: 1 MDHVIGGK-FKLGRKIGSGSFGELYLGVNVQT---GEEVAVK-----LESVKTKHPQLHY 51
+ +IG K +L K+G GSFG + G VAVK + S
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 52 ESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQ 111
E L + L + ++ SL D F L T+ A Q
Sbjct: 61 EVNAMHSLDH-RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 112 LINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENK 171
+ + Y+ S+ F+HRD+ N L+ + V I D+GL + H Y +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQE 172
Query: 172 NLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISE 230
+ + + + S D G L G PW GL Q KI +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229
Query: 231 KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+ P + P + + C + + ED+P + L+ +
Sbjct: 230 EGERLPRP---EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 1e-22
Identities = 54/273 (19%), Positives = 93/273 (34%), Gaps = 17/273 (6%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTG 64
F+ KIG G++G +Y N TGE VA+K L++ P +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 65 VPHLKWFGVEGEYNVMVIDLLGPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHSRG 123
+ L +V + L L+ + L + QL+ + + HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
LHRD+KP N L+ + + D+GLA+ + + A
Sbjct: 123 VLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEI 173
Query: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243
S D+ SLG + + + G ++ + +I + + TP EV+
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWPG 229
Query: 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
S + + R + L R L
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 2e-22
Identities = 40/230 (17%), Positives = 90/230 (39%), Gaps = 15/230 (6%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+++G+G FG + G + +VA+K ++ + E+K+ M L V
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 127
+ ++ + L + +F + +L + + +EY+ S+ FLHR
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 187
D+ N L+ V + D+GL++ D + + R++ +
Sbjct: 125 DLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPEVLMY 175
Query: 188 VEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTP 236
+ S + D+ + G ++ G +P++ T + + I++ L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYR 222
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.0 bits (238), Expect = 2e-22
Identities = 49/236 (20%), Positives = 98/236 (41%), Gaps = 20/236 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--ESVKTKHPQLHYESKLYMLLQGGTGV 65
+F + +G+GSFG + L + ++G A+K+ + K Q+ + +LQ
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR--KFSLKTVLMLADQLINRVEYMHSRG 123
+K + + + + + + ++F++ R +FS A Q++ EY+HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
++RD+KP+N L+ + + + D+G AK+ + GT +
Sbjct: 162 LIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAPE 208
Query: 184 THLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239
L ++ D +LG ++ G P+ Q Y+KI K+ P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFPSHF 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.8 bits (235), Expect = 2e-22
Identities = 42/275 (15%), Positives = 94/275 (34%), Gaps = 19/275 (6%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEE---VAVK---LESVKTKHPQLHYESKLYMLLQGG 62
K+ + IG+G FGE+ G G+ VA+K + + E+ +
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87
Query: 63 TGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR 122
+ ++ + SL+ + +F++ ++ + + ++Y+
Sbjct: 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM 147
Query: 123 GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV 182
++HRD+ N L+ + + D+GL++ D + Y R+ +
Sbjct: 148 NYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRWTAP 202
Query: 183 NTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
+ + D+ S G V+ + G P+ + T + + I + L P
Sbjct: 203 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYRLPPPM--- 256
Query: 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
PS C +P + + +
Sbjct: 257 -DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.9 bits (235), Expect = 2e-22
Identities = 54/301 (17%), Positives = 101/301 (33%), Gaps = 47/301 (15%)
Query: 8 KFKLGRKIGSGSFGELYLG-----VNVQTGEEVAVK---LESVKTKHPQLHYESKLYMLL 59
+ R IG G+FG ++ + + VAVK E+ E+ L
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 60 QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDL-----------------------FNYC 96
V L V ++ + L + +
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 97 NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
S L +A Q+ + Y+ R F+HRD+ N L+G ++ V I D+GL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNI 190
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQG 215
Y+ + N R+ + + D+ + G VL G P+ G
Sbjct: 191 YSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275
+ ++ + + +L E + P E + C S D+P + + R+ +
Sbjct: 246 M---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298
Query: 276 L 276
+
Sbjct: 299 M 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 3e-22
Identities = 48/279 (17%), Positives = 101/279 (36%), Gaps = 28/279 (10%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-------LESVKTKHPQLHYESKLYMLLQG 61
FK + +GSG+FG +Y G+ + GE+V + + + ++ E+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 GTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
V L + ++ + L D + +L Q+ + Y+
Sbjct: 71 -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
R +HRD+ N L+ V I D+GLAK + H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
+ + L + + D+ S G + + GS P+ G+ A + + + + L
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILEKGERLPQPP-- 236
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYS----YLKRLFRD 275
+ C + + +P + ++ RD
Sbjct: 237 --ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 3e-22
Identities = 47/282 (16%), Positives = 103/282 (36%), Gaps = 27/282 (9%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL----ESVKTKHPQLHYESKLYMLLQ 60
+ ++ + +GSG++G + V+ +TG +VA+K + + + E +L ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 61 GGTGVPHLKWFGVEGEYN-----VMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
+ L F + + +V+ +G L L + K + L Q++
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKG 133
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
+ Y+H+ G +HRD+KP N ++ K D + +
Sbjct: 134 LRYIHAAGIIHRDLKPGNLA------------VNEDCELKILDFGLARQADSEMTGYVVT 181
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
A + ++ D+ S+G ++ + G ++G + +I +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKVTGTP 238
Query: 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPD-YSYLKRLFRDL 276
P E + + E +Y L +D + L +L
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.2 bits (231), Expect = 4e-22
Identities = 49/270 (18%), Positives = 102/270 (37%), Gaps = 19/270 (7%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVK-LESVKTKHPQLHYESKLYMLLQGGTGVPH 67
++IGSG FG ++LG ++VA+K + E+++ M L V
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 68 LKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHR 127
+ ++ + L D F+ +T+L + + + Y+ +HR
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 128 DIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG 187
D+ N L+ ++ + + D+G+ + D Q + ++AS
Sbjct: 126 DLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPEVFSF 176
Query: 188 VEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPS 246
S + D+ S G ++ G +P++ + + + IS L + +
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLYKPRLA----ST 229
Query: 247 EFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
++C R ED+P +S L R ++
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.8 bits (230), Expect = 6e-22
Identities = 52/272 (19%), Positives = 95/272 (34%), Gaps = 25/272 (9%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPH 67
+ KL + IG G FG++ LG G +VAVK E+ + L+ V
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 68 LKWFGVEGEYNVMVIDLL-GPSLED-LFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
L E +V + + SL D L + +L + + +EY+ F+
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 125
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 185
HRD+ N L+ + N + D+GL K+ Q ++ +
Sbjct: 126 HRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTAPEAL 172
Query: 186 LGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244
+ S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD----GC 225
Query: 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
P C L +P + L+ +
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 1e-21
Identities = 50/276 (18%), Positives = 100/276 (36%), Gaps = 24/276 (8%)
Query: 8 KFKLGRKIGSGSFGELYLGVNV---QTGEEVAVK---LESVKTKHPQLHYESKLYMLLQG 61
+ +LGR IG G FG+++ G+ + VA+K + + + E+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 62 GTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+ L E +++ L L ++++ A QL + Y+ S
Sbjct: 68 -PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
+ F+HRDI N L+ ++ V + D+GL++ D +K ++ +
Sbjct: 127 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWMA 177
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240
+ + D+ G + L G P+QG+ +I + L +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGERLP----M 230
Query: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
+ P S C + +P ++ LK +
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.6 bits (226), Expect = 3e-21
Identities = 58/274 (21%), Positives = 98/274 (35%), Gaps = 19/274 (6%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHY----ESKLYMLLQGGT 63
K++ KIG G++G ++ N +T E VA+K + + E L L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
V + +V + L+ F+ CN + V QL+ + + HSR
Sbjct: 63 IVRLHDVL-HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
LHRD+KP N L+ ++ ++ + ++GLA+ + IP R T Y +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPPD 171
Query: 184 THLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242
G + S D+ S G + P + +I + + TP E
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRI-FRLLGTPTEEQWP 228
Query: 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
S + L RDL
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 3e-21
Identities = 47/296 (15%), Positives = 96/296 (32%), Gaps = 46/296 (15%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGE-----EVAVKL---ESVKTKHPQLHYESKLYMLL 59
+ G+ +GSG+FG++ + +VAVK+ ++ ++ L E K+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 60 QGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFS----------------- 101
+ +L ++ + L + KFS
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 102 -----LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156
+ +L A Q+ +E++ + +HRD+ N L+ V I D+GLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 214
Query: 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQG 215
+ N ++ + + + + D+ S G +L G P+ G
Sbjct: 215 MSDSNYVV-----RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 216 LKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271
+ + K+ + E C + +P + L
Sbjct: 270 I---PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 5e-21
Identities = 37/275 (13%), Positives = 91/275 (33%), Gaps = 20/275 (7%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEE----VAVK---LESVKTKHPQLHYESKLYMLLQG 61
+ IG+G FGE+Y G+ + + VA+K + + E+ +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 62 GTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS 121
+ ++ + +L+ + +FS+ ++ + + ++Y+ +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 122 RGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYAS 181
++HRD+ N L+ + + D+GL++ D + R+ +
Sbjct: 129 MNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTA 181
Query: 182 VNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241
+ + D+ S G V+ + + + I++ L
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLPTPM--- 236
Query: 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
PS C +P ++ + + L
Sbjct: 237 -DCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 6e-21
Identities = 51/282 (18%), Positives = 100/282 (35%), Gaps = 27/282 (9%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQ 60
+ +++ +GSG++G + + +TG VAVK S + + + E +L ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 61 GGTGVPHLKWF-----GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
+ L F E +V L+G L ++ +K + V L Q++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 133
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
++Y+HS +HRD+KP N + + K D +H +
Sbjct: 134 LKYIHSADIIHRDLKPSNLAV------------NEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
A + ++ D+ S+G ++ L G + G + I
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGTP 238
Query: 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPD-YSYLKRLFRDL 276
E+L K +Y + + + + L DL
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 8e-21
Identities = 52/294 (17%), Positives = 107/294 (36%), Gaps = 37/294 (12%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHP----QLHYESKLYMLLQ 60
+ +++ + IGSG+ G + + VA+K S ++ + + E L +
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 61 GGTGVPHLKWF-----GVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINR 115
+ L F E + +V++L+ +L + + + L Q++
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQMLCG 131
Query: 116 VEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
++++HS G +HRD+KP N ++ + + I+D+GLA+
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VV 180
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
T Y + LG+ D+ S+G ++ +R + + G
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG------------RDYIDQWN 228
Query: 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFD 289
+ + EF E++P Y+ L F LF + D +
Sbjct: 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT--FPKLFPDSLFPADSEHN 280
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 1e-20
Identities = 44/252 (17%), Positives = 87/252 (34%), Gaps = 36/252 (14%)
Query: 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKL-----ESVKTKHPQLHYESKLYMLLQGGT 63
K IG G+FG++ + G + + + K H E ++ L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 64 GVPHLKWFGVEGEYNVMVIDLL-GPSLEDL---------------FNYCNRKFSLKTVLM 107
+ +L Y + I+ +L D N S + +L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 108 LADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPY 167
A + ++Y+ + F+HRD+ N L+G ++ I D+GL++
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG-- 186
Query: 168 RENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYD 226
R+ ++ + + D+ S G +L + G P+ G+ T + Y+
Sbjct: 187 ------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE 237
Query: 227 KISEKKMLTPIE 238
K+ + L
Sbjct: 238 KLPQGYRLEKPL 249
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.4 bits (221), Expect = 1e-20
Identities = 48/247 (19%), Positives = 86/247 (34%), Gaps = 21/247 (8%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKL--------ESVKTKHPQLHYESKLY 56
+ + G ++GSG F + TG + A K + E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57 MLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRV 116
+Q V L +++++L+ F + + Q++N V
Sbjct: 68 KEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 117 EYMHSRGFLHRDIKPDNFLM-GLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTG 175
Y+HS H D+KP+N ++ ++ IID+GLA K K+I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 176 TARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235
T + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF 235
Query: 236 PIEVLCK 242
E
Sbjct: 236 EDEYFSN 242
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 2e-20
Identities = 41/219 (18%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 8 KFKLGRKIGSGSFGELYLGVNV---QTGEEVAVK------LESVKTKHPQLHYESKLYML 58
F+L + +G+G++G+++L + TG+ A+K + E ++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 59 LQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEY 118
++ + L + +++D + +F+ V + +++ +E+
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 119 MHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTAR 178
+H G ++RDIK +N L+ + V + D+GL+K++ +T + + GT
Sbjct: 145 LHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC------GTIE 195
Query: 179 YASVNTHLGVEQ--SRRDDLESLGYVLMYFLRGSLPWQG 215
Y + + G + + D SLG ++ L G+ P+
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 3e-20
Identities = 36/232 (15%), Positives = 77/232 (33%), Gaps = 34/232 (14%)
Query: 8 KFKLGRKIGSGSFGELYLG-----VNVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLL 59
+ G+ +G+G+FG++ + VAVK+ + T+ L E K+ L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 60 QGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDL-----------------FNYCNRKFS 101
+ +L G +++ + L +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
L+ +L + Q+ + ++ S+ +HRD+ N L+ I D+GLA+ ++
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200
Query: 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
+ N ++ + + + D+ S G L
Sbjct: 201 YVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 1e-19
Identities = 51/272 (18%), Positives = 88/272 (32%), Gaps = 24/272 (8%)
Query: 13 RKIGSGSFGELYLGVNVQTGEEVAVK-------LESVKTKHPQLHYESKLYMLLQGGTGV 65
+G G F +Y + T + VA+K E+ + E KL L +
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 66 PHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFL 125
L +V D + LE + + + + + +EY+H L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 126 HRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTH 185
HRD+KP+N L+ ++ + + D+GLAK + P R + T Y +
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172
Query: 186 LGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244
G D+ ++G +L L G + + +I E E
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
F + +S DL
Sbjct: 230 SLPDYVTFKSFPGIPLHHI--FSAAGDDLLDL 259
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 2e-18
Identities = 47/249 (18%), Positives = 92/249 (36%), Gaps = 29/249 (11%)
Query: 8 KFKLGRKIGSGSFGELYLGVN-----VQTGEEVAVK---LESVKTKHPQLHYESKLYMLL 59
K + R++G GSFG +Y GV + VA+K + + + E+ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 60 QGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNR---------KFSLKTVLMLAD 110
V L V++ + L+ SL ++ +A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 111 QLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYREN 170
++ + + Y+++ F+HRD+ N ++ + V I D+G+ + + YR+
Sbjct: 141 EIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRKG 192
Query: 171 KNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKIS 229
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFVM 249
Query: 230 EKKMLTPIE 238
E +L +
Sbjct: 250 EGGLLDKPD 258
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 3e-18
Identities = 43/258 (16%), Positives = 98/258 (37%), Gaps = 38/258 (14%)
Query: 8 KFKLGRKIGSGSFGELYLGVNVQTGEE-------VAVK---LESVKTKHPQLHYESKLYM 57
+ LG+ +G G+FG++ L + ++ VAVK ++ + L E ++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 58 LLQGGTGVPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYC---------------NRKFS 101
++ + +L + ++++ +L + + S
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 102 LKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I D+GLA+ +
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 190
Query: 162 HKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 220
+K N ++ + + + D+ S G +L G P+ G+
Sbjct: 191 YKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P 242
Query: 221 KKQKYDKISEKKMLTPIE 238
++ + + E +
Sbjct: 243 VEELFKLLKEGHRMDKPS 260
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 1e-17
Identities = 48/285 (16%), Positives = 100/285 (35%), Gaps = 26/285 (9%)
Query: 11 LGRKIGSGSFGELYLGVNV---QTGEEVAVK---LESVKTKHPQLHYESKLYMLLQGGTG 64
IG G FG +Y G + AVK + + Q E +
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 65 VPHLKWFGVEGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG 123
+ L ++V+ + L + ++K ++ Q+ ++++ S+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 124 FLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVN 183
F+HRD+ N ++ + V + D+GLA+ D + ++ ++
Sbjct: 151 FVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMALE 204
Query: 184 THLGVEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242
+ + + + D+ S G +L + RG+ P+ + + + + L E
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGRRLLQPE---- 257
Query: 243 SYPSEFTSYFHYCRSLRFEDKPDYS----YLKRLFRDLFIREGYQ 283
P C + E +P +S + +F FI E Y
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST-FIGEHYV 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 1e-17
Identities = 26/161 (16%), Positives = 53/161 (32%), Gaps = 31/161 (19%)
Query: 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKL------------ESVKTKHPQLHYESKL--- 55
+G+ +G G ++ + + E VK E +
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 56 --YMLLQGGTGVPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLI 113
+ LQ G+ K + EG +M E + + ++ + D ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMIL 113
Query: 114 NRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154
V + RG +H D+ N L+ ++IID+ +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 150
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.3 bits (197), Expect = 2e-17
Identities = 55/295 (18%), Positives = 109/295 (36%), Gaps = 40/295 (13%)
Query: 8 KFKLGRKIGSGSFGELYLGV-----NVQTGEEVAVKL---ESVKTKHPQLHYESKLYMLL 59
+ KLG+ +G G+FG++ T VAVK+ + ++H L E K+ + +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 60 QGGTGVPHLKWFGVEGEYNVMVI--DLLGPSLEDLFNYCNRKF---------------SL 102
V +L + +MVI +L +F +L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 103 KTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162
+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D+GLA+ +
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY 190
Query: 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTK 221
+ ++ + T + + D+ S G +L + P+ G+K
Sbjct: 191 VR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--ID 243
Query: 222 KQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276
++ ++ E + + E C +P +S L +L
Sbjct: 244 EEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.9 bits (183), Expect = 2e-15
Identities = 55/227 (24%), Positives = 80/227 (35%), Gaps = 27/227 (11%)
Query: 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGG-T 63
I L IG G FGE++ G GEEVAVK+ S + E+++Y +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHE 57
Query: 64 GVPHLKWFGVEGEYNVMVIDLLGPSLE--DLFNYCNR---------KFSLKTVLMLADQL 112
+ + + L+ E LF+Y NR K +L T LA
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 113 INRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKN 172
+ V HRD+K N L+ K+ I D GLA ++ I +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP---NH 171
Query: 173 LTGTARY------ASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPW 213
GT RY E +R D+ ++G V R
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 465 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.75 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.78 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.71 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-59 Score=460.35 Aligned_cols=296 Identities=74% Similarity=1.335 Sum_probs=268.5
Q ss_pred CCCccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEE
Q 012336 1 MDHVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 1 ~~~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (465)
|+..++++|++++.||+|+||+||+|++..+++.||||++..+.....+..|+++++.++|+++|+.+..+..++...++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 88999999999999999999999999999999999999998888888899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 81 VIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 81 v~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||++++++|.+.+....+.+++.++..++.|++.||+|||++||+||||||+|||+...+.+..++|+|||+|+.+....
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999988778899999999999999999999999999999999999999766678899999999999887766
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....++.......||+.|||||.+.+..++.++|||||||++|||++|+.||...........+..........+.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66655666777889999999999999999999999999999999999999999987776666666666666777777888
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
+..+|+++.+||..||..+|++||++.+|.++|++++.+.+...+..|||+.++..
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 88999999999999999999999999999999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.3e-57 Score=444.94 Aligned_cols=291 Identities=55% Similarity=0.988 Sum_probs=267.6
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+|++++|++++.||+|+||+||+|++..+|+.||||+++.......+..|++++..|+|+++++.+..++.++...++||
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 47899999999999999999999999999999999999887778889999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC--CCCcEEEEecCCcccccccc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR--KSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d--~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++++|.+++......+++.++..++.|++.||+|||++||+||||||+|||++... ..+.+||+|||+|+.+....
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9999999999987778899999999999999999999999999999999999996322 35789999999999887665
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....+......+.||+.|||||++.+..++.++|||||||++|||++|..||.+.......+.+..+.......+.+.+
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 55555666677889999999999999999999999999999999999999999988887777788777777777788888
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCcccccccc
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTIL 293 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~ 293 (465)
+..+|+++.+++..|+..+|++||+++.|.++|++++.+.+...+..|||+.+
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 89999999999999999999999999999999999999999999999999853
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=395.42 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=209.1
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|++..+++.||||++... .....+.+|+.+++.++|+++|..+..+ .+....++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-HDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-EECCEEEEE
Confidence 5799999999999999999999999999999998642 2344688999999999887766655554 566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC
T ss_pred EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCCc
Confidence 9998 8899999975 4679999999999999999999999999999999999999 588999999999997654321
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....||+.|||||++.+..++.++|||||||+||||++|+.||.+. ...+.+..+.......+
T Consensus 161 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~p---- 224 (263)
T d2j4za1 161 ---------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFTFP---- 224 (263)
T ss_dssp ---------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCCCC----
T ss_pred ---------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCCCC----
Confidence 23567999999999999999999999999999999999999999874 34555555555444333
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
..+|+++.+||..||..||++|||+.++ |++.|..
T Consensus 225 -~~~s~~~~~li~~~L~~dp~~R~t~~ei---l~hp~~~ 259 (263)
T d2j4za1 225 -DFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWIT 259 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTCHHHH
T ss_pred -ccCCHHHHHHHHHHccCCHhHCcCHHHH---HcCcCcC
Confidence 4579999999999999999999996665 5555543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=401.46 Aligned_cols=268 Identities=21% Similarity=0.305 Sum_probs=219.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
-.++|++++.||+|+||+||+|++..+++.||||++... .....+.+|++++..++|+++|..+..| .+....|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-QDDEKLY 84 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-ECSSEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-EECCEEE
Confidence 457899999999999999999999999999999998743 2334688999999999987777665554 5667889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 85 ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC-
T ss_pred EEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceeccc
Confidence 999998 7899998875 5689999999999999999999999999999999999999 5889999999999987653
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.... ......+||+.|||||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+
T Consensus 161 ~~~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~p-- 230 (288)
T d1uu3a_ 161 ESKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYDFP-- 230 (288)
T ss_dssp --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCCCC--
T ss_pred CCcc-----cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCCCC--
Confidence 2221 1234568999999999999999999999999999999999999999874 34555555555444333
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++++.+||.+||..||.+|||++++.+ ..+. ..++|+..+||..+.
T Consensus 231 ---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~---~~~i-~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 231 ---EKFFPKARDLVEKLLVLDATKRLGCEEMEG---YGPL-KAHPFFESVTWENLH 279 (288)
T ss_dssp ---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC---HHHH-HTSGGGTTCCCTTGG
T ss_pred ---ccCCHHHHHHHHHHccCCHhHCcCHHHHcC---CHHH-HcCCccCCCCHHHhh
Confidence 467999999999999999999999877643 2222 236788889999765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=397.93 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=203.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
|-++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|+++|..+..+ .+....+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-REGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE-EETTEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee-ccCceeEEE
Confidence 4578999999999999999999999999999999987543 234689999999999987766655554 566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 82 mEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCC
Confidence 9999 7899998863 5679999999999999999999999999999999999999 578899999999998765432
Q ss_pred CcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
.. ......+||+.|||||++.+..+ +.++|||||||++|||++|+.||....... +.+...........
T Consensus 158 ~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~~--- 227 (271)
T d1nvra_ 158 RE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYLN--- 227 (271)
T ss_dssp EE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTST---
T ss_pred cc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCCC---
Confidence 11 12345789999999999998876 678999999999999999999998754332 22222222222221
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
....+++++.+|+.+||+.||++|||++++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 124678999999999999999999997765
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-51 Score=399.15 Aligned_cols=246 Identities=21% Similarity=0.327 Sum_probs=204.4
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|++++.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.++|+++|..+..| .+.+..+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY-LVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEE-EECCEEEEEEE
Confidence 458999999999999999999999999999999987543 234689999999999988777666655 45667899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|+ |++|.+++.. +.+++.++..|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence 98 8899998874 579999999999999999999999999999999999999 5789999999999987654321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.....+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+. .+.+..+........ ....
T Consensus 172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~~--~~~~ 240 (293)
T d1yhwa1 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPEL--QNPE 240 (293)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCCC--SSGG
T ss_pred ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCCC--CCcc
Confidence 23456899999999999999999999999999999999999999987432 333333332222111 1124
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.+++++.+||..||..||++||++.++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~ei 267 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKEL 267 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 679999999999999999999997765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=395.73 Aligned_cols=248 Identities=19% Similarity=0.283 Sum_probs=204.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+.|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+++++.++|+++|..+..+ .+....+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF-YYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-EETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCeEEEEEec
Confidence 569999999999999999999999999999999876533 35789999999999988777766655 456678899999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++....+.+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 8 889999987667789999999999999999999999999999999999999 5889999999999976543211
Q ss_pred cccccCCCCcccccccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 164 HIPYRENKNLTGTARYASVNTHL-----GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
......||+.|||||++. +..|+.++|||||||++|||++|+.||.+..... .+..+........
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~~i~~~~~~~~-- 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLLKIAKSEPPTL-- 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHHHHHSCCCCC--
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHHHHHcCCCCCC--
Confidence 123568999999999984 4558999999999999999999999998865433 3333333322111
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....+++++.+||..||+.||++|||+.+|.
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 11246799999999999999999999977663
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-51 Score=400.48 Aligned_cols=252 Identities=19% Similarity=0.248 Sum_probs=197.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
+.++|++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.++..++|+++|..+..+ .++...+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-ESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEE
Confidence 5788999999999999999999999999999999987543 234577899999999887766665554 566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+...+.++.+||+|||+++......
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999 7999999975 5689999999999999999999999999999999999999765678999999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+.......+.+ .
T Consensus 165 --------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~~~~-~ 232 (307)
T d1a06a_ 165 --------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEFDSP-Y 232 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTTCCCCCTT-T
T ss_pred --------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHhccCCCCCCc-c
Confidence 124567999999999999999999999999999999999999999874 3344555555544433322 3
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+|+++.+||..||..||++||++.++.
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 357899999999999999999999977654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=399.93 Aligned_cols=259 Identities=20% Similarity=0.265 Sum_probs=216.2
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.++..++|++++..+.. ..+....|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~-~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA-FQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEE-EECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEee-eccccccccc
Confidence 6899999999999999999999999999999998743 234568899999999987665555554 4566788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccCC
Confidence 9999 8999999885 5689999999999999999999999999999999999999 588999999999998654322
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+ ..+.+..+.......+
T Consensus 160 ~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~~p---- 225 (337)
T d1o6la_ 160 A-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIRFP---- 225 (337)
T ss_dssp C-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC----
T ss_pred c-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCCCC----
Confidence 1 2346789999999999999999999999999999999999999998843 4455555555544443
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
..+++++.+||..||++||.+||+ +++| ++ ++|+..++|..+..
T Consensus 226 -~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ei---l~-------Hp~f~~i~~~~l~~ 274 (337)
T d1o6la_ 226 -RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV---ME-------HRFFLSINWQDVVQ 274 (337)
T ss_dssp -TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HT-------SGGGTTCCHHHHHT
T ss_pred -ccCCHHHHHHHHhhccCCchhhcccccccHHHH---Hc-------CcccccCCHHHHHh
Confidence 467999999999999999999995 4444 33 56666788987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=388.52 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=205.3
Q ss_pred CccCCce-EEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEe---
Q 012336 3 HVIGGKF-KLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVE--- 74 (465)
Q Consensus 3 ~i~~~~y-~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~--- 74 (465)
....++| ++.++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|+++|..+..+...
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSS
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecccc
Confidence 3456677 7888999999999999999999999999998755322 3578999999999998888888777542
Q ss_pred CcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRG--FLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~g--ivHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
....+|||||+ +++|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||+. +.++.+||+|||
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLG 160 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecC
Confidence 45789999998 8899999975 467999999999999999999999999 99999999999994 357899999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
+++..... ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+.. ...+.+..+...
T Consensus 161 la~~~~~~---------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 161 LATLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSG 228 (270)
T ss_dssp GGGGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTT
T ss_pred cceeccCC---------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcC
Confidence 99764332 1245689999999999876 59999999999999999999999997643 233344444333
Q ss_pred hccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 KMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 ~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
... ..+...+++++.+||.+||+.||++|||+++|.
T Consensus 229 ~~~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 229 VKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp CCC---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCC---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 222 223356789999999999999999999977664
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=393.32 Aligned_cols=247 Identities=21% Similarity=0.235 Sum_probs=197.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeE-eCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGV-EGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv 81 (465)
++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|++++..++|+++|..+..+.. .+...+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999999999999999998765432 347889999999999888888877654 45567899
Q ss_pred Eecc-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 82 IDLL-GPSLEDLFNY---CNRKFSLKTVLMLADQLINRVEYMHSRG-----FLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~---~~~~ls~~~~~~ia~qi~~gL~yLHs~g-----ivHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
|||+ +++|.+++.. ....+++..++.++.||+.||+|||++| |+||||||+|||+ +.++.+||+|||+
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~ 160 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGL 160 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccc
Confidence 9999 8899999864 2567999999999999999999999976 9999999999999 5889999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
++.+..... ......||+.|||||++.+..++.++|||||||++|||++|..||.+.+ ..+.+..+....
T Consensus 161 a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~~ 230 (269)
T d2java1 161 ARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREGK 230 (269)
T ss_dssp HHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTC
T ss_pred eeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcCC
Confidence 987654321 2345789999999999999999999999999999999999999998743 344555555444
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.... ...+++++.+||.+||+.||++||++++|.
T Consensus 231 ~~~~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 231 FRRI----PYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 3322 246799999999999999999999977764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=392.47 Aligned_cols=260 Identities=20% Similarity=0.335 Sum_probs=205.9
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
+-.++|++++.||+|+||+||+|+. +..||||+++.... ...+.+|+.++.+++|+|+|..+.++ .+ ...+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~-~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA-PQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS-SSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-ec-cEEE
Confidence 4568999999999999999999974 34699999875432 23578899999999988877766543 33 4568
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+||||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccc
Confidence 999998 799999998666789999999999999999999999999999999999999 5889999999999977543
Q ss_pred ccCcccccccCCCCccccccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGV---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~---~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
.... .......||+.|||||++.+. .++.++|||||||+||||+||+.||.+... ..+....+.......
T Consensus 157 ~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p 229 (276)
T d1uwha_ 157 WSGS-----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSP 229 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCC
T ss_pred cCCc-----ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCC
Confidence 2221 123456899999999998753 478999999999999999999999987543 222333333333333
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
........+|+++.+||.+||+.||++|||+.+|.+.|+.+..
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3344456789999999999999999999999999999987653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-49 Score=399.16 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=215.2
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|++..+|+.||||++... .....+.+|+.+++.+.|+++|..+..+ .+....++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-ccccccccc
Confidence 6899999999999999999999999999999998643 2334688999999999887777666655 455567788
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|+++ +++|.+++.. .+.+++..+..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.....
T Consensus 120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeecccc-
Confidence 8877 8999998875 4679999999999999999999999999999999999999 58899999999999876432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
.....||+.|||||++.+..++.++|||||||+||||++|..||.+. ...+.+..+.......+
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~p---- 258 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVRFP---- 258 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC----
T ss_pred ---------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCCCC----
Confidence 23568999999999999999999999999999999999999999874 34555555555544433
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccCC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILKY 295 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~ 295 (465)
..+++++.+||..||..||.+|+ ++++|++ ++|+..+||..+..
T Consensus 259 -~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~----------Hp~f~~~~~~~~~~ 307 (350)
T d1rdqe_ 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN----------HKWFATTDWIAIYQ 307 (350)
T ss_dssp -TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT----------SGGGTTCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc----------CccccCCCHHHHHh
Confidence 46799999999999999999995 7666643 67777889987643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=387.84 Aligned_cols=264 Identities=19% Similarity=0.215 Sum_probs=213.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--------CccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++|+++|..+.. ..+..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV-YENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE-EECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE-EEECC
Confidence 57789999999999999999999999999999999875421 2357899999999998776665555 45667
Q ss_pred EEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCC-CCCcEEEEecCCcc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGR-KSNQVYIIDYGLAK 154 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d-~~~~vkL~DFGla~ 154 (465)
..+|||||+ |++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+..++ ....+||+|||+++
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 889999998 8999999975 46799999999999999999999999999999999999995221 12369999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+......
T Consensus 166 ~~~~~~--------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 166 KIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 234 (293)
T ss_dssp ECTTSC--------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC
T ss_pred hcCCCc--------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCC
Confidence 764322 234567999999999999999999999999999999999999999874 445555555555444
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccccccc
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTI 292 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~dw~~ 292 (465)
.+. .....+|+++.+||..||..||++||+++++.+ ++|....+|..
T Consensus 235 ~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~----------hp~~~~~~~~~ 281 (293)
T d1jksa_ 235 FED-EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ----------HPWIKPKDTQQ 281 (293)
T ss_dssp CCH-HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH----------STTTCC-----
T ss_pred CCc-hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc----------CcccCCCChhH
Confidence 443 334578999999999999999999999877643 45555566654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.8e-50 Score=400.11 Aligned_cols=251 Identities=19% Similarity=0.258 Sum_probs=209.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..++|+++|..+.+| .+....||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-EETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEEEc
Confidence 589999999999999999999999999999999875432 23578899999999987777666655 566788999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ |++|.+++....+.+++..+..|+.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+++.+....
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~--- 180 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQ--- 180 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTS---
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheeccccc---
Confidence 8 89999999655667999999999999999999999999999999999999952 246899999999998765422
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
......||+.|||||++.+..++.++|||||||++|||++|..||.+. ...+.+..+.......+. .....
T Consensus 181 -----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~ 251 (350)
T d1koaa2 181 -----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMDD-SAFSG 251 (350)
T ss_dssp -----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSCC-GGGGG
T ss_pred -----ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCc-ccccC
Confidence 123568999999999999999999999999999999999999999874 344555555554443332 23357
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
+++++.+||.+||..||++|||+.+|.+
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8999999999999999999999776643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=399.03 Aligned_cols=260 Identities=19% Similarity=0.291 Sum_probs=204.5
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
++..++|+++++||+|+||+||+|++..+++.||||+++.+... .++.+|+.+++.++|+++|..+..| .+....+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF-YSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-ECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEE
Confidence 36688999999999999999999999999999999998755322 3678999999999987776666655 4556789
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSR-GFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~-givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+||||+ |++|.+++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+|+.+.
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence 999998 7899999975 46799999999999999999999975 99999999999999 588999999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh-----
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK----- 232 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~----- 232 (465)
... ..+.+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+...............
T Consensus 157 ~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 157 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp HHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred CCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 422 245689999999999999999999999999999999999999998754322111100000000
Q ss_pred -------------------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 233 -------------------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 233 -------------------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
...+.......++.++.+|+.+||..||++|||++++ |++.|.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~---L~Hpf~~ 302 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL---MVHAFIK 302 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHH---hhCHhhC
Confidence 0000000011357899999999999999999996665 5555554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.4e-49 Score=391.73 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=214.9
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (465)
++|++++.||+|+||+||+|++..+|+.||||++... .....+.+|+.++..++|+++|..+.. ..+....|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT-FQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE-EECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee-EeeCCeeeeE
Confidence 4799999999999999999999999999999998643 234568899999999988776665555 4567788999
Q ss_pred Eecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 82 IDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 82 ~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
|||+ |++|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC-
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEeccc-
Confidence 9999 8888888875 6779999999999999999999999999999999999999 58899999999999876432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+.......+
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~~p---- 221 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELRFP---- 221 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCCCC----
T ss_pred ---------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCCCC----
Confidence 23568999999999999999999999999999999999999999874 34555555555444333
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCccccccccC
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKP-----DYSYLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+++++.+++.+||..||.+|+ ++++|++ ++|...++|..+.
T Consensus 222 -~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~----------Hp~f~~i~~~~l~ 269 (316)
T d1fota_ 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN----------HPWFKEVVWEKLL 269 (316)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT----------SGGGSSCCHHHHH
T ss_pred -CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc----------CcccccCCHHHHH
Confidence 45789999999999999999996 7666532 6677778898654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-49 Score=390.51 Aligned_cols=262 Identities=16% Similarity=0.257 Sum_probs=201.4
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCc---EEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGE---EVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~---~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
+-.++|++.+.||+|+||+||+|++..+++ .||||.+...... ..+.+|++++.+++|+|+|..++++ .....
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-TKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-eeCCE
Confidence 345789999999999999999999877664 5889987654332 3588999999999988877777665 45567
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++||||+ +++|.+++....+.+++.+++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 88999999 889999888656789999999999999999999999999999999999999 58999999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
....... .........||+.|||||++.+..++.++|||||||+||||+| |..||.+... .+.+..+.......
T Consensus 179 ~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~ 253 (299)
T d1jpaa_ 179 EDDTSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLP 253 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC
T ss_pred cCCCCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC
Confidence 5432211 1112233568999999999999999999999999999999998 8999987543 34444444433222
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
. ...+|+++.+|+..||+.||++||++.+|.+.|+.+..
T Consensus 254 ~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 P----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp C----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 2 14579999999999999999999999999999988754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.5e-49 Score=397.89 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=209.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHHHc--CCCCCceeEEEeEeCcEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYMLLQ--GGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~ 79 (465)
++|++++.||+|+||.||+|++..+|+.||||++... .....+..|..++..++ +|++|..+..++.+....|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5899999999999999999999999999999998643 22234566666665554 2344445555556677889
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+||||+ |++|.+++.. ...+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 999999 8999999975 5679999999999999999999999999999999999999 5889999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
. ......||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.......+....+......
T Consensus 160 ~---------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 227 (364)
T d1omwa3 160 K---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--- 227 (364)
T ss_dssp S---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCC---
T ss_pred C---------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC---
Confidence 2 2345689999999999974 56899999999999999999999999886655544443332222222
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCccccccccCCC
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPD-----YSYLKRLFRDLFIREGYQFDYVFDWTILKYP 296 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~~~~~~~~~~~~~~dw~~~~~~ 296 (465)
....+++++.+||..||..||++||+ +++|++ ++|+..+||..+...
T Consensus 228 --~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~----------Hp~f~~i~~~~~~~~ 279 (364)
T d1omwa3 228 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE----------SPFFRSLDWQMVFLQ 279 (364)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT----------SGGGTTCCHHHHHTT
T ss_pred --CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc----------CccccCCCHHHHhcC
Confidence 22468999999999999999999998 455433 677778899876443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=387.31 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=212.5
Q ss_pred CCceEEEee-EeeeCceEEEEEEEcC--CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRK-IGSGSFGELYLGVNVQ--TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~-LG~G~fG~Vyla~~~~--~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.++|.+.+. ||+|+||+||+|.+.. ++..||||+++..... ..+.+|+.++..++|+++|..++++. . +..+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S-SSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec-c-CeEE
Confidence 467888884 9999999999998754 4558999998754332 35889999999999988888777653 3 3468
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
+||||+ +++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---EETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee---ccCCceeeccchhhhcccc
Confidence 999999 789999987656789999999999999999999999999999999999999 4889999999999987654
Q ss_pred ccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
..... .......||+.|||||++.+..++.++|||||||++|||+| |..||.+... .+.+..+........
T Consensus 162 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~~~i~~~~~~~~- 233 (285)
T d1u59a_ 162 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKRMEC- 233 (285)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHHHHHHTTCCCCC-
T ss_pred ccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCCC-
Confidence 32211 22345679999999999999999999999999999999998 9999988654 334444443332211
Q ss_pred HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 238 EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 238 ~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
...+|+++.+||..||+.||++||++.+|.+.|++.+...
T Consensus 234 ---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 234 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 1467999999999999999999999999999999988654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-49 Score=383.22 Aligned_cols=262 Identities=20% Similarity=0.311 Sum_probs=209.6
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeC--
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEG-- 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~-- 75 (465)
..+.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|++++..+..+..++
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 46789999999999999999999999999999999998754332 25788999999999999888888877654
Q ss_pred -cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 76 -EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 76 -~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
...||||||+ |++|.+++.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||+ +.++.++|+|||++
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI---SATNAVKVMDFGIA 158 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTSCEEECCCTTC
T ss_pred CceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc---Cccccceeehhhhh
Confidence 3688999999 7899988875 5689999999999999999999999999999999999999 48999999999998
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM 233 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (465)
.......... ......+||+.|||||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+.....
T Consensus 159 ~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~ 231 (277)
T d1o6ya_ 159 RAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDP 231 (277)
T ss_dssp EECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred hhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCC
Confidence 7654322211 23456689999999999999999999999999999999999999998743 3344433333332
Q ss_pred cCcHHHHhccCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 012336 234 LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKP-DYSYLKRLFRDL 276 (465)
Q Consensus 234 ~~~~~~~~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~~ 276 (465)
. +.......+|+++.++|.+||..||.+|| +++++.+.|..+
T Consensus 232 ~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 I-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp C-CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C-CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 2 23334467899999999999999999999 888887776654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-50 Score=391.23 Aligned_cols=258 Identities=18% Similarity=0.268 Sum_probs=211.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
+-.++|++.+.||+|+||+||+|++..+++.||||+++.+.. ..++.+|+.++..++|+++|..++.|. ++...+++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-eCCeeEEEe
Confidence 345789999999999999999999999999999999876543 356899999999999888777777664 556678899
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||+ +|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCC
Confidence 998 88999998753 4679999999999999999999999999999999999999 588999999999998765432
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||... ....+.+..+... ...+ .
T Consensus 170 ~------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~~~~i~~~-~~~~---~ 237 (287)
T d1opja_ 170 Y------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKD-YRME---R 237 (287)
T ss_dssp S------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHHHHHHHTT-CCCC---C
T ss_pred c------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHHHHHHhcC-CCCC---C
Confidence 2 1223456899999999999999999999999999999999976665432 2233333333332 2222 1
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
...+|+++.+|+..||+.||++||++.+|.+.|+.++
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2467999999999999999999999999999887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=383.83 Aligned_cols=257 Identities=21% Similarity=0.347 Sum_probs=209.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
|-.++|++++.||+|+||+||+|++ .+++.||||++.... ....+.+|+.++.+++|+++|..++++ .++ ..++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~-~~~-~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE-PIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS-SCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeee-ccC-CeEEEE
Confidence 4567999999999999999999996 467899999987543 334689999999999998888877654 333 457899
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||+ +|+|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence 988 89999877532 3469999999999999999999999999999999999999 589999999999998765422
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......||+.|||||++.+..++.++|||||||++|||+||..| |... ...+.+..+........
T Consensus 164 ~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~---~~~~~~~~i~~~~~~~~--- 231 (272)
T d1qpca_ 164 Y------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVR--- 231 (272)
T ss_dssp E------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCCCC---
T ss_pred c------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcCCCCC---
Confidence 1 223456799999999999998999999999999999999996554 5442 33344444443322211
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
...+|+++.+|+..||+.||++|||+++|.+.|+++|..
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 146799999999999999999999999999999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=391.58 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=211.3
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecC-----CCCccHHHHHHHHHH-HcCCCCCceeEEEeEeCcEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVK-----TKHPQLHYESKLYML-LQGGTGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~-----~~~~~~~~E~~il~~-l~~~~~i~~l~~~~~~~~~~~l 80 (465)
++|++++.||+|+||+||+|++..+++.||||++... .....+..|..++.. +.|++ |..+..+..++...||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~-Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF-LTHMFCTFQTKENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTT-BCCEEEEEECSSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCc-EEEEEEEEccCCceeE
Confidence 5799999999999999999999999999999998743 233456777777765 55555 5555555667778999
Q ss_pred EEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 81 VIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 81 v~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
||||+ +++|.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 vmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhcccc
Confidence 99998 8899999975 5679999999999999999999999999999999999999 58899999999999865432
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEV 239 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (465)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+. ...+.+..+.......+
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~p--- 223 (320)
T d1xjda_ 157 D-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMDNPFYP--- 223 (320)
T ss_dssp T-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCCCC---
T ss_pred c-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCCCC---
Confidence 2 1234568999999999999999999999999999999999999999874 34455555554443333
Q ss_pred HhccCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCccccccccC
Q 012336 240 LCKSYPSEFTSYFHYCRSLRFEDKPDYS-YLKRLFRDLFIREGYQFDYVFDWTILK 294 (465)
Q Consensus 240 ~~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~~~~~~~~~~~~~~dw~~~~ 294 (465)
..+|+++.+||.+||..||++||++. +|++ ++|...++|..+.
T Consensus 224 --~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~----------hpff~~~~~~~l~ 267 (320)
T d1xjda_ 224 --RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ----------HPLFREINWEELE 267 (320)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG----------SGGGTTCCHHHHH
T ss_pred --ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh----------CchhccCCHHHHH
Confidence 46799999999999999999999964 4422 5666667887654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-49 Score=398.93 Aligned_cols=251 Identities=21% Similarity=0.217 Sum_probs=208.7
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC--CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK--HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~--~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.+++.|+|+++|..+.+| .++...|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-ECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEEE
Confidence 4679999999999999999999999999999999876532 23577899999999887776666555 56678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|+ |++|.+++.....+|++.+++.|+.||+.||+|||++||+||||||+|||+.. ..++.+||+|||+|+.+....
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTS--
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCC--
Confidence 99 89999888755667999999999999999999999999999999999999941 256899999999998765432
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......||+.|||||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+.......+ .....
T Consensus 184 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~~ 253 (352)
T d1koba_ 184 ------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFD-EDAFS 253 (352)
T ss_dssp ------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCC-SSTTT
T ss_pred ------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-ccccc
Confidence 1235679999999999999999999999999999999999999998743 3444555544443332 22335
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.+++++.+||..||..||.+||++.+++
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 7899999999999999999999977663
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-49 Score=387.84 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=203.4
Q ss_pred ceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 8 KFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 8 ~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
.|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.++|+++|..+.++ .+....+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-LREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-EECCEEEEEE
Confidence 599999999999999999999999999999998765432 3578899999999987777766655 5667889999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
||+ +++|..++. ..+.+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~-~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp ECCSEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---
T ss_pred EecCCCchHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE---CCCCCEEEeecccccccCC---
Confidence 999 555554444 46789999999999999999999999999999999999999 5889999999999976432
Q ss_pred cccccccCCCCccccccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLG---VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.. ..+.+..+.........
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~~- 235 (309)
T d1u5ra_ 168 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPALQ- 235 (309)
T ss_dssp --------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCCS-
T ss_pred --------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCC-
Confidence 235679999999999864 358999999999999999999999998743 34444444444333221
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG 281 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~ 281 (465)
...+|+++.+||..||..||++|||+++| |++.|....
T Consensus 236 --~~~~s~~~~~li~~~L~~dP~~Rpt~~el---l~Hp~~~~~ 273 (309)
T d1u5ra_ 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVL---LKHRFVLRE 273 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHH---TTCHHHHSC
T ss_pred --CCCCCHHHHHHHHHHCcCChhHCcCHHHH---HhCHHhcCC
Confidence 24579999999999999999999997665 556665543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=378.39 Aligned_cols=255 Identities=20% Similarity=0.273 Sum_probs=201.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
.++|++++.||+|+||+||+|++. +++.||||++.... ....+.+|++++..++|+|++..++.|.. ....++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEe
Confidence 579999999999999999999974 67889999987543 33568999999999998887777776654 4567888998
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++......+++..++.|+.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~-- 156 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY-- 156 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCc--
Confidence 8 999999988666789999999999999999999999999999999999999 6889999999999987654322
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......||+.|+|||++.+..++.++|||||||++|||+| |.+||... ...+.+..+........ + .
T Consensus 157 ----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~~-p---~ 225 (263)
T d1sm2a_ 157 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRLYK-P---R 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCCCC-C---T
T ss_pred ----eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCCCC-c---c
Confidence 12334679999999999999999999999999999999999 45666543 33444444444322221 1 3
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
.+|+++.+++..||+.||++||++++|.+.|+++..
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 558999999999999999999999999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=382.91 Aligned_cols=249 Identities=20% Similarity=0.329 Sum_probs=201.2
Q ss_pred eeEeeeCceEEEEEEEc--CCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEecc-
Q 012336 13 RKIGSGSFGELYLGVNV--QTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDLL- 85 (465)
Q Consensus 13 ~~LG~G~fG~Vyla~~~--~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (465)
++||+|+||+||+|.+. .+++.||||+++..... ..+.+|+.++.+++|+++|..++.|. . +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-S-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-c-CCEEEEEEcCC
Confidence 46999999999999864 35678999998754332 35889999999999988888877653 3 3467999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcccc
Q 012336 86 GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHI 165 (465)
Q Consensus 86 g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~ 165 (465)
+++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+.......
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEE--
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhcccccccc--
Confidence 8899999875 5679999999999999999999999999999999999999 588999999999998765432211
Q ss_pred cccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhccC
Q 012336 166 PYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKSY 244 (465)
Q Consensus 166 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (465)
.......||+.|||||++.+..++.++|||||||++|||++ |..||.+... .+....+...... +. ...+
T Consensus 165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~-~~---p~~~ 235 (277)
T d1xbba_ 165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM-GC---PAGC 235 (277)
T ss_dssp --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC-CC---CTTC
T ss_pred --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC-CC---Cccc
Confidence 22345679999999999999999999999999999999998 9999988543 3444444433222 11 1467
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 245 PSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
|+++.+||..||+.||++||++.+|.+.|++.|.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999999999998874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-48 Score=376.90 Aligned_cols=249 Identities=17% Similarity=0.197 Sum_probs=207.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-----------ccHHHHHHHHHHHcCCCCCceeEEEeE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-----------PQLHYESKLYMLLQGGTGVPHLKWFGV 73 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-----------~~~~~E~~il~~l~~~~~i~~l~~~~~ 73 (465)
|.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+.++..+..|++|..+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 578999999999999999999999999999999998765322 247889999999985555555555566
Q ss_pred eCcEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCC
Q 012336 74 EGEYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGL 152 (465)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGl 152 (465)
++...||||||+ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 788899999999 8899999975 5689999999999999999999999999999999999999 5899999999999
Q ss_pred ccccccccCcccccccCCCCccccccccccccccC------CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHH
Q 012336 153 AKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLG------VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYD 226 (465)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~------~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~ 226 (465)
++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|..||.+.+ ......
T Consensus 157 a~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~ 225 (277)
T d1phka_ 157 SCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLR 225 (277)
T ss_dssp CEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred eeEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHH
Confidence 98765422 2245679999999999863 346889999999999999999999998743 344444
Q ss_pred HHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 227 KISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
.+.......+.+ ....+|+++.+|+.+||+.||.+||++++|
T Consensus 226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 455444433322 224689999999999999999999997765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-49 Score=390.34 Aligned_cols=255 Identities=18% Similarity=0.270 Sum_probs=203.5
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCc-----EEEEEEeecC---CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGE-----EVAVKLESVK---TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~-----~vAvKi~~~~---~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|++++.||+|+||+||+|++..+++ .||||++... .....+.+|+.++..+.+|++|..+..+..+...
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4789999999999999999999876554 6999987643 2334688999999999544444455555556667
Q ss_pred EEEEEecc-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 012336 78 NVMVIDLL-GPSLEDLFNYCN----------------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNF 134 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~----------------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NI 134 (465)
.++||||+ +|+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 89999998 999999997432 2489999999999999999999999999999999999
Q ss_pred eeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCC
Q 012336 135 LMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPW 213 (465)
Q Consensus 135 Ll~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf 213 (465)
|+ +.++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||+||||++ |..||
T Consensus 196 ll---~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 196 LV---THGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp EE---ETTTEEEECCCGGGSCGGGCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred cc---ccCCeEEEeeccccccccCCCce-----eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence 99 58899999999999876543321 12235678999999999999999999999999999999998 89999
Q ss_pred CCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 012336 214 QGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFR 274 (465)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (465)
.+..... .+..+.......+.+ ..+|+++.+||..||+.||++|||+++|.+.|.
T Consensus 268 ~~~~~~~---~~~~~~~~~~~~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 268 PGIPVDA---NFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TTCCCSH---HHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHH---HHHHHHhcCCCCCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 8865432 233333333332222 356899999999999999999999999998875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=390.46 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=204.1
Q ss_pred cCCceEEEe-eEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHH-cCCCCCceeEEEeE---eCcEEE
Q 012336 5 IGGKFKLGR-KIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLL-QGGTGVPHLKWFGV---EGEYNV 79 (465)
Q Consensus 5 ~~~~y~l~~-~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l-~~~~~i~~l~~~~~---~~~~~~ 79 (465)
+-++|.++. .||+|+||+||+|++..+++.||||++.. ...+.+|+.++.++ +|+++|..+..|.. ...+.|
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 346798875 59999999999999999999999999863 45688899998776 46666665555543 246789
Q ss_pred EEEecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 80 MVIDLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
|||||| ||+|.+++... ...|++.++..|+.||+.||+|||++||+||||||+|||+...+..+.+||+|||+++...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999 78999999754 3579999999999999999999999999999999999999644456789999999998765
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHH-HHHhhhhccCc
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-DKISEKKMLTP 236 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 236 (465)
... ......||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.........+ ..+.......+
T Consensus 166 ~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 166 SHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred CCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 432 234568999999999999999999999999999999999999999875443322221 12222222222
Q ss_pred HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 237 IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 237 ~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
.. ....+++++.+||..||..||++||++.++ |.+.|..
T Consensus 238 ~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hp~~~ 276 (335)
T d2ozaa1 238 NP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 276 (335)
T ss_dssp TT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSHHHH
T ss_pred Cc-ccccCCHHHHHHHHHHccCChhHCcCHHHH---HcCHHhh
Confidence 22 224679999999999999999999996655 5566554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=379.60 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=202.6
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCC---cEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTG---EEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~---~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
|-.++|++++.||+|+||+||+|++..++ ..||||++...... ..+.+|+.+++.++|+++|..++++. ...
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCe
Confidence 34579999999999999999999986553 46888887643322 35889999999999988888877663 346
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++|||++ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 78999998 899999887667789999999999999999999999999999999999999 58899999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+..... .+..+.......
T Consensus 159 ~~~~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~~~~ 229 (273)
T d1mp8a_ 159 EDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGERLP 229 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTCCCC
T ss_pred cCCcc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCCCCC
Confidence 44222 22345678999999999999999999999999999999998 899998865543 333334333221
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
....+|+++.+||..||..||++||++.+|.+.|+.+..++
T Consensus 230 ----~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 230 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 12467999999999999999999999999999999887653
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=385.46 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=215.2
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC-ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH-PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~-~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
+-++|++++.||+|+||+||+|++..+++.||||+++.+... ..+.+|++++..++|+++|..+.+| .+....|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF-ESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-EETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEE-EECCEEEEEEe
Confidence 567899999999999999999999999999999998765432 3577999999999987766666555 56678899999
Q ss_pred cc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 84 LL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 84 ~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
|+ |++|.+++...+..+++.++..|+.||+.||+|||++||+||||||+|||+.. +....+||+|||+++......
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~-- 158 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGD-- 158 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTC--
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCC--
Confidence 99 78999999765557999999999999999999999999999999999999942 245689999999998764321
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+. ...+.+..+.......+.. ...
T Consensus 159 ------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~-~~~ 228 (321)
T d1tkia_ 159 ------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFDEE-AFK 228 (321)
T ss_dssp ------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCCHH-HHT
T ss_pred ------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCChh-hcc
Confidence 123457899999999999999999999999999999999999999874 4455566666555544433 345
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
.+++++.+||..||..||++||++.++ |++.|..+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~ei---l~hp~~~~ 263 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLKQ 263 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHH---hcCHhhcc
Confidence 789999999999999999999996665 56666544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=374.84 Aligned_cols=262 Identities=15% Similarity=0.195 Sum_probs=202.3
Q ss_pred CccCCceEEEeeEeeeCceEEEEEEEcCCC----cEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 3 HVIGGKFKLGRKIGSGSFGELYLGVNVQTG----EEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 3 ~i~~~~y~l~~~LG~G~fG~Vyla~~~~~~----~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+|-...|++.+.||+|+||+||+|.+..++ ..||||++...... ..+.+|+.++..++|+|+|..++++. +.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-KY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-cC
Confidence 456788999999999999999999976654 47999998654322 35789999999999888777776664 44
Q ss_pred cEEEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcc
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAK 154 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~ 154 (465)
...+++||++ +++|.+++......+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 158 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhh
Confidence 5567888887 888888887767789999999999999999999999999999999999999 589999999999998
Q ss_pred ccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 155 KYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
......... .......||+.|||||++.+..++.++|||||||++|||++|..||... ....+.+..+......
T Consensus 159 ~~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~--~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 159 VLEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRL 232 (283)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT--CCHHHHHHHHHTTCCC
T ss_pred cccCCCccc----eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc--CCHHHHHHHHhccCCC
Confidence 765432211 1223456899999999999999999999999999999999965554432 2234444444443322
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
+. ...+|+++.++|..||+.||++||++.+|.+.|+.+..
T Consensus 233 -~~---~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 -PT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -CC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CC---chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 21 14579999999999999999999999999999988764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=378.82 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=200.8
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEE-EeEe
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKW-FGVE 74 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~-~~~~ 74 (465)
+-.++|++++.||+|+||.||+|++.. +++.||||+++.... ...+..|..++.++.||++|..+.. +...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 345789999999999999999999754 346899999875432 2357788888988887766655544 4455
Q ss_pred CcEEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
+...+++|||+ +++|.+++... ...+++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 66789999999 89999998743 2348999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG-SLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG-~~Pf~~~~ 217 (465)
+.++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||++| ..||.+..
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp -CGGGCEEECC------CCSCTTS-----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCcEEEccCcchhhccccccc-----cccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 58899999999999876543221 233466899999999999999999999999999999999986 56787654
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
... .....+... ..... ...+|+++.++|.+||+.||++|||+.+|.+.|++++..
T Consensus 242 ~~~--~~~~~~~~~-~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDE--EFCRRLKEG-TRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSH--HHHHHHHHT-CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH--HHHHHHhcC-CCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 322 222222222 22221 145689999999999999999999999999999988653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=371.99 Aligned_cols=252 Identities=17% Similarity=0.292 Sum_probs=211.6
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC-CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT-KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~-~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
.++|+++++||+|+||+||+|++ .+++.||||+++... ....+.+|+.++..++|++++..+++|. +....++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-CSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceEEEEEc
Confidence 47899999999999999999997 578899999988654 3457999999999999988887777665 44567899999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++......+++..+..|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~-- 155 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY-- 155 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSC--
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCc--
Confidence 8 789999987667789999999999999999999999999999999999999 5889999999999986644322
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCK 242 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (465)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+........ + .
T Consensus 156 ----~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~~-p---~ 224 (258)
T d1k2pa_ 156 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRLYR-P---H 224 (258)
T ss_dssp ----CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCCCC-C---T
T ss_pred ----eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCCCC-c---c
Confidence 22334679999999999999999999999999999999998 8999988543 444444444332222 1 4
Q ss_pred cCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 012336 243 SYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRD 275 (465)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (465)
.+|+++.+||.+||+.||++||++++|.+.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 568999999999999999999999999887754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=373.24 Aligned_cols=240 Identities=23% Similarity=0.351 Sum_probs=196.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--------CCccHHHHHHHHHHHcC-CCCCceeEEEeEeC
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--------KHPQLHYESKLYMLLQG-GTGVPHLKWFGVEG 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--------~~~~~~~E~~il~~l~~-~~~i~~l~~~~~~~ 75 (465)
+.++|++.+.||+|+||+||+|++..+++.||||++.... ...++.+|+.+++.+.+ |++|..+..++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 5789999999999999999999999999999999887532 12357899999999984 44555555566677
Q ss_pred cEEEEEEecc-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCc
Q 012336 76 EYNVMVIDLL-G-PSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLA 153 (465)
Q Consensus 76 ~~~~lv~e~~-g-~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla 153 (465)
+..++||+++ + +++.+++.. ...+++.++..++.||+.||+|||++||+||||||+|||+. .+++.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 7888999988 3 577777765 56899999999999999999999999999999999999994 24579999999999
Q ss_pred cccccccCcccccccCCCCccccccccccccccCCCC-CCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh
Q 012336 154 KKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK 232 (465)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (465)
+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||.+. + .+....
T Consensus 159 ~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~---~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------E---EIIRGQ 220 (273)
T ss_dssp EECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------H---HHHHCC
T ss_pred eecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------h---HHhhcc
Confidence 865432 2245689999999999987665 67899999999999999999999752 1 122222
Q ss_pred ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
... ...+|+++.+||.+||..||++|||++++.
T Consensus 221 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 VFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp CCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCC-----CCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 222 256899999999999999999999977764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=379.37 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=202.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCc----EEEEEEeecCC---CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGE----EVAVKLESVKT---KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~----~vAvKi~~~~~---~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (465)
.+|++++.||+|+||+||+|++..+|+ .||||.+.... ....+.+|+.++..++|+++|..++.|. ++..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCeeE
Confidence 579999999999999999999988876 57888765432 2346899999999999988877777654 555666
Q ss_pred EEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccc
Q 012336 80 MVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDL 159 (465)
Q Consensus 80 lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~ 159 (465)
+++++++++|.+.+......+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecccc
Confidence 666677999999988777889999999999999999999999999999999999999 58899999999999876543
Q ss_pred cCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHH
Q 012336 160 QTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIE 238 (465)
Q Consensus 160 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (465)
... .......||+.|+|||++.+..++.++|||||||+||||+| |..||.+........ .+..... .+.+
T Consensus 165 ~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~---~i~~~~~-~~~p 235 (317)
T d1xkka_ 165 EKE-----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILEKGER-LPQP 235 (317)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH---HHHHTCC-CCCC
T ss_pred ccc-----ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcCCC-CCCC
Confidence 221 12234568999999999999999999999999999999998 899998865543332 2333222 1211
Q ss_pred HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 012336 239 VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLF 277 (465)
Q Consensus 239 ~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~ 277 (465)
..+|+++.+++.+||..||++||++.+|.+.|..+.
T Consensus 236 ---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 236 ---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 356899999999999999999999999998887654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=372.32 Aligned_cols=256 Identities=23% Similarity=0.275 Sum_probs=200.0
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCC-C--cEEEEEEeecCCC-----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQT-G--EEVAVKLESVKTK-----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~-~--~~vAvKi~~~~~~-----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|++++.||+|+||+||+|++... + ..||||++..... ...+.+|+.++..++|++++..+++|. +. .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~-~~-~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TP-P 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-ec-c
Confidence 56799999999999999999986533 2 3789998765321 236889999999999988888877774 33 4
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.++||+++ +++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll---~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL---ATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---EETTEEEECCCTTCEEC
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc---ccccceeeccchhhhhc
Confidence 56788887 899998887666789999999999999999999999999999999999999 57899999999999976
Q ss_pred ccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
....... .......|+..|+|||.+.+..++.++|||||||++|||+| |..||.+.+ ..+.+..+.......
T Consensus 162 ~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~ 234 (273)
T d1u46a_ 162 PQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERL 234 (273)
T ss_dssp CC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCC
T ss_pred ccCCCcc----eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCCC
Confidence 5443322 22345568899999999999999999999999999999998 899998754 344455554444333
Q ss_pred cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 236 PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 236 ~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+. ...+|+++.+||..||..||++|||+.+|.+.|++.
T Consensus 235 ~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 PR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 32 246799999999999999999999999999888764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=369.70 Aligned_cols=252 Identities=20% Similarity=0.263 Sum_probs=199.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCC-CcEEEEEEeecCC----CCccHHHHHHHHHHH---cCCCCCceeEEEeE---
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQT-GEEVAVKLESVKT----KHPQLHYESKLYMLL---QGGTGVPHLKWFGV--- 73 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~-~~~vAvKi~~~~~----~~~~~~~E~~il~~l---~~~~~i~~l~~~~~--- 73 (465)
..++|++++.||+|+||+||+|++..+ ++.||||++.... ....+.+|+.+++.| +|++++..+..|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 468999999999999999999999765 6779999986532 234577899988877 47777777766643
Q ss_pred -eCcEEEEEEeccCCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecC
Q 012336 74 -EGEYNVMVIDLLGPSLEDLFN-YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYG 151 (465)
Q Consensus 74 -~~~~~~lv~e~~g~sL~~ll~-~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFG 151 (465)
.....+++|+++.+.+..+.. .....+++..+..++.|++.||+|||++||+||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 235788999999666555444 345679999999999999999999999999999999999999 588999999999
Q ss_pred CccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh
Q 012336 152 LAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK 231 (465)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (465)
+++...... ......||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+. .+.+..+...
T Consensus 162 ~~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~ 230 (305)
T d1blxa_ 162 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDV 230 (305)
T ss_dssp SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHH
T ss_pred hhhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHh
Confidence 997654322 23466899999999999999999999999999999999999999987543 2333322221
Q ss_pred h----------------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 232 K----------------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 232 ~----------------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. ...+.+.+...+++++.+||.+||..||++|||+.++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 1 01112223356789999999999999999999976653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=368.47 Aligned_cols=252 Identities=19% Similarity=0.280 Sum_probs=204.4
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
--++|++++.||+|+||.||+|++ .|..||||+++.+.....+.+|++++++++|++++..++.+.......++||||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356899999999999999999997 578999999987777778999999999999988888887776655667899999
Q ss_pred c-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 85 L-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 85 ~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+ +++|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCC---
Confidence 8 99999998643 2459999999999999999999999999999999999999 58999999999999865432
Q ss_pred ccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCCCCchHHHHHHHhhhhccCcHHHHh
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLC 241 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (465)
.....+|+.|+|||++.+..++.++|||||||++|||+| |++||...... +.+..+...... + ..
T Consensus 157 -------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~~~~~-~---~~ 222 (262)
T d1byga_ 157 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEKGYKM-D---AP 222 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTTTCCC-C---CC
T ss_pred -------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC-C---CC
Confidence 234568999999999999999999999999999999998 79999875443 344444433222 1 12
Q ss_pred ccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 242 KSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
..+|+++.+||.+||..||.+||++.+|.+.|+++-.
T Consensus 223 ~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 4568999999999999999999999999999987643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=367.18 Aligned_cols=250 Identities=21% Similarity=0.237 Sum_probs=200.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++++.||+|+||+||+|++..+++.||||++.... ...++.+|+++++.++|+++|..+..| .++...++||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-EETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-ccccceeEEE
Confidence 58999999999999999999999999999999986543 245688999999999887766665554 5677889999
Q ss_pred eccCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLLGPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
|++++++.+++... ...+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCS-
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCc-
Confidence 99988877776543 4679999999999999999999999999999999999999 588999999999998764322
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh--------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK-------- 232 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------- 232 (465)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+.. ..+..+....
T Consensus 157 ------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 157 ------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp ------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTS
T ss_pred ------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhc
Confidence 2234568999999999987766 588999999999999999999999875432 2222221110
Q ss_pred ----------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ----------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ----------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...........+++++.+|+.+||..||++|||+++|.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01111223346788999999999999999999977764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=370.57 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=200.0
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
|-.++|++++.||+|+||+||+|++.. ++.||||+++.... ...+.+|+.++.+++|+++|..++.+ .++ ..++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~~-~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEE-PIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS-SCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEE-ecC-CeEEEE
Confidence 345789999999999999999999754 46799999875543 34699999999999999888887766 333 357888
Q ss_pred ecc-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccccc
Q 012336 83 DLL-GPSLEDLFNYC-NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQ 160 (465)
Q Consensus 83 e~~-g~sL~~ll~~~-~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~ 160 (465)
||+ +|+|..++... ...+++.+++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence 888 88898887643 4579999999999999999999999999999999999999 588999999999998764332
Q ss_pred CcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHH
Q 012336 161 THKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVL 240 (465)
Q Consensus 161 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (465)
. .......||+.|+|||++.+..++.++|||||||++|||++|..||... ....+.+..+..... .+.
T Consensus 168 ~------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~-~~~--- 235 (285)
T d1fmka3 168 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYR-MPC--- 235 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCC-CCC---
T ss_pred c------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCC-CCC---
Confidence 1 1233467999999999999999999999999999999999965554432 233444444443322 221
Q ss_pred hccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
...+|+++.+||.+||+.||++||++++|.+.|++.
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~ 271 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhh
Confidence 246799999999999999999999999999888754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=375.77 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=201.9
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC----cE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG----EY 77 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~----~~ 77 (465)
++.+|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+.+|+.++|++++..+..+..+. ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 458999999999999999999999999999999998754322 35788999999999988887777765432 45
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
+||+|++++++|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence 788889899999999974 579999999999999999999999999999999999999 588999999999998765
Q ss_pred cccCcccccccCCCCcccccccccccccc-CCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhh------
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHL-GVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISE------ 230 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~-~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~------ 230 (465)
...... ......+||+.|+|||++. +..++.++||||+||++|+|++|..||.+...............
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 161 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 433211 2235578999999999984 45679999999999999999999999987543222111111100
Q ss_pred -----------------hhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 231 -----------------KKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 231 -----------------~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.....+.......+++++.+|+..||..||.+||++.++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0011122334456788999999999999999999977664
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=369.87 Aligned_cols=255 Identities=19% Similarity=0.304 Sum_probs=207.9
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
.++|++++.||+|+||+||+|++.. +++.||||+++..... .++.+|+.++..++|++++..+..+. ....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-VGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-cCCc
Confidence 4689999999999999999999753 5679999998754432 35899999999999988888777765 4556
Q ss_pred EEEEEecc-CCCHHHHHHHc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 012336 78 NVMVIDLL-GPSLEDLFNYC-----------------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDN 133 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~-----------------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~N 133 (465)
.+++|+++ +++|.+++... ...+++..++.|+.|++.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 77888887 89999998642 1248999999999999999999999999999999999
Q ss_pred eeeccCCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCC-CC
Q 012336 134 FLMGLGRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS-LP 212 (465)
Q Consensus 134 ILl~~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~-~P 212 (465)
||+ |.++.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||++|. .|
T Consensus 171 ILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999 68899999999999866443221 2234567999999999999999999999999999999999985 67
Q ss_pred CCCCCCCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 213 WQGLKAGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
|.+.. ..+.+..+........ ...+|+++.+|+..||+.+|.+|||+.+|.+.|+.+
T Consensus 243 ~~~~~---~~e~~~~v~~~~~~~~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 243 YYGMA---HEEVIYYVRDGNILAC----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTSC---HHHHHHHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCC---HHHHHHHHHcCCCCCC----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 87743 3445555554443221 246799999999999999999999999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=369.83 Aligned_cols=246 Identities=19% Similarity=0.220 Sum_probs=195.2
Q ss_pred EEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-------CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEe
Q 012336 11 LGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-------HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVID 83 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-------~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (465)
.++.||+|+||+||+|++..+|+.||||+++.... ...+.+|+.++..++|+++|..+.++. ++...+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-HKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCceeehhh
Confidence 46899999999999999999999999999864321 245889999999999888777766664 5556889999
Q ss_pred ccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 84 LLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 84 ~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
|+.+.+...+...+..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~--- 154 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPN--- 154 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCC---
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCc---
Confidence 99666666655556789999999999999999999999999999999999999 588999999999998765432
Q ss_pred cccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhc---------
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKM--------- 233 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (465)
......+||+.|+|||++.+. .++.++|||||||++|||++|..||.+... .+.+..+.+...
T Consensus 155 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~---~~~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 155 ----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp ----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCTTTSSS
T ss_pred ----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH---HHHHHHHHHhcCCCChhhccc
Confidence 123456799999999998754 579999999999999999999999987543 233333322110
Q ss_pred --------------cCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 234 --------------LTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 234 --------------~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
..+.......+++++.+||..||..||++|||++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1122333456789999999999999999999977663
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=367.22 Aligned_cols=259 Identities=18% Similarity=0.309 Sum_probs=205.0
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCC-------cEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEe
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTG-------EEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVE 74 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~-------~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~ 74 (465)
-.++|++++.||+|+||.||+|+...++ ..||||+++.+... ..+..|...+.++.+|++|..+..++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4689999999999999999999976554 47999998765432 3577888999888544445555454456
Q ss_pred CcEEEEEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 75 GEYNVMVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
....++||||+ +|+|.+++... ...+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-- 168 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 168 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--
Confidence 66788999998 99999999643 2458999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
+.++.+||+|||+++........ .......||+.|+|||.+.+..|+.++|||||||++|||++ |.+||.+..
T Consensus 169 -~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 169 -TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp -CTTCCEEECSTTCCCCGGGCCTT-----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCCeEeccchhhccccccccc-----cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 58899999999999877653321 23456679999999999999999999999999999999998 799998744
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
. .+.+..+...... +. ...+|+++.+||.+||+.||.+||++.+|.+.|+.+..
T Consensus 243 ~---~~~~~~i~~~~~~-~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 V---EELFKLLKEGHRM-DK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp H---HHHHHHHHTTCCC-CC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HHHHHHHHcCCCC-CC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3 4444444433222 21 24679999999999999999999999999999988753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=368.79 Aligned_cols=271 Identities=17% Similarity=0.264 Sum_probs=215.7
Q ss_pred CceEEEeeEeeeCceEEEEEEEc---CCCcEEEEEEeecC------CCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNV---QTGEEVAVKLESVK------TKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEY 77 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~---~~~~~vAvKi~~~~------~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (465)
++|++++.||+|+||+||+|++. .+|+.||||+++.. .....+.+|++++.++.|+++|..+..+..+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999874 36899999987643 2345688999999999998888888888888889
Q ss_pred EEEEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 78 NVMVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 78 ~~lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++|+++ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 99999998 8999999875 5678999999999999999999999999999999999999 58899999999999876
Q ss_pred ccccCcccccccCCCCccccccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~--~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
..... .......|++.|+|||.+.+.. ++.++|||||||+||+|++|..||.+.........+.........
T Consensus 180 ~~~~~------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 180 VADET------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253 (322)
T ss_dssp CGGGG------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred ccccc------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC
Confidence 44322 1234567999999999997654 688999999999999999999999887665554444333222211
Q ss_pred CcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCccccccccCCCCC
Q 012336 235 TPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYS--YLKRLFRDLFIREGYQFDYVFDWTILKYPQT 298 (465)
Q Consensus 235 ~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~~~~~~~~~~~~~~dw~~~~~~~~ 298 (465)
. +...+++++.+||.+||..||++||++. .+.++|+ ++|+..++|..+...+.
T Consensus 254 ~----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~-------Hpff~~i~~~~l~~~~~ 308 (322)
T d1vzoa_ 254 P----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE-------HLFFQKINWDDLAAKKV 308 (322)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT-------SGGGTTCCHHHHHTTCS
T ss_pred C----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc-------CHhhcCCCHHHHHhCCC
Confidence 1 1145799999999999999999999531 1333344 45555677776554333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=371.53 Aligned_cols=249 Identities=18% Similarity=0.286 Sum_probs=198.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeC-----
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEG----- 75 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (465)
+.++|+++++||+|+||+||+|++..+|+.||||+++..... ..+.+|+++|+.++|+++|..+..|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 689999999999999999999999999999999998754332 35788999999999988888877776543
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...|+|||+++.+|..++. ...|++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 96 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHH--hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 2579999999999998887 4679999999999999999999999999999999999999 6899999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. ..+..+......
T Consensus 171 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~---~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 171 ADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTGT 237 (346)
T ss_dssp CCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCC
T ss_pred cCCc----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH---HHHHHHHhccCC
Confidence 6432 2356799999999998875 4689999999999999999999999875432 222222211111
Q ss_pred C--------------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 012336 235 T--------------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKR 271 (465)
Q Consensus 235 ~--------------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (465)
. ........+++++.+||..||..||.+|||+.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1 111222456889999999999999999999776643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=363.50 Aligned_cols=263 Identities=21% Similarity=0.244 Sum_probs=201.6
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC----CCccHHHHHHHHHHHcCCCCCceeEEEeEe-------C
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT----KHPQLHYESKLYMLLQGGTGVPHLKWFGVE-------G 75 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~----~~~~~~~E~~il~~l~~~~~i~~l~~~~~~-------~ 75 (465)
++|+++++||+|+||+||+|++..+|+.||||++..+. ...++.+|+++++.++|++++..+..+... .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 79999999999999999999999999999999976542 234588999999999999888888776442 3
Q ss_pred cEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccc
Q 012336 76 EYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKK 155 (465)
Q Consensus 76 ~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~ 155 (465)
...+++|+++.+.+...+......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence 4678999999888887776656789999999999999999999999999999999999999 5899999999999987
Q ss_pred cccccCcccccccCCCCccccccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhcc
Q 012336 156 YRDLQTHKHIPYRENKNLTGTARYASVNTHLGV-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKML 234 (465)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (465)
+....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.........
T Consensus 167 ~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 65433211 1234456899999999998865 6899999999999999999999999875433332222222111000
Q ss_pred C----------------------cH-H-HHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 235 T----------------------PI-E-VLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 235 ~----------------------~~-~-~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
. .. + ......++++.+||.+||..||++|||++++ |++.|.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el---L~Hpff 308 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA---LNHDFF 308 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH---HcChhh
Confidence 0 00 0 0001236788999999999999999996654 555543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-46 Score=364.79 Aligned_cols=256 Identities=18% Similarity=0.252 Sum_probs=205.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcE--EEEEEeecC---CCCccHHHHHHHHHHHc-CCCCCceeEEEeEeCcEEE
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEE--VAVKLESVK---TKHPQLHYESKLYMLLQ-GGTGVPHLKWFGVEGEYNV 79 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~--vAvKi~~~~---~~~~~~~~E~~il~~l~-~~~~i~~l~~~~~~~~~~~ 79 (465)
-++|++.+.||+|+||+||+|++..++.. ||||.+... .....+.+|++++..+. |+++|..++ +..++...+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~-~~~~~~~~~ 87 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG-ACEHRGYLY 87 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEE-EEEETTEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEE-EEecCCeeE
Confidence 36899999999999999999999888874 667766532 23446899999999995 555555555 556777889
Q ss_pred EEEecc-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCC
Q 012336 80 MVIDLL-GPSLEDLFNYC---------------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSN 143 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~---------------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~ 143 (465)
+||+|+ +|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+ +.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCC
Confidence 999998 89999998632 3579999999999999999999999999999999999999 5889
Q ss_pred cEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCC-CCCCCCCCCchH
Q 012336 144 QVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKK 222 (465)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~-~Pf~~~~~~~~~ 222 (465)
.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. +||.+. ...
T Consensus 165 ~~kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~ 233 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCA 233 (309)
T ss_dssp CEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHH
T ss_pred ceEEccccccccccccc--------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHH
Confidence 99999999997654322 223557999999999999999999999999999999999965 577764 344
Q ss_pred HHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 012336 223 QKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIRE 280 (465)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~ 280 (465)
+.+..+........ ...+|+++.+||.+||+.||++||++.+|.+.|+.++...
T Consensus 234 ~~~~~i~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 234 ELYEKLPQGYRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHHHGGGTCCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHHHhcCCCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 55555544322211 1456899999999999999999999999999999886533
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.4e-46 Score=361.60 Aligned_cols=252 Identities=22% Similarity=0.289 Sum_probs=196.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC----CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK----HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~----~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|+++++||+|+||+||+|++. +++.||||++..... ..++.+|+.+++.++|+++|..+..| ......+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-ECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-ccCCceeEEE
Confidence 58999999999999999999974 889999999875432 34688999999999987777665555 5556778999
Q ss_pred eccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCc
Q 012336 83 DLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTH 162 (465)
Q Consensus 83 e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~ 162 (465)
+++++.+...+....+.+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||++........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCcc-
Confidence 999888877777667889999999999999999999999999999999999999 5889999999999987644221
Q ss_pred ccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhh---------
Q 012336 163 KHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKK--------- 232 (465)
Q Consensus 163 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (465)
......|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+.+.......+.......
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 223457899999999987654 6899999999999999999999998754322222211111000
Q ss_pred ------------ccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 233 ------------MLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 233 ------------~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
...+.......+++++.+||.+||..||++|||+.+|.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00111222345788999999999999999999976663
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=363.65 Aligned_cols=261 Identities=18% Similarity=0.289 Sum_probs=209.6
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEc-----CCCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeCc
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNV-----QTGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEGE 76 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~-----~~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (465)
-.++|++.+.||+|+||.||+|++. .+++.||||+++..... ..+.+|+.++..+.+|++|..+..++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3589999999999999999999863 45679999998754332 357889999999965566666666666677
Q ss_pred EEEEEEecc-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeecc
Q 012336 77 YNVMVIDLL-GPSLEDLFNYCN-----------------RKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGL 138 (465)
Q Consensus 77 ~~~lv~e~~-g~sL~~ll~~~~-----------------~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~ 138 (465)
..+++|||+ +++|.+++.... ..+++..+..|+.||+.||+|||++++|||||||+|||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~-- 178 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-- 178 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc--
Confidence 789999999 899999986432 258999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCCC
Q 012336 139 GRKSNQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (465)
Q Consensus 139 ~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~ellt-G~~Pf~~~~ 217 (465)
+.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+..
T Consensus 179 -~~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 179 -THGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp -ETTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred -cccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 58899999999999876543221 23345789999999999999999999999999999999999 666666644
Q ss_pred CCchHHHHHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 012336 218 AGTKKQKYDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIR 279 (465)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~ 279 (465)
... .+..+.........+ ..+|+++.+||..||+.||++||++.+|.+.|+.....
T Consensus 253 ~~~---~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 253 VDS---KFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SSH---HHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 332 222233333322221 35689999999999999999999999999999877543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=361.82 Aligned_cols=256 Identities=17% Similarity=0.224 Sum_probs=205.8
Q ss_pred EEeeEeeeCceEEEEEEEcCCC---cEEEEEEeecCCC---CccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 11 LGRKIGSGSFGELYLGVNVQTG---EEVAVKLESVKTK---HPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 11 l~~~LG~G~fG~Vyla~~~~~~---~~vAvKi~~~~~~---~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
+.++||+|+||+||+|++..++ ..||||.++.... ...+.+|++++.+++|+++|..++.+.......++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 3678999999999999986653 3699998864322 245899999999999988888888777667788999999
Q ss_pred c-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccCcc
Q 012336 85 L-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQTHK 163 (465)
Q Consensus 85 ~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~~~ 163 (465)
+ +++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||+++.........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc
Confidence 9 899999988656678899999999999999999999999999999999999 688999999999998765433221
Q ss_pred cccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcHHHHhcc
Q 012336 164 HIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPIEVLCKS 243 (465)
Q Consensus 164 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (465)
........||+.|+|||.+.+..++.++||||||+++|||++|..||.... ...+....+........ ...
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~~~~~----p~~ 258 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLLQ----PEY 258 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCCCC----CTT
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCCCCCC----ccc
Confidence 123345679999999999999999999999999999999999877776532 12222333333322211 145
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 012336 244 YPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFI 278 (465)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~ 278 (465)
+|+++.+||..||..||++||++.+|.+.|+.++.
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 68999999999999999999999999999998864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=363.26 Aligned_cols=249 Identities=21% Similarity=0.231 Sum_probs=197.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE-----eCcEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV-----EGEYNVMV 81 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~~~~~lv 81 (465)
-+|+.+++||+|+||+||+|++..+++.||||++..+. ....+|+++++.++|++++..+.+|.. +..+.+||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 37999999999999999999999999999999987543 344579999999999888888877643 33467899
Q ss_pred EeccCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccccc
Q 012336 82 IDLLGPSLEDLFN---YCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRD 158 (465)
Q Consensus 82 ~e~~g~sL~~ll~---~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~ 158 (465)
|||+++++.+.+. .....+++.++..|+.||+.||+|||++||+||||||+|||+. .++..+||+|||+++....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccC
Confidence 9999887766553 2356799999999999999999999999999999999999994 2335899999999987644
Q ss_pred ccCcccccccCCCCccccccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCc-
Q 012336 159 LQTHKHIPYRENKNLTGTARYASVNTHLG-VEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTP- 236 (465)
Q Consensus 159 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (465)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..+........
T Consensus 176 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~~ 244 (350)
T d1q5ka_ 176 GE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTR 244 (350)
T ss_dssp TS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred Cc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCChH
Confidence 22 2245689999999998875 4689999999999999999999999987543 222222221100000
Q ss_pred -----------------------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 237 -----------------------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 237 -----------------------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.......+++++.+|+.+||..||++|||+.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 245 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111234688999999999999999999977653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=361.36 Aligned_cols=268 Identities=21% Similarity=0.239 Sum_probs=204.5
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHH--HHHcCCCCCceeEEEeEeC---cEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLY--MLLQGGTGVPHLKWFGVEG---EYNV 79 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il--~~l~~~~~i~~l~~~~~~~---~~~~ 79 (465)
+..+|.+.+.||+|+||+||+|++ +|+.||||++..+.. ..+..|.+++ ..++|+|+|..+..+..++ ...+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 457899999999999999999986 789999999875432 3444555544 4677888888877776654 3678
Q ss_pred EEEecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCceeeccCCCCCcEEEEec
Q 012336 80 MVIDLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHS--------RGFLHRDIKPDNFLMGLGRKSNQVYIIDY 150 (465)
Q Consensus 80 lv~e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs--------~givHrDLKP~NILl~~~d~~~~vkL~DF 150 (465)
+||||+ +++|.+++.. ..+++..++.++.|++.||.|||+ +||+||||||+|||+ +.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEec
Confidence 999999 8899999984 579999999999999999999996 599999999999999 58899999999
Q ss_pred CCccccccccCcccccccCCCCccccccccccccccCCC------CCCcchHHHHHHHHHHHhcCCCCCCCCCCC-----
Q 012336 151 GLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAG----- 219 (465)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~k~DiwSLGviL~elltG~~Pf~~~~~~----- 219 (465)
|+++.......... .......||+.|+|||++.+.. ++.++|||||||+||||+||..||......
T Consensus 153 Gl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 99987754332111 1234568999999999987653 567899999999999999998887442211
Q ss_pred -------chHHHHHHHhhhhccCc--HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 012336 220 -------TKKQKYDKISEKKMLTP--IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQ 283 (465)
Q Consensus 220 -------~~~~~~~~i~~~~~~~~--~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~ 283 (465)
................. ........+.++.+++.+||..||++||++.+|.+.|+.+..+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 11222222222222211 11112223467999999999999999999999999999998887764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.6e-45 Score=361.77 Aligned_cols=260 Identities=18% Similarity=0.272 Sum_probs=200.1
Q ss_pred cCCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeE--eCcEEEEEE
Q 012336 5 IGGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGV--EGEYNVMVI 82 (465)
Q Consensus 5 ~~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~--~~~~~~lv~ 82 (465)
..++|+++++||+|+||+||+|++..+++.||||+++.. ...++.+|+++|+.+.+|++|..+..++. .....++||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 357899999999999999999999999999999998743 34578899999999985555555554443 345688999
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|..+ .+.+++..+..++.||+.||+|||++||+||||||+|||+. .+++.+||+|||+|+......
T Consensus 112 e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 112 EHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp ECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTC-
T ss_pred eecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCC-
Confidence 998 6677654 35799999999999999999999999999999999999995 345579999999998765432
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhh---------
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEK--------- 231 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (465)
......||+.|+|||.+.+.. ++.++|||||||++|||++|..||........ ....+...
T Consensus 185 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~--~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 185 -------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHH
T ss_pred -------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH--HHHHHHHHHCCchhhhh
Confidence 234567999999999988765 79999999999999999999999976543211 11111100
Q ss_pred ----hccC-------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCccc
Q 012336 232 ----KMLT-------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVF 288 (465)
Q Consensus 232 ----~~~~-------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~~~~~~~~~~~~~ 288 (465)
.... ........+++++.+||.+||..||.+|||++++++ ++|+..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~----------Hp~F~~v 325 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME----------HPYFYTV 325 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT----------SGGGTTS
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc----------CcccCCC
Confidence 0000 000111346789999999999999999999777643 5666666
Q ss_pred ccc
Q 012336 289 DWT 291 (465)
Q Consensus 289 dw~ 291 (465)
.|+
T Consensus 326 ~~~ 328 (328)
T d3bqca1 326 VKD 328 (328)
T ss_dssp CCC
T ss_pred CCC
Confidence 663
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=364.22 Aligned_cols=247 Identities=20% Similarity=0.267 Sum_probs=199.1
Q ss_pred CCceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeE-----eCc
Q 012336 6 GGKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGV-----EGE 76 (465)
Q Consensus 6 ~~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~~ 76 (465)
.++|++++.||+|+||+||+|++..+|+.||||++...... .++.+|+.+++.++|+++|..+..+.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 68999999999999999999999999999999998755332 357899999999999888887777653 334
Q ss_pred EEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCcccc
Q 012336 77 YNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKY 156 (465)
Q Consensus 77 ~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~ 156 (465)
.+++++++++++|.+++. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence 577888888999999986 5679999999999999999999999999999999999999 58899999999999765
Q ss_pred ccccCcccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC
Q 012336 157 RDLQTHKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT 235 (465)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (465)
... .....||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+. ......+.......
T Consensus 172 ~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~---~~~~~~i~~~~~~~ 238 (348)
T d2gfsa1 172 DDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTP 238 (348)
T ss_dssp TGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCC
T ss_pred Ccc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCC
Confidence 432 24567999999999987765 68999999999999999999999987543 22333332222111
Q ss_pred c--------------------------HHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 236 P--------------------------IEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 236 ~--------------------------~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
. .......+++++.+||..||..||.+|||+.++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 1 1122346789999999999999999999976653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=357.70 Aligned_cols=257 Identities=20% Similarity=0.298 Sum_probs=209.1
Q ss_pred ccCCceEEEeeEeeeCceEEEEEEEcC-----CCcEEEEEEeecCCCC---ccHHHHHHHHHHHcCCCCCceeEEEeEeC
Q 012336 4 VIGGKFKLGRKIGSGSFGELYLGVNVQ-----TGEEVAVKLESVKTKH---PQLHYESKLYMLLQGGTGVPHLKWFGVEG 75 (465)
Q Consensus 4 i~~~~y~l~~~LG~G~fG~Vyla~~~~-----~~~~vAvKi~~~~~~~---~~~~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (465)
+-.++|++++.||+|+||+||+|.+.. ++..||||+++..... ..+.+|+.++++++|++++..++.+.. .
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~ 95 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-G 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-S
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-C
Confidence 456899999999999999999998753 3578999998754332 247899999999999888887776654 4
Q ss_pred cEEEEEEecc-CCCHHHHHHHc---------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcE
Q 012336 76 EYNVMVIDLL-GPSLEDLFNYC---------NRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQV 145 (465)
Q Consensus 76 ~~~~lv~e~~-g~sL~~ll~~~---------~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~v 145 (465)
...++||+++ +|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++++
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 4668888888 99999988642 1347999999999999999999999999999999999999 689999
Q ss_pred EEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCCCCCchHHH
Q 012336 146 YIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQK 224 (465)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG-~~Pf~~~~~~~~~~~ 224 (465)
||+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++| ..||.+. ...+.
T Consensus 173 Kl~DFGla~~~~~~~~~-----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHH
T ss_pred EEeecccceeccCCcce-----eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHH
Confidence 99999999876543321 123345789999999999999999999999999999999997 5888774 34555
Q ss_pred HHHHhhhhccCcHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 012336 225 YDKISEKKMLTPIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDL 276 (465)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~~ 276 (465)
+..+......... ..+|+++.++|..||+.+|++||++.+|.+.|+..
T Consensus 245 ~~~i~~~~~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCCCCCCc----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5555544332221 45689999999999999999999999999887654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-44 Score=358.75 Aligned_cols=247 Identities=19% Similarity=0.207 Sum_probs=190.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeE-----eCcE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGV-----EGEY 77 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~-----~~~~ 77 (465)
++|+++++||+|+||+||+|++..+|+.||||++...... .++.+|+.++..++|++++..+.+|.. ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 7899999999999999999999999999999999865433 247899999999998888888877754 3468
Q ss_pred EEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccc
Q 012336 78 NVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYR 157 (465)
Q Consensus 78 ~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~ 157 (465)
.|+||||+.+++.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++++|||+++...
T Consensus 97 ~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAG 170 (355)
T ss_dssp EEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred eEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhccc
Confidence 89999999888777664 579999999999999999999999999999999999999 588999999999988654
Q ss_pred cccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccCcH
Q 012336 158 DLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPI 237 (465)
Q Consensus 158 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (465)
... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....... ..+.........
T Consensus 171 ~~~--------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~---~~i~~~~~~~~~ 239 (355)
T d2b1pa1 171 TSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW---NKVIEQLGTPCP 239 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCH
T ss_pred ccc--------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH---HHHHHhccCCCH
Confidence 422 234567999999999999999999999999999999999999999875432222 221111110000
Q ss_pred -------------------------------------HHHhccCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 012336 238 -------------------------------------EVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYLK 270 (465)
Q Consensus 238 -------------------------------------~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (465)
.......++++.+||.+||..||++|||+++|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 001122467899999999999999999977763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=344.62 Aligned_cols=249 Identities=18% Similarity=0.195 Sum_probs=196.4
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCC----ccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEE
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKH----PQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVI 82 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~----~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (465)
++|++++.||+|+||+||+|++..+++.||||+++..... .++.+|+.+++.++|++++..+.+| .+....++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-ECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-ccccceeEEe
Confidence 5899999999999999999999999999999998765432 3678999999999987776655544 5566777888
Q ss_pred ecc-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEEecCCccccccccC
Q 012336 83 DLL-GPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYIIDYGLAKKYRDLQT 161 (465)
Q Consensus 83 e~~-g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~DFGla~~~~~~~~ 161 (465)
+++ +++|..++ ...+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 81 EFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp ECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCS
T ss_pred eecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCc
Confidence 888 55555544 457889999999999999999999999999999999999999 5789999999999987654322
Q ss_pred cccccccCCCCccccccccccccccCCC-CCCcchHHHHHHHHHHHhcCCCCCCCCCCCchHHHHHHHhhhhccC-----
Q 012336 162 HKHIPYRENKNLTGTARYASVNTHLGVE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLT----- 235 (465)
Q Consensus 162 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~k~DiwSLGviL~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (465)
......+++.|+|||.+.+.. ++.++|||||||++|||++|..||.... ...+.+..+.......
T Consensus 157 -------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 157 -------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp -------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTC
T ss_pred -------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhh
Confidence 223456788999999988765 6899999999999999999999975432 2233333332211110
Q ss_pred -------------------cHHHHhccCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 012336 236 -------------------PIEVLCKSYPSEFTSYFHYCRSLRFEDKPDYSYL 269 (465)
Q Consensus 236 -------------------~~~~~~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (465)
........+++++.+|+.+||..||.+|||++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~ 280 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1112234567899999999999999999997765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-39 Score=326.21 Aligned_cols=259 Identities=23% Similarity=0.274 Sum_probs=185.0
Q ss_pred CCCccC-CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC-CccHHHHHHHHHHHcCC-----------CCCce
Q 012336 1 MDHVIG-GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK-HPQLHYESKLYMLLQGG-----------TGVPH 67 (465)
Q Consensus 1 ~~~i~~-~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~-~~~~~~E~~il~~l~~~-----------~~i~~ 67 (465)
++++|. +||+++++||+|+||+||+|++..+|+.||||+++.+.. ...+.+|+.+++.+.|. +++..
T Consensus 6 ~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~ 85 (362)
T d1q8ya_ 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 85 (362)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred CCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence 356665 679999999999999999999999999999999875532 24567899999988753 34444
Q ss_pred eEEEeE-eCcEEEEEEecc--CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceeeccCCCC
Q 012336 68 LKWFGV-EGEYNVMVIDLL--GPSLEDLFNY-CNRKFSLKTVLMLADQLINRVEYMHS-RGFLHRDIKPDNFLMGLGRKS 142 (465)
Q Consensus 68 l~~~~~-~~~~~~lv~e~~--g~sL~~ll~~-~~~~ls~~~~~~ia~qi~~gL~yLHs-~givHrDLKP~NILl~~~d~~ 142 (465)
+.++.. .....++++.++ +++....... ....+++..+..++.||+.||+|||+ .||+||||||+|||+..++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc
Confidence 444433 334455555544 4454444443 34679999999999999999999998 899999999999999532111
Q ss_pred ---CcEEEEecCCccccccccCcccccccCCCCccccccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCCCCC
Q 012336 143 ---NQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYASVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (465)
Q Consensus 143 ---~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~k~DiwSLGviL~elltG~~Pf~~~~~~ 219 (465)
..++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++++|++|+.||......
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cccceeeEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 25899999999765432 24567999999999999999999999999999999999999999764322
Q ss_pred chH---HHHHHHhhhhccCcHHH-------------------------------------HhccCcHHHHHHHHHHhcCC
Q 012336 220 TKK---QKYDKISEKKMLTPIEV-------------------------------------LCKSYPSEFTSYFHYCRSLR 259 (465)
Q Consensus 220 ~~~---~~~~~i~~~~~~~~~~~-------------------------------------~~~~~p~~l~~li~~cl~~d 259 (465)
... .............+... .....++++.+|+.+||..|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 110 11111100000000000 01234678999999999999
Q ss_pred CCCCCCHHHH
Q 012336 260 FEDKPDYSYL 269 (465)
Q Consensus 260 p~~RPt~~~l 269 (465)
|.+|||+.++
T Consensus 316 P~~Rpta~e~ 325 (362)
T d1q8ya_ 316 PRKRADAGGL 325 (362)
T ss_dssp TTTCBCHHHH
T ss_pred hhHCcCHHHH
Confidence 9999997665
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=1.6e-23 Score=190.37 Aligned_cols=163 Identities=18% Similarity=0.221 Sum_probs=113.0
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCC------------C--------ccHHHHHHHHHHHcCCCCCcee
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTK------------H--------PQLHYESKLYMLLQGGTGVPHL 68 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~------------~--------~~~~~E~~il~~l~~~~~i~~l 68 (465)
+.+.++||+|+||+||+|++ .+|+.||||++..... . .....|...+..+.|.+.+..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46899999999999999997 5789999998653110 0 1123567777777765543333
Q ss_pred EEEeEeCcEEEEEEeccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceeeccCCCCCcEEEE
Q 012336 69 KWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQLINRVEYMHSRGFLHRDIKPDNFLMGLGRKSNQVYII 148 (465)
Q Consensus 69 ~~~~~~~~~~~lv~e~~g~sL~~ll~~~~~~ls~~~~~~ia~qi~~gL~yLHs~givHrDLKP~NILl~~~d~~~~vkL~ 148 (465)
.... .+++|+++.+... ..++...+..++.||+.+|.|||++||+||||||+|||+. ++.++|+
T Consensus 81 ---~~~~--~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 81 ---AWEG--NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp ---EEET--TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred ---EecC--CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 2222 3689999965321 2356667788999999999999999999999999999993 4569999
Q ss_pred ecCCccccccccCcccccccCCCCcccccccccc--c---cccCCCCCCcchHHHHHHHH
Q 012336 149 DYGLAKKYRDLQTHKHIPYRENKNLTGTARYASV--N---THLGVEQSRRDDLESLGYVL 203 (465)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~Gt~~Y~AP--E---~~~~~~~s~k~DiwSLGviL 203 (465)
|||+|+....... ..|... + .+....|+.++|+||+..-+
T Consensus 145 DFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999976532111 111111 0 11234578899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.29 E-value=2.7e-06 Score=78.28 Aligned_cols=83 Identities=16% Similarity=0.251 Sum_probs=60.0
Q ss_pred CceEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCC--CCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 7 GKFKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKT--KHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 7 ~~y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~--~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
..|++++..+.++.+.||+.. ..++.++||+..... ....+..|...+..+...--+|.+..+...+...+++|++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 467777776555567999885 466778889876443 2346788999999887655567777777777888899998
Q ss_pred c-CCCHHH
Q 012336 85 L-GPSLED 91 (465)
Q Consensus 85 ~-g~sL~~ 91 (465)
+ |..+.+
T Consensus 92 l~G~~~~~ 99 (263)
T d1j7la_ 92 ADGVLCSE 99 (263)
T ss_dssp CSSEEHHH
T ss_pred cccccccc
Confidence 8 555543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.75 E-value=4.7e-05 Score=74.59 Aligned_cols=74 Identities=16% Similarity=0.198 Sum_probs=47.8
Q ss_pred EeeEeeeCceEEEEEEEcCCCcEEEEEEeec------C---CCCccHHHHHHHHHHHcCC--CCCceeEEEeEeCcEEEE
Q 012336 12 GRKIGSGSFGELYLGVNVQTGEEVAVKLESV------K---TKHPQLHYESKLYMLLQGG--TGVPHLKWFGVEGEYNVM 80 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~------~---~~~~~~~~E~~il~~l~~~--~~i~~l~~~~~~~~~~~l 80 (465)
.+.||.|..-.||++.+..+++.|+||.-.. + ....+...|...|..+... ..+|.+..+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5578999999999998767788999995321 1 1123466789888877643 345555444 4445678
Q ss_pred EEeccCC
Q 012336 81 VIDLLGP 87 (465)
Q Consensus 81 v~e~~g~ 87 (465)
+|+++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9998843
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=0.0001 Score=66.88 Aligned_cols=73 Identities=12% Similarity=0.019 Sum_probs=51.3
Q ss_pred eEeeeC-ceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCC-CceeEEEeEeCcEEEEEEecc-CCC
Q 012336 14 KIGSGS-FGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTG-VPHLKWFGVEGEYNVMVIDLL-GPS 88 (465)
Q Consensus 14 ~LG~G~-fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~-g~s 88 (465)
.+..|. -+.||+.. ...+..+++|+.... ....+..|...++.+..... +|.+..+..++...+++|+++ |.+
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 334444 36899987 456777889975543 34568889999998876544 566666667777888999988 443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0028 Score=59.63 Aligned_cols=66 Identities=12% Similarity=0.054 Sum_probs=43.3
Q ss_pred eEEEEEEEcCCCcEEEEEEeecC-CCCccHHHHHHHHHHHcCCCCC--cee----EEEeEeCcEEEEEEeccCC
Q 012336 21 GELYLGVNVQTGEEVAVKLESVK-TKHPQLHYESKLYMLLQGGTGV--PHL----KWFGVEGEYNVMVIDLLGP 87 (465)
Q Consensus 21 G~Vyla~~~~~~~~vAvKi~~~~-~~~~~~~~E~~il~~l~~~~~i--~~l----~~~~~~~~~~~lv~e~~g~ 87 (465)
-.||++. ..+|+.|++|+.... ....++..|...+..|....+. ..+ ......+.+.+.++++++|
T Consensus 36 N~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 4799997 468899999997543 2345688899999888743221 111 1222355677888888754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.78 E-value=0.0024 Score=61.83 Aligned_cols=71 Identities=17% Similarity=0.092 Sum_probs=50.1
Q ss_pred EeeEeeeCceEEEEEEEcC-------CCcEEEEEEeecCCCCccHHHHHHHHHHHcCCCCCceeEEEeEeCcEEEEEEec
Q 012336 12 GRKIGSGSFGELYLGVNVQ-------TGEEVAVKLESVKTKHPQLHYESKLYMLLQGGTGVPHLKWFGVEGEYNVMVIDL 84 (465)
Q Consensus 12 ~~~LG~G~fG~Vyla~~~~-------~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (465)
++.|+.|-.=.+|++.... ..+.|.+++.......-...+|..+++.+....+.|.+..++.+ .+++++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4678888888999998542 34678888866333333567899999999877778887766542 467777
Q ss_pred cC
Q 012336 85 LG 86 (465)
Q Consensus 85 ~g 86 (465)
+.
T Consensus 123 i~ 124 (395)
T d1nw1a_ 123 IP 124 (395)
T ss_dssp CC
T ss_pred ec
Confidence 73
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.71 E-value=0.0021 Score=60.01 Aligned_cols=52 Identities=15% Similarity=0.134 Sum_probs=32.6
Q ss_pred eEEEeeEeeeCceEEEEEEEcCCCcEEEEEEeecCCCCccHHHHHHHHHHHcCC
Q 012336 9 FKLGRKIGSGSFGELYLGVNVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQGG 62 (465)
Q Consensus 9 y~l~~~LG~G~fG~Vyla~~~~~~~~vAvKi~~~~~~~~~~~~E~~il~~l~~~ 62 (465)
..-.+.|..|.--+.|++.. ++..+++|+.........+..|..++..|...
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred ceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence 34445566676778899874 34468999986554556778888888887743
|